PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Walker, GM; Neilson, A; Young, D; Raine, PAM				Walker, GM; Neilson, A; Young, D; Raine, PAM			Colour of bile vomiting in intestinal obstruction in the newborn: questionnaire study	BRITISH MEDICAL JOURNAL			English	Article							INFANTS	Objectives To identify the colour that different groups of observers thought represented bile in a newborn's vomit. Design Questionnaires displaying eight colours (pale yellow to dark green). Setting General practices in Glasgow, postnatal ward and level III special care baby unit in a university teaching hospital, and mother and toddler groups in Glasgow. Participants 47 general practitioners, 29 nurses on the baby unit, 48 midwives, and 41 mothers of babies and infants. Outcome measures Participants indicated which colour would represent bile in a baby's vomit. More than one colour could be chosen. Respondents were also asked to indicate one colour that was the best match for bile. Results When any colour could be chosen, 12 (25%) general practitioners, 1 (3%) nurse on the baby unit, 5 (10%) postnatal midwives, and 23 (56%) parents did not consider green an appropriate colour for a baby's vomit containing bile. Twenty three (49%) general practitioners, 7 (24%) neonatal nurses, 15 (31%) postnatal midwives, and 29 (71%) parents thought yellow was the best colour match. Conclusions There is little agreement about the colour of bile vomit in a newborn. It is more pertinent to ask parents about the colour of vomit rather than whether it contained bile. Many general practitioners and parents do not recognise green as an appropriate colour for bile in the vomit of newborns, which may delay surgical referral. Though yellow vomit does not exclude intestinal obstruction, the presence of green vomiting in a baby is a surgical emergency and requires expeditious referral.	Royal Hosp Sick Children, Dept Paediat Surg, Glasgow G3 8SJ, Lanark, Scotland; Univ Strathclyde, Dept Stat & Modelling Sci, Glasgow G1 1XH, Lanark, Scotland	University of Glasgow; University of Strathclyde	Walker, GM (corresponding author), Royal Hosp Sick Children, Dept Paediat Surg, Glasgow G3 8SJ, Lanark, Scotland.	gregorwalker@doctors.org.uk		Young, David/0000-0002-3652-0513				BONADIO W A, 1991, Pediatric Emergency Care, V7, P348, DOI 10.1097/00006565-199112000-00007; Godbole P, 2002, J PEDIATR SURG, V37, P909, DOI 10.1053/jpsu.2002.32909; Kimura K, 2000, AM FAM PHYSICIAN, V61, P2791; LILIEN LD, 1986, AM J DIS CHILD, V140, P662, DOI 10.1001/archpedi.1986.02140210060026; MORLEY CJ, 1991, PEDIATRICS, V88, P1119	5	19	20	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 10	2006	332	7554					1363	1365		10.1136/bmj.38859.614352.55	http://dx.doi.org/10.1136/bmj.38859.614352.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16737979	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000238587000017
J	Birkhead, J; Weston, C; Lowe, D				Birkhead, John; Weston, Clive; Lowe, Derek		MINAP Steering Grp	Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE CORONARY SYNDROMES; ELDERLY-PATIENTS; MANAGEMENT	Objective To examine process of care and outcome for patients admitted with acute myocardial infarction to hospitals in England and Wales in relation to type of consultant care and type of hospital. Design Observational study of 88 782 patients admitted with myocardial infarction during 2004-5, using records from the national audit of myocardial infarction project (MINAP) database. Outcome measures Use of reperfusion treatment and secondary prevention drugs, use of angiography, and 90 day mortality of patients admitted under the care of cardiologists and non-cardiologists in hospitals with and without facilities for coronary intervention. Findings 36% of patients were admitted under the care of a cardiologist and 20% to a hospital with coronary interventional facilities. Patients admitted under cardiologists had fewer comorbidities than other patients and were more likely to have reperfusion treatment (12 266/14 433 (85%) v 13 682/17 064 (80%)) and appropriate secondary prevention drugs. Overall, 27 431/79 374 (35%) of patients had angiography. Relatively more patients admitted to interventional hospitals (8167/14 661; 56%) than to other hospitals had angiography (19 264/64 713; 30%). The adjusted risk of death by 90 days for patients treated in interventional compared with non-interventional hospitals was 0.93 (95% confidence interval 0.82 to 1.06). The adjusted risk of death at 90 days for patients admitted under cardiologists compared with non-cardiologists was 0.86 (0.81 to 0.91). Conclusions Patients cared for by cardiologists had less comorbidity than other patients. They were more likely to receive proved treatments and angiography, and they had a lower adjusted 90 day mortality. Large differences existed in the use of angiography between interventional and non-interventional hospitals. These findings show wide variations in the management and outcome of patients with myocardial infarction in England and Wales.	Royal Coll Physicians, Clin Effectiveness & Evaluat Unit, London NW1 4LE, England; Northampton Gen Hosp, Northampton NN1 5BD, England; Singleton Hosp, Swansea SA2 8QA, W Glam, Wales	Royal College of Physicians; Singleton Hospital	Birkhead, J (corresponding author), Royal Coll Physicians, Clin Effectiveness & Evaluat Unit, London NW1 4LE, England.	john.birkhead@btinternet.com		Weston, Clive/0000-0002-8995-8199				Ayanian JZ, 1997, ARCH INTERN MED, V157, P2570, DOI 10.1001/archinte.157.22.2570; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Birkhead JS, 2004, HEART, V90, P1004, DOI 10.1136/hrt.2004.034470; BIRKHEAD JS, 2001, BASELINE SURVEY FACI; Birkhead JS, 2002, J CLIN EXCELLENCE, V4, P379; Block P, 2003, EUR HEART J, V24, P299, DOI 10.1016/S0195-668X(02)00474-8; BRAUNWALD E, ACC AHA 2002 GUIDELI; British Cardiac Soc Guidelines Med, 2001, HEART, V85, P133; Chen J, 2000, AM J MED, V108, P460, DOI 10.1016/S0002-9343(00)00331-4; Department of Health, 1997, NEW NHS MOD DEP; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Frances CD, 1999, ARCH INTERN MED, V159, P1429, DOI 10.1001/archinte.159.13.1429; Go AS, 2000, AM J MED, V108, P216, DOI 10.1016/S0002-9343(99)00430-1; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Kaul P, 2004, CIRCULATION, V110, P1754, DOI 10.1161/01.CIR.0000142671.06167.91; LEON DA, 1993, LANCET, V342, P479, DOI 10.1016/0140-6736(93)91599-H; Rickards A, 1999, HEART, V82, P18; *ROYAL COLL PHYS, MINAP DAT SET; Van de Werf F, 2005, BRIT MED J, V330, P441, DOI 10.1136/bmj.38335.390718.82; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8	21	60	60	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1306	1308B		10.1136/bmj.38849.440914.AE	http://dx.doi.org/10.1136/bmj.38849.440914.AE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16705004	Green Published, Bronze			2022-12-28	WOS:000238197000021
J	Crook, R; Prance, J; Thomas, KJ; Chorley, SJ; Farrer, I; Ritchie, DA; Pepper, M; Smith, CG				Crook, R.; Prance, J.; Thomas, K. J.; Chorley, S. J.; Farrer, I.; Ritchie, D. A.; Pepper, M.; Smith, C. G.			Conductance quantization at a half-integer plateau in a symmetric GaAs quantum wire	SCIENCE			English	Article							DIMENSIONAL ELECTRON-GAS; POINT CONTACTS; SPIN POLARIZATION; FERROMAGNETIC TRANSITION; CONSTRICTION; TEMPERATURE; FIELD	We present data from an induced gallium arsenide ( GaAs) quantum wire that exhibits an additional conductance plateau at 0.5(2e(2)/h), where e is the charge of an electron and h is Planck's constant, in zero magnetic field. The plateau was most pronounced when the potential landscape was tuned to be symmetric by using low-temperature scanning-probe techniques. Source-drain energy spectroscopy and temperature response support the hypothesis that the origin of the plateau is the spontaneous spin-polarization of the transport electrons: a ferromagnetic phase. Such devices may have applications in the field of spintronics to either generate or detect a spin-polarized current without the complications associated with external magnetic fields or magnetic materials.	Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Crook, R (corresponding author), Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge CB3 0HE, England.	rc230@cam.ac.uk	Farrer, Ian/A-7671-2009; Prance, Jonathan R/B-3536-2013; Ritchie, David/K-2206-2014	Farrer, Ian/0000-0002-3033-4306; Prance, Jonathan R/0000-0001-5009-383X; Ritchie, David/0000-0002-9844-8350	EPSRC [EP/D008506/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D008506/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ashok A, 2005, MOL SIMULAT, V31, P797, DOI 10.1080/08927020500283800; Bartosch L, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.092403; Bruus H, 2001, PHYSICA E, V10, P97, DOI 10.1016/S1386-9477(01)00061-3; BUTTIKER M, 1990, PHYS REV B, V41, P7906, DOI 10.1103/PhysRevB.41.7906; Cronenwett SM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.226805; Crook R, 2003, NATURE, V424, P751, DOI 10.1038/nature01841; Crook R, 2006, PHYSICA E, V34, P686, DOI 10.1016/j.physe.2006.03.061; Daul S, 1998, PHYS REV B, V58, P2635, DOI 10.1103/PhysRevB.58.2635; Gold A, 1996, PHIL MAG LETT, V74, P33, DOI 10.1080/095008396180533; Klironomos AD, 2006, EUROPHYS LETT, V74, P679, DOI 10.1209/epl/i2006-10024-x; Kristensen A, 2000, PHYS REV B, V62, P10950, DOI 10.1103/PhysRevB.62.10950; Nuttinck S, 2000, JPN J APPL PHYS 2, V39, pL655, DOI 10.1143/JJAP.39.L655; PATEL NK, 1991, PHYS REV B, V44, P13549, DOI 10.1103/PhysRevB.44.13549; Reilly DJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.246801; Reilly DJ, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.121311; Roche P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.116602; Thomas KJ, 1998, PHILOS MAG B, V77, P1213, DOI 10.1080/13642819808205012; Thomas KJ, 2002, PHYSICA E, V12, P708, DOI 10.1016/S1386-9477(01)00385-X; Thomas KJ, 1996, PHYS REV LETT, V77, P135, DOI 10.1103/PhysRevLett.77.135; Thomas KJ, 2000, PHYS REV B, V61, P13365, DOI 10.1103/PhysRevB.61.R13365; THORNTON TJ, 1986, PHYS REV LETT, V56, P1198, DOI 10.1103/PhysRevLett.56.1198; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; Wang CK, 1998, PHYS REV B, V57, P4552, DOI 10.1103/PhysRevB.57.4552; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Yang K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.066401; [No title captured]	26	79	81	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1359	1362		10.1126/science.1126445	http://dx.doi.org/10.1126/science.1126445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741116				2022-12-28	WOS:000237961600049
J	Ferner, RE; McDowell, SE				Ferner, R. E.; McDowell, Sarah E.			How NICE may be outflanked	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHARMACEUTICAL-INDUSTRY; MONOCLONAL-ANTIBODY; METASTATIC BREAST; ASSOCIATION; GUIDANCE; DRUGS		City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England	University of Birmingham	Ferner, RE (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England.	r.e.lerner@bham.ac.uk	McDowell, Sarah/G-9230-2011	McDowell, Sarah/0000-0003-0979-3679; Ferner, Robin/0000-0003-3769-1346				*AB INT, NICE GUID IMPL TRACK; *ACT ALZH DRUGS AL, DRUG TREATM WHICH HE; *ALZH DIS INT, NICE GUID DEM DRUGS; *ALZH SOC, DRUGS TREATM ALZH DI; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; *BREAKTHR BREAST C, BREAKTHR COMM AM ROG; *BREAKTHR BREAST C, OUR PARTN; *BREAST CANC CAR, FULL SUPP LIST; *DEP HLTH, 2005, HEW FAST TRACKS CANC; *DIAB UK, GUID PUBL US INH INS; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Ferner RE, 1996, BRIT MED J, V313, P1157, DOI 10.1136/bmj.313.7066.1157; Foot B, 2004, J PUBLIC HEALTH, V26, P52, DOI 10.1093/pubmed/fdh112; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; *HC, QUEST OR WRITT ANSW; *HC HLTH COMM, 2005, 4 HOUS COMM HLTH COM; *HELP AG, THANK YOU; Herxheimer A, 2003, BRIT MED J, V326, P1208, DOI 10.1136/bmj.326.7400.1208; HEWITT P, 2005, COMMUNICATION   1025; *HLTH SOC CAR INF, 2004, HOSP PRESCR; JEFFRIES M, 2005, PHARM MARKETING; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; *LINK PHARM, NIC POIS DEN BRAIN T; Maynard A, 2006, BMJ-BRIT MED J, V332, P906, DOI 10.1136/bmj.332.7546.906; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; *NAT OST SOC, NAT OST SOC CRIT NIC; *NICE, CLIN EFF COST UT PHO; *NICE, DRAFT SCOP MAC DEG A; *NICE, DEV NICE TECHN APPR; OLIVER S, 1995, MAIL SUNDAY LON 0924, P1; *PAT VIEW, 2004, HLTH SOC CAMP NEWS; *PFIZ LTD, SAD DAY PAT NICE DEC; Raftery J, 2006, BRIT MED J, V332, P1266, DOI 10.1136/bmj.332.7552.1266; RAYNER C, 2005, DAILY MAIL LOND 1006, P6; REVILL J, 2005, OBSERVER        0313, P2; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; *SHIR PLC, NICE REQ DAT SUBGR A; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SPINK J, 2001, COMMUNIQUE; STEVEN S, 2001, MAIL SUNDAY     0812, P51; STUTTAFORD T, 2006, TIMES           0130, P11; WOMEN FIGHTING HERCE; 2001, MANCHESTER EVEN 0825, P1; 2001, EXPRESS         0316, P4; GENENTECH STUDY PUBL; 2001, MANCHESTER EVEN 1018, P2; 2001, MANCHESTER EVEN 0825, P2; SHROPSHIRE 6	50	36	36	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2006	332	7552					1268	1271		10.1136/bmj.332.7552.1268	http://dx.doi.org/10.1136/bmj.332.7552.1268			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16735342	Green Published			2022-12-28	WOS:000237984100025
J	Dalton, WS; Friend, SH				Dalton, William S.; Friend, Stephen H.			Cancer biomarkers - An invitation to the table	SCIENCE			English	Editorial Material							DISCOVERY; CHEMOTHERAPY; PACLITAXEL; SIGNATURE; OPINION		Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33613 USA; Merck Res Labs, West Point, PA 19486 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Merck & Company	Friend, SH (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33613 USA.	stephen_friend@merck.com						*AM CANC SOC, CANC STAT 2005; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Baker SG, 2006, CLIN TRIALS, V3, P43, DOI 10.1191/1740774506cn130oa; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Foekens JA, 2006, J CLIN ONCOL, V24, P1665, DOI 10.1200/JCO.2005.03.9115; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hernandez, 2005, IMPLICATIONS GENOMIC; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Naughton John, 2001, BRIEF HIST FUTURE RA; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; RUSSO E, 2006, FDA NCI CMS ANNOUNCE; SIMON R, 2006, PHARMACOGENOMIC 0117, DOI DOI 10.1038/SJ.TPJ.6500349; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wagner P, 2005, CELL CYCLE, V4, P1149, DOI 10.4161/cc.4.9.2038; Whetzel PL, 2006, BIOINFORMATICS, V22, P866, DOI 10.1093/bioinformatics/btl005	23	158	171	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1165	1168		10.1126/science.1125948	http://dx.doi.org/10.1126/science.1125948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728629				2022-12-28	WOS:000237957400039
J	Dimiduk, DM; Woodward, C; LeSar, R; Uchic, MD				Dimiduk, Dennis M.; Woodward, Chris; LeSar, Richard; Uchic, Michael D.			Scale-free intermittent flow in crystal plasticity	SCIENCE			English	Article							DISLOCATION AVALANCHES; SIZE; DEFORMATION; DYNAMICS; BEHAVIOR	Under stress, crystals irreversibly deform through complex dislocation processes that intermittently change the microscopic material shape through isolated slip events. These underlying processes can be revealed in the statistics of the discrete changes. Through ultraprecise nanoscale measurements on nickel microcrystals, we directly determined the size of discrete slip events. The sizes ranged over nearly three orders of magnitude and exhibited a shock-and-aftershock, earthquake-like behavior over time. Analysis of the events reveals power-law scaling between the number of events and their magnitude, or scale-free flow. We show that dislocated crystals are a model system for studying scale-free behavior as observed in many macroscopic systems. In analogy to plate tectonics, smooth macroscopic-scale crystalline glide arises from the spatial and time averages of disruptive earthquake-like events at the nanometer scale.	USAF, Res Lab, Mat & Mfg Directorate, AFRL MLLM, Wright Patterson AFB, OH 45433 USA; Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory; Northwestern University; United States Department of Energy (DOE); Los Alamos National Laboratory	Dimiduk, DM (corresponding author), USAF, Res Lab, Mat & Mfg Directorate, AFRL MLLM, Wright Patterson AFB, OH 45433 USA.	dennis.dimiduk@wpafb.af.mil	LeSar, Richard A/G-1609-2012	LeSar, Richard/0000-0002-8780-935X				BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Cottrell AH, 2002, DISLOCATIONS IN SOLIDS, VOL 11, pVII, DOI 10.1016/S1572-4859(02)80002-X; Dimiduk DM, 2005, ACTA MATER, V53, P4065, DOI 10.1016/j.actamat.2005.05.023; Ewing JA, 1900, PHILOS T R SOC LOND, V193, P353, DOI 10.1098/rsta.1900.0011; GILMAN JJ, 1969, MICROMECHANICS FLOW, P185; GILSEVILLANO J, 1993, MAT SCI TECHNOLOGY, V6, P19; Groma I, 2003, ACTA MATER, V51, P1271, DOI 10.1016/S1359-6454(02)00517-7; Gumbsch P, 2003, SCIENCE, V301, P1857, DOI 10.1126/science.1090482; Koslowski M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.265503; Koslowski M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.125502; Lebyodkin MA, 2005, ACTA MATER, V53, P3403, DOI 10.1016/j.actamat.2005.03.042; Madec R, 2003, SCIENCE, V301, P1879, DOI 10.1126/science.1085477; MADER S, 1963, ELECTRON MICROS, P183; Miguel MC, 2005, MAT SCI ENG A-STRUCT, V400, P191, DOI 10.1016/j.msea.2005.03.067; Miguel MC, 2001, NATURE, V410, P667, DOI 10.1038/35070524; NADGORNY E, 1988, PROGR MAT SCI, V31, P434; Neuhauser H., 1983, Dislocations in solids. Vol.6. Applications and recent advances, P319; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; POND RB, 1973, INHOMOGENEITY PLASTI, P1; Portevin A., 1923, CR HEBD ACAD SCI, V176, P507; Richeton T, 2005, ACTA MATER, V53, P4463, DOI 10.1016/j.actamat.2005.06.007; Richeton T, 2005, NAT MATER, V4, P465, DOI 10.1038/nmat1393; Sammonds P, 2005, NAT MATER, V4, P425, DOI 10.1038/nmat1405; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Uchic MD, 2005, MAT SCI ENG A-STRUCT, V400, P268, DOI 10.1016/j.msea.2005.03.082; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; Weiss J, 2003, SCIENCE, V299, P89, DOI 10.1126/science.1079312; Weiss J, 1997, J PHYS CHEM B, V101, P6113, DOI 10.1021/jp963157f; Zaiser M, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/08/P08004; Zaiser M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.195507	30	454	460	4	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1188	1190		10.1126/science.1123889	http://dx.doi.org/10.1126/science.1123889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728635				2022-12-28	WOS:000237957400046
J	Vierimaa, O; Georgitsi, M; Lehtonen, R; Vahteristo, P; Kokko, A; Raitila, A; Tuppurainen, K; Ebeling, TML; Salmela, PI; Paschke, R; Gundogdu, S; De Menis, E; Makinen, MJ; Launonen, V; Karhu, A; Aaltonen, LA				Vierimaa, Outi; Georgitsi, Marianthi; Lehtonen, Rainer; Vahteristo, Pia; Kokko, Antti; Raitila, Anniina; Tuppurainen, Karoliina; Ebeling, Tapani M. L.; Salmela, Pasi I.; Paschke, Ralf; Gundogdu, Sadi; De Menis, Ernesto; Makinen, Markus J.; Launonen, Virpi; Karhu, Auli; Aaltonen, Lauri A.			Pituitary adenoma predisposition caused by germline mutations in the AIP gene	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; ISOLATED FAMILIAL SOMATOTROPINOMA; ENDOCRINE NEOPLASIA TYPE-1; CHROMOSOME 11Q13; CORE COMPLEX; PROTEIN; XAP2; TUMORS; AHR	Pituitary adenomas are common in the general population, and understanding their molecular basis is of great interest. Combining chip-based technologies with genealogy data, we identified germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene in individuals with pituitary adenoma predisposition (PAP). AIP acts in cytoplasmic retention of the latent form of the aryl hydrocarbon receptor and also has other functions. In a population-based series from Northern Finland, two AIP mutations account for 16% of all patients diagnosed with pituitary adenomas secreting growth hormone and for 40% of the subset of patients who were diagnosed when they were younger than 35 years of age. Typically, PAP patients do not display a strong family history of pituitary adenoma; thus, AIP is an example of a low-penetrance tumor susceptibility gene.	Univ Helsinki, Dept Med Genet, Mol & Canc Biol Res Program, Helsinki 00014, Finland; Oulu Univ Hosp, Dept Clin Genet, Oulu 90029, Finland; Oulu Univ Hosp, Dept Internal Med, Oulu 90029, Finland; Univ Oulu, Dept Pathol, Oulu 90014, Finland; Univ Leipzig, Dept Med 3, D-04103 Leipzig, Germany; Istanbul Univ, Cerrahpasa Med Fac, Div Endocrinol Metab & Diabet, TR-34303 Cerrahpasa, Turkey; Gen Hosp, Dept Internal Med, I-31100 Treviso, Italy	University of Helsinki; University of Oulu; University of Oulu; University of Oulu; Leipzig University; Istanbul University; Istanbul University - Cerrahpasa	Aaltonen, LA (corresponding author), Univ Helsinki, Dept Med Genet, Mol & Canc Biol Res Program, Helsinki 00014, Finland.	lauri.aaltonen@helsinki.fi	Aaltonen, Lauri/A-5375-2010	Aaltonen, Lauri/0000-0001-6839-4286; Stefanius, Karoliina/0000-0002-9456-1954; Ebeling, Tapani/0000-0003-0323-8893; Karhu, Auli/0000-0002-7927-0796; Kuismin, Outi/0000-0002-0157-8985; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Georgitsi, Marianthi/0000-0002-0354-0913				Ackermann F, 1999, EXP CLIN ENDOCR DIAB, V107, P93, DOI 10.1055/s-0029-1212081; Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; BENLIAN P, 1995, EUR J ENDOCRINOL, V133, P451, DOI 10.1530/eje.0.1330451; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; Carver LA, 1997, J BIOL CHEM, V272, P11452; Daly AF, 2005, HORM METAB RES, V37, P347, DOI 10.1055/s-2005-870135; De Menis Ernesto, 2002, Pituitary, V5, P11; Frohman LA, 2004, GROWTH HORM IGF RES, V14, pS90, DOI 10.1016/j.ghir.2004.03.021; Gadelha MR, 1999, J CLIN ENDOCR METAB, V84, P249, DOI 10.1210/jc.84.1.249; Gadelha MR, 2000, J CLIN ENDOCR METAB, V85, P707, DOI 10.1210/jc.85.2.707; Heaney AP, 2004, NAT REV CANCER, V4, P285, DOI 10.1038/nrc1320; Kauppinen-Makelin R, 2005, J CLIN ENDOCR METAB, V90, P4081, DOI 10.1210/jc.2004-1381; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Luccio-Camelo DC, 2004, EUR J ENDOCRINOL, V150, P643, DOI 10.1530/eje.0.1500643; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; Pollenz RS, 2005, J BIOL CHEM, V280, P33346, DOI 10.1074/jbc.M506619200; Riss D, 2003, CANCER RES, V63, P2251; Soares Beatriz Santana, 2004, Pituitary, V7, P95, DOI 10.1007/s11102-005-0-04-0; Soares BS, 2005, J CLIN ENDOCR METAB, V90, P6580, DOI 10.1210/jc.2005-1478; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Tanaka C, 1998, J CLIN ENDOCR METAB, V83, P960, DOI 10.1210/jc.83.3.960; THAKKER RV, 1993, J CLIN INVEST, V91, P2815, DOI 10.1172/JCI116524; Verloes A, 1999, Pituitary, V1, P273, DOI 10.1023/A:1009958510378; Yamada S, 1997, J CLIN ENDOCR METAB, V82, P239, DOI 10.1210/jc.82.1.239	26	407	424	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1228	1230		10.1126/science.1126100	http://dx.doi.org/10.1126/science.1126100			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728643				2022-12-28	WOS:000237957400058
J	Clinton, HR; Obama, B				Clinton, Hillary Rodharn; Obama, Barack			Making patient safety the centerpiece of medical liability reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Kohn KT, 2000, ERR IS HUMAN BUILDIN; Liebman CB, 2004, HEALTH AFFAIR, V23, P22, DOI 10.1377/hlthaff.23.4.22; MARINER WK, 2001, HLTH POLICY FOR 1106, P1; Sage WM, 2003, HEALTH AFFAIR, V22, P26, DOI 10.1377/hlthaff.22.4.26; Thorpe KE, 2004, HLTH AFF MILLWOOD S	5	120	125	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2205	2208		10.1056/NEJMp068100	http://dx.doi.org/10.1056/NEJMp068100			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045RF	16723612				2022-12-28	WOS:000237758900001
J	Rassoulzadegan, M; Grandjean, V; Gounon, P; Vincent, S; Gillot, I; Cuzin, F				Rassoulzadegan, Minoo; Grandjean, Valerie; Gounon, Pierre; Vincent, Stephane; Gillot, Isabelle; Cuzin, Francois			RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse	NATURE			English	Article							C-KIT; EXPRESSION; LOCUS; METHYLATION; MUTATIONS; PATTERNS	Paramutation is a heritable epigenetic modification induced in plants by cross-talk between allelic loci. Here we report a similar modification of the mouse Kit gene in the progeny of heterozygotes with the null mutant Kit(tm1Alf) (a lacZ insertion). In spite of a homozygous wild-type genotype, their offspring maintain, to a variable extent, the white spots characteristic of Kit mutant animals. Efficiently inherited from either male or female parents, the modified phenotype results from a decrease in Kit messenger RNA levels with the accumulation of non-polyadenylated RNA molecules of abnormal sizes. Sustained transcriptional activity at the postmeiotic stages-at which time the gene is normally silent leads to the accumulation of RNA in spermatozoa. Microinjection into fertilized eggs either of total RNA from Kit(tm1Alf/+) heterozygotes or of Kit-specific microRNAs induced a heritable white tail phenotype. Our results identify an unexpected mode of epigenetic inheritance associated with the zygotic transfer of RNA molecules.	INSERM, U636, F-06108 Nice, France; Univ Nice, Lab Genet Dev Normal & Pathol, F-06108 Nice, France; Univ Nice, Ctr Commun Microscopie Appl, F-06108 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Rassoulzadegan, M (corresponding author), INSERM, U636, F-06108 Nice, France.	minoo@unice.fr	Vincent, Stéphane D/M-2046-2013; Rassoulzadegan, Minoo/O-7939-2016; Grandjean, Valerie/O-3935-2016	Vincent, Stéphane D/0000-0003-1638-9615; Valerie, GRANDJEAN/0000-0003-1661-7411				Albanesi C, 1996, DEVELOPMENT, V122, P1291; Bernex F, 1996, DEVELOPMENT, V122, P3023; BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Biggiogera M, 1998, J HISTOCHEM CYTOCHEM, V46, P389, DOI 10.1177/002215549804600313; BRINK RA, 1956, GENETICS, V41, P872; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; Darzynkiewicz Z, 1990, Methods Cell Biol, V33, P285; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Hogan B, 1994, MANIPULATING MOUSE E; Kluppel M, 1997, DEVELOPMENT, V124, P65; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; MANOVA K, 1990, DEVELOPMENT, V110, P1057; MOTRO B, 1991, DEVELOPMENT, V113, P1207; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Sage J, 1999, MECH DEVELOP, V80, P29, DOI 10.1016/S0925-4773(98)00191-9; Sambrook J., 2001, MOL CLONING LAB MANU; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; SORRENTINO V, 1991, ONCOGENE, V6, P149; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Vincent S, 1998, DEVELOPMENT, V125, P4585; YASUDA H, 1993, BIOCHEM BIOPH RES CO, V191, P893, DOI 10.1006/bbrc.1993.1301	28	636	691	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					469	474		10.1038/nature04674	http://dx.doi.org/10.1038/nature04674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724059	Green Submitted			2022-12-28	WOS:000237778900041
J	Matthews, PGD; Seymour, RS				Matthews, PGD; Seymour, RS			Diving insects boost their buoyancy bubbles	NATURE			English	Article							ANISOPS; NOTONECTIDAE; HAEMOGLOBIN; HEMIPTERA		Univ Adelaide, Adelaide, SA, Australia	University of Adelaide	Matthews, PGD (corresponding author), Univ Adelaide, Adelaide, SA, Australia.	philip.matthews@adelaide.edu.au	Seymour, Roger/C-3469-2009	Seymour, Roger/0000-0002-3395-0059				BARE CO, 1929, U KANSAS SCI B, V18, P265; EGE R, 1915, Z ALLG PHYSL, V17, P81; MILLER PL, 1964, NATURE, V201, P1052, DOI 10.1038/2011052a0; MILLER PL, 1966, J EXP BIOL, V44, P529; THORPE WH, 1947, J EXP BIOL, V24, P227; WELLS RMG, 1981, J COMP PHYSIOL, V142, P515, DOI 10.1007/BF00688984	6	35	35	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2006	441	7090					171	171		10.1038/441171a	http://dx.doi.org/10.1038/441171a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688167	Bronze			2022-12-28	WOS:000237418800034
J	Namy, O; Moran, SJ; Stuart, DI; Gilbert, RJC; Brierley, I				Namy, O; Moran, SJ; Stuart, DI; Gilbert, RJC; Brierley, I			A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting	NATURE			English	Article							ELECTRON-DENSITY MAPS; MESSENGER-RNA; GENE-EXPRESSION; 80S RIBOSOME; SIGNAL; TRANSLOCATION; MICROSCOPY	The triplet-based genetic code requires that translating ribosomes maintain the reading frame of a messenger RNA faithfully to ensure correct protein synthesis(1). However, in programmed -1 ribosomal frameshifting(2), a specific subversion of frame maintenance takes place, wherein the ribosome is forced to shift one nucleotide backwards into an overlapping reading frame and to translate an entirely new sequence of amino acids. This process is indispensable in the replication of numerous viral pathogens, including HIV and the coronavirus associated with severe acute respiratory syndrome(3), and is also exploited in the expression of several cellular genes(4). Frameshifting is promoted by an mRNA signal composed of two essential elements: a heptanucleotide 'slippery' sequence(5) and an adjacent mRNA secondary structure, most often an mRNA pseudoknot(6). How these components operate together to manipulate the ribosome is unknown. Here we describe the observation of a ribosome - mRNA pseudoknot complex that is stalled in the process of -1 frameshifting. Cryoelectron microscopic imaging of purified mammalian 80S ribosomes from rabbit reticulocytes paused at a coronavirus pseudoknot reveals an intermediate of the frameshifting process. From this it can be seen how the pseudoknot interacts with the ribosome to block the mRNA entrance channel, compromising the translocation process and leading to a spring-like deformation of the P-site transfer RNA. In addition, we identify movements of the likely eukaryotic ribosomal helicase and confirm a direct interaction between the translocase eEF2 and the P-site tRNA. Together, the structural changes provide a mechanical explanation of how the pseudoknot manipulates the ribosome into a different reading frame.	Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, Cent Chem Lab, Oxford Ctr Mol Sci, Oxford OX1 3QH, England	University of Cambridge; University of Oxford; University of Oxford	Brierley, I (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Tennis Court Rd, Cambridge CB2 1QP, England.	gilbert@strubi.ox.ac.uk; ib103@mole.bio.cam.ac.uk	Namy, olivier/B-8906-2008	Stuart, David/0000-0002-3426-4210; Namy, Olivier/0000-0002-1143-5961	BBSRC [BB/D013305/1, BB/D009499/1] Funding Source: UKRI; MRC [G0500365] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009499/1, BB/D013305/1] Funding Source: Medline; Medical Research Council [G0500365] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Atkins JF, 2001, COLD SPRING HARB SYM, V66, P217, DOI 10.1101/sqb.2001.66.217; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; BRIERLEY I, 2005, VIRUS RES       1128; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Kontos H, 2001, MOL CELL BIOL, V21, P8657, DOI 10.1128/MCB.21.24.8657-8670.2001; Lopinski JD, 2000, MOL CELL BIOL, V20, P1095, DOI 10.1128/MCB.20.4.1095-1103.2000; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; SOMOGYI P, 1993, MOL CELL BIOL, V13, P6931, DOI 10.1128/MCB.13.11.6931; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; TU CL, 1992, P NATL ACAD SCI USA, V89, P8636, DOI 10.1073/pnas.89.18.8636; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WEISS R B, 1989, New Biologist, V1, P159; YELVERTON E, 1994, MOL MICROBIOL, V11, P303, DOI 10.1111/j.1365-2958.1994.tb00310.x; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	29	211	217	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					244	247		10.1038/nature04735	http://dx.doi.org/10.1038/nature04735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688178	Green Published, Bronze			2022-12-28	WOS:000237418800052
J	Studdert, DM; Mello, MM; Gawande, AA; Gandhi, TK; Kachalia, A; Yoon, C; Puopolo, AL; Brennan, TA				Studdert, DM; Mello, MM; Gawande, AA; Gandhi, TK; Kachalia, A; Yoon, C; Puopolo, AL; Brennan, TA			Claims, errors, and compensation payments in medical malpractice litigation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVERSE EVENTS; CARE; NEGLIGENT; STANDARD; RESOLUTION; INJURIES; UTAH	BACKGROUND: In the current debate over tort reform, critics of the medical malpractice system charge that frivolous litigation -- claims that lack evidence of injury, substandard care, or both -- is common and costly. METHODS: Trained physicians reviewed a random sample of 1452 closed malpractice claims from five liability insurers to determine whether a medical injury had occurred and, if so, whether it was due to medical error. We analyzed the prevalence, characteristics, litigation outcomes, and costs of claims that lacked evidence of error. RESULTS: For 3 percent of the claims, there were no verifiable medical injuries, and 37 percent did not involve errors. Most of the claims that were not associated with errors (370 of 515 [72 percent]) or injuries (31 of 37 [84 percent]) did not result in compensation; most that involved injuries due to error did (653 of 889 [73 percent]). Payment of claims not involving errors occurred less frequently than did the converse form of inaccuracy -- nonpayment of claims associated with errors. When claims not involving errors were compensated, payments were significantly lower on average than were payments for claims involving errors ($313,205 vs. $521,560, P=0.004). Overall, claims not involving errors accounted for 13 to 16 percent of the system's total monetary costs. For every dollar spent on compensation, 54 cents went to administrative expenses (including those involving lawyers, experts, and courts). Claims involving errors accounted for 78 percent of total administrative costs. CONCLUSIONS: Claims that lack evidence of error are not uncommon, but most are denied compensation. The vast majority of expenditures go toward litigation over errors and payment of them. The overhead costs of malpractice litigation are exorbitant.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Harvard Risk Management Fdn, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Brigham & Women's Hospital	Studdert, DM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	studdert@hsph.harvard.edu	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Mello, Michelle/0000-0003-2877-4270; Gawande, Atul/0000-0002-1824-9176	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011886, K02HS011285] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BAKER P, 2005, WASHINGTON POST 0106, pA6; Baker T, 2005, J LAW MED ETHICS, V33, P501, DOI 10.1111/j.1748-720X.2005.tb00514.x; Baker T., 2005, MED MALPRACTICE MYTH; BOYLE LV, 2002, TRUTH MED MALPRACTIC; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; CHANDRA A, 2005, HLTH AFF S MILLWOOD; CHENEY FW, 1989, JAMA-J AM MED ASSOC, V261, P1599, DOI 10.1001/jama.261.11.1599; DAO J, 2005, NY TIMES        0114, pA1; FARBER HS, 1994, J LEGAL STUD, V23, P777, DOI 10.1086/467945; Hagihara A, 2003, HEALTH POLICY, V65, P119, DOI 10.1016/S0168-8510(02)00214-2; IPP DA, 2002, MACINTOSH, V1; JOHNSON WG, 1992, JAMA-J AM MED ASSOC, V267, P2487, DOI 10.1001/jama.267.18.2487; Kohn KT, 2000, ERR IS HUMAN BUILDIN; LaBine SJ, 1996, LAW HUMAN BEHAV, V20, P501, DOI 10.1007/BF01499038; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; M Sowka, 1980, NATL ASS INSURANCE C; *NAT HLTH SERV, 2003, MAK AM CONS PAP SETT; National Practitioner Data Bank, PUBL US DAT FIL; Phillips RL, 2004, QUAL SAF HEALTH CARE, V13, P121, DOI 10.1136/qshc.2003.008029; *PHYS INS ASS AM, 2000, DAT SHAR REP 2000; Posner R., 1987, EC STRUCTURE TORT LA; Sieg H, 2000, J POLIT ECON, V108, P1006, DOI 10.1086/317677; SLOAN FA, 1990, LAW SOC REV, V24, P997, DOI 10.2307/3053617; Sloan Frank A., 1993, SUING MED MALPRACTIC; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Studdert DM, 2004, NEW ENGL J MED, V350, P283, DOI 10.1056/NEJMhpr035470; Studdert DM, 2000, MED CARE, V38, P250, DOI 10.1097/00005650-200003000-00002; STUDDERT DM, 2000, INDIANA LAW REV, V33, P1643; TARAGIN MI, 1992, ANN INTERN MED, V117, P780, DOI 10.7326/0003-4819-117-9-780; Thomas EJ, 1999, INQUIRY-J HEALTH CAR, V36, P255; VIDMAR N, 1995, MED MALPRACTICE AM J; WEILER PC, 1991, MED MALPRACTICE TRIA; Weiler PC, 1993, MEASURE MALPRACTICE; 1990, BLACKS LAW DICT DEFI	36	550	559	1	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2024	2033		10.1056/NEJMsa054479	http://dx.doi.org/10.1056/NEJMsa054479			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040XA	16687715				2022-12-28	WOS:000237413100007
J	Bossuyt, PM; Irwig, L; Craig, J; Glasziou, P				Bossuyt, PM; Irwig, L; Craig, J; Glasziou, P			Diagnosis - Comparative accuracy: assessing new tests against existing diagnostic pathways	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL TESTS		Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 DE Amsterdam, Netherlands; Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; Univ Sydney, Childrens Hosp Westmead, Sch Publ Hlth, Dept Nephrol,Screening & Test Evaluat Program, Sydney, NSW, Australia; Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Sydney; University of Sydney; University of Oxford	Bossuyt, PM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 DE Amsterdam, Netherlands.	p.m.bossuyt@amc.uva.nl	Bossuyt, Patrick M/AAR-1183-2021; Glasziou, Paul/A-7832-2008; Bossuyt, Patrick M./B-4557-2016; Craig, Jonathan/E-2813-2013	Bossuyt, Patrick M/0000-0003-4427-0128; Glasziou, Paul/0000-0001-7564-073X; Bossuyt, Patrick M./0000-0003-4427-0128; Craig, Jonathan/0000-0002-2548-4035				Alonzo TA, 2002, STAT MED, V21, P835, DOI 10.1002/sim.1058; Arroll B, 2005, BRIT MED J, V331, P884, DOI 10.1136/bmj.38607.464537.7C; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bossuyt PMM, 2000, LANCET, V356, P1844, DOI 10.1016/S0140-6736(00)03246-3; Bruns DE, 2001, CLIN CHEM, V47, P1547; Chock C, 1997, J CLIN EPIDEMIOL, V50, P1211, DOI 10.1016/S0895-4356(97)00122-4; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; IRWIG L, 2002, BRIT MED J, V324, P69; Knottnerus JA, 2002, BMJ-BRIT MED J, V324, P477, DOI 10.1136/bmj.324.7335.477; Macaskill P, 2002, STAT MED, V21, P2527, DOI 10.1002/sim.1227; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; Pepe M. S., 2003, STAT EVALUATION MED; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	16	274	282	2	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 6	2006	332	7549					1089	1092		10.1136/bmj.332.7549.1089	http://dx.doi.org/10.1136/bmj.332.7549.1089			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16675820	Green Published, Green Submitted			2022-12-28	WOS:000237518400025
J	Hardin, PE; Yu, W				Hardin, PE; Yu, W			Circadian transcription: Passing the HAT to CLOCK	CELL			English	Editorial Material							HISTONE ACETYLATION; BINDING		Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Texas A&M Univ, Ctr Res Biol Clocks, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Hardin, PE (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	phardin@mail.bio.tamu.edu		Hardin, Paul/0000-0002-3370-9011				Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Doi M., 2006, CELL; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406	10	28	31	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 5	2006	125	3					424	426		10.1016/j.cell.2006.04.010	http://dx.doi.org/10.1016/j.cell.2006.04.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678086	Bronze			2022-12-28	WOS:000237506100006
J	Wells, CD; Fawcett, JP; Traweger, A; Yamanaka, Y; Goudreault, M; Elder, K; Kulkarni, S; Gish, G; Virag, C; Lim, C; Colwill, K; Starostine, A; Metalnikov, P; Pawson, T				Wells, Clark D.; Fawcett, James P.; Traweger, Andreas; Yamanaka, Yojiro; Goudreault, Marilyn; Elder, Kelly; Kulkarni, Sarang; Gish, Gerald; Virag, Cristina; Lim, Caesar; Colwill, Karen; Starostine, Andrei; Metalnikov, Pavel; Pawson, Tony			A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells	CELL			English	Article							TIGHT JUNCTION FORMATION; SACCHAROMYCES-CEREVISIAE; DOWN-REGULATION; MEMBRANE; BINDING; DOMAIN; ANGIOMOTIN; RAC1; INTERACTS; FAMILY	Using functional and proteomic screens of proteins that regulate the Cdc42 GTPase, we have identified a network of protein interactions that center around the Cdc42 RhoGAP Rich1 and organize apical polarity in MDCK epithelial cells. Rich1 binds the scaffolding protein angiomotin (Amot) and is thereby targeted to a protein complex at tight junctions (TJs) containing the PDZ-domain proteins Pals1, Patj, and Par-3. Regulation of Cdc42 by Rich1 is necessary for maintenance of TJs, and Rich1 is therefore an important mediator of this polarity complex. Furthermore, the coiled-coil domain of Amot, with which it binds Rich1, is necessary for localization to apical membranes and is required for Amot to relocalize Pals1 and Par-3 to internal puncta. We propose that Rich1 and Amot maintain TJ integrity by the coordinate regulation of Cdc42 and by linking specific components of the TJ to intracellular protein trafficking.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.	pawson@mshri.on.ca	Pawson, Tony J/E-4578-2013; Traweger, Andreas/M-1460-2015; Colwill, Karen/K-5101-2012; Gish, Gerald D/C-7228-2017	Colwill, Karen/0000-0002-8979-1659; Metalnikov, Pavel/0000-0003-3261-4421; Yamanaka, Yojiro/0000-0003-1483-8691; Traweger, Andreas/0000-0002-0220-4766; Fawcett, Jim/0000-0003-0043-2164				Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Fogg VC, 2005, J CELL SCI, V118, P2859, DOI 10.1242/jcs.02412; Garrard SM, 2003, EMBO J, V22, P1125, DOI 10.1093/emboj/cdg110; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Levchenko T, 2004, ONCOGENE, V23, P1469, DOI 10.1038/sj.onc.1207264; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Moreau J, 2005, GENE, V350, P137, DOI 10.1016/j.gene.2005.02.001; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; Navarro P, 1997, BBA-PROTEIN STRUCT M, V1343, P187, DOI 10.1016/S0167-4838(97)00108-8; Nishimura M, 2002, J BIOL CHEM, V277, P5583, DOI 10.1074/jbc.M110154200; NOBES C, 1994, CURR OPIN GENET DEV, V4, P77, DOI 10.1016/0959-437X(94)90094-9; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; Patrie KM, 2005, BBA-MOL CELL RES, V1745, P131, DOI 10.1016/j.bbamcr.2005.05.011; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Richnau N, 2004, BIOCHEM BIOPH RES CO, V320, P1034, DOI 10.1016/j.bbrc.2004.05.221; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Roh MH, 2003, AM J PHYSIOL-RENAL, V285, pF377, DOI 10.1152/ajprenal.00086.2003; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shimono A, 2003, CURR BIOL, V13, P613, DOI 10.1016/S0960-9822(03)00204-5; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	50	263	280	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					535	548		10.1016/j.cell.2006.02.045	http://dx.doi.org/10.1016/j.cell.2006.02.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678097	Bronze			2022-12-28	WOS:000237506100019
J	Perera, R				Perera, R			Commentary: Statistics and death from meningococcal disease in children	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Perera, R (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	rafael.perera@dphpc.ox.ac.uk		Perera, Rafael/0000-0003-2418-2091				CARTWRIGHT K, 1992, BMJ-BRIT MED J, V305, P143, DOI 10.1136/bmj.305.6846.143; Harnden A, 2006, BRIT MED J, V332, P1295, DOI 10.1136/bmj.38789.723611.55; JULIOUS SA, 1994, BRIT MED J, V309, P1480, DOI 10.1136/bmj.309.6967.1480; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4	5	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 3	2006	332	7553					1297	1298		10.1136/bmj.332.7553.1297	http://dx.doi.org/10.1136/bmj.332.7553.1297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16740556	Bronze, Green Published			2022-12-28	WOS:000238197000015
J	Bewley, GP; Lathrop, DP; Sreenivasan, KR				Bewley, Gregory P.; Lathrop, Daniel P.; Sreenivasan, Katepalli R.			Superfluid helium - Visualization of quantized vortices	NATURE			English	Article							LIQUID HELIUM; PARTICLES; FLOW		Univ Maryland, Dept Phys, Inst Res Elect & Appl Phys, Inst Phys Sci & Technol, College Pk, MD 20742 USA; Int Ctr Theoret Phys, I-34014 Trieste, Italy; Yale Univ, Dept Mech Engn, New Haven, CT 06520 USA	University System of Maryland; University of Maryland College Park; Abdus Salam International Centre for Theoretical Physics (ICTP); Yale University	Bewley, GP (corresponding author), Univ Maryland, Dept Phys, Inst Res Elect & Appl Phys, Inst Phys Sci & Technol, College Pk, MD 20742 USA.	dpl@complex.umd.edu	Bewley, Gregory P/E-1594-2017	Lathrop, Daniel/0000-0001-9282-3247				CHOPRA KL, 1957, PHYS REV, V108, P157, DOI 10.1103/PhysRev.108.157; CHUNG DY, 1965, PHYS REV LETT, V14, P892, DOI 10.1103/PhysRevLett.14.892; Donnelly R. J., 1991, QUANTIZED VORTICES H, V2; Feynman R. P., 1955, PROG LOW TEMP PHYS, V1, P17; MURAKAMI M, 1989, CRYOGENICS, V29, P438, DOI 10.1016/0011-2275(89)90276-2; PARKS PE, 1966, PHYS REV LETT, V16, P45, DOI 10.1103/PhysRevLett.16.45; Poole DR, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.064514; YARMCHUK EJ, 1979, PHYS REV LETT, V43, P214, DOI 10.1103/PhysRevLett.43.214; Zhang T, 2005, NAT PHYS, V1, P36, DOI 10.1038/nphys114; [No title captured]	10	284	288	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					588	588		10.1038/441588a	http://dx.doi.org/10.1038/441588a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738652	Bronze			2022-12-28	WOS:000237920800034
J	Jansen, TL; Spoorenberg, A				Jansen, TL; Spoorenberg, A			A medical mystery - Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Ctr Leeuwarden, NL-8934 AD Leeuwarden, Netherlands	Medical Center Leeuwarden	Jansen, TL (corresponding author), Med Ctr Leeuwarden, NL-8934 AD Leeuwarden, Netherlands.			Jansen, Tim L/0000-0003-3026-3154					0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2375	2375		10.1056/NEJMicm041004	http://dx.doi.org/10.1056/NEJMicm041004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738274				2022-12-28	WOS:000237918500010
J	Moran, K; Backman, J; Brinkhuis, H; Clemens, SC; Cronin, T; Dickens, GR; Eynaud, F; Gattacceca, J; Jakobsson, M; Jordan, RW; Kaminski, M; King, J; Koc, N; Krylov, A; Martinez, N; Matthiessen, J; McInroy, D; Moore, TC; Onodera, J; O'Regan, M; Palike, H; Rea, B; Rio, D; Sakamoto, T; Smith, DC; Stein, R; St John, K; Suto, I; Suzuki, N; Takahashi, K; Watanabe, M; Yamamoto, M; Farrell, J; Frank, M; Kubik, P; Jokat, W; Kristoffersen, Y				Moran, Kathryn; Backman, Jan; Brinkhuis, Henk; Clemens, Steven C.; Cronin, Thomas; Dickens, Gerald R.; Eynaud, Frederique; Gattacceca, Jerome; Jakobsson, Martin; Jordan, Richard W.; Kaminski, Michael; King, John; Koc, Nalan; Krylov, Alexey; Martinez, Nahysa; Matthiessen, Jens; McInroy, David; Moore, Theodore C.; Onodera, Jonaotaro; O'Regan, Matthew; Palike, Heiko; Rea, Brice; Rio, Domenico; Sakamoto, Tatsuhiko; Smith, David C.; Stein, Ruediger; St John, Kristen; Suto, Itsuki; Suzuki, Noritoshi; Takahashi, Kozo; Watanabe, Mahito; Yamamoto, Masanobu; Farrell, John; Frank, Martin; Kubik, Peter; Jokat, Wilfried; Kristoffersen, Yngve			The Cenozoic palaeoenvironment of the Arctic Ocean	NATURE			English	Article							THERMOHALINE CIRCULATION; SEDIMENTATION-RATES; GLACIATION	The history of the Arctic Ocean during the Cenozoic era ( 0 - 65 million years ago) is largely unknown from direct evidence. Here we present a Cenozoic palaeoceanographic record constructed from >400 m of sediment core from a recent drilling expedition to the Lomonosov ridge in the Arctic Ocean. Our record shows a palaeoenvironmental transition from a warm 'greenhouse' world, during the late Palaeocene and early Eocene epochs, to a colder 'icehouse' world influenced by sea ice and icebergs from the middle Eocene epoch to the present. For the most recent similar to 14 Myr, we find sedimentation rates of 1 - 2 cm per thousand years, in stark contrast to the substantially lower rates proposed in earlier studies; this record of the Neogene reveals cooling of the Arctic that was synchronous with the expansion of Greenland ice (similar to 3.2 Myr ago) and East Antarctic ice (similar to 14 Myr ago). We find evidence for the first occurrence of ice-rafted debris in the middle Eocene epoch (similar to 45 Myr ago), some 35 Myr earlier than previously thought; fresh surface waters were present at,49 Myr ago, before the onset of ice-rafted debris. Also, the temperatures of surface waters during the Palaeocene/Eocene thermal maximum (similar to 55 Myr ago) appear to have been substantially warmer than previously estimated. The revised timing of the earliest Arctic cooling events coincides with those from Antarctica, supporting arguments for bipolar symmetry in climate change.	Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; Univ Rhode Isl, Dept Ocean Engn, Narragansett, RI 02882 USA; Stockholm Univ, Dept Geol & Geochem, SE-10691 Stockholm, Sweden; Univ Utrecht, Dept Biol, Palaeobot & Palynol Lab, NL-3584 DC Utrecht, Netherlands; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; US Geol Survey, Reston, VA 20192 USA; Rice Univ, Dept Earth Sci, Houston, TX 77251 USA; Univ Bordeaux, Dept Geol & Oceanog, F-33405 Talence, France; CNRS, CEREGE, Dept Geophys, F-13545 Aix En Provence, France; Yamagata Univ, Dept Earth & Environm Sci, Yamagata 9908560, Japan; UCL, Dept Earth Sci, London WC1E 6BT, England; Norwegian Polar Res Inst, Polar Environm Ctr, N-9296 Tromso, Norway; VNIIOkeangeol, Dept Lithol & Geochem, St Petersburg 190121, Russia; Boston Univ, Boston, MA 02215 USA; Alfred Wegener Inst Fdn Polar & Marine Res, D-27515 Bremerhaven, Germany; British Geol Survey, Edinburgh EH9 3LA, Midlothian, Scotland; Univ Michigan, Ann Arbor, MI 48109 USA; Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan; Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Aberdeen, Dept Geog & Environm, Aberdeen AB24 3UF, Scotland; Univ Padua, Dept Geol Paleontol & Geophys, I-35137 Padua, Italy; JAMSTEC, IFREE, Yokosuka, Kanagawa 2370061, Japan; James Madison Univ, Dept Geol & Environm Sci, Harrisonburg, VA 22807 USA; Nagoya Univ, Dept Earth & Planetary Sci, Nagoya, Aichi 4648602, Japan; Tohoku Univ, Inst Geol & Palaeontol, Sendai, Miyagi 9808578, Japan; Geol Survey Japan, Inst Geosci, Ibaraki 3058567, Japan; Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; IFM GEOMAR, Leibniz Inst Marine Sci, D-24148 Kiel, Germany; ETH, Paul Scherrer Inst, CH-8093 Zurich, Switzerland; Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway	University of Rhode Island; University of Rhode Island; Stockholm University; Utrecht University; Brown University; United States Department of the Interior; United States Geological Survey; Rice University; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Yamagata University; University of London; University College London; Norwegian Polar Institute; Boston University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Michigan System; University of Michigan; Kyushu University; NERC National Oceanography Centre; University of Southampton; University of Aberdeen; University of Padua; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); James Madison University; Nagoya University; Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Swiss Federal Institutes of Technology Domain; ETH Zurich; Paul Scherrer Institute; University of Bergen	Moran, K (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	kate.moran@gso.uri.edu	Brinkhuis, Henk/B-4223-2009; Gattacceca, Jerome/AAG-5651-2019; O'Regan, Matt/P-6277-2019; O'Regan, Matt/B-2157-2010; Krylov, Alexey/R-4723-2019; Watanabe, Mahito/N-2494-2018; Krylov, Alexey A/J-4174-2014; Dickens, Gerald R/G-1222-2011; Yamamoto, Masanobu/A-6990-2012; Kaminski, Michael/K-3334-2012; Moore, Theodore/N-8848-2014; Palike, Heiko/A-6560-2008; Jakobsson, Martin/F-6214-2010; Smith, David/A-8309-2013	Gattacceca, Jerome/0000-0002-1639-7140; O'Regan, Matt/0000-0002-6046-1488; Krylov, Alexey/0000-0001-5539-9758; Watanabe, Mahito/0000-0002-7567-8954; Krylov, Alexey A/0000-0001-5539-9758; Yamamoto, Masanobu/0000-0003-1312-825X; Moore, Theodore/0000-0003-4121-1325; Palike, Heiko/0000-0003-3386-0923; Smith, David/0000-0003-0627-5788; Takahashi, Kozo/0000-0001-8660-4371; Jakobsson, Martin/0000-0002-9033-3559; Frank, Martin/0000-0002-8606-4421; Jokat, Wilfried/0000-0002-7793-5854; Rea, Brice/0000-0002-9928-145X; Kaminski, Michael A/0000-0002-7344-5874; Jordan, Richard/0000-0002-8997-7349; Dickens, Gerald/0000-0003-2869-4860; Eynaud, Frederique/0000-0003-1283-7425; Stein, Ruediger/0000-0002-4453-9564; Brinkhuis, Henk/0000-0003-0253-6610; Matthiessen, Jens/0000-0002-6952-2494; Onodera, Jonaotaro/0000-0001-6942-2285	Natural Environment Research Council [bgs03002] Funding Source: researchfish; NERC [bgs03002] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Backman J, 2004, QUATERNARY SCI REV, V23, P1435, DOI 10.1016/j.quascirev.2003.12.005; BACKMAN J, 1979, STOCKHOLM CONTRIB GE, V32, P115; BACKMAN J, 2001, JOIDES J, V27, P18; BACKMAN J, IN PRESS P IODP EXP; Backman J, 2005, SCI DRILL, V1, P12, DOI 10.5194/sd-1-12-2005; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; Clark D.L., 1980, GEOLOGICAL SOC AM SP, V181, P57, DOI DOI 10.1130/SPE181; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; Crouch EM, 2001, GEOLOGY, V29, P315, DOI 10.1130/0091-7613(2001)029<0315:GDEAWT>2.0.CO;2; Curry R, 2005, SCIENCE, V308, P1772, DOI 10.1126/science.1109477; Driscoll NW, 1998, SCIENCE, V282, P436, DOI 10.1126/science.282.5388.436; Einarsson T, 1967, BERING LAND BRIDGE, P312; FLOWER BP, 1993, PALEOCEANOGRAPHY, V8, P811, DOI 10.1029/93PA02196; Heezen B., 1961, GEOLOGY ARCTIC, V1, P622; Holland MM, 2001, J CLIMATE, V14, P656, DOI 10.1175/1520-0442(2001)014<0656:TROIOI>2.0.CO;2; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jakobsson M., 2000, EOS T AM GEOPHYS UN, V81, P89, DOI [DOI 10.1029/00EO00059, DOI 10.1130/G32153.1]; Jakobsson M, 2000, EOS T AGU, V81, P93, DOI DOI 10.1029/00E000059; Jansen E, 2000, PALEOCEANOGRAPHY, V15, P709, DOI 10.1029/1999PA000435; JOKAT W, 1992, GEOLOGY, V20, P887, DOI 10.1130/0091-7613(1992)020<0887:LRADSC>2.3.CO;2; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; Knox RWO, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P91; Kristoffersen Y, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000985; LARSEN HC, 1994, P ODP INIT REP, V152; LAWVER LA, 2002, SPEC PAP GEOL SOC AM, V360, P333; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Nowaczyk NR, 2001, PALEOCEANOGRAPHY, V16, P368, DOI 10.1029/2000PA000521; PAGANI M, UNPUB NATURE; Polyak L, 2001, NATURE, V410, P453, DOI 10.1038/35068536; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Sloan LC, 1996, PALAEOGEOGR PALAEOCL, V119, P275, DOI 10.1016/0031-0182(95)00012-7; SLOAN LC, 1992, PALAEOGEOGR PALAEOCL, V93, P183, DOI 10.1016/0031-0182(92)90096-N; Tripati A, 2005, SCIENCE, V308, P1894, DOI 10.1126/science.1109202; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Tripati A, 2001, PALAEOGEOGR PALAEOCL, V170, P101, DOI 10.1016/S0031-0182(01)00230-9; VOGT P, 1989, J GEOPHYS RES, V84, P1071; Wignall P.B., 1994, J PALEONTOL; WILSON JT, 1963, NATURE, V198, P925; Winkler A, 2002, INT J EARTH SCI, V91, P133, DOI 10.1007/s005310100199; WITTE WK, 1988, QUATERNARY RES, V29, P43, DOI 10.1016/0033-5894(88)90070-1	41	381	409	4	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					601	605		10.1038/nature04800	http://dx.doi.org/10.1038/nature04800			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738653	Green Published			2022-12-28	WOS:000237920800039
J	Johnson, BA				Johnson, BA			Pills for speedballing or cocaine dependence	LANCET			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; CONTINGENCY MANAGEMENT; DRUG-ABUSE; METHADONE; ADDICTION; BUPROPION; TOPIRAMATE; OUTCOMES		Univ Virginia, Dept Psychiat Med, Charlottesville, VA 22908 USA	University of Virginia	Johnson, BA (corresponding author), Univ Virginia, Dept Psychiat Med, Charlottesville, VA 22908 USA.	bankolejohnson@virginia.edu			NIDA NIH HHS [1 R01 DA017296-01A1, 2 R01 DA12191-05] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012191, R01DA017296] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmed SH, 2005, P NATL ACAD SCI USA, V102, P11533, DOI 10.1073/pnas.0504438102; Carroll KM, 2004, ARCH GEN PSYCHIAT, V61, P264, DOI 10.1001/archpsyc.61.3.264; Grabowski J, 2004, NEUROPSYCHOPHARMACOL, V29, P969, DOI 10.1038/sj.npp.1300392; Hubbard RL, 1997, PSYCHOL ADDICT BEHAV, V11, P261, DOI 10.1037/0893-164X.11.4.261; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Johnson BA, 2005, ALCOHOL CLIN EXP RES, V29, P1528, DOI 10.1097/01.alc.0000174690.63787.fc; Johnson BA, 2005, CNS DRUGS, V19, P873, DOI 10.2165/00023210-200519100-00005; JOHNSON BA, 2006, DRUG ALCOHOL DE 0502; Kampman KM, 2004, DRUG ALCOHOL DEPEN, V75, P233, DOI 10.1016/j.drugalcdep.2004.03.008; Kosten T, 2005, PHARMACOL THERAPEUT, V108, P76, DOI 10.1016/j.pharmthera.2005.06.009; Lindsey KP, 2004, J PHARMACOL EXP THER, V309, P959, DOI 10.1124/jpet.103.060293; Margolin A, 1995, DRUG ALCOHOL DEPEN, V40, P125, DOI 10.1016/0376-8716(95)01198-6; Oliveto A, 2001, DRUG ALCOHOL DEPEN, V63, P155, DOI 10.1016/S0376-8716(00)00198-8; Poling J, 2006, ARCH GEN PSYCHIAT, V63, P219, DOI 10.1001/archpsyc.63.2.219; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Robinson TE, 2004, SCIENCE, V305, P951, DOI 10.1126/science.1102496; Schottenfeld RS, 2005, AM J PSYCHIAT, V162, P340, DOI 10.1176/appi.ajp.162.2.340; Shoptaw S, 2003, J CLIN PSYCHIAT, V64, P1440, DOI 10.4088/JCP.v64n1207; Sofuoglu M, 2005, ADDICT BEHAV, V30, P1125, DOI 10.1016/j.addbeh.2004.10.010; Vocci FJ, 2005, AM J PSYCHIAT, V162, P1432, DOI 10.1176/appi.ajp.162.8.1432	20	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY-JUN	2006	367	9524					1714	1716		10.1016/S0140-6736(06)68749-7	http://dx.doi.org/10.1016/S0140-6736(06)68749-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731254				2022-12-28	WOS:000237854000009
J	De Gobbi, M; Viprakisit, V; Hughes, JR; Fisher, C; Buckle, VJ; Ayyub, H; Gibbons, RJ; Vernimmen, D; Yoshinaga, Y; de Jong, P; Cheng, JF; Rubin, EM; Wood, WG; Bowden, D; Higgs, DR				De Gobbi, Marco; Viprakisit, Vip; Hughes, Jim R.; Fisher, Chris; Buckle, Veronica J.; Ayyub, Helena; Gibbons, Richard J.; Vernimmen, Douglas; Yoshinaga, Yuko; de Jong, Pieter; Cheng, Jan-Fang; Rubin, Edward M.; Wood, William G.; Bowden, Don; Higgs, Douglas R.			A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter	SCIENCE			English	Article							GLOBIN GENES; HUMAN GENOME; CLUSTER; REGION; POLYMORPHISMS; ACTIVATION; SEQUENCES; COMPLEX; GATA-1; ZETA	We describe a pathogenetic mechanism underlying a variant form of the inherited blood disorder a thalassemia. Association studies of affected individuals from Melanesia localized the disease trait to the telomeric region of human chromosome 16, which includes the alpha-globin gene cluster, but no molecular defects were detected by conventional approaches. After resequencing and using a. combination of chromatin immunoprecipitation and expression analysis on a tiled oligonucleotide array, we identified a gain-of-function regulatory single-nucleotide polymorphism (rSNP) in a nongenic region between the alpha-globin genes and their upstream regulatory elements. The rSNP creates a new promoterlike element that interferes with normal activation of at[ downstream alpha-like globin genes. Thus, our work illustrates a strategy for distinguishing between neutral and functionally important rSNPs, and it also identifies a pathogenetic mechanism that could potentially underlie other genetic diseases.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; Mahidol Univ, Siriraj Hosp, Dept Pediat, Bangkok 10700, Thailand; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Monash Univ, Dept Anat & Cell Biol, Melbourne, Vic 3004, Australia	University of Oxford; Mahidol University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Monash University	Higgs, DR (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	doug.higgs@imm.ox.ac.uk	De Gobbi, Marco/E-8136-2013	De Gobbi, Marco/0000-0003-4261-7642; Cheng, Jan-Fang/0000-0001-7315-7613	Medical Research Council [MC_U137961147, MC_U137961145, MC_U137961143] Funding Source: Medline; MRC [MC_U137961143, MC_U137961145, MC_U137961147] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Anguita E, 2002, BLOOD, V100, P3450, DOI 10.1182/blood-2002-05-1409; Esperet C, 2000, J BIOL CHEM, V275, P25831, DOI 10.1074/jbc.M001757200; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; HIGGS DR, 1989, BLOOD, V73, P1081; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Leder A, 1997, BLOOD, V90, P1275, DOI 10.1182/blood.V90.3.1275.1275_1275_1282; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; VYAS P, 1992, CELL, V69, P781, DOI 10.1016/0092-8674(92)90290-S; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WINICHAGOON P, 1982, NUCLEIC ACIDS RES, V10, P5853, DOI 10.1093/nar/10.19.5853	16	202	223	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1215	1217		10.1126/science.1126431	http://dx.doi.org/10.1126/science.1126431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728641				2022-12-28	WOS:000237957400054
J	Fu, Q; Johanson, CM; Wallace, JM; Reichler, T				Fu, Qiang; Johanson, Celeste M.; Wallace, John M.; Reichler, Thomas			Enhanced mid-latitude tropospheric warming in satellite measurements	SCIENCE			English	Article							DROUGHT		Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; Lanzhou Univ, Coll Atmospher Sci, Lanzhou 730000, Gansu, Peoples R China; Univ Utah, Dept Meteorol, Salt Lake City, UT 84112 USA	University of Washington; University of Washington Seattle; Lanzhou University; Utah System of Higher Education; University of Utah	Fu, Q (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	qfu@atmos.washington.edu	Burgess, Thomas F/M-7144-2013; Fu, Qiang/W-5836-2019	Burgess, Thomas F/0000-0003-2682-5812; Reichler, Thomas/0000-0002-5004-0110				Fu Q, 2004, NATURE, V429, P55, DOI 10.1038/nature02524; Hoerling M, 2003, SCIENCE, V299, P691, DOI 10.1126/science.1079053; Houghton J. T., 2001, CLIMATE CHANGE 2001; Lau NC, 2005, J CLIMATE, V18, P2922, DOI 10.1175/JCLI3445.1; LEROY SS, 2006, 18 C CLIM VAR CHANG; Mears CA, 2003, J CLIMATE, V16, P3650, DOI 10.1175/1520-0442(2003)016<3650:AROTMC>2.0.CO;2; REICHLER T, 2005, 17 C CLIM VAR CHANG; Schubert SD, 2004, J CLIMATE, V17, P485, DOI [10.1175/1520-0442(2004)017<0485:COLDIT>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;0485:COLDIT&gt;2.0.CO;2]; Smith TM, 2005, J CLIMATE, V18, P2021, DOI 10.1175/JCLI3362.1	9	267	297	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1179	1179		10.1126/science.1125566	http://dx.doi.org/10.1126/science.1125566			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728633	Green Submitted			2022-12-28	WOS:000237957400043
J	Seeman, E; Delmas, PD				Seeman, Ego; Delmas, Pierre D.			Mechanisms of disease - Bone quality - The material and structural basis of bone strength and fragility	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CANCELLOUS BONE; TRABECULAR BONE; SEX-DIFFERENCES; FEMORAL-NECK; CORTICAL BONE; POSTMENOPAUSAL OSTEOPOROSIS; VERTEBRAL FRAGILITY; BIOMECHANICAL BASIS; MINERAL DENSITY; CELLS		Univ Melbourne, Austin Hlth, Dept Endocrinol, Melbourne, Vic 3084, Australia; Univ Lyon 1, Dept Rheumatol, F-69365 Lyon, France; INSERM, Res Unit 403, F-69008 Lyon, France	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm)	Seeman, E (corresponding author), Univ Melbourne, Austin Hlth, Dept Endocrinol, Melbourne, Vic 3084, Australia.	egos@unimelb.edu.au	Seeman, Ego/AAC-3656-2019	Seeman, Ego/0000-0002-9692-048X				Aaron JE, 2000, BONE, V27, P277, DOI 10.1016/S8756-3282(00)00328-8; AARON JE, 1987, CLIN ORTHOP RELAT R, P260; Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Albright F, 1941, J AMER MED ASSOC, V116, P2465, DOI 10.1001/jama.1941.02820220007002; Arlot M E, 1990, Osteoporos Int, V1, P41, DOI 10.1007/BF01880415; Bailey AJ, 1999, CALCIFIED TISSUE INT, V65, P203, DOI 10.1007/s002239900683; BALENA R, 1992, J BONE MINER RES, V7, P1475; Banse X, 2002, J BONE MINER RES, V17, P1621, DOI 10.1359/jbmr.2002.17.9.1621; Boivin G, 2003, J CLIN ENDOCR METAB, V88, P4199, DOI 10.1210/jc.2002-022020; Boivin G, 2002, CONNECT TISSUE RES, V43, P535, DOI 10.1080/03008200290000934; Boivin GY, 2000, BONE, V27, P687, DOI 10.1016/S8756-3282(00)00376-8; BONADIO J, 1993, J CLIN INVEST, V92, P1697, DOI 10.1172/JCI116756; Borah B, 2004, BONE, V34, P736, DOI 10.1016/j.bone.2003.12.013; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; BROWN JP, 1984, LANCET, V1, P1091; BROWN JP, 1987, J CLIN ENDOCR METAB, V64, P954, DOI 10.1210/jcem-64-5-954; Ciarelli TE, 2003, BONE, V32, P311, DOI 10.1016/S8756-3282(02)00975-4; CURREY JD, 1969, J BIOMECH, V2, P1, DOI 10.1016/0021-9290(69)90036-0; CURREY JD, 2002, BONES STRUCTURE MECH, P1; Delmas PD, 2000, BONE, V27, P1, DOI 10.1016/S8756-3282(00)00301-X; DELMAS PD, 2000, OSTEOPOROS INT S1, V11, pS5; DELMAS PD, IN PRESS BONE; Duan YB, 2001, J BONE MINER RES, V16, P2267, DOI 10.1359/jbmr.2001.16.12.2267; Duan YB, 2005, BONE, V36, P987, DOI 10.1016/j.bone.2004.11.016; Duan YB, 2003, J BONE MINER RES, V18, P1766, DOI 10.1359/jbmr.2003.18.10.1766; ERIKSEN EF, 1990, J BONE MINER RES, V5, P311, DOI 10.1002/jbmr.5650050402; FOLDES J, 1991, J BONE MINER RES, V6, P759; Frost HM., 1964, LAWS BONE STRUCTURE; Garnero P, 2002, J BONE MINER RES, V17, P826, DOI 10.1359/jbmr.2002.17.5.826; GILSANZ V, 1988, CALCIFIED TISSUE INT, V43, P260, DOI 10.1007/BF02555144; GILSANZ V, 1991, NEW ENGL J MED, V325, P1597, DOI 10.1056/NEJM199112053252302; GILSANZ V, 1988, RADIOLOGY, V166, P847, DOI 10.1148/radiology.166.3.3340782; Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; HAZENBERG JG, 2004, P BOOK 14 C EUR SOC; Jiang YB, 2003, J BONE MINER RES, V18, P1932, DOI 10.1359/jbmr.2003.18.11.1932; Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555; Komatsubara S, 2003, J BONE MINER RES, V18, P512, DOI 10.1359/jbmr.2003.18.3.512; Kozloff KM, 2004, J BONE MINER RES, V19, P614, DOI 10.1359/JBMR.040111; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Legrand E, 2000, J BONE MINER RES, V15, P13, DOI 10.1359/jbmr.2000.15.1.13; Li J, 2001, CALCIFIED TISSUE INT, V69, P281, DOI 10.1007/s002230010036; LIPS P, 1978, CALC TISS RES, V26, P13, DOI 10.1007/BF02013227; Lorenzo J, 2000, J CLIN INVEST, V106, P749, DOI 10.1172/JCI11089; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Marotti G, 1996, Ital J Anat Embryol, V101, P25; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Martin TJ, 2004, TRENDS ENDOCRIN MET, V15, P49, DOI 10.1016/j.tem.2004.01.002; Mashiba T, 2000, J BONE MINER RES, V15, P613, DOI 10.1359/jbmr.2000.15.4.613; McBride DJ, 1998, CALCIFIED TISSUE INT, V62, P172, DOI 10.1007/s002239900412; Meunier PJ, 1997, BONE, V21, P373, DOI 10.1016/S8756-3282(97)00170-1; Murray PDF, 1925, J ANAT, V59, P379; Nalla RK, 2004, BONE, V35, P1240, DOI 10.1016/j.bone.2004.07.016; Nieves JW, 2005, J BONE MINER RES, V20, P529, DOI 10.1359/JBMR.041005; Nishida S, 1999, J BONE MINER METAB, V17, P171, DOI 10.1007/s007740050081; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; Oreffo ROC, 1998, CLIN SCI, V94, P549, DOI 10.1042/cs0940549; Orwoll ES, 2003, J BONE MINER RES, V18, P949, DOI 10.1359/jbmr.2003.18.6.949; Parfitt A. M., 1996, P315; Parfitt AM, 2000, BONE, V27, P487, DOI 10.1016/S8756-3282(00)00353-7; PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; Parfitt AM, 1997, J BONE MINER RES, V12, P1864, DOI 10.1359/jbmr.1997.12.11.1864; PARFITT AM, 1980, MINER ELECTROL METAB, V4, P273; Qiu SJ, 2005, BONE, V37, P10, DOI 10.1016/j.bone.2005.01.023; Qiu SJ, 2003, J BONE MINER RES, V18, P1657, DOI 10.1359/jbmr.2003.18.9.1657; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; RUFF CB, 1988, J ORTHOP RES, V6, P886, DOI 10.1002/jor.1100060613; RUFF CB, 1993, AM J PHYS ANTHROPOL, V91, P21, DOI 10.1002/ajpa.1330910103; SCHAFFLER MB, 2005, P NIAMS ASBMR SCI M; Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101; SEEMAN E, 1989, NEW ENGL J MED, V320, P554, DOI 10.1056/NEJM198903023200903; Seeman E, 1997, J BONE MINER RES, V12, P509, DOI 10.1359/jbmr.1997.12.4.509; Sornay-Rendu E, 2005, J BONE MINER RES, V20, P1813, DOI 10.1359/JBMR.050609; Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120; Taylor D, 1997, J ORTHOP RES, V15, P601, DOI 10.1002/jor.1100150417; Theobald TM, 1998, OSTEOPOROSIS INT, V8, P61, DOI 10.1007/s001980050049; Turner CH, 2002, OSTEOPOROSIS INT, V13, P97, DOI 10.1007/s001980200000; van der Linden JC, 2001, J BONE MINER RES, V16, P457, DOI 10.1359/jbmr.2001.16.3.457; VEDI S, 1984, METAB BONE DIS RELAT, V5, P69, DOI 10.1016/0221-8747(83)90004-8; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; WAINWRIGHT SA, 1982, MECH DESIGN ORGANISM, P1; Wang XF, 2005, BONE, V37, P599, DOI 10.1016/j.bone.2005.06.001; Wang XF, 2005, BONE, V36, P978, DOI 10.1016/j.bone.2004.11.015; Whyte MP, 2003, NEW ENGL J MED, V349, P457, DOI 10.1056/NEJMoa023110; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7; Zebaze RMD, 2005, BONE, V37, P243, DOI 10.1016/j.bone.2005.03.019	90	1389	1444	17	193	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2250	2261		10.1056/NEJMra053077	http://dx.doi.org/10.1056/NEJMra053077			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045RF	16723616				2022-12-28	WOS:000237758900006
J	Miech, RA; Kumanyika, SK; Stettler, N; Link, BG; Phelan, JC; Chang, VW				Miech, Richard A.; Kumanyika, Shiriki K.; Stettler, Nicolas; Link, Bruce G.; Phelan, Jo C.; Chang, Virginia W.			Trends in the association of poverty with overweight among US adolescents, 1971-2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS-INDEX; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; UNITED-STATES; SOCIOECONOMIC-STATUS; NUTRIENT INTAKE; CHILDREN; OBESITY; HEALTH; PREVALENCE	Context Prevalence of adolescent overweight in the United States has increased substantially during the past 3 decades. Whether socioeconomic disparities in adolescent overweight increased, decreased, or remained constant during this period is not known. Objective To examine trends in adolescent overweight from 1971 to 2004 by family poverty status, as well as trends in potentially relevant eating and physical activity behaviors. Design, Setting, and Participants Four cross-sectional, nationally representative surveys (US National Health and Nutrition Examination Surveys [NHANES] of 1971-1974, 1976-1980, 1988-1994, and 1999-2004) were examined for trends in the prevalence of overweight among adolescents aged 12 to 17 years by family poverty status. Main Outcome Measures Prevalence of adolescent overweight, defined as body mass index at or above the 95th percentile for age and sex in the 2000 Centers for Disease Control and Prevention growth charts. Intermediate outcomes were physical inactivity in the past 30 days, proportion of caloric intake from sweetened beverages (24-hour recall), and whether respondent skipped breakfast (24-hour recall). Results Trends in the association of adolescent overweight with family poverty differed by age stratum (P=.01). In 12- to 14-year-old adolescents, prevalence did not significantly differ by family poverty status in any of the surveys; however, among non-Hispanic black adolescents, overweight prevalence increased faster in nonpoor vs poor families. In contrast, a widening disparity that disfavored adolescents from poor families was present in the 15- to 17-year-old adolescents. This trend was similar among male, female, non-Hispanic white, and non-Hispanic black adolescents, resulting in an overall prevalence of overweight in 1999-2004 more than 50% higher among adolescents in poor vs nonpoor families (23.3% vs 14.4%, respectively; P <.001). Additional analyses suggest that physical inactivity, sweetened beverage consumption, and skipping breakfast may contribute to these disparities. Conclusions Trends of increasing overweight showed a greater impact in families living below the poverty line vs not living below the poverty line among older (15-17 years) but not younger (12-14 years) adolescents. Furthermore, physical inactivity, high consumption of sweetened beverages, and breakfast skipping may be candidate targets for prevention programs aimed at reducing this recently emerged disparity.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Univ Penn, Sch Med, Dept Med, Vet Affairs Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Columbia University; Columbia University; New York State Psychiatry Institute; University of Pennsylvania; University of Pennsylvania	Miech, RA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, 624 N Broadway,Hampton House 853, Baltimore, MD 21205 USA.	rmiech@jhsph.edu	Link, Bruce/AAO-9094-2021; Link, Bruce G/N-9087-2013; Miech, Richard/B-3170-2016	Miech, Richard/0000-0002-2722-3277; Link, Bruce/0000-0001-9980-7450	NCRR NIH HHS [5K23RR016073, K23 RR016073] Funding Source: Medline; NICHD NIH HHS [K12HD043459] Funding Source: Medline; NIDA NIH HHS [K01 DA015089, 1K01DA015089] Funding Source: Medline; NIMHD NIH HHS [P60 MD000209] Funding Source: Medline; NIMH NIH HHS [K02MH65330] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016073] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH065330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA015089] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aiken L.S., 1991, MULTIPLE REGRESSION; [Anonymous], CENS BUR MEAS POV; Berkey CS, 2003, INT J OBESITY, V27, P1258, DOI 10.1038/sj.ijo.0802402; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Cohen J., 1983, APPL MULTIPLE REGRES; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; DELVA J, 2005, OBESITY LIFESTYLE HA; Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026; Dowda M, 2001, ARCH PEDIAT ADOL MED, V155, P711, DOI 10.1001/archpedi.155.6.711; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Drewnowski A, 2003, J NUTR, V133, p838S, DOI 10.1093/jn/133.3.838S; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Fisher GM, DEV ORSHANSKY POVERT; French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820; Goran MI, 1998, AM J CLIN NUTR, V67, P309, DOI 10.1093/ajcn/67.2.309; Gordon-Larsen P, 2003, OBES RES, V11, P121, DOI 10.1038/oby.2003.20; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Guenther PM, 2005, J AM DIET ASSOC, V105, P1266, DOI 10.1016/j.jada.2005.05.014; Guo, 2002, VITAL HLTH STAT, V11, DOI DOI 10.1016/J.BBRC.2015.06.114; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Jahns L, 2003, EUR J CLIN NUTR, V57, P1295, DOI 10.1038/sj.ejcn.1601691; Janz KF, 2000, MED SCI SPORT EXER, V32, P1250, DOI 10.1097/00005768-200007000-00011; Lee RE, 2002, AM J PUBLIC HEALTH, V92, P428, DOI 10.2105/AJPH.92.3.428; Levin S, 2003, ARCH PEDIAT ADOL MED, V157, P816, DOI 10.1001/archpedi.157.8.816; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; MCDOWELL M, 1989, 14 NAT NUTR DAT C JU; Molnar BE, 2004, AM J HEALTH PROMOT, V18, P378, DOI 10.4278/0890-1171-18.5.378; Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2; *NAT CTR HLTH STAT, 2000, NHANES 1999 2001 DIE; *NAT CTR HLTH STAT, 2000, PERS DIET INT PROC M; Nawaz H, 2001, AM J PREV MED, V20, P294, DOI 10.1016/S0749-3797(01)00293-8; Nelson MC, 2005, AM J PREV MED, V28, P259, DOI 10.1016/j.amepre.2004.12.006; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303; Post GB, 2001, BRIT J NUTR, V85, P375, DOI 10.1079/BJN2000249; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; StataCorp, 2004, STAT STAT SOFTW REL; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; *THOMS W BUS HLTH, STAT ACT PROM NUTR I; Troiano RP, 1998, PEDIATRICS, V101, P497; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; US Bureau of the Census, CURR POP SURV 2005; *US DEP HHS, 2004, PHYS ACT HLTH REP SU; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; *USDA, 2004, US DEP AGR SURV NUTR; *WEST INC, 1992, NHANES 3 REF MAN REP; Williams J, 2005, JAMA-J AM MED ASSOC, V293, P70, DOI 10.1001/jama.293.1.70; World Health Organization, 2004, GLOB STRAT DIET PHYS; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	53	196	200	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2385	2393		10.1001/jama.295.20.2385	http://dx.doi.org/10.1001/jama.295.20.2385			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045HY	16720824	Bronze			2022-12-28	WOS:000237734400024
J	McDowell, SE; Coleman, JJ; Ferner, RE				McDowell, Sarah E.; Coleman, Jamie J.; Ferner, R. E.			Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONVERTING ENZYME-INHIBITORS; INTRACRANIAL HEMORRHAGE; THROMBOLYTIC THERAPY; EVENTS; COUGH; RACE; SAFETY; HYPERTENSION; ASSOCIATION; ANGIOEDEMA	Objective To review the evidence for ethnic differences in susceptibility to adverse drug reactions (ADRs) to cardiovascular drugs. Design Systematic review and meta-analysis. Data sources We searched Medline and Embase to March 2005. Reference lists of identified articles were hand searched for further relevant articles. Review methods Studies were eligible for inclusion if they included at least two ethnic groups and one or more ADRs. We excluded case reports and case series. Results 564 studies contained some description of ethnicity and an ADR, and 132 of them related to cardiovascular therapies. Twenty four studies provided data for ADRs for at least two ethnic groups and were therefore eligible for inclusion. In pooled analyses the relative risk of angio-oedema from angiotensin converting enzyme (ACE) inhibitors in black compared with non-black patients was 3.0 (95% confidence interval 2.5 to 3.7); the relative risk of cough from ACE inhibitors was 2.7 (1.6 to 4.5) in East Asian compared with white patients; and the relative risk of intracranial haemorrhage with thrombolytic therapy was 1.5 (1.2 to 1.9) in black compared with non-black patients. Conclusion Patients from different ethnic groups have different risks for important ADRs to cardiovascular drugs. Ethnic group may therefore be one determinant of harms of a given treatment in the individual patient, either because it acts as a surrogate measure of genetic make up or because cultural factors alter the risk. Data are sparse, and regulators should consider asking for better data before licensing.	City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England; Univ Birmingham, Dept Clin Pharmacol, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham	Ferner, RE (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England.	r.e.ferner@bham.ac.uk	McDowell, Sarah/G-9230-2011	McDowell, Sarah/0000-0003-0979-3679; Coleman, Jamie/0000-0002-7512-5153; Ferner, Robin/0000-0003-3769-1346				Abbosh J, 1999, ANN ALLERG ASTHMA IM, V82, P473, DOI 10.1016/S1081-1206(10)62723-8; Adigun A Q, 2001, West Afr J Med, V20, P46; Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; [Anonymous], 2005, BRIT NAT FORM; Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; Bailey David G, 2004, Am J Cardiovasc Drugs, V4, P281, DOI 10.2165/00129784-200404050-00002; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Berges-Gimeno MP, 2002, ANN ALLERG ASTHMA IM, V89, P474, DOI 10.1016/S1081-1206(10)62084-4; Berkowitz SD, 1997, CIRCULATION, V95, P2508, DOI 10.1161/01.CIR.95.11.2508; Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P943, DOI 10.1177/0091270003256065; BLACK HR, 1992, AM J HYPERTENS, V5, P141, DOI 10.1093/ajh/5.3.141; Brass LM, 2000, STROKE, V31, P1802, DOI 10.1161/01.STR.31.8.1802; *BRIT MED ASS, 2005, 49 BMA RPS GB; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Burkhart Greg A., 1996, Pharmacoepidemiology and Drug Safety, V5, P149; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; CHAN WK, 1993, EUR J CLIN PHARMACOL, V44, P299, DOI 10.1007/BF00271377; Cohn JN, 2004, AM J HYPERTENS, V17, P134, DOI 10.1016/j.amjhyper.2003.09.017; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Derry S, 2001, BMC Med Res Methodol, V1, P7, DOI 10.1186/1471-2288-1-7; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Elliott WJ, 1996, CLIN PHARMACOL THER, V60, P582, DOI 10.1016/S0009-9236(96)90155-1; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Gibbs CR, 1999, BRIT J CLIN PHARMACO, V48, P861; Gowda Ramesh M, 2003, Am J Ther, V10, P259, DOI 10.1097/00045391-200307000-00005; Gurwitz JH, 1998, ANN INTERN MED, V129, P597, DOI 10.7326/0003-4819-129-8-199810150-00002; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hughes DA, 2004, PHARMACOGENETICS, V14, P335, DOI 10.1097/00008571-200406000-00002; Hui KK, 1997, ARCH INTERN MED, V157, P1345, DOI 10.1001/archinte.157.12.1345; *INT COMM MED J ED, 2005, UN REQ MAN SUBM BIOM; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Ishimitsu T, 1997, JPN HEART J, V38, P831; Julius Stevo, 2004, J Clin Hypertens (Greenwich), V6, P10; KEMPIN SJ, 1983, NEW ENGL J MED, V308, P1229; Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; Loke Y K, 2001, BMC Clin Pharmacol, V1, P3, DOI 10.1186/1472-6904-1-3; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MARKS AD, 1986, CURR MED RES OPIN, V10, P296, DOI 10.1185/03007998609111094; Morales D, 2004, CURR MED RES OPIN, V20, P1235, DOI 10.1185/030079904125004367; Morimoto T, 2004, J EVAL CLIN PRACT, V10, P499, DOI 10.1111/j.1365-2753.2003.00484.x; Morimoto T, 2004, J GEN INTERN MED, V19, P684, DOI 10.1111/j.1525-1497.2004.30016.x; MULINARI R, 1987, CLIN THER, V9, P678; Phillips KA, 2001, JAMA-J AM MED ASSOC, V286, P2270, DOI 10.1001/jama.286.18.2270; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Potempa K, 1993, J Am Acad Nurse Pract, V5, P211, DOI 10.1111/j.1745-7599.1993.tb00874.x; PRISANT LM, 1991, J FAM PRACTICE, V33, P481; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Risch N., 2002, GENOME BIOL, V3; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Tate SK, 2004, NAT GENET, V36, pS34, DOI 10.1038/ng1437; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; WARREN JL, 1994, ARCH INTERN MED, V154, P1482, DOI 10.1001/archinte.154.13.1482; White RH, 1999, AM J MED, V107, P414, DOI 10.1016/S0002-9343(99)00267-3; Winker MA, 2004, JAMA-J AM MED ASSOC, V292, P1612, DOI 10.1001/jama.292.13.1612; WOO KS, 1995, BRIT J CLIN PHARMACO, V40, P141; WOO KS, 1995, AM J CARDIOL, V75, P967; Wood AJJ, 2001, NEW ENGL J MED, V344, P1393, DOI 10.1056/NEJM200105033441811; Wright JT, 2005, JAMA-J AM MED ASSOC, V293, P1595, DOI 10.1001/jama.293.13.1595; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815	63	167	174	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2006	332	7551					1177	1180		10.1136/bmj.38803.528113.55	http://dx.doi.org/10.1136/bmj.38803.528113.55			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048GJ	16679330	Green Published, hybrid			2022-12-28	WOS:000237935300014
J	Panatier, A; Theodosis, DT; Mothet, JP; Touquet, B; Pollegioni, L; Poulain, DA; Oliet, SHR				Panatier, Aude; Theodosis, Dionysia T.; Mothet, Jean-Pierre; Touquet, Bastien; Pollegioni, Loredano; Poulain, Dominique A.; Oliet, Stephane H. R.			Glia-derived D-serine controls NMDA receptor activity and synaptic memory	CELL			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; AMINO-ACID OXIDASE; BACILLUS-SUBTILIS; OXYTOCIN NEURONS; GLYCINE OXIDASE; RAT-BRAIN; RELEASE; ASTROCYTES; PLASTICITY	The NMDA receptor is a key player in excitatory transmission and synaptic plasticity in the central nervous system. Its activation requires the binding of both glutamate and a coagonist like D-serine to its glycine site. AS D-serine is released exclusively by astrocytes, we studied the physiological impact of the glial environment on NMDA receptor-dependent activity and plasticity. To this end, we took advantage of the changing astrocytic ensheathing of neurons occurring in the supraoptic nucleus during lactation. We provide direct evidence that in this hypothalamic structure the endogenous coagonist of NMDA receptors is D-serine and not glycine. Consequently, the degree of astrocytic coverage of neurons governs the level of glycine site occupancy on the NMDA receptor, thereby affecting their availability for activation and thus the activity dependence of long-term synaptic changes. Such a contribution of astrocytes to synaptic metaplasticity fuels the emerging concept that astrocytes are dynamic partners of brain signaling.	INSERM, U378, F-33077 Bordeaux, France; Univ Bordeaux 2, F-33077 Bordeaux, France; CNRS, UPR9040, F-91198 Gif Sur Yvette, France; Ecole Prat Hautes Etud, F-33077 Bordeaux, France; Univ Insubria, Dept Biotechnol & Mol Sci, I-21100 Varese, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Insubria	Oliet, SHR (corresponding author), INSERM, U378, F-33077 Bordeaux, France.	stephane.oliet@bordeaux.inserm.fr	Jansen, Heiko T./A-5770-2008; Touquet, Bastien/F-4757-2019; Touquet, Bastien/AAO-9681-2020; Mothet, Jean-Pierre/ABE-3066-2020	Jansen, Heiko T./0000-0003-0178-396X; Touquet, Bastien/0000-0002-2619-9818; Touquet, Bastien/0000-0002-2619-9818; POLLEGIONI, LOREDANO/0000-0003-1733-7243; Oliet, Stephane/0000-0003-0595-9029; MOTHET, Jean-Pierre/0000-0003-4991-0614; Panatier, Aude/0000-0002-6107-4463				Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Brussaard AB, 1997, NEURON, V19, P1103, DOI 10.1016/S0896-6273(00)80401-8; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DANIELLO A, 1993, COMP BIOCHEM PHYS B, V105, P731, DOI 10.1016/0305-0491(93)90113-J; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; Hatton GI, 1997, ANNU REV NEUROSCI, V20, P375, DOI 10.1146/annurev.neuro.20.1.375; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Hussy N, 1997, J PHYSIOL-LONDON, V502, P609, DOI 10.1111/j.1469-7793.1997.609bj.x; Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200; Job V, 2002, EUR J BIOCHEM, V269, P1456, DOI 10.1046/j.1432-1033.2002.02790.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jourdain P, 1998, J NEUROSCI, V18, P6641; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; KUBO T, 1987, NEUROSCI LETT, V74, P331, DOI 10.1016/0304-3940(87)90319-3; Laming PR, 2000, NEUROSCI BIOBEHAV R, V24, P295, DOI 10.1016/S0149-7634(99)00080-9; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Miyazaki M, 1999, EXP BRAIN RES, V129, P191; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Oliet SHR, 1999, J PHYSIOL-LONDON, V520, P815, DOI 10.1111/j.1469-7793.1999.00815.x; Piet R, 2004, P NATL ACAD SCI USA, V101, P2151, DOI 10.1073/pnas.0308408100; Rampon C, 1996, NEUROSCIENCE, V75, P737, DOI 10.1016/0306-4522(96)00278-3; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Stern JE, 2000, J PHYSIOL-LONDON, V526, P109, DOI 10.1111/j.1469-7793.2000.t01-1-00109.x; Stern JE, 1999, J NEUROSCI, V19, P3367; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	51	643	670	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					775	784		10.1016/j.cell.2006.02.051	http://dx.doi.org/10.1016/j.cell.2006.02.051			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713567	Bronze			2022-12-28	WOS:000237886000021
J	Simon, JA				Simon, JA			Using isoform-specific inhibitors to target lipid kinases	CELL			English	Editorial Material							DISCOVERY; PATHWAY; MICE	In this issue of Cell, Knight et al. (2006) present a detailed pharmacological analysis of the PI3 kinase (PI3-K) family using small molecule inhibitors. They conclude that p110 alpha, a PI3-K isoform, has a critical role in insulin signaling. In a related Cancer Cell paper, Fan et al. (2006) show that blocking activation of both p110 alpha. and the kinase mTOR with a small molecule inhibitor limits the growth of gliomas.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Simon, JA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, D2-100,1100 Fairview Ave N, Seattle, WA 98109 USA.	jsimon@fhcrc.org						Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; FOUKAS LC, 2006, NATURE; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952	9	5	12	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 19	2006	125	4					647	649		10.1016/j.cell.2006.05.008	http://dx.doi.org/10.1016/j.cell.2006.05.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713558	Bronze			2022-12-28	WOS:000237886000010
J	Suddendorf, T				Suddendorf, T			Foresight and evolution of the human mind	SCIENCE			English	Editorial Material							MENTAL TIME-TRAVEL; GREAT APES; FUTURE; ANIMALS		Univ Queensland, Sch Psychol, Early Cognit Dev Unit, Brisbane, Qld 4072, Australia	University of Queensland	Suddendorf, T (corresponding author), Univ Queensland, Sch Psychol, Early Cognit Dev Unit, Brisbane, Qld 4072, Australia.	t.suddendorf@psy.uq.edu.au	Suddendorf, Thomas/A-1631-2017	Suddendorf, Thomas/0000-0003-3328-7442				BISCHOF N, 1985, RATZEL OPIDUS; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; DALLY JM, 2006, SCIENCE         0518; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Kohler W., 1927, MENTALITY APES, V2nd ed.; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Suddendorf T, 2005, LEARN MOTIV, V36, P110, DOI 10.1016/j.lmot.2005.02.010; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6; Suddendorf T, 2001, PSYCHOL BULL, V127, P629, DOI 10.1037//0033-2909.127.5.629; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]	17	102	106	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2006	312	5776					1006	1007		10.1126/science.1129217	http://dx.doi.org/10.1126/science.1129217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	043UX	16709773				2022-12-28	WOS:000237628800030
J	Tomlin, D; Kayali, MA; King-Casas, B; Anen, C; Camerer, CF; Quartz, SR; Montague, PR				Tomlin, D; Kayali, MA; King-Casas, B; Anen, C; Camerer, CF; Quartz, SR; Montague, PR			Agent-specific responses in the cingulate cortex during economic exchanges	SCIENCE			English	Article							ANTERIOR CINGULATE; NEURAL BASIS; SELF; FMRI; MIND; EVOLUTION; ATTRIBUTION; COOPERATION; INTUITION; ATTENTION	Interactions with other responsive agents lie at the core of all social exchange. During a social exchange with a partner, one fundamental variable that must be computed correctly is who gets credit for a shared outcome; this assignment is crucial for deciding on an optimal level of cooperation that avoids simple exploitation. We carried out an iterated, two-person economic exchange and made simultaneous hemodynamic measurements from each player's brain. These joint measurements revealed agent-specific responses in the social domain ("me'' and "not me'') arranged in a systematic spatial pattern along the cingulate cortex. This systematic response pattern did not depend on metrical aspects of the exchange, and it disappeared completely in the absence of a responding partner.	Baylor Coll Med, Dept Neurol, Human Neuroimaging Lab, Houston, TX 77030 USA; Baylor Coll Med, Ctr Theoret Neurosci, Dept Psychiat, Houston, TX 77030 USA; CALTECH, Social Cognit Neurosci Lab, Div Humanities & Social Sci 228 77, Pasadena, CA 91125 USA	Baylor College of Medicine; Baylor College of Medicine; California Institute of Technology	Tomlin, D (corresponding author), Baylor Coll Med, Dept Neurol, Human Neuroimaging Lab, 1 Baylor Plaza, Houston, TX 77030 USA.				NIDA NIH HHS [DA11723, DA14883] Funding Source: Medline; NIMH NIH HHS [MH52797] Funding Source: Medline; NINDS NIH HHS [NS045790] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723, R21DA014883] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; CICHOCKI A, 2003, ADAPTIVE BLIND SIGNA; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Georgieff N, 1998, CONSCIOUS COGN, V7, P465, DOI 10.1006/ccog.1998.0367; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Johns LC, 2001, PSYCHOL MED, V31, P705, DOI 10.1017/S0033291701003774; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Lieberman MD, 2005, COGNITIVE NEUROSCIENCE OF SOCIAL BEHAVIOUR, P195, DOI 10.4324/9780203311875_chapter_7; Lieberman MD, 2004, J PERS SOC PSYCHOL, V87, P421, DOI 10.1037/0022-3514.87.4.421; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Nielsen FA, 2005, NEUROIMAGE, V27, P520, DOI 10.1016/j.neuroimage.2005.04.034; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Ochsner KN, 2001, NEUROPSYCHOLOGIA, V39, P219, DOI 10.1016/S0028-3932(00)00114-7; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Phan KL, 2003, NEUROPSYCHOPHARMACOL, V28, P1344, DOI 10.1038/sj.npp.1300186; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Wicker B, 2003, NEUROPSYCHOLOGIA, V41, P139, DOI 10.1016/S0028-3932(02)00144-6	53	151	155	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1047	1050		10.1126/science.1125596	http://dx.doi.org/10.1126/science.1125596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	043UX	16709783				2022-12-28	WOS:000237628800044
J	Whitcomb, DC				Whitcomb, DC			Acute pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE NECROTIZING PANCREATITIS; RISK-FACTOR; PARENTERAL-NUTRITION; COMPUTED-TOMOGRAPHY; PROGNOSTIC FACTORS; EARLY PREDICTION; APACHE-II; MANAGEMENT; SEVERITY; ASPIRATION		Univ Pittsburgh, Presbyterian Med Ctr, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whitcomb, DC (corresponding author), Univ Pittsburgh, Presbyterian Med Ctr, Div Gastroenterol Hepatol & Nutr, Mezzanine Level 2,C Wing,200 Lothrop St, Pittsburgh, PA 15213 USA.	whitcomb@pitt.edu						ALOMRAN M, 2003, COCHRANE DB SYST REV, V1; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Arvanitakis M, 2004, GASTROENTEROLOGY, V126, P715, DOI 10.1053/j.gastro.2003.12.006; Ayub K, 2004, COCHRANE DB SYST REV, V4; Baillargeon JD, 1998, AM J GASTROENTEROL, V93, P2130; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Banks PA, 1995, INT J PANCREATOL, V18, P265; Baron TH, 2002, GASTROINTEST ENDOSC, V56, P7, DOI 10.1067/mge.2002.125106; Bassi C, 2003, COCHRANE DB SYST REV; Batiste Marcelo C, 2002, Nutr Clin Care, V5, P115, DOI 10.1046/j.1523-5408.2002.t01-1-00005.x; BLAMEY SL, 1984, GUT, V25, P1340, DOI 10.1136/gut.25.12.1340; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; DeFrances C.J., 2005, ADV DATA VITAL HLTH; Draganov P, 2005, GASTROENTEROLOGY, V128, P756, DOI 10.1053/j.gastro.2005.01.037; Gastineau DA, 2001, TRANSFUSION, V41, P4, DOI 10.1046/j.1537-2995.2001.41010004.x; Jacobson BC, 2005, GASTROINTEST ENDOSC, V61, P363, DOI 10.1016/S0016-5107(04)02779-8; Johnson CD, 2001, GUT, V48, P62, DOI 10.1136/gut.48.1.62; Kemppainen E, 1997, GUT, V41, P690, DOI 10.1136/gut.41.5.690; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kozarek RA, 1998, GASTROINTEST ENDOSC, V47, pAB33; Lankisch PG, 2002, PANCREAS, V25, P411, DOI 10.1097/00006676-200211000-00015; LARVIN M, 1989, LANCET, V2, P201; Levy P, 2005, PANCREATOLOGY, V5, P450, DOI 10.1159/000086547; Marik PE, 2004, BMJ-BRIT MED J, V328, P1407, DOI 10.1136/bmj.38118.593900.55; Martinez J, 2004, PANCREATOLOGY, V4, P42, DOI 10.1159/000077025; Mayerle J, 2005, NAT CLIN PRACT GASTR, V2, P473, DOI 10.1038/ncpgasthep0293; Mayumi Toshihiko, 2002, J Hepatobiliary Pancreat Surg, V9, P413, DOI 10.1007/s005340200051; McArthur KE, 1996, ALIMENT PHARM THERAP, V10, P23; McClave Stephen A, 2002, Semin Gastrointest Dis, V13, P154; McKay CJ, 2004, BRIT J SURG, V91, P1243, DOI 10.1002/bjs.4750; Meier R, 2002, CLIN NUTR, V21, P173, DOI 10.1054/clnu.2002.0543; MORINVILLE V, 2005, GASTROENTEROL HEPATO, V1, P195; Nathens AB, 2004, CRIT CARE MED, V32, P2524, DOI 10.1097/01.CCM.0000148222.09869.92; Nathens Avery B, 2004, Proc Am Thorac Soc, V1, P289; Neoptolemos JP, 2000, LANCET, V355, P1955, DOI 10.1016/S0140-6736(00)02327-8; *NIH, 1998, NIH PUBL; Nordback I, 2001, J GASTROINTEST SURG, V5, P113, DOI 10.1016/S1091-255X(01)80021-4; Papachristou GI, 2005, CLIN GASTROENTEROL H, V3, P475, DOI 10.1016/S1542-3565(05)00163-1; Papachristou GI, 2004, GASTROENTEROL CLIN N, V33, P871, DOI 10.1016/j.gtc.2004.07.004; PEDERZOLI P, 1993, SURG GYNECOL OBSTET, V176, P480; RANSON JHC, 1976, SURG GYNECOL OBSTET, V143, P209; RANSON JHC, 1982, AM J GASTROENTEROL, V77, P633; Rau B, 1998, BRIT J SURG, V85, P179; Robert JH, 2002, WORLD J SURG, V26, P612, DOI 10.1007/s00268-001-0278-y; Romagnuolo J, 2005, GASTROINTEST ENDOSC, V61, P86, DOI 10.1016/S0016-5107(04)02472-1; Somogyi L, 2001, GASTROENTEROLOGY, V120, P708, DOI 10.1053/gast.2001.22333; STEINBERG WM, 1987, GASTROENTEROLOGY, V93, P1420, DOI 10.1016/0016-5085(87)90275-7; TENNER S, 1994, AM J GASTROENTEROL, V89, P1863; Uhl W, 2003, PANCREATOLOGY, V3, DOI 10.1159/000067684; Venneman NG, 2005, AM J GASTROENTEROL, V100, P2540, DOI 10.1111/j.1572-0241.2005.00317.x; Whitcomb DC, 2004, GUT, V53, P1710, DOI 10.1136/gut.2003.015511; WHITCOMB DC, 2004, PEDIAT GASTROINTESTI, P1584; Windsor ACJ, 1998, GUT, V42, P431, DOI 10.1136/gut.42.3.431; Working Party of the British Society of Gastroenterology, 2005, GUT, V54, P1, DOI DOI 10.1136/GUT.2004.047126	54	518	565	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2142	2150		10.1056/NEJMcp054958	http://dx.doi.org/10.1056/NEJMcp054958			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707751				2022-12-28	WOS:000237575400008
J	Sharp, D				Sharp, D			Jules Rimet's bananas	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							Craig CM, 2006, NATURWISSENSCHAFTEN, V93, P97, DOI 10.1007/s00114-005-0071-0	1	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2006	367	9522					1561	1562		10.1016/S0140-6736(06)68673-X	http://dx.doi.org/10.1016/S0140-6736(06)68673-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698398				2022-12-28	WOS:000237598000010
J	Heymann, DL; Aylward, RB				Heymann, DL; Aylward, RB			Poliomyelitis eradication and pandemic influenza	LANCET			English	Editorial Material							POLIO		World Hlth Org, Polio Eradicat Initiat, Geneva 27, Switzerland	World Health Organization	Heymann, DL (corresponding author), World Hlth Org, Polio Eradicat Initiat, Geneva 27, Switzerland.	heymannd@who.int						[Anonymous], 2004, Wkly Epidemiol Rec, V79, P425; Heymann DL, 2004, EPIDEMIOL INFECT, V132, P779, DOI 10.1017/s0950268804002638; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; 2005, WKLY EPIDEMIOL REC, V80, P141	4	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 6	2006	367	9521					1462	1464		10.1016/S0140-6736(06)68624-8	http://dx.doi.org/10.1016/S0140-6736(06)68624-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679142	Bronze, Green Published			2022-12-28	WOS:000237324200005
J	White, H; Perkins, K				White, H; Perkins, K			A secretary by any other name	LANCET			English	Editorial Material									British Soc Med Secretaries, Edinburgh EH9 3AH, Midlothian, Scotland		Perkins, K (corresponding author), British Soc Med Secretaries, Edinburgh EH9 3AH, Midlothian, Scotland.	bsms@kathyperkins.co.uk						DAVIES M, 2006, J MED SECRETARIES, V7, P18; *DEP HLTH, AG CHANG; NEWMAN M, 2004, HOSP DOCTOR     1202; 2006, AGENDA CHANGE   0124; 2006, DAILY TELEGRAPH 0415	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1466	1467		10.1016/S0140-6736(06)68626-1	http://dx.doi.org/10.1016/S0140-6736(06)68626-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679144				2022-12-28	WOS:000237324200007
J	Forouhar, AS; Liebling, M; Hickerson, A; Nasiraei-Moghaddam, A; Tsai, HJ; Hove, JR; Fraser, SE; Dickinson, ME; Gharib, M				Forouhar, AS; Liebling, M; Hickerson, A; Nasiraei-Moghaddam, A; Tsai, HJ; Hove, JR; Fraser, SE; Dickinson, ME; Gharib, M			The embryonic vertebrate heart tube is a dynamic suction pump	SCIENCE			English	Article							ZEBRAFISH	The embryonic vertebrate heart begins pumping blood long before the development of discernable chambers and valves. At these early stages, the heart tube has been described as a peristaltic pump. Recent advances in confocal laser scanning microscopy and four-dimensional visualization have warranted another look at early cardiac structure and function. We examined the movement of cells in the embryonic zebrafish heart tube and the flow of blood through the heart and obtained results that contradict peristalsis as a pumping mechanism in the embryonic heart. We propose a more likely explanation of early cardiac dynamics in which the pumping action results from suction due to elastic wave propagation in the heart tube.	CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA; CALTECH, Biol Imaging Ctr, Beckman Inst, Pasadena, CA 91125 USA; Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei, Taiwan; Univ Cincinnati, Genome Res Inst, Cincinnati, OH 45221 USA; Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA	California Institute of Technology; California Institute of Technology; National Taiwan University; University System of Ohio; University of Cincinnati; Baylor College of Medicine	Gharib, M (corresponding author), CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA.	mgharib@caltech.edu	Liebling, Michael/A-1498-2009; Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Gharib, Mohammed/0000-0001-9611-1693; Liebling, Michael/0000-0001-7608-2733	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078694] Funding Source: NIH RePORTER; NHLBI NIH HHS [5R01HL078694] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Buckberg G D, 2001, Semin Thorac Cardiovasc Surg, V13, P342; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Gilbert S.F., 2000, DEV BIOL; Hickerson AI, 2005, EXP FLUIDS, V38, P534, DOI 10.1007/s00348-005-0946-z; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Liebling M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2061567; NICHOLS WW, 1988, MCDONALDS BLOOD FLOW, P98; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; VOGEL S, 1994, LIFE MOVING FLUIDS, P323; Yelon D, 2001, DEV DYNAM, V222, P552, DOI 10.1002/dvdy.1243	11	200	206	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					751	753		10.1126/science.1123775	http://dx.doi.org/10.1126/science.1123775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675702	Green Published			2022-12-28	WOS:000237312100052
J	Song, K; Backs, J; McAnally, J; Qi, X; Gerard, RD; Richardson, JA; Hill, JA; Bassel-Duby, R; Olson, EN				Song, Kunhua; Backs, Johannes; McAnally, John; Qi, Xiaoxia; Gerard, Robert D.; Richardson, James A.; Hill, Joseph A.; Bassel-Duby, Rhonda; Olson, Eric N.			The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases	CELL			English	Article							CONGENITAL HEART-DISEASE; SERUM RESPONSE FACTOR; HOMEOBOX GENE NKX2-5; DNA-BINDING PROTEIN; HOLT-ORAM-SYNDROME; PRESSURE-OVERLOAD; NUCLEAR EXPORT; HYPERTROPHY; EXPRESSION; DIFFERENTIATION	Postnatal cardiac myocytes respond to diverse signals by hypertrophic growth and activation of a fetal gene program. In an effort to discover regulators of cardiac hypertrophy, we performed a eukaryotic expression screen for activators of the atrial natriuretic factor (ANF) gene, a cardiac-specific marker of hypertrophic signaling. We discovered that a family of transcriptional coactivators, called CAMTAs, promotes cardiomyocyte hypertrophy and activates the ANF gene, at least in part, by associating with the cardiac homeodomain protein Nkx2-5. The transcriptional activity of CAMTAs is governed by association with class II histone deacetylases (HDACs), which negatively regulate cardiac growth. Mice homozygous for a mutation in a CAMTA gene are defective in cardiac growth in response to pressure overload and neurohumoral signaling, whereas mice lacking HDAC5, a class II HDAC, are sensitized to the prohypertrophic actions of CAMTA. These findings reveal a transcriptional regulatory mechanism that modulates cardiac growth and gene expression by linking hypertrophic signals to the cardiac genome.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Song, K (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu						Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JN, 1996, DEVELOPMENT, V122, P3809; Cleaver OB, 1996, DEVELOPMENT, V122, P3549; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Fu YC, 1998, DEVELOPMENT, V125, P4439; HARRISON BC, 2006, IN PRESS MOL CELL BI; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Kasahara H, 2003, J MOL CELL CARDIOL, V35, P243, DOI 10.1016/S0022-2828(03)00002-6; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2006, MOL BIOL CELL, V17, P438, DOI 10.1091/mbc.E05-07-0612; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Rosenthal N, 1999, J CLIN INVEST, V104, P1483, DOI 10.1172/JCI8825; Saadane N, 1999, BRIT J PHARMACOL, V127, P1165, DOI 10.1038/sj.bjp.0702676; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; SILVA ODE, 1994, PLANT MOL BIOL, V25, P921, DOI 10.1007/BF00028887; Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Temsah R, 2005, REGUL PEPTIDES, V128, P177, DOI 10.1016/j.regpep.2004.12.026; Thompson JT, 1998, AM J PHYSIOL-HEART C, V274, pH1569, DOI 10.1152/ajpheart.1998.274.5.H1569; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	42	128	134	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					453	466		10.1016/j.cell.2006.02.048	http://dx.doi.org/10.1016/j.cell.2006.02.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678093	Bronze			2022-12-28	WOS:000237506100013
J	Kettlewell, S; Moyes, C; Bray, C; Soutar, D; MacKay, A; Byrne, D; Shoaib, T; Majumder, B; MacKie, R				Kettlewell, Stephen; Moyes, Colin; Bray, Caroline; Soutar, David; MacKay, Alan; Byrne, Dominique; Shoaib, Tairrair; Majumder, Barun; MacKie, Rona			Value of sentinel node status as a prognostic factor in melanoma: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LYMPH-NODE; ADJUVANT THERAPY; BREAST-CANCER; INTERFERON-ALPHA-2B; RISK; LYMPHADENECTOMY; DISSECTION; BIOPSY	Objective To establish the prognostic value of knowledge of sentinel node status in melanoma. Design Single centre prospective observational study, with sentinel nodes identified by lymphoscintigraphy, gamma probe, and intraoperative blue dye and examined by both conventional histopathology and immunopathology Setting Specialist surgical service in west of Scotland. Participants 482 patients with melanoma who consented to sentinel node biopsy in 1996-2003. Main outcome measure Time to recurrence of or death from melanoma. Results Of 472 patients who consented to sentinel node biopsy and in whom at least one sentinel node was identified, 367 (78%) had no tumour in the sentinel node. At mean follow-up of 42 months, 299 (82%) of this group were alive and free from disease, 24 were alive with melanoma recurrence, and 31 had died of melanoma. Of 105 patients with a positive sentinel node biopsy, 44 (42%) were alive and disease free, 12 were alive with recurrence, and 46 had died of melanoma. The survival difference between patients who were negative and those who were positive for turnout in the sentinel node was highly significant at all thickness levels over 1.0 mm (P < 0.001). Multivariate analysis showed that sentinel node status was independent of tumour thickness and ulceration. 71/105 (68%) patients with a positive sentinel node had a negative completion lymphadenectomy, and 44/71 (62%) were alive and disease free at follow-up; 34 patients with a positive sentinel node had further nodes involved, and only 4 (12%) were disease free (P < 0.001).16 patients (13 sentinel node biopsy positive 3 negative) died of other causes. Conclusion Sentinel node status is a highly significant predictor of prognosis in melanoma and should be considered in adjuvant studies. However, it should not be regarded as a standard of care until mature data from ongoing randomised trials are available.	Univ Glasgow, Dept Publ Hlth & Hlth Policy, Glasgow G12 8RZ, Lanark, Scotland; Hairmyres Hosp, Hairmyres G75 8RG, Lanark, Scotland; Royal Alexandra Hosp, Paisley PA2 9PN, Renfrew, Scotland; Greater Glasgow NHS Board, Glasgow G3 8YZ, Lanark, Scotland; Glasgow Royal Infirm, Canniesburn Plast Surg Unit, Glasgow G4 0SF, Lanark, Scotland; Glasgow Royal Infirm, Gen Surg Unit, Glasgow G4 0SF, Lanark, Scotland; Gartnavel Royal Hosp, Glasgow G12 0YN, Lanark, Scotland	University of Glasgow; University Hospital Hairmyres; University of Glasgow; University of Glasgow; Gartnavel Royal Hospital	MacKie, R (corresponding author), Univ Glasgow, Dept Publ Hlth & Hlth Policy, Glasgow G12 8RZ, Lanark, Scotland.	R.M.Mackie@clinmed.gla.ac.uk	Kelly, Caroline/AAZ-4146-2021	Kelly, Caroline/0000-0002-5330-7888				Balch CM, 1996, ANN SURG, V224, P255, DOI 10.1097/00000658-199609000-00002; Bergkvist L, 2005, BRIT J SURG, V92, P1221, DOI 10.1002/bjs.5052; CABANAS RM, 1977, CANCER, V39, P456, DOI 10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I; Doting MHE, 2002, EUR J SURG ONCOL, V28, P673, DOI 10.1053/ejso.2002.1297; Eggermont AMM, 2005, LANCET, V366, P1189, DOI 10.1016/S0140-6736(05)67482-X; FLEISSIG A, 2005, BREAST CANC RES TREA, V15, P1; Gershenwald JE, 1999, J CLIN ONCOL, V17, P976, DOI 10.1200/JCO.1999.17.3.976; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6; Kretschmer L, 2005, EUR J CANCER, V41, P531, DOI 10.1016/j.ejca.2004.11.019; Mcelrath-Garza A, 2005, J CLIN ONCOL, V23, p713S; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Morton DL, 2003, ANN SURG, V238, P538, DOI 10.1097/01.sla.0000086543.45557.cb; MORTON DL, 2005, J CLIN ONCOL, V23, P168; Veronesi U, 1999, JNCI-J NATL CANCER I, V91, P368, DOI 10.1093/jnci/91.4.368	17	50	52	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1423	1425		10.1136/bmj.38849.680509.AE	http://dx.doi.org/10.1136/bmj.38849.680509.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16735303	Green Published, Bronze			2022-12-28	WOS:000238550800031
J	Crampton, P; Carr, J				Crampton, Peter; Carr, Julia			Commentary: Socially or materially marginal children are less likely to be fully immunised - a systems response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Otago, Wellington Sch Med & Hlth Sci, Dept Publ Hlth, Wellington, New Zealand; Capital & Coast Dist Hlth Board, Serv Planning & Funding Directorate, Wellington, New Zealand	University of Otago	Crampton, P (corresponding author), Univ Otago, Wellington Sch Med & Hlth Sci, Dept Publ Hlth, POB 7343, Wellington, New Zealand.	peter.crampton@otago.ac.nz						Bond L, 1998, AUST NZ J PUBL HEAL, V22, P441, DOI 10.1111/j.1467-842X.1998.tb01411.x; Haglund B J, 1988, Scand J Prim Health Care Suppl, V1, P11; *NAT VACC ADV COMM, 1999, JAMA-J AM MED ASSOC, V281, P363; Samad L, 2006, BMJ-BRIT MED J, V332, P1312, DOI 10.1136/bmj.332.7553.1312; Schuster MA, 1998, PEDIATRICS, V101, P999, DOI 10.1542/peds.101.6.999	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1314	1314		10.1136/bmj.332.7553.1314	http://dx.doi.org/10.1136/bmj.332.7553.1314			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051YG	16740560	Bronze, Green Published			2022-12-28	WOS:000238197000024
J	Samad, L; Tate, AR; Dezateux, C; Peckham, C; Butler, N; Bedford, H				Samad, Lamiya; Tate, A. Rosemary; Dezateux, Carol; Peckham, Catherine; Butler, Neville; Bedford, Helen		Millennium Cohort Study Child Hlth	Differences in risk factors for partial and no immunisation in the first year of life: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To compare demographic, social, maternal, and infant related factors associated with partial immunisation and no immunisation in the first year of life in the United Kingdom. Design Prospective cohort study. Setting Sample of electoral wards in England, Wales, Scotland, and Northern Ireland, stratified by measures of ethnic composition and social disadvantage. Participants 18 488 infants born between September 2000 and January 2002, resident in the UK and eligible to receive child benefit (a universal benefit available to all families) at age 9 months. Main outcome measure Immunisation. status at 9 months of age, defined as fully immunised, partially immunised, or not immunised. Results Overall in the UK, 3.3% of infants were partially immunised and 1.1% were unimmunised; these rates were highest in England (3.6% and 1.3%, respectively; P < 0.01). Residence in ethnic or disadvantaged wards, larger family size, lone or teenaged parenthood, maternal smoking in pregnancy, and admission to hospital by 9 months of age were independently associated with partial immunisation status. In contrast, a higher proportion of mothers of unimmunised infants were educated to degree level or above (1.9%), were older (3.1%), or were of black Caribbean ethnicity (4.7%). Conclusions Mothers of unimmunised infants differ in terms of age and education from those of partially immunised infants. Interventions to reduce incomplete immunisation in infancy need different approaches.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London	Bedford, H (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	h.bedford@ich.ucl.ac.uk	Dezateux, Carol/A-3416-2009; Tate, Anne Rosemary/AAK-4512-2020; peckham, catherine s/I-6300-2013	Dezateux, Carol/0000-0001-9787-6276				BAKER MR, 1984, BRIT MED J, V288, P1075, DOI 10.1136/bmj.288.6423.1075; BENNETT P, 1992, HEALTH EDUC RES, V7, P341, DOI 10.1093/her/7.3.341; BHOPAL RS, 1988, COMMUNITY MED, V10, P215; *HLTH PROT AG, Q COMM DIS REP COVER; Plewis I, 2004, MILLENNIUM COHORT ST	5	82	83	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1312	1313		10.1136/bmj.332.7553.1312	http://dx.doi.org/10.1136/bmj.332.7553.1312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16740559	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000238197000023
J	Demura, H; Kobayashi, S; Nemoto, E; Matsumoto, N; Furuya, M; Yukishita, A; Muranaka, N; Morita, H; Shirakawa, K; Maruya, M; Ohyama, H; Uo, M; Kubota, T; Hashimoto, T; Kawaguchi, J; Fujiwara, A; Saito, J; Sasaki, S; Miyamoto, H; Hirata, N				Demura, H; Kobayashi, S; Nemoto, E; Matsumoto, N; Furuya, M; Yukishita, A; Muranaka, N; Morita, H; Shirakawa, K; Maruya, M; Ohyama, H; Uo, M; Kubota, T; Hashimoto, T; Kawaguchi, J; Fujiwara, A; Saito, J; Sasaki, S; Miyamoto, H; Hirata, N			Pole and global shape of 25143 Itokawa	SCIENCE			English	Article							ASTEROID-25143 ITOKAWA; RADAR OBSERVATIONS; 1998 SF36; MUSES-C	The locations of the pole and rotation axis of asteroid 25143 Itokawa were derived from Asteroid Multiband Imaging Camera data on the Hayabusa spacecraft. The retrograde pole orientation had a right ascension of 90.53 degrees and a declination of - 66.30 degrees ( 52000 equinox) or equivalently 128.5 degrees and - 89.66 degrees in ecliptic coordinates with a 3.9 degrees margin of error. The surface area is 0.393 square kilometers, the volume is 0.018378 cubic kilometers with a 5% margin of error, and the three axis lengths are 535 meters by 298 meters by 244 meters. The global Itokawa revealed a boomerang-shaped appearance composed of two distinct parts with partly faceted regions and a constricted ring structure.	Univ Aizu, Dept Comp Software, Aizu Wakamatsu, Fukushima 9658580, Japan; CosmoLogic, Midori Ku, Yokohama, Kanagawa 2260016, Japan; NEC Aerosp Syst, Tokyo 1838551, Japan; NEC TOSHIBA Space Syst, Tokyo 1838551, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Natl Astron Observ Japan, Mizusawa, Oshu 0230861, Japan; Univ Tokyo, Dept Geosyst Engn, Tokyo 1138656, Japan; Planetary Sci Inst, Tucson, AZ 85719 USA; Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan	University of Aizu; Toshiba Corporation; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Tokyo; Kobe University	Demura, H (corresponding author), Univ Aizu, Dept Comp Software, Ikki Machi, Aizu Wakamatsu, Fukushima 9658580, Japan.		Miyamoto, Hideaki/B-9666-2008; Miyamoto, Hideaki/E-3381-2012; Sasaki, Sho/S-3845-2019	Miyamoto, Hideaki/0000-0001-8013-6124; Sasaki, Sho/0000-0002-7646-5248; Hirata, Naru/0000-0002-2435-604X				Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Kaasalainen M, 2003, ASTRON ASTROPHYS, V405, pL29, DOI 10.1051/0004-6361:20030819; KAASALAINEN M, 2004, IN PRESS P HAY S; Muller TG, 2005, ASTRON ASTROPHYS, V443, P347, DOI 10.1051/0004-6361:20053862; Nakamura T, 2001, EARTH PLANETS SPACE, V53, P1047, DOI 10.1186/BF03351703; Ostro SJ, 2005, METEORIT PLANET SCI, V40, P1563, DOI 10.1111/j.1945-5100.2005.tb00131.x; Ostro SJ, 2004, METEORIT PLANET SCI, V39, P407, DOI 10.1111/j.1945-5100.2004.tb00102.x; OSTRO SJ, 2004, IN PRESS P HAY S; Robinson MS, 2002, METEORIT PLANET SCI, V37, P1651, DOI 10.1111/j.1945-5100.2002.tb01157.x; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; SEIDELMAN PK, 2003, CELEST MECH DYN ASTR, V91, P203; SULLIVAN RJ, 2002, ASTEROID, V3; THOMAS PC, 1994, ICARUS, V107, P23, DOI 10.1006/icar.1994.1004	14	79	80	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1347	1349		10.1126/science.1126574	http://dx.doi.org/10.1126/science.1126574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741112				2022-12-28	WOS:000237961600045
J	Vaiva, G; Ducrocq, F; Meyer, P; Mathieu, D; Philippe, A; Libersa, C; Goudemand, M				Vaiva, G; Ducrocq, F; Meyer, P; Mathieu, D; Philippe, A; Libersa, C; Goudemand, M			Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study	BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED INTERVENTION; MENTAL-DISORDERS; CONTROLLED TRIAL; FOLLOW-UP; CARE; INPATIENT	Objective To determine the effects over one year of contacting patients by telephone one month or three months after being discharged from an emergency department for deliberate self poisoning compared with usual treatment. Design Multicentre, randomised controlled trial. Setting 13 emergency departments in the north of France. Participants 605 people discharged from an emergency department after attempted suicide by deliberate self poisoning. Intervention The intervention consisted of contacting patients by telephone at one month or three months after discharge from an emergency department for attempted suicide to evaluate die success of recommended treatment or to adjust treatment. Control patients received treatment as usual, in most cases referral back to their general practitioner. Main outcome measures The primary outcome measures were proportion of participants who reattempted suicide, number of deaths by suicide, and losses to follow-up at 13 months' follow-up. Secondary outcome measures were types and number of contacts with health care. Results On an intention to treat basis, the three groups did not differ significantly for further suicide attempts, deaths by suicide, or losses to follow-up: contact at one month (intervention 23% (34/147) v controls 30% (93/312), difference 7%,95% confidence interval - 2% to 15% three months (25% (36/146) v 30%, difference 5%, - 4% to 14%). Participants contacted at one month were less likely at follow-up to report having reattempted suicide (12% v 22% in control group, difference 10%, 2% to 18%). Conclusion Contacting people by telephone one month after being discharged from an emergency department for deliberate self poisoning may help reduce the number of reattempted suicides over one year.	Univ Hosp Lille, Sch Med, F-59037 Lille, France; Hop Henri Mondor, INSERM, U513, Sch Med, F-94010 Creteil, France	Universite de Franche-Comte; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte	Vaiva, G (corresponding author), Univ Hosp Lille, Sch Med, 6 Rue Prof Laguesse, F-59037 Lille, France.	gvaiva@chru-lille.fr	DUCROCQ, Francois/O-7342-2014; VAIVA, Guillaume/J-8983-2015	DUCROCQ, Francois/0000-0002-0664-761X; VAIVA, Guillaume/0000-0003-2462-008X				BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Beecham J, 1992, MEASURING MENTAL HLT; Cedereke M, 2002, EUR PSYCHIAT, V17, P82, DOI 10.1016/S0924-9338(02)00632-6; Evans MO, 1999, BRIT J PSYCHIAT, V175, P23, DOI 10.1192/bjp.175.1.23; Foster T, 1997, BRIT J PSYCHIAT, V170, P447, DOI 10.1192/bjp.170.5.447; Guthrie E, 2001, BRIT MED J, V323, P135, DOI 10.1136/bmj.323.7305.135; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; HAWTON K, 1988, BRIT J PSYCHIAT, V152, P359, DOI 10.1192/bjp.152.3.359; HAWTON K, 1987, PSYCHOL MED, V17, P751, DOI 10.1017/S0033291700025988; Holley HL, 1998, SOC PSYCH PSYCH EPID, V33, P543, DOI 10.1007/s001270050092; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; OJEHAGEN A, 1992, ACTA PSYCHIAT SCAND, V85, P370, DOI 10.1111/j.1600-0447.1992.tb10321.x; PARIENTE P D, 1990, Psychiatrie and Psychobiologie, V5, P49; RYNGNESTAD T, 1997, NORDISK LAEGEFOREN, V117, P3065; SALKOVSKIS PM, 1990, BRIT J PSYCHIAT, V157, P871, DOI 10.1192/bjp.157.6.871; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; VanderSande R, 1997, BRIT J PSYCHIAT, V171, P35, DOI 10.1192/bjp.171.1.35; vanderSande R, 1997, ACTA PSYCHIAT SCAND, V96, P43; VANHEERINGEN C, 1995, PSYCHOL MED, V25, P963, DOI 10.1017/S0033291700037454; 1998, 7 EUR S SUIC SUIC BE	21	171	171	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2006	332	7552					1241	1244		10.1136/bmj.332.7552.1241	http://dx.doi.org/10.1136/bmj.332.7552.1241			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048ZC	16735333	Bronze, Green Published			2022-12-28	WOS:000237984100016
J	Rosenstock, L				Rosenstock, L			Protecting special interests in the name of "good science"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY; HEALTH; FROGS		Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Rosenstock, L (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, 650 Charles E Young Dr,16-035 CHS, Los Angeles, CA 90095 USA.	lindarosenstock@ph.ucla.edu						*AM ASS ADV SCI, 2005, POL BRIEF DAT QUAL; *ASS AM MED COLL, 2001, AAMC COMM OMB INF QU; Baba A, 2005, AM J PUBLIC HEALTH, V95, pS20, DOI 10.2105/AJPH.2004.050963; BROAD W, 1982, BETRAYERS TRUTH, P26; *CTR REG EFF, REG INF; Hayes T, 2002, NATURE, V419, P895, DOI 10.1038/419895a; Hayes T, 2003, ENVIRON HEALTH PERSP, V111, P568, DOI 10.1289/ehp.5932; Michaels D, 2005, AM J PUBLIC HEALTH, V95, pS39, DOI 10.2105/AJPH.2004.043059; Michaels D, 2005, SCI AM, V292, P96, DOI 10.1038/scientificamerican0605-96; Mooney Chris, 2005, REPUBLICAN WAR SCI; *OFF MAN BUDG, GUID ENS MAINT QUAL; Porter JE, 2005, JAMA-J AM MED ASSOC, V294, P1385, DOI 10.1001/jama.294.11.1385; Rosenstock L, 2002, AM J PUBLIC HEALTH, V92, P14, DOI 10.2105/AJPH.92.1.14; Union of Concerned Scientists, 2004, SCI INT POL INV BUSH; *US DEP HHS, REQ CORR HHS RESP; *US DEP HHS, CAS192249 US DEP HHS; *US EPA, UNPUB EPA INF QUAL G; *US EPA, US EPA REV HUM HLTH; Wadman M, 2005, NATURE, V433, P671, DOI 10.1038/433671a; Wagner W, 2005, AM J PUBLIC HEALTH, V95, pS99, DOI 10.2105/AJPH.2004.044792; Weiss Rick, 2004, Washington Post, pA8; Weiss Rick, 2004, WASH POST, pA19; 2005, FED REG, V70, P2664	23	6	6	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2407	2410		10.1001/jama.295.20.2407	http://dx.doi.org/10.1001/jama.295.20.2407			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720826				2022-12-28	WOS:000237734400026
J	Ceaser, M				Ceaser, M			Court ends Colombia's abortion ban	LANCET			English	Editorial Material																			0	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2006	367	9523					1645	1646		10.1016/S0140-6736(06)68715-1	http://dx.doi.org/10.1016/S0140-6736(06)68715-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045LH	16718862				2022-12-28	WOS:000237743100012
J	Armstrong, GL; Wasley, A; Simard, EP; McQuillan, GM; Kuhnert, WL; Alter, MJ				Armstrong, Gregory L.; Wasley, Annemarie; Simard, Edgar P.; McQuillan, Geraldine M.; Kuhnert, Wendi L.; Alter, Miriam J.			The prevalence of hepatitis C virus infection in the United States, 1999 through 2002	ANNALS OF INTERNAL MEDICINE			English	Article							INJECTION-DRUG USERS; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; INCREASE	Background: Defining the primary characteristics of persons infected with hepatitis C virus (HCV) enables physicians to more easily identify persons who are most likely to benefit from testing for the disease. Objective: To describe the HCV-infected population in the United States. Design: Nationally representative household survey. Setting: U.S. civilian, noninstitutionalized population. Participants: 15 079 participants in the National Health and Nutrition Examination Survey between 1999 and 2002. Measurements: All participants provided medical histories, and those who were 20 to 59 years of age provided histories of drug use and sexual practices. Participants were tested for antibodies to HCV (anti-HCV) and HCV RNA, and their serum alanine aminotransferase (ALT) levels were measured. Results: The prevalence of anti-HCV in the United States was 1.6% (95% CI, 1.3% to 1.9%), equating to an estimated 4.1 million (C), 3.4 million to 4.9 million) anti-HCV-positive persons nationwide; 1.3% or 3.2 million (CI, 2.7 million to 3.9 million) persons had chronic HCV infection. Peak prevalence of anti-HCV (4.3%) was observed among persons 40 to 49 years of age. A total of 48.4% of anti-HCV-positive persons between 20 and 59 years of age reported a history of injection drug use, the strongest risk factor for HCV infection. Of all persons reporting such a history, 83.3% had not used injection drugs for at least 1 year before the survey. Other significant risk factors included 20 or more lifetime sex partners and blood transfusion before 1992. Abnormal serum ALT levels were found in 58.7% of HCV RNA-positive persons. Three characteristics (abnormal serum ALT level, any history of injection drug use, and history of blood transfusion before 1992) identified 85.1% of HCV RNA-positive participants between 20 and 59 years of age. Limitations: Incarcerated and homeless persons were not included in the survey. Conclusions: Many Americans are infected with HCV. Most were born between 1945 and 1964 and can be identified with current screening criteria. History of injection drug use is the strongest risk factor for infection.	Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Armstrong, GL (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Mailstop G-37,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	GArmstrong@cdc.gov	Simard, Edgar/G-4552-2010	Simard, Edgar/0000-0001-8093-2067				Alter HJ, 2000, NAT MED, V6, P1082, DOI 10.1038/80394; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Alter MJ, 2004, ANN INTERN MED, V141, P715, DOI 10.7326/0003-4819-141-9-200411020-00013; ALTER MJ, 1990, JAMA-J AM MED ASSOC, V264, P2231, DOI 10.1001/jama.264.17.2231; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; ARMSTRONG GL, 2004, P 42 ANN M INF DIS S, P191; *CDCP, GEN INF NHANES INT D; *CDCP, NHANES 2001 2002 PUB; *CDCP, 58 DCP; *CDCP, NHANES AN GUID; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Cheung RC, 2002, J CLIN GASTROENTEROL, V34, P476, DOI 10.1097/00004836-200204000-00021; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Des Jarlais DC, 2003, AM J EPIDEMIOL, V157, P467, DOI 10.1093/aje/kwf222; DONAHUE JG, 1992, NEW ENGL J MED, V327, P369, DOI 10.1056/NEJM199208063270601; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; Fuller CM, 2004, J URBAN HEALTH, V81, P20, DOI 10.1093/jurban/jth084; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Johnston L D, 1997, NIDA Res Monogr, V167, P59; Murphy EL, 2000, HEPATOLOGY, V31, P756, DOI 10.1002/hep.510310329; Orton SL, 2004, TRANSFUSION, V44, P275, DOI 10.1111/j.1537-2995.2004.00623.x; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; Thomas DL, 2000, HEPATOLOGY, V31, P790, DOI 10.1002/hep.510310336; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562	30	1556	1601	0	48	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2006	144	10					705	714		10.7326/0003-4819-144-10-200605160-00004	http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043XO	16702586				2022-12-28	WOS:000237636400001
J	Spaulding, AC; Weinbaum, CM; Lau, DTY; Sterling, R; Seeff, LB; Margolis, HS; Hoofnagle, JH				Spaulding, Anne C.; Weinbaum, Cindy M.; Lau, Daryl T. -Y.; Sterling, Richard; Seeff, Leonard B.; Margolis, Harold S.; Hoofnagle, Jay H.			A framework for management of hepatitis C in prisons	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-INFECTION; THERAPY; INMATES; ALCOHOL	The prevalence of chronic hepatitis C virus (HCV) infection in prisons ranges from 12% to 31%. There are generally accepted - albeit still evolving - guidelines for identification and treatment of hepatitis C in the community. However, there is less agreement among health professionals caring for prisoners about best practices for identification, medical management, and treatment of hepatitis C. inmates often lack health care before incarceration. In prisons, infected persons could be identified and the management of infection initiated; however, the high prevalence of HCV infection among prisoners would impose a disproportionate cost for hepatitis C care on the correctional system. The optimal solution is for prison and public health systems in the United States to jointly provide targeted HCV testing and standard-of-care hepatitis C medical management, treatment, and prevention programs to prison inmate populations. The authors report on a January 2003 meeting of experts in prison health, public health, hepatology, and infectious diseases and explore the clinical care, prevention, and collaboration needed to provide hepatitis C management in prisoners.	Ctr Dis Control & Prevent, Atlanta, GA USA; Univ Texas, Med Branch, Galveston, TX 77555 USA; Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA; Natl Inst Hlth, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Medical Branch Galveston; Virginia Commonwealth University; National Institutes of Health (NIH) - USA	Spaulding, AC (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	aspauld@emory.edu	lau, daryl/AAH-5057-2020					ALLEN S, 2003, CONS MAN HEP C PRIS; Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; Alter MJ, 2004, ANN INTERN MED, V141, P715, DOI 10.7326/0003-4819-141-9-200411020-00013; ANNO BJ, 2001, CORRECTIONAL HLTH CA; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; [Anonymous], 1997, HEPATOLOGY, V26, pS2; [Anonymous], 2002, HLTH STAT SOON TO BE, V1; [Anonymous], 1999, PRISON J, DOI DOI 10.1177/0032885599079003002; [Anonymous], NAT HEP C PREV STRAT; [Anonymous], PRISONERS 1999; *ASS STAT TERR HLT, 2002, HEP C INC POP NEXT W; Asselah T, 2003, GUT, V52, P900, DOI 10.1136/gut.52.6.900; Bacon BR, 2002, HEPATOLOGY, V36, pS179, DOI 10.1053/jhep.2002.36386; BECK AJ, 2002, HIV PRISONS JAILS 20; Beck AJ, 2004, HEPATITIS TESTING TR; Beck Allen J., 1999, PRISONERS 1998; BELENKO S, 1998, BARS SUBSTANCE ABUSE; Bhattacharya R, 2003, J CLIN GASTROENTEROL, V36, P242, DOI 10.1097/00004836-200303000-00012; BURNETT D, 2003, CONS MAN HEP C PRIS; CASSIDY W, 2003, CONS MAN HEP C PRIS; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Conklin TJ, 1998, AM J PUBLIC HEALTH, V88, P1249; CURRAN J, 2003, CONS MAN HEP C PRIS; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; Edlin BR, 2002, HEPATOLOGY, V36, pS210, DOI 10.1053/jhep.2002.36809; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; *FED BUR PRIS, FED BUR PRIS CLIN PR; FIELDS HF, 2003, CONS MAN HEP C PRIS; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; GOTTULA R, 2003, CONS MAN HEP C PRIS; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; HARRISON PM, 2004, PRISON JAIL INMATES; HARRISON PM, 2003, PRISONERS 2002; *HRSA HIV AIDS BUR, LAW POL POL NOT; Hughes T., 2004, REENTRY TRENDS US; HUGHES T, 2003, NATL CORRECTIONS REP; *IMM ACT COAL, MOD PROGR HEP A B C; *LA DEP CORR, 2003, TREATM PROT HEP C; LAU D, 2003, CONS MAN HEP C PRIS; Lindsay KL, 2002, HEPATOLOGY, V36, pS114, DOI 10.1053/jhep.2002.36226; McCollister KE, 2003, J QUANT CRIMINOL, V19, P389, DOI 10.1023/B:JOQC.0000005441.49529.61; Mumola C. J., 1999, SUBSTANCE ABUSE TREA; *NAT COMM CORR HLT, 2002, HEP ED INM; *NAT CTR HIV STD T, PUBL HLTH CRIM JUST; PARIS J, 2003, CONS MAN HEP C PRIS; PARIS J, 2005, J CORRECT HEALTH CAR, V11, P199; Peters MG, 2002, HEPATOLOGY, V36, pS220, DOI 10.1053/jhep.2002.36811; PFISTER JR, 2001, TARGETED HEPATITIS C; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; RIEGER D, 2003, CONS MAN HEP C PRIS; ROLD W, 2003, CONS MAN HEP C PRIS; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P947; SPAULDING A, 2003, CONS MAN HEP C PRIS; Sterling RK, 2005, AM J GASTROENTEROL, V100, P313, DOI 10.1111/j.1572-0241.2005.40116.x; Sterling RK, 2004, AM J GASTROENTEROL, V99, P866, DOI 10.1111/j.1572-0241.2004.30310.x; STERN MF, 2003, CONS MAN HEP C PRIS; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Sylvestre DL, 2005, J SUBST ABUSE TREAT, V29, P159, DOI 10.1016/j.jsat.2005.06.002; THEODORE D, 2003, CONS MAN HEP C PRIS; THOMAS D, 2003, CONS MAN HEP C PRIS; US Department of Justice Office of Justice Programs National Institute of Justice, 2002, IMPL TEL CORR FAC; *US PUBL HLTH SERV, 1997, HIV PREV B MED ADV P; WEINBAUM C, 2003, CONS MAN HEP C PRIS; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562	67	67	67	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2006	144	10					762	769		10.7326/0003-4819-144-10-200605160-00010	http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043XO	16702592				2022-12-28	WOS:000237636400007
J	Goyal, M; Wiznitzer, M				Goyal, M; Wiznitzer, M			Emergency management of seizures in children	LANCET			English	Editorial Material							CONVULSIVE STATUS EPILEPTICUS		Rainbow Babies & Childrens Hosp, Epilepsy Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Wiznitzer, M (corresponding author), Rainbow Babies & Childrens Hosp, Epilepsy Ctr, Cleveland, OH 44106 USA.	max.wiznitzer@cwru.edu	Goyal, Mayank/AAE-7323-2019					Ahmad S, 2006, LANCET, V367, P1591, DOI 10.1016/S0140-6736(06)68696-0; Appleton R, 2000, ARCH DIS CHILD, V83, P415; Browne T R, 1983, Adv Neurol, V34, P509; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Goodkin HP, 2003, EPILEPSIA, V44, P1109, DOI 10.1046/j.1528-1157.2003.62402.x; Rey E, 1999, CLIN PHARMACOKINET, V36, P409, DOI 10.2165/00003088-199936060-00003	6	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1555	1556		10.1016/S0140-6736(06)68669-8	http://dx.doi.org/10.1016/S0140-6736(06)68669-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698394				2022-12-28	WOS:000237598000006
J	Kumpf, M; Sieverding, L; Gass, M; Kaulitz, R; Ziemer, G; Hofbeck, M				Kumpf, M; Sieverding, L; Gass, M; Kaulitz, R; Ziemer, G; Hofbeck, M			Lesson of the week - Anomalous origin of left coronary artery in young athletes with syncope	BRITISH MEDICAL JOURNAL			English	Article							SUDDEN-DEATH; AORTIC SINUS; IDENTIFICATION; ADOLESCENTS		Univ Klinikum Tubingen, Dept Pediat Cardiol Pulmonol & Intens Care, D-72076 Tubingen, Germany; Univ Klinikum Tubingen, Dept Thorac & Cardiovasc Surg, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kumpf, M (corresponding author), Univ Klinikum Tubingen, Dept Pediat Cardiol Pulmonol & Intens Care, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	matthias.kumpf@med.uni-tuebingen.de	Hofbeck, Michael/ABB-3259-2020	Hofbeck, Michael/0000-0001-7034-1132				Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; Davis JA, 2001, J AM COLL CARDIOL, V37, P593, DOI 10.1016/S0735-1097(00)01136-0; Driscoll DJ, 1997, J AM COLL CARDIOL, V29, P1039, DOI 10.1016/S0735-1097(97)00020-X; Frommelt PC, 2001, PEDIATR CARDIOL, V22, P327, DOI 10.1007/s002460010239; MCCONNELL MV, 1995, CIRCULATION, V92, P3158, DOI 10.1161/01.CIR.92.11.3158; MUSTAFA I, 1981, J THORAC CARDIOV SUR, V82, P297; Romp RL, 2003, ANN THORAC SURG, V76, P589, DOI 10.1016/S0003-4975(03)00436-3; Schmitt R, 2005, EUR RADIOL, V15, P1110, DOI 10.1007/s00330-005-2707-z; Zipes DP, 2005, J AM COLL CARDIOL, V45, P1354, DOI 10.1016/j.jacc.2005.02.014	10	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 13	2006	332	7550					1139	1141		10.1136/bmj.332.7550.1139	http://dx.doi.org/10.1136/bmj.332.7550.1139			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16690672	Green Published			2022-12-28	WOS:000237682700027
J	Laifer, G; Frei, R; Adler, H; Fluckiger, U				Laifer, G; Frei, R; Adler, H; Fluckiger, U			Necrotising pneumonia complicating a nasal furuncle	LANCET			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; METHICILLIN		Univ Basel Hosp, Div Infect Dis, CH-4031 Basel, Switzerland; Univ Basel Hosp, Microbiol Lab, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Laifer, G (corresponding author), Univ Basel Hosp, Div Infect Dis, CH-4031 Basel, Switzerland.	laiferg@uhbs.ch						Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nolte O, 2005, EUR J CLIN MICROBIOL, V24, P477, DOI 10.1007/s10096-005-1354-2; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9	5	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2006	367	9522					1628	1628		10.1016/S0140-6736(06)68702-3	http://dx.doi.org/10.1016/S0140-6736(06)68702-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698418				2022-12-28	WOS:000237598000036
J	Flier, JS				Flier, JS			Neuroscience - Regulating energy balance: The substrate strikes back	SCIENCE			English	Editorial Material							S6 KINASE; TOR; INSULIN; ACTIVATION; OBESITY; PATHWAY		Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Flier, JS (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA.	jflier@bidmc.harvard.edu	Flier, jeffrey/AAG-6223-2019					ANDERSON GH, 1994, MODERN NUTR HLTH DIS, P520; Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Choi YH, 2001, BRAIN RES, V892, P320, DOI 10.1016/S0006-8993(00)03267-4; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Long X, 2003, CURR TOP MICROBIOL, V279, P115; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	20	30	30	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					861	+		10.1126/science.1127971	http://dx.doi.org/10.1126/science.1127971			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690851				2022-12-28	WOS:000237452900030
J	Yoon, A; Peng, G; Brandenburg, Y; Zollo, O; Xu, W; Rego, E; Ruggero, D				Yoon, A; Peng, G; Brandenburg, Y; Zollo, O; Xu, W; Rego, E; Ruggero, D			Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita	SCIENCE			English	Article							P27(KIP1) MESSENGER-RNA; RIBOSOME-ENTRY-SITE; MICE LACKING; CELL-DEATH; ACCUMULATION; ASSOCIATION; HYPERPLASIA; EXPRESSION; INITIATION; DEFICIENT	The DKC1 gene encodes a pseudouridine synthase that modifies ribosomal RNA ( rRNA). DKC1 is mutated in people with X-linked dyskeratosis congenita (X-DC), a disease characterized by bone marrow failure, skin abnormalities, and increased susceptibility to cancer. How alterations in ribosome modification might lead to cancer and other features of the disease remains unknown. Using an unbiased proteomics strategy, we discovered a specific defect in IRES ( internal ribosome entry site) - dependent translation in Dkc1(m) mice and in cells from X-DC patients. This defect results in impaired translation of messenger RNAs containing IRES elements, including those encoding the tumor suppressor p27(Kip1) and the antiapoptotic factors Bcl-xL and XIAP (X-linked Inhibitor of Apoptosis Protein). Moreover, Dkc1(m) ribosomes were unable to direct translation from IRES elements present in viral messenger RNAs. These findings reveal a potential mechanism by which defective ribosome activity leads to disease and cancer.	Fox Chase Canc Ctr, Human Genet Program, Philadelphia, PA 19111 USA; Univ Sao Paulo, Ctr Cell Based Therapy, Fdn Hemoctr Ribeirao Preto, BR-05508 Sao Paulo, Brazil	Fox Chase Cancer Center; Universidade de Sao Paulo	Ruggero, D (corresponding author), Fox Chase Canc Ctr, Human Genet Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	davide.ruggero@fccc.edu	Rego, Eduardo M/A-1058-2012; Rego, Eduardo M./Y-5572-2019; Rego, Eduardo/AFS-7973-2022	Rego, Eduardo M/0000-0003-1567-4086; Rego, Eduardo M./0000-0003-1567-4086; Rego, Eduardo/0000-0003-1567-4086				Cho SC, 2005, MOL CELL BIOL, V25, P1283, DOI 10.1128/MCB.25.4.1283-1297.2005; Dokal I, 1996, Curr Opin Hematol, V3, P453; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Gasper NA, 2002, INFECT IMMUN, V70, P4075, DOI 10.1128/IAI.70.8.4075-4082.2002; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Millard SS, 1997, J BIOL CHEM, V272, P7093, DOI 10.1074/jbc.272.11.7093; Miskimins WK, 2001, MOL CELL BIOL, V21, P4960, DOI 10.1128/MCB.21.15.4960-4967.2001; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; PELLETIER J, 1989, J VIROL, V63, P441, DOI 10.1128/JVI.63.1.441-444.1989; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Sharma V, 2006, J IMMUNOL, V176, P97, DOI 10.4049/jimmunol.176.1.97; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Stauber AJ, 2005, MOL PHARMACOL, V67, P681, DOI 10.1124/mol.104.007278; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Wang C, 2002, MOL CELL BIOL, V22, P8457, DOI 10.1128/MCB.22.24.8457-8466.2002; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6	29	306	316	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					902	906		10.1126/science.1123835	http://dx.doi.org/10.1126/science.1123835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690864				2022-12-28	WOS:000237452900045
J	Holland, G; Ballentine, CJ				Holland, G; Ballentine, CJ			Seawater subduction controls the heavy noble gas composition of the mantle	NATURE			English	Article							MID-ATLANTIC RIDGE; LOIHI SEAMOUNT; NEON ISOTOPES; MASS-TRANSFER; POPPING ROCK; LAU BASIN; SYSTEMATICS; HELIUM; ORIGIN; ARGON	The relationship between solar volatiles and those now in the Earth's atmosphere and mantle reservoirs provides insight into the processes controlling the acquisition of volatiles during planetary accretion and their subsequent evolution. Whereas the light noble gases ( helium and neon) in the Earth's mantle preserve a solar-like isotopic composition, heavy noble gases ( argon, krypton and xenon) have an isotopic composition very similar to that of the modern atmosphere, with radiogenic and ( in the case of xenon) solar contributions. Mantle noble gases in a magmatic CO2 natural gas field have been previously corrected for shallow atmosphere/groundwater and crustal additions. Here we analyse new data from this field and show that the elemental composition of non-radiogenic heavy noble gases in the mantle is remarkably similar to that of sea water. We challenge the popular concept of a noble gas `subduction barrier' - the convecting mantle noble gas isotopic and elemental composition is explained by subduction of sediment and seawater-dominated pore fluids. This accounts for similar to 100% of the non-radiogenic argon and krypton and 80% of the xenon. Approximately 50% of the convecting mantle water concentration can then be explained by this mechanism. Enhanced recycling of subducted material to the mantle plume source region then accounts for the lower ratio of radiogenic to non-radiogenic heavy noble gas isotopes and higher water content of plume-derived basalts.	Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England	University of Manchester	Holland, G (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Oxford Rd, Manchester M13 9PL, Lancs, England.	g.holland@manchester.ac.uk		Ballentine, Chris/0000-0001-9382-070X	Natural Environment Research Council [NER/A/S/2002/00960] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; Bach W, 1998, EARTH PLANET SC LETT, V160, P297, DOI 10.1016/S0012-821X(98)00091-0; Ballantyne GH, 2005, INT J MED ROBOT COMP, V1, P5, DOI 10.1002/rcs.35; Ballentine CJ, 2000, EARTH PLANET SC LETT, V180, P39, DOI 10.1016/S0012-821X(00)00161-8; Ballentine CJ, 2005, NATURE, V433, P33, DOI 10.1038/nature03182; Ballentine CJ, 2002, PHILOS T ROY SOC A, V360, P2611, DOI 10.1098/rsta.2002.1083; Burnard P, 1997, SCIENCE, V276, P568, DOI 10.1126/science.276.5312.568; Burnard PG, 1998, CHEM GEOL, V147, P99, DOI 10.1016/S0009-2541(97)00175-7; Caffee MW, 1999, SCIENCE, V285, P2115, DOI 10.1126/science.285.5436.2115; Class C, 2005, NATURE, V436, P1107, DOI 10.1038/nature03930; Dixon JE, 2001, J PETROL, V42, P627, DOI 10.1093/petrology/42.3.627; Ellam RM, 2004, EARTH PLANET SC LETT, V228, P511, DOI 10.1016/j.epsl.2004.10.020; FARLEY KA, 1994, GEOCHIM COSMOCHIM AC, V58, P2509; Harrison D, 1999, EARTH PLANET SC LETT, V171, P199, DOI 10.1016/S0012-821X(99)00143-0; Harrison D, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000325; Hauri E, 2002, CHEM GEOL, V183, P115, DOI 10.1016/S0009-2541(01)00374-6; HILTON DR, 1993, GEOCHIM COSMOCHIM AC, V57, P2819, DOI 10.1016/0016-7037(93)90392-A; Hilton DR, 2002, REV MINERAL GEOCHEM, V47, P319, DOI 10.2138/rmg.2002.47.9; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; HONDA M, 1987, J GEOPHYS RES-SOLID, V92, P12507, DOI 10.1029/JB092iB12p12507; Kent AJR, 1999, CHEM GEOL, V156, P299, DOI 10.1016/S0009-2541(98)00188-0; Kent AJR, 1999, GEOCHIM COSMOCHIM AC, V63, P2749, DOI 10.1016/S0016-7037(99)00215-X; Kingsley RH, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000199; Kunz J, 1998, SCIENCE, V280, P877, DOI 10.1126/science.280.5365.877; Kunz J, 1999, NATURE, V399, P649, DOI 10.1038/21352; LUPTON JE, 1975, EARTH PLANET SC LETT, V26, P133, DOI 10.1016/0012-821X(75)90080-1; MATSUDA J, 1986, GEOCHEM J, V20, P71, DOI 10.2343/geochemj.20.71; Moreira M, 1998, SCIENCE, V279, P1178, DOI 10.1126/science.279.5354.1178; Ott U, 2002, REV MINERAL GEOCHEM, V47, P71, DOI 10.2138/rmg.2002.47.3; PATTERSON DB, 1990, GEOPHYS RES LETT, V17, P705, DOI 10.1029/GL017i006p00705; Pepin RO, 2002, REV MINERAL GEOCHEM, V47, P191, DOI 10.2138/rmg.2002.47.7; PORCELLI D, 1995, GEOCHIM COSMOCHIM AC, V59, P1991, DOI 10.1016/0016-7037(95)00122-0; PORCELLI D, 1995, GEOCHIM COSMOCHIM AC, V59, P4921, DOI 10.1016/0016-7037(95)00336-3; POREDA R, 1986, EARTH PLANET SC LETT, V78, P1, DOI 10.1016/0012-821X(86)90168-8; Robert F, 2000, SPACE SCI REV, V92, P201, DOI 10.1023/A:1005291127595; Sarda P, 2005, NATURE, V436, P95, DOI 10.1038/nature03636; Sarda P, 1999, SCIENCE, V283, P666, DOI 10.1126/science.283.5402.666; SARDA P, 1990, EARTH PLANET SC LETT, V97, P268, DOI 10.1016/0012-821X(90)90047-2; SARDA P, 1988, EARTH PLANET SC LETT, V91, P73, DOI 10.1016/0012-821X(88)90152-5; Sarda P, 2000, J GEOPHYS RES-SOL EA, V105, P5973, DOI 10.1029/1999JB900282; Seta A, 2001, EARTH PLANET SC LETT, V188, P211, DOI 10.1016/S0012-821X(01)00307-7; Simons K, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000173; STAUDACHER T, 1988, EARTH PLANET SC LETT, V89, P173, DOI 10.1016/0012-821X(88)90170-7; THOMPSON AB, 1992, NATURE, V358, P295, DOI 10.1038/358295a0; Tolstikhin I, 2005, PHYS EARTH PLANET IN, V148, P109, DOI 10.1016/j.pepi.2004.05.011; Trieloff M, 2000, SCIENCE, V288, P1036, DOI 10.1126/science.288.5468.1036; Trieloff M, 2002, EARTH PLANET SC LETT, V200, P297, DOI 10.1016/S0012-821X(02)00639-8; van Keken P. E., 2003, TREATISE GEOCHEMISTR, V2, P471; YORK D, 1969, EARTH PLANET SC LETT, V5, P320	49	199	203	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					186	191		10.1038/nature04761	http://dx.doi.org/10.1038/nature04761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688169				2022-12-28	WOS:000237418800038
J	Barennes, H; Balima-Koussoube, T; Nagot, N; Charpentier, JC; Pussard, E				Barennes, H; Balima-Koussoube, T; Nagot, N; Charpentier, JC; Pussard, E			Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CEREBRAL MALARIA; IN-VIVO; PHARMACOKINETICS; QUINIMAX(R)	Objective To compare the safety and efficacy of quinine given by the rectal route with quinine given by the intramuscular route in children with moderately severe Plasmodium falciparum malaria. Design Randomised, open, clinical trial. Setting Health centre in Burkina Faso. Participants 898 children with moderately severe P falciparum malaria who were unable to take oral treatment. Intervention Rectal quinine (20 mg/kg diluted to 30 mg/ml in water solution) or intramuscular quinine (12.5 mg/kg) every 12 hours until oral quinine could be taken. Main outcome measures Primary safety outcome was the presence of blood in stools and secondary safety outcome was diarrhoea. Primary efficacy outcome was early treatment failure and secondary efficacy outcomes were late clinical and parasitological failures, fever clearance time, and time to oral intake. Results Blood in stools and diarrhoea were more common in children given quinine by the rectal route than by the intramuscular route (blood in stools: 5% v 1%, absolute difference 3.9%, 95% confidence interval 1.8% to 6.1%: diarrhoea: 5% v 1%, 3.5%, 1.3% to 5.7%). On anoscopy, inflammatory lesions (9/248, 3%) were associated with bloody striations in stools. Side effects of rectal quinine were rare and transitory. Local pain (90%), inflammation (79%), and transient impairment of mobility (15%) were observed with intramuscular quinine. Early treatment failure was higher in the rectal group (6% v 3%, absolute difference 3.0%, 95% confidence interval 0.2% to 5.9%). All except two children in each group had negative blood slide results at day 5. Fever recurrence at day 7 was higher in the intramuscular group (37/375 v 18/395, absolute difference 5.3%, 1.6% to 8.9%). Other efficacy outcomes (late clinical failure, late parasitological failure, fever clearance time, time to starting oral intake and rate of deterioration to severe malaria) did not differ. Conclusion Quinine given through the rectal route has art acceptable safety profile and could be Used in the early management of malaria in children in sub-Saharan Africa, halting progression to severe disease.	Ctr MURAZ, Bobo Dioulasso, Burkina Faso; Methodol & Res Ctr, Cernay Les Reims, France; Hop Kremlin Bicetre, Serv Pharmacol, Le Kremlin Bicetre, France	Centre Muraz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Barennes, H (corresponding author), Inst Francophone Med Trop, BP 9519, Viangchan, Laos.	hubert.barennes@auf.org	PUSSARD, Eric/S-6059-2018; Nagot, Nicolas/I-9467-2014; pussard, eric/J-9916-2013; Barennes, hubert/E-9728-2011	Nagot, Nicolas/0000-0002-3493-2821				Aceng JR, 2005, BMJ-BRIT MED J, V330, P334, DOI 10.1136/bmj.330.7487.334; Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Assimadi J K, 2002, Med Trop (Mars), V62, P158; BARENNES H, 1994, TROP DOCT, V24, P32, DOI 10.1177/004947559402400115; Barennes H, 1999, Med Trop (Mars), V59, P383; Barennes H, 2003, EUR J CLIN PHARMACOL, V58, P649, DOI 10.1007/s00228-002-0546-2; Barennes H, 2001, Sante, V11, P145; BARENNES H, 1995, T ROY SOC TROP MED H, V89, P418, DOI 10.1016/0035-9203(95)90036-5; Barennes H, 1996, BRIT J CLIN PHARMACO, V41, P389, DOI 10.1046/j.1365-2125.1996.03246.x; Barennes H, 1998, T ROY SOC TROP MED H, V92, P437, DOI 10.1016/S0035-9203(98)91083-5; Barnes KI, 2004, LANCET, V363, P1598, DOI 10.1016/S0140-6736(04)16203-X; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BOUREIMA SH, 1996, MALARIA, V8, P25; DELNERO L, 1994, AM J TROP MED HYG, V50, P102, DOI 10.4269/ajtmh.1994.50.102; DIALLO AH, 2003, B SOC PATHOL EXOT, P99; Faiz MA, 2005, LANCET, V366, P717; Fawaz F, 2004, INT J PHARMACEUT, V280, P151, DOI 10.1016/j.ijpharm.2004.05.002; Harouna Y, 2000, Bull Soc Pathol Exot, V93, P328; Huygens P., 2002, Cahiers d'Etudes et de Recherches Francophones/Sante, V12, P357; LEHESRAN JY, 1999, MULT IN MAL AFR MAL, pC86; Pussard E, 2004, ANTIMICROB AGENTS CH, V48, P4422, DOI 10.1128/AAC.48.11.4422-4426.2004; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; SIMONSEN L, 1999, B WORLD HEALTH ORGAN, V77, P79; VANHOOGDALEM EJ, 1991, CLIN PHARMACOKINET, V21, P11, DOI 10.2165/00003088-199121010-00002; WHO, 2001, MON ANT DRUG RES REP	25	18	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1055	1057		10.1136/bmj.332.7549.1055	http://dx.doi.org/10.1136/bmj.332.7549.1055			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16675812	Green Published, Bronze			2022-12-28	WOS:000237518400013
J	Chan, AW; Upshur, R; Singh, JA; Ghersi, D; Chapuis, F; Altman, DG				Chan, AW; Upshur, R; Singh, JA; Ghersi, D; Chapuis, F; Altman, DG			Research protocols - Waiving confidentiality for the greater good	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESEARCH ETHICS COMMITTEES; CLINICAL-RESEARCH; RANDOMIZED-TRIALS; PUBLICATION BIAS; FOLLOW-UP; FATE	Research protocols are usually kept confidential to protect intellectual and commercial interests. But secrecy can also hide deviations that affect the validity of results and threaten the integrity of medical research.	Canadian Inst Hlth Res, Randomized Controlled Trials Unit, Toronto, ON, Canada; Univ Toronto, Primary Care Res Unit, Toronto, ON, Canada; Ctr AIDS Program Res, Bioeth & Hlth Law Programme, Durban, South Africa; Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia; Univ Lyon 1, Hosp Civils Lyon, Clin Epidemiol Unit, F-69365 Lyon, France; Canc Res UK, Oxford, England; NHS Ctr Stat Med, Oxford, England	Institute for Work & Health; University of Toronto; University of Sydney; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cancer Research UK	Chan, AW (corresponding author), Canadian Inst Hlth Res, Randomized Controlled Trials Unit, Toronto, ON, Canada.	anwen.chan@utoronto.ca	Singh, Jerome Amir/ABG-1573-2021	Upshur, Ross/0000-0003-1128-0557				Academy of Medical Sciences, 2006, PERS DAT PUBL GOOD U; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; CHAN MHW, 1991, PHASE TRANSITION   S, V2, P1; *COMM NAT INF LIB, LOI 78 17 6 JAN 1978; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; DEANGELIS CD, 2005, JAMA; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; *DEP HLTH, 2001, GOV ARR NHS RES ETH; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71; Ghersi D, 2004, LANCET ONCOL, V5, P325, DOI 10.1016/S1470-2045(04)01473-1; GIAMMONA M, 1983, CLIN RES, V31, P572; GLASZIOU P, 2000, BRIT MED J, V328, P121; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1645, DOI 10.1001/jama.295.14.1645; Hahn S, 2002, J EVAL CLIN PRACT, V8, P353, DOI 10.1046/j.1365-2753.2002.00314.x; International Conference on Harmonisation of technical requirements for pharmaceuticals for human use (ICH), 1996, GUID GOOD CLIN PRACT; Jones G, 2004, BRIT MED J, V329, P1360, DOI 10.1136/bmj.329.7479.1360; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; LIN WT, 2000, J ASSOC INF SYST, V1, P1; Mann H, 2002, LANCET, V360, P406, DOI 10.1016/S0140-6736(02)09613-7; Marshall E, 2004, SCIENCE, V304, P1576, DOI 10.1126/science.304.5677.1576; McCabe S, 2005, PLOS MED, V2, P169, DOI 10.1371/journal.pmed.0020049; *MED RES COUNC, 2000, PERS INF MED RES; *MED RES COUNC CAN, 2003, TRIC POL STAT ETH CO; MILLER ED, 2001, J HOPKINS NEWS INFOR; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; MURRAY GD, 2001, BRIT MED J, V32, P1461; *NAT HLTH MED RES, 1999, NAT STAT ETH COND 1; *NAT LTH MED RES C, 1999, NAT STAT ETH COND 2; *NIH, PRIV BOARDS HIPAA PI; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; RELMAN AS, 1990, NEW ENGL J MED, V323, P1355; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; WEIJER C, 1995, CAN MED ASSOC J, V152, P1973	36	36	36	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1086	1089		10.1136/bmj.332.7549.1086	http://dx.doi.org/10.1136/bmj.332.7549.1086			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16675819	Green Published			2022-12-28	WOS:000237518400024
J	Persiani, R; Biondi, A; Buccelletti, F; Rausei, S; Silveri, NG				Persiani, R; Biondi, A; Buccelletti, F; Rausei, S; Silveri, NG			Unusual acute abdomen: to operate or not to operate?	LANCET			English	Editorial Material							HEREDITARY ANGIOEDEMA		Catholic Univ, Dept Internal & Emergency Med, I-00168 Rome, Italy; Catholic Univ, Dept Surg, Gen Surg Unit, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Buccelletti, F (corresponding author), Catholic Univ, Dept Internal & Emergency Med, Largo A Gemelli 8, I-00168 Rome, Italy.	francesco.buccelletti@mssm.edu	Biondi, Alberto/K-4781-2018; Buccelletti, Francesco/AAS-3826-2020; Rausei, Stefano/AAM-7898-2021	Biondi, Alberto/0000-0002-2470-7858; Rausei, Stefano/0000-0002-6676-2935; Persiani, Roberto/0000-0001-5584-6095				De Backer AI, 2001, AM J ROENTGENOL, V176, P649, DOI 10.2214/ajr.176.3.1760649; Gompels MM, 2005, CLIN EXP IMMUNOL, V139, P379, DOI 10.1111/j.1365-2249.2005.02726.x; Koruth JS, 2005, GASTROINTEST ENDOSC, V61, P907, DOI 10.1016/S0016-5107(05)00334-2; Nzeako UC, 2001, ARCH INTERN MED, V161, P2417, DOI 10.1001/archinte.161.20.2417	4	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1548	1548		10.1016/S0140-6736(06)68655-8	http://dx.doi.org/10.1016/S0140-6736(06)68655-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679169				2022-12-28	WOS:000237324200036
J	Stebbing, J; Sanitt, A; Nelson, M; Powles, T; Gazzard, B; Bower, M				Stebbing, J; Sanitt, A; Nelson, M; Powles, T; Gazzard, B; Bower, M			A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy	LANCET			English	Article							ADULT HIV-INFECTION; CLINICAL-TRIALS; DNA-SEQUENCES; TAT PROTEIN; HERPESVIRUS; REGRESSION; IMMUNODEFICIENCY; MODELS; RECOMMENDATIONS; QUANTIFICATION	Background AIDS-associated Kaposi's sarcoma remains common in individuals with HIV-1 infection in the era of highly active antiretroviral therapy (HAART). We developed a simple model for predicting mortality on the basis of clinical characteristics present at the time of diagnosis of Kaposi's sarcoma. Methods Of 5873 individuals with HIV-1 infection, 326 (6%) developed Kaposi's sarcoma; for 262 (80%) this was their first AIDS-defining illness. We did univariate and multivariate Cox regression analyses to identify covariates predictive of overall survival and validated our model with an independent data set of 446 patients with Kaposi's sarcoma. Results in the primary model, we developed a prognostic score from 0 to 15 starting at 10. Having Kaposi's sarcoma as the AIDS-defining illness (-3 points) and increasing CD4 count (-1 point for every complete 100 cells per mm(3)) improved prognosis; age of 50 years or older (2 points) and having another AIDS-associated illness at the same time (3 points) conveyed a poorer prognosis. In individuals with prognostic scores of 0, 5, 10, and 15, probability of survival at 1-year was 0.993, 0.967, 0.834, and 0.378, and at 5 years was 0.984, 0.918, 0.631, and 0.084, respectively. Increasing prognostic score by 1 increased I-year death hazard ratio by 40% (95% Cl 28-53%; bootstrapped hazard ratio 1.39, 1.25-1.51). The index had concordance of 76.8% (71.7-82.3). Interpretation We identified four prognostic factors that can be used to obtain an accurate prognostic index at diagnosis of AIDS-associated Kaposi's sarcoma. This index is widely applicable and can be used to guide therapeutic options.	Chelsea & Westminster Hosp, Dept Oncol, London SW10 9NH, England; Chelsea & Westminster Hosp, Dept HIV Med, London SW10 9NH, England	Imperial College London; Imperial College London	Stebbing, J (corresponding author), Chelsea & Westminster Hosp, Dept Oncol, London SW10 9NH, England.	justinstebbing@gmail.com; m.bower@imperial.ac.uk		Sanitt, Adam/0000-0003-2349-283X; Bower, Mark/0000-0002-4077-6351; Stebbing, Justin/0000-0002-1117-6947				ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; Bourboulia D, 2004, AIDS, V18, P485, DOI 10.1097/00002030-200402200-00015; Bower M, 2005, ANN INTERN MED, V143, P265, DOI 10.7326/0003-4819-143-4-200508160-00007; Bower M, 2005, J CLIN ONCOL, V23, P5224, DOI 10.1200/JCO.2005.14.597; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; COX DR, 1972, J R STAT SOC B, V34, P187; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Engels EA, 2003, AIDS, V17, P1847, DOI 10.1097/00002030-200308150-00015; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Fleming TR, 2000, BIOMETRICS, V56, P971, DOI 10.1111/j.0006-341X.2000.0971.x; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; FRIEDMANKIEN AE, 1982, ANN INTERN MED, V96, P693, DOI 10.7326/0003-4819-96-6-693; Gill R, 1982, Experientia Suppl, V41, P187; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Holkova B, 2001, J CLIN ONCOL, V19, P3848, DOI 10.1200/JCO.2001.19.18.3848; Hothorn T, 2003, COMPUT STAT DATA AN, V43, P121, DOI 10.1016/S0167-9473(02)00225-6; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KOCH R, 1982, VERH K INN MED WIESB; Krown SE, 2004, J CLIN ONCOL, V22, P399, DOI 10.1200/JCO.2004.08.064; Krown SE, 1997, J CLIN ONCOL, V15, P3085, DOI 10.1200/JCO.1997.15.9.3085; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Marcelin AG, 2004, AIDS RES HUM RETROV, V20, P704, DOI 10.1089/0889222041524689; Mariotti M, 2006, J CELL BIOCHEM, V98, P301, DOI 10.1002/jcb.20770; Nasti G, 2005, J CLIN ONCOL, V23, P2433, DOI 10.1200/JCO.2005.05.790; Nasti G, 2003, CANCER-AM CANCER SOC, V98, P2440, DOI 10.1002/cncr.11816; Nasti G, 2003, J CLIN ONCOL, V21, P2876, DOI 10.1200/JCO.2003.10.162; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Portsmouth S, 2003, AIDS, V17, pF17, DOI 10.1097/00002030-200307250-00001; Pozniak A, 2003, HIV Med, V4 Suppl 1, P1; Quinlivan EB, 2002, J INFECT DIS, V185, P1736, DOI 10.1086/340652; Reitz MS, 1999, J NATL CANCER I, V91, P1453, DOI 10.1093/jnci/91.17.1453; Royston P, 2000, STAT MED, V19, P1831, DOI 10.1002/1097-0258(20000730)19:14<1831::AID-SIM502>3.0.CO;2-1; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sgadari C, 2002, NAT MED, V8, P225, DOI 10.1038/nm0302-225; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Spano J P, 2000, HIV Med, V1, P232, DOI 10.1046/j.1468-1293.2000.00034.x; Stebbing J, 2006, ANN ONCOL, V17, P503, DOI 10.1093/annonc/mdj091; Stebbing J, 2004, J CLIN ONCOL, V22, P2177, DOI 10.1200/JCO.2004.11.097; Stebbing J, 2004, TRENDS MOL MED, V10, P187, DOI 10.1016/j.molmed.2004.02.006; Stebbing J, 2003, J ANTIMICROB CHEMOTH, V51, P1095, DOI 10.1093/jac/dkg199; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Venables W., 2013, MODERN APPL STAT S, V53, P86; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	56	67	71	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1495	1502		10.1016/S0140-6736(06)68649-2	http://dx.doi.org/10.1016/S0140-6736(06)68649-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679162				2022-12-28	WOS:000237324200029
J	Yin, Y; He, X; Szewczyk, P; Nguyen, T; Chang, G				Yin, Y; He, X; Szewczyk, P; Nguyen, T; Chang, G			Structure of the multidrug transporter EmrD from Escherichia coli	SCIENCE			English	Article							MAJOR FACILITATOR SUPERFAMILY; EFFLUX PUMP; CRYSTAL-STRUCTURE; MECHANISM; RESISTANCE; MEMBRANE; BINDING; PROTEIN; MDFA; MSBA	EmrD is a multidrug transporter from the Major Facilitator Superfamily that expels amphipathic compounds across the inner membrane of Escherichia coli. Here, we report the x-ray structure of EmrD determined to a resolution of 3.5 angstroms. The structure reveals an interior that is composed mostly of hydrophobic residues, which is consistent with its role transporting amphipathic molecules. Two long loops extend into the inner leaflet side of the cell membrane. This region can serve to recognize and bind substrate directly from the lipid bilayer. We propose that multisubstrate specificity, binding, and transport are facilitated by these loop regions and the internal cavity.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,CB-105, La Jolla, CA 92037 USA.	gchang@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070480, R21GM065798] Funding Source: NIH RePORTER; NIGMS NIH HHS [R21 GM065798-02, R21 GM065798-01, R01 GM070480, GM65798, GM70480] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adler J, 2005, J BIOL CHEM, V280, P2721, DOI 10.1074/jbc.M412332200; Adler J, 2004, J BIOL CHEM, V279, P8957, DOI 10.1074/jbc.M313422200; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Braibant M, 2005, ANTIMICROB AGENTS CH, V49, P2965, DOI 10.1128/AAC.49.7.2965-2971.2005; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; DELANO WL, PYMOL MOL VISUALIZAT; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; KASIANOWICZ J, 1984, J MEMBRANE BIOL, V82, P179, DOI 10.1007/BF01868942; Klyachko KA, 1997, J BACTERIOL, V179, P2189, DOI 10.1128/jb.179.7.2189-2193.1997; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; KRULWICH TA, 1990, MICROBIOL REV, V54, P52, DOI 10.1128/MMBR.54.1.52-65.1990; Mazurkiewicz P, 2002, J BIOL CHEM, V277, P26081, DOI 10.1074/jbc.M203141200; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murray DS, 2004, J BIOL CHEM, V279, P14365, DOI 10.1074/jbc.M313870200; NARODITSKAYA V, 1993, BIOCHEM BIOPH RES CO, V196, P803, DOI 10.1006/bbrc.1993.2320; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; PAULSEN IT, 2002, MICROBIAL MULTIDRUG; Pornillos O, 2005, SCIENCE, V310, P1950, DOI 10.1126/science.1119776; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Saier MH, 2003, MOL MICROBIOL, V48, P1145, DOI 10.1046/j.1365-2958.2003.03499.x; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005	33	303	309	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					741	744		10.1126/science.1125629	http://dx.doi.org/10.1126/science.1125629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675700	Green Accepted			2022-12-28	WOS:000237312100049
J	Berry, JF; Bill, E; Bothe, E; George, SD; Mienert, B; Neese, F; Wieghardt, K				Berry, John F.; Bill, Eckhard; Bothe, Eberhard; George, Serena DeBeer; Mienert, Bernd; Neese, Frank; Wieghardt, Karl			An octahedral coordination complex of iron(VI)	SCIENCE			English	Article							WASTE-WATER TREATMENT; SPECTROSCOPIC CHARACTERIZATION; METHANE MONOOXYGENASE; ELECTRONIC-STRUCTURE; CYTOCHROME P450CAM; CRYSTAL-STRUCTURE; DFT CALCULATIONS; NONHEME; HYDROXYLATION; HYDROGENASE	The hexavalent state, considered to be the highest oxidation level accessible for iron, has previously been found only in the tetrahedral ferrate dianion, FeO42-. We report the photochemical synthesis of another Fe(VI) compound, an octahedrally coordinated dication bearing a terminal nitrido ligand. Mossbauer and x-ray absorption spectra, supported by density functional theory, are consistent with the octahedral structure having an Fe=N triple bond of 1.57 angstroms and a singlet d(xy)(2) ground electronic configuration. The compound is stable at 77 kelvin and yields a high-spin spin Fe(III) species upon warming.	Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA	Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Wieghardt, K (corresponding author), Max Planck Inst Bioanorgan Chem, Stiftstr 34-36, D-45470 Mulheim, Germany.	wieghardt@mpi-muelheim.mpg.de	Wieghardt, Karl/B-4179-2014; DeBeer, Serena/T-6420-2018; DeBeer, Serena/G-6718-2012; Neese, Frank/J-4959-2014	Wieghardt, Karl/0000-0003-0600-7855; DeBeer, Serena/0000-0002-5196-3400; Neese, Frank/0000-0003-4691-0547; Berry, John/0000-0002-6805-0640				Aliaga-Alcalde N, 2005, ANGEW CHEM INT EDIT, V44, P2908, DOI 10.1002/anie.200462368; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Berry JF, 2006, INORG CHEM, V45, P2027, DOI 10.1021/ic051823y; Berry JF, 2005, J AM CHEM SOC, V127, P11550, DOI 10.1021/ja052673t; Betley TA, 2004, J AM CHEM SOC, V126, P6252, DOI 10.1021/ja048713v; Bowen L.H., 1993, MOSSBAUER SPECTROSCO, V1, P115; Bukowski MR, 2005, SCIENCE, V310, P1000, DOI 10.1126/science.1119092; Chanda A, 2006, J INORG BIOCHEM, V100, P606, DOI 10.1016/j.jinorgbio.2005.12.016; Costas M, 2001, J AM CHEM SOC, V123, P12931, DOI 10.1021/ja017204f; Cummins CC, 2006, ANGEW CHEM INT EDIT, V45, P862, DOI 10.1002/anie.200503327; CUMMINS CC, 1994, INORG CHEM, V33, P395, DOI 10.1021/ic00080a033; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Delaude L, 1996, J ORG CHEM, V61, P6360, DOI 10.1021/jo960633p; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Grapperhaus CA, 2000, INORG CHEM, V39, P5306, DOI 10.1021/ic0005238; Grapperhaus CA, 2001, INORG CHEM, V40, P4191, DOI 10.1021/ic001370r; Greenwood N. N., 1971, MOSSBAUER SPECTROSCO; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; Jensen MP, 2005, J AM CHEM SOC, V127, P10512, DOI 10.1021/ja0438765; Jiang JQ, 2002, WATER RES, V36, P1397, DOI 10.1016/S0043-1354(01)00358-X; Kaizer J, 2004, J AM CHEM SOC, V126, P472, DOI 10.1021/ja037288n; KAZAMA F, 1994, FEMS MICROBIOL LETT, V118, P345, DOI 10.1016/0378-1097(94)90527-4; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Klinker EJ, 2005, ANGEW CHEM INT EDIT, V44, P3690, DOI 10.1002/anie.200500485; Kumar D, 2005, J AM CHEM SOC, V127, P8026, DOI 10.1021/ja0512428; Licht S, 1999, SCIENCE, V285, P1039, DOI 10.1126/science.285.5430.1039; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Meyer K, 1999, J AM CHEM SOC, V121, P4859, DOI 10.1021/ja983454t; MISKOWSKI VM, 1996, ADV TRANSIT MET COOR, V1, P159; Murad E., 1987, MOSSBAUER SPECTROSCO, V2, P507; Nakamoto K, 2002, COORDIN CHEM REV, V226, P153, DOI 10.1016/S0010-8545(01)00425-8; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Rohde JU, 2004, J AM CHEM SOC, V126, P16750, DOI 10.1021/ja047667w; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Russo U., 1989, MOSSBAUER SPECTROSCO, V3, P289; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sharma VK, 2004, WATER SCI TECHNOL, V49, P69, DOI 10.2166/wst.2004.0223; Shima S, 2005, J AM CHEM SOC, V127, P10430, DOI 10.1021/ja051895o; Slep LD, 2003, J AM CHEM SOC, V125, P15554, DOI 10.1021/ja030377f; Thomas CM, 2006, J AM CHEM SOC, V128, P4956, DOI 10.1021/ja0604358; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0	44	232	235	6	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1937	1941		10.1126/science.1128506	http://dx.doi.org/10.1126/science.1128506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16741074				2022-12-28	WOS:000238848100055
J	Ravnskov, U; Rosch, PJ; Sutter, MC; Houston, MC				Ravnskov, Uffe; Rosch, Paul J.; Sutter, Morley C.; Houston, Mark C.			Controversy - Should we lower cholesterol as much as possible?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RISK; ATORVASTATIN; SIMVASTATIN; PRAVASTATIN; DECREASES; STATINS		New York Med Coll, Dept Med, Valhalla, NY 10595 USA; New York Med Coll, Dept Psychiat, Valhalla, NY 10595 USA; Univ British Columbia, Fac Med, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; Vanderbilt Univ, Sch Med, St Thomas Hosp, Nashville, TN 37212 USA	New York Medical College; New York Medical College; University of British Columbia; Saint Thomas Hospital; Vanderbilt University	Ravnskov, U (corresponding author), Magle Stora Kyrkogata 9, S-22350 Lund, Sweden.	ravnskov@tele2.se						FOLKERS K, 1990, P NATL ACAD SCI USA, V87, P8931, DOI 10.1073/pnas.87.22.8931; Gaist D, 2002, NEUROLOGY, V58, P1333, DOI 10.1212/WNL.58.9.1333; Getz L, 2005, BMJ-BRIT MED J, V331, P551, DOI 10.1136/bmj.38555.648623.8F; Golomb BA, 2004, QJM-INT J MED, V97, P229, DOI 10.1093/qjmed/hch035; Golomb Beatrice Alexandra, 2005, Expert Opin Drug Saf, V4, P389, DOI 10.1517/14740338.4.3.389; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; King DS, 2003, PHARMACOTHERAPY, V23, P1663, DOI 10.1592/phco.23.15.1663.31953; Lang AE, 2003, MOVEMENT DISORD, V18, P1, DOI 10.1002/mds.10410; LaRosa JC, 2005, NEW ENGL J MED, V353, P95; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Newman TB, 1996, JAMA-J AM MED ASSOC, V275, P55, DOI 10.1001/jama.275.1.55; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Ravnskov U, 2005, NEW ENGL J MED, V353, P94; Rizvi K, 2002, FAM PRACT, V19, P95, DOI 10.1093/fampra/19.1.95; Rockwood K, 2003, NEUROL RES, V25, P601, DOI 10.1179/016164103101202039; Rundek T, 2004, ARCH NEUROL-CHICAGO, V61, P889, DOI 10.1001/archneur.61.6.889; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Scott H D, 1987, R I Med J, V70, P311; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sinzinger H, 2004, BRIT J CLIN PHARMACO, V57, P525, DOI 10.1111/j.1365-2125.2003.02044.x; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720	23	30	31	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1330	1332		10.1136/bmj.332.7553.1330	http://dx.doi.org/10.1136/bmj.332.7553.1330			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051YG	16740566	Green Published			2022-12-28	WOS:000238197000029
J	Mukherjee, S; Keitany, G; Li, Y; Wang, Y; Ball, HL; Goldsmith, EJ; Orth, K				Mukherjee, Sohini; Keitany, Gladys; Li, Yan; Wang, Yong; Ball, Haydn L.; Goldsmith, Elizabeth J.; Orth, Kim			Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation	SCIENCE			English	Article							ARYLAMINE N-ACETYLTRANSFERASES; EFFECTOR YOPJ; RESPONSES; PROTEINS	Yersinia species use a variety of type III effector proteins to target eukaryotic signaling systems. The effector Yop) inhibits mitogen-activated protein kinase (MAPK) and the nu clear factor kappa B (NF kappa B) signaling pathways used in innate immune response by preventing activation of the family of MAPK kinases (MAPKK). We show that Yop) acted as an acetyltransferase, using acetylcoenzyme A (CoA) to modify the critical serine and threonine residues in the activation loop of MAPKK6 and thereby blocking phosphorylation. The acetylation on MAPKK6 directly competed with phosphorylation, preventing activation of the modified protein. This covalent modification may be used as a general regulatory mechanism in biological signaling.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Prot Chem Technol Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072134] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI056404] Funding Source: Medline; NIDDK NIH HHS [R21-DK072134] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BODE AM, 2005, SCI STKE, pRE4; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hardie G., 1995, PROTEIN KINASE FACTS, P418; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; Palmer LE, 1999, INFECT IMMUN, V67, P708, DOI 10.1128/IAI.67.2.708-716.1999; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sim E, 2000, HUM MOL GENET, V9, P2435, DOI 10.1093/hmg/9.16.2435; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Yoon S, 2003, J BIOL CHEM, V278, P2131, DOI 10.1074/jbc.M209905200	16	453	475	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1211	1214		10.1126/science.1126867	http://dx.doi.org/10.1126/science.1126867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728640				2022-12-28	WOS:000237957400053
J	Repp, J; Meyer, G; Paavilainen, S; Olsson, FE; Persson, M				Repp, Jascha; Meyer, Gerhard; Paavilainen, Sami; Olsson, Fredrik E.; Persson, Mats			Imaging bond formation between a gold atom and pentacene on an insulating surface	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; MOLECULE	A covalent bond between an individual pentacene molecule and a gold atom was formed by means of single-molecule chemistry inside a scanning tunneling microscope junction. The bond formation is reversible, and different structural isomers can be produced. The single-molecule synthesis was done on ultrathin insulating films that electronically isolated the reactants and products from their environment. Direct imaging of the orbital hybridization upon bond formation provides insight into the energetic shifts and occupation of the molecular resonances.	IBM Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland; Tampere Univ Technol, Inst Phys, Tampere 33720, Finland; Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden; Univ Liverpool, Dept Chem, Liverpool L69 3BX, Merseyside, England; Univ Liverpool, Surface Sci Res Ctr, Liverpool L69 3BX, Merseyside, England	International Business Machines (IBM); Tampere University; Chalmers University of Technology; University of Liverpool; University of Liverpool	Repp, J (corresponding author), IBM Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.	jre@zurich.ibm.com	Persson, Mats O/A-7514-2011; Paavilainen, Sami/B-7772-2010; Repp, Jascha/B-1843-2014	Persson, Mats O/0000-0002-1443-9490; Paavilainen, Sami/0000-0002-8987-8674; Repp, Jascha/0000-0003-2883-7083				EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Flood AH, 2004, SCIENCE, V306, P2055, DOI 10.1126/science.1106195; Hahn JR, 2001, PHYS REV LETT, V87, DOI [10.1103/PhysRevLett.87.166102, 10.1103/PhysRevLett.87.196102]; Hla SW, 2000, PHYS REV LETT, V85, P2777, DOI 10.1103/PhysRevLett.85.2777; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lee HJ, 1999, SCIENCE, V286, P1719, DOI 10.1126/science.286.5445.1719; Olsson FE, 2003, SURF SCI, V540, P172, DOI 10.1016/S0039-6028(03)00783-0; Pacchioni G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.226104; Qiu XH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.206102; Repp J, 2004, SCIENCE, V305, P493, DOI 10.1126/science.1099557; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; Repp J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.225503; Stipe BC, 1997, PHYS REV LETT, V78, P4410, DOI 10.1103/PhysRevLett.78.4410; TERSOFF J, 1983, PHYS REV LETT, V50, P1998, DOI 10.1103/PhysRevLett.50.1998; VOLLHARDT KPC, 2002, ORGANIC CHEM; Wu SW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.236802; Yamachika R, 2004, SCIENCE, V304, P281, DOI 10.1126/science.1095069	18	265	267	8	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1196	1199		10.1126/science.1126073	http://dx.doi.org/10.1126/science.1126073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728636				2022-12-28	WOS:000237957400048
J	Arroyo, JG				Arroyo, Jorge G.			A 76-year-old man with macular degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							AGE-RELATED MACULOPATHY; SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL GROWTH-FACTOR; CHLAMYDIA-PNEUMONIAE INFECTION; FACTOR-H POLYMORPHISM; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PHOTODYNAMIC THERAPY; 5-YEAR INCIDENCE; INTRAVITREAL INJECTION		Beth Israel Deaconess Med Ctr, Div Ophthalmol, Retina Serv, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Arroyo, JG (corresponding author), Beth Israel Deaconess Med Ctr, Div Ophthalmol, Retina Serv, Shapiro 5th Floor,330 Brookline Ave, Boston, MA 02215 USA.	jarroyo@bidmc.harvard.edu		Arroyo, Jorge/0000-0001-9812-296X				Abdel-Meguid A, 2003, BRIT J OPHTHALMOL, V87, P615, DOI 10.1136/bjo.87.5.615; Abdelsalam A, 1999, SURV OPHTHALMOL, V44, P1, DOI 10.1016/S0039-6257(99)00072-7; Adamis AP, 2005, RETINA-J RET VIT DIS, V25, P111, DOI 10.1097/00006982-200502000-00001; Aisenbrey S, 2003, AM J OPHTHALMOL, V135, P748, DOI 10.1016/S0002-9394(03)00145-4; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; [Anonymous], 1991, Arch Ophthalmol, V109, P1109; [Anonymous], 2004, Drugs R D, V5, P58; [Anonymous], 1998, Ophthalmology, V105, P11; Arnold J, 2001, AM J OPHTHALMOL, V131, P541; Auricchio A, 2002, MOL THER, V6, P490, DOI 10.1006/mthe.2002.0702; Barik S, 2004, ANN MED, V36, P540, DOI 10.1080/07853890410018817; Bergink GJ, 1998, GRAEF ARCH CLIN EXP, V236, P321, DOI 10.1007/s004170050085; Bosch T, 2005, THER APHER DIAL, V9, P459, DOI 10.1111/j.1744-9987.2005.00306.x; BRESSLER NM, 1995, ARCH OPHTHALMOL-CHIC, V113, P301, DOI 10.1001/archopht.1995.01100030055022; Bressler NM, 2004, OPHTHALMOLOGY, V111, P1993, DOI 10.1016/j.ophtha.2004.07.023; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Bressler NM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1307; Bressler NM, 2001, OPHTHALMOLOGY, V108, P435, DOI 10.1016/S0161-6420(00)00666-7; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Brunel JM, 2005, CURR CANCER DRUG TAR, V5, P267, DOI 10.2174/1568009054064642; BURGESS DB, 1993, ARCH OPHTHALMOL-CHIC, V111, P1189; Campochiaro PA, 2006, GENE THER, V13, P559, DOI 10.1038/sj.gt.3302653; Char DH, 1999, AM J OPHTHALMOL, V127, P574, DOI 10.1016/S0002-9394(99)00038-0; Cho EY, 2004, ARCH OPHTHALMOL-CHIC, V122, P883, DOI 10.1001/archopht.122.6.883; CHRISTEN WG, 1994, AM J MED, V97, pS14, DOI 10.1016/0002-9343(94)90293-3; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; Christen WG, 2001, ARCH OPHTHALMOL-CHIC, V119, P1143, DOI 10.1001/archopht.119.8.1143; Ciulla TA, 2002, BRIT J OPHTHALMOL, V86, P209, DOI 10.1136/bjo.86.2.209; Ciulla TA, 2002, AM J OPHTHALMOL, V134, P905, DOI 10.1016/S0002-9394(02)01821-4; Ciulla TA, 2001, BRIT J OPHTHALMOL, V85, P510, DOI 10.1136/bjo.85.5.510; Ciulla Thomas A, 2004, Curr Opin Ophthalmol, V15, P211, DOI 10.1097/01.icu.0000120711.35941.76; *CLINICALTRIALS, LIST MAC DEG TRIALS; *CLINICALTRIALS, RAN NAIV PREV TREAT; Complications of Age-Related Macular Degeneration Prevention Trial Study Group, 2004, Clin Trials, V1, P91; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; Desatnik H, 2000, RETINA-J RET VIT DIS, V20, P143, DOI 10.1097/00006982-200003000-00005; Duffield-Lillico AJ, 2004, JNCI-J NATL CANCER I, V96, P1729, DOI 10.1093/jnci/djh344; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; *FDN FIGHT BLIND, PREL DAT PHAS 3 TRIA; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Fish G, 2003, OPHTHALMOLOGY, V110, P979, DOI 10.1016/S0161-6420(03)00085-X; Flower RW, 2002, AM J OPHTHALMOL, V134, P228, DOI 10.1016/S0002-9394(02)01579-9; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; FRIEDMAN E, 1989, OPHTHALMOLOGY, V96, P104; FRIEDMAN E, 1995, OPHTHALMOLOGY, V102, P640, DOI 10.1016/S0161-6420(95)30974-8; Friedman E, 1997, AM J OPHTHALMOL, V124, P677, DOI 10.1016/S0002-9394(14)70906-7; Gass JDM, 2003, RETINA-J RET VIT DIS, V23, P741, DOI 10.1097/00006982-200312000-00001; Gillies MC, 2004, ARCH OPHTHALMOL-CHIC, V122, P336, DOI 10.1001/archopht.122.3.336; Goodman GE, 2004, J NATL CANCER I, V96, P1743, DOI 10.1093/jnci/djh320; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Grossniklaus HE, 2005, ARCH OPHTHALMOL-CHIC, V123, P914; Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; HAWKINS BS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1200; HAWKINS BS, 1986, ARCH OPHTHALMOL-CHIC, V104, P694; Hawkins BS, 2004, OPHTHALMOLOGY, V111, P1967, DOI 10.1016/j.ophtha.2004.07.021; Heier JS, 2005, AM SOC RET SPEC 23 A; HO A, 2006, MAC SOC 29 ANN M FEB; HOGAN M J, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P64; HOLZ FG, 1994, ARCH OPHTHALMOL-CHIC, V112, P402, DOI 10.1001/archopht.1994.01090150132035; Hsu J, 2005, CAN J OPHTHALMOL, V40, P320, DOI 10.1016/S0008-4182(05)80075-4; Husain D, 1996, ARCH OPHTHALMOL-CHIC, V114, P978, DOI 10.1001/archopht.1996.01100140186012; INGBER DE, 1986, ENDOCRINOLOGY, V119, P1768, DOI 10.1210/endo-119-4-1768; JAMPOL LM, 1991, ARCH OPHTHALMOL-CHIC, V109, P789, DOI 10.1001/archopht.1991.01080060053022; Johnson LV, 2000, EXP EYE RES, V70, P441, DOI 10.1006/exer.1999.0798; Kalayoglu MV, 2005, GRAEF ARCH CLIN EXP, V243, P1080, DOI 10.1007/s00417-005-1169-y; Kalayoglu MV, 2003, ARCH OPHTHALMOL-CHIC, V121, P478, DOI 10.1001/archopht.121.4.478; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein BEK, 2001, AM J EPIDEMIOL, V154, P207, DOI 10.1093/aje/154.3.207; Klein R, 2005, AM J OPHTHALMOL, V140, P35, DOI 10.1016/j.ajo.2005.01.051; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 2003, ARCH OPHTHALMOL-CHIC, V121, P1151, DOI 10.1001/archopht.121.8.1151; KLEIN R, 1995, OPHTHALMOLOGY, V102, P371; Klein R, 1997, OPHTHALMOLOGY, V104, P1804, DOI 10.1016/S0161-6420(97)30023-2; Klein R, 2001, ARCH OPHTHALMOL-CHIC, V119, P1354; KLEIN R, 1993, OPHTHALMOLOGY, V100, P406; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koh Sean S., 2004, International Ophthalmology Clinics, V44, P73, DOI 10.1097/00004397-200404410-00009; Kramer M, 1996, OPHTHALMOLOGY, V103, P427; Lai JC, 2002, ARCH OPHTHALMOL-CHIC, V120, P1317, DOI 10.1001/archopht.120.10.1317; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Maguire MG, 1997, ARCH OPHTHALMOL-CHIC, V115, P741; MAGUIRE MG, 1995, ARCH OPHTHALMOL-CHIC, V113, P190; Mainster M A, 2001, Semin Ophthalmol, V16, P55, DOI 10.1076/soph.16.2.55.4213; McGwin G, 2003, BRIT J OPHTHALMOL, V87, P1121, DOI 10.1136/bjo.87.9.1121; Michels S, 2005, OPHTHALMOLOGY, V112, P1035, DOI 10.1016/j.ophtha.2005.02.007; Miller DM, 2004, AM J OPHTHALMOL, V138, P323, DOI 10.1016/j.ajo.2004.03.018; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; MILLER JW, 1995, ARCH OPHTHALMOL-CHIC, V113, P810, DOI 10.1001/archopht.1995.01100060136048; Mruthyunjaya P, 2004, OPHTHALMOLOGY, V111, P1715, DOI 10.1016/j.ophtha.2004.03.022; Niffenegger J, 1998, OPHTHALMOLOGY, V105, P1364; Patel N, 2005, IMMUNOLOGY, V115, P422, DOI 10.1111/j.1365-2567.2005.02173.x; Paunksnis A, 2005, EUR J OPHTHALMOL, V15, P255, DOI 10.1177/112067210501500213; Penn JS, 2001, INVEST OPHTH VIS SCI, V42, P283; Pertile G, 2002, AM J OPHTHALMOL, V134, P560, DOI 10.1016/S0002-9394(02)01641-0; Pulido J, 2005, J CLIN APHERESIS, V20, P185, DOI 10.1002/jca.20047; Pulido Jose S, 2002, Trans Am Ophthalmol Soc, V100, P85; Pulido JS, 2005, J CLIN APHERESIS, V20, P168, DOI 10.1002/jca.20066; Quillen DA, 1999, AM FAM PHYSICIAN, V60, P99; REGILLO C, 2004, AM AC OPHTH M OCT 23; Reich SJ, 2003, CURR OPIN GENET DEV, V13, P317, DOI 10.1016/S0959-437X(03)00043-1; REICHEL E, 2005, MAC SOC M FEBR 24 26; Robman L, 2005, AM J EPIDEMIOL, V161, P1013, DOI 10.1093/aje/kwi130; Rosenfeld PJ, 2005, OPHTHAL SURG LAS IM, V36, P331, DOI 10.3928/1542-8877-20050701-14; Russell S, 2003, OPHTHALMOLOGY, V110, P2372, DOI 10.1016/j.ophtha.2003.08.020; Schmidt-Erfurth U, 2000, SURV OPHTHALMOL, V45, P195, DOI 10.1016/S0039-6257(00)00158-2; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Shiraga F, 1998, OPHTHALMOLOGY, V105, P662, DOI 10.1016/S0161-6420(98)94021-0; Smeeth L, 2005, BRIT J OPHTHALMOL, V89, P1171, DOI 10.1136/bjo.2004.064477; Smith W, 1996, ARCH OPHTHALMOL-CHIC, V114, P1518, DOI 10.1001/archopht.1996.01100140716016; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Smithen LM, 2004, AM J OPHTHALMOL, V138, P740, DOI 10.1016/j.ajo.2004.06.067; Sternberg P, 1996, ARCH OPHTHALMOL-CHIC, V114, P400; Sternberg P, 2003, OPHTHALMOLOGY, V110, P971, DOI 10.1016/S0161-6420(03)00098-8; Tolentino MJ, 2004, RETINA-J RET VIT DIS, V24, P132, DOI 10.1097/00006982-200402000-00018; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; van Wijngaarden P, 2005, JAMA-J AM MED ASSOC, V293, P1509, DOI 10.1001/jama.293.12.1509; Vine AK, 2005, OPHTHALMOLOGY, V112, P2076, DOI 10.1016/j.ophtha.2005.07.004; Westfall AC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1075, DOI 10.1001/archopht.123.8.1075; Wilson HL, 2004, AM J OPHTHALMOL, V137, P615, DOI 10.1016/j.ajo.2003.10.025; Woodburn KW, 2002, RETINA-J RET VIT DIS, V22, P391, DOI 10.1097/00006982-200208000-00001; Yeh DC, 2004, INVEST OPHTH VIS SCI, V45, P2368, DOI 10.1167/iovs.03-0981; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645; Zack DJ, 1999, MOL VIS, V5, pU37; Zarbin MA, 1998, EUR J OPHTHALMOL, V8, P199, DOI 10.1177/112067219800800401; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	141	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2394	2406		10.1001/jama.295.20.2394	http://dx.doi.org/10.1001/jama.295.20.2394			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720825				2022-12-28	WOS:000237734400025
J	Sheridan, DJ				Sheridan, Desmond J.			Reversing the decline of academic medicine in Europe	LANCET			English	Editorial Material							CLINICAL-RESEARCH; BIOMEDICAL-RESEARCH; 5 FUTURES		St Marys Hosp, Fac Med, Imperial Coll, Acad Cardiol Unit, London W2 1NY, England	Imperial College London	Sheridan, DJ (corresponding author), St Marys Hosp, Fac Med, Imperial Coll, Acad Cardiol Unit, Praed St, London W2 1NY, England.	d.sheridan@imperial.ac.uk						*AC MED SCI, 2003, STRENGTH CLIN RES; [Anonymous], FRAMEWORK PROGRAMME; Awasthi S, 2005, PLOS MED, V2, P606, DOI 10.1371/journal.pmed.0020207; Banatvala J, 2005, LANCET, V365, P458; Bassand JP, 2002, LANCET, V360, P1866, DOI 10.1016/S0140-6736(02)11776-4; Clark J, 2005, BRIT MED J, V331, P101, DOI 10.1136/bmj.331.7508.101; Commonwealth Fund Task Force on Academic Health Centers, 2003, ENV FUT AC HLTH CTR; *COUNC HEADS MED S, 2004, CLIN AC STAFF LEV UK; ELPIDOFOROS S, 2005, BRIT MED J, V331, P192; European Federation of Pharmaceutical Industries and Associations, 1997, PHARM IND FIG; Fatovic-Ferencic S, 2005, BMJ-BRIT MED J, V331, P194, DOI 10.1136/bmj.331.7510.194; Forde A, 2005, SCIENCE, V308, P428, DOI 10.1126/science.308.5720.428; Gennery B, 2005, CLIN MED, V5, P39, DOI 10.7861/clinmedicine.5-1-39; Groth Carl-Gustav, 2003, Lakartidningen, V100, P1824; Guttmacher AE, 2005, JAMA-J AM MED ASSOC, V294, P1399, DOI 10.1001/jama.294.11.1399; Hexeberg E, 1998, Tidsskr Nor Laegeforen, V118, P103; Ioannidis JPA, 2004, BMJ-BRIT MED J, V329, P789; Kennedy D, 2005, SCIENCE, V308, P165, DOI 10.1126/science.1112920; Lakhani A, 2005, BRIT MED J, V330, P1426, DOI 10.1136/bmj.330.7505.1426; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Lindahl S, 2000, LANCET, V356, pS54, DOI 10.1016/S0140-6736(00)92040-3; Ludvigsson Jonas F, 2005, Nature, V434, P542, DOI 10.1038/nj7032-542b; Peters K, 2004, CLIN MED, V4, P551, DOI 10.7861/clinmedicine.4-6-551; Pusey C, 2004, CLIN MED, V4, P483, DOI 10.7861/clinmedicine.4-6-483; Rahman A, 2005, BRIT MED J, V330, P153, DOI 10.1136/bmj.330.7483.153; Saracci R, 2005, BRIT MED J, V330, P1459, DOI 10.1136/bmj.330.7506.1459; Scott T, 2004, BMJ-BRIT MED J, V329, P1484, DOI 10.1136/bmj.329.7480.1484; Tugwell P, 2004, LANCET, V363, P836, DOI 10.1016/S0140-6736(04)15772-3; Van Der Meer J W M, 2005, Verh K Acad Geneeskd Belg, V67, P67; Vlassov V, 2005, BMJ-BRIT MED J, V331, P906, DOI 10.1136/bmj.331.7521.906-a; Watson R, 2005, BMJ-BRIT MED J, V330, P746, DOI 10.1136/bmj.330.7494.746-b; Wilhelm MJ, 2004, THORAC CARDIOV SURG, V52, P117, DOI 10.1055/s-2004-817807; Williams G, 2004, BMJ-BRIT MED J, V329, P92, DOI 10.1136/bmj.329.7457.92; Zannad F, 2001, THERAPIE, V56, P341; BEST RES BEST HLTH N	35	49	49	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2006	367	9523					1698	1701		10.1016/S0140-6736(06)68739-4	http://dx.doi.org/10.1016/S0140-6736(06)68739-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714192				2022-12-28	WOS:000237743100035
J	Grantham, JJ; Torres, VE; Chapman, AB; Guay-Woodford, LM; Bae, KT; King, BF; Wetzel, LH; Baumgarten, DA; Kenney, PJ; Harris, PC; Klahr, S; Bennett, WM; Hirschman, GN; Meyers, CM; Zhang, XL; Zhu, F; Miller, JP				Grantham, JJ; Torres, VE; Chapman, AB; Guay-Woodford, LM; Bae, KT; King, BF; Wetzel, LH; Baumgarten, DA; Kenney, PJ; Harris, PC; Klahr, S; Bennett, WM; Hirschman, GN; Meyers, CM; Zhang, XL; Zhu, F; Miller, JP		CRISP Investigators	Volume progression in polycystic kidney disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL-DOMINANT; RENAL-FUNCTION; MANAGEMENT; CONSORTIUM; SEVERITY; CRISP; ADPKD; CYST	Background: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive enlargement of cyst-filled kidneys. Methods: In a three-year study, we measured the rates of change in total kidney volume, total cyst volume, and iothalamate clearance in patients with ADPKD. Of a total of 241 patients, in 232 patients without azotemia who were 15 to 46 years old at baseline we used magnetic-resonance imaging to correlate the total kidney volume and total cyst volume with iothalamate clearance. Statistical methods included analysis of variance, Pearson correlation, and multivariate regression analysis. Results: Total kidney volume and total cyst volume increased exponentially, a result consistent with an expansion process dependent on growth. The mean (+/-SD) total kidney volume was 1060+/-642 ml at baseline and increased by a mean of 204+/-246 ml (5.27+/-3.92 percent per year, P < 0.001) over a three-year period among 214 patients. Total cyst volume increased by 218+/-263 ml (P < 0.001) during the same period among 210 patients. The baseline total kidney volume predicted the subsequent rate of increase in volume, independently of age. A baseline total kidney volume above 1500 ml in 51 patients was associated with a declining glomerular filtration rate (by 4.33+/-8.07 ml per minute per year, P < 0.001). Total kidney volume increased more in 135 patients with PKD1 mutations (by 245+/-268 ml) than in 28 patients with PKD2 mutations (by 136+/-100 ml, P=0.03). Conclusions: Kidney enlargement resulting from the expansion of cysts in patients with ADPKD is continuous and quantifiable and is associated with the decline of renal function. Higher rates of kidney enlargement are associated with a more rapid decrease in renal function.	Univ Kansas, Med Ctr, Dept Internal Med, Kidney Inst, Kansas City, KS 66160 USA; Mayo Clin Coll Med, Dept Radiol, Rochester, MN USA; Mayo Clin Coll Med, Div Nephrol & Hypertens, Rochester, MN USA; Emory Univ, Sch Med, Div Nephrol, Atlanta, GA USA; Univ Alabama Birmingham, Sch Med, Dept Med, Div Renal, Birmingham, AL USA; Univ Alabama Birmingham, Sch Med, Dept Radiol, Birmingham, AL USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biostat, St Louis, MO 63110 USA; Legacy Good Samaritan Hosp, Portland, OR USA; NIDDKD, NIH, Bethesda, MD 20892 USA	University of Kansas; University of Kansas Medical Center; Mayo Clinic; Mayo Clinic; Emory University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Grantham, JJ (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kidney Inst, Maildrop 3018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jgrantha@kumc.edu		Miller, J Philip/0000-0003-4568-6846	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039, M01RR000052, M01RR000585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK056943, U01DK056961, U01DK056956, U01DK056957] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00039, M01-RR00585, M01-RR00052] Funding Source: Medline; NIDDK NIH HHS [DK56961, DK56957, DK56956, DK56943] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bae KT, 2000, J COMPUT ASSIST TOMO, V24, P614, DOI 10.1097/00004728-200007000-00019; Bajwa ZH, 2004, KIDNEY INT, V66, P1561, DOI 10.1111/j.1523-1755.2004.00921.x; Bajwa ZH, 2001, KIDNEY INT, V60, P1631, DOI 10.1046/j.1523-1755.2001.00985.x; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; Chapman AB, 2003, ADV RENAL REPLACE TH, V10, P24, DOI 10.1053/jarr.2003.50005; Choukroun G, 1995, J AM SOC NEPHROL, V6, P1634; Fick-Brosnahan G, 1999, AM J KIDNEY DIS, V34, P639, DOI 10.1016/S0272-6386(99)70387-2; Fick-Brosnahan GM, 2002, AM J KIDNEY DIS, V39, P1127, DOI 10.1053/ajkd.2002.33379; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; Grantham J, 2000, KIDNEY PHYSL PATHOPH, V2, P2513; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Grantham JJ, 1997, KIDNEY INT, pS93; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Johnson AM, 1997, J AM SOC NEPHROL, V8, P1560; King BF, 2000, J AM SOC NEPHROL, V11, P1505, DOI 10.1681/ASN.V1181505; King BF, 2003, KIDNEY INT, V64, P2214, DOI 10.1046/j.1523-1755.2003.00326.x; Magistroni R, 2003, J AM SOC NEPHROL, V14, P1164, DOI 10.1097/01.ASN.0000061774.90975.25; O'Neill WC, 2005, AM J KIDNEY DIS, V46, P1058, DOI 10.1053/j.ajkd.2005.08.026; RAVINE D, 1993, AM J KIDNEY DIS, V22, P803, DOI 10.1016/S0272-6386(12)70338-4; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Sise C, 2000, KIDNEY INT, V58, P2492, DOI 10.1046/j.1523-1755.2000.00433.x; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; THOMPSON PA, 2002, P 27 ANN SAS US GROU; THOMSEN HS, 1981, UROL RADIOL, V3, P85, DOI 10.1007/BF02927815; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; van den Dool SW, 2005, RADIOLOGY, V236, P189, DOI 10.1148/radiol.2361021463; Wilson DM, 1997, AM J KIDNEY DIS, V30, P646, DOI 10.1016/S0272-6386(97)90488-1	29	539	560	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2122	2130		10.1056/NEJMoa054341	http://dx.doi.org/10.1056/NEJMoa054341			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707749	Bronze			2022-12-28	WOS:000237575400006
J	Pace, NR				Pace, NR			Time for a change	NATURE			English	Editorial Material									Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Pace, NR (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.							Sapp J, 2005, MICROBIOL MOL BIOL R, V69, P292, DOI 10.1128/MMBR.69.2.292-305.2005; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004	2	113	123	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2006	441	7091					289	289		10.1038/441289a	http://dx.doi.org/10.1038/441289a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710401				2022-12-28	WOS:000237593200025
J	Campbell, LV				Campbell, LV			Our patients remain with us: that is what experience means	LANCET			English	Editorial Material									St Vincents Hosp, Ctr Diabet, Sydney, NSW 2010, Australia	St Vincents Hospital Sydney	Campbell, LV (corresponding author), St Vincents Hosp, Ctr Diabet, Sydney, NSW 2010, Australia.	l.campbell@gawan.org.au	Campbell, Lesley V/B-2271-2008						0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2006	367	9522					1626	1627		10.1016/S0140-6736(06)68701-1	http://dx.doi.org/10.1016/S0140-6736(06)68701-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698417				2022-12-28	WOS:000237598000035
J	Jakobsen, B; Poulsen, HF; Lienert, U; Almer, J; Shastri, SD; Sorensen, HO; Gundlach, C; Pantleon, W				Jakobsen, B; Poulsen, HF; Lienert, U; Almer, J; Shastri, SD; Sorensen, HO; Gundlach, C; Pantleon, W			Formation and subdivision of deformation structures during plastic deformation	SCIENCE			English	Article							COPPER SINGLE-CRYSTALS; DISLOCATION ARRANGEMENT; DIE VERSETZUNGSANORDNUNG; STRAIN; METALS; FCC; POLYCRYSTALS; ORIENTATION; EVOLUTION; ROTATION	During plastic deformation of metals and alloys, dislocations arrange in ordered patterns. How and when these self-organization processes take place have remained elusive, because in situ observations have not been feasible. We present an x-ray diffraction method that provided data on the dynamics of individual, deeply embedded dislocation structures. During tensile deformation of pure copper, dislocation-free regions were identified. They showed an unexpected intermittent dynamics, for example, appearing and disappearing with proceeding deformation and even displaying transient splitting behavior. Insight into these processes is relevant for an understanding of the strength and work-hardening of deformed materials.	Riso Natl Lab, Ctr Fundamental Res Met Struct Dimens 4, Mat Res Dept, DK-4000 Roskilde, Denmark; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Technical University of Denmark; United States Department of Energy (DOE); Argonne National Laboratory	Poulsen, HF (corresponding author), Riso Natl Lab, Ctr Fundamental Res Met Struct Dimens 4, Mat Res Dept, DK-4000 Roskilde, Denmark.	henning.friis.poulsen@risoe.dk	Sørensen, Henning Osholm/C-7479-2012; Gundlach, Carsten/B-9122-2008; Poulsen, Henning F/A-4131-2012; Pantleon, Wolfgang/L-9657-2014; Sørensen, Henning Osholm/AAA-5023-2022	Sørensen, Henning Osholm/0000-0002-7004-547X; Gundlach, Carsten/0000-0002-2895-1882; Poulsen, Henning F/0000-0001-7876-4113; Pantleon, Wolfgang/0000-0001-6418-6260; Sørensen, Henning Osholm/0000-0002-7004-547X; Jakobsen, Bo/0000-0002-4018-6431				ARGON AS, 1993, ACTA METALL MATER, V41, P3289, DOI 10.1016/0956-7151(93)90058-Z; Barabash RI, 1999, J APPL CRYSTALLOGR, V32, P1050, DOI 10.1107/S0021889899010237; Cizek P, 2001, SCRIPTA MATER, V45, P815, DOI 10.1016/S1359-6462(01)01100-9; ESSMANN U, 1965, PHYS STATUS SOLIDI, V12, P707, DOI 10.1002/pssb.19650120218; ESSMANN U, 1963, PHYS STATUS SOLIDI, V3, P932, DOI 10.1002/pssb.19630030512; Estrin Y, 1998, ACTA MATER, V46, P5509, DOI 10.1016/S1359-6454(98)00196-7; GOTTLER E, 1973, PHILOS MAG, V28, P1057, DOI 10.1080/14786437308220968; Hahner P, 1996, ACTA MATER, V44, P2345, DOI 10.1016/1359-6454(95)00364-9; Hughes DA, 1997, ACTA MATER, V45, P105, DOI 10.1016/S1359-6454(96)00153-X; Hughes DA, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.135503; Kassner ME, 2002, METALL MATER TRANS A, V33, P311, DOI 10.1007/s11661-002-0092-7; KRIVOGLAZ MA, 1969, THEORY XRAY NEUTRON; Larson BC, 2002, NATURE, V415, P887, DOI 10.1038/415887a; Lauridsen EM, 2001, J APPL CRYSTALLOGR, V34, P744, DOI 10.1107/S0021889801014170; Liu Q, 1998, P ROY SOC A-MATH PHY, V454, P2555, DOI 10.1098/rspa.1998.0271; Margulies L, 2001, SCIENCE, V291, P2392, DOI 10.1126/science.1057956; MUGHRABI H, 1986, PHILOS MAG A, V53, P793, DOI 10.1080/01418618608245293; MUGHRABI H, 1971, PHILOS MAG, V23, P869, DOI 10.1080/14786437108216994; Nabarro FRN, 1967, THEORY CRYSTAL DISLO; NIX WD, 1985, METALL TRANS A, V16, P2215, DOI 10.1007/BF02670420; Poulsen H. H., 2004, 3 DIMENSIONAL XRAY D; PRINZ FB, 1984, ACTA METALL MATER, V32, P1021, DOI 10.1016/0001-6160(84)90004-X; Roters F, 2000, ACTA MATER, V48, P4181, DOI 10.1016/S1359-6454(00)00289-5; Rudolph P, 2005, CRYST RES TECHNOL, V40, P7, DOI 10.1002/crat.200410302; STEEDS JW, 1966, PROC R SOC LON SER-A, V292, P343, DOI 10.1098/rspa.1966.0139; Wilkens M., 1970, Physica Status Solidi A, V2, P359, DOI 10.1002/pssa.19700020224; ZEHETBAUER M, 1993, ACTA METALL MATER, V41, P589, DOI 10.1016/0956-7151(93)90089-B	28	217	220	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					889	892		10.1126/science.1124141	http://dx.doi.org/10.1126/science.1124141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690859				2022-12-28	WOS:000237452900040
J	Loureiro, J; Lilley, BN; Spooner, E; Noriega, V; Tortorella, D; Ploegh, HL				Loureiro, Joana; Lilley, Brendan N.; Spooner, Eric; Noriega, Vanessa; Tortorella, Domenico; Ploegh, Hidde L.			Signal peptide peptidase is required for dislocation from the endoplasmic reticulum	NATURE			English	Article							I MEMBRANE-PROTEIN; COMPLEX CLASS-I; INTRAMEMBRANE PROTEOLYSIS; MISFOLDED PROTEINS; ASPARTIC PROTEASES; CYTOSOL; ER; DIFFERENTIATION; GLYCOPROTEIN; DESTRUCTION	Human cytomegalovirus ( HCMV) prevents the display of class I major histocompatibility complex (MHC) peptide complexes at the surface of infected cells as a means of escaping immune detection(1). Two HCMV-encoded immunoevasins, US2 and US11, induce the dislocation of class I MHC heavy chains from the endoplasmic reticulum membrane and target them for proteasomal degradation in the cytosol(2,3). Although the outcome of the dislocation reactions catalysed is similar, US2 and US11 operate differently: Derlin-1 is a key component of the US11 but not the US2 pathway(4). So far, proteins essential for US2-dependent dislocation have not been identified. Here we compare interacting partners of wild-type US2 with those of a dislocation-incompetent US2 mutant, and identify signal peptide peptidase (SPP) as a partner for the active form of US2. We show that a decrease in SPP levels by RNA-mediated interference inhibits heavy-chain dislocation by US2 but not by US11. Our data implicate SPP in the US2 pathway and indicate the possibility of a previously unknown function for this intramembrane-cleaving aspartic protease in dislocation from the endoplasmic reticulum.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Pathol Funct Proteom Ctr, Boston, MA 02115 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10021 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu		Loureiro, Joana/0000-0003-2793-5810; Tortorella, Domenico/0000-0003-0961-3535				Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Crawshaw SG, 2004, BIOCHEM J, V384, P9, DOI 10.1042/BJ20041216; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Gewurz BE, 2002, J BIOL CHEM, V277, P11306, DOI 10.1074/jbc.M107904200; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Lemberg MK, 2004, FEBS LETT, V564, P213, DOI 10.1016/S0014-5793(04)00192-9; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; ROQUES BP, 1983, P NATL ACAD SCI-BIOL, V80, P3178, DOI 10.1073/pnas.80.11.3178; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Tarasova NI, 2005, J MED CHEM, V48, P3768, DOI 10.1021/jm049065t; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	30	111	112	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					894	897		10.1038/nature04830	http://dx.doi.org/10.1038/nature04830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16738546				2022-12-28	WOS:000238254100047
J	Davenport, TRB; Stanley, WT; Sargis, EJ; De Luca, DW; Mpunga, NE; Machaga, SJ; Olson, LE				Davenport, TRB; Stanley, WT; Sargis, EJ; De Luca, DW; Mpunga, NE; Machaga, SJ; Olson, LE			A new genus of African monkey, Rungwecebus: Morphology, ecology, and molecular phylogenetics	SCIENCE			English	Article							OLD-WORLD MONKEYS; MANGABEYS; PAPIONINI; SEQUENCES; ORIGIN; CLADE	A new species of African monkey, Lophocebus kipunji, was described in 2005 based on observations from two sites in Tanzania. We have since obtained a specimen killed by a farmer on Mount Rungwe, the type locality. Detailed molecular phylogenetic analyses of this specimen demonstrate that the genus Lophocebus is diphyletic. We provide a description of a new genus of African monkey and of the only preserved specimen of this primate. We also present information on the animal's ecology and conservation.	Wildlife Conservat Soc, So Highlands Conservat Programme, Mbeya, Tanzania; Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; Univ Alaska Museum, Fairbanks, AK 99775 USA	Field Museum of Natural History (Chicago); Yale University; University of Alaska System; University of Alaska Fairbanks	Davenport, TRB (corresponding author), Wildlife Conservat Soc, So Highlands Conservat Programme, POB 1475, Mbeya, Tanzania.	tdavenport@wcs.org		Olson, Link/0000-0002-2481-5701	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016466] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-16466-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BYRNE RW, 1981, BEHAVIOUR, V78, P283, DOI 10.1163/156853981X00365; CRONIN JE, 1976, NATURE, V260, P700, DOI 10.1038/260700a0; Davenport T.R.B., 2005, AFR GEOGR, V13, P56; Dinesen Lars, 1994, Ibis, V136, P2; DISOTELL TR, 1994, AM J PHYS ANTHROPOL, V94, P47, DOI 10.1002/ajpa.1330940105; Fleagle JG, 2002, J HUM EVOL, V42, P267, DOI 10.1006/jhev.2001.0526; GROVES C P, 1978, Primates, V19, P1, DOI 10.1007/BF02373224; Groves C.P., 2001, PRIMATE TAXONOMY; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Harris EE, 2000, J HUM EVOL, V38, P235, DOI 10.1006/jhev.1999.0318; Jones, 2005, ARC J, V18, P1; Jones T, 2005, SCIENCE, V308, P1161, DOI 10.1126/science.1109191; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Page SL, 2001, MOL PHYLOGENET EVOL, V18, P14, DOI 10.1006/mpev.2000.0895; Page SL, 1999, MOL PHYLOGENET EVOL, V13, P348, DOI 10.1006/mpev.1999.0653; Range F, 2004, ETHOLOGY, V110, P301, DOI 10.1111/j.1439-0310.2004.00973.x; SCHWARTZ E, 1928, ANN MAG NAT HIST, V10, P664; Stanley WT, 2005, J ZOOL, V265, P269, DOI 10.1017/S0952836904006314; Waser P.M., 1982, P117	19	95	101	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1378	1381		10.1126/science.1125631	http://dx.doi.org/10.1126/science.1125631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048QM	16690815				2022-12-28	WOS:000237961600055
J	Trinder, J; Brocklehurst, P; Porter, R; Read, M; Vyas, S; Smith, L				Trinder, J.; Brocklehurst, P.; Porter, R.; Read, M.; Vyas, S.; Smith, L.			Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; TRIMESTER MISCARRIAGE; CLINICAL-TRIAL; EVACUATION; MISOPROSTOL; CURETTAGE	Objective To ascertain whether a clinically important difference exists in the incidence of gynaecological infection between surgical management and expectant or medical management of miscarriage. Design Randomised controlled trial comparing medical and expectant management with surgical management of first trimester miscarriage. Setting Early pregnancy assessment units of seven hospitals in the United Kingdom. Participants Women of less than 13 weeks' gestation, with a diagnosis of early fetal demise or incomplete miscarriage. Interventions Expectant management (no specific intervention); medical management (vaginal dose of misoprostol preceded, for women with early fetal demise, by oral mifepristone 24-48 hours earlier); surgical management (surgical evacuation). Main outcome measures Confirmed gynaecological infection at 14 days and eight weeks; need for unplanned admission or surgical intervention. Results 1200 women were recruited: 399 to expectant management, 398 to medical management, and 403 to surgical management. No differences were found in the incidence of confirmed infection within 14 days between the expectant group (3%) and the surgical group (3%) (risk difference 0.2%, 95% confidence interval - 2.2% to 2.7%) or between the medical group (2%) and the surgical group (0.7%, - 1.6% to 3.1%). Compared with the surgical group, the number of unplanned hospital admissions was significantly higher in both the expectant group (risk difference - 41%, - 47% to - 36%) and the medical group (- 10%, - 15% to - 6%). Similarly, when compared with the surgical group, the number of women who had art unplanned surgical curettage was significantly higher in the expectant group (risk difference - 39%, - 44% to - 34%) and the medical group (- 30%, - 35% to - 25%). Conclusions The incidence of gynaecological infection after surgical, expectant, and medical management of first trimester miscarriage is low (2-3%), and no evidence exists of a difference by the method of management. However, significantly more unplanned admissions mid unplanned surgical curettage occurred after expectant management and medical management than after surgical management.	Southmead Gen Hosp, Bristol BS10 5NB, Avon, England; Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; Royal United Hosp, Bath BA1 3NG, Avon, England; Gloucestershire Royal NHS Hosp, Gloucester GL1 3NN, England; E Somerset Res Consortium, W Coker BA22 9AH, Somerset, England	Southmead Hospital; University of Oxford; Gloucestershire Hospitals NHS Foundation Trust	Trinder, J (corresponding author), St Michaels Hosp, Dept Obstet & Gynaecol, Southwell St, Bristol BS2 8EG, Avon, England.	jo.trinder@bristol.ac.uk	Brocklehurst, Peter/B-5804-2011					Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; [Anonymous], 1993, BMJ, V307, P532; Bagratee JS, 2004, HUM REPROD, V19, P266, DOI 10.1093/humrep/deh049; Bradley E, 1998, HOSP MED, V59, P451; BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313; Cahill DJ, 2001, BRIT MED J, V322, P1315, DOI 10.1136/bmj.322.7298.1315; Chipchase J, 1997, BRIT J OBSTET GYNAEC, V104, P840, DOI 10.1111/j.1471-0528.1997.tb12030.x; Chung T, 1997, ACTA OBSTET GYN SCAN, V76, P248, DOI 10.1111/j.1600-0412.1997.tb07854.x; Chung TKH, 1999, FERTIL STERIL, V71, P1054, DOI 10.1016/S0015-0282(99)00128-4; DEJONGE ETM, 1995, BRIT MED J, V311, P662, DOI 10.1136/bmj.311.7006.662; Demetroulis C, 2001, HUM REPROD, V16, P365, DOI 10.1093/humrep/16.2.365; ELREFAEY H, 1995, NEW ENGL J MED, V332, P983, DOI 10.1056/NEJM199504133321502; Gronlund L, 2002, ACTA OBSTET GYN SCAN, V81, P781, DOI 10.1034/j.1600-0412.2002.810816.x; HAMILTONFAIRLEY D, 1997, PROBLEMS EARLY PREGN, P277; HENSHAW RC, 1993, BMJ-BRIT MED J, V306, P894, DOI 10.1136/bmj.306.6882.894; Jurkovic D, 1998, ULTRASOUND OBST GYN, V11, P161, DOI 10.1046/j.1469-0705.1998.11030161.x; Luise C, 2002, BMJ-BRIT MED J, V324, P873, DOI 10.1136/bmj.324.7342.873; Moodliar S, 2005, INT J GYNECOL OBSTET, V91, P21, DOI 10.1016/j.ijgo.2005.06.009; Muffley PE, 2002, AM J OBSTET GYNECOL, V187, P321, DOI 10.1067/mob.2002.126205; Ngai SW, 2001, HUM REPROD, V16, P1493, DOI 10.1093/humrep/16.7.1493; Nielsen S, 1999, BRIT J OBSTET GYNAEC, V106, P804, DOI 10.1111/j.1471-0528.1999.tb08401.x; NIELSEN S, 1995, LANCET, V345, P84, DOI 10.1016/S0140-6736(95)90060-8; *ROYAL COLL OBST G, 2000, MAN PREGN LOSS CLIN; *ROYAL COLL OBST G, 2000, MAN EARL PREGN LOSS; Royal College of Radiologists Royal College of Obstetricians and Gynaecologists, 1995, GUID ULTR PROC EARL; Sahin HG, 2001, EUR J CONTRACEP REPR, V6, P141, DOI 10.1080/713604229; Sairam S, 2001, ULTRASOUND OBST GYN, V17, P506, DOI 10.1046/j.1469-0705.2001.00364.x; Shelley JM, 2005, AUST NZ J OBSTET GYN, V45, P122, DOI 10.1111/j.1479-828X.2005.00357.x; Weeks A, 2005, OBSTET GYNECOL, V106, P540, DOI 10.1097/01.AOG.0000173799.82687.dc; Wieringa-de Waard M, 2002, HUM REPROD, V17, P2445, DOI 10.1093/humrep/17.9.2445; Wood SL, 2002, OBSTET GYNECOL, V99, P563, DOI 10.1016/S0029-7844(01)01765-3; Zhang J, 2005, NEW ENGL J MED, V353, P761, DOI 10.1056/NEJMoa044064	32	168	173	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2006	332	7552					1235	1238		10.1136/bmj.38828.593125.55	http://dx.doi.org/10.1136/bmj.38828.593125.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16707509	Bronze, Green Published			2022-12-28	WOS:000237984100014
J	Broecker, WS				Broecker, WS			Was the younger dryas triggered by a flood?	SCIENCE			English	Editorial Material							GLACIAL LAKE AGASSIZ; NORTHWEST LABRADOR SEA; MELTWATER; CLIMATE; EVENT		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Broecker, WS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	broecker@ldeo.columbia.edu						ANDREWS JT, 1994, CAN J EARTH SCI, V31, P90, DOI 10.1139/e94-008; ANDREWS JT, 1994, QUATERNARY RES, V41, P26, DOI 10.1006/qres.1994.1003; ANDREWS JT, 1995, PALEOCEANOGRAPHY, V10, P943, DOI 10.1029/95PA01426; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Brand U, 2005, QUATERNARY SCI REV, V24, P1463, DOI 10.1016/j.quascirev.2004.11.002; BROECKER WS, 1989, NATURE, V341, P250; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; de Vernal A, 1996, NATURE, V381, P774, DOI 10.1038/381774a0; Fisher TG, 2003, QUATERNARY RES, V59, P271, DOI 10.1016/S0033-5894(03)00011-5; FISHER TG, 1994, QUATERNARY SCI REV, V13, P845, DOI 10.1016/0277-3791(94)90005-1; JOHNSON RG, 1976, QUATERNARY RES, V6, P325, DOI 10.1016/0033-5894(67)90001-4; LOWELL TV, 2005, EOS, V86, P365, DOI DOI 10.1029/2005EO400001; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; RINTERKNECHT V, 2004, EOS, V85, P47; ROOTH C, 1982, PROG OCEANOGR, V11, P131, DOI 10.1016/0079-6611(82)90006-4; Seager R., 2005, GEN CIRCULATION ATMO; Teller JT, 2005, QUATERNARY SCI REV, V24, P1890, DOI 10.1016/j.quascirev.2005.01.008; Teller JT, 2002, QUATERNARY SCI REV, V21, P879, DOI 10.1016/S0277-3791(01)00145-7; TELLER JT, 1983, GLACIAL LAKE AGASSIZ, P261	19	140	148	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2006	312	5777					1146	1148		10.1126/science.1123253	http://dx.doi.org/10.1126/science.1123253			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728622				2022-12-28	WOS:000237957400030
J	Rockhold, FW; Krall, RL				Rockhold, FW; Krall, RL			Trial summaries on results databases and journal publication	LANCET			English	Editorial Material									GlaxoSmithKline Inc, Res & Dev, King Of Prussia, PA 19406 USA	GlaxoSmithKline	Rockhold, FW (corresponding author), GlaxoSmithKline Inc, Res & Dev, King Of Prussia, PA 19406 USA.	frank.w.rockhold@gsk.com	Rockhold, Frank W./C-7078-2019	Rockhold, Frank W./0000-0003-3732-4765				De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; GlaxoSmithKline, 2006, GLAXOSMITHKLINE CLIN; INT C HARM GUID E3 S	3	8	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2006	367	9523					1635	1636		10.1016/S0140-6736(06)68710-2	http://dx.doi.org/10.1016/S0140-6736(06)68710-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714168				2022-12-28	WOS:000237743100006
J	Pritchard, KI; Shepherd, LE; O'Malley, FP; Andrulis, IL; Tu, DS; Bramwell, VH; Levine, MN				Pritchard, KI; Shepherd, LE; O'Malley, FP; Andrulis, IL; Tu, DS; Bramwell, VH; Levine, MN		Natl Canc Inst Canada Clin Trials	HER2 and responsiveness of breast cancer to adjuvant chemotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	38th Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 18-21, 2002	ORLANDO, FL	Amer Soc Clin Oncol			II-ALPHA; PREMENOPAUSAL WOMEN; PREDICTIVE MARKERS; IN-SITU; HER-2/NEU OVEREXPRESSION; RANDOMIZED-TRIAL; NODE; CYCLOPHOSPHAMIDE; METHOTREXATE; FLUOROURACIL	Background: Amplification of the human epidermal growth factor receptor type 2 (HER2, also called HER2/neu) gene and overexpression of its product in breast-cancer cells may be associated with responsiveness to anthracycline-containing chemotherapy regimens. Methods: In the randomized, controlled Mammary.5 trial, we studied 639 formalin-fixed paraffin-embedded specimens obtained from 710 premenopausal women with node-positive breast cancer who had received either cyclophosphamide, epirubicin, and fluorouracil (CEF) or cyclophosphamide, methotrexate, and fluorouracil (CMF) as adjuvant chemotherapy. HER2 amplification or overexpression was evaluated with the use of fluorescence in situ hybridization, immunohistochemical analysis, and polymerase-chain-reaction analysis. Results: Amplification of HER2 was associated with a poor prognosis regardless of the type of treatment. In patients whose tumors showed amplification of HER2, CEF was superior to CMF when assessed on the basis of relapse-free survival (hazard ratio, 0.52; 95 percent confidence interval, 0.34 to 0.80; P=0.003) and overall survival (hazard ratio, 0.65; 95 percent confidence interval, 0.42 to 1.02; P=0.06). For women whose tumors lacked amplification of HER2, CEF did not improve relapse-free survival (hazard ratio for relapse, 0.91; 95 percent confidence interval, 0.71 to 1.18; P=0.49) or overall survival (hazard ratio for death, 1.06; 95 percent confidence interval, 0.83 to 1.44; P=0.68). The adjusted hazard ratio for the interaction between treatment and HER2 amplification was 1.96 for relapse-free survival (95 percent confidence interval, 1.15 to 3.36; P=0.01) and 2.04 for overall survival (95 percent confidence interval, 1.14 to 3.65; P=0.02). Conclusions: Amplification of HER2 in breast-cancer cells is associated with clinical responsiveness to anthracycline-containing chemotherapy. (cancer.gov number, NCI-V90-0027.).	Univ Toronto, Toronto Sunnybrook Reg Canc Ctr, Toronto, ON M4N 3M5, Canada; Queens Univ, Kingston, ON, Canada; Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Mt Sinai Hosp, Fred A Litwin Ctr Canc Genet, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; Univ Calgary, Dept Oncol, Calgary, AB, Canada; Tom Baker Canc Clin, Calgary, AB, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Queens University - Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Calgary; Tom Baker Cancer Clinic; University of Calgary; McMaster University; McMaster University	Pritchard, KI (corresponding author), Univ Toronto, Toronto Sunnybrook Reg Canc Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	kathy.pritchard@sunnybrook.ca	Andrulis, Irene L./E-7267-2013; Pritchard, Kathleen I/I-2184-2014	Pritchard, Kathleen I/0000-0003-0758-9666				ALLRED DC, 1992, J CLIN ONCOL, V10, P599, DOI 10.1200/JCO.1992.10.4.599; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; ARNOULD L, 2003, BREAST CANC RES TREA, V76, pA538; BONNETERRE J, 2003, P AN M AM SOC CLIN, V22, pA93; CARPENTER JT, 1994, P AN M AM SOC CLIN, V13, pA68; Clahsen PC, 1998, J CLIN ONCOL, V16, P470, DOI 10.1200/JCO.1998.16.2.470; DELAURENTIIS M, 2001, P AN M AM SOC CLIN, V20, pA133; DELMASTRO L, 2004, J CLIN ONCOL S, V22, pA571; DEPLACIDO S, 1995, BRIT J CANCER, V71, P1283, DOI 10.1038/bjc.1995.248; Di Leo A, 2002, CLIN CANCER RES, V8, P1107; Di Leo A, 2001, ANN ONCOL, V12, P1081, DOI 10.1023/A:1011669223035; DILEO A, 1999, P AN M AM SOC CLIN, V18, pA69; Dressler LG, 2005, J CLIN ONCOL, V23, P4287, DOI 10.1200/JCO.2005.11.012; FISHER B, 1990, J CLIN ONCOL, V8, P1483, DOI 10.1200/JCO.1990.8.9.1483; GOLDHIRSCH A, 1989, NEW ENGL J MED, V320, P491; GOLDHIRSCH A, 1988, NEW ENGL J MED, V319, P677; GUSTERSON BA, 1992, J CLIN ONCOL, V10, P1049, DOI 10.1200/JCO.1992.10.7.1049; Isola J. J., 2000, Breast Cancer Research and Treatment, V64, P31; Jarvinen TAH, 1999, GENE CHROMOSOME CANC, V26, P142; Knoop AS, 2005, J CLIN ONCOL, V23, P7483, DOI 10.1200/JCO.2005.11.007; Konecny G, 2001, BREAST CANCER RES TR, V69, P53, DOI 10.1023/A:1012226006395; LANDIS JR, 1977, BIOMETRICS, V33, P671, DOI 10.2307/2529465; Latta EK, 2002, MODERN PATHOL, V15, P1318, DOI 10.1097/01.MP.0000038462.62634.B1; Levine MN, 2005, J CLIN ONCOL, V23, P5166, DOI 10.1200/JCO.2005.09.423; Levine MN, 1998, J CLIN ONCOL, V16, P2651, DOI 10.1200/JCO.1998.16.8.2651; LEVINE MN, 1993, EUR J CANCER, V29A, P37, DOI 10.1016/0959-8049(93)90573-X; MANSOUR EG, 1989, NEW ENGL J MED, V320, P485, DOI 10.1056/NEJM198902233200803; MOLITERNI A, 1991, J CLIN ONCOL, V9, P1124, DOI 10.1200/JCO.1991.9.7.1124; Moliterni A, 2003, J CLIN ONCOL, V21, P458, DOI 10.1200/JCO.2003.04.021; Mueller RE, 2004, GENE CHROMOSOME CANC, V39, P288, DOI 10.1002/gcc.20008; O'Malley FP, 2001, AM J CLIN PATHOL, V115, P504; Paik S, 2000, J NATL CANCER I, V92, P1991, DOI 10.1093/jnci/92.24.1991; Paik SM, 1998, JNCI-J NATL CANCER I, V90, P1361, DOI 10.1093/jnci/90.18.1361; Pegram MD, 1997, ONCOGENE, V15, P537, DOI 10.1038/sj.onc.1201222; Press MF, 2005, CLIN CANCER RES, V11, P6598, DOI 10.1158/1078-0432.CCR-05-0636; Press MF, 2005, J CLIN ONCOL, V23, p847S; PRITCHARD KI, 2002, P AN M AM SOC CLIN, V21, pA42; Ravdin P, 1998, P AN M AM SOC CLIN, V17, p97a; Rodenhuis S, 2003, NEW ENGL J MED, V349, P7, DOI 10.1056/NEJMoa022794; SLAMON D, 2005, 28 SAN ANT BREAST CA; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Thor AD, 1998, JNCI-J NATL CANCER I, V90, P1346, DOI 10.1093/jnci/90.18.1346; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; WOOD WC, 1994, NEW ENGL J MED, V331, P139	44	411	439	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2103	2111		10.1056/NEJMoa054504	http://dx.doi.org/10.1056/NEJMoa054504			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	043BX	16707747				2022-12-28	WOS:000237575400004
J	Parashar, UD; Glass, RI				Parashar, UD; Glass, RI			Public health - Progress toward rotavirus vaccines	SCIENCE			English	Editorial Material							ORAL VACCINES; INTUSSUSCEPTION; EFFICACY; INFANTS; SAFETY		Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Parashar, UD (corresponding author), Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA 30333 USA.	uap2@cdc.gov						Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; JOHN TJ, 1976, BRIT MED J, V1, P812, DOI 10.1136/bmj.1.6013.812; Levine MM, 1997, LANCET, V349, P220, DOI 10.1016/S0140-6736(97)22004-0; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; PARASHAR UD, 2005, 43 ANN M INF DIS SOC; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Weijer C, 2000, BRIT MED J, V321, P525, DOI 10.1136/bmj.321.7260.525	10	39	40	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					851	852		10.1126/science.1128827	http://dx.doi.org/10.1126/science.1128827			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041JQ	16690845				2022-12-28	WOS:000237452900024
J	van den Heuvel, MGL; De Graaff, MP; Dekker, C				van den Heuvel, MGL; De Graaff, MP; Dekker, C			Molecular sorting by electrical steering of microtubules in kinesin-coated channels	SCIENCE			English	Article							FLEXURAL RIGIDITY; DRIVEN; TRANSPORT; MOTOR; ELECTROPHORESIS; NANOSTRUCTURES; MOVEMENTS; MOTILITY; SHUTTLES; DNA	Integration of biomolecular motors in nanoengineered structures raises the intriguing possibility of manipulating materials on nanometer scales. We have managed to integrate kinesin motor proteins in closed submicron channels and to realize active electrical control of the direction of individual kinesin-propelled microtubule filaments at Y junctions. Using this technique, we demonstrate molecular sorting of differently labeled microtubules. We attribute the steering of microtubules to electric field - induced bending of the leading tip. From measurements of the orientation-dependent electrophoretic motion of individual, freely suspended microtubules, we estimate the net applied force on the tip to be in the picoNewton range and we infer an effective charge of 12 e - per tubulin dimer under physiological conditions.	Delft Univ Technol, Kavli Inst nanosci, Sect Mol Biophys, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst nanosci, Sect Mol Biophys, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	dekker@mb.tn.tudelft.nl		Dekker, Cees/0000-0001-6273-071X				Bohm KJ, 2005, IEEE T ADV PACKAGING, V28, P571, DOI 10.1109/TADVP.2005.858314; Clemmens J, 2003, LANGMUIR, V19, P10967, DOI 10.1021/la035519y; Dittrich PS, 2003, ANAL CHEM, V75, P5767, DOI 10.1021/ac034568c; DUKE T, 1995, PHYS REV LETT, V74, P330, DOI 10.1103/PhysRevLett.74.330; Felgner H, 1996, J CELL SCI, V109, P509; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Hess H, 2004, CHEM-EUR J, V10, P2110, DOI 10.1002/chem.200305712; Hess H, 2001, J Biotechnol, V82, P67, DOI 10.1016/S1389-0352(01)00029-0; Hiratsuka Y, 2001, BIOPHYS J, V81, P1555, DOI 10.1016/S0006-3495(01)75809-2; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Jia LL, 2004, BIOMED MICRODEVICES, V6, P67, DOI 10.1023/B:BMMD.0000013368.89455.8d; Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101; Moorjani SG, 2003, NANO LETT, V3, P633, DOI 10.1021/nl034001b; Nitta T, 2005, NANO LETT, V5, P1337, DOI 10.1021/nl050586t; Nogales E, 1998, NATURE, V393, P191, DOI 10.1038/30288; Patolsky F, 2004, NAT MATER, V3, P692, DOI 10.1038/nmat1205; Ramachandran S, 2006, SMALL, V2, P330, DOI 10.1002/smll.200500265; ROBINSON KR, 1975, SCIENCE, V187, P70, DOI 10.1126/science.1167318; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; STIGTER D, 1991, BIOPOLYMERS, V31, P169, DOI 10.1002/bip.360310205; Stigter D, 1998, BIOPHYS J, V75, P1197, DOI 10.1016/S0006-3495(98)74039-1; STIGTER D, 1978, J PHYS CHEM-US, V82, P1417, DOI 10.1021/j100501a019; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Stracke R, 2002, BIOCHEM BIOPH RES CO, V293, P602, DOI 10.1016/S0006-291X(02)00251-6; van den Heuvel MGL, 2005, NANO LETT, V5, P1117, DOI 10.1021/nl0506554; van den Heuvel MGL, 2005, NANO LETT, V5, P235, DOI 10.1021/nl048291n; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308; Yokokawa R, 2004, NANO LETT, V4, P2265, DOI 10.1021/nl048851i	31	197	200	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					910	914		10.1126/science.1124258	http://dx.doi.org/10.1126/science.1124258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690866				2022-12-28	WOS:000237452900047
J	Agnor, CB; Hamilton, DP				Agnor, CB; Hamilton, DP			Neptune's capture of its moon Triton in a binary-planet gravitational encounter	NATURE			English	Article							KUIPER-BELT BINARIES; ORBITAL EVOLUTION; GAS DRAG; ORIGIN; ASTEROIDS	Triton is Neptune's principal satellite and is by far the largest retrograde satellite in the Solar System ( its mass is similar to 40 per cent greater than that of Pluto). Its inclined and circular orbit lies between a group of small inner prograde satellites and a number of exterior irregular satellites with both prograde and retrograde orbits. This unusual configuration has led to the belief that Triton originally orbited the Sun before being captured in orbit around Neptune(1-3). Existing models(4-6) for its capture, however, all have significant bottlenecks that make their effectiveness doubtful. Here we report that a three-body gravitational encounter between a binary system (of similar to 10(3)-kilometre-sized bodies) and Neptune is a far more likely explanation for Triton's capture. Our model predicts that Triton was once a member of a binary with a range of plausible characteristics, including ones similar to the Pluto - Charon pair.	Univ Calif Santa Cruz, Dept Earth Sci, Ctr Origin Dynam & Evolut Planets, Santa Cruz, CA 95064 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University of California System; University of California Santa Cruz; University System of Maryland; University of Maryland College Park	Agnor, CB (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Ctr Origin Dynam & Evolut Planets, 1156 High St, Santa Cruz, CA 95064 USA.	cagnor@pmc.ucsc.edu						Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; Astakhov SA, 2005, MON NOT R ASTRON SOC, V360, P401, DOI 10.1111/j.1365-2966.2005.09072.x; BENNER LAM, 1995, ICARUS, V114, P1, DOI 10.1006/icar.1995.1039; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; Cuk M, 2005, ASTROPHYS J, V626, pL113, DOI 10.1086/431743; Durda DD, 2004, ICARUS, V170, P242, DOI 10.1016/j.icarus.2004.04.002; Funato Y, 2004, NATURE, V427, P518, DOI 10.1038/nature02323; GOLDREICH P, 1989, SCIENCE, V245, P500, DOI 10.1126/science.245.4917.500; Goldreich P, 2004, ANNU REV ASTRON ASTR, V42, P549, DOI 10.1146/annurev.astro.42.053102.134004; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Gomes RS, 2004, ICARUS, V170, P492, DOI 10.1016/j.icarus.2004.03.011; Hahn JM, 1999, ASTRON J, V117, P3041, DOI 10.1086/300891; HAMILTON DP, 1992, ICARUS, V96, P43, DOI 10.1016/0019-1035(92)90005-R; HAMILTON DP, 2005, AAS DIV DYN ASTRON M, V36; HEGGIE DC, 1975, MON NOT R ASTRON SOC, V173, P729, DOI 10.1093/mnras/173.3.729; HILLS JG, 1991, ASTRON J, V102, P704, DOI 10.1086/115905; Lissauer JJ, 1995, SPACE SCI S, P37; Margot JL, 2002, SCIENCE, V296, P1445, DOI 10.1126/science.1072094; MCCORD TB, 1966, ASTRON J, V71, P585, DOI 10.1086/109967; MCKINNON WB, 1984, NATURE, V311, P355, DOI 10.1038/311355a0; McKinnon WB, 1995, ICARUS, V118, P392, DOI 10.1006/icar.1995.1199; McKinnon WB, 1995, SPACE SCI S, P807; Merline W.J., 2002, ASTEROIDS, VIII, P289; POLLACK JB, 1979, ICARUS, V37, P587, DOI 10.1016/0019-1035(79)90016-2; Stephens DC, 2006, ASTRON J, V131, P1142, DOI 10.1086/498715; Tsui KH, 2002, PLANET SPACE SCI, V50, P269, DOI 10.1016/S0032-0633(01)00131-3; Ward WR, 2001, ASTR SOC P, V245, P111; Weidenschilling SJ, 2002, ICARUS, V160, P212, DOI 10.1006/icar.2002.6952	30	172	175	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					192	194		10.1038/nature04792	http://dx.doi.org/10.1038/nature04792			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688170				2022-12-28	WOS:000237418800039
J	Basch, ML; Bronner-Fraser, M; Garcia-Castro, MI				Basch, ML; Bronner-Fraser, M; Garcia-Castro, MI			Specification of the neural crest occurs during gastrulation and requires Pax7	NATURE			English	Article							PLATE; SIGNALS; DIFFERENTIATION; INDUCTION; EPIDERMIS; XENOPUS; BORDER; CHICK; CELLS; FATE	The neural crest is a stem population critical for development of the vertebrate craniofacial skeleton and peripheral ganglia. Neural crest cells originate along the border between the neural plate and epidermis(1), migrate extensively and generate numerous derivatives, including neurons and glia of the peripheral nervous system, melanocytes, bone and cartilage of the head skeleton(2). Impaired neural crest development is associated with human defects, including cleft palate(3). Classically, the neural crest has been thought to form by interactions at the border between neural and non-neural ectoderm or mesoderm(4-7), and defined factors such as bone morphogenetic proteins (BMPs) and Wnt proteins have been postulated as neural crest-inducers(8-13). Although competence to induce crest cells declines after stage 10 ( ref. 14), little is known about when neural crest induction begins in vivo. Here we report that neural crest induction is underway during gastrulation and well before proper neural plate appearance. We show that a restricted region of chick epiblast ( stage 3 - 4) is specified to generate neural crest cells when explanted under non-inducing conditions. This region expresses the transcription factor Pax7 by stage 41 and later contributes to neural folds and migrating neural crest. In chicken embryos, Pax7 is required for neural crest formation in vivo, because blocking its translation inhibits expression of the neural crest markers Slug, Sox9, Sox10 and HNK-1. Our results indicate that neural crest specification initiates earlier than previously assumed, independently of mesodermal and neural tissues, and that Pax7 has a crucial function during neural crest development.	CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA; Yale Univ, MCDB, New Haven, CT 06520 USA	California Institute of Technology; Yale University	Garcia-Castro, MI (corresponding author), CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA.	martin.garcia-castro@yale.edu	Basch, Martin/I-6632-2012	Bronner, Marianne/0000-0003-4274-1862; Garcia-Castro, Martin I./0000-0001-5128-0004				Bang AG, 1997, DEVELOPMENT, V124, P2075; Basch Martin L, 2004, Birth Defects Res C Embryo Today, V72, P109, DOI 10.1002/bdrc.20015; Basch ML, 2000, DEV NEUROSCI-BASEL, V22, P217, DOI 10.1159/000017444; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; Fernandez-Garre P, 2002, DEVELOPMENT, V129, P2807; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; His W., 1868, UNTERSUCHUNGEN ERSTE; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin NM, 1999, NEURAL CREST, V2; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Mansouri A, 1996, DEVELOPMENT, V122, P831; Mansouri A, 1998, CRIT REV ONCOGENESIS, V9, P141, DOI 10.1615/CritRevOncog.v9.i2.40; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Mayor R, 1997, DEV BIOL, V189, P1, DOI 10.1006/dbio.1997.8634; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; MOURY JD, 1989, DEV BIOL, V133, P44, DOI 10.1016/0012-1606(89)90295-9; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Pera E, 1999, DEVELOPMENT, V126, P63; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Streit A, 1998, DEVELOPMENT, V125, P507; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601	30	268	273	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					218	222		10.1038/nature04684	http://dx.doi.org/10.1038/nature04684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688176				2022-12-28	WOS:000237418800046
J	Vitale, S; Cotch, MF; Sperduto, RD				Vitale, S; Cotch, MF; Sperduto, RD			Prevalence of visual impairment in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLUE MOUNTAINS EYE; MEXICAN-AMERICAN POPULATION; HIP FRACTURE; VISION IMPAIRMENT; OLDER POPULATION; PROYECTO VER; BLINDNESS; RISK	Context The prevalence of visual impairment in the US public has not been surveyed nationally in several decades. Objective To estimate the number of US individuals aged 12 years or older who have impaired distance vision due to uncorrected refractive error. Design, Setting, and Participants The National Health and Nutrition Examination Survey ( NHANES), using a multistage probability sampling design, included a vision evaluation in a mobile examination center. Visual acuity data were obtained from 13 265 of 14 203 participants (93.4%) who visited the mobile examination center in 1999-2002. Visual impairment was defined as presenting distance visual acuity of 20/50 or worse in the better-seeing eye. Visual impairment due to uncorrected refractive error was defined as ( presenting) visual impairment that improved, aided by automated refraction results, to 20/40 or better in the better-seeing eye. Main Outcome Measures Presenting distance visual acuity ( measured with usual corrective lenses, if any) and distance visual acuity after automated refraction. Results Overall, 1190 study participants had visual impairment ( weighted prevalence, 6.4%; 95% confidence interval [CI], 6.0%-6.8%), and of these, 83.3% could achieve good visual acuity with correction ( 95% CI, 80.9%-85.8%). Extrapolating these findings to the general US population, approximately 14 million individuals aged 12 years or older have visual impairment ( defined as distance visual acuity of 20/50 or worse), and of these, more than 11 million individuals could have their vision improved to 20/40 or better with refractive correction. Conclusions Visual impairment due to uncorrected refractive error is a common condition in the United States. Providing appropriate refractive correction to those individuals whose vision can be improved is an important public health endeavor with implications for safety and quality of life.	NEI, Div Epidemiol & Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Vitale, S (corresponding author), NEI, Div Epidemiol & Clin Res, NIH, 5635 Fishers Ln 1100,MSC 9301, Bethesda, MD 20892 USA.	sev@nei.nih.gov		Cotch, Mary Frances/0000-0002-2046-4350; vitale, susan/0000-0002-5972-6848	NATIONAL EYE INSTITUTE [Z01EY000402] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA EY000402-12, ZIA EY000402-09, Z01 EY000402-07, ZIA EY000402-15, Z01 EY000402-06, ZIA EY000402-13, ZIA EY000402-10, ZIA EY000402-08, ZIA EY000402-14, ZIA EY000402-11, Z99 EY999999] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allen PM, 2003, OPTOMETRY VISION SCI, V80, P245, DOI 10.1097/00006324-200303000-00014; Broman AT, 2002, INVEST OPHTH VIS SCI, V43, P3393; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Dimitrov PN, 2003, INVEST OPHTH VIS SCI, V44, P5075, DOI 10.1167/iovs.02-0457; Engel A, 1978, Vital Health Stat 1, P1; Evans BJW, 2004, OPHTHAL PHYSL OPT, V24, P161, DOI 10.1111/j.1475-1313.2004.00197.x; FELSON DT, 1989, J AM GERIATR SOC, V37, P495, DOI 10.1111/j.1532-5415.1989.tb05678.x; Foran S, 2002, AM J OPHTHALMOL, V134, P712, DOI 10.1016/S0002-9394(02)01673-2; HERON G, 1995, OPHTHAL PHYSL OPT, V15, P23, DOI 10.1016/0275-5408(95)92788-G; Ivers RQ, 2000, AM J EPIDEMIOL, V152, P633, DOI 10.1093/aje/152.7.633; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Keeffe JE, 2002, BRIT J OPHTHALMOL, V86, P1118, DOI 10.1136/bjo.86.10.1118; Klein RJ, 2001, HLTH PEOPLE 2010 STA; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Munoz B, 2002, INVEST OPHTH VIS SCI, V43, P608; *NAT CTR HLTH STAT, 2004, DHHS PUBL; *NAT CTR HLTH STAT, 2002, NHANES 1999 2000 ADD; *NAT CTR HLTH STAT, 2004, NHANES AN GUID JUN 2; *NAT HLTH NUTR EX, PUBL US DAT FIL; *NAT HLTH NUTR EX, VIS PROC MAN; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; Owsley C, 1999, SURV OPHTHALMOL, V43, P535, DOI 10.1016/S0039-6257(99)00035-1; Pesudovs K, 2004, J CATARACT REFR SURG, V30, P1921, DOI 10.1016/j.jcrs.2004.01.033; Roberts I, 1995, Inj Prev, V1, P12, DOI 10.1136/ip.1.1.12; Rose K, 2001, CLIN EXP OPHTHALMOL, V29, P116, DOI 10.1046/j.1442-9071.2001.00389.x; Swanson MW, 2004, OPHTHAL EPIDEMIOL, V11, P227, DOI 10.1080/09286580490514540; Thiagalingam S, 2002, BRIT J OPHTHALMOL, V86, P1041, DOI 10.1136/bjo.86.9.1041; Tsai SY, 2003, J FORMOS MED ASSOC, V102, P86; Zwerling C, 1998, J OCCUP ENVIRON MED, V40, P720, DOI 10.1097/00043764-199808000-00010; 1985, VITAL HLTH STAT, V1, P1	30	238	244	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2006	295	18					2158	2163		10.1001/jama.295.18.2158	http://dx.doi.org/10.1001/jama.295.18.2158			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040OW	16684986				2022-12-28	WOS:000237391300025
J	Lawn, JE; Cousens, SN; Darmstadt, GL; Bhutta, ZA; Martines, J; Paul, V; Knippenberg, R; Fogstod, H				Lawn, JE; Cousens, SN; Darmstadt, GL; Bhutta, ZA; Martines, J; Paul, V; Knippenberg, R; Fogstod, H		Lancet Neonatal Survival Series St	1 year after The Lancet Neonatal Survival Series - was the call for action heard?	LANCET			English	Editorial Material							PRETERM INFANTS; COUNTRIES; HEALTH; TRIAL; INTERVENTIONS; INFECTIONS; MORTALITY; CHILDREN; LIVES; SAVE		Saving Newborn Lives Save Children USA, ZA-7405 Cape Town, South Africa; Inst Child Hlth, Cape Town, South Africa; London Sch Hyg & Trop Med, London WC1, England; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Save Children USA, Washington, DC USA; Aga Khan Univ, Karachi, Pakistan; WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland; All India Inst Med Sci, Dept Paediat, WHO Collaborating Ctr Training & Res Newborn Care, New Delhi, India; Hlth Sect UNICEF, New York, NY USA; WHO, Making Pregnancy Safer Initiat, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	Save the Children; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Save the Children; Aga Khan University; University of Geneva; World Health Organization; All India Institute of Medical Sciences (AIIMS) New Delhi; UNICEF; World Health Organization	Lawn, JE (corresponding author), Saving Newborn Lives Save Children USA, 11 S Way, ZA-7405 Cape Town, South Africa.	joylawn@yahoo.co.uk	Darmstadt, Gary/AAU-7488-2020; Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443; Darmstadt, Gary/0000-0002-7522-5824	Medical Research Council [G0700837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2004, MATERNAL CHILD HLTH, V1st; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; Darmstadt GL, 2005, LANCET, V365, P1039, DOI 10.1016/S0140-6736(05)74228-8; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Darmstadt GL, 2004, PEDIATR INFECT DIS J, V23, P719, DOI 10.1097/01.inf.0000133047.50836.6f; DARMSTADT GL, 2005, COMMUNITY BEHAV CHAN; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Freedman LP, 2005, LANCET, V365, P997, DOI 10.1016/S0140-6736(05)71090-4; Horton R, 2006, LANCET, V367, P3, DOI 10.1016/S0140-6736(06)67899-9; HORTON R, LANCET, V365, P821; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P531; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; Were F N, 2005, East Afr Med J, V82, P545; *WHO, LANC NEON SURV SER; World Health Organisation, 2005, WORLD HLTH REP MAK E	21	76	76	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1541	1547		10.1016/S0140-6736(06)68587-5	http://dx.doi.org/10.1016/S0140-6736(06)68587-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679168	Green Published, Bronze			2022-12-28	WOS:000237324200035
J	Perucca, E; Tomson, T				Perucca, E; Tomson, T			Prenatal exposure to antiepileptic drugs	LANCET			English	Editorial Material							FETAL ANTICONVULSANT SYNDROMES; IN-UTERO; CHILDREN; TERATOGENICITY; EPILEPSY; RISKS; BIRTH		Univ Pavia, Dept Internal Med & Therapeut, Clin Pharmacol Unit, I-27100 Pavia, Italy; Mondino Fdn, IRCCS C, Inst Neurol, Diagnost Lab, I-27100 Pavia, Italy; Mondino Fdn, IRCCS C, Inst Neurol, Lab Appl Biol Res, I-27100 Pavia, Italy; Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	University of Pavia; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione Casimiro Mondino; Karolinska Institutet	Perucca, E (corresponding author), Univ Pavia, Dept Internal Med & Therapeut, Clin Pharmacol Unit, I-27100 Pavia, Italy.	perucca@unipv.it	Perucca, Emilio/Q-7308-2019	Perucca, Emilio/0000-0001-8703-223X				Adab N, 2001, J NEUROL NEUROSUR PS, V70, P15, DOI 10.1136/jnnp.70.1.15; ADAMS J, 1990, NEUROTOXICOL TERATOL, V12, P203, DOI 10.1016/0892-0362(90)90092-Q; ARDINGER HH, 1988, AM J MED GENET, V29, P171, DOI 10.1002/ajmg.1320290123; Dean JCS, 2002, J MED GENET, V39, P251, DOI 10.1136/jmg.39.4.251; Eriksson K, 2005, EPILEPSY RES, V65, P189, DOI 10.1016/j.eplepsyres.2005.06.001; Gaily E, 2004, NEUROLOGY, V62, P28, DOI 10.1212/WNL.62.1.28; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Holmes LB, 2002, J MED GENET, V39, P245, DOI 10.1136/jmg.39.4.245; JONES KL, 1989, NEW ENGL J MED, V320, P1480; Kini U, 2006, ARCH DIS CHILD-FETAL, V91, pF90, DOI 10.1136/adc.2004.067421; LOMBROSO C, 1897, UOMO DELINQUENTE; Moore SJ, 2000, J MED GENET, V37, P489, DOI 10.1136/jmg.37.7.489; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; Vinten J, 2005, NEUROLOGY, V64, P949, DOI 10.1212/01.WNL.0000154514.82948.69	15	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 6	2006	367	9521					1467	1469		10.1016/S0140-6736(06)68627-3	http://dx.doi.org/10.1016/S0140-6736(06)68627-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679145				2022-12-28	WOS:000237324200008
J	England, R				England, Roger			Coordinating HIV control efforts: what to do with the national AIDS commissions	LANCET			English	Editorial Material							SEX WORKERS; PREVALENCE; AFRICA; HEALTH				England, R (corresponding author), POB 1350, Grande Anse, Grenada.	rengland@caribsurf.com						*AIDSP, GLOB FUND OBS NEWSL; Ainsworth M, 2000, LANCET, V356, P55, DOI 10.1016/S0140-6736(00)02440-5; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; *CENTR BUR STAT MI, 2003, ORC MACR KEN DEM HLT; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; *DEP INT DEV HLTH, 2004, ENGL R EXP CONTR PRI; *GLOB FUND FIGHT A, TUB MAL CURR GRANT C; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; *JOINT UN PROGR HI, 3 ON ACT WE AR WE GO; *JOINT UN PROGR HI, GLOB TASK TEAM IMPR; *JOINT UN PROGR HI, SUPP MAINSTR AIDS DE; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; LOWNDES CM, 2003, 15 BIENN C INT SOC S; *MON AIDS PAND NET, 2001, STAT TRENDS HIV AIDS; Ramjee G, 2002, SEX TRANSM DIS, V29, P44, DOI 10.1097/00007435-200201000-00008; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Sandiford P, 2002, PUBLIC POLICY PRIVAT; *TANZ COMM AIDS NB, TANZ HIV AIDS IND SU; *UN DEV PROGR WORL, MAINSTR HIV AIDS SEC; Wong ML, 2004, AIDS, V18, P1195, DOI 10.1097/00002030-200405210-00013; *WORLD BANK, INT REV MULT HIV AID; *WORLD BANK OP EV, COMM RES IMPR EFF HI; 2004, MONITORING AIDS PAND	25	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1786	1789		10.1016/S0140-6736(06)68774-6	http://dx.doi.org/10.1016/S0140-6736(06)68774-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731274				2022-12-28	WOS:000237854000034
J	Lopez, AD; Mathers, CD; Ezzati, M; Jamison, DT; Murray, CJL				Lopez, Alan D.; Mathers, Colin D.; Ezzati, Majid; Jamison, Dean T.; Murray, Christopher J. L.			Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data	LANCET			English	Article							DEATH	Background Our aim was to calculate the global burden of disease and risk factors for 2001, to examine regional trends from 1990 to 2001, and to provide a starting point for the analysis of the Disease Control Priorities Project (DCPP). Methods We calculated mortality, incidence, prevalence, and disability adjusted life years (DALYs) for 136 diseases and injuries, for seven income/geographic country groups. To assess trends, we re-estimated all-cause mortality for 1990 with the same methods as for 2001. We estimated mortality and disease burden attributable to 19 risk factors. Findings About 56 million people died in 2001. Of these, 10.6 million were children, 99% of whom lived in low-and-middle-income countries. More than half of child deaths in 2001 were attributable to acute respiratory infections, measles, diarrhoea, malaria, and HIV/AIDS. The ten leading diseases for global disease burden were perinatal conditions, lower respiratory infections, ischaemic heart disease, cerebrovascular disease, HIV/AIDS, diarrhoeal diseases, unipolar major depression, malaria, chronic obstructive pulmonary disease, and tuberculosis. There was a 20% reduction in global disease burden per head due to communicable, maternal, perinatal, and nutritional conditions between 1990 and 2001. Almost half the disease burden in low-and-middle-income countries is now from non-communicable diseases (disease burden per head in Sub-Saharan Africa and the low-and-middle-income countries of Europe and Central Asia increased between 1990 and 2001). Undernutrition remains the leading risk factor for health loss. An estimated 45% of global mortality and 36% of global disease burden are attributable to the joint hazardous effects of the 19 risk factors studied. Uncertainty in all-cause mortality estimates ranged from around 1% in high-income countries to 15-20% in Sub-Saharan Africa. Uncertainty was larger for mortality from specific diseases, and for incidence and prevalence of non-fatal outcomes. Interpretation Despite uncertainties about mortality and burden of disease estimates, our findings suggest that substantial gains in health have been achieved in most populations, countered by the HIV/AIDS epidemic in Sub-Saharan Africa and setbacks in adult mortality in countries of the former Soviet Union. our results on major disease, injury, and risk factor causes of loss of health, together with information on the cost-effectiveness of interventions, can assist in accelerating progress towards better health and reducing the persistent differentials in health between poor and rich countries.	Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia; WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; NIH, Fogarty Int Ctr, Washington, DC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Queensland; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of California System; University of California San Francisco	Lopez, AD (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia.	a.lopez@sph.uq.edu.au	Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010; Choobkar, Saeed/AAA-3212-2020; Haghighatian, Zahra/AAA-3186-2020; Azadbakht, Morteza/ABA-2569-2020	Lopez, Alan D/0000-0001-5818-6512; Azadbakht, Morteza/0000-0001-8103-3506; Mathers, Colin/0000-0002-0617-6731	NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; NIA NIH HHS [P01-AG17625] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anand S, 1998, WORLD DEV, V26, P307, DOI 10.1016/S0305-750X(97)10019-5; [Anonymous], 2002, WORLD MORTALITY 2000; [Anonymous], POPULATION STUDIES; Barendregt JJ., 2003, POPUL HEALTH METR, V1, P4, DOI [DOI 10.1186/1478-7954-1-4, 10.1186/1478-7954-1-4]; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cooper RS, 1998, LANCET, V351, P208, DOI 10.1016/S0140-6736(97)06512-4; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M, 2004, COMP QUANTIFICATION; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; Jamison DT, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P427; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P17; Lozano R., 1995, J INT DEV, V7, P555, DOI DOI 10.1002/JID.3380070314; Mahapatra P., 2002, ESTIMATING NATL BURD; Mathers C., 1999, BURDEN DIS INJURY AU; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; McKee M, 2001, BRIT MED J, V323, P1051, DOI 10.1136/bmj.323.7320.1051; Murray, 2002, SUMMARY MEASURES POP, P205; Murray C.J.L., 1996, HARVARD SCH PUBLIC H; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Murray CJL, 1996, GLOBAL HLTH STAT; Powles J, 2002, LANCET, V360, P1342, DOI 10.1016/S0140-6736(02)11412-7; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Williams A, 1999, HEALTH ECON, V8, P1; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 1992, INT CLASS DIS REL HL	32	3857	4002	13	665	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1747	1757		10.1016/S0140-6736(06)68770-9	http://dx.doi.org/10.1016/S0140-6736(06)68770-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047BE	16731270				2022-12-28	WOS:000237854000030
J	Raftery, J				Raftery, J			Resource allocation - NICE work	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Southampton, Wessex Inst Hlth Res & Dev, Southampton SO16 7PX, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Wessex Inst Hlth Res & Dev, Southampton SO16 7PX, Hants, England.	j.p.raftery@soton.ac.uk							0	73	73	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2006	332	7552					1266	1266		10.1136/bmj.332.7552.1266	http://dx.doi.org/10.1136/bmj.332.7552.1266			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16735341	Green Published, Green Submitted			2022-12-28	WOS:000237984100023
J	Baselga, J				Baselga, Jose			Targeting tyrosine kinases in cancer: The second wave	SCIENCE			English	Editorial Material							MONOCLONAL-ANTIBODY CETUXIMAB; SQUAMOUS-CELL CARCINOMA; LUNG ADENOCARCINOMAS; ADJUVANT CHEMOTHERAPY; SINGLE-AGENT; GROWTH; MUTATIONS; INHIBITOR; GEFITINIB; RESISTANCE		Vall Hebron Univ Hosp, Oncol Program, Barcelona 08035, Spain; Univ Autonoma Barcelona, Vall Hebron Res Inst, Barcelona 08035, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Baselga, J (corresponding author), Vall Hebron Univ Hosp, Oncol Program, Barcelona 08035, Spain.	jbaselga@vhebron.net						Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Baselga J, 2004, NAT MED, V10, P786, DOI 10.1038/nm0804-786; Baselga J, 2005, J CLIN ONCOL, V23, P5568, DOI 10.1200/JCO.2005.07.119; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chakravarti A, 2002, CANCER RES, V62, P200; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DEMETRI GD, 2004, ASCO M ABSTR, V22, P3001; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; GOMEZ HL, 2005, ASCO ANN M ABSTR 13, V23, P3046; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; LORUSSO P, 2005, ASCO M ABSTR, V23, P3011; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matar P, 2004, CLIN CANCER RES, V10, P6487, DOI 10.1158/1078-0432.CCR-04-0870; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Moore M.J., 2005, J CLIN ONCOL, V23, P1; Nakao M, 1996, LEUKEMIA, V10, P1911; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; STORNIOLO AM, 2005, ASCO M ABSTR, V23, P559; Talpaz M, 2005, BLOOD, V106, p16A; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	52	380	423	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1175	1178		10.1126/science.1125951	http://dx.doi.org/10.1126/science.1125951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728632				2022-12-28	WOS:000237957400042
J	Peters, CJ				Peters, CJ			Focus on research: Lymphocytic choriomeningitis virus - An old enemy up to new tricks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Peters, CJ (corresponding author), Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA.							GREGG MB, 1975, B WORLD HEALTH ORGAN, V52, P549; Lehmann-Grube F., 1971, LYMPHOCYTIC CHORIOME; Mets MB, 2000, AM J OPHTHALMOL, V130, P209, DOI 10.1016/S0002-9394(00)00570-5; PETERS CJ, 1995, EXOTIC VIRAL INFECT, P227; Zinkernagel RM, 2002, CURR TOP MICROBIOL, V263, P1	5	64	65	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2208	2211		10.1056/NEJMp068021	http://dx.doi.org/10.1056/NEJMp068021			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045RF	16723613				2022-12-28	WOS:000237758900002
J	Cooper, PJ; Chico, ME; Vaca, MG; Moncayo, AL; Bland, JM; Mafla, E; Sanchez, F; Rodrigues, LC; Strachan, DP; Griffin, GE				Cooper, PJ; Chico, ME; Vaca, MG; Moncayo, AL; Bland, JM; Mafla, E; Sanchez, F; Rodrigues, LC; Strachan, DP; Griffin, GE			Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial	LANCET			English	Article							INTESTINAL HELMINTH INFECTION; RURAL AREA; GABONESE SCHOOLCHILDREN; ALLERGIC REACTIVITY; ASTHMA; RISK; INFESTATION; ETHIOPIA; DISEASE; URBAN	Background Epidemiological studies have shown inverse associations between geohelminth (intestinal helminth) infection and atopy, leading to the suggestion that geohelminths might protect against allergy. Periodic deworming of school children with anthelmintics is a widely implemented intervention and has raised concerns that such programmes could increase allergy. We investigated the effect of repeated anthelmintic treatments with albendazole over 12 months on the prevalence of atopy and clinical indices of allergy. Methods We did a cluster-randomised controlled trial in schoolchildren from 68 rural schools. Children were randomly assigned by school to either albendazole (34 schools, 1164 children) every 2 months for 12 months, or to no intervention (34 schools, 1209 children). The intervention schools received a total of seven albendazole treatments. The primary outcome was atopy at 12 months (allergen skin-test reactivity), and analysis was by intention-to-treat for whole-school analyses and per protocol for children. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN61195515. Findings Data for analysis were available for all schools and from 67.4% (784 of 1164) and 70.1% (848 of 1209) of children in albendazole and no-treatment groups, respectively. Albendazole treatment caused large reductions in geohelminth prevalence over the study period (adjusted odds ratio 0.13, 95% CI 0.09-0.19, p<0.001), but there was no evidence that treatment was associated with an increase in atopy prevalence (0.97, 0.68-1.39, p=0.862), or clinical allergy (wheeze, 1.07, 0.54-2.11, p=0.848) in the albendazole compared with the no-treatment group. Interpretation We saw no increase in the prevalence of atopy or clinical allergy associated with albendazole treatment. Deworming programmes for schoolchildren are unlikely to be accompanied by an increase in allergy.	St Georges Univ London, Div Cellular & Mol Med, London WC1E 7HU, England; St Georges Univ London, Div Community Hlth Sci, London WC1E 7HU, England; Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; London Sch Hyg & Trop Med, London WC1, England	St Georges University London; St Georges University London; University of York - UK; University of London; London School of Hygiene & Tropical Medicine	Cooper, PJ (corresponding author), Hosp Pedro Vicente Maldonado, Casilla 17-14-30, Carcelen, Quito, Ecuador.	pcooper@ecnet.ec	RODRIGUES, LAURA CUNHA/AAO-4130-2021; Moncayo, Ana/AHA-0137-2022	Moncayo, Ana/0000-0003-3592-7503; Rodrigues, Laura Cunha/0000-0001-9008-660X	Wellcome Trust [060120/Z/99/C] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Cooper PJ, 2003, J ALLERGY CLIN IMMUN, V111, P995, DOI 10.1067/mai.2003.1348; Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837; Cooper PJ, 2004, CLIN EXP ALLERGY, V34, P845, DOI 10.1111/j.1365-2222.2004.01958.x; Cooper PJ, 2002, J INFECT DIS, V186, P1307, DOI 10.1086/344318; Cooper PJ, 2003, AM J RESP CRIT CARE, V168, P313, DOI 10.1164/rccm.200211-1320OC; Dagoye D, 2003, AM J RESP CRIT CARE, V167, P1369, DOI 10.1164/rccm.200210-1204OC; HAGEL I, 1993, PARASITE IMMUNOL, V15, P311, DOI 10.1111/j.1365-3024.1993.tb00615.x; Kerry SM, 2001, STAT MED, V20, P377, DOI 10.1002/1097-0258(20010215)20:3<377::AID-SIM799>3.0.CO;2-N; LYNCH NR, 1993, J ALLERGY CLIN IMMUN, V92, P404, DOI 10.1016/0091-6749(93)90119-Z; LYNCH NR, 1992, INT ARCH ALLERGY IMM, V98, P77, DOI 10.1159/000236167; Nyan OA, 2001, CLIN EXP ALLERGY, V31, P1672, DOI 10.1046/j.1365-2222.2001.00987.x; Palmer LJ, 2002, AM J RESP CRIT CARE, V165, P1489, DOI 10.1164/rccm.2107020; Peisong G, 2004, GENES IMMUN, V5, P58, DOI 10.1038/sj.gene.6364030; Priftanji A, 2001, LANCET, V358, P1426, DOI 10.1016/S0140-6736(01)06521-7; Savioli L, 2005, LANCET, V365, P1520, DOI 10.1016/S0140-6736(05)66433-1; Savioli L, 2004, NAT REV MICROBIOL, V2, P618, DOI 10.1038/nrmicro962; Scrivener S, 2001, LANCET, V358, P1493, DOI 10.1016/S0140-6736(01)06579-5; Turner JD, 2003, J INFECT DIS, V188, P1768, DOI 10.1086/379370; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; van den Biggelaar AHJ, 2001, INT ARCH ALLERGY IMM, V126, P231, DOI 10.1159/000049519; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Weiss ST, 2000, J ALLERGY CLIN IMMUN, V105, P205, DOI 10.1016/S0091-6749(00)90067-8; *WHO, 1985, WHOPDP852; *WHO, 2001, 5419 WHO; Yazdanbakhsh M, 2001, TRENDS IMMUNOL, V22, P372, DOI 10.1016/S1471-4906(01)01958-5	26	104	106	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2006	367	9522					1598	1603		10.1016/S0140-6736(06)68697-2	http://dx.doi.org/10.1016/S0140-6736(06)68697-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698413				2022-12-28	WOS:000237598000031
J	Xue, S; Calvin, K; Li, H				Xue, S; Calvin, K; Li, H			RNA recognition and cleavage by a splicing endonuclease	SCIENCE			English	Article							SUBSTRATE RECOGNITION; INTRON ENDONUCLEASE; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; HALOBACTERIUM-VOLCANII; CRYSTAL-STRUCTURE; ARCHAEAL INTRONS; IDENTIFICATION; PROTEIN; EVOLUTION	The RNA splicing endonuclease cleaves two phosphodiester bonds within folded precursor RNAs during intron removal, producing the functional RNAs required for protein synthesis. Here we describe at a resolution of 2.85 angstroms the structure of a splicing endonuclease from Archaeglobus fulgidus bound with a bulge-helix-bulge RNA containing a noncleaved and a cleaved splice site. The endonuclease dimer cooperatively recognized a flipped-out bulge base and stabilizes sharply bent bulge backbones that are poised for an in-line RNA cleavage reaction. Cooperativity arises because an arginine pair from one catalytic domain sandwiches a nucleobase within the bulge cleaved by the other catalytic domain.	Florida State Univ, Inst Mol Biophys, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Li, H (corresponding author), Florida State Univ, Inst Mol Biophys, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	hongli@sb.fsu.edu		Li, Hong/0000-0003-2046-9861	NIGMS NIH HHS [R01 GM099604] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; BALDI MI, 1992, SCIENCE, V255, P1404, DOI 10.1126/science.1542788; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Biot C, 2002, J BIOL CHEM, V277, P40816, DOI 10.1074/jbc.M205719200; BUFARDECI E, 1993, EMBO J, V12, P4697, DOI 10.1002/j.1460-2075.1993.tb06158.x; Calvin K, 2005, J MOL BIOL, V353, P952, DOI 10.1016/j.jmb.2005.09.035; CULVER GM, 1993, SCIENCE, V261, P206, DOI 10.1126/science.8392224; Diener JL, 1998, MOL CELL, V1, P883, DOI 10.1016/S1097-2765(00)80087-8; GREER CL, 1987, MOL CELL BIOL, V7, P76, DOI 10.1128/MCB.7.1.76; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; Hershkovitz E, 2003, NUCLEIC ACIDS RES, V31, P6249, DOI 10.1093/nar/gkg835; KJEMS J, 1989, CAN J MICROBIOL, V35, P210, DOI 10.1139/m89-033; KlemanLeyer K, 1997, CELL, V89, P839, DOI 10.1016/S0092-8674(00)80269-X; KNAPP G, 1979, CELL, V18, P37, DOI 10.1016/0092-8674(79)90351-9; Li H, 2000, J MOL BIOL, V302, P639, DOI 10.1006/jmbi.2000.3941; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; LykkeAndersen J, 1997, EMBO J, V16, P6290, DOI 10.1093/emboj/16.20.6290; LykkeAndersen J, 1997, TRENDS BIOCHEM SCI, V22, P326, DOI 10.1016/S0968-0004(97)01113-4; Marck C, 2003, RNA, V9, P1516, DOI 10.1261/rna.5132503; MIAO F, 1993, J BIOL CHEM, V268, P672; Negri ED, 1997, CELL, V89, P859, DOI 10.1016/S0092-8674(00)80271-8; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; REYES VM, 1988, CELL, V55, P719, DOI 10.1016/0092-8674(88)90230-9; Tang TH, 2002, NUCLEIC ACIDS RES, V30, P921, DOI 10.1093/nar/30.4.921; THOMPSON LD, 1988, J BIOL CHEM, V263, P17951; THOMPSON LD, 1990, J BIOL CHEM, V265, P18104; Tocchini-Valentini GD, 2005, P NATL ACAD SCI USA, V102, P8933, DOI 10.1073/pnas.0502350102; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; TROTTA CR, IN PRESS NATURE; Watanabe Y, 2002, FEBS LETT, V510, P27, DOI 10.1016/S0014-5793(01)03219-7; Zhang YM, 2004, ACTA CRYSTALLOGR D, V60, P447, DOI 10.1107/S0907444903029482	36	78	84	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					906	910		10.1126/science.1126629	http://dx.doi.org/10.1126/science.1126629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690865				2022-12-28	WOS:000237452900046
J	Bartscherer, K; Pelte, N; Ingelfinger, D; Boutros, M				Bartscherer, Kerstin; Pelte, Nadege; Ingelfinger, Dierk; Boutros, Michael			Secretion of Wnt Ligands requires Evi, a conserved transmembrane protein	CELL			English	Article							DORSAL-VENTRAL AXIS; LONG-RANGE ACTION; TRANSCRIPTION FACTOR; PLASMA-MEMBRANE; GENE-PRODUCT; WINGLESS; DROSOPHILA; POLARITY; TRANSPORT; HEDGEHOG	Wnt signaling pathways are important for multiple biological processes during development and disease. Wnt proteins are secreted factors that activate target-gene expression in both a short- and long-range manner. Currently, little is known about how Writs are released from cells and which factors facilitate their secretion. Here, we identify a conserved multipass transmembrane protein, Evenness interrupted (Evi/Wls), through an RNAi survey for transmembrane proteins involved in Drosophila Wingless (Wg) signaling. During development, evi mutants have patterning defects that phenocopy wg loss-of-function alleles and fail to express Wg target genes. evi's function is evolutionarily conserved as depletion of its human homolog disrupts Wnt signaling in human cells. Epistasis experiments and clonal analysis place evi in the Wg-producing cell. Our results show that Wg is retained by evi mutant cells and suggest that evi is the founding member of a gene family specifically required for Wg/Wnt secretion.	German Canc Res Ctr, Boveri Grp Signalling & Funct Genom, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Boutros, M (corresponding author), German Canc Res Ctr, Boveri Grp Signalling & Funct Genom, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	m.boutros@dkfz.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X				Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; BAKER NE, 1988, DEVELOPMENT, V102, P489; Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Campbell G, 1998, DEVELOPMENT, V125, P4483; Chou TB, 1996, GENETICS, V144, P1673; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P1661; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Hild M, 2004, GENOME BIOL, V5; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lawrence PA, 1996, DEVELOPMENT, V122, P4095; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Moline MM, 1999, DEVELOPMENT, V126, P4375; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Seto ES, 2004, TRENDS CELL BIOL, V14, P45, DOI 10.1016/j.tcb.2003.11.004; STAPLETON M, 2002, GENOME BIOL, V0003; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	52	420	435	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					523	533		10.1016/j.cell.2006.04.009	http://dx.doi.org/10.1016/j.cell.2006.04.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678096	Bronze			2022-12-28	WOS:000237506100018
J	Cloos, PAC; Christensen, J; Agger, K; Maiolica, A; Rappsilber, J; Antal, T; Hansen, KH; Helin, K				Cloos, Paul A. C.; Christensen, Jesper; Agger, Karl; Maiolica, Alessio; Rappsilber, Juri; Antal, Torben; Hansen, Klaus H.; Helin, Kristian			The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3	NATURE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROSTATE-CANCER; METHYLATION; SENESCENCE; HETEROCHROMATIN; GENE; IDENTIFICATION; PROTEINS; AMPLICON; REVEALS	Methylation of lysine and arginine residues on histone tails affects chromatin structure and gene transcription(1-3). Tri- and dimethylation of lysine 9 on histone H3 (H3K9me3/me2) is required for the binding of the repressive protein HP1 and is associated with heterochromatin formation and transcriptional repression in a variety of species(4-6). H3K9me3 has long been regarded as a 'permanent' epigenetic mark(7,8). In a search for proteins and complexes interacting with H3K9me3, we identified the protein GASC1 ( gene amplified in squamous cell carcinoma 1)(9), which belongs to the JMJD2 ( jumonji domain containing 2) subfamily of the jumonji family, and is also known as JMJD2C(10). Here we show that three members of this subfamily of proteins demethylate H3K9me3/me2 in vitro through a hydroxylation reaction requiring iron and alpha-ketoglutarate as cofactors. Furthermore, we demonstrate that ectopic expression of GASC1 or other JMJD2 members markedly decreases H3K9me3/me2 levels, increases H3K9me1 levels, delocalizes HP1 and reduces heterochromatin in vivo. Previously, GASC1 was found to be amplified in several cell lines derived from oesophageal squamous carcinomas(9,11,12), and in agreement with a contribution of GASC1 to tumour development, inhibition of GASC1 expression decreases cell proliferation. Thus, in addition to identifying GASC1 as a histone trimethyl demethylase, we suggest a model for how this enzyme might be involved in cancer development, and propose it as a target for anti-cancer therapy.	Biotech Res & Innovat Ctr, DK-2100 Copenhagen, Denmark; FIRC Inst Mol Oncol, I-20139 Milan, Italy; Univ Copenhagen, Fac Hlth Sci, DK-2200 Copenhagen, Denmark	IFOM - FIRC Institute of Molecular Oncology; University of Copenhagen	Helin, K (corresponding author), Biotech Res & Innovat Ctr, Fruebjergvej 3, DK-2100 Copenhagen, Denmark.	kristian.helin@bric.dk	Helin, Kristian/K-2526-2019; Hu, Ruogu/B-2203-2008; Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Helin, Kristian/HDM-8306-2022	Rappsilber, Juri/0000-0001-5999-1310; Helin, Kristian/0000-0003-1975-6097; Hansen, Klaus/0000-0001-9657-8816; Cloos, Paul/0000-0001-5863-0054				Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Katoh M, 2004, INT J ONCOL, V24, P1623; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Knowles HJ, 2003, CANCER RES, V63, P1764; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Yang ZQ, 2001, JPN J CANCER RES, V92, P423, DOI 10.1111/j.1349-7006.2001.tb01112.x; Yang ZQ, 2000, CANCER RES, V60, P4735; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	30	562	594	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					307	311		10.1038/nature04837	http://dx.doi.org/10.1038/nature04837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16732293				2022-12-28	WOS:000239122100040
J	Leonhardt, U				Leonhardt, Ulf			Optical conformal mapping	SCIENCE			English	Article							INVISIBLE BODIES; METAMATERIALS; REFRACTION; INDEX	An invisibility device should guide light around an object as if nothing were there, regardless of where the light comes from. Ideal invisibility devices are impossible, owing to the wave nature of light. This study develops a general recipe for the design of media that create perfect invisibility within the accuracy of geometrical optics. The imperfections of invisibility can be made arbitrarily small to hide objects that are much larger than the wavelength. With the use of modern metamaterials, practical demonstrations of such devices may be possible. The method developed here can also be applied to escape detection by other electromagnetic waves or sound.	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland	University of St Andrews	Leonhardt, U (corresponding author), Univ St Andrews, Sch Phys & Astron, N Haugh, St Andrews KY16 9SS, Fife, Scotland.	ulf@st-andrews.ac.uk			Engineering and Physical Sciences Research Council [EP/C523229/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ablowitz M.J., 1997, COMPLEX VARIABLES IN; Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; Arnol'd VI., 1990, HUYGENS BARROW NEWTO, DOI DOI 10.1007/978-3-0348-9129-5; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Gbur G, 2003, PROG OPTICS, V45, P273, DOI 10.1016/S0079-6638(03)80007-0; Grbic A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.117403; Grigorenko AN, 2005, NATURE, V438, P335, DOI 10.1038/nature04242; Jackson J. D, 1998, CLASSICAL ELECTRODYN, VThird; KERKER M, 1975, J OPT SOC AM, V65, P376, DOI 10.1364/JOSA.65.000376; Kerker M., 1969, SCATTERING LIGHT; Landau LD, 1976, MECHANICS; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; NACHMAN AI, 1988, ANN MATH, V128, P531, DOI 10.2307/1971435; NEEDHAM T, 1993, AM MATH MON, V100, P119, DOI 10.2307/2323768; Needham T., 2002, VISUAL COMPLEX ANAL; Nehari Z., 1952, CONFORMAL MAPPING; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; ROBNIK M, 1983, J PHYS A-MATH GEN, V16, P3971, DOI 10.1088/0305-4470/16/17/014; ROBNIK M, 1986, J PHYS A-MATH GEN, V19, P669, DOI 10.1088/0305-4470/19/5/020; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; WOLF E, 1993, J MOD OPTIC, V40, P785, DOI 10.1080/09500349314550821; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025	23	3244	3341	31	687	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1777	1780		10.1126/science.1126493	http://dx.doi.org/10.1126/science.1126493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16728596				2022-12-28	WOS:000238452800052
J	Kemler, MA; de Vet, HCW; Barendse, GAM; van den Wildenberg, FAJM; van Kleef, M				Kemler, Marius A.; de Vet, Henrica C. W.; Barendse, Gerard A. M.; van den Wildenberg, Frans A. J. M.; van Kleef, Maarten			Spinal cord stimulation for chronic reflex sympathetic dystrophy - Five-year follow-up	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							SYNDROME TYPE-I; PAIN; IMPACT; TRIAL; LIFE		Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, NL-1007 MB Amsterdam, Netherlands; Maastricht Univ Hosp, NL-6202 AZ Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC)	Kemler, MA (corresponding author), Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands.	mvk@anaesth.azm.nl		Kemler, Marius/0000-0003-0306-1565				Kemler MA, 2000, J PAIN SYMPTOM MANAG, V20, P68, DOI 10.1016/S0885-3924(00)00170-6; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kemler MA, 2004, ANN NEUROL, V55, P13, DOI 10.1002/ana.10996; Kemler MA, 2002, J PAIN SYMPTOM MANAG, V23, P433, DOI 10.1016/S0885-3924(02)00386-X; Kemler MA, 2001, ANESTHESIOLOGY, V95, P72, DOI 10.1097/00000542-200107000-00016	5	77	84	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2394	2396		10.1056/NEJMc055504	http://dx.doi.org/10.1056/NEJMc055504			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738284	Bronze			2022-12-28	WOS:000237918500032
J	Klussmann, M; Iwamura, H; Mathew, SP; Wells, DH; Pandya, U; Armstrong, A; Blackmond, DG				Klussmann, Martin; Iwamura, Hiroshi; Mathew, Suju P.; Wells, David H., Jr.; Pandya, Urvish; Armstrong, Alan; Blackmond, Donna G.			Thermodynamic control of asymmetric amplification in amino acid catalysis	NATURE			English	Article							ENANTIOMERIC EXCESS; SYMMETRY-BREAKING; AUTOCATALYSIS; ORIGIN; MECHANISM	Ever since Pasteur noticed that tartrate crystals exist in two non-superimposable forms that are mirror images of one another - as are left and right hands - the phenomenon of chirality has intrigued scientists. On the molecular level, chirality often has a profound impact on recognition and interaction events and is thus important to biochemistry and pharmacology. In chemical synthesis, much effort has been directed towards developing asymmetric synthesis strategies that yield product molecules with a significant excess of either the left-handed or right-handed enantiomer. This is usually achieved by making use of chiral auxiliaries or catalysts that influence the course of a reaction, with the enantiomeric excess (ee) of the product linearly related to the ee of the auxiliary or catalyst used. In recent years, however, an increasing number of asymmetric reactions have been documented where this relationship is nonlinear(1), an effect that can lead to asymmetric amplification. Theoretical models(2,3) have long suggested that autocatalytic processes can result in kinetically controlled asymmetric amplification, a prediction that has now been verified experimentally(4-6) and rationalized mechanistically(7-14) for an autocatalytic alkylation reaction. Here we show an alternative mechanism that gives rise to asymmetric amplification based on the equilibrium solid-liquid phase behaviour of amino acids in solution. This amplification mechanismis robust and can operate in aqueous systems, making it an appealing proposition for explaining one of the most tantalizing examples of asymmetric amplification - the development of high enantiomeric excess in biomolecules from a presumably racemic prebiotic world.	Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn & Chem Technol, London SW7 2AZ, England	Imperial College London; Imperial College London	Blackmond, DG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.	d.blackmond@imperial.ac.uk		Klussmann, Martin/0000-0002-9026-205X; Armstrong, Alan/0000-0002-3692-3099				Agami C., 1988, B SOC CHIM FR    MAY, V3, P499; Blackmond DG, 2000, ACCOUNTS CHEM RES, V33, P402, DOI 10.1021/ar990083s; Blackmond DG, 2001, J AM CHEM SOC, V123, P10103, DOI 10.1021/ja0165133; Blackmond DG, 2004, P NATL ACAD SCI USA, V101, P5732, DOI 10.1073/pnas.0308363101; Blackmond DG, 2002, ADV SYNTH CATAL, V344, P156, DOI 10.1002/1615-4169(200202)344:2<156::AID-ADSC156>3.0.CO;2-1; Borsenberger V, 2004, CHEM BIODIVERS, V1, P203, DOI 10.1002/cbdv.200490020; Buono FG, 2003, J AM CHEM SOC, V125, P8978, DOI 10.1021/ja034705n; Buono FG, 2004, ANGEW CHEM INT EDIT, V43, P2099, DOI 10.1002/anie.200353086; Calvin M., 1969, MOL EVOLUTION; Cordova A, 2005, CHEM COMMUN, P3586, DOI 10.1039/b507968n; FRANK FC, 1953, BIOCHIM BIOPHYS ACTA, V11, P459, DOI 10.1016/0006-3002(53)90082-1; Girard C, 1998, ANGEW CHEM INT EDIT, V37, P2923, DOI 10.1002/(SICI)1521-3773(19981116)37:21<2922::AID-ANIE2922>3.0.CO;2-1; Gridnev ID, 2003, ORG BIOMOL CHEM, V1, P3811, DOI 10.1039/b307382n; Gridnev ID, 2004, ANGEW CHEM INT EDIT, V43, P4884, DOI 10.1002/anie.200353572; Gridnev ID, 2004, P NATL ACAD SCI USA, V101, P5727, DOI 10.1073/pnas.0308178101; Hoang L, 2003, J AM CHEM SOC, V125, P16, DOI 10.1021/ja028634o; Iwamura H, 2004, J AM CHEM SOC, V126, P11770, DOI 10.1021/ja046258x; JACQUES J, 1981, ENANTIOMERS RACEMATE, pCH3; Kondepudi DK, 2001, ACCOUNTS CHEM RES, V34, P946, DOI 10.1021/ar010089t; KONDEPUDI DK, 1990, SCIENCE, V250, P975, DOI 10.1126/science.250.4983.975; Mathew SP, 2004, ANGEW CHEM INT EDIT, V43, P3317, DOI 10.1002/anie.200453997; MOROWITZ HJ, 1969, J THEOR BIOL, V25, P491, DOI 10.1016/S0022-5193(69)80035-4; Podlech J, 2001, CELL MOL LIFE SCI, V58, P44, DOI 10.1007/PL00000777; Rodrigo AA, 2004, CHIRALITY, V16, P499, DOI 10.1002/chir.20067; Roozeboom H.W.B., 1899, Z. Physik. Ch., V28, P494; Shibata T, 1996, CHEM COMMUN, P1235, DOI 10.1039/cc9960001235; Shibata T, 1996, J AM CHEM SOC, V118, P471, DOI 10.1021/ja953066g; SOAI K, 1995, NATURE, V378, P767, DOI 10.1038/378767a0; Takats Z, 2003, ANGEW CHEM INT EDIT, V42, P3521, DOI 10.1002/anie.200351210; Welch CJ, 2001, CHIRALITY, V13, P425, DOI 10.1002/chir.1055	30	320	326	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					621	623		10.1038/nature04780	http://dx.doi.org/10.1038/nature04780			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738656				2022-12-28	WOS:000237920800044
J	Smyth, MJ				Smyth, MJ			Imatinib mesylate - Uncovering a fast track to adaptive immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DENDRITIC CELLS		Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia	Peter Maccallum Cancer Center	Smyth, MJ (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia.		Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240				Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Josien R, 1997, J EXP MED, V186, P467, DOI 10.1084/jem.186.3.467; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356	5	17	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2282	2284		10.1056/NEJMcibr061878	http://dx.doi.org/10.1056/NEJMcibr061878			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045RF	16723621				2022-12-28	WOS:000237758900014
J	Lin, OS; Kozarek, RA; Schembre, DB; Ayub, K; Gluck, M; Drennan, F; Soon, MS; Rabeneck, L				Lin, OS; Kozarek, RA; Schembre, DB; Ayub, K; Gluck, M; Drennan, F; Soon, MS; Rabeneck, L			Screening colonoscopy in very elderly patients - Prevalence of neoplasia and estimated impact on life expectancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL-OCCULT-BLOOD; QUALITY-OF-LIFE; COLORECTAL-CANCER; COLONIC POLYPS; CONVENIENT APPROXIMATION; UNRESECTED POLYPS; NATURAL-HISTORY; RISK; SIGMOIDOSCOPY; OCTOGENARIANS	Context Current guidelines do not include an upper age cutoff for colorectal cancer screening with colonoscopy. Although the prevalence of colonic neoplasia increases with age, life expectancy decreases. Thus, the benefit of screening colonoscopy in very elderly patients may be limited. Objective To compare estimated life-years saved with screening colonoscopy in very elderly vs younger persons. Design, Setting, and Participants Cross-sectional study conducted among 1244 asymptomatic individuals in 3 age groups (50-54 years [n = 1034], 75-79 years [n = 147], and >= 80 years [n = 63]) who underwent screening colonoscopy at a US teaching hospital and clinic. Main Outcome Measures Prevalence of various types of colon neoplasia; estimated gain in life expectancy, calculated as life expectancy - (life expectancy during polyp lag time + life expectancy after colorectal cancer diagnosis); and comparison of mean gain in life expectancy across the 3 groups. Life expectancy and mortality data were derived from life tables, previous studies, and national databases. Results The prevalence of neoplasia was 13.8% in the 50- to 54-year-old group, 26.5% in the 75- to 79-year-old group, and 28.6% in the group aged 80 years or older. Despite higher prevalence of neoplasia in elderly patients, mean extension in life expectancy was much lower in the group aged 80 years or older than in the 50- to 54-year-old group (0.13 vs 0.85 years). In sensitivity analysis, with longer polyp lag times the mean extension in life expectancy decreased more in the elderly than in the younger patients; alternatively, if it was assumed that a smaller proportion of adenomas progress to colorectal cancer, the mean extension in life expectancy decreased less in the elderly than in the younger patients. Conclusions Even though prevalence of neoplasia increases with age, screening colonoscopy in very elderly persons (aged >= 80 years) results in only 15% of the expected gain in life expectancy in younger patients. Screening colonoscopy in very elderly patients should be performed only after careful consideration of potential benefits, risks, and patient preferences.	Virginia Mason Med Ctr, Gastroenterol Sect, Seattle, WA 98101 USA; Changhua Christian Med Ctr, Div Gastroenterol, Changhua, Taiwan; Univ Toronto, Dept Med, Div Gastroenterol, Toronto, ON, Canada	Virginia Mason Medical Center; University of Toronto	Lin, OS (corresponding author), Virginia Mason Med Ctr, Gastroenterol Sect, 1100 9th Ave,C3-Gas, Seattle, WA 98101 USA.	Otto.Lin@vmmc.org	Kozarek, Richard/AAF-2695-2020					Arora A, 2004, GASTROINTEST ENDOSC, V60, P408, DOI 10.1016/S0016-5107(04)01715-8; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; BAT L, 1992, POSTGRAD MED J, V68, P355, DOI 10.1136/pgmj.68.799.355; BECK JR, 1982, AM J MED, V73, P883, DOI 10.1016/0002-9343(82)90786-0; BECK JR, 1982, AM J MED, V73, P889, DOI 10.1016/0002-9343(82)90787-2; Bersentes K, 1997, AM J GASTROENTEROL, V92, P1117; CARROLL RLA, 1980, PREV MED, V9, P741, DOI 10.1016/0091-7435(80)90018-3; Chatrenet P, 1993, Eur J Med, V2, P411; Chen CD, 2003, BRIT J CANCER, V88, P1866, DOI 10.1038/sj.bjc.6601007; FIGIEL LS, 1965, ACTA RADIOL DIAGN, V3, P417, DOI 10.1177/028418516500300504; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; HOFSTAD B, 1994, SCAND J GASTROENTERO, V29, P640, DOI 10.3109/00365529409092485; Hofstad B, 1996, GUT, V39, P449, DOI 10.1136/gut.39.3.449; Hofstad B, 1997, Gastrointest Endosc Clin N Am, V7, P345; Inadomi JM, 2000, GASTROINTEST ENDOSC, V51, P517, DOI 10.1016/S0016-5107(00)70282-3; KNOERNSCHILD H E, 1963, Surg Forum, V14, P137; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; KOZUKA S, 1975, DIS COLON RECTUM, V18, P494, DOI 10.1007/BF02587218; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lagares-Garcia JA, 2001, SURG ENDOSC, V15, P262, DOI 10.1007/s004640000339; Loeve F, 2005, EUR J CANCER, V41, P416, DOI 10.1016/j.ejca.2004.11.007; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Lukens FJ, 2002, AM J GASTROENTEROL, V97, P1722; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Ramsey SD, 2002, AM J GASTROENTEROL, V97, P1228, DOI 10.1111/j.1572-0241.2002.05694.x; Ramsey SD, 2000, CANCER-AM CANCER SOC, V88, P1294, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.3.CO;2-D; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Sardinha TC, 1999, INT J COLORECTAL DIS, V14, P172, DOI 10.1007/s003840050205; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SHINYA H, 1979, ANN SURG, V190, P679, DOI 10.1097/00000658-197912000-00001; Stevens T, 2003, AM J GASTROENTEROL, V98, P1881, DOI 10.1016/S0002-9270(03)00425-8; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; URE T, 1995, SURG ENDOSC-ULTRAS, V9, P505; Villavicencio R T, 2000, Semin Gastrointest Dis, V11, P185; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yoong KKY, 2005, POSTGRAD MED J, V81, P196, DOI 10.1136/pgmj.2004.023374	45	121	122	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2357	2365		10.1001/jama.295.20.2357	http://dx.doi.org/10.1001/jama.295.20.2357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720821	Bronze			2022-12-28	WOS:000237734400021
J	Sim, I; Chan, AW; Gulmezoglu, AM; Evans, T; Pang, T				Sim, I; Chan, AW; Gulmezoglu, AM; Evans, T; Pang, T			Clinical trial registration: transparency is the watchword	LANCET			English	Editorial Material							INJURY					simi@who.int						[Anonymous], 2006, INT CLIN TRIALS REG; Cleaton-Jones P, 2006, LANCET, V367, P458, DOI 10.1016/S0140-6736(06)68158-0; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; CURFMAN GD, 2000, NEW ENGL J MED, V243, P1520; De Angelis CD, 2005, ANN INTERN MED, V143, P146, DOI 10.7326/0003-4819-143-2-200507190-00016; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; PALMISANO S, 2005, NEWSWEEK ISSUES 1202; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; PEARSON H, 2006, NATURE          0317; Stephens Joe, 2006, Washington Post, pA21; Sykes R, 1998, BRIT MED J, V317, P1172, DOI 10.1136/bmj.317.7167.1172; VINCE G, 2006, NEW SCI, V189, P56; *WHO, 2006, INT CLIN TRIALS R 21; *WHO, 2006, INT CLIN TRIALS R 22; Wood AJJ, 2006, NEW ENGL J MED, V354, P1869, DOI 10.1056/NEJMp068082; World Medical Association, 2004, DECL HELS	18	113	118	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2006	367	9523					1631	1633		10.1016/S0140-6736(06)68708-4	http://dx.doi.org/10.1016/S0140-6736(06)68708-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714166				2022-12-28	WOS:000237743100004
J	Humbert, S; Saudou, F				Humbert, Sandrine; Saudou, Frederic			The ataxia-ome: Connecting disease proteins of the cerebellum	CELL			English	Editorial Material							INTERACTION NETWORK; ALPHA-SYNUCLEIN; PARKIN	In this issue of Cell, Lim et al. (2006) describe a protein-protein interaction network for inherited human ataxias, a group of diseases characterized by degeneration of cerebellar Purkinje cells. This protein interactome shows that the cerebellar ataxias not only share clinical and pathological characteristics but also have proteins, processes, and pathways in common.	Inst Curie, CNRS, UMR 146, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Humbert, S (corresponding author), Inst Curie, CNRS, UMR 146, F-91405 Orsay, France.	sandrine.humbert@curie.u-psud.fr; frederic.saudou@curie.u-psud.fr	Humbert, Sandrine/S-2981-2016; SAUDOU, Frédéric/L-3454-2014	SAUDOU, Frédéric/0000-0001-6107-1046; Humbert, Sandrine/0000-0002-9501-2658				Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stevanin G, 2003, BRAIN, V126, P1599, DOI 10.1093/brain/awg155; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474	8	8	8	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					645	647		10.1016/j.cell.2006.05.007	http://dx.doi.org/10.1016/j.cell.2006.05.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713557	Bronze			2022-12-28	WOS:000237886000009
J	Guthrie, RD				Guthrie, RD			New carbon dates link climatic change with human colonization and Pleistocene extinctions	NATURE			English	Article							BERINGIA; ALASKA; VEGETATION; PENINSULA; HORSES; END; BP	Drastic ecological restructuring, species redistribution and extinctions mark the Pleistocene-Holocene transition, but an insufficiency of numbers of well-dated large mammal fossils from this transition have impeded progress in understanding the various causative links(1). Here I add many new radiocarbon dates to those already published on late Pleistocene fossils from Alaska and the Yukon Territory (AK - YT) and show previously unrecognized patterns. Species that survived the Pleistocene, for example, bison ( Bison priscus, which evolved into Bison bison), wapiti (Cervus canadensis) and, to a smaller degree, moose (Alces alces), began to increase in numbers and continued to do so before and during human colonization and before the regional extinction of horse ( Equus ferus) and mammoth (Mammuthus primigenius). These patterns allow us to reject, at least in AK - YT, some hypotheses of late Pleistocene extinction: 'Blitzkrieg' version of simultaneous human overkill(2), 'keystone' removal(3), and 'palaeo-disease'(4). Hypotheses of a subtler human impact and/or ecological replacement or displacement are more consistent with the data. The new patterns of dates indicate a radical ecological sorting during a uniquely forage-rich transitional period, affecting all large mammals, including humans.	Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99709 USA	University of Alaska System; University of Alaska Fairbanks	Guthrie, RD (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99709 USA.	ffrdg@uaf.edu						Ager T.A., 1983, LATE QUATERNARY ENV, P128; ANDERSON PM, 1991, J BIOGEOGR, V18, P565, DOI 10.2307/2845692; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Bever M, 2001, ARCTIC ANTHR, V38; Bigelow NH, 2001, ARCTIC ANTHROPOL, V38, P171; BOESKOROV GG, 2003, U ALASKA AQC WORKSH, V8; BRYANT JP, 1980, ANNU REV ECOL SYST, V11, P261, DOI 10.1146/annurev.es.11.110180.001401; DUMOND DE, 1995, J WORLD PREHIST, V9, P401, DOI 10.1007/BF02221118; FRANZMANN AW, 2002, ECOLOGY MANAGEMENT N; Goetcheus VG, 2001, QUATERNARY SCI REV, V20, P135, DOI 10.1016/S0277-3791(00)00127-X; Graham R.W., 1984, P223; Grayson DK, 2003, J ARCHAEOL SCI, V30, P585, DOI 10.1016/S0305-4403(02)00205-4; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; HOPKINS DM, 1981, QUATERNARY RES, V15, P217, DOI 10.1016/0033-5894(81)90028-4; KUTZBACH JE, 1985, NATURE, V317, P130, DOI 10.1038/317130a0; LOZHKIN AV, 1993, QUATERNARY RES, V39, P314, DOI 10.1006/qres.1993.1038; MacPhee RDE, 2002, J ARCHAEOL SCI, V29, P1017, DOI 10.1006/jasc.2001.0802; Martin P. S., 1984, QUATERNARY EXTINCTIO, P345; MATHEUS PM, 2001, 0119 US DEP INT BUR; Porter S., 1983, LATE QUATERNARY ENV, V1, P71; POTTER B, 2004, THESIS U ALASKA FAIR; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Sher AV, 2005, QUATERNARY SCI REV, V24, P533, DOI 10.1016/j.quascirev.2004.09.007; Slobodin S, 2001, ARCTIC ANTHROPOL, V38, P31; STEPHENSON RO, 2001, WILDLIFE PEOPLE NO N, P125; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Yesner DR, 2001, QUATERNARY SCI REV, V20, P315, DOI 10.1016/S0277-3791(00)00114-1; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824; [No title captured]	30	217	228	3	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					207	209		10.1038/nature04604	http://dx.doi.org/10.1038/nature04604			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688174				2022-12-28	WOS:000237418800043
J	Kaushansky, K				Kaushansky, K			Mechanisms of disease: Lineage-specific hematopoietic growth factors	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COLONY-STIMULATING-FACTOR; RECOMBINANT-HUMAN-ERYTHROPOIETIN; BLOOD PROGENITOR CELLS; ACUTE MYELOID-LEUKEMIA; C-MPL; THROMBOPOIETIN PRODUCTION; CHRONIC NEUTROPENIA; FACTOR-RECEPTOR; BREAST-CANCER; UP-REGULATION		Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA	University of California System; University of California San Diego	Kaushansky, K (corresponding author), 402 Dickinson St,Suite 380, San Diego, CA 92103 USA.							Archimbaud E, 1999, BLOOD, V94, P3694, DOI 10.1182/blood.V94.11.3694.423k18_3694_3701; Ballmaier M, 2001, BLOOD, V97, P139, DOI 10.1182/blood.V97.1.139; Bennett CL, 2005, BLOOD, V106, P3343, DOI 10.1182/blood-2005-02-0508; Bokemeyer C, 2004, EUR J CANCER, V40, P2201, DOI 10.1016/j.ejca.2004.07.015; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bussel JB, 2005, BLOOD, V106, p68A, DOI 10.1182/blood.V106.11.220.220; Calhoun EA, 2005, PHARMACOECONOMICS, V23, P767, DOI 10.2165/00019053-200523080-00003; CARNOT P, 1906, C R HEBD SEANCES A M, V3, P384; CAZZOLA M, 1995, BLOOD, V86, P4446, DOI 10.1182/blood.V86.12.4446.bloodjournal86124446; Chan IT, 2004, CELL CYCLE, V3, P536; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; Dale DC, 2003, AM J HEMATOL, V72, P82, DOI 10.1002/ajh.10255; DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Ding F, 2004, BLOOD, V103, P4198, DOI 10.1182/blood-2003-10-3471; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Griesshammer M, 1999, J INTERN MED, V245, P295, DOI 10.1046/j.1365-2796.1999.00452.x; Hareng L, 2002, BIOL CHEM, V383, P1501, DOI 10.1515/BC.2002.172; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henry MK, 2004, EXP CELL RES, V299, P257, DOI 10.1016/j.yexcr.2004.06.003; Heuser M, 2005, ANN HEMATOL, V84, P697, DOI 10.1007/s00277-005-1087-4; Hunter MG, 2004, J IMMUNOL, V173, P5036, DOI 10.4049/jimmunol.173.8.5036; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; JACOBSON LO, 1957, NATURE, V179, P633, DOI 10.1038/179633a0; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kaushansky K, 2005, ANN NY ACAD SCI, V1044, P139, DOI 10.1196/annals.1349.018; Kaushansky K, 2005, BLOOD, V105, P4187, DOI 10.1182/blood-2005-03-1287; Kaushansky K, 1998, NEW ENGL J MED, V339, P746, DOI 10.1056/NEJM199809103391107; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Kirito K, 2003, BLOOD, V102, P3172, DOI 10.1182/blood-2003-03-0944; Kojima H, 2001, EXP HEMATOL, V29, P616, DOI 10.1016/S0301-472X(01)00623-3; KRANTZ SB, 1991, BLOOD, V77, P419; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Leyland-Jones B, 2003, LANCET ONCOL, V4, P459, DOI 10.1016/S1470-2045(03)01163-X; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mauro MJ, 2001, CURR OPIN ONCOL, V13, P3, DOI 10.1097/00001622-200101000-00002; MCCARTY JM, 1995, BLOOD, V86, P3668, DOI 10.1182/blood.V86.10.3668.bloodjournal86103668; MILLER CB, 1990, NEW ENGL J MED, V322, P1689, DOI 10.1056/NEJM199006143222401; MIURA Y, 1994, J BIOL CHEM, V269, P29962; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; Mora-Garcia P, 2000, J BIOL CHEM, V275, P22418, DOI 10.1074/jbc.M001731200; OHNO R, 1990, NEW ENGL J MED, V323, P871, DOI 10.1056/NEJM199009273231304; Pastore YD, 2003, BLOOD, V101, P1591, DOI 10.1182/blood-2002-06-1843; Qian SG, 1998, BLOOD, V92, P2189, DOI 10.1182/blood.V92.6.2189; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Relling MV, 2003, BLOOD, V101, P3862, DOI 10.1182/blood-2002-08-2405; Repetto L, 2003, EUR J CANCER, V39, P2264, DOI 10.1016/S0959-8049(03)00662-2; Ringden O, 2004, J CLIN ONCOL, V22, P416, DOI 10.1200/JCO.2004.06.102; Rizzo JD, 2002, BLOOD, V100, P2303, DOI 10.1182/blood-2002-06-1767; SHERIDAN WP, 1992, LANCET, V339, P640, DOI 10.1016/0140-6736(92)90795-5; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Slichter SJ, 2004, TRANSFUS MED REV, V18, P153, DOI 10.1016/j.tmrv.2004.03.003; Smith RE, 2003, J CLIN ONCOL, V21, P1195, DOI 10.1200/JCO.2003.03.114; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Somlo G, 1999, BLOOD, V93, P2798; Spiekermann K, 1997, LEUKEMIA, V11, P466, DOI 10.1038/sj.leu.2400607; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sungaran R, 1997, BLOOD, V89, P101, DOI 10.1182/blood.V89.1.101; Vadhan-Raj S, 2000, ANN INTERN MED, V132, P364, DOI 10.7326/0003-4819-132-5-200003070-00005; Van Os R, 2002, J HEMATOTH STEM CELL, V11, P513, DOI 10.1089/15258160260090979; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; Wolber EM, 2000, J INTERF CYTOK RES, V20, P499, DOI 10.1089/10799900050023915; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yanagida M, 1997, BRIT J HAEMATOL, V99, P739, DOI 10.1046/j.1365-2141.1997.4843288.x; Yang C, 1999, BRIT J HAEMATOL, V105, P478, DOI 10.1111/j.1365-2141.1999.01359.x	78	312	381	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2034	2045		10.1056/NEJMra052706	http://dx.doi.org/10.1056/NEJMra052706			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687716				2022-12-28	WOS:000237413100008
J	Ameratunga, S; Hijar, M; Norton, R				Ameratunga, S; Hijar, M; Norton, R			Road-traffic injuries: confronting disparities to address a global-health problem	LANCET			English	Review							PUBLIC-HEALTH; MOTORCYCLE ACCIDENTS; CHILD INJURY; SOCIAL-CLASS; SAFETY; CRASHES; MORTALITY; RISK; DISABILITY; DEATHS	Evidence suggests that the present and projected global burden of road-traffic injuries is disproportionately borne by countries that can least afford to meet the health service, economic, and societal challenges posed. Although the evidence base on which these estimates are made remains somewhat precarious in view of the limited data systems in most low-income and middle-income countries (as per the classification on the World Bank website), these projections highlight the essential need to address road-traffic injuries as a public-health priority. Most well-evaluated effective interventions do not directly focus on efforts to protect vulnerable road users, such as motorcyclists and pedestrians. Yet, these groups comprise the majority of road-traffic victims in low-income and middle-income countries, and consequently, the majority of the road-traffic victims globally. Appropriately responding to these disparities in available evidence and prevention efforts is necessary if we are to comprehensively address this global-health dilemma.	Univ Auckland, Fac Med & Hlth Sci, Injury Prevent Res Ctr, Auckland 1, New Zealand; Natl Inst Publ Hlth, Ctr Populat Hlth, Cuernavaca, Morelos, Mexico; Univ Sydney, Geog Inst Int Hlth, Sydney, NSW 2006, Australia	University of Auckland; Instituto Nacional de Salud Publica; University of Sydney	Ameratunga, S (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Injury Prevent Res Ctr, Auckland 1, New Zealand.	s.ameratunga@auckland.ac.nz		Ameratunga, Shanthi/0000-0001-8042-2251	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aeron-Thomas A, 2005, COCHRANE DB SYST REV, V2; AERONTHOMAS A, 2004, MORBIDITY IMPACT ROA; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P77, DOI 10.1076/icsp.10.1.77.14113; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P69, DOI 10.1076/icsp.10.1.69.14107; Alsop J, 2001, ACCIDENT ANAL PREV, V33, P353, DOI 10.1016/S0001-4575(00)00049-X; Ameratunga SN, 2004, INJURY, V35, P1116, DOI 10.1016/j.injury.2003.12.016; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], COCHRANE DATABASE SY; Babor TF, 2003, ALCOHOL NO ORDINARY; Bendak S, 2005, ACCIDENT ANAL PREV, V37, P367, DOI 10.1016/j.aap.2004.10.007; Bishai D, 2006, HEALTH ECON, V15, P65, DOI 10.1002/hec.1020; Bonnie RJ, 1999, REDUCING BURDEN INJU; Borrell C, 2005, INJURY PREV, V11, P138, DOI 10.1136/ip.2004.006346; BRUHNING E, 1997, HLTH CROSSROADS TRAN, P109; Bunn F., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003110, DOI 10.1002/14651858.CD003110]; CARLSSON A, 2003, EVALUATION ROADS DES; CATER N, 1998, WORLD DIS REPORT 199; CIRILLO JA, 1986, TRANSPORT RES REC, V1068, P90; Conrad P, 1996, ACCIDENT ANAL PREV, V28, P193, DOI 10.1016/0001-4575(95)00056-9; Cryer P C, 2001, Inj Prev, V7, P234; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; Cummings P, 2002, BRIT MED J, V324, P1119, DOI 10.1136/bmj.324.7346.1119; Dandona R, 2004, NATL MED J INDIA, V17, P74; de Figueiredo LFP, 2001, INJURY, V32, P91, DOI 10.1016/S0020-1383(00)00172-8; Dharmaratne Samath D, 2004, J Coll Physicians Surg Pak, V14, P729; EDLIN AS, 2002, PERMILE PREMIUMS AUT; El-Sadig M, 2004, ACCIDENT ANAL PREV, V36, P399, DOI 10.1016/S0001-4575(03)00033-2; Elder RW, 2004, AM J PREV MED, V27, P57, DOI 10.1016/j.amepre.2004.03.002; Elder RW., 2002, TRAFFIC INJ PREV, V3, P266, DOI DOI 10.1080/15389580214623; Elvik R., 2004, HDB ROAD SAFETY MEAS; *EUR ROAD SAF ACT, 2003, HALV NUMB ROAD ACC V; European Transportation Safety Council, 1999, POL ENF STRAT RED TR; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; FUHRER MJ, 1997, ASSESSING MED REHABI; Ganveer Gunjan B, 2005, Indian J Med Sci, V59, P9; GEZIARY H, 2004, E MEDITERR HEALTH J, V1, P252; Ghaffar Abdul, 2004, J Coll Physicians Surg Pak, V14, P739; GREEN MM, 1993, MED J AUSTRALIA, V159, P529, DOI 10.5694/j.1326-5377.1993.tb138006.x; Hagenzieker MP, 1997, ACCIDENT ANAL PREV, V29, P759, DOI 10.1016/S0001-4575(97)00045-6; Harris GT, 2005, INJURY PREV, V11, P102, DOI 10.1136/ip.2004.007179; Hartling L, 2004, COCHRANE DB SYST REV, V2; HERRSTEDT L, 1997, VTI C A 3, V9, P41; Hijar M, 2004, ACCIDENT ANAL PREV, V36, P37, DOI 10.1016/S0001-4575(02)00112-4; Hijar M, 2003, LANCET, V362, P833, DOI 10.1016/S0140-6736(03)14260-2; Hijar Martha, 2003, Inj Control Saf Promot, V10, P37, DOI 10.1076/icsp.10.1.37.14108; Hyder AA, 2006, HEALTH POLICY, V77, P129, DOI 10.1016/j.healthpol.2005.07.008; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; Inclan C, 2005, SOC SCI MED, V61, P2007, DOI 10.1016/j.socscimed.2005.04.024; *INT ROAD TRAFF AC, 1994, SPEC REP REP ROAD AC; *IRTAD, FED HIGHW RES I ORG; Jacobs G., 2000, 445 TRL; JACOBS GD, 1986, ACCIDENT ANAL PREV, V18, P119, DOI 10.1016/0001-4575(86)90056-4; JAMES H, 1991, TRAFFIC ENG CONTROL, V33, P574; Kopits E., 2003, 3035 WORLD BANK; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kulanthayan S, 2000, Med J Malaysia, V55, P40; Laflamme L, 2000, Inj Prev, V6, P293, DOI 10.1136/ip.6.4.293; *LAND TRANSP SAF A, 2001, MOT ACC NZ 2000 STAT; LANGLEY J, 1994, ACCIDENT ANAL PREV, V26, P549, DOI 10.1016/0001-4575(94)90046-9; LITMAN T, 2004, DISTANCE BASED VEHIC; London J, 2002, B WORLD HEALTH ORGAN, V80, P357; Lund J, 2001, ACCIDENT ANAL PREV, V33, P19, DOI 10.1016/S0001-4575(00)00011-7; MAHESHWARI J, 1989, J TRAFFIC MED, V17, P23; Mayou R, 2003, INJURY, V34, P197, DOI 10.1016/S0020-1383(02)00285-1; MILLER TR, 1989, ACCIDENT ANAL PREV, V21, P303, DOI 10.1016/0001-4575(89)90022-5; Mock C, 2005, B WORLD HEALTH ORGAN, V83, P294; Mock C, 1999, Inj Prev, V5, P268; Mock CN, 1997, J TRAUMA, V42, P504, DOI 10.1097/00005373-199703000-00019; Mohan D, 2002, INT J EPIDEMIOL, V31, P527, DOI 10.1093/ije/31.3.527; MOHAN D, 1984, ACCIDENT ANAL PREV, V16, P279, DOI 10.1016/0001-4575(84)90022-8; MOHAN D, 2003, B WORLD HEALTH ORGAN, V1, P684; Mutto Milton, 2002, Afr Health Sci, V2, P89; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P13, DOI 10.1076/icsp.10.1.13.14116; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; *NAT HIGHW TRAFF S, 1987, EC COST SOC MOT VEH; NORGHANI M, 1908, USE EXPOSURE CONTROL; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; Odero Wilson, 2003, Inj Control Saf Promot, V10, P53, DOI 10.1076/icsp.10.1.53.14103; OECD (Organisation for Economic Co-operation and Development),, 2003, ROAD SAF IMP NEW TEC; Ossenbruggen PJ, 2001, ACCIDENT ANAL PREV, V33, P485, DOI 10.1016/S0001-4575(00)00062-2; Peden M, 2002, INJURY LEADING CAUSE; Peden M., 2004, WORLD REPORT ROAD TR; Peden Margie, 2005, Int J Inj Contr Saf Promot, V12, P85, DOI 10.1080/15660970500086130; PEDEN MM, 2001, WHONMHVIP0103; Pless B, 2004, BMJ-BRIT MED J, V328, P846, DOI 10.1136/bmj.328.7444.846; Radin URS, 1996, ACCIDENT ANAL PREV, V28, P325, DOI 10.1016/0001-4575(95)00071-2; Razzak JA, 1998, INT J EPIDEMIOL, V27, P866, DOI 10.1093/ije/27.5.866; Razzak Junaid Abdul, 2005, Prehosp Emerg Care, V9, P355, DOI 10.1080/10903120590962049; ROBERTS I, 1994, NEW ZEAL MED J, V107, P331; ROBERTS I, 1995, BRIT MED J, V310, P91, DOI 10.1136/bmj.310.6972.91; Roberts I, 2004, BMJ-BRIT MED J, V328, P845, DOI 10.1136/bmj.328.7444.845; Roberts I, 1996, J EPIDEMIOL COMMUN H, V50, P162, DOI 10.1136/jech.50.2.162; Roberts I, 1996, BRIT MED J, V313, P784; Roberts I, 1997, J EPIDEMIOL COMMUN H, V51, P334, DOI 10.1136/jech.51.3.334; ROMAO F, 2002, ROAD TRAFFIC INJURIE; RUTLEDGE R, 1995, SURG CLIN N AM, V75, P305, DOI 10.1016/S0039-6109(16)46590-4; Sabbagh-Ehrlich S, 2005, INJURY PREV, V11, P110, DOI 10.1136/ip.2004.007682; SALIFU M, 1998, GHANA ENG, V18, P23; SATHIYASEKRAN B, 1991, J FORENSIC SCI, V5, P63; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; SINGER S, 2004, JCPSP-J COLL PHYSICI, V14, P709; SODERLUND N, 1995, B WORLD HEALTH ORGAN, V73, P175; SUPRAMANIAM V, 1984, ACCIDENT ANAL PREV, V16, P157, DOI 10.1016/0001-4575(84)90009-5; Suriyawongpaisal Paibul, 2003, Inj Control Saf Promot, V10, P95, DOI 10.1076/icsp.10.1.95.14110; Swaddiwudhipong Witaya, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P37; Thompson DC, 2000, COCHRANE DB SYST REV, V2; *UN GEN ASS, 2005, 58289A60181 UN GEN A; *UN GEN ASS, 2005, ARES605 UN GEN ASS; *UN GEN ASS, 2004, ARES58289 UN GEN ASS; Wang Sheng-Yong, 2003, Inj Control Saf Promot, V10, P83, DOI 10.1076/icsp.10.1.83.14105; *WHO, 2001, WO REP 2001 STAT ANN; Yang LF, 2003, LETT PEPT SCI, V10, P89, DOI 10.1007/BF02443647; Yuan W, 2000, ACCIDENT ANAL PREV, V32, P559, DOI 10.1016/S0001-4575(99)00078-0; ZADOR PL, 1985, AM J PUBLIC HEALTH, V75, P543, DOI 10.2105/AJPH.75.5.543; Zaza S, 2001, AM J PREV MED, V21, P31, DOI 10.1016/S0749-3797(01)00377-4; ZHANG J, 2005, INJ CONTROL SAF PROM, V11, P159	117	310	323	1	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1533	1540		10.1016/S0140-6736(06)68654-6	http://dx.doi.org/10.1016/S0140-6736(06)68654-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	039RJ	16679167				2022-12-28	WOS:000237324200034
J	Bharadwaj, R; Kolodkin, AL				Bharadwaj, Rajnish; Kolodkin, Alex L.			Descrambling DSCAM diversity	CELL			English	Editorial Material							DROSOPHILA DSCAM		Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Howard Hughes Med Inst, 725 N Wolfe St 1001 PCTB, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu						CHEN BE, 2006, CELL; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	10	5	5	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					421	424		10.1016/j.cell.2006.04.012	http://dx.doi.org/10.1016/j.cell.2006.04.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678085	Bronze			2022-12-28	WOS:000237506100005
J	Fleire, SJ; Goldman, JP; Carrasco, YR; Weber, M; Bray, D; Batista, FD				Fleire, SJ; Goldman, JP; Carrasco, YR; Weber, M; Bray, D; Batista, FD			B cell ligand discrimination through a spreading and contraction response	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; REACTIVE LYMPHOCYTES-B; IMMUNOLOGICAL SYNAPSE; ACTIN POLYMERIZATION; ANTIGEN RECEPTOR; TRANSGENIC MICE; T-CELLS; ACTIVATION; SEGREGATION; SENSITIVITY	B cells recognize foreign antigens by virtue of cell surface immunoglobulin receptors and are most effectively activated by membrane-bound ligands. Here, we show that in the early stages of this process, B cells exhibit a two-phase response in which they first spread over the antigen-bearing membrane and then contract, thereby collecting bound antigen into a central aggregate. The extent of this response, which is both signaling- and actin-dependent, determines the quantity of antigen accumulated and hence the degree of B cell activation. Brownian dynamic simulations reproduce essential features of the antigen collection process and suggest a possible basis for affinity discrimination. We propose that dynamic spreading is an important step of the immune response.	Canc Res UK, London Res Inst, Lymphocyte Interact Lab, London WC2A 3PX, England; Univ Kent, Comp Lab, Canterbury CT2 7NF, Kent, England; Univ Cambridge, Cambridge CB2 3DY, England	Cancer Research UK; University of Kent; University of Cambridge	Batista, FD (corresponding author), Canc Res UK, London Res Inst, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	facundo.batista@cancer.org.uk	Carrasco, Yolanda/X-2629-2019	Weber, Michele/0000-0003-2056-3751; Carrasco, Yolanda R./0000-0003-2148-1926; Goldman, Jacki/0000-0002-2981-5022	PHS HHS [G64713] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Burroughs NJ, 2002, BIOPHYS J, V83, P1784, DOI 10.1016/S0006-3495(02)73944-1; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee SJE, 2002, TRENDS IMMUNOL, V23, P500, DOI 10.1016/S1471-4906(02)02325-6; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; PARSEY MV, 1993, J IMMUNOL, V151, P1881; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Teh YM, 1997, J EXP MED, V185, P1753, DOI 10.1084/jem.185.10.1753; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; Wykes M, 1998, J IMMUNOL, V161, P1313	25	316	321	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					738	741		10.1126/science.1123940	http://dx.doi.org/10.1126/science.1123940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675699				2022-12-28	WOS:000237312100048
J	Srivastava, P; Currie, GP; Britton, J				Srivastava, Prasima; Currie, Graerne P.; Britton, John			ABC of chronic obstructive pulmonary disease - Smoking cessation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Currie, Graeme P/0000-0002-5711-9147				Hughes J., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB2; Jamrozik K, 2004, BRIT MED J, V328, P759, DOI 10.1136/bmj.328.7442.759; Molyneux AN, 2004, BRIT MED J, V328, P454, DOI 10.1136/bmj.328.7437.454; Roddy E, 2004, BRIT MED J, V328, P509, DOI 10.1136/bmj.328.7438.509; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987	6	12	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1324	1326		10.1136/bmj.332.7553.1324	http://dx.doi.org/10.1136/bmj.332.7553.1324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16740563	Green Published			2022-12-28	WOS:000238197000027
J	Rankenburg, K; Brandon, AD; Neal, CR				Rankenburg, K.; Brandon, A. D.; Neal, C. R.			Neodymium isotope evidence for a chondritic composition of the Moon	SCIENCE			English	Article							HF-W CHRONOMETRY; LUNAR DIFFERENTIATION; ND-142 EVIDENCE; MARE BASALTS; CONSTRAINTS; EVOLUTION; ACCRETION; PLANETS; ORIGIN; AGES	Samarium-neodymium isotope data for six lunar basalts show that the bulk Moon has a Nd-142/Nd-144 ratio that is indistinguishable from that of chondritic meteorites but is 20 parts per million less than most samples from Earth. The Sm/Nd formation interval of the lunar mantle from these data is 215(-21)(+23) million years after the onset of solar system condensation. Because both Earth and the Moon likely formed in the same region of the solar nebula, Earth should also have a chondritic bulk composition. In order to mass balance the Nd budget, these constraints require that a complementary reservoir with a lower Nd-142/Nd-144 value resides in Earth's mantle.	NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Notre Dame	Rankenburg, K (corresponding author), NASA, Lyndon B Johnson Space Ctr, Mail Code KR, Houston, TX 77058 USA.	kai.rankenburg1@jsc.nasa.gov	Neal, Clive R/C-2316-2014	Rankenburg, Kai/0000-0003-3708-9304				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Becker TW, 1999, EARTH PLANET SC LETT, V171, P351, DOI 10.1016/S0012-821X(99)00160-0; Boyet M, 2003, EARTH PLANET SC LETT, V214, P427, DOI 10.1016/S0012-821X(03)00423-0; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; CARLSON RW, 1979, EARTH PLANET SC LETT, V45, P123, DOI 10.1016/0012-821X(79)90114-6; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Caro G, 2005, NATURE, V436, P246, DOI 10.1038/nature03827; Elkins-Tanton LT, 2003, METEORIT PLANET SCI, V38, P515, DOI 10.1111/j.1945-5100.2003.tb00024.x; Elkins-Tanton LT, 2002, EARTH PLANET SC LETT, V196, P239, DOI 10.1016/S0012-821X(01)00613-6; Gnos E, 2004, SCIENCE, V305, P657, DOI 10.1126/science.1099397; Halliday AN, 2004, NATURE, V427, P505, DOI 10.1038/nature02275; Halliday AN, 2001, EARTH PLANET SC LETT, V192, P545, DOI 10.1016/S0012-821X(01)00479-4; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; Hess PC, 2001, J GEOPHYS RES-PLANET, V106, P28023, DOI 10.1029/2000JE001416; JACOBSEN SB, 2003, P LUN PLAN SCI C, V34, P1913; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Kleine T, 2005, SCIENCE, V310, P1671, DOI 10.1126/science.1118842; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; KLEINE T, 2003, P MET SOC, V66, P5212; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; Norman MD, 2003, METEORIT PLANET SCI, V38, P645, DOI 10.1111/j.1945-5100.2003.tb00031.x; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; NYQUIST LE, 1992, GEOCHIM COSMOCHIM AC, V56, P2213, DOI 10.1016/0016-7037(92)90185-L; NYQUIST LE, 1991, LUNAR PLANET SCI, V22, P985; PACES JB, 1991, GEOCHIM COSMOCHIM AC, V55, P2025, DOI 10.1016/0016-7037(91)90040-C; Palme H, 2004, SCIENCE, V304, P977, DOI 10.1126/science.1097059; Ringwood A. E, 1976, P 7 LUNAR SCI C, V7, P1697; Shearer CK, 2000, GEOCHIM COSMOCHIM AC, V64, P3599, DOI 10.1016/S0016-7037(00)00442-7; Snyder G. A., 2000, ORIGIN EARTH MOON, p361 395; SNYDER GA, 1992, GEOCHIM COSMOCHIM AC, V56, P3809, DOI 10.1016/0016-7037(92)90172-F; TERA F, 1974, P LUN SCI C, V5, P571; Tolstikhin I, 2005, PHYS EARTH PLANET IN, V148, P109, DOI 10.1016/j.pepi.2004.05.011; Wetherill G. W, 1986, ORIGIN MOON, P519; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	38	84	91	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1369	1372		10.1126/science.1126114	http://dx.doi.org/10.1126/science.1126114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741118				2022-12-28	WOS:000237961600052
J	Brumm, A; Aziz, F; van den Bergh, GD; Morwood, MJ; Moore, MW; Kurniawan, I; Hobbs, DR; Fullagar, R				Brumm, Adam; Aziz, Fachroel; van den Bergh, Gert D.; Morwood, Michael J.; Moore, Mark W.; Kurniawan, Iwan; Hobbs, Douglas R.; Fullagar, Richard			Early stone technology on Flores and its implications for Homo floresiensis	NATURE			English	Article							LATE PLEISTOCENE; INDONESIA; PALEOANTHROPOLOGY; ARTIFACTS; HOMININ	In the Soa Basin of central Flores, eastern Indonesia, stratified archaeological sites, including Mata Menge, Boa Lesa and Kobatuwa ( Fig. 1), contain stone artefacts associated with the fossilized remains of Stegodon florensis, Komodo dragon, rat and various other taxa. These sites have been dated to 840 - 700 kyr BP ( thousand years before present)(1). The authenticity of the Soa Basin artefacts and their provenance have been demonstrated by previous work(2-6), but to quell lingering doubts(7), here we describe the context, attributes and production modes of 507 artefacts excavated at Mata Menge. We also note specific similarities, and apparent technological continuity, between the Mata Menge stone artefacts and those excavated from Late Pleistocene levels at Liang Bua cave, 50 km to the west. The latter artefacts, dated to between 95 - 74 and 12 kyr ago(8,9), are associated with the remains of a dwarfed descendent of S. florensis, Komodo dragon, rat and a small-bodied hominin species, Homo floresiensis, which had a brain size of about 400 cubic centimetres(10,11). The Mata Menge evidence negates claims that stone artefacts associated with H. floresiensis are so complex that they must have been made by modern humans ( Homo sapiens)(7).	Australian Natl Univ, Dept Archaeol & Nat Hist, Res Sch Pacific & Asian Studies, Canberra, ACT 0200, Australia; Geol Res & Dev Ctr, Bandung 40122, Indonesia; Naturalis Natl Museum Nat Hist, NL-2300 RA Leiden, Netherlands; Univ New England, Sch Human & Environm Studies, Dept Archaeol & Palaeoanthropol, Armidale, NSW 2351, Australia; Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; Univ Sydney, Dept Archaeol, Sydney, NSW 2006, Australia	Australian National University; University of New England; University of Wollongong; University of Sydney	Brumm, A (corresponding author), Australian Natl Univ, Dept Archaeol & Nat Hist, Res Sch Pacific & Asian Studies, Canberra, ACT 0200, Australia.	adam.brumm@anu.edu.au; mmorwood@pobox.une.edu.au	Moore, Mark W/B-4729-2015; Fullagar, Richard/AAT-1155-2020; van den Bergh, Gerrit D/I-7670-2016	Moore, Mark W/0000-0003-4768-5329; van den Bergh, Gerrit Dirk/0000-0003-1507-3336; Fullagar, Richard/0000-0003-1047-1466				[Anonymous], 1986, BAR INT SERIES; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Culotta E, 2005, SCIENCE, V310, P208; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Lahr MM, 2004, NATURE, V431, P1043, DOI 10.1038/4311043a; MARINGER J, 1970, ANTHROPOS, V65, P638; MARINGER J, 1970, ANTHROPOS, V65, P229; MOORE MW, 2005, THESIS U NEW ENGLAND; Morwood M.J., 1997, AUST ARCHAEOL, V44, P26; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Morwood MJ, 1999, ANTIQUITY, V73, P273, DOI 10.1017/S0003598X00088244; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; O'Sullivan PB, 2001, GEOLOGY, V29, P607, DOI 10.1130/0091-7613(2001)029<0607:AIOTGA>2.0.CO;2; Shea JJ., 1999, GEOARCHAEOLOGY, V14, P191, DOI [10.1002/(SICI)1520-6548(199902)14:23.0.CO;2-K, DOI 10.1002/(SICI)1520-6548(199902)14:23.0.CO;2-K, DOI 10.1002/(SICI)1520-6548(199902)14:2]; SONDAAR PY, 1994, CR ACAD SCI II, V319, P1255; VANDENBERGH GD, 1997, SCRIPTA GEOLOGICA, V117, P1	17	99	104	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					624	628		10.1038/nature04618	http://dx.doi.org/10.1038/nature04618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048AU	16738657				2022-12-28	WOS:000237920800045
J	Kroeger, A; Lenhart, A; Ochoa, M; Villegas, E; Levy, M; Alexander, N; McCall, PJ				Kroeger, Axel; Lenhart, Audrey; Ochoa, Manuel; Villegas, Elci; Levy, Michael; Alexander, Neal; McCall, P. J.			Effective control of dengue vectors with curtains and water container covers treated with insecticide in Mexico and Venezuela: cluster randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AEDES-AEGYPTI; BED NETS; TRANSMISSION; DISPERSAL	Objectives To measure the impact on the dengue vector population (Aedes aegypti) and disease transmission of window curtains and water container covers treated with insecticide. Design Cluster randomised controlled trial based on entomological surveys and, for TruJillo only, serological survey. In addition, each site had a non-randomised external control. Setting 18 urban sectors in Veracruz (Mexico) and 18 in Trujillo (Venezuela). Participants 4743 inhabitants (1095 houses) in Veracruz and 5306 inhabitants (1122 houses) in Trujillo. Intervention Sectors were paired according to entomological indices, and one sector in each pair was randomly allocated to receive treatment. In Veracruz, the intervention comprised curtains treated with lambdacyhalothrin and water treatment with pyriproxyfen chips (an insect growth regulator). In Trujillo, the intervention comprised curtains treated with longlasting deltamethrin (PermaNet) plus water jar covers of the same material. Follow-up surveys were conducted at intervals, with the final survey after 12 months in Veracruz and nine months in Trujillo. Main outcome measures Reduction in entomological indices, specifically the Breteau and house indices. Results In both study sites, indices at the end of the trial were significantly lower than those at baseline, though with no significant differences between control and intervention arms. The mean Breteau index dropped from 60% (intervention clusters) and 113% (control) to 7% (intervention) and 12% (control) in Veracruz mid from 38% to 11% (intervention) and from 34% to 17% (control) in Trujillo. The pupae per person and container indices showed similar patterns. hi contrast, in nearby communities not in die trial die entomological indices followed the rainfall pattern. The intervention reduced mosquito, populations in neighbouring control clusters (spill-over effect); and houses closer to treated houses were less likely to have infestations than those further away. This created a community effect whereby mosquito numbers were reduced throughout the study site. The observed effects were probably associated with the use of materials treated with insecticide at both sites because in Veracruz, people did not accept and use the pyriproxyfen chips. Conclusion Window curtains and domestic water container covers treated with insecticide can reduce densities of dengue vectors to low levels and potentially affect dengue transmission.	World Hlth Org, Special Programme Res & Training Trop Med TDR WHO, Geneva, Switzerland; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; IMSS OPORTUNIDADES, Mexico City 06600, DF, Mexico; Univ Los Andes, Nucleo Rafael Rangel, Ctr Invest Jose Witremundo Torrealba, Trujillo, Venezuela; Emory Univ, Div Biol & Biomed Sci, Program Populat Biol Evolut & Ecol, Atlanta, GA 30322 USA; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	World Health Organization; Liverpool School of Tropical Medicine; University of Liverpool; University of Los Andes Venezuela; Emory University; University of London; London School of Hygiene & Tropical Medicine	Kroeger, A (corresponding author), World Hlth Org, Special Programme Res & Training Trop Med TDR WHO, Geneva, Switzerland.	kroegera@who.int		McCall, Philip J/0000-0002-0007-3985; Kroeger, Axel/0000-0001-8438-2904	Medical Research Council [G0700837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ACOSTA C, 2005, MED C REV, V7, P21; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; FOCKS D, 2004, WHOTDRIDEDEN031; Gimnig JE, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.115; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Kroeger A, 2003, AM J TROP MED HYG, V68, P307, DOI 10.4269/ajtmh.2003.68.307; Kroeger A, 2002, BMJ-BRIT MED J, V325, P810, DOI 10.1136/bmj.325.7368.810; Lenhart AE, 2005, ACTA TROP, V96, P56, DOI 10.1016/j.actatropica.2005.06.020; Nahlen BL, 2003, AM J TROP MED HYG, V68, P1; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; NATHAN MB, 1991, J AM MOSQUITO CONTR, V7, P400; Pan American Health Organization (PAHO), 1994, DENGUE DENGUE HEMORR; Parks W, 2004, WHOCDSWMC20042; Pedersen EM, 2002, ANN TROP MED PARASIT, V96, pS91, DOI 10.1179/000349802125002437; REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Waller L.A., 2004, APPL SPATIAL STAT PU; WHO, 2001, 4 WHOPES WORK GROUP, P50	21	186	197	0	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2006	332	7552					1247	1250A		10.1136/bmj.332.7552.1247	http://dx.doi.org/10.1136/bmj.332.7552.1247			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16735334	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000237984100018
J	Kerbel, RS				Kerbel, Robert S.			Antiangiogenic therapy: A universal chemosensitization strategy for cancer?	SCIENCE			English	Editorial Material							ENDOTHELIAL GROWTH-FACTOR; METASTATIC BREAST-CANCER; METRONOMIC CHEMOTHERAPY; TUMOR ANGIOGENESIS; RANDOMIZED-TRIAL; CELLS; CYCLOPHOSPHAMIDE; CHEMORESISTANCE; NORMALIZATION; BEVACIZUMAB		Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathobiol, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Kerbel, RS (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Biophys, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	robert.kerbel@sri.utoronto.ca						ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bertolini F, 2003, CANCER RES, V63, P4342; Browder T, 2000, CANCER RES, V60, P1878; CANADY C, 2005, ONCOL NEWS INT, V14, P8; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Citron ML, 2004, CANCER INVEST, V22, P555, DOI 10.1081/CNV-200027134; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cohn DE, 2006, GYNECOL ONCOL, V102, P134, DOI 10.1016/j.ygyno.2006.01.030; Colleoni M, 2002, ANN ONCOL, V13, P73, DOI 10.1093/annonc/mdf013; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Emmenegger U, 2004, CANCER RES, V64, P3994, DOI 10.1158/0008-5472.CAN-04-0580; ESCUDIER B, 2005, 2005 ASCO ANN M P, V23, pS380; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Franco M, 2006, CANCER RES, V66, P3639, DOI 10.1158/0008-5472.CAN-05-3295; Furstenberger G, 2006, BRIT J CANCER, V94, P524, DOI 10.1038/sj.bjc.6602952; Giannoni DS, 2002, APPL LINGUIST, V23, P1, DOI 10.1093/applin/23.1.1; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hudis Clifford A, 2005, Oncology (Williston Park), V19, P26; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kieran MW, 2005, J PEDIAT HEMATOL ONC, V27, P573, DOI 10.1097/01.mph.0000183863.10792.d4; Kim JE, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/005; Kindler HL, 2005, J CLIN ONCOL, V23, P8033, DOI 10.1200/JCO.2005.01.9661; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Ma L, 2005, CANCER RES, V65, P5365, DOI 10.1158/0008-5472.CAN-04-3156; Marx J, 2005, SCIENCE, V308, P1248, DOI 10.1126/science.308.5726.1248; Miller KD, 2001, J CLIN ONCOL, V19, P1195, DOI 10.1200/JCO.2001.19.4.1195; MILLER KD, 2005, 41 ANN M AM SOC CLIN; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; SANDLER AB, 2005, 2005 ASCO ANN M P, V23, pS2; Schrag D, 2004, NEW ENGL J MED, V351, P317, DOI 10.1056/NEJMp048143; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shaked Y, 2005, BLOOD, V106, P3058, DOI 10.1182/blood-2005-04-1422; Sweeney CJ, 2001, CANCER RES, V61, P3369; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Vogelzang NJ, 2006, J CLIN ONCOL, V24, P1, DOI 10.1200/JCO.2005.03.7234; Wang JY, 2003, ANTI-CANCER DRUG, V14, P13, DOI 10.1097/00001813-200301000-00003; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327	53	397	419	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1171	1175		10.1126/science.1125950	http://dx.doi.org/10.1126/science.1125950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728631				2022-12-28	WOS:000237957400041
J	Pouyssegur, J; Dayan, F; Mazure, NM				Pouyssegur, Jacques; Dayan, Frederic; Mazure, Nathalie M.			Hypoxia signalling in cancer and approaches to enforce tumour regression	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; ACTIVATED PROTEIN-KINASES; INDUCIBLE FACTOR-I; MESSENGER-RNA STABILITY; TRANSCRIPTIONAL ACTIVITY; LYSYL-OXIDASE; AMINO-ACID; E-CADHERIN; TUBEROUS SCLEROSIS; FACTOR EXPRESSION	Tumour cells emerge as a result of genetic alteration of signal circuitries promoting cell growth and survival, whereas their expansion relies on nutrient supply. Oxygen limitation is central in controlling neovascularization, glucose metabolism, survival and tumour spread. This pleiotropic action is orchestrated by hypoxia-inducible factor (HIF), which is a master transcriptional factor in nutrient stress signalling. Understanding the role of HIF in intracellular pH (pH(i)) regulation, metabolism, cell invasion, autophagy and cell death is crucial for developing novel anticancer therapies. There are new approaches to enforce necrotic cell death and tumour regression by targeting tumour metabolism and pH(i)-control systems.	Univ Nice, Ctr Antoine Lacassagne, CNRS,UMR 6543, Inst Signalling Dev Biol & Canc Res, F-06189 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne	Pouyssegur, J (corresponding author), Univ Nice, Ctr Antoine Lacassagne, CNRS,UMR 6543, Inst Signalling Dev Biol & Canc Res, 33 Ave Valombrose, F-06189 Nice, France.	pouysseg@unice.fr		Mazure, Nathalie/0000-0003-1350-7161				Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Beavon IRG, 1999, J CLIN PATHOL-MOL PA, V52, P179, DOI 10.1136/mp.52.4.179; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Berra E, 2001, FEBS LETT, V491, P85, DOI 10.1016/S0014-5793(01)02159-7; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Funasaka T, 2005, FASEB J, V19, P1422, DOI 10.1096/fj.05-3699com; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gothie E, 2000, J BIOL CHEM, V275, P6922, DOI 10.1074/jbc.275.10.6922; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2003, J AM SOC NEPHROL, V14, P2703, DOI 10.1097/01.ASN.0000092803.69761.41; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kirschmann DA, 2002, CANCER RES, V62, P4478; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mandriota SJ, 1998, CIRC RES, V83, P852, DOI 10.1161/01.RES.83.8.852; Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; NEWELL K, 1993, P NATL ACAD SCI USA, V90, P1127, DOI 10.1073/pnas.90.3.1127; Nobukini T, 2004, NOVART FDN SYMP, V262, P265; Nobukini Takahiro, 2004, Novartis Found Symp, V262, P148; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Potter C, 2004, CELL CYCLE, V3, P164; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Pouyssegur J, 2001, Novartis Found Symp, V240, P186; Pouyssegur J., 2001, NOVART FDN SYMP, V240, P196; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rak J, 2000, CANCER RES, V60, P490; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thomas G, 2004, NOVART FDN SYMP, V262, P154; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; Wong P, 2002, BRIT J CANCER, V87, P238, DOI 10.1038/sj.bjc.6600424	105	1307	1368	6	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					437	443		10.1038/nature04871	http://dx.doi.org/10.1038/nature04871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724055				2022-12-28	WOS:000237778900036
J	Singh, H; Turner, D; Xue, L; Targownik, LE; Bernstein, CN				Singh, Harminder; Turner, Donna; Xue, Lin; Targownik, Laura E.; Bernstein, Charles N.			Risk of developing colorectal cancer following a negative colonoscopy examination - Evidence for a 10-year interval between colonoscopies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURVEILLANCE COLONOSCOPY; ASYMPTOMATIC ADULTS; PREVENTION; SIGMOIDOSCOPY; PREVALENCE; CARCINOMAS; MANITOBA; SCREEN; COLON; RATES	Context Limited evidence exists to guide the optimal frequency of repeat endoscopic examination for colorectal cancer screening after a negative colonoscopy. Objective To determine the duration and magnitude of the risk of developing colorectal cancer following performance of a negative colonoscopy. Design, Setting, and Patients Population-based retrospective analysis of individuals whose colonoscopy evaluations did not result in a diagnosis of colorectal neoplasia. Patients who had been evaluated between April 1, 1989, and December 31, 2003, were identified using Manitoba Health's physician billing claims database (N = 35 975). Standardized incidence ratios (SIRs) were calculated to compare colorectal cancer incidence in our cohort with colorectal cancer incidence in the provincial population. Stratified analysis was performed to determine the duration of the reduced risk. Patients with a history of colorectal cancer prior to the index colonoscopy, inflammatory bowel disease, resective colorectal surgery, and lower gastrointestinal endoscopy within the 5 years before the index colonoscopy were excluded. Cohort members were followed up from the time of the index colonoscopy until diagnosis of colorectal cancer, death, out-migration from Manitoba, or end of the study period on December 31, 2003. Main Outcome Measure Incidence of colorectal cancer. Results A negative colonoscopy was associated with SIRs of 0.69 (95% confidence interval [CI], 0.59-0.81) at 6 months, 0.66 (95% CI, 0.56-0.78) at 1 year, 0.59 (95% CI, 0.48-0.72) at 2 years, 0.55 (95% CI, 0.41-0.73) at 5 years, and 0.28 (95% CI, 0.09-0.65) at 10 years. The proportion of colorectal cancer located in the right side of the colon was significantly higher in the colonoscopy cohort than the rate in the Manitoba population (47% vs 28%; P <. 001). Conclusions The risk of developing colorectal cancer remains decreased for more than 10 years following the performance of a negative colonoscopy. There is a need to improve the early detection rate of right-sided colorectal neoplasia in usual clinical practice.	Canc Care Manitoba, Dept Internal Med, Winnipeg, MB, Canada; Canc Care Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; Univ Manitoba, Inflammatory Bowel Dis Clin & Res Ctr, Winnipeg, MB, Canada	University of Manitoba	Singh, H (corresponding author), Gastroenterol Sect, 804-715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	singh@cc.umanitoba.ca	Targownik, Laura/ABD-2427-2021	Targownik, Laura/0000-0002-4366-9076				Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; BAILAR JC, 1964, BIOMETRICS, V20, P639; Barclay RI, 2005, GASTROINTEST ENDOSC, V61, pAB107, DOI 10.1016/S0016-5107(05)00682-6; Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Blanchard JF, 1996, DIABETES CARE, V19, P807, DOI 10.2337/diacare.19.8.807; Blanchard JF, 1997, DIABETES CARE, V20, P512, DOI 10.2337/diacare.20.4.512; *CAN CANC SOC NCI, 2005, CAN CANC STAT 2005; Chirieac LR, 2005, AM J SURG PATHOL, V29, P429, DOI 10.1097/01.pas.0000155144.53047.7d; Cotterchio M, 2005, CANCER CAUSE CONTROL, V16, P865, DOI 10.1007/s10552-005-2370-3; Gorski TF, 1999, DIS COLON RECTUM, V42, P877, DOI 10.1007/BF02237093; HENNEKENS CH, 1997, EPIDEMIOLOGY MED, P82; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Konishi K, 1999, GUT, V45, P818, DOI 10.1136/gut.45.6.818; Lewis JD, 2003, ARCH INTERN MED, V163, P413, DOI 10.1001/archinte.163.4.413; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; Okamoto M, 2005, DIS COLON RECTUM, V48, P101, DOI 10.1007/s10350-004-0754-1; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; ROOS LL, 1982, MED CARE, V20, P266, DOI 10.1097/00005650-198203000-00003; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; Schoen RE, 2003, AM J GASTROENTEROL, V98, P1237, DOI 10.1016/S0002-9270(03)00271-5; Soetikno R, 2006, GASTROENTEROLOGY, V130, P566, DOI 10.1053/j.gastro.2005.12.006; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	36	333	368	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2366	2373		10.1001/jama.295.20.2366	http://dx.doi.org/10.1001/jama.295.20.2366			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720822	Bronze			2022-12-28	WOS:000237734400022
J	Telford, RJ; Vandvik, V; Birks, HJB				Telford, RJ; Vandvik, V; Birks, HJB			Dispersal limitations matter for microbial morphospecies	SCIENCE			English	Article									Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; Univ Bergen, Dept Biol, Ecol & Environm Change Res Grp, N-5007 Bergen, Norway; UCL, Environm Change Res Ctr, London WC1H 0AP, England	Bjerknes Centre for Climate Research; University of Bergen; University of London; University College London	Telford, RJ (corresponding author), Bjerknes Ctr Climate Res, Allegaten 55, N-5007 Bergen, Norway.	richard.telford@bjerknes.uib.no	Telford, Richard/C-1668-2008; Telford, Richard/AAD-2249-2019; Birks, John B/C-3103-2008; Vandvik, Vigdis/C-1924-2008	Telford, Richard/0000-0001-9826-3076; Telford, Richard/0000-0001-9826-3076; Birks, John B/0000-0002-5891-9859; Vandvik, Vigdis/0000-0003-4651-4798				de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Fenchel T, 2003, SCIENCE, V301, P925, DOI 10.1126/science.1089242; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Theriot EC, 2006, PALEOBIOLOGY, V32, P38, DOI 10.1666/0094-8373(2006)032[0038:LQRMEO]2.0.CO;2; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	6	171	175	7	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2006	312	5776					1015	1015		10.1126/science.1125669	http://dx.doi.org/10.1126/science.1125669			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709777	Green Accepted			2022-12-28	WOS:000237628800034
J	Zipfel, C; Kunze, G; Chinchilla, D; Caniard, A; Jones, JDG; Boller, T; Felix, G				Zipfel, Cyril; Kunze, Gernot; Chinchilla, Delphine; Caniard, Anne; Jones, Jonathan D. G.; Boller, Thomas; Felix, Georg			Perception of the bacterial PAMP EF-Tu by the receptor EFR restricts Agrobacterium-mediated transformation	CELL			English	Article							ELONGATION-FACTOR TU; INNATE IMMUNITY; ARABIDOPSIS-THALIANA; ELICITOR FLAGELLIN; KINASE; DEFENSE; PLANTS; PROTEINS; ANIMALS; CELLS	Higher eukaryotes sense microbes through the perception of pathogen-associated molecular patterns (PAMPs). Arabidopsis plants detect a variety of PAMPs including conserved domains of bacterial flagellin and of bacterial EF-Tu. Here, we show that flagellin and EF-Tu activate a common set of signaling events and defense responses but without clear synergistic effects. Treatment with either PAMP results in increased binding sites for both PAMPs. We used this finding in a targeted reverse-genetic approach to identify a receptor kinase essential for EF-Tu perception, which we called EFR. Nicotiana benthamiana, a plant unable to perceive EFTu, acquires EF-Tu binding sites and responsiveness upon transient expression of EFR. Arabidopsis efr mutants show enhanced susceptibility to the bacterium Agrobacterium tumefaciens, as revealed by a higher efficiency of T-DNA transformation. These results demonstrate that EFR is the EF-Tu receptor and that plant defense responses induced by PAMPs such as EF-Tu reduce transformation by Agrobacterium.	Univ Basel, Inst Bot, Zurich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Basel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Zipfel, C (corresponding author), Univ Tubingen, ZMBP, Morgenstelle 5, D-72076 Tubingen, Germany.	cyril.zipfel@sainsbury-laboratory.ac.uk; georg.felix@unibas.ch	Boller, Thomas/G-3500-2012; ZIPFEL, CYRIL B/D-7103-2011; Jones, Jonathan DG/J-5129-2012; ZIPFEL, CYRIL/ABD-5076-2021	Boller, Thomas/0000-0001-6768-7503; ZIPFEL, CYRIL B/0000-0003-4935-8583; Jones, Jonathan DG/0000-0002-4953-261X; ZIPFEL, CYRIL/0000-0003-4935-8583; Kunze, Gernot/0000-0002-2039-2836				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dievart A, 2003, CURR OPIN PLANT BIOL, V6, P507, DOI 10.1016/S1369-5266(03)00089-X; Ditt RF, 2005, FEMS MICROBIOL LETT, V247, P207, DOI 10.1016/j.femsle.2005.05.010; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; Espinosa A, 2004, CELL MICROBIOL, V6, P1027, DOI 10.1111/j.1462-5822.2004.00452.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fliegmann J, 2004, J BIOL CHEM, V279, P1132, DOI 10.1074/jbc.M308552200; Gelvin SB, 2005, NATURE, V433, P583, DOI 10.1038/433583a; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeppesen MG, 2005, J BIOL CHEM, V280, P5071, DOI 10.1074/jbc.M411782200; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Matsubayashi Y, 2000, J BIOL CHEM, V275, P15520, DOI 10.1074/jbc.275.20.15520; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meindl T, 1998, PLANT CELL, V10, P1561, DOI 10.1105/tpc.10.9.1561; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Pfund C, 2004, MOL PLANT MICROBE IN, V17, P696, DOI 10.1094/MPMI.2004.17.6.696; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Scheer JM, 2002, P NATL ACAD SCI USA, V99, P9585, DOI 10.1073/pnas.132266499; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Singh P, 2004, ENVIRON MICROBIOL, V6, P1149, DOI 10.1111/j.1462-2920.2004.00622.x; SUZUKI K, 1995, PLANT CELL, V7, P639, DOI 10.1105/tpc.7.5.639; Umemoto N, 1997, P NATL ACAD SCI USA, V94, P1029, DOI 10.1073/pnas.94.3.1029; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Watt SA, 2005, PROTEOMICS, V5, P153, DOI 10.1002/pmic.200400905; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Zhu YM, 2003, PLANT PHYSIOL, V132, P494, DOI 10.1104/pp.103.020420; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	50	1219	1303	11	283	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					749	760		10.1016/j.cell.2006.03.037	http://dx.doi.org/10.1016/j.cell.2006.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713565	Bronze			2022-12-28	WOS:000237886000019
J	Verma, S; Lindsay, TF				Verma, S; Lindsay, TF			Regression of aortic aneurysms through pharmacologic therapy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RUPTURE		Univ Toronto, Toronto, ON, Canada	University of Toronto	Verma, S (corresponding author), Univ Toronto, Toronto, ON, Canada.							Fillinger MF, 2002, J VASC SURG, V36, P589, DOI 10.1067/mva.2002.125478; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Wilson WRW, 2006, CIRCULATION, V113, P438, DOI 10.1161/CIRCULATIONAHA.105.551572; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	4	12	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2067	2068		10.1056/NEJMcibr060899	http://dx.doi.org/10.1056/NEJMcibr060899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687722	Green Published			2022-12-28	WOS:000237413100016
J	Steinman, G				Steinman, G			Can the chance of having twins be modified by diet?	LANCET			English	Editorial Material							MECHANISMS; GENETICS		Long Isl Jewish Med Ctr, Dept Obstet & Gynecol, New York, NY 11103 USA	Northwell Health	Steinman, G (corresponding author), Long Isl Jewish Med Ctr, Dept Obstet & Gynecol, New York, NY 11103 USA.	dav4601@aol.com						ALLEN NE, 2000, CANCER EPIDEM BIOMAR, V11, P1441; Aukema HM, 2001, KIDNEY INT, V59, P52, DOI 10.1046/j.1523-1755.2001.00465.x; Blickstein I., 2005, MULTIPLE PREGNANCY E; BULMER MG, 1959, BMJ-BRIT MED J, V1, P29, DOI 10.1136/bmj.1.5113.29; Daxenberger A, 1998, ANALYST, V123, P2429, DOI 10.1039/a804923h; Echternkamp SE, 2004, J ANIM SCI, V82, P459; Haggarty P, 2006, LANCET, V367, P1513, DOI 10.1016/S0140-6736(06)68651-0; JAMES WH, 1985, ANN HUM BIOL, V12, P441, DOI 10.1080/03014468500008001; Khamsi F, 2001, ENDOCRINE, V14, P175, DOI 10.1385/ENDO:14:2:175; Lien S, 2000, MAMM GENOME, V11, P877, DOI 10.1007/s003350010180; MARINHO AO, 1986, ACTA GENET MED GEMEL, V35, P201, DOI 10.1017/S0001566000005717; Meulemans WJ, 1996, AM J MED GENET, V61, P258, DOI 10.1002/(SICI)1096-8628(19960122)61:3<258::AID-AJMG10>3.0.CO;2-S; NEWMAN RB, 2000, MULTIFETAL PREGNANCY; NYLANDER PP, 1969, ANN HUM GENET, V33, P41, DOI 10.1111/j.1469-1809.1969.tb01627.x; POLLARD R, 1995, HUM BIOL, V67, P921; Steinman G, 2002, J REPROD MED, V47, P313; Steinman G, 2003, J REPROD MED, V48, P583; STEINMAN G, IN PRESS J REPROD ME; Vollset SE, 2005, EPIDEMIOLOGY, V16, P201, DOI 10.1097/01.ede.0000152914.84962.13; Yanovski JA, 2000, J PEDIATR-US, V137, P826, DOI 10.1067/mpd.2000.109151	20	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1461	1462		10.1016/S0140-6736(06)68623-6	http://dx.doi.org/10.1016/S0140-6736(06)68623-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679141				2022-12-28	WOS:000237324200004
J	Ding, QJ; Hesketh, T				Ding, Qu Jian; Hesketh, Therese			Family size, fertility preferences, and sex ratio in China in the era of the one child family policy: results from national family planning and reproductive health survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTHS	Objectives To examine the impact of the one child family policy in China on fertility, preferred family size, and sex ratio. Design Secondary analysis of data from the Chinese cross sectional national family planning and reproductive health survey, 2001. Interviews of representative sample of women aged 15-49. Results Data were obtained from 39 585 women, with a total of 73202 pregnancies and 56 830 live births. The average fertility rate in women over 35 (n = 17 078) was 1.94 (2.1 in rural areas and 1.4 in urban areas) and for women under 35 (n = 11543) 1.73 (1.25 and 1.79). Smaller families were associated with younger age, higher level of education, and living in an urban area. The male to female ratio was 1.15 and rose from 1.11 in 1980-9 to 1.23 for 1996-2001. Most women wanted small families: 35% preferred one child and 57% preferred two. Conclusion Since the one child family policy began, the total birth rate and preferred family size have decreased, and a gross imbalance in the sex ratio has emerged.	Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England; Zhejiang Univ, Inst Populat Studies, Hangzhou 310012, Peoples R China	University of London; University College London; Zhejiang University	Hesketh, T (corresponding author), Inst Child Hlth, Ctr Int Child Hlth, 30 Guilford St, London WC1N 1EH, England.	t.hesketh@ich.ucl.ac.uk		Hesketh, Therese/0000-0002-7564-9221				Bogg L, 1998, AM J PUBLIC HEALTH, V88, P649, DOI 10.2105/AJPH.88.4.649; COALE AJ, 1994, DEMOGRAPHY, V31, P459, DOI 10.2307/2061752; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Goodkind DM, 2004, POP STUD-J DEMOG, V58, P281, DOI 10.1080/0032472042000272348; GREENHALGH S, 1987, SCIENCE, V235, P1167, DOI 10.1126/science.3823877; Gu B, 1995, Asia Pac Popul J, V10, P17; Hesketh T, 2005, NEW ENGL J MED, V353, P1171, DOI 10.1056/NEJMhpr051833; Li JH, 2004, SOC SCI MED, V59, P695, DOI 10.1016/j.socscimed.2003.11.041; Merli MG, 2000, DEMOGRAPHY, V37, P109, DOI 10.2307/2648100; PEABODY JW, 1992, AM J PERINAT, V9, P401, DOI 10.1055/s-2007-999275; Retherford RD, 2005, POPUL DEV REV, V31, P57, DOI 10.1111/j.1728-4457.2005.00052.x; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; *UNDP, 2003, HUM DEV IND WORLD DE; Winckler EA, 2002, POPUL DEV REV, V28, P379, DOI 10.1111/j.1728-4457.2002.00379.x; *WORLD BANK HLTH N, DEV DAT 2004; YAO XW, 1994, BASIC DATA CHINAS PO; Zhu WX, 2003, ARCH DIS CHILD, V88, P463, DOI 10.1136/adc.88.6.463	17	107	109	5	91	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2006	333	7564					371	373		10.1136/bmj.38775.672662.80	http://dx.doi.org/10.1136/bmj.38775.672662.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	078OD	16690642	Green Published			2022-12-28	WOS:000240112200015
J	McCannon, CJ; Schall, MW; Calkins, DR; Nazem, AG				McCannon, CJ; Schall, MW; Calkins, DR; Nazem, AG			Quality improvement - Saving 100 000 lives in US hospitals	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE		Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	McCannon, CJ (corresponding author), Inst Healthcare Improvement, 20 Univ Ave, Cambridge, MA 02138 USA.	jmccannon@ihi.org						*100000 LIV CAMP, CAMP MAT; [Anonymous], 2000, NEW EC IND GOVT ED; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; *COMM FUND, 2004, 1 COMM FUND INT WORK; Hackbarth AD, 2006, ACP GUIDE HOSP   APR, P1; *I MED COMM QUAL H, 1999, TO ERR IS HUM; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Massoud MR., 2006, FRAMEWORK SPREAD LOC; Massoud R., 2019, APPROACH RAPID SCALE; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nolan K, 2005, JT COMM J QUAL PATIE, V31, P339, DOI 10.1016/S1553-7250(05)31045-2; Rogers E., 2003, DIFFUSION INNOVATION, VFifth	13	51	52	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 3	2006	332	7553					1328	1330		10.1136/bmj.332.7553.1328	http://dx.doi.org/10.1136/bmj.332.7553.1328			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051YG	16740565	Green Published			2022-12-28	WOS:000238197000028
J	Yano, H; Kubota, T; Miyamoto, H; Okada, T; Scheeres, D; Takagi, Y; Yoshida, K; Abe, M; Abe, S; Barnouin-Jha, O; Fujiwara, A; Hasegawa, S; Hashimoto, T; Ishiguro, M; Kato, M; Kawaguchi, J; Mukai, T; Saito, J; Sasaki, S; Yoshikawa, M				Yano, H; Kubota, T; Miyamoto, H; Okada, T; Scheeres, D; Takagi, Y; Yoshida, K; Abe, M; Abe, S; Barnouin-Jha, O; Fujiwara, A; Hasegawa, S; Hashimoto, T; Ishiguro, M; Kato, M; Kawaguchi, J; Mukai, T; Saito, J; Sasaki, S; Yoshikawa, M			Touchdown of the Hayabusa spacecraft at the Muses Sea on Itokawa	SCIENCE			English	Article							ASTEROID 433-EROS; DUST	After global observations of asteroid 25143 Itokawa by the Hayabusa spacecraft, we selected the smooth terrain of the Muses Sea for two touchdowns carried out on 19 and 25 November 2005 UTC for the first asteroid sample collection with an impact sampling mechanism. Here, we report initial findings about geological features, surface condition, regolith grain size, compositional variation, and constraints on the physical properties of this site by using both scientific and housekeeping data during the descent sequence of the first touchdown. Close-up images revealed the first touchdown site as a regolith field densely filled with size-sorted, millimeter- to centimeter-sized grains.	Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Planetary Sci, Kanagawa 2298510, Japan; Univ Tokyo, Dept Geosyst Engn, Tokyo 1138656, Japan; Univ Michigan, Ann Arbor, MI 48109 USA; Toho Gakuen Univ, Nagoya, Aichi 4658515, Japan; Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan; Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Seoul Natl Univ, Seoul 151742, South Korea; Natl Astron Observ Japan, Mizusawa, Iwate 0230861, Japan	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; University of Michigan System; University of Michigan; Tohoku University; Kobe University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Seoul National University (SNU); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Yano, H (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Planetary Sci, 3-1-1 Yoshinodai, Kanagawa 2298510, Japan.	yano@isas.jaxa.jp	Yoshida, Kazuya/AAC-3248-2019; Miyamoto, Hideaki/B-9666-2008; Kubota, Takashi/GPP-4986-2022; Barnouin, Olivier S/I-7475-2015; Miyamoto, Hideaki/E-3381-2012; Sasaki, Sho/S-3845-2019; Hasegawa, Sunao/R-4768-2017	Yoshida, Kazuya/0000-0003-3889-5877; Miyamoto, Hideaki/0000-0001-8013-6124; Barnouin, Olivier S/0000-0002-3578-7750; Sasaki, Sho/0000-0002-7646-5248; SCHEERES, DANIEL/0000-0003-0558-3842; Hasegawa, Sunao/0000-0001-6366-2608; Abe, Shinsuke/0000-0002-6247-4979				Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Cheng AF, 2002, METEORIT PLANET SCI, V37, P1095, DOI 10.1111/j.1945-5100.2002.tb00880.x; Colwell JE, 2003, ICARUS, V164, P188, DOI 10.1016/S0019-1035(03)00083-6; D'Anna G, 2003, NATURE, V424, P909, DOI 10.1038/nature01867; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Gilardi G, 2002, MECH MACH THEORY, V37, P1213, DOI 10.1016/S0094-114X(02)00045-9; Hertz H., 1896, MISCELLANEOUS PAPERS; Horz F, 1997, METEORIT PLANET SCI, V32, P179; Kawaguchi J, 2003, ACTA ASTRONAUT, V52, P117, DOI 10.1016/S0094-5765(02)00146-7; KUBOTA T, 2001, P 11 ASTR S ISAS JAP, P294; KUSHIRO I, 2003, 1 COMP MUSES C ASTR; Lee P, 1996, ICARUS, V124, P181, DOI 10.1006/icar.1996.0197; MATSUDA T, 2001, THESIS TOKYO I TECHN; Michel P, 2005, ICARUS, V179, P291, DOI 10.1016/j.icarus.2005.07.018; Muller TG, 2005, ASTRON ASTROPHYS, V443, P347, DOI 10.1051/0004-6361:20053862; OKADA T, 2006, ADV GEOSCIENCE, V3, P119; Okada T, 2006, SCIENCE, V312, P1338, DOI 10.1126/science.1125731; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; Veverka J, 2001, SCIENCE, V292, P484, DOI 10.1126/science.1058651; Veverka J, 2001, NATURE, V413, P390, DOI 10.1038/35096507; YANO H, 2003, P ASTR COM MET 2002, P103; Yoshida K, 2001, ADV ASTRONAUT SCI, V108, P481	22	276	289	6	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1350	1353		10.1126/science.1126164	http://dx.doi.org/10.1126/science.1126164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741113				2022-12-28	WOS:000237961600046
J	Katon, WJ				Katon, Wayne J.			Panic disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENERALIZED ANXIETY DISORDER; COLLABORATIVE CARE INTERVENTION; PSYCHIATRIC-DISORDERS; COST-EFFECTIVENESS; SUICIDAL IDEATION; SOCIAL PHOBIA; LIFE EVENTS; PRIME-MD; COMORBIDITY; DEPRESSION		Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Katon, WJ (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Box 356560,1959 NE Pacific St, Seattle, WA 98195 USA.	wkaton@u.washington.edu						Amer Psychiat Assoc, 1998, AM J PSYCHIAT, V155, P1; American Psychiatric Association, 1990, BENZ DEP TOX AB TASK; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews G, 2003, AUST NZ J PSYCHIAT, V37, P641, DOI 10.1080/j.1440-1614.2003.01254.x; Barlow DH, 2000, JAMA-J AM MED ASSOC, V284, P2450; Barlow DH, 2000, JAMA-J AM MED ASSOC, V283, P2529, DOI 10.1001/jama.283.19.2529; BARLOW DH, 2000, JAMA-J AM MED ASSOC, V284, P2597; BARSKY AJ, 1994, J GEN INTERN MED, V9, P306, DOI 10.1007/BF02599176; Bradwejn J, 2005, BRIT J PSYCHIAT, V187, P352, DOI 10.1192/bjp.187.4.352; Breslau N, 1999, ARCH GEN PSYCHIAT, V56, P1141, DOI 10.1001/archpsyc.56.12.1141; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; CROWE RR, 1983, ARCH GEN PSYCHIAT, V40, P1065; FOGARTY J, 1994, ARCH FAM MED, V3, P55; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P681, DOI 10.1001/archpsyc.58.7.681; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Gould RA, 1995, CLIN PSYCHOL REV, V15, P819, DOI 10.1016/0272-7358(95)00048-8; Hettema JM, 2005, ARCH GEN PSYCHIAT, V62, P182, DOI 10.1001/archpsyc.62.2.182; Katon W, 2006, PSYCHOL MED, V36, P353, DOI 10.1017/S0033291705006896; KATON W, 1988, AM J MED, V84, P1, DOI 10.1016/0002-9343(88)90001-0; KATON W, 1994, NIH PUBLICATION; Katon WJ, 2004, PSYCHOSOM MED, V66, P349, DOI 10.1097/01.psy.0000126202.89941.ea; Katon WJ, 2002, ARCH GEN PSYCHIAT, V59, P1098, DOI 10.1001/archpsyc.59.12.1098; KATON WJ, 1991, J GEN INTERN MED, V6, P277, DOI 10.1007/BF02597420; KELLER MB, 1993, PROG NEURO-PSYCHOPH, V17, P551, DOI 10.1016/0278-5846(93)90005-D; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Landon Terri M, 2004, J Psychiatr Pract, V10, P211, DOI 10.1097/00131746-200407000-00002; Leon A C, 1995, Arch Fam Med, V4, P857, DOI 10.1001/archfami.4.10.857; Manfro GG, 1996, J AFFECT DISORDERS, V41, P135, DOI 10.1016/S0165-0327(96)00081-X; MARGRAF J, 1988, PSYCHOSOM MED, V50, P93, DOI 10.1097/00006842-198803000-00001; Merikangas KR, 2003, ARCH GEN PSYCHIAT, V60, P993, DOI 10.1001/archpsyc.60.9.993; Mitte K, 2005, J AFFECT DISORDERS, V88, P27, DOI 10.1016/j.jad.2005.05.003; Otto MW, 2001, AM J PSYCHIAT, V158, P1989, DOI 10.1176/appi.ajp.158.12.1989; Pilowsky DJ, 2006, DEPRESS ANXIETY, V23, P11, DOI 10.1002/da.20092; ROYBYRNE P, 1994, J GEN INTERN MED, V9, P507, DOI 10.1007/BF02599221; ROYBYRNE PP, 1986, AM J PSYCHIAT, V143, P1424; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Simon G E, 1992, Psychiatr Med, V10, P49; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stein MB, 1999, PSYCHOSOM MED, V61, P359, DOI 10.1097/00006842-199905000-00016; STEWART WF, 1989, PSYCHOSOM MED, V51, P559, DOI 10.1097/00006842-198909000-00007; Susman Jeffrey, 2005, Prim Care Companion J Clin Psychiatry, V7, P5; TORGERSEN S, 1983, ARCH GEN PSYCHIAT, V40, P1085; Vickers K, 2004, J ABNORM PSYCHOL, V113, P582, DOI 10.1037/0021-843X.113.4.582; WALKER EA, 1995, PSYCHOL MED, V25, P1259, DOI 10.1017/S0033291700033225; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P305; Weissman MM, 2004, ARCH GEN PSYCHIAT, V61, P273, DOI 10.1001/archpsyc.61.3.273; Westen D, 2001, J CONSULT CLIN PSYCH, V69, P875, DOI 10.1037//0022-006X.69.6.875; Yonkers KA, 2003, DEPRESS ANXIETY, V17, P173, DOI 10.1002/da.10106	50	51	55	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2360	U20		10.1056/NEJMcp052466	http://dx.doi.org/10.1056/NEJMcp052466			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047ZZ	16738272				2022-12-28	WOS:000237918500008
J	Wignall, PB; McArthur, JM; Little, CTS; Hallam, A				Wignall, Paul B.; McArthur, John M.; Little, Crispin T. S.; Hallam, Anthony			Palaeoceanography - Methane release in the Early Jurassic period	NATURE			English	Letter							OCEANIC ANOXIC EVENT; MASS EXTINCTION; CONTRASTS		Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; UCL, Dept Geol Sci, London WC1E 6BT, England; Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England	University of Leeds; University of London; University College London; University of Birmingham	Wignall, PB (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	wignall@earth.leeds.ac.uk	McArthur, John/C-2705-2008; McArthur, John/AAL-6354-2020	McArthur, John/0000-0003-1461-7805; McArthur, John/0000-0003-1461-7805; Little, Crispin/0000-0002-1917-4460				Bailey TR, 2003, EARTH PLANET SC LETT, V212, P307, DOI 10.1016/S0012-821X(03)00278-4; Harries PJ, 1999, PALAEOGEOGR PALAEOCL, V154, P39, DOI 10.1016/S0031-0182(99)00086-3; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Katz ME, 2005, MAR GEOL, V217, P323, DOI 10.1016/j.margeo.2004.08.005; Kemp DB, 2005, NATURE, V437, P396, DOI 10.1038/nature04037; LITTLE CTS, 1995, GEOLOGY, V23, P495, DOI 10.1130/0091-7613(1995)023<0495:EJMEAG>2.3.CO;2; LITTLE CTS, 1994, THESIS U BRISTOL; McElwain JC, 2005, NATURE, V435, P479, DOI 10.1038/nature03618; Saelen G, 1998, GEOLOGY, V26, P747, DOI 10.1130/0091-7613(1998)026<0747:EOROIL>2.3.CO;2; van de Schootbrugge B, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001102; Wignall PB, 2005, AM J SCI, V305, P1014, DOI 10.2475/ajs.305.10.1014	11	27	27	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2006	441	7093					E5	E5		10.1038/nature04905	http://dx.doi.org/10.1038/nature04905			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738612				2022-12-28	WOS:000237920800035
J	Martin, DR; Semelka, R				Martin, DR; Semelka, R			Health effects of ionising radiation from diagnostic CT	LANCET			English	Editorial Material									Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA; Univ N Carolina, Dept Radiol, Chapel Hill, NC USA	Emory University; University of North Carolina; University of North Carolina Chapel Hill	Martin, DR (corresponding author), Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA.	dmartin@emory.edu						*COMM ASS HLTH RIS, 2005, BEIR 7 HLTH RISKS EX; Katz SI, 2006, AM J ROENTGENOL, V186, P1120, DOI 10.2214/AJR.04.1838; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Linton OW, 2003, AM J ROENTGENOL, V181, P321, DOI 10.2214/ajr.181.2.1810321; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Lynch DA, 2005, RADIOLOGY, V236, P10, DOI 10.1148/radiol.2361031674; MARTIN DR, 2005, ABDOMINAL PELVIC MRI; MARTIN DR, 2005, MAGN RESON IMAGING C, V13, P211; Morcos SK, 2005, J VASC INTERV RADIOL, V16, P13, DOI 10.1097/01.RVI.0000145224.02920.C2; Parker MS, 2005, AM J ROENTGENOL, V185, P1228, DOI 10.2214/AJR.04.0770; ULRICH H, 1946, NEW ENGL J MED, V234, P742	11	68	69	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY-JUN	2006	367	9524					1712	1714		10.1016/S0140-6736(06)68748-5	http://dx.doi.org/10.1016/S0140-6736(06)68748-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047BE	16731253				2022-12-28	WOS:000237854000008
J	Sepkowitz, KA				Sepkowitz, KA			Health of the world's Roma population	LANCET			English	Editorial Material							NEEDS		Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sepkowitz, KA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	sepkowik@mskcc.org						de Courten BV, 2003, DIABETES RES CLIN PR, V62, P95, DOI 10.1016/S0168-8227(03)00162-1; Hajioff S, 2000, J EPIDEMIOL COMMUN H, V54, P864, DOI 10.1136/jech.54.11.864; Koupilova I, 2001, SOC SCI MED, V53, P1191, DOI 10.1016/S0277-9536(00)00419-6; Kovac Carl, 2002, BMJ, V324, P755; Nesvadbova L, 2000, Cent Eur J Public Health, V8, P141; ORGOVANOVA K, 2005, ROMA SLOVAKIA; PACKER C, 2005, HLTH STATUS ROMA PRI; United Nations Development Program, 2003, AV DEP TRAP ROM HUM; Van Cleemput P, 2000, ARCH DIS CHILD, V82, P32, DOI 10.1136/adc.82.1.32; Zeman CL, 2003, ETHNIC HEALTH, V8, P223, DOI 10.1080/1355785032000136434	10	52	53	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY-JUN	2006	367	9524					1707	1708		10.1016/S0140-6736(06)68746-1	http://dx.doi.org/10.1016/S0140-6736(06)68746-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731250				2022-12-28	WOS:000237854000005
J	Shaw, RJ; Cantley, LC				Shaw, Reuben J.; Cantley, Lewis C.			Ras, PI(3)K and mTOR signalling controls tumour cell growth	NATURE			English	Review							TUBEROUS SCLEROSIS COMPLEX; AKT/PROTEIN-KINASE-B; MAMMALIAN TARGET; HUMAN CANCER; SUPPRESSOR; AKT; RAPAMYCIN; PHOSPHORYLATION; PTEN; GENE	All eukaryotic cells coordinate cell growth with the availability of nutrients in their environment. The mTOR protein kinase has emerged as a critical growth-control node, receiving stimulatory signals from Ras and phosphatidylinositol-3-OH kinase (PI(3)K) downstream from growth factors, as well as nutrient inputs in the form of amino-acid, glucose and oxygen availability. Notably, components of the Ras and PI( 3) K signalling pathways are mutated in most human cancers. The preponderance of mutations in these interconnected pathways suggests that the loss of growth-control checkpoints and promotion of cell survival in nutrient-limited conditions may be an obligate event in tumorigenesis.	Salk Inst Biol Studies, Dulbecco Lab Canc Res, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	Salk Institute; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Dulbecco Lab Canc Res, 10010 N Torrey Pines Rd, La Jolla, CA 92093 USA.	shaw@salk.edu; lcantley@hms.harvard.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Cullen PJ, 2001, CURR BIOL, V11, pR342, DOI 10.1016/S0960-9822(01)00189-0; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Granville CA, 2006, CLIN CANCER RES, V12, P679, DOI 10.1158/1078-0432.CCR-05-1654; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hammerman PS, 2004, TRENDS BIOCHEM SCI, V29, P586, DOI 10.1016/j.tibs.2004.09.008; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Teitell MA, 2005, NAT REV CANCER, V5, P640, DOI 10.1038/nrc1672; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; To MD, 2005, CELL CYCLE, V4, P1185, DOI 10.4161/cc.4.9.2039; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	84	1614	1713	5	288	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					424	430		10.1038/nature04869	http://dx.doi.org/10.1038/nature04869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724053				2022-12-28	WOS:000237778900034
J	Uehara, T; Nakamura, T; Yao, DD; Shi, ZQ; Gu, ZZ; Ma, YL; Masliah, E; Nomura, Y; Lipton, SA				Uehara, Takashi; Nakamura, Tomohiro; Yao, Dongdong; Shi, Zhong-Qing; Gu, Zezong; Ma, Yuliang; Masliah, Eliezer; Nomura, Yasuyuki; Lipton, Stuart A.			S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; APOPTOTIC CELL-DEATH; PARKINSONS-DISEASE; NITRIC-OXIDE; PATHWAY; THIOREDOXIN; POLYPEPTIDE; ISCHEMIA; CULTURES	Stress proteins located in the cytosol or endoplasmic reticulum (ER) maintain cell homeostasis and afford tolerance to severe insults(1-3). In neurodegenerative diseases, several chaperones ameliorate the accumulation of misfolded proteins triggered by oxidative or nitrosative stress, or of mutated gene products(4,5). Although severe ER stress can induce apoptosis(2,6), the ER withstands relatively mild insults through the expression of stress proteins or chaperones such as glucose-regulated protein (GRP) and protein-disulphide isomerase (PDI), which assist in the maturation and transport of unfolded secretory proteins. PDI catalyses thiol-disulphide exchange, thus facilitating disulphide bond formation and rearrangement reactions(7-10). PDI has two domains that function as independent active sites with homology to the small, redox-active protein thioredoxin(7,8). During neurodegenerative disorders and cerebral ischaemia, the accumulation of immature and denatured proteins results in ER dysfunction(11), but the upregulation of PDI represents an adaptive response to protect neuronal cells(12-14). Here we show, in brains manifesting sporadic Parkinson's or Alzheimer's disease, that PDI is S-nitrosylated, a reaction transferring a nitric oxide (NO) group to a critical cysteine thiol to affect protein function(15-18). NO-induced S-nitrosylation of PDI inhibits its enzymatic activity, leads to the accumulation of polyubiquitinated proteins, and activates the unfolded protein response. S-Nitrosylation also abrogates PDI-mediated attenuation of neuronal cell death triggered by ER stress, misfolded proteins or proteasome inhibition. Thus, PDI prevents neurotoxicity associated with ER stress and protein misfolding, but NO blocks this protective effect in neurodegenerative disorders through the S-nitrosylation of PDI.	Burnham Inst Med Res, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; Burnham Inst Med Res, Proteom Facil, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido 0600812, Japan	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Hokkaido University	Lipton, SA (corresponding author), Burnham Inst Med Res, Ctr Neurosci & Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@burnham.org		Lipton, Stuart/0000-0002-3490-1259; Uehara, Takashi/0000-0002-8545-4006				Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Gilbert HF, 1998, METHOD ENZYMOL, V290, P26, DOI 10.1016/S0076-6879(98)90005-2; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Nishikawa A, 2004, BIOCHEM BIOPH RES CO, V318, P435, DOI 10.1016/j.bbrc.2004.04.048; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sliskovic I, 2005, J BIOL CHEM, V280, P8733, DOI 10.1074/jbc.M408080200; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; VUORI K, 1992, J BIOL CHEM, V267, P7211; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101	30	722	745	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					513	517		10.1038/nature04782	http://dx.doi.org/10.1038/nature04782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724068				2022-12-28	WOS:000237778900051
J	Friedman, WE				Friedman, WE			Embryological evidence for developmental lability during early angiosperm evolution	NATURE			English	Article							BASAL ANGIOSPERMS; PHYLOGENETIC ANALYSES; FEMALE GAMETOPHYTE; FLORAL STRUCTURES; FLOWERING PLANTS; LINEAGES; GENES; AUSTROBAILEYALES; MITOCHONDRIAL; ORIGIN	Recent advances in angiosperm phylogeny reconstruction(1-3), palaeobotany(4,5) and comparative organismic biology(6-8) have provided the impetus for a major re-evaluation of the earliest phases of the diversification of flowering plants. We now know that within the first fifteen million years of angiosperm history, three major lineages of flowering plants - monocotyledons, eumagnoliids and eudicotyledons - were established(5), and that within this window of time, tremendous variation in vegetative and floral characteristics evolved. Here I report on a novel type of embryo sac ( angiosperm female gametophyte or haploid egg-producing structure) in Amborella trichopoda, the sole member of the most ancient extant angiosperm lineage. This is the first new pattern of embryo sac structure to be discovered among angiosperms in well over half a century. This discovery also supports the emerging view(9-12) that the earliest phases of angiosperm evolution were characterized by an extensive degree of developmental experimentation and structural lability, and may provide evidence of a critical link to the gymnospermous ancestors of flowering plants.	Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Friedman, WE (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	ned@colorado.edu		Friedman, William Edward/0000-0003-0374-3427				Carlquist S, 2002, AM J BOT, V89, P185, DOI 10.3732/ajb.89.2.185; Crane PR, 2004, AM J BOT, V91, P1683, DOI 10.3732/ajb.91.10.1683; Cronquist A., 1988, EVOLUTION CLASSIFICA; Davis G. L., 1966, SYSTEMATIC EMBRYOLOG; De Craene LPR, 2003, INT J PLANT SCI, V164, pS329, DOI 10.1086/377063; DONOGHUE MJ, 1992, ECOLOGY AND EVOLUTION OF PLANT REPRODUCTION, P356; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Endress PK, 2001, J EXP ZOOL, V291, P105, DOI 10.1002/jez.1063; Feild TS, 2003, INT J PLANT SCI, V164, pS129, DOI 10.1086/374193; Friedman WE, 2004, PLANT CELL, V16, pS119, DOI 10.1105/tpc.017277; Friedman WE, 2003, INT J PLANT SCI, V164, pS293, DOI 10.1086/376877; Friis EM, 2000, GRANA, V39, P226, DOI 10.1080/00173130052017262; Gifford EM, 1989, MORPHOLOGY EVOLUTION; Guo FL, 2004, PROTOPLASMA, V223, P111, DOI 10.1007/s00709-004-0045-7; HUANG BQ, 1992, INT REV CYTOL, V140, P233, DOI 10.1016/S0074-7696(08)61099-2; Johri, 1963, RECENT ADV EMBRYOLOG; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Parkinson CL, 1999, CURR BIOL, V9, P1485, DOI 10.1016/S0960-9822(00)80119-0; Porsch O., 1907, VERSUCH PHYLOGENETIS; Qiu YL, 2005, INT J PLANT SCI, V166, P815, DOI 10.1086/431800; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Schnarf K, 1931, VERGLEICHENDE EMBRYO; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Soltis PS, 2004, AM J BOT, V91, P1614, DOI 10.3732/ajb.91.10.1614; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Tobe H, 2000, J PLANT RES, V113, P271, DOI 10.1007/PL00013935; Williams JH, 2004, AM J BOT, V91, P332, DOI 10.3732/ajb.91.3.332; Williams JH, 2002, NATURE, V415, P522, DOI 10.1038/415522a; Zanis MJ, 2003, ANN MO BOT GARD, V90, P129, DOI 10.2307/3298579	30	78	82	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					337	340		10.1038/nature04690	http://dx.doi.org/10.1038/nature04690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710419				2022-12-28	WOS:000237593200045
J	Levine, ES; Blitz, L; Heiles, C				Levine, ES; Blitz, L; Heiles, C			The spiral structure of the outer Milky Way in hydrogen	SCIENCE			English	Article							SENSITIVITY HI SURVEY; DENSITY-WAVE THEORY; FINAL DATA RELEASE; NEUTRAL HYDROGEN; SOLAR CIRCLE; GALAXY; SKY; DISTANCE; REGIONS; ARM	We produce a detailed map of the perturbed surface density of neutral hydrogen in the outer Milky Way disk, demonstrating that the Galaxy is a non-axisymmetric multiarmed spiral. Spiral structure in the southern half of the Galaxy can be traced out to at least 25 kiloparsecs, implying a minimum radius for the gas disk. Overdensities in the surface density are coincident with regions of reduced gas thickness. The ratio of the surface density to the local median surface density is relatively constant along an arm. Logarithmic spirals can be fit to the arms with pitch angles of 20 degrees to 25 degrees.	Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Levine, ES (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	elevine@astron.berkeley.edu		Levine, Evan/0000-0001-9671-4646				Arnal EM, 2000, ASTRON ASTROPHYS SUP, V142, P35, DOI 10.1051/aas:2000134; Bajaja E, 2005, ASTRON ASTROPHYS, V440, P767, DOI 10.1051/0004-6361:20041863; BURTON WB, 1971, ASTRON ASTROPHYS, V10, P76; DIETER NH, 1971, ASTRON ASTROPHYS, V12, P59; GEORGELIN YM, 1976, ASTRON ASTROPHYS, V49, P57; Hartmann D., 1997, ATLAS GALACTIC NEUTR; HENDERSON AP, 1982, ASTROPHYS J, V263, P116, DOI 10.1086/160486; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; KERR FJ, 1965, STARS STELLAR SYSTEM, V5, P167; KNAPP GR, 1978, ASTRON J, V83, P1585, DOI 10.1086/112367; Levine ES, 2006, ASTROPHYS J, V643, P881, DOI 10.1086/503091; Malin D.F., 1977, AAS PHOTO B, V16, P10; McClure-Griffiths NM, 2004, ASTROPHYS J, V607, pL127, DOI 10.1086/422031; MILLER JS, 1968, ASTROPHYS J, V151, P473, DOI 10.1086/149450; MORGAN WW, 1953, ASTROPHYS J, V118, P318, DOI 10.1086/145754; Olling RP, 1998, MON NOT R ASTRON SOC, V297, P943, DOI 10.1046/j.1365-8711.1998.01577.x; REID MJ, 1993, ANNU REV ASTRON ASTR, V31, P345; TUVE MA, 1972, ASTRON J, V77, P652, DOI 10.1086/111332; Vallee JP, 2005, ASTRON J, V130, P569, DOI 10.1086/431744; van de Hulst HC., 1954, B ASTRON I NETHERLAN, V12, P117; Xu Y, 2006, SCIENCE, V311, P54, DOI 10.1126/science.1120914; YUAN C, 1969, ASTROPHYS J, V158, P871, DOI 10.1086/150248	23	127	127	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1773	1777		10.1126/science.1128455	http://dx.doi.org/10.1126/science.1128455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16741076	Green Submitted			2022-12-28	WOS:000238452800051
J	Bieber, FR; Brenner, CH; Lazer, D				Bieber, FR; Brenner, CH; Lazer, D			Human genetics - Finding criminals through DNA of their relatives	SCIENCE			English	Editorial Material							IDENTIFICATION; INFORMATION; VICTIMS; ISSUES		Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; DNA VIEW, Oakland, CA 94611 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Harvard University	Bieber, FR (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	fbieber@partners.org	Bieber, Frederick/W-7764-2019	Bieber, Frederick/0000-0002-2120-9829	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002836] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R01 HG2836-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuter D, 2005, SCIENCE, V307, P1052, DOI 10.1126/science.1109682; BIEBER FR, 2004, DNA CRIMINAL JUSTICE, P23; Bieber FR, 2006, J LAW MED ETHICS, V34, P222, DOI 10.1111/j.1748-720X.2006.00029.x; Biesecker LG, 2005, SCIENCE, V310, P1122, DOI 10.1126/science.1116608; Brenner CH, 2006, FORENSIC SCI INT, V157, P172, DOI 10.1016/j.forsciint.2005.11.003; Brenner CH, 2003, THEOR POPUL BIOL, V63, P173, DOI 10.1016/S0040-5809(03)00008-X; Budowle B, 1999, J FORENSIC SCI, V44, P1277; Budowle Bruce, 2005, Legal Medicine, V7, P230, DOI 10.1016/j.legalmed.2005.01.001; Butler J. M., 2005, FORENSIC DNA TYPING; CARDWELL D, 2006, NY TIMES        0504; Etzioni A, 2004, DNA CRIMINAL JUSTICE, P197; GRIFFITHS A, 2004, INTRO GENETIC ANAL; Kaye DH, 2004, DNA CRIMINAL JUSTICE, P247; Lazer D, 2004, DNA CRIMINAL JUSTICE, P357; Lazer D, 2006, J LAW MED ETHICS, V34, P366, DOI 10.1111/j.1748-720X.2006.00041.x; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Smith CA, 2004, J CHILD PSYCHOL PSYC, V45, P230, DOI 10.1111/j.1469-7610.2004.00216.x; *US BUR JUST STAT, 1999, 170013 NJC US DEP JU, P62; Williams R, 2005, J LAW MED ETHICS, V33, P545, DOI 10.1111/j.1748-720X.2005.tb00517.x; WILLING R, 2005, US TODAY        0607, P1	21	108	113	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1315	1316		10.1126/science.1122655	http://dx.doi.org/10.1126/science.1122655			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048QM	16690817				2022-12-28	WOS:000237961600031
J	Gill, SR; Pop, M; DeBoy, RT; Eckburg, PB; Turnbaugh, PJ; Samuel, BS; Gordon, JI; Relman, DA; Fraser-Liggett, CM; Nelson, KE				Gill, Steven R.; Pop, Mihai; DeBoy, Robert T.; Eckburg, Paul B.; Turnbaugh, Peter J.; Samuel, Buck S.; Gordon, Jeffrey I.; Relman, David A.; Fraser-Liggett, Claire M.; Nelson, Karen E.			Metagenomic analysis of the human distal gut microbiome	SCIENCE			English	Article							ISOPRENOID BIOSYNTHESIS; ANTIOXIDANT ACTIVITY; BACTERIA; MICROORGANISMS; MICROFLORA; FLAVONOIDS; INDUCTION; DIVERSITY; EVOLUTION; INTESTINE	The human intestinal microbiota is composed of 10(13) to 10(14) microorganisms whose collective genome ("microbiome'') contains at least 100 times as many genes as our own genome. We analyzed similar to 78 million base pairs of unique DNA sequence and 2062 polymerase chain reaction amplified 16S ribosomal DNA sequences obtained from the fecal DNAs of two healthy adults. Using metabolic function analyses of identified genes, we compared our human genome with the average content of previously sequenced microbial genomes. Our microbiome has significantly enriched metabolism of glycans, amino acids, and xenobiotics; methanogenesis; and 2-methyl-D-erythritol 4-phosphate pathway - mediated biosynthesis of vitamins and isoprenoids. Thus, humans are superorganisms whose metabolism represents an amalgamation of microbial and human attributes.	Inst Genom Res, Rockville, MD 20850 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; George Washington Univ, Sch Med, Dept Physiol & Pharmacol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Microbiol & Trop Dis, Washington, DC 20037 USA	J. Craig Venter Institute; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Washington University (WUSTL); George Washington University; George Washington University	Gill, SR (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA.	srgill@buffalo.edu	Samuel, Buck/I-3837-2019; Pop, Mihai/A-7987-2013; WU, TAKLON/A-2827-2010; ravegnini, gloria/K-1330-2016	Samuel, Buck/0000-0002-4347-3997; Pop, Mihai/0000-0001-9617-5304; ravegnini, gloria/0000-0002-7774-402X; Turnbaugh, Peter/0000-0002-0888-2875; Relman, David A./0000-0001-8331-1354; Fraser, Claire/0000-0003-1462-2428	NIAID NIH HHS [AI51259, R01 AI051259-04, R01 AI051259] Funding Source: Medline; NIDDK NIH HHS [DK70977] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070977] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Begley M, 2004, FEBS LETT, V561, P99, DOI 10.1016/S0014-5793(04)00131-0; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; MALLETT AK, 1983, APPL ENVIRON MICROB, V46, P591, DOI 10.1128/AEM.46.3.591-595.1983; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reiners JJ, 1999, CARCINOGENESIS, V20, P1561, DOI 10.1093/carcin/20.8.1561; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rychlik JL, 2000, CURR MICROBIOL, V40, P176, DOI 10.1007/s002849910035; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Schneider H, 1999, ARCH MICROBIOL, V171, P81, DOI 10.1007/s002030050682; STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Umeno D, 2005, MICROBIOL MOL BIOL R, V69, P51, DOI 10.1128/MMBR.69.1.51-78.2005; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang KC, 2000, BBA-MOL CELL BIOL L, V1529, P33, DOI 10.1016/S1388-1981(00)00136-0; Williamson G, 1996, CARCINOGENESIS, V17, P2385, DOI 10.1093/carcin/17.11.2385	29	2990	3247	25	1026	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1355	1359		10.1126/science.1124234	http://dx.doi.org/10.1126/science.1124234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741115	Green Accepted			2022-12-28	WOS:000237961600048
J	Behringer, DC; Butler, MJ; Shields, JD				Behringer, Donald C.; Butler, Mark J.; Shields, Jeffrey D.			Avoidance of disease by social lobsters	NATURE			English	Article							PATHOGEN TRANSMISSION; PANULIRUS-ARGUS; PARASITES		Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA	Old Dominion University; William & Mary; Virginia Institute of Marine Science	Behringer, DC (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	mbutler@odu.edu						ANDERSON RM, 1982, POPULATION BIOL INFE; Bushmann PJ, 2000, J CHEM ECOL, V26, P883, DOI 10.1023/A:1005404107918; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Derby CD, 2000, PHYSIOL BEHAV, V69, P203, DOI 10.1016/S0031-9384(00)00202-X; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; MINCHELLA DJ, 1985, PARASITOLOGY, V90, P205, DOI 10.1017/S0031182000049143; Nevitt G, 2000, MAR ECOL PROG SER, V203, P225, DOI 10.3354/meps203225; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; ROSENQVIST G, 1995, ANIM BEHAV, V49, P1039, DOI 10.1006/anbe.1995.0133; Shields JD, 2004, DIS AQUAT ORGAN, V59, P109, DOI 10.3354/dao059109; WASHBURN JO, 1991, SCIENCE, V253, P185, DOI 10.1126/science.1906637	13	200	202	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					421	421		10.1038/441421a	http://dx.doi.org/10.1038/441421a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724051	Bronze			2022-12-28	WOS:000237778900030
J	Menson, EN; Walker, AS; Sharland, M; Wells, C; Tudor-Williams, G; Riordan, FAI; Lyall, EGH; Gibb, DM				Menson, Esse N.; Walker, A. Sarah; Sharland, Mike; Wells, Carole; Tudor-Williams, Gareth; Riordan, F. Andrew I.; Lyall, E. G. Hermione; Gibb, Diana M.		Collaborative HIV Paediat Study St	Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMBINATION THERAPY; NELFINAVIR; PHARMACOKINETICS; INHIBITORS; MORTALITY; INFANTS	Objective To measure the extent of underflosing of antiretroviral drugs in children. Design Multicentre cohort study. Setting Clinical centres in hospitals in the United Kingdom and Ireland in the collaborative HIV paediatric study (CHIPS). Participants 615 HIV infected children aged 2-12 years receiving antiretrovirals. Main outcome measures Doses relative to weight and height compared with current recommended doses in 2004 European guidelines. Results The CHIPS cohort of 934 children comprises 80% of diagnosed HIV infected children in the UK and Ireland between January 1997 and March 2005, of which 66% (615) aged 2-12 years were prescribed antiretrovirals. Actual doses standardised to weight or surface area varied widely across individual drugs, anfiretroviral class, and calendar time, with children underdosed (prescribed less than 90% of current recommended doses) from 6-62% child time at risk. Three serious issues in prescribing antiretrovirals, which may also be relevant to paediatric prescribing in general, were identified. Firstly, dosing was inadequate before incorrect recommendations at licensing were later revised when important pharmacokinetic results emerged. Secondly, guidelines stating dosage alternatives (by weight/surface area) for the same drug led to different and inconsistent doses. And, thirdly, ongoing growth was not adjusted for. Conclusions Largely inadvertently, HIV infected children in die United Kingdom and Ireland have been underdosed with antiretrovirals, 1-highlighting problems applicable throughout paediatric prescribing.	MRC, Clin Trials Unit, London NW1 2DA, England; St Georges Hosp NHS Trust, London SW17 0QT, England; St Marys Hosp NHS Trust, London W2 1NY, England; Royal Liverpool Childrens NHS Trust, Liverpool L12 2AP, Merseyside, England	Medical Research Council Clinical Trials Unit; St Georges University London; Alder Hey Children's NHS Foundation Trust	Walker, AS (corresponding author), MRC, Clin Trials Unit, London NW1 2DA, England.	sarah.walker@ctu.mrc.ac.uk	Walker, Sarah/HDM-8717-2022	Gibb, Diana/0000-0002-9738-5490; sharland, mike/0000-0001-8626-8291	Medical Research Council [MC_U122886353, MC_U122886351] Funding Source: Medline; MRC [MC_U122886353, MC_U122886351] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADES AE, 1993, BRIT MED J, V306, P1296, DOI 10.1136/bmj.306.6888.1296; ALEXANIAN A, 2005, 12 C RETR OPP INF BO; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; COSTELLO I, 2005, BNF CHILDREN; *FOOD DRUG ADM, 2006, PED DRUG DEV; Gatti G, 2003, CLIN INFECT DIS, V36, P1476, DOI 10.1086/375062; Gibb DM, 2003, BMJ-BRIT MED J, V327, P1019, DOI 10.1136/bmj.327.7422.1019; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Kauffman R E, 2000, Paediatr Drugs, V2, P411, DOI 10.2165/00128072-200002060-00001; King JR, 2002, CLIN PHARMACOKINET, V41, P1115, DOI 10.2165/00003088-200241140-00001; Krogstad P, 1999, CLIN INFECT DIS, V28, P1109, DOI 10.1086/514759; Litalien C, 2003, PEDIATR INFECT DIS J, V22, P48, DOI 10.1097/00006454-200301000-00014; Martin A, 2000, TEACH SOCIOL, V28, P1, DOI 10.2307/1319417; *MED CHILDR, 2004, EURACTIV; Ponnet M, 2005, INT J STD AIDS, V16, P420, DOI 10.1258/0956462054094114; Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x; Sharland M, 2000, EUR J PEDIATR, V159, P649, DOI 10.1007/PL00008400; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; 't Jong GW, 2002, BRIT MED J, V324, P1313, DOI 10.1136/bmj.324.7349.1313; Turner S, 1998, BRIT MED J, V316, P343, DOI 10.1136/bmj.316.7128.343	20	80	81	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2006	332	7551					1183	1186		10.1136/bmj.332.7551.1183	http://dx.doi.org/10.1136/bmj.332.7551.1183			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048GJ	16709991	Green Published, Bronze			2022-12-28	WOS:000237935300016
J	Massoumi, R; Chmielarska, K; Hennecke, K; Pfeifer, A; Fassler, R				Massoumi, Ramin; Chmielarska, Katarzyna; Hennecke, Katharina; Pfeifer, Alexander; Faessler, Reinhard			Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappa B signaling	CELL			English	Article							BCL-3 EXPRESSION; ACTIVATION; ENCODES; GROWTH; P50; IDENTIFICATION; KERATINOCYTES; TRANSLOCATION; TRANSCRIPTION; ASSOCIATION	Mutations in the CYLD gene cause tumors of hair-follicle keratinocytes. The CYLD gene encodes a deubiquitinase that removes lysine 63-linked ubiquitin chains from TRAF2 and inhibits p65/p50 NF-kappa B activation. Here we show that mice lacking Cyld are highly susceptible to chemically induced skin tumors. Cyld(-/-) tumors and keratinocytes treated with 12-O-tetradecanoylphorbol-13 acetate (TPA) or UV light are hyperproliferative and have elevated cyclin D1 levels. The cyclin 131 elevation is caused not by increased p65/p5O action but rather by increased nuclear activity of Bcl-3-associated NF-kappa B p50 and p52. In Cyld(+/+) keratinocytes, TPA or UV light triggers the translocation of Cyld from the cytoplasm to the perinuclear region, where Cyld binds and deubiquitinates Bcl-3, thereby preventing nuclear accumulation of Bcl-3 and p50/Bcl-3- or p52/Bcl-3-dependent proliferation. These data indicate that, depending on the external signals, Cyld can negatively regulate different NF-kappa B pathways; inactivation of TRAF2 controls survival and inflammation, while inhibition of Bcl-3 controls proliferation and tumor growth.	Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; Univ Munich, Dept Pharm, D-81377 Munich, Germany	Max Planck Society; University of Munich	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de	Massoumi, Ramin/AAG-4786-2019	Masoumi, Katarzyna/0000-0002-9277-6505				Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Brasier AR, 2001, J BIOL CHEM, V276, P32080, DOI 10.1074/jbc.M102949200; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Budunova IV, 1999, ONCOGENE, V18, P7423, DOI 10.1038/sj.onc.1203104; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hirai Y, 2004, INT J ONCOL, V24, P977; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; MCKEITHAN TW, 1990, GENE CHROMOSOME CANC, V1, P247, DOI 10.1002/gcc.2870010310; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Nishikori M, 2003, BLOOD, V101, P2789, DOI 10.1182/blood-2002-08-2464; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Regamey A, 2003, J EXP MED, V198, P1959, DOI 10.1084/jem.20031187; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Romero MR, 1999, EXP DERMATOL, V8, P53, DOI 10.1111/j.1600-0625.1999.tb00348.x; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Strobel P, 2002, AM J SURG PATHOL, V26, P119, DOI 10.1097/00000478-200201000-00016; Thornburg NJ, 2003, CANCER RES, V63, P8293; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; VANBALKOM IDC, 1994, J MED GENET, V31, P321, DOI 10.1136/jmg.31.4.321; Watanabe N, 1997, EMBO J, V16, P3609, DOI 10.1093/emboj/16.12.3609; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WEST R, 2001, CHEM ORGANIC SILICON, V3, P1; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Zhang MY, 1998, BLOOD, V92, P1225, DOI 10.1182/blood.V92.4.1225.416k20_1225_1234; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915	40	389	409	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					665	677		10.1016/j.cell.2006.03.041	http://dx.doi.org/10.1016/j.cell.2006.03.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713561	Bronze			2022-12-28	WOS:000237886000013
J	Morton, CC; Nance, WE				Morton, CC; Nance, WE			Current concepts: Newborn hearing screening - A silent revolution	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONGENITAL CYTOMEGALOVIRUS-INFECTION; GENOTYPE-PHENOTYPE CORRELATION; PENDRED-SYNDROME; GJB2 CONNEXIN-26; GENE MUTATION; DEAFNESS; CHILDREN; IDENTIFICATION; LANGUAGE; DFNB1		Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Pediat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Otolaryngol, Richmond, VA 23298 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Nance, WE (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Sanger Hall,11th Floor,1101 E Marshall St,POB 980, Richmond, VA 23298 USA.	nance@mail2.vcu.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006707, R01DC003402, R01DC004293] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC006707, DC04293, DC03402] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACMG, 2002, Genet Med, V4, P162; Barbi M, 2003, PEDIATR INFECT DIS J, V22, P39, DOI 10.1097/00006454-200301000-00012; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Cryns K, 2004, J MED GENET, V41, P147, DOI 10.1136/jmg.2003.013896; del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; DOWNS M P, 1970, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V74, P1208; DOWNS MP, 1995, INT J PEDIATR OTORHI, V32, P257, DOI 10.1016/0165-5876(95)01183-C; DOWNS MP, 1964, J AUD RES, V4, P69; FischelGhodsian N, 1997, AM J OTOLARYNG, V18, P173, DOI 10.1016/S0196-0709(97)90078-8; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; Fowler KB, 1999, J PEDIATR-US, V135, P60, DOI 10.1016/S0022-3476(99)70328-8; Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8; Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; GRAY RF, 1989, INT J PEDIATR OTORHI, V18, P97, DOI 10.1016/0165-5876(89)90062-1; Harrison Melody, 2003, Ear and Hearing, V24, P89, DOI 10.1097/01.AUD.0000051749.40991.1F; Hayes D, 2003, MENT RETARD DEV D R, V9, P65, DOI 10.1002/mrdd.10061; Hulander M, 2003, DEVELOPMENT, V130, P2013, DOI 10.1242/dev.00376; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Johnson J L, 1997, Hawaii Med J, V56, P352; Johnson JL, 2005, PEDIATRICS, V116, P663, DOI 10.1542/peds.2004-1688; *JOINT COMM INF HE, 2000 POS STAT; Kennedy C, 2004, ARCH DIS CHILD-FETAL, V89, pF378, DOI 10.1136/adc.2003.034454; *MA UN NEWB HEAR S, 2004 ANN REP; Mehl AL, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e7; Murgia A, 1999, J MED GENET, V36, P829; Nance WE, 2006, J CLIN VIROL, V35, P221, DOI 10.1016/j.jcv.2005.09.017; Nance WE, 2000, LANCET, V356, P500, DOI 10.1016/S0140-6736(00)02565-4; Nance WE, 2004, AM J HUM GENET, V74, P1081, DOI 10.1086/420979; Nance WE, 2003, MENT RETARD DEV D R, V9, P109, DOI 10.1002/mrdd.10067; *NCHAM, STAT UNHS SUMM STAT; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; PECKHAM CS, 1987, ARCH DIS CHILD, V62, P1233, DOI 10.1136/adc.62.12.1233; Preciado DA, 2004, OTOLARYNG HEAD NECK, V131, P804, DOI 10.1016/j.otohns.2004.06.707; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Schimmenti LA, 2004, GENET MED, V6, P521, DOI 10.1097/01.GIM.0000144187.21727.28; SEVICE RF, 2006, SCIENCE, V311, P1544; Toriello H., 2004, HEREDITARY HEARING L; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; Vohr B, 2003, MENT RETARD DEV D R, V9, P218, DOI 10.1002/mrdd.10082; White Karl R., 1993, Seminars in Hearing, V14, P18; White KR, 2003, MENT RETARD DEV D R, V9, P79, DOI 10.1002/mrdd.10063; Yoshinaga-Itano C, 2003, MENT RETARD DEV D R, V9, P252, DOI 10.1002/mrdd.10088; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161; 2004, 3 ANN NAT EHDI M WAS	47	955	1066	5	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2151	2164		10.1056/NEJMra050700	http://dx.doi.org/10.1056/NEJMra050700			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707752				2022-12-28	WOS:000237575400009
J	Woo, SB; Hellstein, JW; Kalmar, JR				Woo, Sook-Bin; Hellstein, John W.; Kalmar, John R.			Systematic review: Bisphosphonates and osteonecrosis of the jaws	ANNALS OF INTERNAL MEDICINE			English	Review							DELTA T-CELLS; ZOLEDRONIC ACID; MULTIPLE-MYELOMA; AVASCULAR NECROSIS; BONE-MARROW; ALENDRONATE THERAPY; CANCER-PATIENTS; RISK-FACTORS; DOUBLE-BLIND; OSTEORADIONECROSIS	Osteonecrosis of the jaws is a recently described adverse side effect of bisphosphonate therapy. Patients with multiple myeloma and metastatic carcinoma to the skeleton who are receiving intravenous, nitrogen-containing bisphosphonates are at greatest risk for osteonecrosis of the jaws; these patients represent 94% of published cases. The mandible is more commonly affected than the maxilla (2:1 ratio), and 60% of cases are preceded by a dental surgical procedure. Oversuppression of bone turnover is probably the primary mechanism for the development of this condition, although there may be contributing comorbid factors. All sites of potential jaw infection should be eliminated before bisphosphonate therapy is initiated in these patients to reduce the necessity of subsequent dentoalveolar surgery. Conservative debridement of necrotic bone, pain control, infection management, use of antimicrobial oral rinses, and withdrawal of bisphosphonates are preferable to aggressive surgical measures for treating this condition. The degree of risk for osteonecrosis in patients taking oral bisphosphonates, such as alendronate, for osteoporosis is uncertain and warrants careful monitoring.	Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; Univ Iowa, Coll Dent, Iowa City, IA 52242 USA; Ohio State Univ, Coll Dent, Columbus, OH 43210 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard School of Dental Medicine; University of Iowa; University System of Ohio; Ohio State University	Woo, SB (corresponding author), Brigham & Womens Hosp, 45 Francis St, Boston, MA 02115 USA.							Bagan JV, 2006, ORAL ONCOL, V42, P327, DOI 10.1016/j.oraloncology.2005.08.001; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0; Bishay N, 1999, ORAL SURG ORAL MED O, V87, P375, DOI 10.1016/S1079-2104(99)70227-1; Carter G, 2005, MED J AUSTRALIA, V182, P413, DOI 10.5694/j.1326-5377.2005.tb06761.x; Carter GD, 2003, AUST DENT J, V48, P268; Demerjian N, 1999, CLIN RHEUMATOL, V18, P349, DOI 10.1007/s100670050116; Drexler HCA, 2000, FASEB J, V14, P65, DOI 10.1096/fasebj.14.1.65; Durie BGM, 2005, NEW ENGL J MED, V353, P99; ESTILO CS, 2004, P AN M AM SOC CLIN, V22, P750; *EXP PAN REC PREV, 2004, PROF ED MAT; Ficarra G, 2005, J CLIN PERIODONTOL, V32, P1123, DOI 10.1111/j.1600-051X.2005.00842.x; Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80; Gibbs SDJ, 2005, MED J AUSTRALIA, V183, P549, DOI 10.5694/j.1326-5377.2005.tb07172.x; Gonzalez-Moles MA, 2000, J ORAL PATHOL MED, V29, P514, DOI 10.1034/j.1600-0714.2000.291006.x; Goodship A E, 1994, Ann Oncol, V5 Suppl 7, pS53; Green JR, 2004, ONCOLOGIST, V9, P3, DOI 10.1634/theoncologist.9-90004-3; HUGHES DE, 1989, J CLIN INVEST, V83, P1930, DOI 10.1172/JCI114100; JONES JR, 2005, ANN M AM SOC CLIN ON; Katz H, 2005, J ENDODONT, V31, P831, DOI 10.1097/01.don.0000186481.96169.cd; Kunzmann V, 2000, BLOOD, V96, P384; Lenz JH, 2005, J CRANIO MAXILL SURG, V33, P395, DOI 10.1016/j.jcms.2005.07.007; Li CY, 2001, J BONE MINER RES, V16, P429, DOI 10.1359/jbmr.2001.16.3.429; Lin JH, 1999, INT J CLIN PRACT, P18; Lipton A, 2000, CANCER, V88, P1082, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z; Lugassy G, 2004, AM J MED, V117, P440, DOI 10.1016/j.amjmed.2004.04.015; Mariani S, 2005, LEUKEMIA, V19, P664, DOI 10.1038/sj.leu.2403693; Markiewicz MR, 2005, J AM DENT ASSOC, V136, P1669, DOI 10.14219/jada.archive.2005.0109; Marunick Mark, 2005, J Mich Dent Assoc, V87, P44; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; MARX RE, 1983, J ORAL MAXIL SURG, V41, P283, DOI 10.1016/0278-2391(83)90294-X; Mashiba T, 2005, J BONE MINER METAB, V23, P36, DOI 10.1007/BF03026321; McCloskey EV, 2001, BRIT J HAEMATOL, V113, P1035, DOI 10.1046/j.1365-2141.2001.02851.x; Melo MD, 2005, J AM DENT ASSOC, V136, P1675, DOI 10.14219/jada.archive.2005.0110; Merigo E, 2005, J ORAL PATHOL MED, V34, P613, DOI 10.1111/j.1600-0714.2005.00351.x; Migliorati CA, 2005, CANCER, V104, P83, DOI 10.1002/cncr.21130; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Ott SM, 2005, J CLIN ENDOCR METAB, V90, P1897, DOI 10.1210/jc.2005-0057; Ott SM, 2001, J CLIN ENDOCR METAB, V86, P1835, DOI 10.1210/jc.86.4.1835; PASTORZUAZAGA D, 2003, MED ORAL PATOL ORAL, V11, pE76; Pectasides D, 2005, ANTICANCER RES, V25, P1457; PETERS E, 1993, ORAL SURG ORAL MED O, V75, P739, DOI 10.1016/0030-4220(93)90433-5; PHILIPONE E, 2005, GEN DENT, V53, P163; Philipone Elizabeth, 2005, Gen Dent, V53, P163; Pires FR, 2005, ORAL DIS, V11, P365, DOI 10.1111/j.1601-0825.2005.01130.x; Polizzotto MN, 2006, BRIT J HAEMATOL, V132, P114, DOI 10.1111/j.1365-2141.2005.05833.x; Purcell PM, 2005, MED J AUSTRALIA, V182, P417, DOI 10.5694/j.1326-5377.2005.tb06762.x; Rajkumar SV, 2002, J CLIN ONCOL, V20, P4319, DOI 10.1200/JCO.2002.02.116; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Reuther T, 2003, INT J ORAL MAX SURG, V32, P289, DOI 10.1054/ijom.2002.0332; Ruggiero S, 2006, J ONCOL PRACT, V2, P7, DOI 10.1200/JOP.2.1.7; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Russell RGG, 1999, OSTEOPOROSIS INT, V9, P66, DOI 10.1007/PL00004164; Saad Fred, 2005, Clin Prostate Cancer, V4, P31, DOI 10.3816/CGC.2005.n.009; Santini D, 2003, ANN ONCOL, V14, P1468, DOI 10.1093/annonc/mdg401; Sarathy AP, 2005, J ENDODONT, V31, P759, DOI 10.1097/01.don.0000182737.09980.2c; Sitters Michael A, 2005, Tex Dent J, V122, P968; Starck W J, 1995, Int J Oral Maxillofac Implants, V10, P74; Thorn JJ, 2000, J ORAL MAXIL SURG, V58, P1088, DOI 10.1053/joms.2000.9562; Throndson Roger R, 2005, Tex Dent J, V122, P960; Vannucchi Alessandro M, 2005, Br J Haematol, V128, P738, DOI 10.1111/j.1365-2141.2005.05382.x; Viale Pamela Hallquist, 2005, Clin J Oncol Nurs, V9, P355; Vincenzi B, 2005, J INTERF CYTOK RES, V25, P144, DOI 10.1089/jir.2005.25.144; Vitte C, 1996, ENDOCRINOLOGY, V137, P2324, DOI 10.1210/en.137.6.2324; Wang J, 2003, J ORAL MAXIL SURG, V61, P1104, DOI 10.1016/S0278-2391(03)00328-8; Weinstein RS, 2000, J BONE MINER RES, V15, P621, DOI 10.1359/jbmr.2000.15.4.621; Whyte MP, 2003, NEW ENGL J MED, V349, P457, DOI 10.1056/NEJMoa023110; Woo SB, 1997, J AM DENT ASSOC, V128, P189, DOI 10.14219/jada.archive.1997.0163; Wood J, 2002, J PHARMACOL EXP THER, V302, P1055, DOI 10.1124/jpet.102.035295; Yeo Aidan Choon-Poh, 2005, Singapore Dent J, V27, P36; Zarychanski R, 2006, AM J HEMATOL, V81, P73, DOI 10.1002/ajh.20481	71	896	967	2	91	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2006	144	10					753	761		10.7326/0003-4819-144-10-200605160-00009	http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043XO	16702591				2022-12-28	WOS:000237636400006
J	Ahmad, S; Ellis, JC; Hamwendo, H; Molyneux, E				Ahmad, S; Ellis, JC; Hamwendo, H; Molyneux, E			Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial	LANCET			English	Article							STATUS EPILEPTICUS; BUCCAL MIDAZOLAM; RECTAL DIAZEPAM; SEIZURES; CHILDHOOD; PHARMACOKINETICS; DELIVERY	Background In sub-Saharan Africa, rectal diazepam or intramuscular paraldehyde are commonly used as first-line anticonvulsant agents in the emergency treatment of seizures in children. These treatments can be expensive and sometimes toxic. We aimed to assess a drug and delivery system that is potentially more effective, safer, and easier to administer than those presently in use. Methods We did an open randomised trial in a paediatric emergency department of a tertiary hospital in Malawi. 160 children aged over 2 months with seizures persisting for more than 5 min were randomly assigned to receive either intranasal lorazepam (100 mu g/kg, n=80) or intramuscular paraldehyde (0.2 mL/kg, n=80). The primary outcome measure was whether the presenting seizure stopped with one dose of assigned anticonvulsant agent within 10 min of administration. The primary analysis was by intention-to-treat. This study is registered with ClinicalTrials.gov, number NCT00116064. Findings Intranasal lorazepam stopped convulsions within 10 min in 60 (75%) episodes treated (absolute risk 0.75, 95% CI 0.64-0.84), and intramuscular paraldehyde in 49 (61.3%; absolute risk 0.61, 95% Cl 0.49-0.72). No clinically important cardiorespiratory events were seen in either group (95% binomial exact Cl 0-4.5%), and all children finished the trial. Interpretation Intranasal lorazepam is effective, safe, and provides a less invasive alternative to intramuscular paraldehyde in children with protracted convulsions. The ease of use of this drug makes it an attractive and preferable prehospital treatment option.	Birmingham Childrens Hosp NHS Trust, Paediat Intens Care Unit, Birmingham, W Midlands, England; Univ Malawi, Coll Med, Dept Paediat, Zomba, Malawi	University of Malawi	Ahmad, S (corresponding author), Birmingham Childrens Hosp NHS Trust, Paediat Intens Care Unit, Birmingham, W Midlands, England.	doctorshaf@hotmail.com						APPLETON R, 1995, DEV MED CHILD NEUROL, V37, P682; Appleton R, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858; CERLESS RG, 1983, ARCH NEUROL-CHICAGO, V40, P477; CHOONARA IA, 1987, ARCH DIS CHILD, V62, P771, DOI 10.1136/adc.62.8.771; Crawley J, 2000, LANCET, V355, P701, DOI 10.1016/S0140-6736(99)07148-2; Eriksson KJ, 1997, DEV MED CHILD NEUROL, V39, P652; Frey WH, 1997, DRUG DELIV, V4, P87, DOI 10.3109/10717549709051878; *IMAC, 2000, MAN CHILD SER INF SE; KNUDSEN FU, 1979, ARCH DIS CHILD, V54, P855, DOI 10.1136/adc.54.11.855; MACKWAYJONES K, 2005, ADV PAEEIAT LIFE SUP; Maegaki Y, 2005, NEUROPEDIATRICS, V36, P186, DOI 10.1055/s-2005-865611; McIntyre J, 2005, LANCET, V366, P205, DOI 10.1016/S0140-6736(05)66909-7; Molyneux E, 1999, LANCET, V354, P1616, DOI 10.1016/S0140-6736(99)04552-3; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; *OFF CLIN RES AFF, 2001, GOOD CLIN PRACT HDB; OJUAWO A, 2001, NIGERIAN MED J, V40, P67; REIG S, 2005, AN PEDIAT BARC, V63, P307; Rey E, 1999, CLIN PHARMACOKINET, V36, P409, DOI 10.2165/00003088-199936060-00003; *ROYAL PHARM SOC G, 2005, BRIT NAT FORM CHILDR; Sahin M, 2001, EPILEPSIA, V42, P1461, DOI 10.1046/j.1528-1157.2001.21301.x; Scott RC, 1999, LANCET, V353, P623, DOI 10.1016/S0140-6736(98)06425-3; Scott RC, 1998, EPILEPSIA, V39, P290, DOI 10.1111/j.1528-1157.1998.tb01375.x; Shorvon S, 2001, J NEUROL NEUROSUR PS, V70, P22; Talegaonkar S., 2004, Indian Journal of Pharmacology, V36, P140; Wermeling DPH, 2001, J CLIN PHARMACOL, V41, P1225, DOI 10.1177/00912700122012779; Wilson MT, 2004, ARCH DIS CHILD, V89, P50, DOI 10.1136/adc.2002.019836	27	75	77	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1591	1597		10.1016/S0140-6736(06)68696-0	http://dx.doi.org/10.1016/S0140-6736(06)68696-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698412				2022-12-28	WOS:000237598000030
J	Kubin, L				Kubin, L			Materials science - Collective defect behavior under stress	SCIENCE			English	Editorial Material									Off Natl Etud & Rech Aerosp, CNRS, Lab Etud Microstruct, F-92322 Chatillon, France	Centre National de la Recherche Scientifique (CNRS); National Office for Aerospace Studies & Research (ONERA); UDICE-French Research Universities; Universite Paris Saclay	Kubin, L (corresponding author), Off Natl Etud & Rech Aerosp, CNRS, Lab Etud Microstruct, BP 72, F-92322 Chatillon, France.	kubin@onera.fr						Gomez-Garcia D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.125503; Gundlach C, 2004, SCRIPTA MATER, V50, P477, DOI 10.1016/j.scriptamat.2003.10.034; Jakobsen B, 2006, SCIENCE, V312, P889, DOI 10.1126/science.1124141; Neubert M, 2001, PROG CRYST GROWTH CH, V43, P119, DOI 10.1016/S0960-8974(01)00005-5; Rudolph P, 2005, CRYST RES TECHNOL, V40, P7, DOI 10.1002/crat.200410302; Zaiser M, 2002, DISLOCATIONS IN SOLIDS, VOL 11, P1	6	6	6	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					864	865		10.1126/science.1125799	http://dx.doi.org/10.1126/science.1125799			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690852				2022-12-28	WOS:000237452900031
J	Wang, Q; Pan, J; Snell, WJ				Wang, Qian; Pan, Junmin; Snell, William J.			Intraflagellar transport particles participate directly in cilium-generated signaling in Chlamydomonas	CELL			English	Article							DEPENDENT PROTEIN-KINASE; LEFT-RIGHT ASYMMETRY; MATING-TYPE PLUS; KINESIN-II; MOLECULAR CHARACTERIZATION; FLAGELLAR ADHESION; GREEN-ALGA; C-ELEGANS; WILD-TYPE; PHOSPHORYLATION	Primary cilia are widely used for signal transduction during development and in homeostasis and are assembled and maintained by intraflagellar transport (IFT). Here, we have dissected the role of IFT in signaling within the flagella (structural and functional counterparts of cilia) of the biflagellated green alga Chlamydomonas. Using a conditional IFT mutant enables us to deplete the IFT machinery from intact, existing flagella. We identify a cGMP-dependent protein kinase (CrPKG) within flagella as the substrate of a protein tyrosine kinase activated by flagellar adhesion during fertilization. We demonstrate that flagellar adhesion stimulates association of CrPKG with a new flagellar compartment. Moreover, formation of the compartment requires IFT, and IFT particles themselves are part of the compartment. Our results lead to a model in which the IFT machinery is required not only for assembling cilia and flagella but also for organizing a signaling pathway within the organelles during cilium-generated signaling.	Univ Texas, SW Med Sch, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Snell, WJ (corresponding author), Univ Texas, SW Med Sch, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	william.snell@utsouthwestern.edu	Pan, Junmin/H-2673-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025661] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-025661, R01 GM025661] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAIR WS, 1983, CELL, V33, P183, DOI 10.1016/0092-8674(83)90347-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANN KS, 1995, CELL MOTIL CYTOSKEL, V30, P252, DOI 10.1002/cm.970300403; Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baker DA, 2005, FRONT BIOSCI, V10, P1229, DOI 10.2741/1615; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Bloodgood RA, 2000, CELL BIOL INT, V24, P857, DOI 10.1006/cbir.2000.0598; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Christensen ST, 2005, CELL BIOL INT, V29, P347, DOI 10.1016/j.cellbi.2005.02.003; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Deng WS, 2003, BIOCHEM J, V374, P559, DOI 10.1042/BJ20030474; Donald RGK, 2002, MOL BIOCHEM PARASIT, V120, P165, DOI 10.1016/S0166-6851(01)00451-0; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gertsberg I, 2004, J GEN PHYSIOL, V124, P527, DOI 10.1085/jgp.200409153; GOODENOUGH UW, 1975, J CELL BIOL, V67, P623, DOI 10.1083/jcb.67.3.623; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Harris PC, 2004, MOL GENET METAB, V81, P75, DOI 10.1016/j.ymgme.2003.10.010; Huang KY, 2004, MOL BIOL CELL, V15, P3605, DOI 10.1091/mbc.E04-01-0010; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Koutoulis A, 1997, J CELL BIOL, V137, P1069, DOI 10.1083/jcb.137.5.1069; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; LUX FG, 1991, GENETICS, V128, P549; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mendez A, 2003, J NEUROSCI, V23, P3124; MESLAND DAM, 1980, J CELL BIOL, V84, P599, DOI 10.1083/jcb.84.3.599; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pan JM, 2000, CURR OPIN MICROBIOL, V3, P596, DOI 10.1016/S1369-5274(00)00146-6; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4; Pan JM, 2003, J CELL SCI, V116, P2179, DOI 10.1242/jcs.00438; Pan JM, 2002, MOL BIOL CELL, V13, P1417, DOI 10.1091/mbc.01-11-0531; PASQUALE SM, 1987, J CELL BIOL, V105, P2279, DOI 10.1083/jcb.105.5.2279; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pedersen LB, 2003, CURR BIOL, V13, P1969, DOI 10.1016/j.cub.2003.10.058; Piperno G, 1996, J CELL BIOL, V133, P371, DOI 10.1083/jcb.133.2.371; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; POOLE CA, 1985, CELL MOTIL CYTOSKEL, V5, P175, DOI 10.1002/cm.970050302; Praetorius HA, 2004, AM J PHYSIOL-RENAL, V287, pF969, DOI 10.1152/ajprenal.00096.2004; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; SHABB JB, 1991, J BIOL CHEM, V266, P24320; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Teilmann SC, 2005, CELL BIOL INT, V29, P340, DOI 10.1016/j.cellbi.2005.03.006; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; Vondriska TM, 2004, J MOL CELL CARDIOL, V37, P391, DOI 10.1016/j.yjmcc.2004.04.021; Wang Q, 2003, J BIOL CHEM, V278, P32936, DOI 10.1074/jbc.M303261200; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; White MA, 2005, ANNU REV PHARMACOL, V45, P587, DOI 10.1146/annurev.pharmtox.45.120403.095807; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; ZHANG YH, 1994, J CELL BIOL, V125, P617, DOI 10.1083/jcb.125.3.617; Zhao YX, 2003, ANAL CHEM, V75, P3751, DOI 10.1021/ac034184m	76	114	119	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					549	562		10.1016/j.cell.2006.02.044	http://dx.doi.org/10.1016/j.cell.2006.02.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678098	Bronze			2022-12-28	WOS:000237506100020
J	Tilman, D; Reich, PB; Knops, JMH				Tilman, David; Reich, Peter B.; Knops, Johannes M. H.			Biodiversity and ecosystem stability in a decade-long grassland experiment	NATURE			English	Article							PLANT-COMMUNITIES; PRODUCTIVITY; DIVERSITY; DROUGHT	Human-driven ecosystem simplification has highlighted questions about how the number of species in an ecosystem influences its functioning. Although biodiversity is now known to affect ecosystem productivity(1-6), its effects on stability are debated(6-13). Here we present a long-term experimental field test of the diversity - stability hypothesis. During a decade of data collection in an experiment that directly controlled the number of perennial prairie species(4), growing-season climate varied considerably, causing year-to-year variation in abundances of plant species and in ecosystem productivity. We found that greater numbers of plant species led to greater temporal stability of ecosystem annual aboveground plant production. In particular, the decadal temporal stability of the ecosystem, whether measured with intervals of two, five or ten years, was significantly greater at higher plant diversity and tended to increase as plots matured. Ecosystem stability was also positively dependent on root mass, which is a measure of perenniating biomass. Temporal stability of the ecosystem increased with diversity, despite a lower temporal stability of individual species, because of both portfolio ( statistical averaging) and overyielding effects. However, we found no evidence of a covariance effect. Our results indicate that the reliable, efficient and sustainable supply of some foods ( for example, livestock fodder), biofuels and ecosystem services can be enhanced by the use of biodiversity.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Lincoln	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.	tilman@umn.edu	Knops, Johannes/AAA-8546-2020; Tilman, David/ABD-5309-2021	Reich, Peter/0000-0003-4424-662X				Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Elton C. S., 1958, ECOLOGY INVASIONS; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; FRANK DA, 1991, OIKOS, V62, P360, DOI 10.2307/3545501; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; May R.M., 1973, STABILITY COMPLEXITY; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; MCNAUGHTON SJ, 1993, ECOL STU AN, V99, P361; Naeem S, 2002, NATURE, V416, P23, DOI 10.1038/416023a; Naeem S, 1996, OIKOS, V76, P259, DOI 10.2307/3546198; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; TILMAN D, 1992, OECOLOGIA, V89, P257, DOI 10.1007/BF00317226; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0	29	1239	1421	64	1530	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2006	441	7093					629	632		10.1038/nature04742	http://dx.doi.org/10.1038/nature04742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738658	Green Published			2022-12-28	WOS:000237920800046
J	Schiermeier, Q				Schiermeier, Q			Carbon market survives gas leaks	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2006	441	7092					405	405		10.1038/441405a	http://dx.doi.org/10.1038/441405a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724033	Bronze			2022-12-28	WOS:000237778900014
J	Mehta, N; Aisenberg, G				Mehta, N; Aisenberg, G			Necrobacillosis without Lemierre's syndrome	LANCET			English	Editorial Material							SEPTIC PULMONARY-EMBOLISM		Univ Texas, Gen Med Ctr, Lyndon B Johnson Hosp, Houston, TX 77026 USA	University of Texas System	Mehta, N (corresponding author), Univ Texas, Gen Med Ctr, Lyndon B Johnson Hosp, Houston, TX 77026 USA.	Niraj.N.Mehta@uth.tmc.edu						Brazier JS, 2002, J MED MICROBIOL, V51, P269, DOI 10.1099/0022-1317-51-3-269; Cook RJ, 2005, CHEST, V128, P162, DOI 10.1378/chest.128.1.162; Kuduvalli PM, 2005, ACTA ANAESTH SCAND, V49, P572, DOI 10.1111/j.1399-6576.2005.00611.x; Lemierre A, 1936, LANCET, V1, P701; Wong KS, 2002, ARCH DIS CHILD, V87, P312, DOI 10.1136/adc.87.4.312	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2006	367	9523					1702	1702		10.1016/S0140-6736(06)68740-0	http://dx.doi.org/10.1016/S0140-6736(06)68740-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714193				2022-12-28	WOS:000237743100036
J	Hutko, AR; Lay, T; Garnero, EJ; Revenaugh, J				Hutko, AR; Lay, T; Garnero, EJ; Revenaugh, J			Seismic detection of folded, subducted lithosphere at the core-mantle boundary	NATURE			English	Article							POST-PEROVSKITE PHASE; SHEAR VELOCITY STRUCTURE; BENEATH	Seismic tomography has been used to infer that some descending slabs of oceanic lithosphere plunge deep into the Earth's lower mantle(1,2). The fate of these slabs has remained unresolved, but it has been postulated that their ultimate destination is the lower-most few hundred kilometres of the mantle, known as the D '' region. Relatively cold slab material may account for high seismic velocities imaged in D '' beneath areas of long-lived plate subduction, and for reflections from a seismic velocity discontinuity just above the anomalously high wave speed regions(3,4). The D '' discontinuity itself is probably the result of a phase change in relatively low-temperature magnesium silicate perovskite(5,6). Here, we present images of the D '' region beneath the Cocos plate using Kirchhoff migration of horizontally polarized shear waves, and find a 100-km vertical step occurring over less than 100 km laterally in an otherwise flat D '' shear velocity discontinuity. Folding and piling of a cold slab that has reached the core - mantle boundary, as observed in numerical and experimental models, can account for the step by a 100-km elevation of the post-perovskite phase boundary due to a 700 degrees C lateral temperature reduction in the folded slab. We detect localized low velocities at the edge of the slab material, which may result from upwellings caused by the slab laterally displacing a thin hot thermal boundary layer.	Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	University of California System; University of California Santa Cruz; Arizona State University; Arizona State University-Tempe; University of Minnesota System; University of Minnesota Twin Cities	Hutko, AR (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, 1156 High St, Santa Cruz, CA 95064 USA.	ahutko@pmc.ucsc.edu	Revenaugh, Justin/GVR-8368-2022; Lay, Thorne/ABE-6272-2021	Revenaugh, Justin/0000-0002-7855-5159; 				Ding XM, 1997, PHYS EARTH PLANET IN, V101, P245, DOI 10.1016/S0031-9201(97)00001-0; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Flores C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024366; Grand SP, 2002, PHILOS T R SOC A, V360, P2475, DOI 10.1098/rsta.2002.1077; Grand SP., 1997, GSA TODAY, V7, P1; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Hung SH, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003373; Kito T, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002677; LAY T, 1983, GEOPHYS J ROY ASTR S, V75, P799, DOI 10.1111/j.1365-246X.1983.tb05010.x; Lay T, 2004, GEOPHYS MONOGR SER, V150, P25, DOI 10.1029/150GM04; Lay T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020300; Lay T, 1996, J GEOPHYS RES-SOL EA, V101, P20023, DOI 10.1029/96JB01887; LAY T, 2005, EOS T AGU, V86, P1; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; Megnin C, 2000, GEOPHYS J INT, V143, P709, DOI 10.1046/j.1365-246X.2000.00298.x; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Ni SD, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001545; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Reasoner C, 1999, J GEOPHYS RES-SOL EA, V104, P955, DOI 10.1029/1998JB900053; REVENAUGH J, 1995, SCIENCE, V268, P1888, DOI 10.1126/science.268.5219.1888; Ritsema J, 2000, Sci Prog, V83 ( Pt 3), P243; Rokosky JM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018902; Tan E, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000238; Thomas C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003013; Thomas C, 1999, J GEOPHYS RES-SOL EA, V104, P15073, DOI 10.1029/1999JB900128; Wen LX, 2001, EARTH PLANET SC LETT, V189, P141, DOI 10.1016/S0012-821X(01)00365-X; Wysession ME, 1998, GEODYNAMICS, V28, P273	27	106	108	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					333	336		10.1038/nature04757	http://dx.doi.org/10.1038/nature04757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710418				2022-12-28	WOS:000237593200044
J	Halic, M; Gartmann, M; Schlenker, O; Mielke, T; Pool, MR; Sinning, I; Beckmann, R				Halic, M; Gartmann, M; Schlenker, O; Mielke, T; Pool, MR; Sinning, I; Beckmann, R			Signal recognition particle receptor exposes the ribosomal translocon binding site	SCIENCE			English	Article							SRP RECEPTOR; ESCHERICHIA-COLI; BETA-SUBUNIT; ENDOPLASMIC-RETICULUM; GTPASE; DOMAIN; COMPLEXES; CHANNEL; FTSY; RNA	Signal sequences of secretory and membrane proteins are recognized by the signal recognition particle (SRP) as they emerge from the ribosome. This results in their targeting to the membrane by docking with the SRP receptor, which facilitates transfer of the ribosome to the translocon. Here, we present the 8 angstrom cryo - electron microscopy structure of a "docking complex'' consisting of a SRP-bound 80S ribosome and the SRP receptor. Interaction of the SRP receptor with both SRP and the ribosome rearranged the S domain of SRP such that a ribosomal binding site for the translocon, the L23e/L35 site, became exposed, whereas Alu domain - mediated elongation arrest persisted.	Univ Med Sch Berlin, Charite, Inst Biochem, D-10117 Berlin, Germany; Univ Heidelberg, Biochem Ctr BZH, D-69120 Heidelberg, Germany; Max Planck Inst Mol Genet, Ultrastruct Network, USN, D-14195 Berlin, Germany; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Max Planck Society; University of Manchester	Beckmann, R (corresponding author), Univ Med Sch Berlin, Charite, Inst Biochem, Monbijoustr 2, D-10117 Berlin, Germany.	beckmann@lmb.uni-muenchen.de	Halic, Mario/X-2163-2018; Pool, Martin R./AAB-9181-2021; Sinning, Irmgard/A-2982-2010	Pool, Martin R./0000-0003-3071-1535; 				Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Bacher G, 1999, J CELL BIOL, V146, P723, DOI 10.1083/jcb.146.4.723; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Buskiewicz I, 2005, RNA, V11, P947, DOI 10.1261/rna.7242305; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Chu FX, 2004, P NATL ACAD SCI USA, V101, P16454, DOI 10.1073/pnas.0407456101; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; Gu SQ, 2003, RNA, V9, P566, DOI 10.1261/rna.2196403; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Legate KR, 2000, J BIOL CHEM, V275, P27439; Mandon EC, 2003, J CELL BIOL, V162, P575, DOI 10.1083/jcb.200303143; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Moller I, 1998, P NATL ACAD SCI USA, V95, P13425, DOI 10.1073/pnas.95.23.13425; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Spanggord RJ, 2005, NAT STRUCT MOL BIOL, V12, P1116, DOI 10.1038/nsmb1025; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853	28	109	116	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					745	747		10.1126/science.1124864	http://dx.doi.org/10.1126/science.1124864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675701	Green Published			2022-12-28	WOS:000237312100050
J	Scholey, JM; Anderson, KV				Scholey, Jonathan M.; Anderson, Kathryn V.			Intraflagellar transport and cilium-based signaling	CELL			English	Review							PLANAR CELL POLARITY; CAENORHABDITIS-ELEGANS; REPRESSOR FUNCTIONS; KINESIN-II; PROTEINS; CHLAMYDOMONAS; MOUSE; IFT; LOCALIZATION; ACTIVATOR		Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cell Biol, Davis, CA 95616 USA; Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA	University of California System; University of California Davis; Memorial Sloan Kettering Cancer Center	Scholey, JM (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cell Biol, Davis, CA 95616 USA.	jmscholey@ucdavis.edu		Anderson, Kathryn/0000-0003-1657-2161				Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; FLANNERY RJ, 2006, BIOPHYS J; Haycraft CJ, 2005, PLOS GENET; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Lanjuin A, 2004, CURR OPIN NEUROBIOL, V14, P22, DOI 10.1016/j.conb.2004.01.006; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; MESLAND DAM, 1980, J CELL BIOL, V84, P599, DOI 10.1083/jcb.84.3.599; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pan JM, 2002, MOL BIOL CELL, V13, P1417, DOI 10.1091/mbc.01-11-0531; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Peden EM, 2005, CURR BIOL, V15, P394, DOI 10.1016/j.cub.2004.12.073; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552	19	161	168	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 5	2006	125	3					439	442		10.1016/j.cell.2006.04.013	http://dx.doi.org/10.1016/j.cell.2006.04.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678091	Bronze			2022-12-28	WOS:000237506100011
J	Jacobson, BC; Somers, SC; Fuchs, CS; Kelly, CP; Camargo, CA				Jacobson, Brian C.; Somers, Samuel C.; Fuchs, Charles S.; Kelly, Ciaran P.; Camargo, Carlos A., Jr.			Body-mass index and symptoms of gastroesophageal reflux in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; EROSIVE ESOPHAGITIS; UNITED-STATES; DISEASE; POPULATION; OBESITY; PREVALENCE; ADENOCARCINOMA; QUESTIONNAIRE; HEARTBURN	Background: Overweight and obese persons are at increased risk for gastroesophageal reflux disease. An association between body-mass index (BMI) -- the weight in kilograms divided by the square of the height in meters -- and symptoms of gastroesophageal reflux disease in persons of normal weight has not been demonstrated. Methods: In 2000, we used a supplemental questionnaire to determine the frequency, severity, and duration of symptoms of gastroesophageal reflux disease among randomly selected participants in the Nurses' Health Study. After categorizing women according to BMI as measured in 1998, we used logistic-regression models to study the association between BMI and symptoms of gastroesophageal reflux disease. Results: Of 10,545 women who completed the questionnaire (response rate, 86 percent), 2310 (22 percent) reported having symptoms at least once a week, and 3419 (55 percent of those who had any symptoms) described their symptoms as moderate in severity. We observed a dose-dependent relationship between increasing BMI and frequent reflux symptoms (multivariate P for trend <0.001). As compared with women who had a BMI of 20.0 to 22.4, the multivariate odds ratios for frequent symptoms were 0.67 (95 percent confidence interval, 0.48 to 0.93) for a BMI of less than 20.0, 1.38 (95 percent confidence interval, 1.13 to 1.67) for a BMI of 22.5 to 24.9, 2.20 (95 percent confidence interval, 1.81 to 2.66) for a BMI of 25.0 to 27.4, 2.43 (95 percent confidence interval, 1.96 to 3.01) for a BMI of 27.5 to 29.9, 2.92 (95 percent confidence interval, 2.35 to 3.62) for a BMI of 30.0 to 34.9, and 2.93 (95 percent confidence interval, 2.24 to 3.85) for a BMI of 35.0 or more. Even in women with a normal baseline BMI, an increase in BMI of more than 3.5, as compared with no weight changes, was associated with an increased risk of frequent symptoms of reflux (odds ratio, 2.80; 95 percent confidence interval, 1.63 to 4.82). Conclusions: BMI is associated with symptoms of gastroesophageal reflux disease in both normal-weight and overweight women. Even moderate weight gain among persons of normal weight may cause or exacerbate symptoms of reflux.	Boston Univ, Med Ctr, Sch Med, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Boston Med Ctr, Boston, MA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Boston Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Jacobson, BC (corresponding author), Boston Univ, Med Ctr, Sch Med, 85 E Concord St,Rm 7721, Boston, MA 02118 USA.	brian.jacobson@bmc.org	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; Jacobson, Brian/0000-0001-7064-2357	NIAID NIH HHS [R21 AI-52338, R21 AI052338] Funding Source: Medline; NIDDK NIH HHS [K08 DK070706, K08 DK070706-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI052338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK070706] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN LI, 1991, J INTERN MED, V230, P5, DOI 10.1111/j.1365-2796.1991.tb00399.x; Diaz-Rubio M, 2004, ALIMENT PHARM THER, V19, P95, DOI 10.1046/j.1365-2036.2003.01769.x; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P1692, DOI 10.1053/j.gastro.2004.03.077; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Henke CJ, 2000, AM J GASTROENTEROL, V95, P788; Johnson DA, 2004, GASTROENTEROLOGY, V126, P660, DOI 10.1053/j.gastro.2003.12.001; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; Kulig M, 2004, J CLIN EPIDEMIOL, V57, P580, DOI 10.1016/j.jclinepi.2003.10.010; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2000, GUT, V47, P26, DOI 10.1136/gut.47.1.26; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; LOCKE GR, 1994, MAYO CLIN PROC, V69, P539, DOI 10.1016/S0025-6196(12)62245-9; Locke GR, 1999, AM J MED, V106, P642, DOI 10.1016/S0002-9343(99)00121-7; Murray L, 2003, INT J EPIDEMIOL, V32, P645, DOI 10.1093/ije/dyg108; Nilsson M, 2003, JAMA-J AM MED ASSOC, V290, P66, DOI 10.1001/jama.290.1.66; Oliveria SA, 1999, ARCH INTERN MED, V159, P1592, DOI 10.1001/archinte.159.14.1592; Revicki DA, 1998, AM J MED, V104, P252, DOI 10.1016/S0002-9343(97)00354-9; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; STRANGHELLINI V, 1999, SCAND J GASTROENTE S, V231, P20; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wu AH, 2003, CANCER, V98, P940, DOI 10.1002/cncr.11568	25	373	396	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2340	U18		10.1056/NEJMoa054391	http://dx.doi.org/10.1056/NEJMoa054391			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738270	Green Accepted			2022-12-28	WOS:000237918500006
J	Axelrod, BN				Axelrod, BN			Interpreting symptoms in military personnel after combat	LANCET			English	Editorial Material							GULF-WAR; VETERANS; INJURY		Dept Vet Affairs Med Ctr, Psychol Sect, Mental Hlth Serv, Detroit, MI 48201 USA		Axelrod, BN (corresponding author), Dept Vet Affairs Med Ctr, Psychol Sect, Mental Hlth Serv, Detroit, MI 48201 USA.	bradley.axelrod@va.gov						Axelrod BN, 2000, CLIN NEUROPSYCHOL, V14, P344, DOI 10.1076/1385-4046(200008)14:3;1-P;FT344; Axelrod BN, 1997, J NEUROPSYCH CLIN N, V9, P23; DECOSTA JM, 1871, AM J MED SCI, V61, P17; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; GREEN GM, 1994, JAMA-J AM MED ASSOC, V272, P391, DOI 10.1001/jama.1994.03520050071033; Horn O, 2006, LANCET, V367, P1742, DOI 10.1016/S0140-6736(06)68661-3; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; *I MED, 2005, GULF WAR HLTH, V3; Institute of Medicine, 2003, GULF WAR HLTH, V2; Institute of Medicine, 2000, GULF WAR HLTH; KROENKE K, 1990, ARCH INTERN MED, V150, P1985; Sillanpaa MC, 1997, J CLIN EXP NEUROPSYC, V19, P211, DOI 10.1080/01688639708403852; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	14	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY-JUN	2006	367	9524					1709	1710		10.1016/S0140-6736(06)68663-7	http://dx.doi.org/10.1016/S0140-6736(06)68663-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731251				2022-12-28	WOS:000237854000006
J	Worby, CA; Dixon, JE				Worby, Carolyn A.; Dixon, Jack E.			Bacteria seize control by acetylating host proteins	SCIENCE			English	Editorial Material							NF-KAPPA-B; YERSINIA EFFECTOR; ALPHA PRODUCTION; DOWN-REGULATION; YOPJ; TRANSCRIPTION; INHIBITION; ACTIVATION; KINASES		Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jedixon@ucsd.edu						Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Brubaker R R, 1972, Curr Top Microbiol Immunol, V57, P111; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Palmer LE, 1999, INFECT IMMUN, V67, P708, DOI 10.1128/IAI.67.2.708-716.1999; Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	10	5	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1150	1151		10.1126/science.1128785	http://dx.doi.org/10.1126/science.1128785			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16731519				2022-12-28	WOS:000237957400033
J	Embley, RW; Chadwick, WW; Baker, ET; Butterfield, DA; Resing, JA; De Ronde, CEJ; Tunnicliffe, V; Lupton, JE; Juniper, SK; Rubin, KH; Stern, RJ; Lebon, GT; Nakamura, K; Merle, SG; Hein, JR; Wiens, DA; Tamura, Y				Embley, Robert W.; Chadwick, William W., Jr.; Baker, Edward T.; Butterfield, David A.; Resing, Joseph A.; De Ronde, Cornel E. J.; Tunnicliffe, Verena; Lupton, John E.; Juniper, S. Kim; Rubin, Kenneth H.; Stern, Robert J.; Lebon, Geoffrey T.; Nakamura, Ko-ichi; Merle, Susan G.; Hein, James R.; Wiens, Douglas A.; Tamura, Yoshihiko			Long-term eruptive activity at a submarine arc volcano	NATURE			English	Article							EVENT; EVOLUTION; MAGMA; RIDGE	Three-quarters of the Earth's volcanic activity is submarine, located mostly along the mid-ocean ridges, with the remainder along intraoceanic arcs and hotspots at depths varying from greater than 4,000 m to near the sea surface. Most observations and sampling of submarine eruptions have been indirect, made from surface vessels or made after the fact(1-6). We describe here direct observations and sampling of an eruption at a submarine arc volcano named NW Rota-1, located 60 km northwest of the island of Rota (Commonwealth of the Northern Mariana Islands). We observed a pulsating plume permeated with droplets of molten sulphur disgorging volcanic ash and lapilli from a 15-m diameter pit in March 2004 and again in October 2005 near the summit of the volcano at a water depth of 555 m (depth in 2004). A turbid layer found on the flanks of the volcano (in 2004) at depths from 700 m to more than 1,400 m was probably formed by mass-wasting events related to the eruption. Long-term eruptive activity has produced an unusual chemical environment and a very unstable benthic habitat exploited by only a few mobile decapod species. Such conditions are perhaps distinctive of active arc and hotspot volcanoes.	NOAA, PMEL, Newport, OR 97365 USA; Oregon State Univ, CIMRS, Newport, OR 97365 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Washington, JISAO, Seattle, WA 98115 USA; Inst Geol & Nucl Sci, Lower Hutt, New Zealand; Univ Victoria, Sch Earth & Ocean Sci, Dept Biol, Victoria, BC V8W 3N5, Canada; Univ Quebec, GEOTOP Res Ctr, Montreal, PQ H3C 3P8, Canada; Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; Univ Texas, Dept Geosci, Richardson, TX 75083 USA; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan; US Geol Survey, Menlo Pk, CA 94025 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Japan Agcy Marine Earth Sci & Technol, IFREE, Yokosuka, Kanagawa, Japan	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; GNS Science - New Zealand; University of Victoria; University of Quebec; University of Quebec Montreal; University of Hawaii System; University of Texas System; University of Texas Dallas; National Institute of Advanced Industrial Science & Technology (AIST); United States Department of the Interior; United States Geological Survey; Washington University (WUSTL); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Embley, RW (corresponding author), NOAA, PMEL, 2115 SE OSU Dr, Newport, OR 97365 USA.	robert.w.embley@noaa.gov	Tunnicliffe, Verena/D-1056-2014; Stern, Robert/N-8344-2019; Wiens, Douglas A/J-9259-2016; Hein, James/R-7123-2019; Rubin, Kenneth H/B-3685-2008; Baker, Edward/C-7688-2015; Resing, Joseph A/J-6110-2017; Chadwick, William W./R-7623-2019; Butterfield, David/H-3815-2016; Juniper, Kim/N-6769-2015	Stern, Robert/0000-0002-8083-4632; Wiens, Douglas A/0000-0002-5169-4386; Rubin, Kenneth H/0000-0002-8554-1337; Baker, Edward/0000-0002-8794-4180; Resing, Joseph A/0000-0002-7334-4176; Chadwick, William W./0000-0002-5129-4569; Butterfield, David/0000-0002-1595-9279; Juniper, Kim/0000-0002-7608-260X; Tamura, Yoshihiko/0000-0002-3705-7815				Baker ET, 2002, GEOLOGY, V30, P975, DOI 10.1130/0091-7613(2002)030<0975:OASOAO>2.0.CO;2; BAKER ET, 1987, NATURE, V329, P149, DOI 10.1038/329149a0; Butterfield DA, 1997, PHILOS T R SOC A, V355, P369, DOI 10.1098/rsta.1997.0013; Chadwick WW, 1998, DEEP-SEA RES PT II, V45, P2547, DOI 10.1016/S0967-0645(98)00083-6; CHEMINEE JL, 1991, EARTH PLANET SC LETT, V107, P318, DOI 10.1016/0012-821X(91)90079-W; Cowen JP, 2004, GEOPH MONOG SERIES, V144, P227, DOI 10.1029/144GM15; Delaney JR, 1998, SCIENCE, V281, P222, DOI 10.1126/science.281.5374.222; Embley RW, 2004, GEOPHYS MONOGR SER, V144, P75, DOI 10.1029/144GM06; EMBLEY RW, 1995, GEOPHYS RES LETT, V22, P143, DOI 10.1029/94GL02281; Embley RW, 2004, EOS T AM GEOPHYS UN, V85, P37, DOI DOI 10.1029/2004EO040001; Fiske RS, 1998, B VOLCANOL, V59, P262, DOI 10.1007/s004450050190; Fox CG, 2001, NATURE, V412, P727, DOI 10.1038/35089066; GREGG TKP, 1995, GEOLOGY, V23, P73, DOI 10.1130/0091-7613(1995)023<0073:QOSLFM>2.3.CO;2; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; HUBER R, 1990, NATURE, V345, P179, DOI 10.1038/345179a0; KARL DM, 1988, NATURE, V335, P532, DOI 10.1038/335532a0; KOKELAAR BP, 1983, J VOLCANOL GEOTH RES, V19, P239, DOI 10.1016/0377-0273(83)90112-9; Koyaguchi T, 1996, J GEOPHYS RES-SOL EA, V101, P5561, DOI 10.1029/95JB01687; LEBON GT, 2004, T AGU, V85; MIYABE S, 2004, EOS S, V85; RUBIN KH, 1989, NATURE, V341, P50, DOI 10.1038/341050a0; RUBIN KH, 1994, NATURE, V368, P841, DOI 10.1038/368841a0; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Stern RJ, 2002, REV GEOPHYS, V40, DOI 10.1029/2001RG000108; STERN RJ, 2004, EOS S, V85; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; VONDAMM KL, 1995, NATURE, V375, P47, DOI 10.1038/375047a0; White JD., 2003, EXPLOSIVE SUBAQUEOUS, V140, P1, DOI DOI 10.1029/140GM01	28	109	112	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					494	497		10.1038/nature04762	http://dx.doi.org/10.1038/nature04762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724063				2022-12-28	WOS:000237778900046
J	MacLean, RC; Gudelj, I				MacLean, RC; Gudelj, I			Resource competition and social conflict in experimental populations of yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PRISONERS-DILEMMA; EVOLUTION; COOPERATION	Understanding the conditions that promote the maintenance of cooperation is a classic problem in evolutionary biology(1-5). The essence of this dilemma is captured by the 'tragedy of the commons' 6: how can a group of individuals that exploit resources in a cooperative manner resist invasion by 'cheaters' who selfishly use common resources to maximize their individual reproduction at the expense of the group(7,8)? Here, we investigate this conflict through experimental competitions between isogenic cheater and cooperator strains of yeast with alternative pathways of glucose metabolism(9), and by using mathematical models of microbial biochemistry(10). We show that both coexistence and competitive exclusion are possible outcomes of this conflict, depending on the spatial and temporal structure of the environment. Both of these outcomes are driven by trade-offs between the rate and efficiency of conversion of resources into offspring that are mediated by metabolic intermediates.	Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Bath, Dept Math Sci, Bath BA2 7AY, Avon, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Bath	MacLean, RC (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	c.maclean@imperial.ac.uk		MacLean, Craig/0000-0002-7941-813X	Natural Environment Research Council [NE/B501998/2, NE/B501998/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		AXELROD R, 1988, SCIENCE, V242, P1385, DOI 10.1126/science.242.4884.1385; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P469; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Elbing K, 2004, APPL ENVIRON MICROB, V70, P5323, DOI 10.1128/AEM.70.9.5323-5330.2004; Frick T, 2003, NATURWISSENSCHAFTEN, V90, P327, DOI 10.1007/s00114-003-0434-3; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; HARDIN G, 1968, SCIENCE, V162, P1248; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; NOWAK M, 1993, P NATL ACAD SCI USA, V90, P5091, DOI 10.1073/pnas.90.11.5091; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Otterstedt K, 2004, EMBO REP, V5, P532, DOI 10.1038/sj.embor.7400132; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pfeiffer T, 2005, TRENDS BIOCHEM SCI, V30, P20, DOI 10.1016/j.tibs.2004.11.006; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5	20	209	213	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2006	441	7092					498	501		10.1038/nature04624	http://dx.doi.org/10.1038/nature04624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724064				2022-12-28	WOS:000237778900047
J	Trotman, LC; Alimonti, A; Scaglioni, PP; Koutcher, JA; Cordon-Cardo, C; Pandolfi, PP				Trotman, Lloyd C.; Alimonti, Andrea; Scaglioni, Pier Paolo; Koutcher, Jason A.; Cordon-Cardo, Carlos; Pandolfi, Pier Paolo			Identification of a tumour suppressor network opposing nuclear Akt function	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROSTATE-CANCER; CELL-SURVIVAL; PTEN; MICE; PML; PHOSPHATASES; APOPTOSIS; MUTATION; FOXO3A	The proto-oncogene AKT (also known as PKB) is activated in many human cancers, mostly owing to loss of the PTEN tumour suppressor(1). In such tumours, AKT becomes enriched at cell membranes where it is activated by phosphorylation. Yet many targets inhibited by phosphorylated AKT (for example, the FOXO transcription factors) are nuclear; it has remained unclear how relevant nuclear phosphorylated AKT (pAKT) function is for tumorigenesis. Here we show that the PML tumour suppressor prevents cancer by inactivating pAKT inside the nucleus. We find in a mouse model that Pml loss markedly accelerates tumour onset, incidence and progression in Pten-heterozygous mutants, and leads to female sterility with features that recapitulate the phenotype of Foxo3a knockout mice(2). We show that Pml deficiency on its own leads to tumorigenesis in the prostate, a tissue that is exquisitely sensitive to pAkt levels, and demonstrate that Pml specifically recruits the Akt phosphatase PP2a as well as pAkt into Pml nuclear bodies. Notably, we find that Pml-null cells are impaired in PP2a phosphatase activity towards Akt, and thus accumulate nuclear pAkt. As a consequence, the progressive reduction in Pml dose leads to inactivation of Foxo3a-mediated transcription of proapoptotic Bim and the cell cycle inhibitor p27(kip1). Our results demonstrate that Pml orchestrates a nuclear tumour suppressor network for inactivation of nuclear pAkt, and thus highlight the importance of AKT compartmentalization in human cancer pathogenesis and treatment.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Radiol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Med Phys, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Alimonti, Andrea/J-4150-2012	Scaglioni, Pier Paolo/0000-0002-6036-5138; Alimonti, Andrea/0000-0002-9362-2313	NCI NIH HHS [R01 CA137050, P50 CA092629-05, P50 CA092629] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA137050, P50CA092629] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brenkman AB, 2003, TRENDS MOL MED, V9, P464, DOI 10.1016/j.molmed.2003.09.003; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Porkka KP, 2004, EUR UROL, V45, P683, DOI 10.1016/j.eururo.2004.01.012; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073	30	326	336	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2006	441	7092					523	527		10.1038/nature04809	http://dx.doi.org/10.1038/nature04809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16680151	Green Accepted			2022-12-28	WOS:000237778900053
J	Das, SK; Sarwate, D; Mordani, JK; Ng, KJ; Nel, M				Das, Saroj Kumar; Sarwate, Devdatta; Mordani, J. K.; Ng, K. J.; Nel, Mark			Interactive case report - 70 year old man with scrotal swelling, abdominal aortic aneurysm, and renal lesions: case outcome	BRITISH MEDICAL JOURNAL			English	Editorial Material									Hillingdon Hosp, Uxbridge UB8 3NN, Middx, England		Das, SK (corresponding author), Hillingdon Hosp, Uxbridge UB8 3NN, Middx, England.	saroj.das@imperial.ac.uk		Das, Saroj/0000-0003-3228-1225					0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 20	2006	332	7551					1198	1198		10.1136/bmj.332.7551.1198	http://dx.doi.org/10.1136/bmj.332.7551.1198			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048GJ	16709994	Green Published			2022-12-28	WOS:000237935300021
J	Nijs, KAND; de Graaf, C; Kok, FJ; van Staveren, WA				Nijs, KAND; de Graaf, C; Kok, FJ; van Staveren, WA			Effect of family style mealtimes on quality of life, physical performance, and body weight of nursing home residents: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							OLDER-PEOPLE; DEMENTIA; DISEASE	Objective To assess the effect of family style mealtimes on quality of life, physical performance, and body weight of nursing home residents with chronic somatic diseases. Design Cluster randomised trial. Setting Five Dutch nursing homes. Participants 178 residents (mean age 77 years). Two wards in each home were randomised to intervention (95 participants) or control groups (83). Intervention During six months the intervention group took their meals family style and the control group received the usual individual pre-plated service. Main outcome measures Quality of life (perceived safety; autonomy; and sensory, physical, and psychosocial functioning), gross and fine motor function, and body weight. Results The difference in change between the groups was significant for overall quality of life (6.1 units, 95% confidence interval 2.1 to 10.3), fine motor function (1.8 units, 0.6 to 3.0), and body weight (1.5 kg, 0.6 to 2.4). Conclusion Family style mealtimes maintain quality of life, physical performance, and body weight of nursing home residents With chronic somatic diseases.	Univ Wageningen & Res Ctr, Dept Human Nutr, NL-6700 EV Wageningen, Netherlands	Wageningen University & Research	Nijs, KAND (corresponding author), Univ Wageningen & Res Ctr, Dept Human Nutr, POB 8129, NL-6700 EV Wageningen, Netherlands.	Kristel.Nijs@wur.nl						Altus Deborah E, 2002, J Gerontol Nurs, V28, P47; Amarantos E, 2001, J GERONTOL A-BIOL, V56, P54, DOI 10.1093/gerona/56.suppl_2.54; Berkhout A M, 1989, Tijdschr Gerontol Geriatr, V20, P211; Binder EF, 2001, GERONTOLOGIST, V41, P671, DOI 10.1093/geront/41.5.671; CAMPBELL MK, 2004, BRIT MED J, V323, P702; Coull AJ, 2004, AGE AGEING, V33, P348, DOI 10.1093/ageing/afh098; DEBRUIN AF, 1994, J CLIN EPIDEMIOL, V47, P869; Dierkx R I, 2000, Tijdschr Gerontol Geriatr, V31, P52; ERDMAN RAM, 1993, PSYCHOL REP, V72, P1027, DOI 10.2466/pr0.1993.72.3.1027; Goddaer J, 1994, Arch Psychiatr Nurs, V8, P150, DOI 10.1016/0883-9417(94)90048-5; Keller HH, 2004, J GERONTOL A-BIOL, V59, P68; Kerse N, 2005, J AM GERIATR SOC, V53, P1951, DOI 10.1111/j.1532-5415.2005.00466.x; Kiebzak GM, 2002, HEART LUNG, V31, P207, DOI 10.1067/mhl.2002.124299; LAWTON MP, 1975, J GERONTOL, V30, P85, DOI 10.1093/geronj/30.1.85; Mathey MFAM, 2001, PREV MED, V32, P416, DOI 10.1006/pmed.2001.0816; Nijs Kristel, 2003, Tijdschr Gerontol Geriatr, V34, P246; Patrick DL, 2000, J CLIN EPIDEMIOL, V53, P779, DOI 10.1016/S0895-4356(00)00205-5; Ragneskog H, 1996, SCAND J CARING SCI, V10, P11, DOI 10.1111/j.1471-6712.1996.tb00304.x; RAGNESKOG H, 1996, SCAND J CARING SCI, V10, P111; Remsburg RE, 2001, J AM DIET ASSOC, V101, P1460, DOI 10.1016/S0002-8223(01)00352-2; Shatenstein B, 2000, J AM DIET ASSOC, V100, P1354, DOI 10.1016/S0002-8223(00)00381-3; Sidenvall B, 1999, J ADV NURS, V30, P319, DOI 10.1046/j.1365-2648.1999.01082.x; van Campen C, 1998, Tijdschr Gerontol Geriatr, V29, P11; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Wears RL, 2002, ACAD EMERG MED, V9, P330, DOI 10.1197/aemj.9.4.330	25	158	165	1	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 20	2006	332	7551					1180	1183		10.1136/bmj.38825.401181.7C	http://dx.doi.org/10.1136/bmj.38825.401181.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048GJ	16679331	Green Published, Bronze			2022-12-28	WOS:000237935300015
J	Sachs, JD; Reid, WV				Sachs, JD; Reid, WV			Environment - Investments toward sustainable development	SCIENCE			English	Editorial Material									Columbia Univ, UN Millennium Project, New York, NY 10027 USA; Columbia Univ, Earth Inst, New York, NY 10027 USA; Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; Stanford Univ, Millennium Ecosyst Assessment, Stanford, CA 94305 USA	Columbia University; Columbia University; Stanford University; Stanford University	Reid, WV (corresponding author), David & Lucile Packard Fdn, Los Altos, CA 94022 USA.	wreid@packard.org						[Anonymous], 2005, EC HUM WELL BEING SY; *MILL EC ASS, 2005, GLOB ASS REP, V2; *MILL EC ASS, 2005, GLOB ASS REP, V3; *MILL EC ASS, 2005, GLOB ASS REP, V4; Millennium Ecosystem Assessment, 2005, GLOB ASS REP, V1; UN Millennium Project, 2005, INV DEV PRACT PLAN A	6	94	105	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1002	1002		10.1126/science.1124822	http://dx.doi.org/10.1126/science.1124822			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	043UX	16709769				2022-12-28	WOS:000237628800026
J	Sun, AW; Lauher, JW; Goroff, NS				Sun, AW; Lauher, JW; Goroff, NS			Preparation of poly(diiododiacetylene), an ordered conjugated polymer of carbon and iodine	SCIENCE			English	Article							MULTICOMPONENT MOLECULAR CONDUCTORS; C-13 NMR; PHYSICAL-PROPERTIES; LEWIS-BASES; COMPLEXES; MODEL; 1-IODOACETYLENES; IODOALKYNES; DERIVATIVES; DIACETYLENE	Conjugated organic polymers generally must include large substituents for stability, either contained within or appended to the polymer chain. In polydiacetylenes, the substituents fulfill another important role: During topochemical polymerization, they control the spacing between the diyne monomers to produce an ordered polymer. By using a co-crystal scaffolding, we have prepared poly( diiododiacetylene), or PIDA, a nearly unadorned carbon chain substituted with only single-atom iodine side groups. The monomer, diiodobutadiyne, forms co-crystals with bis( nitrile) oxalamides, aligned by hydrogen bonds between oxalamide groups and weak Lewis acid-base interactions between nitriles and iodoalkynes. In co-crystals with one oxalamide host, the diyne undergoes spontaneous topochemical polymerization to form PIDA. The structure of the dark blue crystals, which look copper-colored under reflected light, has been confirmed by single-crystal x-ray diffraction, ultraviolet-visible absorption spectroscopy, and scanning electron microscopy.	SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goroff, NS (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.	nancy.goroff@sunysb.edu						Baeyer A, 1885, BER DTSCH CHEM GES, V18, P2269, DOI [DOI 10.1002/CBER.18850180296, 10.1002/cber.18850180296]; BAUGHMAN RH, 1974, J POLYM SCI POL PHYS, V12, P1511, DOI 10.1002/pol.1974.180120801; Bloor D., 1985, NATO ASI SERIES E, V102; Carpick RW, 2004, J PHYS-CONDENS MAT, V16, pR679, DOI 10.1088/0953-8984/16/23/R01; Chan YH, 2005, J PHYS CHEM B, V109, P19161, DOI 10.1021/jp0529366; Coe S, 1997, J AM CHEM SOC, V119, P86, DOI 10.1021/ja961958q; Crihfield A, 2003, CRYST GROWTH DES, V3, P313, DOI 10.1021/cg0340042; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; Eisler S, 2005, J AM CHEM SOC, V127, P2666, DOI 10.1021/ja044526l; Fowler FW, 2000, J PHYS ORG CHEM, V13, P850, DOI 10.1002/1099-1395(200012)13:12<850::AID-POC316>3.0.CO;2-L; Gibtner T, 2002, CHEM-EUR J, V8, P408, DOI 10.1002/1521-3765(20020118)8:2<408::AID-CHEM408>3.0.CO;2-L; Goroff NS, 2005, ORG LETT, V7, P1891, DOI 10.1021/ol050184s; HEILBRONNER E, 1974, J AM CHEM SOC, V96, P4252; Heimann R.B., 1999, CARBYNE CARBYNOID ST; Hino S, 2001, AIP CONF PROC, V590, P521, DOI 10.1063/1.1420165; Hlavaty J, 2001, CARBON, V39, P53, DOI 10.1016/S0008-6223(00)00072-5; KANE JJ, 1995, J AM CHEM SOC, V117, P12003, DOI 10.1021/ja00153a026; Kavan L, 1997, CHEM REV, V97, P3061, DOI 10.1021/cr960003n; Lam JWY, 2005, ACCOUNTS CHEM RES, V38, P745, DOI 10.1021/ar040012f; LAURENCE C, 1983, CAN J CHEM, V61, P135, DOI 10.1139/v83-024; LAURENCE C, 1981, J AM CHEM SOC, V103, P2567, DOI 10.1021/ja00400a014; McQuade DT, 2000, CHEM REV, V100, P2537, DOI 10.1021/cr9801014; Metrangolo P, 2001, CHEM-EUR J, V7, P2511, DOI 10.1002/1521-3765(20010618)7:12<2511::AID-CHEM25110>3.0.CO;2-T; Moss WN, 2005, J ORG CHEM, V70, P802, DOI 10.1021/jo0481809; Nguyen TL, 2001, J AM CHEM SOC, V123, P11057, DOI 10.1021/ja016635v; Nunzi JM, 2002, CR PHYS, V3, P523, DOI 10.1016/S1631-0705(02)01335-X; Rege PD, 2002, J AM CHEM SOC, V124, P370, DOI 10.1021/ja016290g; Sarkar A, 2000, J MATER CHEM, V10, P819, DOI 10.1039/a907438d; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Straus F, 1930, BER DTSCH CHEM GES, V63, P1886, DOI 10.1002/cber.19300630740; Webb JA, 2004, J ORG CHEM, V69, P660, DOI 10.1021/jo035584c; Webb JA, 2002, ANGEW CHEM INT EDIT, V41, P3011, DOI 10.1002/1521-3773(20020816)41:16<3011::AID-ANIE3011>3.0.CO;2-0; WEGNER G, 1969, Z NATURFORSCH PT B, VB 24, P824; Yamamoto HM, 1999, SYNTHETIC MET, V102, P1448, DOI 10.1016/S0379-6779(98)00284-7; Yamamoto HM, 1999, SYNTHETIC MET, V102, P1515, DOI 10.1016/S0379-6779(98)00930-8; Zheng QL, 2005, J AM CHEM SOC, V127, P10508, DOI 10.1021/ja0534598	36	319	322	8	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1030	1034		10.1126/science.1124621	http://dx.doi.org/10.1126/science.1124621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	043UX	16709780				2022-12-28	WOS:000237628800039
J	Tully, JC				Tully, JC			Mode-selective control of surface reactions	SCIENCE			English	Editorial Material							OXIDE-SEMICONDUCTOR TRANSISTORS; HOT-ELECTRON DEGRADATION; REDUCTION; CHEMISTRY; NACL(100); CO		Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Dept Phys, New Haven, CT 06520 USA; Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Tully, JC (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	john.tully@yale.edu	Tully, John/GPX-7632-2022					Avouris P, 1996, SURF SCI, V363, P368, DOI 10.1016/0039-6028(96)00163-X; BRONIKOWSKI MJ, 1993, J PHYS CHEM-US, V97, P2194, DOI 10.1021/j100112a021; CHANG HC, 1990, PHYS REV LETT, V65, P2125, DOI 10.1103/PhysRevLett.65.2125; Corcelli SA, 2002, J PHYS CHEM A, V106, P10849, DOI 10.1021/jp0205012; HUSSLA I, 1985, PHYS REV B, V32, P3489, DOI 10.1103/PhysRevB.32.3489; Liu ZH, 2006, SCIENCE, V312, P1024, DOI 10.1126/science.1124529; Lyding JW, 1996, APPL PHYS LETT, V68, P2526, DOI 10.1063/1.116172; Redlich B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159487; REIDER GA, 1991, J CHEM PHYS, V94, P4080, DOI 10.1063/1.460660; SINHA A, 1990, J CHEM PHYS, V92, P6333, DOI 10.1063/1.458312; Van de Walle CG, 1996, APPL PHYS LETT, V69, P2441, DOI 10.1063/1.117664	11	27	27	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1004	1005		10.1126/science.1126341	http://dx.doi.org/10.1126/science.1126341			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709771				2022-12-28	WOS:000237628800028
J	Fiegna, F; Yu, YTN; Kadam, SV; Velicer, GJ				Fiegna, F; Yu, YTN; Kadam, SV; Velicer, GJ			Evolution of an obligate social cheater to a superior cooperator	NATURE			English	Article							BACTERIUM MYXOCOCCUS-XANTHUS; PARASITE WASP; MOTILITY; ORIGIN; RESISTANCE; MUTUALISM; CONFLICT; BIOLOGY; BROOD; PILI	Obligate relationships have evolved many times and can be parasitic or mutualistic. Obligate organisms rely on others to survive and thus coevolve with their host or partner. An important but little explored question is whether obligate status is an evolutionarily terminal condition or whether obligate lineages can evolve back to an autonomous lifestyle. The bacterium Myxococcus xanthus survives starvation by the social development of spore-bearing fruiting bodies. Some M. xanthus genotypes defective at fruiting body development in isolation can nonetheless exploit proficient genotypes in chimaeric groups. Here we report an evolutionary transition from obligate dependence on an altruistic host to an autonomous mode of social cooperation. This restoration of social independence was caused by a single mutation of large effect that confers fitness superiority over both ancestral genotypes, including immunity from exploitation by the ancestral cheater. Thus, a temporary state of obligate cheating served as an evolutionary stepping-stone to a novel state of autonomous social dominance.	Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	Max Planck Society	Velicer, GJ (corresponding author), Max Planck Inst Dev Biol, Spemannstr 35, D-72076 Tubingen, Germany.	gregory.velicer@tuebingen.mpg.de						Alexander J, 1999, J CELL SCI, V112, P2993; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Cervo R, 2004, AM NAT, V164, P814, DOI 10.1086/425987; Dale C, 2003, MOL BIOL EVOL, V20, P1188, DOI 10.1093/molbev/msg138; Dugatkin LA, 2005, P ROY SOC B-BIOL SCI, V272, P79, DOI 10.1098/rspb.2004.2916; Fiegna F, 2005, PLOS BIOL, V3, P1980, DOI 10.1371/journal.pbio.0030370; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Foitzik S, 2003, BEHAV ECOL, V14, P80, DOI 10.1093/beheco/14.1.80; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Frank SA, 2003, EVOLUTION, V57, P693; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Keller L, 1999, LEVELS SELECTION EVO; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Lorenzi MC, 2004, PARASITOLOGY, V129, P643, DOI 10.1017/S0031182004005992; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; PELLMYR O, 1992, P NATL ACAD SCI USA, V89, P2927, DOI 10.1073/pnas.89.7.2927; Pellmyr O, 2002, P NATL ACAD SCI USA, V99, P5498, DOI 10.1073/pnas.072588699; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Rodriguez AM, 1999, J BACTERIOL, V181, P4381, DOI 10.1128/JB.181.14.4381-4390.1999; Rosenberg E, 1984, MYXOBACTERIA DEV CEL, P109; Rothstein SI, 1998, PARASITIC BIRDS THEI; Sachs JL, 2005, P NATL ACAD SCI USA, V102, P390, DOI 10.1073/pnas.0405738102; SEIDLER RJ, 1969, J BACTERIOL, V100, P769, DOI 10.1128/JB.100.2.769-785.1969; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Sorenson MD, 2001, EVOLUTION, V55, P2550; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Sumner S, 2004, INSECT SOC, V51, P37, DOI 10.1007/s00040-003-0723-z; Szathmary E, 1995, MAJOR TRANSITIONS EV; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Velicer GJ, 2003, NATURE, V425, P75, DOI 10.1038/nature01908; Velicer GJ, 2002, J BACTERIOL, V184, P2719, DOI 10.1128/JB.184.10.2719-2727.2002; VELICER GJ, IN PRESS P NATL ACAD; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wall D, 1999, J BACTERIOL, V181, P24, DOI 10.1128/JB.181.1.24-33.1999; Williamson VM, 2003, CURR OPIN PLANT BIOL, V6, P327, DOI 10.1016/S1369-5266(03)00059-1; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x	48	121	123	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2006	441	7091					310	314		10.1038/nature04677	http://dx.doi.org/10.1038/nature04677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710413				2022-12-28	WOS:000237593200039
J	Kim, S; Wong, P; Coulombe, PA				Kim, S; Wong, P; Coulombe, PA			A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth	NATURE			English	Article							INTERMEDIATE-FILAMENTS; SIGNALING PATHWAY; IN-VIVO; MTOR; SKIN; DOWNSTREAM; COMPLEX; BINDING; PHOSPHORYLATION; PROGRESSION	Cell growth, an increase in mass and size, is a highly regulated cellular event. The Akt/mTOR ( mammalian target of rapamycin) signalling pathway has a central role in the control of protein synthesis and thus the growth of cells, tissues and organisms(1). A striking example of a physiological context requiring rapid cell growth is tissue repair in response to injury(2). Here we show that keratin 17, an intermediate filament protein rapidly induced in wounded stratified epithelia(3), regulates cell growth through binding to the adaptor protein 14-3-3 sigma. Mouse skin keratinocytes lacking keratin 17 (ref. 4) show depressed protein translation and are of smaller size, correlating with decreased Akt/mTOR signalling activity. Other signalling kinases have normal activity, pointing to the specificity of this defect. Two amino acid residues located in the amino-terminal head domain of keratin 17 are required for the serum-dependent relocalization of 14-3-3 sigma from the nucleus to the cytoplasm, and for the concomitant stimulation of mTOR activity and cell growth. These findings reveal a new and unexpected role for the intermediate filament cytoskeleton in influencing cell growth and size by regulating protein synthesis.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	coulombe@jhmi.edu	Kim, Seyun/B-3387-2012					Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bereiter-Hahn J., 1986, BIOL INTEGUMENT, P443; Bernot KM, 2004, METHOD CELL BIOL, V78, P453; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Coulombe PA, 2004, EUR J CELL BIOL, V83, P735, DOI 10.1078/0171-9335-00443; DePianto D, 2004, EXP CELL RES, V301, P68, DOI 10.1016/j.yexcr.2004.08.007; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mazzalupo S, 2003, DEV DYNAM, V226, P356, DOI 10.1002/dvdy.10245; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; PRASAD GL, 1992, CELL GROWTH DIFFER, V3, P507; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	30	339	356	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					362	365		10.1038/nature04659	http://dx.doi.org/10.1038/nature04659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710422				2022-12-28	WOS:000237593200051
J	Berthold, HK; Unverdorben, S; Degenhardt, R; Bulitta, M; Gouni-Berthold, I				Berthold, HK; Unverdorben, S; Degenhardt, R; Bulitta, M; Gouni-Berthold, I			Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LDL CHOLESTEROL; FOLLOW-UP; LOVASTATIN; EFFICACY; TOLERABILITY; ATORVASTATIN; PRAVASTATIN; EZETIMIBE; DISEASE; PROFILE	Context Policosanol is a natural substance derived from sugar cane that is advertised for its lipid-lowering effects as a nonprescription drug. More than 80 placebo-controlled or comparative trials, performed mostly by a single research institute, suggest that policosanol at doses of 5 to 40 mg/d has lipoprotein-lowering effects comparable with statins. Objectives To determine the lipoprotein-lowering effects of Cuban sugar cane derived policosanol and to establish, if effective, dose-dependency up to 80 mg/d in patients with hypercholesterolemia or combined hyperlipidemia. Design, Setting, and Participants A multicenter ( lipid outpatient clinics and general practitioners in Germany), randomized, double-blind, placebo-controlled, parallel-group trial conducted from September 29, 2000, to May 10, 2001, of patients with hypercholesterolemia or combined hyperlipidemia having baseline low-density lipoprotein cholesterol (LDL-C) levels of at least 150 mg/dL (>= 3.88 mmol/L) and either no or 1 cardiovascular risk factor other than known coronary heart disease, or baseline LDL-C levels of between 150 and 189 mg/dL (3.88-4.89 mmol/L) and 2 or more risk factors. Interventions Open-label 6-week placebo and diet run-in phase followed by a double-blind 12-week treatment phase after randomization to 5 groups: 10, 20, 40, or 80 mg/d of policosanol or placebo. Main Outcome Measure The percentage change of LDL-C, with changes in other lipoproteins as secondary outcome measures. Results A total of 143 patients were randomized to 5 equal groups and were analyzed on an intention-to-treat basis. In none of the 5 treatment groups did LDL-C levels decrease more than 10% from baseline. No statistically significant difference between policosanol and placebo was observed. A nonparametric test analyzing dose-dependency yielded nonsignificant results. In none of the secondary outcome measures, namely total cholesterol, high-density lipoprotein cholesterol (HDL-C), very low-density lipoprotein cholesterol, triglycerides, lipoprotein( a), and ratio of total or LDL-C to HDL-C, were there any significant effects of policosanol. Policosanol was tolerated well without serious adverse events. Conclusion In patients with hypercholesterolemia or combined hyperlipidemia, the sugar cane - derived policosanol in usual and high doses does not demonstrate a reduction in lipid levels beyond placebo.	Ctr Cardiovasc Dis, Inst Clin Res, Dept Clin Pharmacol, Rotenburg, Germany; Clin Res Management Pharmaberatung GmbH, Rheinbach, Germany; Univ Cologne, Dept Internal Med 2, Cologne, Germany	University of Cologne	Berthold, HK (corresponding author), German Med Assoc, Drug Commiss, Herbert Lewin Pl 1, D-10623 Berlin, Germany.	berthold@uni-bonn.de	Berthold, Heiner K./E-6017-2011; Degenhardt, Richard/GZL-2649-2022	Berthold, Heiner K./0000-0002-1457-2216; 				Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; AUFENANGER J, 1989, J CLIN CHEM CLIN BIO, V27, P807; Batista J, 1996, INT J CLIN PHARM TH, V34, P134; Castano G, 2002, INT J CLIN PHARM RES, V22, P89; Castano G, 1999, INT J CLIN PHARM RES, V19, P105; Castano G, 2003, DRUG AGING, V20, P153, DOI 10.2165/00002512-200320020-00006; Castano G, 2003, ANGIOLOGY, V54, P25, DOI 10.1177/000331970305400104; Chen JT, 2005, PHARMACOTHERAPY, V25, P171, DOI 10.1592/phco.25.2.171.56942; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crespo N, 1999, INT J CLIN PHARM RES, V19, P117; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Gouni-Berthold I, 2002, AM HEART J, V143, P356, DOI 10.1067/mhj.2002.119997; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HOWARD BV, 1995, AM J CLIN NUTR, V62, p488S, DOI 10.1093/ajcn/62.2.488S; Janikula Mark, 2002, Altern Med Rev, V7, P203; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Lin YG, 2004, METABOLISM, V53, P1309, DOI 10.1016/j.metabol.2004.05.006; McCarty MF, 2005, MED HYPOTHESES, V64, P636, DOI 10.1016/j.mehy.2003.12.051; Menendez R, 2001, ARCH MED RES, V32, P8, DOI 10.1016/S0188-4409(00)00265-4; Mirkin A, 2001, INT J CLIN PHARM RES, V21, P31; Nikitin YP, 2000, TERAPEVT ARKH, V72, P7; O'Neill R T, 1987, Drug Inf J, V21, P9; Pearson TA, 2005, MAYO CLIN PROC, V80, P587, DOI 10.4065/80.5.587; Prat H, 1999, REV MED CHILE, V127, P286; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; Smith SC, 2001, CIRCULATION, V104, P1577, DOI 10.1161/hc3801.097475; Tan C. E., 2003, SMJ Singapore Medical Journal, V44, P635; Terpstra T, 1952, INDAGATIONES MATHEMA, V14, P327; Varady KA, 2003, NUTR REV, V61, P376, DOI 10.1301/nr.2003.nov.376-383; Wang YW, 2003, LIPIDS, V38, P165, DOI 10.1007/s11745-003-1047-3; Wood D, 1998, EUR HEART J, V19, P1434	33	125	130	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2006	295	19					2262	2269		10.1001/jama.295.19.2262	http://dx.doi.org/10.1001/jama.295.19.2262			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042UX	16705107	Bronze			2022-12-28	WOS:000237556600024
J	Brown, JS; Bradley, CS; Subak, LL; Richter, HE; Kraus, SR; Brubaker, L; Lin, F; Vittinghoff, E; Grady, D				Brown, Jeanette S.; Bradley, Catherine S.; Subak, Leslee L.; Richter, Holly E.; Kraus, Stephen R.; Brubaker, Linda; Lin, Feng; Vittinghoff, Eric; Grady, Deborah		Diagnost Aspects Incontinence Stu	The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence	ANNALS OF INTERNAL MEDICINE			English	Article							EPIDEMIOLOGIC SURVEY; CONFIDENCE-INTERVALS; SEVERITY INDEX; WOMEN; QUESTIONNAIRE; VALIDITY; HISTORY; PREVALENCE; DIAGNOSIS; COMMUNITY	Background: Urinary incontinence is common in women. Because treatments differ, urge incontinence should be distinguished from stress incontinence. To make this distinction, current guidelines recommend an extensive evaluation that is too time-consuming for primary care practice. Objective: To test the accuracy of a simple questionnaire to categorize type of urinary incontinence in women. Design: Multicenter, prospective study of the accuracy of the 3 Incontinence Questions (3IQ) compared with an extended evaluation to distinguish between urge incontinence and stress incontinence. Setting: 5 academic medical centers in the United States. Participants: 301 women enrolled from April to December 2004 who were older than 40 years of age (mean age, 56 years [SD, 11]) with untreated incontinence for an average of 7 years (SD, 7) and a broad range of incontinence severity. Measurements: All participants included in the analyses answered the 31Q questionnaire, and a urologist or urogynecologist who was blinded to the responses performed the extended evaluation. Sensitivity, specificity, and likelihood ratios were determined for the 3IQ. Results: For classification of urge incontinence and with the extended evaluation as the gold standard, the 3IQ had a sensitivity of 0.75 (95% CI, 0.68 to 0.81), a specificity of 0.77 (CI, 0.69 to 0.84), and a positive likelihood ratio of 3.29 (CI, 2.39 to 4.51). For classification of stress incontinence, the sensitivity was 0.86 (CI, 0.79 to 0.90), the specificity was 0.60 (CI, 0.51 to 0.68), and the positive likelihood ratio was 2.13 (CI, 1.71 to 2.66). Limitations: Participants were enrolled by urologists and urogynecologists at academic medical centers. Conclusions: The 31Q questionnaire is a simple, quick, and noninvasive test with acceptable accuracy for classifying urge and stress incontinence and may be appropriate for use in primary care settings. Similar studies are needed in other populations. We also need a clinical trial comparing the outcomes of treatments based on the 31Q and the extended evaluation.	Univ Calif San Francisco, San Francisco, CA 94115 USA; San Francisco VA Med Ctr, San Francisco, CA USA; Univ Iowa, Iowa City, IA 52242 USA; Univ Alabama Birmingham, Birmingham, AL 35487 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA; Loyola Univ, Maywood, IL 60153 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Iowa; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio; Loyola University Chicago	Brown, JS (corresponding author), Univ Calif San Francisco, 1635 Divisadero St,Suite 600, San Francisco, CA 94115 USA.	brownj@obgyn.ucsf.edu	Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589; Bradley, Catherine/0000-0002-7402-5476; Richter, Holly E/0000-0001-7741-5771	FOGARTY INTERNATIONAL CENTER [D43TW000909] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA094107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064538] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW000909] Funding Source: Medline; NCI NIH HHS [R01 CA094107] Funding Source: Medline; NIDDK NIH HHS [P50 DK064538-03S1, P50 DK064538-02S1, P50 DK064538-04, P50 DK064538-010003, P50 DK064538-03, P50 DK064538, P50 DK064538-02, P50 DK064538-01] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrams P, 2000, LANCET, V355, P2153; Bradley CS, 2005, AM J OBSTET GYNECOL, V192, P66, DOI 10.1016/j.ajog.2004.07.037; Brown JS, 1999, OBSTET GYNECOL, V94, P66, DOI 10.1016/S0029-7844(99)00263-X; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Diokno AC, 1999, J UROLOGY, V161, P1263, DOI 10.1016/S0022-5347(01)61652-5; Fantl JA, 1996, AM FAM PHYSICIAN, V54, P1661; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Haeusler G, 2002, OBSTET GYNECOL, V100, P1003, DOI 10.1016/S0029-7844(02)02238-X; Hanley J, 2001, BRIT MED J, V322, P1096, DOI 10.1136/bmj.322.7294.1096; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; Hay-Smith EJ, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001407; Holroyd-Leduc JM, 2004, JAMA-J AM MED ASSOC, V291, P986, DOI 10.1001/jama.291.8.986; Hunskaar S, 2000, INT UROGYNECOL J, V11, P301, DOI 10.1007/s001920070021; Ishiko O, 2000, INT J GYNECOL OBSTET, V68, P131, DOI 10.1016/S0020-7292(99)00182-4; Jones T V, 1998, J Am Board Fam Pract, V11, P207; Kirschner-Hermanns R, 1998, J UROLOGY, V159, P1903, DOI 10.1016/S0022-5347(01)63191-4; Klovning A, 1996, ACTA OBSTET GYN SCAN, V75, P941, DOI 10.3109/00016349609055032; LAGROJANSSEN ALM, 1991, BRIT J UROL, V67, P569, DOI 10.1111/j.1464-410X.1991.tb15217.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lemack GE, 1999, UROLOGY, V54, P461, DOI 10.1016/S0090-4295(99)00246-0; MONSOUR MJ, 1991, STAT MED, V10, P443, DOI 10.1002/sim.4780100316; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Roe B, 2000, COCHRANE DB SYST REV; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; SANDVIK H, 1995, J CLIN EPIDEMIOL, V48, P339, DOI 10.1016/0895-4356(94)00147-I; Shaw C, 2001, FAM PRACT, V18, P48, DOI 10.1093/fampra/18.1.48; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Thom D, 1998, J AM GERIATR SOC, V46, P473, DOI 10.1111/j.1532-5415.1998.tb02469.x; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; UEBERSAX JS, 1995, NEUROUROL URODYNAM, V14, P131, DOI 10.1002/nau.1930140206	30	120	121	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2006	144	10					715	723		10.7326/0003-4819-144-10-200605160-00005	http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043XO	16702587	Green Accepted			2022-12-28	WOS:000237636400002
J	Maier, WD; Andreoli, MAG; McDonald, I; Higgins, MD; Boyce, AJ; Shukolyukov, A; Lugmair, GW; Ashwal, LD; Graser, P; Ripley, EM; Hart, RJ				Maier, WD; Andreoli, MAG; McDonald, I; Higgins, MD; Boyce, AJ; Shukolyukov, A; Lugmair, GW; Ashwal, LD; Graser, P; Ripley, EM; Hart, RJ			Discovery of a 25-cm asteroid clast in the giant Morokweng impact crater, South Africa	NATURE			English	Article							ISOTOPIC EVIDENCE; CHICXULUB; COMPONENTS; METEORITE; MELT	Meteorites provide a sample of Solar System bodies and so constrain the types of objects that have collided with Earth over time. Meteorites analysed to date, however, are unlikely to be representative of the entire population and it is also possible that changes in their nature have occurred with time(1). Large objects are widely believed to be completely melted or vaporized during high-angle impact with the Earth(2,3). Consequently, identification of large impactors relies on indirect chemical tracers, notably the platinum-group elements(4). Here we report the discovery of a large (25-cm), unaltered, fossil meteorite, and several smaller fragments within the impact melt of the giant (> 70 km diameter), 145-Myr-old Morokweng crater, South Africa. The large fragment ( clast) resembles an LL6 chondrite breccia, but contains anomalously iron-rich silicates, Fe-Ni sulphides, and no troilite or metal. It has chondritic chromium isotope ratios and identical platinum-group element ratios to the bulk impact melt. These features allow the unambiguous characterization of an impactor at a large crater. Furthermore, the unusual composition of the meteorite suggests that the Morokweng asteroid incorporated part of the LL chondrite parent body not represented by objects at present reaching the Earth.	Univ Quebec Chicoutimi, Chicoutimi, PQ G7H 2B1, Canada; Univ Pretoria, Dept Geol, ZA-0002 Pretoria, South Africa; S African Nucl Energy Corp, ZA-0001 Pretoria, South Africa; Univ Witwatersrand, Sch Geosci, ZA-2050 Johannesburg, South Africa; Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, Wales; Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; Ithemba LABS Gauteng, ZA-2050 Johannesburg, South Africa	University of Quebec; University of Quebec Chicoutimi; University of Pretoria; The South African Nuclear Energy Corporation SOC Limited (Necsa); University of Witwatersrand; Cardiff University; Scottish Universities Research & Reactor Center; University of California System; University of California San Diego; Scripps Institution of Oceanography; Indiana University System; Indiana University Bloomington; National Research Foundation - South Africa; iThemba LABS	Maier, WD (corresponding author), Univ Quebec Chicoutimi, Chicoutimi, PQ G7H 2B1, Canada.	wolfgang_maier@uqac.ca	Boyce, Adrian J/D-2263-2010; Boyce, Adrian/AAH-3203-2020	Boyce, Adrian J/0000-0002-9680-0787; Boyce, Adrian/0000-0002-9680-0787; Andreoli, Marco/0000-0002-6688-2208; McDonald, Iain/0000-0001-9066-7244; Higgins, Michael/0000-0003-3331-851X	NERC [icsf010001] Funding Source: UKRI; Natural Environment Research Council [icsf010001] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andreoli MAG, 1999, GEOL S AM S, P91; BENOIT PH, 1992, SCIENCE, V255, P1685, DOI 10.1126/science.255.5052.1685; BREARLEY AJ, 1996, REV MINEROLOGY, V36; EBIHARA M, 1996, LUNAR PLANET SCI C, V27, P329; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3171, DOI 10.1016/0016-7037(93)90301-C; GRIEVE RAF, 1991, METEORITICS, V26, P175, DOI 10.1111/j.1945-5100.1991.tb01038.x; Grossman JN, 1998, METEORIT PLANET SCI, V33, pA221, DOI 10.1111/j.1945-5100.1998.tb01336.x; Hart RJ, 1997, EARTH PLANET SC LETT, V147, P25, DOI 10.1016/S0012-821X(97)00006-X; Hart RJ, 2002, EARTH PLANET SC LETT, V198, P49, DOI 10.1016/S0012-821X(02)00497-1; IVANOV BA, 2005, LUNAR PLANET SCI CD, V36, P1443; Koeberl C, 1998, GEOL SOC SPEC PUBL, V140, P133, DOI 10.1144/GSL.SP.1998.140.01.11; Koeberl C, 1997, GEOLOGY, V25, P731, DOI 10.1130/0091-7613(1997)025<0731:MSAALI>2.3.CO;2; Koeberl C, 2003, GEOCHIM COSMOCHIM AC, V67, P1837, DOI 10.1016/S0016-7037(02)00994-8; Kyte FT, 2002, DEEP-SEA RES PT II, V49, P1063, DOI 10.1016/S0967-0645(01)00141-2; Kyte FT, 1998, NATURE, V396, P237, DOI 10.1038/24322; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; MAIER WD, 2003, T I MIN METALL, V112, pB150; McDonald I, 2006, IMPACT STUD, P257, DOI 10.1007/3-540-25736-5_12; MCDONALD I, 2001, GEOCHIM COSMOCHIM AC, V65, P113; MCSWEEN HY, 1993, GEOCHIM COSMOCHIM AC, V57, P1105, DOI 10.1016/0016-7037(93)90044-W; PALME H, 1978, GEOCHIM COSMOCHIM AC, V42, P313, DOI 10.1016/0016-7037(78)90184-9; Pierazzo E, 1999, EARTH PLANET SC LETT, V165, P163, DOI 10.1016/S0012-821X(98)00263-5; Pierazzo E, 2000, METEORIT PLANET SCI, V35, P117, DOI 10.1111/j.1945-5100.2000.tb01979.x; Reimold WU, 1999, GEOL SOC AM SPEC PAP, P61; Schultz PH, 1996, GEOLOGY, V24, P963, DOI 10.1130/0091-7613(1996)024<0963:CTCIAA>2.3.CO;2; SCHULTZ PH, 1997, LUNAR PLANET SCI C, V28, P1261; Shukolyukov A, 1998, SCIENCE, V282, P927, DOI 10.1126/science.282.5390.927; Shukolyukov A, 1999, METEORIT PLANET SCI, V34, pA107; Tagle R, 2004, METEORIT PLANET SCI, V39, P1009, DOI 10.1111/j.1945-5100.2004.tb00942.x; THORSLUND P, 1981, NATURE, V289, P285, DOI 10.1038/289285a0; Wagner T, 2002, GEOCHIM COSMOCHIM AC, V66, P2855, DOI 10.1016/S0016-7037(02)00891-8; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066	33	55	55	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					203	206		10.1038/nature04751	http://dx.doi.org/10.1038/nature04751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688173				2022-12-28	WOS:000237418800042
J	Busemann, H; Young, AF; Alexander, CMO; Hoppe, P; Mukhopadhyay, S; Nittler, LR				Busemann, H; Young, AF; Alexander, CMO; Hoppe, P; Mukhopadhyay, S; Nittler, LR			Interstellar chemistry recorded in organic matter from primitive meteorites	SCIENCE			English	Article							NITROGEN; PRESOLAR; CARBON; DEUTERIUM; FRACTIONATION; ORIGIN	Organic matter in extraterrestrial materials has isotopic anomalies in hydrogen and nitrogen that suggest an origin in the presolar molecular cloud or perhaps in the protoplanetary disk. Interplanetary dust particles are generally regarded as the most primitive solar system matter available, in part because until recently they exhibited the most extreme isotope anomalies. However, we show that hydrogen and nitrogen isotopic compositions in carbonaceous chondrite organic matter reach and even exceed those found in interplanetary dust particles. Hence, both meteorites ( originating from the asteroid belt) and interplanetary dust particles ( possibly from comets) preserve primitive organics that were a component of the original building blocks of the solar system.	Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Max Planck Inst Chem, Otto Hahn Inst, D-55128 Mainz, Germany	Carnegie Institution for Science; Max Planck Society	Busemann, H (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	busemann@dtm.ciw.edu	Alexander, Conel M. O'D./N-7533-2013; Young, Andrea F/H-9697-2012; Hoppe, Peter/B-3032-2015	Alexander, Conel M. O'D./0000-0002-8558-1427; Young, Andrea F/0000-0001-5954-8028; Hoppe, Peter/0000-0003-3681-050X; Busemann, Henner/0000-0002-0867-6908				Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Aleon J, 2005, NATURE, V437, P385, DOI 10.1038/nature03947; Aleon J, 2004, ICARUS, V167, P424, DOI 10.1016/j.icarus.2003.10.012; Alexander CMO, 1998, METEORIT PLANET SCI, V33, P603, DOI 10.1111/j.1945-5100.1998.tb01667.x; Alexander CMOD, 2005, METEORIT PLANET SCI, V40, pA15; Bradley J, 2005, SCIENCE, V307, P244, DOI 10.1126/science.1106717; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; CLAYTON RN, 2002, LUNAR PLANET SCI, V33, P1326; Cody GD, 2005, GEOCHIM COSMOCHIM AC, V69, P1085, DOI 10.1016/j.gca.2004.08.031; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; Gail HP, 2001, ASTRON ASTROPHYS, V378, P192, DOI 10.1051/0004-6361:20011130; Geiss J, 2003, SPACE SCI REV, V106, P3, DOI 10.1023/A:1024651232758; Gilmour I, 2005, TREATISE GEOCHEM, V1, P269; GUAN Y, 1998, LUNAR PLANET SCI, V29, P1760; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Huss GR, 2003, GEOCHIM COSMOCHIM AC, V67, P4823, DOI 10.1016/j.gca.2003.07.019; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2003, SPACE SCI REV, V106, P155, DOI 10.1023/A:1024637704533; Nakamura K., 2002, INT J ASTROBIOL, V1, P179, DOI DOI 10.1017/; Nittler LR, 2003, EARTH PLANET SC LETT, V209, P259, DOI 10.1016/S0012-821X(02)01153-6; PENDLETON YJ, 1994, ASTROPHYS J, V437, P683, DOI 10.1086/175031; Robert F, 2003, SPACE SCI REV, V106, P87, DOI 10.1023/A:1024629402715; Sandford SA, 2001, METEORIT PLANET SCI, V36, P1117, DOI 10.1111/j.1945-5100.2001.tb01948.x; Sugiura N, 2001, METEORIT PLANET SCI, V36, P515, DOI 10.1111/j.1945-5100.2001.tb01893.x; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; Wooden DH, 2005, ASP C SER, V341, P774	28	297	299	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					727	730		10.1126/science.1123878	http://dx.doi.org/10.1126/science.1123878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675696				2022-12-28	WOS:000237312100045
J	Ching, W; Nusse, R				Ching, Wendy; Nusse, Roel			A dedicated Wnt secretion factor	CELL			English	Editorial Material							WINGLESS; PROTEIN		Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr, B271, Stanford, CA 94305 USA.	rnusse@stanford.edu	Ching, Wai-Yim/B-4686-2009	Ching, Wai-Yim/0000-0001-7738-8822				Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	8	45	45	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					432	433		10.1016/j.cell.2006.04.018	http://dx.doi.org/10.1016/j.cell.2006.04.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678089	Bronze			2022-12-28	WOS:000237506100009
J	Stein, PD; Fowler, SE; Goodman, LR; Gottschalk, A; Hales, CA; Hull, RD; Leeper, KV; Popovich, J; Quinn, DA; Sos, TA; Sostman, HD; Tapson, VF; Wakefield, TW; Weg, JG; Woodard, PK				Stein, Paul D.; Fowler, Sarah E.; Goodman, Lawrence R.; Gottschalk, Alexander; Hales, Charles A.; Hull, Russell D.; Leeper, Kenneth V., Jr.; Popovich, John, Jr.; Quinn, Deborah A.; Sos, Thomas A.; Sostman, H. Dirk; Tapson, Victor F.; Wakefield, Thomas W.; Weg, John G.; Woodard, Pamela K.		PIOPED II Investigators	Multidetector computed tomography for acute pulmonary embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ROW SPIRAL CT; D-DIMER; THROMBOEMBOLIC DISEASE; VENOUS THROMBOSIS; CLINICAL-MODEL; HELICAL CT; LUNG-SCAN; ANGIOGRAPHY; DIAGNOSIS; VENOGRAPHY	Background: The accuracy of multidetector computed tomographic angiography (CTA) for the diagnosis of acute pulmonary embolism has not been determined conclusively. Methods: The Prospective Investigation of Pulmonary Embolism Diagnosis II trial was a prospective, multicenter investigation of the accuracy of multidetector CTA alone and combined with venous-phase imaging (CTA-CTV) for the diagnosis of acute pulmonary embolism. We used a composite reference test to confirm or rule out the diagnosis of pulmonary embolism. Results: Among 824 patients with a reference diagnosis and a completed CT study, CTA was inconclusive in 51 because of poor image quality. Excluding such inconclusive studies, the sensitivity of CTA was 83 percent and the specificity was 96 percent. Positive predictive values were 96 percent with a concordantly high or low probability on clinical assessment, 92 percent with an intermediate probability on clinical assessment, and nondiagnostic if clinical probability was discordant. CTA-CTV was inconclusive in 87 of 824 patients because the image quality of either CTA or CTV was poor. The sensitivity of CTA-CTV for pulmonary embolism was 90 percent, and specificity was 95 percent. CTA-CTV was also nondiagnostic with a discordant clinical probability. Conclusions: In patients with suspected pulmonary embolism, multidetector CTA-CTV has a higher diagnostic sensitivity than does CTA alone, with similar specificity. The predictive value of either CTA or CTA-CTV is high with a concordant clinical assessment, but additional testing is necessary when the clinical probability is inconsistent with the imaging results.	St Joseph Mercy Oakland Hosp, Dept Res, Pontiac, MI 48341 USA; Wayne State Univ, Dept Med, Detroit, MI 48202 USA; George Washington Univ, Dept Epidemiol & Biostat, Ctr Biostat, Rockville, MD USA; Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA; Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Calgary, Dept Med, Calgary, AB, Canada; Emory Univ, Dept Med, Atlanta, GA 30322 USA; Henry Ford Hosp, Dept Med, Detroit, MI 48202 USA; Weill Cornell Med Coll, Dept Radiol, New York, NY USA; Weill Cornell Med Coll, Houston, TX USA; Methodist Hosp, Houston, TX 77030 USA; Duke Univ, Dept Med, Durham, NC USA; Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; Washington Univ, Dept Radiol, St Louis, MO 63130 USA	Saint Joseph Mercy Health System (SJMHS); Wayne State University; George Washington University; Medical College of Wisconsin; Michigan State University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Calgary; Emory University; Henry Ford Health System; Henry Ford Hospital; Cornell University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL)	Stein, PD (corresponding author), St Joseph Mercy Oakland Hosp, Dept Res, 44405 Woodward Ave, Pontiac, MI 48341 USA.	steinp@trinity-health.org	Woodard, Pamela/AAC-3892-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL067453, U01HL063899, U01HL063941, U01HL063931, U01HL063942, U01HL063928, U01HL063981, U01HL063940, U01HL063932, U01HL063982] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL63942, HL63981, HL67453, HL63931, HL63928, HL63982, HL063932, HL63899, HL63941, HL63940] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cham MD, 2005, RADIOLOGY, V234, P591, DOI 10.1148/radiol.2342021656; Coche E, 2003, RADIOLOGY, V229, P757, DOI 10.1148/radiol.2293020889; Coche EQ, 2004, RADIOLOGY, V232, P627; Drucker EA, 1998, RADIOLOGY, V209, P235, DOI 10.1148/radiology.209.1.9769837; Eisner MD, 2003, AM J MED, V114, P232, DOI 10.1016/S0002-9343(03)00008-1; Fisher L, 1993, BIOSTATISTICS METHOD, P206; Ghaye B, 2000, JBR-BTR, V83, P271; Gottschalk A, 2002, SEMIN NUCL MED, V32, P173, DOI 10.1053/snuc.2002.124177; HENRY JW, 1995, CHEST, V107, P1375, DOI 10.1378/chest.107.5.1375; HULL RD, 1985, CHEST, V88, P819, DOI 10.1378/chest.88.6.819; HULL RD, 1983, ANN INTERN MED, V98, P891, DOI 10.7326/0003-4819-98-6-891; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kavanagh EC, 2004, AM J ROENTGENOL, V182, P499, DOI 10.2214/ajr.182.2.1820499; KIPPER MS, 1982, CHEST, V82, P411, DOI 10.1378/chest.82.4.411; Lijmer JG, 2000, JAMA-J AM MED ASSOC, V283, P1963; Loud PA, 2001, RADIOLOGY, V219, P498, DOI 10.1148/radiology.219.2.r01ma26498; Moores LK, 2005, ANN INTERN MED, V142, P802, DOI 10.7326/0003-4819-142-9-200505030-00028; Moores LK, 2004, ANN INTERN MED, V141, P866, DOI 10.7326/0003-4819-141-11-200412070-00011; Otmani A., 1998, Annales de Cardiologie et d'Angeiologie, V47, P707; Patel S, 2003, RADIOLOGY, V227, P455, DOI 10.1148/radiol.2272011139; Perrier A, 2000, ARCH INTERN MED, V160, P512, DOI 10.1001/archinte.160.4.512; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Pruszczyk P, 1997, CHEST, V112, P722, DOI 10.1378/chest.112.3.722; Quiroz R, 2005, JAMA-J AM MED ASSOC, V293, P2012, DOI 10.1001/jama.293.16.2012; Raptopoulos V, 2001, RADIOLOGY, V221, P606, DOI 10.1148/radiol.2213010473; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; Remy-Jardin M, 2002, EUR RADIOL, V12, P1971, DOI 10.1007/s00330-002-1485-0; Revel MP, 2005, RADIOLOGY, V234, P265, DOI 10.1148/radiol.2341031880; Richman PB, 2003, J THROMB HAEMOST, V1, P652, DOI 10.1046/j.1538-7836.2003.00231.x; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sox HC, 2004, ANN INTERN MED, V140, P602, DOI 10.7326/0003-4819-140-8-200404200-00005; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Winer-Muram HT, 2004, RADIOLOGY, V233, P806, DOI 10.1148/radiol.2333031744	39	1078	1160	4	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2317	U7		10.1056/NEJMoa052367	http://dx.doi.org/10.1056/NEJMoa052367			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738268				2022-12-28	WOS:000237918500004
J	Schattschneider, P; Rubino, S; Hebert, C; Rusz, J; Kunes, J; Novak, P; Carlino, E; Fabrizioli, M; Panaccione, G; Rossi, G				Schattschneider, P.; Rubino, S.; Hebert, C.; Rusz, J.; Kunes, J.; Novak, P.; Carlino, E.; Fabrizioli, M.; Panaccione, G.; Rossi, G.			Detection of magnetic circular dichroism using a transmission electron microscope	NATURE			English	Article							X-RAY-DICHROISM; SPECTROSCOPY; ORIGIN; IRON; CO	A material is said to exhibit dichroism if its photon absorption spectrum depends on the polarization of the incident radiation. In the case of X-ray magnetic circular dichroism (XMCD), the absorption cross-section of a ferromagnet or a paramagnet in a magnetic field changes when the helicity of a circularly polarized photon is reversed relative to the magnetization direction. Although similarities between X-ray absorption and electron energy-loss spectroscopy in a transmission electron microscope (TEM) have long been recognized, it has been assumed that extending such equivalence to circular dichroism would require the electron beam in the TEM to be spin-polarized. Recently, it was argued on theoretical grounds that this assumption is probably wrong(1). Here we report the direct experimental detection of magnetic circular dichroism in a TEM. We compare our measurements of electron energy-loss magnetic chiral dichroism (EMCD) with XMCD spectra obtained from the same specimen that, together with theoretical calculations, show that chiral atomic transitions in a specimen are accessible with inelastic electron scattering under particular scattering conditions. This finding could have important consequences for the study of magnetism on the nanometre and subnanometre scales, as EMCD offers the potential for such spatial resolution down to the nanometre scale while providing depth information-in contrast to X-ray methods, which are mainly surface-sensitive.	Vienna Univ Technol, Serv Ctr Transmiss Electron Microscopy, A-1040 Vienna, Austria; Vienna Univ Technol, Inst Festkorperphys, A-1040 Vienna, Austria; Inst Phys ASCR, Prague 16253 6, Czech Republic; CNR Natl Lab, TASC INFM, I-34012 Trieste, Italy; Univ Trieste, I-34100 Trieste, Italy; Univ Modena & Reggio Emilia, Dipartimento Fis, I-41100 Modena, Italy	Technische Universitat Wien; Technische Universitat Wien; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; University of Trieste; Universita di Modena e Reggio Emilia	Schattschneider, P (corresponding author), Vienna Univ Technol, Serv Ctr Transmiss Electron Microscopy, Wiedner Hauptstr 8-10-052, A-1040 Vienna, Austria.	schatt@ifp.tuwien.ac.at	Rubino, Stefano/AAH-3390-2021; Novak, Pavel/G-6692-2014; Hébert, Cécile/B-9381-2012; Rusz, Ján/A-3324-2008; Rubino, Stefano/I-4063-2012; Carlino, Elvio/C-3607-2015; Kunes, Jan/B-4484-2008; ROSSI, GIORGIO/D-9781-2018	Rubino, Stefano/0000-0001-5738-0591; Hébert, Cécile/0000-0002-7086-1901; Rusz, Ján/0000-0002-0074-1349; Rubino, Stefano/0000-0001-5738-0591; Carlino, Elvio/0000-0003-0285-7297; Kunes, Jan/0000-0001-9682-7640; Schattschneider, Peter/0000-0002-1225-7554; ROSSI, GIORGIO/0000-0002-9330-7436; Novak, Pavel/0000-0002-6213-0383				Blaha P., 2001, AUGMENTED PLANE WAVE; CARRA P, 1993, PHYS REV LETT, V70, P694, DOI 10.1103/PhysRevLett.70.694; CHEN CT, 1995, PHYS REV LETT, V75, P152, DOI 10.1103/PhysRevLett.75.152; Hebert C, 2003, ULTRAMICROSCOPY, V96, P463, DOI 10.1016/S0304-3991(03)00108-6; HITCHCOCK AP, 1992, JPN J APPL PHYS S32, V32, P176; KOHL H, 1985, ADV IMAG ELECTR PHYS, V65, P173, DOI 10.1016/S0065-2539(08)60878-1; Mathur N, 2003, PHYS TODAY, V56, P25, DOI 10.1063/1.1554133; Nelhiebel M, 2000, PHYS REV LETT, V85, P1847, DOI 10.1103/PhysRevLett.85.1847; NELHIEBEL M, 1999, PHYS REV B, V59, P10969; Ohldag H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.247201; SCHUTZ G, 1987, PHYS REV LETT, V58, P737, DOI 10.1103/PhysRevLett.58.737; Stohr J, 1999, J MAGN MAGN MATER, V200, P470, DOI 10.1016/S0304-8853(99)00407-2; Stohr J, 1995, J ELECTRON SPECTROSC, V75, P253, DOI 10.1016/0368-2048(95)02537-5; THOLE BT, 1992, PHYS REV LETT, V68, P1943, DOI 10.1103/PhysRevLett.68.1943; TISCHER M, 1995, PHYS REV LETT, V75, P1602, DOI 10.1103/PhysRevLett.75.1602; VANDERLAAN G, 1986, PHYS REV B, V34, P6529, DOI 10.1103/PhysRevB.34.6529; Vogel J, 1996, PHYS REV B, V53, P3409, DOI 10.1103/PhysRevB.53.3409; WELLER D, 1995, PHYS REV LETT, V75, P3752, DOI 10.1103/PhysRevLett.75.3752; WON C, 1993, PHYS REV LETT, V91; WU Y, 1992, PHYS REV LETT, V69, P2307, DOI 10.1103/PhysRevLett.69.2307; Yuan J, 1997, J APPL PHYS, V81, P5087, DOI 10.1063/1.364480	21	241	248	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					486	488		10.1038/nature04778	http://dx.doi.org/10.1038/nature04778			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724061				2022-12-28	WOS:000237778900044
J	Schumann, R				Schumann, R			Research in bariatric surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Tufts New England Med Ctr, Dept Anesthesiol, Boston, MA 02111 USA	Tufts Medical Center	Schumann, R (corresponding author), Tufts New England Med Ctr, Dept Anesthesiol, Boston, MA 02111 USA.	rschumann@tufts-nemc.org						Courcoulas AP, 2005, JAMA-J AM MED ASSOC, V294, P1957, DOI 10.1001/jama.294.15.1957; *NJ DEP HLTH SEN S, REP REC BAR WORK GRO; Ridley N, 2005, OBES RES, V13, P205	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2355	2355		10.1001/jama.295.20.2355-a	http://dx.doi.org/10.1001/jama.295.20.2355-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720820				2022-12-28	WOS:000237734400017
J	Bresson, JL; Perronne, C; Launay, O; Gerdil, C; Saville, M; Wood, J; Hoschler, K; Zambon, MC				Bresson, Jean-Louis; Perronne, Christian; Launay, Odile; Gerdil, Catherine; Saville, Melanie; Wood, John; Hoeschler, Katja; Zambon, Maria C.			Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial	LANCET			English	Article							A H5N1; MF59-ADJUVANTED INFLUENZA; PANDEMIC VACCINES; VIRUSES	Background Pathogenic avian influenza A virus H5N1 has caused outbreaks in poultry and migratory birds in Asia, Africa, and Europe, and caused disease and death in people. Although person-to-person spread of current H5N1 strains is unlikely, the virus is a potential source of a future influenza pandemic. Our aim was to assess the safety and immunogenicity of a vaccine against the H5N1 strain. Methods We did a randomised, open-label, non-controlled phase I trial in 300 volunteers aged 18-40 years and assigned one of six inactivated split influenza A/Vietnam/1194/2004 (H5N1) influenza vaccine formulations, comprising 7.5 mu g (with adjuvant n=50, without adjuvant n=49), 15 mu g (n=50, n=50), or 30 mu g (n=51, n=50) of haemagglutinin with or without aluminium hydroxide adjuvant. Individuals received two vaccinations (on days 0 and 21) and provided blood samples (on days 0, 21, and 42) for analysis by haemagglutination inhibition and microneutralisation. We recorded all adverse events. Analyses were descriptive. Findings All formulations were well tolerated, with no serious adverse events, few severe reactions, and no oral temperatures of more than 38 degrees C. All formulations induced an immune response, and responses were detectable in some individuals after only one dose. The adjuvanted 30 mu g formulation induced the greatest response (67% haemagglutinin-inhibition seroconversion rate after two vaccinations). Adjuvant did not improve the response to the lower doses. Two vaccinations of non-adjuvanted 7.5 mu g, adjuvanted 15 mu g, or non-adjuvanted 15 mu g seroconverted more than 40% of participants (haemagglutinin-inhibition test only). Haemagglutinin inhibition and neutralising results were comparable. Interpretation A two-dose regimen with an adjuvanted 30 mu g inactivated H5N1 vaccine was safe and showed an immune response consistent with European regulatory requirements for licensure of seasonal influenza vaccine. We noted encouraging responses with lower doses of antigen that need further study to ascertain their relevance for the choice of the final pandemic vaccine.	Sanofi Pasteur, Dept Res & Dev, F-69280 Marcy Letoile, France; Grp Hosp Univ Necker Enfants Malad, Ctr Invest Clin, Paris, France; Hop Raymond Poincare, Unite Malad Infect & Trop, Garches, France; Univ Paris 05, Hop Cochin, AP HP,Fac Med, CIC Vaccinol Cochin Pasteur,Serv Med Interne, Paris, France; Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; Hlth Protect Agcy, London, England	Sanofi-Aventis; Sanofi France; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institute for Biological Standards & Control; Health Protection Agency	Saville, M (corresponding author), Sanofi Pasteur, Dept Res & Dev, 5141 Ave Marcel Merieux, F-69280 Marcy Letoile, France.	Melanie.Saville@sanofipasteur.com						[Anonymous], WHO GLOB INFL PREP P; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; European Committee for Proprietary Medicinal Products, 1997, CPMPBWP21496 EUR AG; European Committee for Proprietary Medicinal Products, 2004, CPMPVEG471703 EUR AG; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; Lina B, 2000, BIOLOGICALS, V28, P95, DOI 10.1006/biol.2000.0245; Meijer A, 2006, J VIROL METHODS, V132, P113, DOI 10.1016/j.jviromet.2005.10.001; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Stephenson I, 2004, LANCET INFECT DIS, V4, P499, DOI 10.1016/S1473-3099(04)01105-3; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; *WHO, WHO BIOS RISK ASS GU; *WHO, 2006, H5N1 AV INFL TIM; *WHO, CUM NUMB CONF CAS AV; Wood JM, 2002, VACCINE, V20, pB40, DOI 10.1016/S0264-410X(02)00509-1	20	340	390	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2006	367	9523					1657	1664		10.1016/S0140-6736(06)68656-X	http://dx.doi.org/10.1016/S0140-6736(06)68656-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714186				2022-12-28	WOS:000237743100029
J	Meyer, S; Struffert, T; Gottschling, S				Meyer, S; Struffert, T; Gottschling, S			Tuberculous meningitis	LANCET			English	Editorial Material									Univ Hosp Saarland, Dept Paediat, D-66421 Homburg, Germany; Univ Hosp Saarland, Dept Neuroradiol, D-66421 Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Meyer, S (corresponding author), Univ Hosp Saarland, Dept Paediat, Kirrbergerstr, D-66421 Homburg, Germany.	sascha.meyer@uniklinik-saarland.de							0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2006	367	9523					1682	1682		10.1016/S0140-6736(06)68736-9	http://dx.doi.org/10.1016/S0140-6736(06)68736-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714189				2022-12-28	WOS:000237743100032
J	Holt, JK; Park, HG; Wang, YM; Stadermann, M; Artyukhin, AB; Grigoropoulos, CP; Noy, A; Bakajin, O				Holt, JK; Park, HG; Wang, YM; Stadermann, M; Artyukhin, AB; Grigoropoulos, CP; Noy, A; Bakajin, O			Fast mass transport through sub-2-nanometer carbon nanotubes	SCIENCE			English	Article							MEMBRANE; GASES; FLOW	We report gas and water flow measurements through microfabricated membranes in which aligned carbon nanotubes with diameters of less than 2 nanometers serve as pores. The measured gas flow exceeds predictions of the Knudsen diffusion model by more than an order of magnitude. The measured water flow exceeds values calculated from continuum hydrodynamics models by more than three orders of magnitude and is comparable to flow rates extrapolated from molecular dynamics simulations. The gas and water permeabilities of these nanotube-based membranes are several orders of magnitude higher than those of commercial polycarbonate membranes, despite having pore sizes an order of magnitude smaller. These membranes enable fundamental studies of mass transport in confined environments, as well as more energy-efficient nanoscale filtration.	Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Livermore, CA 94550 USA; Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley	Bakajin, O (corresponding author), Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Livermore, CA 94550 USA.	bakajin1@llnl.gov	Park, Hyung Gyu/AAF-7701-2020; Park, Hyung Gyu/F-3056-2013; Bakajin, Olgica/A-9745-2008; Stadermann, Michael/A-5936-2012; Han, Kyuhee/B-6201-2009; Wang, Yinmin (Morris)/F-2249-2010	Park, Hyung Gyu/0000-0001-8121-2344; Park, Hyung Gyu/0000-0001-8121-2344; Stadermann, Michael/0000-0001-8920-3581; Wang, Yinmin (MORRIS)/0000-0003-0393-5154; Grigoropoulos, Costas/0000-0002-8505-4037; Noy, Aleksandr/0000-0003-4924-2652; Wang, Yinmin (Morris)/0000-0002-7161-2034				Ackerman DM, 2003, MOL SIMULAT, V29, P677, DOI 10.1080/0892702031000103239; Agre P, 2001, CURR TOP MEMBR, V51, P1, DOI 10.1016/S1063-5823(01)51003-0; Baudry J, 2001, LANGMUIR, V17, P5232, DOI 10.1021/la0009994; Bhatia SK, 2005, MOL SIMULAT, V31, P643, DOI 10.1080/00268970500108403; Bittner EW, 2003, CARBON, V41, P1231, DOI 10.1016/S0008-6223(03)00055-1; Chen HB, 2006, J PHYS CHEM B, V110, P1971, DOI 10.1021/jp056911i; Chen HB, 2006, J MEMBRANE SCI, V269, P152, DOI 10.1016/j.memsci.2005.06.030; Cottin-Bizonne C, 2002, EUR PHYS J E, V9, P47, DOI 10.1140/epje/i2001-10112-9; Craig VSJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.054504; Cui H, 2000, J APPL PHYS, V88, P6072, DOI 10.1063/1.1320024; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Holt JK, 2004, NANO LETT, V4, P2245, DOI 10.1021/nl048876h; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Kalra A, 2003, P NATL ACAD SCI USA, V100, P10175, DOI 10.1073/pnas.1633354100; Koga K, 2001, NATURE, V412, P802, DOI 10.1038/35090532; Kolesnikov AI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035503; Kotsalis EM, 2004, INT J MULTIPHAS FLOW, V30, P995, DOI 10.1016/j.ijmultiphaseflow.2004.03.009; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Leger C, 1996, J MEMBRANE SCI, V120, P187, DOI 10.1016/0376-7388(96)00143-3; Li J, 1999, APPL PHYS LETT, V75, P367, DOI 10.1063/1.124377; Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a; Maruyama S, 2005, CHEM PHYS LETT, V403, P320, DOI 10.1016/j.cplett.2005.01.031; Mills A. F., 2001, MASS TRANSFER, P68; Naguib N, 2004, NANO LETT, V4, P2237, DOI 10.1021/nl0484907; Skoulidas AI, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.185901; Wang YY, 2005, J APPL PHYS, V98, DOI 10.1063/1.1946198	27	2323	2423	41	1161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1034	1037		10.1126/science.1126298	http://dx.doi.org/10.1126/science.1126298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709781				2022-12-28	WOS:000237628800040
J	Wang, J; Soisson, SM; Young, K; Shoop, W; Kodali, S; Galgoci, A; Painter, R; Parthasarathy, G; Tang, YS; Cummings, R; Ha, S; Dorso, K; Motyl, M; Jayasuriya, H; Ondeyka, J; Herath, K; Zhang, CW; Hernandez, L; Allocco, J; Basilio, A; Tormo, JR; Genilloud, O; Vicente, F; Pelaez, F; Colwell, L; Lee, SH; Michael, B; Felcetto, T; Gill, C; Silver, LL; Hermes, JD; Bartizal, K; Barrett, J; Schmatz, D; Becker, JW; Cully, D; Singh, SB				Wang, J; Soisson, SM; Young, K; Shoop, W; Kodali, S; Galgoci, A; Painter, R; Parthasarathy, G; Tang, YS; Cummings, R; Ha, S; Dorso, K; Motyl, M; Jayasuriya, H; Ondeyka, J; Herath, K; Zhang, CW; Hernandez, L; Allocco, J; Basilio, A; Tormo, JR; Genilloud, O; Vicente, F; Pelaez, F; Colwell, L; Lee, SH; Michael, B; Felcetto, T; Gill, C; Silver, LL; Hermes, JD; Bartizal, K; Barrett, J; Schmatz, D; Becker, JW; Cully, D; Singh, SB			Platensimycin is a selective FabF inhibitor with potent antibiotic properties	NATURE			English	Article							FATTY-ACID BIOSYNTHESIS; SYNTHASE-III FABH; ESCHERICHIA-COLI; CARRIER; THIOLACTOMYCIN; DISCOVERY; CERULENIN; CONDENSATION	Bacterial infection remains a serious threat to human lives because of emerging resistance to existing antibiotics. Although the scientific community has avidly pursued the discovery of new antibiotics that interact with new targets, these efforts have met with limited success since the early 1960s(1,2). Here we report the discovery of platensimycin, a previously unknown class of antibiotics produced by Streptomyces platensis. Platensimycin demonstrates strong, broad-spectrum Gram-positive antibacterial activity by selectively inhibiting cellular lipid biosynthesis. We show that this anti-bacterial effect is exerted through the selective targeting of beta-ketoacyl-(acyl-carrier-protein(ACP)) synthase I/II (FabF/B) in the synthetic pathway of fatty acids. Direct binding assays show that platensimycin interacts specifically with the acyl-enzyme intermediate of the target protein, and X-ray crystallographic studies reveal that a specific conformational change that occurs on acylation must take place before the inhibitor can bind. Treatment with platensimycin eradicates Staphylococcus aureus infection in mice. Because of its unique mode of action, platensimycin shows no cross-resistance to other key antibiotic-resistant strains tested, including methicillin-resistant S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant enterococci. Platensimycin is the most potent inhibitor reported for the FabF/ B condensing enzymes, and is the only inhibitor of these targets that shows broad-spectrum activity, in vivo efficacy and no observed toxicity.	Merck Res Labs, Rahway, NJ 07065 USA	Merck & Company	Wang, J (corresponding author), Merck Res Labs, Rahway, NJ 07065 USA.	jun_wang2@merck.com; stephen_soisson@merck.com; sheo_singh@merck.com	Genilloud, Olga/I-2779-2015; Pelaez, Fernando/K-1790-2014; Silver, Lynn L/A-7789-2009; vicente, francisca/N-5126-2014; Tormo, Jose R/M-1044-2014	Genilloud, Olga/0000-0002-4202-1219; Silver, Lynn L/0000-0002-8416-0487; vicente, francisca/0000-0003-3198-9205; Pelaez, Fernando/0000-0002-4861-586X; Tormo, Jose R/0000-0001-6984-2941				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Butler MS, 2006, BIOCHEM PHARMACOL, V71, P919, DOI 10.1016/j.bcp.2005.10.012; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7; Kodali S, 2005, J BIOL CHEM, V280, P1669, DOI 10.1074/jbc.M406848200; Lai CY, 2003, J BIOL CHEM, V278, P51494, DOI 10.1074/jbc.M308638200; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; MATSUMAE A, 1964, J ANTIBIOT, V17, P1; McGuire KA, 2001, BIOCHEMISTRY-US, V40, P9836, DOI 10.1021/bi0105577; NOTO T, 1982, J ANTIBIOT, V35, P401, DOI 10.7164/antibiotics.35.401; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Revill WP, 2001, J BACTERIOL, V183, P3526, DOI 10.1128/JB.183.11.3526-3530.2001; Schujman GE, 2001, J BACTERIOL, V183, P3032, DOI 10.1128/JB.183.10.3032-3040.2001; Singh SB, 2006, BIOCHEM PHARMACOL, V71, P1006, DOI 10.1016/j.bcp.2005.12.016; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; TSAY JT, 1992, J BACTERIOL, V174, P508, DOI 10.1128/jb.174.2.508-513.1992; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Witkowski A, 1999, BIOCHEMISTRY-US, V38, P11643, DOI 10.1021/bi990993h; Young K, 2006, ANTIMICROB AGENTS CH, V50, P519, DOI 10.1128/AAC.50.2.519-526.2006; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200	25	671	711	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					358	361		10.1038/nature04784	http://dx.doi.org/10.1038/nature04784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	043IB	16710421				2022-12-28	WOS:000237593200050
J	Devereux, G				Devereux, Graham			ABC of chronic obstructive pulmonary disease - Definition, epidemiology, and risk factors	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Aberdeen, Dept Environm & Occupat Med, Aberdeen AB9 1FX, Scotland	University of Aberdeen	Devereux, G (corresponding author), Univ Aberdeen, Dept Environm & Occupat Med, Aberdeen AB9 1FX, Scotland.							Anto JM, 2001, EUR RESPIR J, V17, P982, DOI 10.1183/09031936.01.17509820; Britton M, 2003, RESP MED, V97, pS71, DOI 10.1016/S0954-6111(03)80027-6; Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55; *NAT COLL CTR CHRO, 2004, THORAX S1, V59, P192; Pride NB, 2002, CURR OPIN PULM MED, V8, P95, DOI 10.1097/00063198-200203000-00003	5	71	81	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 13	2006	332	7550					1142	1144		10.1136/bmj.332.7550.1142	http://dx.doi.org/10.1136/bmj.332.7550.1142			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16690673	Green Published			2022-12-28	WOS:000237682700028
J	Gubbins, D; Jones, AL; Finlay, CC				Gubbins, D; Jones, AL; Finlay, CC			Fall in Earth's magnetic field is erratic	SCIENCE			English	Article								Earth's magnetic field has decayed by about 5% per century since measurements began in 1840. Directional measurements predate those of intensity by more than 250 years, and we combined the global model of directions with paleomagnetic intensity measurements to estimate the fall in strength for this earlier period ( 1590 to 1840 A. D.). We found that magnetic field strength was nearly constant throughout this time, in contrast to the later period. Extrapolating to the core surface showed that the fall in strength originated in patches of reverse magnetic flux in the Southern Hemisphere. These patches were detectable by directional data alone; the pre-1840 model showed little or no evidence of them, supporting the conclusion of a steady dipole up to 1840.	Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Gubbins, D (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	gubbins@earth.leeds.ac.uk	Finlay, Christopher C/B-5062-2014	Finlay, Christopher C/0000-0002-4592-2290; Gubbins, David/0000-0002-8125-4752	Natural Environment Research Council [NER/O/S/2003/00674, NER/O/S/2001/01227] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BLOXHAM J, 1989, PHILOS T R SOC A, V329, P415, DOI 10.1098/rsta.1989.0087; Gubbins D, 1996, PHYS EARTH PLANET IN, V98, P193, DOI 10.1016/S0031-9201(96)03187-1; Hulot G, 2002, NATURE, V416, P620, DOI 10.1038/416620a; Hulot G, 1997, GEOPHYS J INT, V129, P347, DOI 10.1111/j.1365-246X.1997.tb01587.x; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; Korte M, 2005, EARTH PLANET SC LETT, V236, P348, DOI 10.1016/j.epsl.2004.12.031; KORTE M, 2005, GEOCHEM GEOPHYS GEOS; MCELHINNY MW, 1982, J GEOMAGN GEOELECTR, V34, P39, DOI 10.5636/jgg.34.39; PRESS WH, 2002, NUMERICAL RECIPES FO; WILLIAMSON JH, 1968, CAN J PHYS, V46, P1846	10	128	131	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					900	902		10.1126/science.1124855	http://dx.doi.org/10.1126/science.1124855			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690863				2022-12-28	WOS:000237452900044
J	Brown, KM; Kondeatis, E; Vaughan, RW; Kon, SP; Farmer, CKT; Taylor, JD; He, X; Johnston, A; Horsfield, C; Janssen, BJC; Gros, P; Zhou, WD; Sacks, SH; Sheerin, NS				Brown, KM; Kondeatis, E; Vaughan, RW; Kon, SP; Farmer, CKT; Taylor, JD; He, X; Johnston, A; Horsfield, C; Janssen, BJC; Gros, P; Zhou, WD; Sacks, SH; Sheerin, NS			Influence of donor C3 allotype on late renal-transplantation outcome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-COMPLEMENT COMPONENT-C3; CHRONIC ALLOGRAFT NEPHROPATHY; MOLECULAR ANALYSIS; REJECTION; CELLS; SYSTEM; POLYMORPHISMS; ACTIVATION; CAPACITY; IMMUNITY	BACKGROUND: The complement system has a critical role in both the innate and the adaptive immune responses. In humans, C3 exists as two main allotypes, F (fast) and S (slow), which are known to affect the incidence of inflammatory disease. We conducted a study to address the influence of these alleles on late renal-graft outcome. METHODS: We determined the C3 allotypes of 662 pairs of adult kidney donors and recipients from 1993 through 2002 and then related C3F/S polymorphism status to demographic and clinical outcome data. The median length of follow-up was 3.3 years. RESULTS: Analysis of 513 pairs of white donors and recipients identified 113 C3S/S recipients of a C3S/F or a C3F/F kidney and 179 C3S/S recipients of a C3S/S kidney. Graft survival was significantly better with a C3F/F or C3F/S donor allotype than a C3S/S allotype (P=0.05). The hazard ratio for graft loss of C3S/S kidneys, as compared with C3F/F or C3F/S kidneys, was 2.21 (95 percent confidence interval, 1.04 to 4.72; P=0.04). The graft function of C3F/F or C3F/S donor kidneys was significantly better than that of C3S/S donor kidneys (P<0.001). The effect of the C3F allele was specific to recipients who did not themselves possess this allele. Multivariate analysis excluded effects of other factors known to influence graft outcome. CONCLUSIONS: Expression of C3 alleles by donor renal cells appears to have a differential effect on late graft outcome. Among white C3S/S recipients, receipt of a C3F/F or C3F/S donor kidney, rather than a C3S/S donor kidney, is associated with a significantly better long-term outcome. These findings suggest that the two alleles have functional differences.	Guys Hosp, Univ London Kings Coll, Dept Nephrol & Transplantat, London SE1 9RT, England; Guys Hosp, Clin Transplantat Lab, London SE1 9RT, England; Kings Coll Hosp London, London, England; Kent & Canterbury Hosp, Canterbury, Kent, England; Barts & London Queen Marys Sch Med & Dent, Barts & London, Dept Clin Pharmacol, London, England; Guys & St Thomas Natl Hlth Serv Fdn Trust, Dept Histopathol, London, England; Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Dept Crystal & Struct Chem, Utrecht, Netherlands	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Kent; University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; Utrecht University	Sheerin, NS (corresponding author), Guys Hosp, Univ London Kings Coll, Dept Nephrol & Transplantat, 5th Fl,Thomas Guy House, London SE1 9RT, England.	neil.sheerin@kcl.ac.uk	Gros, Piet/I-5569-2016; Janssen, Bert/I-3338-2016; Gros, Piet/AAD-6452-2019	Gros, Piet/0000-0002-7782-2585; Janssen, Bert/0000-0002-8101-8370; Gros, Piet/0000-0002-7782-2585; Farmer, Christopher/0000-0003-1736-8242; Sacks, Steven/0000-0001-6361-9095; Johnston, Atholl/0000-0001-5787-2270	MRC [G0000771] Funding Source: UKRI; Medical Research Council [G0000771] Funding Source: Medline; Wellcome Trust [066800-Z-02-2] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aftali B, 2005, TRANSPLANTATION, V79, P304, DOI 10.1097/01.TP.0000151145.12706.2A; ALPER CA, 1968, J CLIN INVEST, V47, P2181, DOI 10.1172/JCI105904; Andrews PA, 1995, TRANSPLANTATION, V60, P1342; [Anonymous], 2004, 2004 ANN REP US ORG; ARVILOMMI H, 1974, NATURE, V251, P740, DOI 10.1038/251740a0; Barton MK, 2001, GENOME BIOL, V2; Bostom AG, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022011.35035.F3; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; ERDEI A, 1991, IMMUNOL TODAY, V12, P332, DOI 10.1016/0167-5699(91)90011-H; Exner M, 2004, TRANSPLANTATION, V77, P538, DOI 10.1097/01.TP.0000113467.36269.F8; FEUCHT HE, 1993, KIDNEY INT, V43, P1333, DOI 10.1038/ki.1993.187; FINN JE, 1993, CLIN EXP IMMUNOL, V91, P410; FINN JE, 1994, NEPHROL DIAL TRANSPL, V9, P1564; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Hoffmann S, 2004, KIDNEY INT, V66, P1686, DOI 10.1111/j.1523-1755.2004.00936.x; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; KOCH C, 1986, IMMUNOGENETICS, V23, P322, DOI 10.1007/BF00398796; Li K, 2004, J AM SOC NEPHROL, V15, P2414, DOI 10.1097/01.ASN.0000135974.06478.7B; MCLEAN RH, 1984, J PEDIATR-US, V105, P179, DOI 10.1016/S0022-3476(84)80110-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Naughton MA, 1996, J IMMUNOL, V156, P3051; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Paul LC, 1999, KIDNEY INT, V56, P783, DOI 10.1046/j.1523-1755.1999.00611.x; POZNANSKY MC, 1989, J IMMUNOL, V143, P1254; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Pratt JR, 2000, AM J PATHOL, V157, P825, DOI 10.1016/S0002-9440(10)64596-8; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; RAMBAUSEK M, 1987, Nephrology Dialysis Transplantation, V2, P208; Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6; Sacks SH, 2002, CURR OPIN NEPHROL HY, V11, P627, DOI 10.1097/00041552-200211000-00009; Tang S, 1999, J IMMUNOL, V162, P4336; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zhou WD, 2006, BLOOD, V107, P2461, DOI 10.1182/blood-2005-08-3144; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	35	137	139	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2014	2023		10.1056/NEJMoa052825	http://dx.doi.org/10.1056/NEJMoa052825			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687714	Green Published			2022-12-28	WOS:000237413100006
J	Haggarty, P; McCallum, H; McBain, H; Andrews, K; Duthie, S; McNeill, G; Templeton, A; Haites, N; Campbell, D; Bhattachayra, S				Haggarty, P; McCallum, H; McBain, H; Andrews, K; Duthie, S; McNeill, G; Templeton, A; Haites, N; Campbell, D; Bhattachayra, S			Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study	LANCET			English	Article							EARLY-PREGNANCY LOSS; FOLIC-ACID; TWIN PREGNANCY; HYPERHOMOCYSTEINEMIA; METHYLATION; WOMEN; RISK	Background There is a need to understand what affects the success of in-vitro fertilisation (IVF) and the rate of resulting twin births so that pregnancy rates can be improved and multiple gestations avoided. Our aim was to assess the role of B vitamins and genetics. Methods We did a prospective cohort study of 602 women undergoing fertility treatment. We assessed intake of folate and vitamin B12 with a questionnaire and measured their plasma and red-blood-cell concentrations by radioimmunoassay. We measured five B-vitamin-related gene variants in women who received treatment and in 932 women who conceived naturally. Findings The likelihood of a twin birth after IVF rose with increased concentrations of plasma folate (1.52, 1.01-2.28; p=0.032) and red-cell folate (1.28, 1.00-1.65; p=0.039). There was no association between folate and vitamin B12 levels and likelihood of a successful pregnancy. Women homozygous for the 1298 CC variant of methylenetetrahydrofolate reductase (MTHFR), rather than the AA variant, were less likely to produce a livebirth after IVF (0.24, 0.08-0.71; p=0.003) or to have had a previous pregnancy (0.42, 0.21-0.81; p=0.008). Interpretation Our findings suggest that MTHFR genotype is linked to a woman's potential to produce healthy embryos (possibly through interaction with genes related to DNA methylation). In women likely to have a successful IVF pregnancy, high folate status increases the likelihood of twin birth after multiple embryo transfer. Proposals to fortify the UK diet with folic acid could lead to an increase in the number of twins born after IVF.	Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Dept Occupat & Environm Med, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Dept Med Genet, Aberdeen AB25 2ZD, Scotland; Rowett Res Inst, Nutr & Epigenet Grp, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen	Haggarty, P (corresponding author), Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen AB25 2ZD, Scotland.	p.haggarty@abdn.ac.uk	Haggarty, Paul/C-1696-2009	Duthie, Susan/0000-0002-7990-4437				Andersen AN, 2004, HUM REPROD, V19, P490, DOI 10.1093/humrep/deh129; Azem F, 2004, HUM REPROD, V19, P368, DOI 10.1093/humrep/deh069; Berry RJ, 2005, BMJ-BRIT MED J, V330, P815, DOI 10.1136/bmj.38369.437789.82; Bhattacharya S, 2001, LANCET, V357, P2075, DOI 10.1016/S0140-6736(00)05179-5; Campbell DM, 2004, INT J GYNECOL OBSTET, V84, P71, DOI 10.1016/S0020-7292(03)00314-X; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; *CDCP, 2002, ASS REPR TECHN SUCC; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Committee on Medical Aspects of Food and Nutrition Policy, 2000, FOL AC PREV DIS; Copyright &COPY;, 2004, NAT I HLTH CLIN EXC; Czeizel AE, 2004, AM J OBSTET GYNECOL, V191, P790, DOI 10.1016/j.ajog.2004.02.018; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gosden R, 2003, LANCET, V361, P1975, DOI 10.1016/S0140-6736(03)13592-1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; *HUM FERT EMBR AUT, 2002, 11 HUM FERT EMBR AUT; Kirk KM, 2001, EVOLUTION, V55, P423; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; Masson LF, 2003, PUBLIC HEALTH NUTR, V6, P313, DOI 10.1079/PHN2002429; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Nelen WLDM, 2000, FERTIL STERIL, V74, P1196, DOI 10.1016/S0015-0282(00)01595-8; Nelen WLDM, 2000, OBSTET GYNECOL, V95, P519, DOI 10.1016/S0029-7844(99)00610-9; O'Neill C, 1998, HUM REPROD, V13, P1312, DOI 10.1093/humrep/13.5.1312; PETTERSON B, 1993, BRIT MED J, V307, P1239, DOI 10.1136/bmj.307.6914.1239; Quinlivan EP, 2003, AM J CLIN NUTR, V77, P221, DOI 10.1093/ajcn/77.1.221; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; te Velde ER, 2000, LANCET, V355, P1928, DOI 10.1016/S0140-6736(00)02320-5; Templeton A, 1996, LANCET, V348, P1402, DOI 10.1016/S0140-6736(96)05291-9; TEMPLETON A, 1998, EVIDENCE BASED FERTI, P265; van Rumste MM, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001301	29	108	113	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1513	1519		10.1016/S0140-6736(06)68651-0	http://dx.doi.org/10.1016/S0140-6736(06)68651-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679164				2022-12-28	WOS:000237324200031
J	Banziger, C; Soldini, D; Schutt, C; Zipperlen, P; Hausmann, G; Basler, K				Banziger, Carla; Soldini, Davide; Schuett, Corina; Zipperlen, Peder; Hausmann, George; Basler, Konrad			Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells	CELL			English	Article							LONG-RANGE ACTION; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; WINGLESS SIGNAL; POLARITY; ENCODES; PATHWAY; MECHANISMS; GLYPICANS; TRANSDUCE	Cell-cell communication via Wnt signals represents a fundamental means by which animal development and homeostasis are controlled. The identification of components of the Wnt pathway is reaching saturation for the transduction process in receiving cells but is incomplete concerning the events occurring in Wnt-secreting cells. Here, we describe the discovery of a novel Wnt pathway component, Wntless (Wls/Evi), and show that it is required for Wingless-dependent patterning processes in Drosophila, for MOM-2-governed polarization of blastomeres; in C. elegans, and for Wnt3a-mediated communication between cultured human cells. In each of these cases, Wls is acting in the Wnt-sending cells to promote the secretion of Wnt proteins. Since loss of Wls function has no effect on other signaling pathways yet appears to impede all the Wnt signals we analyzed, we propose that Wls represents an ancient partner for Writs dedicated to promoting their secretion into the extracellular milieu.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; PhD Program Mol Life Sci, Zurich, Switzerland; Genet Co Inc, CH-8952 Schlieren, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.unizh.ch		Basler, Konrad/0000-0003-3534-1529				Baeg GH, 2001, DEVELOPMENT, V128, P87; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Blair SS, 2005, CURR BIOL, V15, pR92, DOI 10.1016/j.cub.2005.01.026; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; COUSO JP, 1994, DEVELOPMENT, V120, P621; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; DINARDO S, 1988, NATURE, V332, P604, DOI 10.1038/332604a0; Eisenmann DM, 2000, GENETICS, V156, P1097; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Gerlitz O, 2002, INT J DEV BIOL, V46, P173; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jiang LI, 1999, DEV BIOL, V211, P88, DOI 10.1006/dbio.1999.9293; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kozopas KM, 1998, GENE DEV, V12, P1155, DOI 10.1101/gad.12.8.1155; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Millar JBA, 2002, GENOME BIOL, V3; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; PEIFER M, 1991, DEVELOPMENT, V111, P1029; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	43	528	547	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					509	522		10.1016/j.cell.2006.02.049	http://dx.doi.org/10.1016/j.cell.2006.02.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678095	Bronze			2022-12-28	WOS:000237506100017
J	Albert, J; Aliu, E; Anderhub, H; Antoranz, P; Armada, A; Asensio, M; Baixeras, C; Barrio, JA; Bartelt, M; Bartko, H; Bastieri, D; Bavikadi, SR; Bednarek, W; Berger, K; Bigongiari, C; Biland, A; Bisesi, E; Bock, RK; Bordas, P; Bosch-Ramon, V; Bretz, T; Britvitch, I; Camara, M; Carmona, E; Chilingarian, A; Ciprini, S; Coarasa, JA; Commichau, S; Contreras, JL; Cortina, J; Curtef, V; Danielyan, V; Dazzi, F; De Angelis, A; de los Reyes, R; De Lotto, B; Domingo-Santamaria, E; Dorner, D; Doro, M; Errando, M; Fagiolini, M; Ferenc, D; Fernandez, E; Firpo, R; Flix, J; Fonseca, MV; Font, L; Fuchs, M; Galante, N; Garczarczyk, M; Gaug, M; Giller, M; Goebel, F; Hakobyan, D; Hayashida, M; Hengstebeck, T; Hohne, D; Hose, J; Hsu, CC; Isar, PG; Jacon, P; Kalekin, O; Kosyra, R; Kranich, D; Laatiaoui, M; Laille, A; Lenisa, T; Liebing, P; Lindfors, E; Lombardi, S; Longo, F; Lopez, J; Lopez, M; Lorenz, E; Lucarelli, F; Majumdar, P; Maneva, G; Mannheim, K; Mansutti, O; Mariotti, M; Martinez, M; Mase, K; Mazin, D; Merck, C; Meucci, M; Meyer, M; Miranda, JM; Mirzoyan, R; Mizobuchi, S; Moralejo, A; Nilsson, K; Ona-Wilhelmi, E; Orduna, R; Otte, N; Oya, I; Paneque, D; Paoletti, R; Paredes, JM; Pasanen, M; Pascoli, D; Pauss, F; Pavel, N; Pegna, R; Persic, M; Peruzzo, L; Piccioli, A; Poller, M; Pooley, G; Prandini, E; Raymers, A; Rhode, W; Ribo, M; Rico, J; Riegel, B; Rissi, M; Robert, A; Romero, GE; Rugamer, S; Saggion, A; Sanchez, A; Sartori, P; Scalzotto, V; Scapin, V; Schmitt, R; Schweizer, T; Shayduk, M; Shinozaki, K; Shore, SN; Sidro, N; Sillanpaa, A; Sobczynska, D; Stamerra, A; Stark, LS; Takalo, L; Temnikov, P; Tescaro, D; Teshima, M; Tonello, N; Torres, A; Torres, DF; Turini, N; Vankov, H; Vitale, V; Wagner, RM; Wibig, T; Wittek, W; Zanin, R; Zapatero, J				Albert, J.; Aliu, E.; Anderhub, H.; Antoranz, P.; Armada, A.; Asensio, M.; Baixeras, C.; Barrio, J. A.; Bartelt, M.; Bartko, H.; Bastieri, D.; Bavikadi, S. R.; Bednarek, W.; Berger, K.; Bigongiari, C.; Biland, A.; Bisesi, E.; Bock, R. K.; Bordas, P.; Bosch-Ramon, V.; Bretz, T.; Britvitch, I.; Camara, M.; Carmona, E.; Chilingarian, A.; Ciprini, S.; Coarasa, J. A.; Commichau, S.; Contreras, J. L.; Cortina, J.; Curtef, V.; Danielyan, V.; Dazzi, F.; De Angelis, A.; Reyes, R. de los; De Lotto, B.; Domingo-Santamaria, E.; Dorner, D.; Doro, M.; Errando, M.; Fagiolini, M.; Ferenc, D.; Fernandez, E.; Firpo, R.; Flix, J.; Fonseca, M. V.; Font, L.; Fuchs, M.; Galante, N.; Garczarczyk, M.; Gaug, M.; Giller, M.; Goebel, F.; Hakobyan, D.; Hayashida, M.; Hengstebeck, T.; Hoehne, D.; Hose, J.; Hsu, C. C.; Isar, P. G.; Jacon, P.; Kalekin, O.; Kosyra, R.; Kranich, D.; Laatiaoui, M.; Laille, A.; Lenisa, T.; Liebing, P.; Lindfors, E.; Lombardi, S.; Longo, F.; Lopez, J.; Lopez, M.; Lorenz, E.; Lucarelli, F.; Majumdar, P.; Maneva, G.; Mannheim, K.; Mansutti, O.; Mariotti, M.; Martinez, M.; Mase, K.; Mazin, D.; Merck, C.; Meucci, M.; Meyer, M.; Miranda, J. M.; Mirzoyan, R.; Mizobuchi, S.; Moralejo, A.; Nilsson, K.; Ona-Wilhelmi, E.; Orduna, R.; Otte, N.; Oya, I.; Paneque, D.; Paoletti, R.; Paredes, J. M.; Pasanen, M.; Pascoli, D.; Pauss, F.; Pavel, N.; Pegna, R.; Persic, M.; Peruzzo, L.; Piccioli, A.; Poller, M.; Pooley, G.; Prandini, E.; Raymers, A.; Rhode, W.; Ribo, M.; Rico, J.; Riegel, B.; Rissi, M.; Robert, A.; Romero, G. E.; Ruegamer, S.; Saggion, A.; Sanchez, A.; Sartori, P.; Scalzotto, V.; Scapin, V.; Schmitt, R.; Schweizer, T.; Shayduk, M.; Shinozaki, K.; Shore, S. N.; Sidro, N.; Sillanpaa, A.; Sobczynska, D.; Stamerra, A.; Stark, L. S.; Takalo, L.; Temnikov, P.; Tescaro, D.; Teshima, M.; Tonello, N.; Torres, A.; Torres, D. F.; Turini, N.; Vankov, H.; Vitale, V.; Wagner, R. M.; Wibig, T.; Wittek, W.; Zanin, R.; Zapatero, J.			Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303	SCIENCE			English	Article							LS-I +61-DEGREES-303; SOURCE 2CG 135+01; X-RAY; STAR LSI+61-DEGREES-303; LIGHT-CURVE; BINARY; I+61-DEGREES-303; LS-I+61-303; PARAMETERS; DISCOVERY	Microquasars are binary star systems with relativistic radio-emitting jets. They are potential sources of cosmic rays and can be used to elucidate the physics of relativistic jets. We report the detection of variable gamma-ray emission above 100 gigaelectron volts from the microquasar LSI+61 303. Six orbital cycles were recorded. Several detections occur at a similar orbital phase, which suggests that the emission is periodic. The strongest gamma-ray emission is not observed when the two stars are closest to one another, implying a strong orbital modulation of the emission or absorption processes.	Inst Fis Altes Energies, E-08193 Barcelona, Spain; Univ Wurzburg, D-97074 Wurzburg, Germany; ETH, CH-8093 Zurich, Switzerland; Univ Complutense, E-28040 Madrid, Spain; Univ Autonoma Barcelona, E-08193 Barcelona, Spain; Univ Dortmund, D-44227 Dortmund, Germany; Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; Univ Padua, I-35131 Padua, Italy; Ist Nazl Fis Nucl, I-35131 Padua, Italy; Univ Udine, I-33100 Udine, Italy; INFN Trieste, I-33100 Udine, Italy; Univ Lodz, PL-90236 Lodz, Poland; Univ Barcelona, E-08028 Barcelona, Spain; Yerevan Phys Inst, Yerevan 375036, Armenia; Tuorla Observ, FI-21500 Piikkio, Finland; Univ Siena, I-53100 Siena, Italy; INFN Pisa, I-53100 Siena, Italy; Univ Calif Davis, Davis, CA 95616 USA; Humboldt Univ, D-12489 Berlin, Germany; Univ Trieste, I-34100 Trieste, Italy; Ist Nazl Fis Nucl, I-34100 Trieste, Italy; Inst Nucl Energy Res, BG-1784 Sofia, Bulgaria; Osserv Astron Trieste, I-34100 Trieste, Italy; Univ Cambridge, Cavendish Lab, Cambridge CB3 OHE, England; Natl Univ La Plata, Fac Ciencias Astron & Geofis, RA-1900 La Plata, Argentina; Inst Argentino Radioastron CC5, RA-1894 Villa Elisa, Argentina; Univ Pisa, I-56100 Pisa, Italy; Ist Nazl Fis Nucl, I-56100 Pisa, Italy; CSIC, Inst Ciencies Espai, E-08193 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); University of Wurzburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Complutense University of Madrid; Autonomous University of Barcelona; Dortmund University of Technology; Max Planck Society; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); University of Lodz; University of Barcelona; Yerevan Physics Institute; University of Turku; University of Siena; Istituto Nazionale di Fisica Nucleare (INFN); University of California System; University of California Davis; Humboldt University of Berlin; University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); Bulgarian Academy of Sciences; Istituto Nazionale Astrofisica (INAF); University of Cambridge; National University of La Plata; Instituto Argentino de Radioastronomia; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE)	Rico, J (corresponding author), Inst Fis Altes Energies, E-08193 Barcelona, Spain.	jrico@ifae.es; nsidro@ifae.es	Otte, Adam Nepomuk/L-4638-2019; Fernandez, Enrique/L-5387-2014; De Angelis, Alessandro/B-5372-2009; Cortina, Juan/C-2783-2017; Coma, Pol Bordas/AAA-2332-2020; Bosch-Ramon, Valenti/E-5274-2016; González, Jose Luis Contreras/K-7255-2014; Antoranz, Pedro/H-5095-2015; Tonello, Nadia/L-8065-2014; López-Moya, Marcos/L-2304-2014; Wibig, Tadeusz/GLV-0635-2022; Ribó, Marc/B-3579-2015; Flix, Josep/G-5414-2012; Miranda, Jose/HCI-6099-2022; Rodríguez, Manel Martínez/C-2539-2017; González, María Victoria Fonseca/E-8093-2019; Gonzalez, María Victoria Fonseca MV Fonseca/I-2004-2015; Bastieri, Denis/AAC-5917-2020; Barrio, Juan A/L-3227-2014; Torres, Diego F./AAF-7931-2019; Torres, Diego F/ABD-7940-2020; Chilingarian, Ashot/B-1901-2014; Maneva, Galina M/L-7120-2016; Isar, Paula Gina/B-5808-2011; de Ona Wilhelmi, Emma/U-5587-2017; Torres, Diego F./O-9422-2016; Bretz, Thomas/AAK-8726-2020; Fernández, Ester/K-9734-2014; Laatiaoui, Mustapha/Q-6295-2016; Mazin, Daniel/N-8038-2016; Gaug, Markus/L-2340-2014; Bisesi, Erica/AAL-9712-2020; Mannheim, Karl/F-6705-2012; Font, Lluís/L-4197-2014; Doro, Michele/F-9458-2012; Rico, Javier/K-8004-2014; Temnikov, Petar P./L-6999-2016; Miranda, Jose Miguel/F-2913-2013; Olaizola, Abelardo Moralejo/M-2916-2014; ZANIN, Roberta/B-2316-2018; Lombardi, Saverio/Q-2818-2018	Otte, Adam Nepomuk/0000-0002-5955-6383; Fernandez, Enrique/0000-0002-6405-9488; Cortina, Juan/0000-0003-4576-0452; Coma, Pol Bordas/0000-0002-0266-8536; Bosch-Ramon, Valenti/0000-0002-6043-5079; González, Jose Luis Contreras/0000-0001-7282-2394; Antoranz, Pedro/0000-0002-3015-3601; Tonello, Nadia/0000-0003-0550-1667; López-Moya, Marcos/0000-0002-8791-7908; Wibig, Tadeusz/0000-0002-2078-0580; Ribó, Marc/0000-0002-9931-4557; Flix, Josep/0000-0003-2688-8047; Rodríguez, Manel Martínez/0000-0002-9763-9155; González, María Victoria Fonseca/0000-0003-2235-0725; Gonzalez, María Victoria Fonseca MV Fonseca/0000-0003-2235-0725; Bastieri, Denis/0000-0002-6954-8862; Barrio, Juan A/0000-0002-0965-0259; Torres, Diego F./0000-0002-1522-9065; Chilingarian, Ashot/0000-0002-2018-9715; Maneva, Galina M/0000-0002-5959-4179; de Ona Wilhelmi, Emma/0000-0002-5401-0744; Torres, Diego F./0000-0002-1522-9065; Bretz, Thomas/0000-0002-3800-5531; Laatiaoui, Mustapha/0000-0003-0105-8303; Mazin, Daniel/0000-0002-2010-4005; Gaug, Markus/0000-0001-8442-7877; Font, Lluís/0000-0003-2109-5961; Doro, Michele/0000-0001-9104-3214; Rico, Javier/0000-0003-4137-1134; Temnikov, Petar P./0000-0002-9559-3384; Miranda, Jose Miguel/0000-0002-1472-9690; Olaizola, Abelardo Moralejo/0000-0002-1344-9080; Bednarek, Wlodek/0000-0003-0605-108X; Bartelt, Matthias/0000-0003-4239-3490; ZANIN, Roberta/0000-0001-6320-1801; Lombardi, Saverio/0000-0002-6336-865X; Persic, Massimo/0000-0003-1853-4900; Oya, Igor/0000-0002-3881-9324; Turini, Nicola/0000-0002-9395-5230; Bigongiari, Ciro/0000-0003-3293-8522; Paredes, Josep M./0000-0002-1566-9044; Paoletti, Riccardo/0000-0003-0158-2826; Stamerra, Antonio/0000-0002-9430-5264; de los Reyes Lopez, Raquel/0000-0003-0485-9552; Lucarelli, Fabrizio/0000-0002-6311-764X; Mansutti, Oriana/0000-0001-5758-4658; Ciprini, Stefano/0000-0002-0712-2479; Bisesi, Erica/0000-0003-3939-2913; Dazzi, Francesco/0000-0001-5409-6544; De Lotto, Barbara/0000-0003-3624-4480; Rhode, Wolfgang/0000-0003-2636-5000; Sobczynska, Dorota/0000-0003-4973-7903; Errando, Manel/0000-0002-1853-863X; Prandini, Elisa/0000-0003-4502-9053; Hsu, Ching-Cheng/0000-0001-9406-2023; Romero, Gustavo E./0000-0002-5260-1807				Aharonian F, 2005, SCIENCE, V309, P746, DOI 10.1126/science.1113764; Albert J, 2006, ASTROPHYS J, V637, pL41, DOI 10.1086/500364; Albert J, 2006, ASTROPHYS J, V638, pL101, DOI 10.1086/501164; Atoyan AM, 1999, MON NOT R ASTRON SOC, V302, P253, DOI 10.1046/j.1365-8711.1999.02172.x; Bednarek W, 2006, MON NOT R ASTRON SOC, V368, P579, DOI 10.1111/j.1365-2966.2006.10121.x; Bosch-Ramon V, 2006, ASTRON ASTROPHYS, V447, P263, DOI 10.1051/0004-6361:20053633; Bosch-Ramon V, 2004, ASTRON ASTROPHYS, V425, P1069, DOI 10.1051/0004-6361:20041185; Casares J, 2005, MON NOT R ASTRON SOC, V360, P1105, DOI 10.1111/j.1365-2966.2005.09106.x; Dubus G, 2006, ASTRON ASTROPHYS, V451, P9, DOI 10.1051/0004-6361:20054233; Fegan SJ, 2005, ASTROPHYS J, V624, P638, DOI 10.1086/429123; FRAIL DA, 1991, ASTRON J, V101, P2126, DOI 10.1086/115833; GOLDONI P, 1995, ASTRON ASTROPHYS, V299, P751; Gregory PC, 2002, ASTROPHYS J, V575, P427, DOI 10.1086/341257; GREGORY PC, 1978, NATURE, V272, P704, DOI 10.1038/272704a0; Harrison FA, 2000, ASTROPHYS J, V528, P454, DOI 10.1086/308157; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; Heinz S, 2002, ASTRON ASTROPHYS, V390, P751, DOI 10.1051/0004-6361:20020615; HERMSEN W, 1977, NATURE, V269, P494, DOI 10.1038/269494a0; HUTCHINGS JB, 1981, PUBL ASTRON SOC PAC, V93, P486, DOI 10.1086/130863; Kniffen DA, 1997, ASTROPHYS J, V486, P126, DOI 10.1086/304490; Maraschi L., 1981, MNRAS, V194, P1; MARTI J, 1995, ASTRON ASTROPHYS, V298, P151; Massi M, 2004, ASTRON ASTROPHYS, V422, P267, DOI 10.1051/0004-6361:20047145; Massi M, 2004, ASTRON ASTROPHYS, V414, pL1, DOI 10.1051/0004-6361:20031760; Massi M, 2001, ASTRON ASTROPHYS, V376, P217, DOI 10.1051/0004-6361:20010953; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; PAREDES JM, 1990, ASTRON ASTROPHYS, V232, P377; Paredes JM, 2000, SCIENCE, V288, P2340, DOI 10.1126/science.288.5475.2340; Rolke WA, 2005, NUCL INSTRUM METH A, V551, P493, DOI 10.1016/j.nima.2005.05.068; Romero GE, 2005, ASTROPHYS J, V632, P1093, DOI 10.1086/444446; Romero GE, 2003, ASTRON ASTROPHYS, V410, pL1, DOI [10.1051/0004-6361:20031314-1, 10.1051/0004-6361:20031314]; Tavani M, 1998, ASTROPHYS J, V497, pL89, DOI 10.1086/311281; Taylor AR, 1996, ASTRON ASTROPHYS, V305, P817	33	333	334	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1771	1773		10.1126/science.1128177	http://dx.doi.org/10.1126/science.1128177			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16709745	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000238452800050
J	Hebting, Y; Schaeffer, P; Behrens, A; Adam, P; Schmitt, G; Schneckenburger, P; Bernasconi, SM; Albrecht, P				Hebting, Y.; Schaeffer, P.; Behrens, A.; Adam, P.; Schmitt, G.; Schneckenburger, P.; Bernasconi, S. M.; Albrecht, P.			Biomarker evidence for a major preservation pathway of sedimentary organic carbon	SCIENCE			English	Article							GREEN RIVER SHALE; PHOTOSYNTHETIC BACTERIA; NATURAL ENVIRONMENTS; SULFUR BACTERIA; BETA-CAROTENE; LAKE CADAGNO; REDUCTION; MATTER; THIOLS; DERIVATIVES	Hydrogenation processes leading from biomolecules to fossil biomarkers in anoxic sediments are crucial for the preservation of organic matter. However, these processes are still poorly understood. The present identification of several reduced carotenoids in recent sediments attests that these processes operate at the earliest stages of diagenesis without structural or stereochemical specificity, implying a nonbiological reduction pathway. Sulfur species ( e. g., H 2 S) are the hydrogen donors involved in such reduction, as demonstrated with laboratory experiments. These reactions allow the preservation of abundant organic carbon in the rock record.	Univ Strasbourg 1, Ecole Chim Polymeres Mat Strasbourg, UMR 7509, CNRS,Lab Geochim Bioorgan, F-67200 Strasbourg, France; Swiss Fed Inst Technol, Inst Geol, CH-8092 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Albrecht, P (corresponding author), Univ Strasbourg 1, Ecole Chim Polymeres Mat Strasbourg, UMR 7509, CNRS,Lab Geochim Bioorgan, 25 Rue Becquerel, F-67200 Strasbourg, France.	albrecht@chimie.u-strasbg.fr	Bernasconi, Stefano M/E-5394-2010	Bernasconi, Stefano M/0000-0001-7672-8856				Adam P, 2000, GEOCHIM COSMOCHIM AC, V64, P3485, DOI 10.1016/S0016-7037(00)00443-9; ADAM P, 1993, GEOCHIM COSMOCHIM AC, V57, P3395, DOI 10.1016/0016-7037(93)90547-A; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Burhan RYP, 2002, GEOCHIM COSMOCHIM AC, V66, P4085, DOI 10.1016/S0016-7037(02)00979-1; Cody GD, 2000, SCIENCE, V289, P1337, DOI 10.1126/science.289.5483.1337; Damste JSS, 1997, PURE APPL CHEM, V69, P2067, DOI 10.1351/pac199769102067; Del Don C, 2001, AQUAT SCI, V63, P70, DOI 10.1007/PL00001345; Elsner M, 2004, ENVIRON SCI TECHNOL, V38, P799, DOI 10.1021/es0345569; HARTGERS WA, 1994, ORG GEOCHEM, V22, P703, DOI 10.1016/0146-6380(94)90134-1; HARTGERS WA, 1993, J CHEM SOC CHEM COMM, P1715, DOI 10.1039/c39930001715; Hebting Y, 2003, ORG LETT, V5, P1571, DOI 10.1021/ol034374j; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; HUNT JM, 1996, PETROLEUM GEOCHEMIST, P60; Koopmans MP, 1997, ORG GEOCHEM, V26, P451, DOI 10.1016/S0146-6380(97)00025-9; MAYER R, 1963, ANGEW CHEM, V21, P1011; MEISSNER JWG, 1994, TETRAHEDRON LETT, V35, P2757, DOI 10.1016/S0040-4039(00)77025-0; MURPHY MTJ, 1967, SCIENCE, V157, P1040, DOI 10.1126/science.157.3792.1040; NISHIMURA M, 1978, GEOCHIM COSMOCHIM AC, V42, P349, DOI 10.1016/0016-7037(78)90265-X; Peters K.E., 2005, BIOMARKER GUIDE; Putschew A, 1998, ORG GEOCHEM, V29, P1849, DOI 10.1016/S0146-6380(98)00170-3; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Schaeffer P, 1997, TETRAHEDRON LETT, V38, P8413, DOI 10.1016/S0040-4039(97)10235-0; Schaefle J., 1977, TETRAHEDRON LETT, V18, P3673, DOI [DOI 10.1016/S0040-4039(01)83324-4, 10.1016/S0040-4039(01)83324-4]; Schneckenburger P, 1998, TETRAHEDRON LETT, V39, P447, DOI 10.1016/S0040-4039(97)10572-X; SCHWARZENBACH RP, 1990, ENVIRON SCI TECHNOL, V24, P1566, DOI 10.1021/es00080a017; SINNINGHEDAMSTE JS, 1989, GEOCHIM COSMOCHIM AC, V53, P1343; Tonolla M, 2005, APPL ENVIRON MICROB, V71, P3544, DOI 10.1128/AEM.71.7.3544-3550.2005; WAKEHAM SG, 1989, NATURE, V342, P787, DOI 10.1038/342787a0; WATTS CD, 1977, GEOCHIM COSMOCHIM AC, V41, P493, DOI 10.1016/0016-7037(77)90287-3; Zuallig H., 1985, SCHWEIZ Z HYDROL, V47, P87, DOI 10.1007/BF02551937	31	112	123	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1627	1631		10.1126/science.1126372	http://dx.doi.org/10.1126/science.1126372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16690819				2022-12-28	WOS:000238288600038
J	Bampton, PA; Schloithe, A; Bull, J; Fraser, RJ; Padbury, RTA; Watson, DI				Bampton, Peter A.; Schloithe, Anne; Bull, Jeff; Fraser, Robert J.; Padbury, Rob T. A.; Watson, David I.			Quality improvement report - Improving surveillance for Barrett's oesophagus	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADENOCARCINOMA; GUIDELINES; RISK	Problem A retrospective audit of surveillance for Barrett's oesophagus 1996-2001 identified the need to improve adherence to guidelines for the endoscopic surveillance of patients with Barrett's oesophagus. Design Prospective audit of the effect of disseminating guidelines in 2002. Prospective audit of the effect of introducing local guidelines and Barrett's oesophagus surveillance officers, 2003-2005. Setting Two general hospitals in Australia, 2002-5. All adult patients diagnosed with Barrett's oesophagus were included. Key measures for improvement Proportions of patients in a Barrett's oesophagus surveillance programme who had-appropriate time intervals between follow-up endoscopies and who had appropriate numbers of biopsies collected at endoscopy. Strategies for change Local guidelines were laid down. Surveillance coordinators for Barrett's oesophagus were introduced to manage the process according to a clinical protocol designed for each patient. Effects of change Disseminating guidelines had little effect on practice. Six months after surveillance coordinators were introduced, adherence to the planned surveillance interval increased from 17% to 92% and the number of endoscopies at which sufficient biopsies were collected increased from 45% to 83%. These changes have been maintained. Lessons learnt Disseminating guidelines and results of an audit on endoscopic surveillance in Barrett's oesophagus had no effect on practice. Introducing coordinators who proactively managed the process greatly improved adherence to guidelines.	Flinders Med Ctr, Dept Gastroenterol & Hepatol, Bedford Pk, SA 5042, Australia; Flinders Univ S Australia, Dept Surg, Bedford Pk, SA 5042, Australia; Flinders Med Ctr, Div Surg & Specialty Serv, Bedford Pk, SA 5042, Australia; Repatriat Gen Hosp, Invest & Procedure Unit, Daw Pk, SA 5042, Australia; Repatriat Gen Hosp, Dept Gastroenterol, Daw Pk, SA 5042, Australia	Flinders Medical Centre; Flinders University South Australia; Flinders Medical Centre	Bampton, PA (corresponding author), Flinders Med Ctr, Dept Gastroenterol & Hepatol, Bedford Pk, SA 5042, Australia.	Peter.bampton@flinders.edu.au	Watson, David/W-8280-2019	Watson, David/0000-0002-7683-2693				[Anonymous], GUID DIAGN MAN BARR; Bampton PA, 2002, MED J AUSTRALIA, V176, P155, DOI 10.5694/j.1326-5377.2002.tb04344.x; Basu KK, 2004, EUR J GASTROEN HEPAT, V16, P171, DOI 10.1097/00042737-200402000-00008; Bulkley G, 2000, J GASTROINTEST SURG, V4, P115; Fountoulakis A, 2004, BRIT J SURG, V91, P997, DOI 10.1002/bjs.4591; Jankowski JA, 2002, GASTROENTEROLOGY, V122, P588, DOI 10.1053/gast.2002.31599; Mandal A, 2003, ALIMENT PHARM THER, V17, P1319, DOI 10.1046/j.1365-2036.2003.01586.x; MIROS M, 1991, GUT, V32, P1441, DOI 10.1136/gut.32.12.1441; PETERS JH, 1994, J THORAC CARDIOV SUR, V108, P813, DOI 10.1016/S0022-5223(94)70178-4; Ramnath G, 2004, MED J AUSTRALIA, V180, P139, DOI 10.5694/j.1326-5377.2004.tb05840.x; Sampliner RE, 1998, AM J GASTROENTEROL, V93, P1028; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; van Sandick JW, 1998, GUT, V43, P216, DOI 10.1136/gut.43.2.216	13	32	32	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1320	1323		10.1136/bmj.332.7553.1320	http://dx.doi.org/10.1136/bmj.332.7553.1320			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16740562	Green Published			2022-12-28	WOS:000238197000026
J	Fujiwara, A; Kawaguchi, J; Yeomans, DK; Abe, M; Mukai, T; Okada, T; Saito, J; Yano, H; Yoshikawa, M; Scheeres, DJ; Barnouin-Jha, O; Cheng, AF; Demura, H; Gaskell, RW; Hirata, N; Ikeda, H; Kominato, T; Miyamoto, H; Nakamura, AM; Nakamura, R; Sasaki, S; Uesugi, K				Fujiwara, A.; Kawaguchi, J.; Yeomans, D. K.; Abe, M.; Mukai, T.; Okada, T.; Saito, J.; Yano, H.; Yoshikawa, M.; Scheeres, D. J.; Barnouin-Jha, O.; Cheng, A. F.; Demura, H.; Gaskell, R. W.; Hirata, N.; Ikeda, H.; Kominato, T.; Miyamoto, H.; Nakamura, A. M.; Nakamura, R.; Sasaki, S.; Uesugi, K.			The rubble-pile asteroid Itokawa as observed by Hayabusa	SCIENCE			English	Article							1998 SF36; DISRUPTION; SPACECRAFT; CRATERS; IMAGES; SHAPE; POLE	During the interval from September through early December 2005, the Hayabusa spacecraft was in close proximity to near-Earth asteroid 25143 Itokawa, and a variety of data were taken on its shape, mass, and surface topography as well as its mineralogic and elemental abundances. The asteroid's orthogonal axes are 535, 294, and 209 meters, the mass is 3.51 x 10(10) kilograms, and the estimated bulk density is 1.9 +/- 0.13 grams per cubic centimeter. The correspondence between the smooth areas on the surface ( Muses Sea and Sagamihara) and the gravitationally low regions suggests mass movement and an effective resurfacing process by impact jolting. Itokawa is considered to be a rubble-pile body because of its low bulk density, high porosity, boulder-rich appearance, and shape. The existence of very large boulders and pillars suggests an early collisional breakup of a preexisting parent asteroid followed by a re-agglomeration into a rubble-pile object.	JAXA, ISAS, Kanagawa 2298510, Japan; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Aizu Univ, Sch Comp Sci & Engn, Fukushima 9658580, Japan; NEC Aerosp Syst Ltd, Kanagawa 2240053, Japan; Univ Tokyo, Dept Geosyst Engn, Tokyo 1138656, Japan; Natl Inst Adv Ind Sci & Technol, GTRC, Tsukuba, Ibaraki 3058568, Japan; Natl Astron Observ Japan, Mizusawa Astrodynam Observ, Mizusawa, Iwate 0230861, Japan	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Kobe University; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Aizu; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Fujiwara, A (corresponding author), JAXA, ISAS, 3-1-1 Yoshinodai, Kanagawa 2298510, Japan.	fujiwara@planeta.sci.isas.jaxa.jp	Miyamoto, Hideaki/B-9666-2008; Nakamura, Akiko M/I-1993-2012; Nakamura, Akiko/AAC-4191-2020; Barnouin, Olivier S/I-7475-2015; Miyamoto, Hideaki/E-3381-2012; Sasaki, Sho/S-3845-2019	Miyamoto, Hideaki/0000-0001-8013-6124; Nakamura, Akiko M/0000-0001-6990-8496; Nakamura, Akiko/0000-0001-6990-8496; Barnouin, Olivier S/0000-0002-3578-7750; Sasaki, Sho/0000-0002-7646-5248; Hirata, Naru/0000-0002-2435-604X; SCHEERES, DANIEL/0000-0003-0558-3842				Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Abe S, 2006, SCIENCE, V312, P1344, DOI 10.1126/science.1126272; Asphaug E, 1998, NATURE, V393, P437, DOI 10.1038/30911; Asphaug E, 2002, ASTEROIDS, P463; Binzel RP, 2001, METEORIT PLANET SCI, V36, P1167, DOI 10.1111/j.1945-5100.2001.tb01950.x; Britt D. T., 2002, ASTEROIDS 3, VIII, P485; Chapman CR, 2002, ICARUS, V155, P104, DOI 10.1006/icar.2001.6744; Cheng AF, 2002, METEORIT PLANET SCI, V37, P1095, DOI 10.1111/j.1945-5100.2002.tb00880.x; Demura H, 2006, SCIENCE, V312, P1347, DOI 10.1126/science.1126574; FUJIWARA A, 1993, ICARUS, V105, P345, DOI 10.1006/icar.1993.1131; GAULT DE, 1963, TND1767 NASA, P39; Kaasalainen M, 2003, ASTRON ASTROPHYS, V405, pL29, DOI 10.1051/0004-6361:20030819; Kawaguchi J, 2003, ACTA ASTRONAUT, V52, P117, DOI 10.1016/S0094-5765(02)00146-7; Lee P, 1996, ICARUS, V124, P181, DOI 10.1006/icar.1996.0197; Merline W.J., 2002, ASTEROIDS, VIII, P289; Michel P, 2005, ICARUS, V179, P291, DOI 10.1016/j.icarus.2005.07.018; Michel P, 2003, NATURE, V421, P608, DOI 10.1038/nature01364; Muller TG, 2005, ASTRON ASTROPHYS, V443, P347, DOI 10.1051/0004-6361:20053862; NAKAMURA A, 1991, ICARUS, V92, P132, DOI 10.1016/0019-1035(91)90040-Z; NISHIHARA S, 2005, LUN PLAN SCI C, V36; Ohba Y, 2003, EARTH PLANETS SPACE, V55, P341, DOI 10.1186/BF03351767; Okada T, 2006, SCIENCE, V312, P1338, DOI 10.1126/science.1125731; Ostro SJ, 2004, METEORIT PLANET SCI, V39, P407, DOI 10.1111/j.1945-5100.2004.tb00102.x; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; Scheeres DJ, 1996, ICARUS, V121, P67, DOI 10.1006/icar.1996.0072; Thomas PC, 2001, NATURE, V413, P394, DOI 10.1038/35096513; Veverka J, 1997, SCIENCE, V278, P2109, DOI 10.1126/science.278.5346.2109; Werner RA, 1996, CELEST MECH DYN ASTR, V65, P313; Whiteley RJ, 2002, ICARUS, V157, P139, DOI 10.1006/icar.2001.6796; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164	30	609	621	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1330	1334		10.1126/science.1125841	http://dx.doi.org/10.1126/science.1125841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741107				2022-12-28	WOS:000237961600040
J	Bach, PB; McClellan, MB				Bach, PB; McClellan, MB			The first months of the prescription-drug benefit - A CMS update	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Medicare, Washington, DC USA; Ctr Medicaid Serv, Washington, DC USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Bach, PB (corresponding author), Ctr Medicare, Washington, DC USA.							Bach PB, 2005, NEW ENGL J MED, V353, P2733, DOI 10.1056/NEJMp058249; FOSTER RS, 2005, COMMUNICATION; HOLTZEAKIN D, COMMUNICATION; 2005, FED REG, V70, P4468	4	28	28	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2312	2314		10.1056/NEJMp068108	http://dx.doi.org/10.1056/NEJMp068108			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738266				2022-12-28	WOS:000237918500002
J	Olendorf, R; Rodd, FH; Punzalan, D; Houde, AE; Hurt, C; Reznick, DN; Hughes, KA				Olendorf, Robert; Rodd, F. Helen; Punzalan, David; Houde, Anne E.; Hurt, Carla; Reznick, David N.; Hughes, Kimberly A.			Frequency-dependent survival in natural guppy populations	NATURE			English	Article							RETICULATA-PETERS PISCES; LIFE-HISTORY EVOLUTION; POECILIA-RETICULATA; SEXUAL SELECTION; FEMALE CHOICE; COLOR POLYMORPHISM; MATE PREFERENCE; MALE TRAITS; PREDATION; PATTERNS	The maintenance of genetic variation in traits under natural selection is a long-standing paradox in evolutionary biology(1-3). Of the processes capable of maintaining variation, negative frequency-dependent selection ( where rare types are favoured by selection) is the most powerful, at least in theory(1); however, few experimental studies have confirmed that this process operates in nature. One of the most extreme, unexplained genetic polymorphisms is seen in the colour patterns of male guppies ( Poecilia reticulata)(4,5). Here we manipulated the frequencies of males with different colour patterns in three natural populations to estimate survival rates, and found that rare phenotypes had a highly significant survival advantage compared to common phenotypes. Evidence from humans(6,7) and other species(8,9) implicates frequency-dependent survival in the maintenance of molecular, morphological and health-related polymorphisms. As a controlled manipulation in nature, this study provides unequivocal support for frequency-dependent survival - an evolutionary process capable of maintaining extreme polymorphism.	Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; Univ Illinois, Inst Genome Biol, Urbana, IL 61801 USA; Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada; Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA; Naos Marine Lab, Smithsonian Trop Res Inst, Panama City, Panama; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Toronto; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Riverside	Hughes, KA (corresponding author), Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA.	kahughes@life.uiuc.edu	Hurt, Carla/A-3284-2011	Punzalan, David/0000-0003-2105-4561; Hurt, Carla/0000-0001-5850-033X; reznick, david/0000-0002-1144-0568; Olendorf, Robert/0000-0003-3353-5637				Bond AB, 2002, NATURE, V415, P609, DOI 10.1038/415609a; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Brooks R, 2000, NATURE, V406, P67, DOI 10.1038/35017552; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Bryant MJ, 2004, AM NAT, V163, P55, DOI 10.1086/380650; Charlesworth B, 2000, EVOL GENET, P369; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; FARR JA, 1977, EVOLUTION, V31, P162, DOI 10.1111/j.1558-5646.1977.tb00993.x; FARR JA, 1980, BEHAVIOUR, V74, P38, DOI 10.1163/156853980X00311; Godin JGJ, 2003, BEHAV ECOL, V14, P194, DOI 10.1093/beheco/14.2.194; Grether GF, 2000, EVOLUTION, V54, P1712, DOI 10.1111/j.0014-3820.2000.tb00715.x; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Hughes KA, 2005, J EVOLUTION BIOL, V18, P35, DOI 10.1111/j.1420-9101.2004.00806.x; JONES JS, 1977, ANNU REV ECOL SYST, V8, P109, DOI 10.1146/annurev.es.08.110177.000545; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Littell RC, 2002, SAS LINEAR MODELS; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Punzalan D, 2005, EVOL ECOL, V19, P303, DOI 10.1007/s10682-005-2777-z; REID DG, 1987, BIOL J LINN SOC, V30, P1, DOI 10.1111/j.1095-8312.1987.tb00284.x; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; RODD FH, 1991, OIKOS, V62, P13, DOI 10.2307/3545440; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053	29	191	197	3	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					633	636		10.1038/nature04646	http://dx.doi.org/10.1038/nature04646			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738659				2022-12-28	WOS:000237920800047
J	Slaughter, LM				Slaughter, LM			Medicare Part D - The product of a broken process	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		CONNOLLY C, 2003, WASHINGTON POST 0316, pA5; PEAR R, 2003, NY TIMES        1120, pA25	2	14	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2314	2315		10.1056/NEJMp068116	http://dx.doi.org/10.1056/NEJMp068116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047ZZ	16738267				2022-12-28	WOS:000237918500003
J	Boyle, P; Ariyaratne, MAY; Barrington, R; Bartelink, H; Bartsch, G; Berns, A; de Valeriola, D; Dinshaw, KA; Eggermont, AMM; Gray, N; Kakizoe, T; Karki, BS; Kaslar, M; Kerr, DJ; Khayat, D; Khuhaprema, T; Kim, IH; Martin-Moreno, J; McVie, G; Park, JG; Philip, T; Ringborg, U; Rodger, A; Seffrin, JR; Semiglazov, V; Soo, KC; Sun, YT; Thomas, R; Tursz, T; Veronesi, U; Wiestler, O; Yoo, KY; Zatonski, W; Zhao, P				Boyle, Peter; Ariyaratne, M. A. Yasantha; Barrington, Ruth; Bartelink, Harry; Bartsch, Georg; Berns, Anton; de Valeriola, Dominique; Dinshaw, Ketayun A.; Eggermont, Alexander M. M.; Gray, Nigel; Kakizoe, Tadao; Karki, Balman Singh; Kaslar, Miklos; Kerr, David J.; Khayat, David; Khuhaprema, Thiravud; Kim, In-Hoo; Martin-Moreno, Jose; McVie, Gordon; Park, Jae-Gahb; Philip, Thierry; Ringborg, Ulrik; Rodger, Alan; Seffrin, John R.; Semiglazov, Vlacimir; Soo, Khee Chee; Sun, Yun-tian; Thomas, Robert; Tursz, Thomas; Veronesi, Umberto; Wiestler, Otmar; Yoo, Keun-Young; Zatonski, Witold; Zhao, Ping			Tobacco: deadly in any form or disguise	LANCET			English	Editorial Material							SMOKING		Int Agcy Res Canc, F-69372 Lyon, France; Govt Canc Inst, Canc Control Programme, Maharagamma, Sri Lanka; Hlth Res Board, Dublin, Ireland; Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; Univ Innsbruck, Urol Clin, A-6020 Innsbruck, Austria; Inst Jules Bordet, B-1000 Brussels, Belgium; Tata Mem Hosp, Bombay, Maharashtra, India; European Org Res Treatment Canc, Brussels, Belgium; Natl Canc Ctr, Tokyo 104, Japan; BP Koirala Mem Canc Hosp, Bharatpur, Chitwan, Nepal; Natl Inst Oncol, Budapest, Hungary; Univ Oxford, Dept Clin Pharmacol, Oxford, England; Natl Canc Inst, Paris, France; Natl Canc Inst, Bangkok, Thailand; Natl Canc Ctr, Seoul, South Korea; Univ Valencia, Fac Med, Valencia, Spain; European Inst Oncol, Milan, Italy; Ctr Leon Berard, F-69373 Lyon, France; Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland; Amer Canc Soc, Atlanta, GA 30329 USA; NN Petrov Oncol Res Inst, St Petersburg, Russia; Natl Canc Ctr, Singapore, Singapore; Peking Union Med Coll, Beijing, Peoples R China; Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia; Inst Gustave Roussy, Villejuif, France; German Canc Res Ctr, D-6900 Heidelberg, Germany; Seoul Natl Univ, Coll Med, Seoul, South Korea; Maria Sklodowska Curie Inst Oncol, Warsaw, Poland	World Health Organization; International Agency for Research on Cancer (IARC); Health Research Board - Ireland; Netherlands Cancer Institute; University of Innsbruck; Institut Jules Bordet; Tata Memorial Centre (TMC); Tata Memorial Hospital; European Organisation for Research & Treatment of Cancer; National Cancer Center - Japan; National Institute of Oncology Hungary; University of Oxford; Institut National du Cancer (INCA) France; National Cancer Institute - Thailand; National Cancer Center - Korea (NCC); University of Valencia; IRCCS European Institute of Oncology (IEO); UNICANCER; Centre Leon Berard; Karolinska Institutet; Beatson Oncology Centre; American Cancer Society; N.N. Petrov Research Institute of Oncology; National Cancer Centre Singapore (NCCS); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peter Maccallum Cancer Center; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Seoul National University (SNU); Maria Sklodowska-Curie National Research Institute of Oncology	Boyle, P (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	director@iarc.fr	Park, Jae-Gahb/J-5494-2012; Yoo, Keun-Young/J-5548-2012; Boyle, Peter/A-4380-2014; Martin-Moreno, Jose M./S-7733-2016	Boyle, Peter/0000-0001-6251-0610; Martin-Moreno, Jose M./0000-0002-8648-5541				Chen ZM, 1997, JAMA-J AM MED ASSOC, V278, P1500, DOI 10.1001/jama.278.18.1500; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fernandez E, 2006, TOB CONTROL, V15, P79; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; *INT AG RES CANC, 2006, REV RISK SMOK CESS; *INT AG RES CANC, 2005, SMOK TOB TOB REL NIT; International Agency for Research on Cancer, 2004, TOB SMOK INV SMOK	7	13	13	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1710	1712		10.1016/S0140-6736(06)68747-3	http://dx.doi.org/10.1016/S0140-6736(06)68747-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731252				2022-12-28	WOS:000237854000007
J	Horn, O; Hull, L; Jones, M; Murphy, D; Browne, T; Fear, NT; Hotopf, M; Rona, RJ; Wessely, S				Horn, Oded; Hull, Lisa; Jones, Margaret; Murphy, Dominic; Browne, Tess; Fear, Nicola T.; Hotopf, Matthew; Rona, Roberto J.; Wessely, Simon			Is there an Iraq war syndrome? Comparison of the health of UK service personnel after the Gulf and Iraq wars	LANCET			English	Article							PERSIAN-GULF; VETERANS; MORTALITY; SYMPTOMS	Background UK armed forces personnel who took part in the 1991 Gulf war experienced an increase in symptomatic ill health, colloquially known as Gulf war syndrome. Speculation about an Iraq war syndrome has already started. Methods We compared the health of male regular UK armed forces personnel deployed to Iraq during the 2003 war (n=3642) with that of their colleagues who were not deployed (n=4295), and compared these findings with those from our previous survey after the 1991 war. Data were obtained by questionnaire. Findings Graphs comparing frequencies of 50 non-specific symptoms in the past month in deployed and non-deployed groups did not show an increase in prevalence of symptoms equivalent to that observed after the Gulf war. For the Iraq war survey, odds ratios (ORs) for self-reported symptoms ranged from 0.8 to 1.3. Five symptoms were significantly increased, and two decreased, in deployed individuals, whereas prevalence greatly increased for all symptoms in the Gulf war study (ORs 1.9-3.9). Fatigue was not increased after the 2003 Iraq war (OR 1.08; 95% CI 0.98-1.19) but was greatly increased after the 1991 Gulf war (3.39; 3.00-3.83). Personnel deployed to the Gulf war were more likely 1.70-2.35) than those not deployed to report their health as fair or poor; no such effect was found for the Iraq (2.00, war (0.94, 0.82-1.09). Interpretation Increases in common symptoms in the 2003 Iraq war group were slight, and no pattern suggestive of a new syndrome was present. We consider several explanations for these differences.	Kings Coll London, Inst Psychiat, Kings Ctr Mil Hlth Res, London SE5 9RJ, England	University of London; King's College London	Wessely, S (corresponding author), Kings Coll London, Inst Psychiat, Kings Ctr Mil Hlth Res, London SE5 9RJ, England.	s.wessely@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008; Fear, Nicola/A-1917-2012; Hotopf, Matthew/E-4971-2010	Fear, Nicola/0000-0002-5792-2925; Hotopf, Matthew/0000-0002-3980-4466; Wessely, Simon Charles/0000-0002-6743-9929; Rona, Roberto/0000-0003-3739-5571				Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; *CAN DEP NAT DEF, 1998, HLTH STUD CAN FORC P; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; Croft P, 2000, BRIT MED J, V320, P1552, DOI 10.1136/bmj.320.7249.1552; Eisen SA, 2005, ANN INTERN MED, V142, P881, DOI 10.7326/0003-4819-142-11-200506070-00005; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Hotopf M, 2000, BRIT MED J, V320, P1363, DOI 10.1136/bmj.320.7246.1363; Hotopf M, 2003, BRIT MED J, V327, P1370, DOI 10.1136/bmj.327.7428.1370; HOTOPF M, 2006, LANCET          0516, DOI DOI 10.1016/S0140-6736(06)68662-5; Ishoy T, 1999, DAN MED BULL, V46, P416; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; Kelsall HL, 2004, OCCUP ENVIRON MED, V61, P1006, DOI 10.1136/oem.2003.009258; Macfarlane GJ, 2000, LANCET, V356, P17, DOI 10.1016/S0140-6736(00)02428-4; Macfarlane GJ, 2003, BRIT MED J, V327, P1373, DOI 10.1136/bmj.327.7428.1373; Rose MR, 2003, NEUROLOGY, V61, P730, DOI 10.1212/WNL.61.6.730; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wessely S, 2006, PHILOS T ROY SOC B, V361, P531, DOI 10.1098/rstb.2006.1813	20	30	31	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1742	1746		10.1016/S0140-6736(06)68661-3	http://dx.doi.org/10.1016/S0140-6736(06)68661-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731269				2022-12-28	WOS:000237854000029
J	Pocock, SJ				Pocock, SJ			Statistics in practice - The simplest statistical test: how to check for a difference between treatments	BRITISH MEDICAL JOURNAL			English	Review							TRIAL		Univ London London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Pocock, SJ (corresponding author), Univ London London Sch Hyg & Trop Med, Med Stat Unit, Keppel St, London WC1E 7HT, England.	Stuart.Pocock@lshtm.ac.uk						Armitage P, 2002, STAT METHODS MED RES, P156; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *FOOD DRUG ADM, STAT REV BRIEF DOC A; Kastrati A, 2005, JAMA-J AM MED ASSOC, V294, P819, DOI 10.1001/jama.294.7.819; MEIKLE J, 2005, GUARDIAN        1210, P1; Pocock S, 2004, EUR HEART J, V25, P1974, DOI 10.1016/j.ehj.2004.09.015; WOOLSON RF, 1987, STAT METHODS ANAL BI, P205	8	40	40	1	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2006	332	7552					1256	1258		10.1136/bmj.332.7552.1256	http://dx.doi.org/10.1136/bmj.332.7552.1256			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16735336	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000237984100020
J	Annas, GJ				Annas, George J.			Intelligent judging - Evolution in the classroom and the courtroom	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1982, HASTINGS CENT REP, V12, P22, DOI 10.2307/3561802; BUMILLER E, 2005, NY TIMES        0803, pA14; Culotta E, 2005, SCIENCE, V310, P1878, DOI 10.1126/science.310.5756.1878; DRINAN RF, 2004, CAN GOD CAESAR COEXI; Eccles J. C, 1989, EVOLUTION BRAIN CREA; FISHER I, 2006, NY TIMES        1206, pA12; Gould Stephen, 1999, ROCK AGES SCI RELIG; Hawking Stephen W., 1988, BRIEF HIST TIME BIG; Holden C, 2006, SCIENCE, V311, P769, DOI 10.1126/science.311.5762.769; LEWONTIN R, 2005, NEW YORK REV BO 1020, P51; MONASTERSKY R, 2006, CHRONICLE HIGHE 0203, pA14; *PEW RES CTR, 2005, READ POLLS EV CREAT; RUDOREN J, 2006, NY TIMES        0214, pA12; RUDOREN J, 2006, NY TIMES        0215, pA14; Smith George P, 2005, J Contemp Health Law Policy, V21, P169; Steering Committee on Science and Creationism, 1999, SCI CREAT VIEW NAT A	16	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2277	2281		10.1056/NEJMlim055660	http://dx.doi.org/10.1056/NEJMlim055660			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045RF	16723620	Green Published			2022-12-28	WOS:000237758900013
J	Bejerano-Sagie, M; Oppenheimer-Shaanan, Y; Berlatzky, I; Rouvinski, A; Meyerovich, M; Ben-Yehuda, S				Bejerano-Sagie, Michal; Oppenheimer-Shaanan, Yaara; Berlatzky, Idit; Rouvinski, Alex; Meyerovich, Mor; Ben-Yehuda, Sigal			A checkpoint protein that scans the chromosome for damage at the start of sporulation in Bacillus subtilis	CELL			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; CELL-DIVISION; INITIATION; GENE; LOCALIZATION; VISUALIZATION; ACTIVATION	In response to DNA damage, cells activate checkpoint signaling cascades to control cell-cycle progression and elicit DNA repair in order to maintain genomic integrity. The sensing and repair of lesions is critical for Bacillus subtilis cells entering the developmental process of sporulation as damaged DNA may prevent the cells from completing spore morphogenesis. We report the identification of the protein DisA (DNA integrity scanning protein, annotated YacK), which is required to delay the initiation of sporulation in response to chromosomal damage. DisA is a nonspecific DNA binding protein that forms a single focus, which moves rapidly within the bacterial cell, pausing at sites of DNA damage. We propose that the DisA focus scans along the chromosomes searching for lesions. Upon encountering a lesion, DisA delays entry into sporulation until the damage is repaired.	Hebrew Univ Jerusalem, Fac Med, Dept Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Ben-Yehuda, S (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Mol Biol, POB 12272, IL-91120 Jerusalem, Israel.	sigalbe@md.huji.ac.il						Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Harwood C.R., 1990, MOL BIOL METHODS BAC; IRETON K, 1992, P NATL ACAD SCI USA, V89, P8808, DOI 10.1073/pnas.89.18.8808; IRETON K, 1994, CELL MOL BIOL RES, V40, P193; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; Kidane D, 2005, J CELL BIOL, V170, P357, DOI 10.1083/jcb.200412090; Kruger E, 1996, MOL MICROBIOL, V20, P713, DOI 10.1111/j.1365-2958.1996.tb02511.x; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; Lemon KP, 2000, J BACTERIOL, V182, P2989, DOI 10.1128/JB.182.10.2989-2991.2000; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Li L, 2005, J CELL BIOCHEM, V94, P298, DOI 10.1002/jcb.20355; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2005, BIOCHIMIE, V87, P579, DOI 10.1016/j.biochi.2004.10.023; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Pan Q, 2001, MOL CELL, V8, P873, DOI 10.1016/S1097-2765(01)00362-8; PEREGO M, 2001, BACILLUS SUBTILIS IT, P473; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; PIGGOT PJ, 2001, BACILLUS SUBTILIS IT, P483; Pogliano J, 2002, J BACTERIOL, V184, P1743, DOI 10.1128/JB.184.4.1743-1749.2002; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shafikhani SH, 2004, FEMS MICROBIOL LETT, V231, P99, DOI 10.1016/S0378-1097(03)00936-4; SHARROCK RA, 1984, MOL GEN GENET, V194, P260, DOI 10.1007/BF00383525; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; Sonenshein AL, 2000, CURR OPIN MICROBIOL, V3, P561, DOI 10.1016/S1369-5274(00)00141-7; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Straube A, 2004, EUR J NEUROL, V11, P83, DOI 10.1046/j.1468-1331.2003.00754.x; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; YORK K, 1992, J BACTERIOL, V174, P2648, DOI 10.1128/jb.174.8.2648-2658.1992; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1	41	115	120	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					679	690		10.1016/j.cell.2006.03.039	http://dx.doi.org/10.1016/j.cell.2006.03.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713562	Bronze			2022-12-28	WOS:000237886000014
J	Martin, RD; MacLarnon, AM; Phillips, JL; Dussubieux, L; Williams, PR; Dobyns, WB				Martin, RD; MacLarnon, AM; Phillips, JL; Dussubieux, L; Williams, PR; Dobyns, WB			Comment on "The brain of LB1, Homo floresiensis"	SCIENCE			English	Editorial Material							EVOLUTIONARY SIGNIFICANCE; LATE PLEISTOCENE; HOMININ		Field Museum Nat Hist, Chicago, IL 60605 USA; Roehampton Univ, Sch Human & Life Sci, London SW15 4JD, England; Univ Illinois, Dept Anthropol, Chicago, IL 60607 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Field Museum of Natural History (Chicago); Roehampton University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Martin, RD (corresponding author), Field Museum Nat Hist, Chicago, IL 60605 USA.	rdmartin@fieldmuseum.org	Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; MacLarnon, Ann/0000-0003-2722-4998				ACCORDI FS, 1971, ATTI ACCAD NAZ LIN, V51, P111; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; DRUDRURY EG, 1919, T R SOC S AFR, V8, P149; Falk D, 2005, SCIENCE, V310, DOI 10.1126/science.1117062; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; HOLLOWAY RL, 1980, AM J PHYS ANTHROPOL, V53, P109, DOI 10.1002/ajpa.1330530115; Humphry G, 1895, J Anat Physiol, V29, P304; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; Kohler M, 2004, BRAIN BEHAV EVOLUT, V63, P125, DOI 10.1159/000076239; Kruska DCT, 2005, BRAIN BEHAV EVOLUT, V65, P73, DOI 10.1159/000082979; Lister AM, 1996, SYM ZOOL S, P277; Martin R.D., 1985, P147; Miles M, 1996, HIST PSYCHIATR, V7, P571, DOI 10.1177/0957154X9600702808; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Roth V.L., 1992, Oxford Surveys in Evolutionary Biology, V8, P259; SHORTT J, 1874, J ANTHR I GT BRIT IR, V3, P265; Stanyon R., 1993, Human Evolution, V8, P205, DOI 10.1007/BF02436715; VOGT C, 1867, ARCH ANTHR, V2, P129; Weber J, 2005, SCIENCE, V310, DOI 10.1126/science.1114789; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930	23	54	56	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776								10.1126/science.1121144	http://dx.doi.org/10.1126/science.1121144			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709768				2022-12-28	WOS:000237628800022
J	Pavri, R; Zhu, B; Li, GH; Trojer, P; Mandal, S; Shilatifard, A; Reinberg, D				Pavri, Rushad; Zhu, Bing; Li, Guohong; Trojer, Patrick; Mandal, Subhrangsu; Shilatifard, Ali; Reinberg, Danny			Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II	CELL			English	Article							H3 LYSINE-4 METHYLATION; RETINOIC ACID RECEPTOR; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ELONGATION; IN-VITRO; PAF1 COMPLEX; CHROMATIN-STRUCTURE; X-RECEPTOR; YEAST; MEDIATOR	Over the past years, a large number of histone posttranslational modifications have been described, some of which function to attain a repressed chromatin structure, while others facilitate activation by allowing access of regulators to DNA. Histone H2B monoubiquitination is a mark associated with transcriptional activity. Using a highly reconstituted chromatin-transcription system incorporating the inducible RAR beta 2 promoter, we find that the establishment of H2B monoubiquitination by RNF20/40 and UbcH6 is dependent on the transcription elongation regulator complex PAF, the histone chaperone FACT, and transcription. H2B monoubiquitination facilitates FACT function, thereby stimulating transcript elongation and the generation of longer transcripts. These in vitro analyses and corroborating in vivo experiments demonstrate that elongation by RNA polymerase II through the nucleosomal barrier is minimally dependent upon (1) FACT and (2) the recruitment of PAF and the H2B monoubiquitination machinery.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA; St Louis Univ, Sch Med, Dept Biochem, St Louis, MO 63104 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Saint Louis University	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, 683 Hoes Lane, Piscataway, NJ 08854 USA.	reinbedf@umdnj.edu		Mandal, Subhrangsu/0000-0001-8495-9881; Pavri, Rushad/0000-0002-6191-6333; Reinberg, Danny/0000-0003-4288-2016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM037120] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37120] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; Dilworth FJ, 1999, P NATL ACAD SCI USA, V96, P1995, DOI 10.1073/pnas.96.5.1995; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; FLORES O, 1989, J BIOL CHEM, V264, P8913; FLORES O, 1992, J BIOL CHEM, V267, P2786; Formosa T, 2002, GENETICS, V162, P1557; Glass CK, 2000, GENE DEV, V14, P121; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lefebvre B, 2002, MOL CELL BIOL, V22, P1446, DOI 10.1128/MCB.22.5.1446-1459.2002; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Loyola A, 2003, MOL CELL BIOL, V23, P6759, DOI 10.1128/MCB.23.19.6759-6768.2003; Loyola A, 2001, GENE DEV, V15, P2837; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; SIMS RJ, 2006, UNPUB REGULATION RNA, V4; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	66	519	550	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					703	717		10.1016/j.cell.2006.04.029	http://dx.doi.org/10.1016/j.cell.2006.04.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713563	Bronze			2022-12-28	WOS:000237886000016
J	Iber, D; Clarkson, J; Yudkin, MD; Campbell, ID				Iber, D; Clarkson, J; Yudkin, MD; Campbell, ID			The mechanism of cell differentiation in Bacillus subtilis	NATURE			English	Article							TRANSCRIPTION FACTOR SIGMA(F); GENE-EXPRESSION; RNA-POLYMERASE; SPORULATION; ACTIVATION; SPOIIAB; REGULATOR; PROTEIN	Sporulation in Bacillus subtilis serves as a model for the development of two different cell types from a single cell(1). Although much information has been accumulated about the mechanisms that initiate the developmental programmes(2), important questions remain that can be answered only by quantitative analysis. Here we develop, with the help of existing and new experimental results, a mathematical model that reproduces published in vitro experiments and explains how the activation of the key transcription factor is regulated. The model identifies the difference in volume between the two cell types as the primary trigger for determining cell fate. It shows that this effect depends on the allosteric behaviour of a key protein kinase and on a low rate of dephosphorylation by the corresponding phosphatase; both predicted effects are confirmed experimentally.	Univ Oxford, Inst Math, Ctr Math Biol, Oxford OX1 3LB, England; Univ Oxford, Dept Biochem, Microbiol Unit, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Iber, D (corresponding author), Univ Oxford, Inst Math, Ctr Math Biol, 24-29 St Giles, Oxford OX1 3LB, England.	iber@maths.ox.ac.uk; michael.yudkin@kellogg.ox.ac.uk	Iber, Dagmar/V-2846-2019	Iber, Dagmar/0000-0001-8051-1035	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Carniol K, 2004, J BIOL CHEM, V279, P14860, DOI 10.1074/jbc.M314274200; Clarkson J, 2004, J MOL BIOL, V342, P1187, DOI 10.1016/j.jmb.2004.07.090; Clarkson J, 2004, J MOL BIOL, V340, P203, DOI 10.1016/j.jmb.2004.04.061; Clarkson J, 2004, BIOCHEMISTRY-US, V43, P3120, DOI 10.1021/bi036014+; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Dworkin J, 2001, CELL, V107, P339, DOI 10.1016/S0092-8674(01)00528-1; EISENSTADT E, 1973, J BACTERIOL, V113, P1363, DOI 10.1128/JB.113.3.1363-1372.1973; Frandsen N, 1999, GENE DEV, V13, P394, DOI 10.1101/gad.13.4.394; Fujita M, 1998, GENE, V221, P185, DOI 10.1016/S0378-1119(98)00452-1; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; Lee CS, 2000, J BACTERIOL, V182, P6250, DOI 10.1128/JB.182.21.6250-6253.2000; Lord M, 1999, J BACTERIOL, V181, P2346, DOI 10.1128/JB.181.8.2346-2350.1999; Lucet I, 1999, J BACTERIOL, V181, P3242, DOI 10.1128/JB.181.10.3242-3245.1999; Magnin T, 1997, J BACTERIOL, V179, P3922, DOI 10.1128/jb.179.12.3922-3927.1997; Pan Q, 2001, MOL CELL, V8, P873, DOI 10.1016/S1097-2765(01)00362-8; Schroeter R, 1999, FEMS MICROBIOL LETT, V174, P117, DOI 10.1016/S0378-1097(99)00117-2; Shu JC, 2004, BIOCHEM J, V384, P169, DOI 10.1042/BJ20040923; Yudkin MD, 2005, MOL MICROBIOL, V56, P578, DOI 10.1111/j.1365-2958.2005.04594.x	22	45	47	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					371	374		10.1038/nature04666	http://dx.doi.org/10.1038/nature04666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710423				2022-12-28	WOS:000237593200053
J	Toff, WD; Jones, CI; Ford, I; Pearse, RJ; Watson, HG; Watt, SJ; Ross, JAS; Gradwell, DP; Batchelor, AJ; Abrams, KR; Meijers, JCM; Goodall, AH; Greaves, M				Toff, WD; Jones, CI; Ford, I; Pearse, RJ; Watson, HG; Watt, SJ; Ross, JAS; Gradwell, DP; Batchelor, AJ; Abrams, KR; Meijers, JCM; Goodall, AH; Greaves, M			Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FLOW-CYTOMETRIC ANALYSIS; HUMAN-BEINGS; PLASMA; BLOOD	Context The link between long-haul air travel and venous thromboembolism is the subject of continuing debate. It remains unclear whether the reduced cabin pressure and oxygen tension in the airplane cabin create an increased risk compared with seated immobility at ground level. Objective To determine whether hypobaric hypoxia, which may be encountered during air travel, activates hemostasis. Design, Setting, and Participants A single-blind, crossover study, performed in a hypobaric chamber, to assess the effect of an 8- hour seated exposure to hypobaric hypoxia on hemostasis in 73 healthy volunteers, which was conducted in the United Kingdom from September 2003 to November 2005. Participants were screened for factor V Leiden G1691A and prothrombin G20210A mutation and were excluded if they tested positive. Blood was drawn before and after exposure to assess activation of hemostasis. Interventions Individuals were exposed alternately ( >= 1 week apart) to hypobaric hypoxia, similar to the conditions of reduced cabin pressure during commercial air travel ( equivalent to atmospheric pressure at an altitude of 2438 m), and normobaric normoxia ( control condition; equivalent to atmospheric conditions at ground level, circa 70 m above sea level). Main Outcome Measures Comparative changes in markers of coagulation activation, fibrinolysis, platelet activation, and endothelial cell activation. Results Changes were observed in some hemostatic markers during the normobaric exposure, attributed to prolonged sitting and circadian variation. However, there were no significant differences between the changes in the hypobaric and the normobaric exposures. For example, the median difference in change between the hypobaric and normobaric exposure was 0 ng/mL for thrombin-antithrombin complex (95% CI, - 0.30 to 0.30 ng/mL); - 0.20 nmol/L for prothrombin fragment 1 + 2 ( 95% CI, - 0.03 to 0.01 nmol/L); 1.38 ng/mL for D-dimer ( 95% CI, - 3.63 to 9.72 ng/ mL); and - 2.00% for endogenous thrombin potential ( 95% CI, - 4.00% to 1.00%). Conclusion Our findings do not support the hypothesis that hypobaric hypoxia, of the degree that might be encountered during long-haul air travel, is associated with prothrombotic alterations in the hemostatic system in healthy individuals at low risk of venous thromboembolism.	Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland; Univ Aberdeen, Dept Environm & Occupat Med, Aberdeen, Scotland; Royal AF Ctr Aviat Med, Henlow, Beds, England; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Leicester; University of Leicester; University of Aberdeen; University of Aberdeen; University of Amsterdam; Academic Medical Center Amsterdam	Toff, WD (corresponding author), Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Clin Sci Wing, Groby Rd, Leicester LE3 9QP, Leics, England.	w.toff@le.ac.uk	Meijers, J.C.M./S-5981-2019; Ford, Ian/ABE-6145-2020; Abrams, Keith/AAA-2557-2020	Meijers, J.C.M./0000-0002-4198-6780; Jones, Chris/0000-0001-7537-1509; Abrams, Keith/0000-0002-7557-1567; Goodall, Alison/0000-0002-7883-9645; Toff, William/0000-0001-5631-4496				*AIRW STAND, 2004, TRANSP CAT AIRPL DES; ANDREOTTI F, 1991, CHRONOBIOL INT, V8, P336, DOI 10.3109/07420529109059170; Bartsch T, 2001, LANCET, V357, P955; Bendz B, 2000, LANCET, V356, P1657, DOI 10.1016/S0140-6736(00)03165-2; Bendz B, 2001, LANCET, V357, P955, DOI 10.1016/S0140-6736(05)71652-4; BOOTH NA, 1988, BRIT J HAEMATOL, V70, P327, DOI 10.1111/j.1365-2141.1988.tb02490.x; Crosby A, 2003, LANCET, V361, P2207, DOI 10.1016/S0140-6736(03)13777-4; Dalen JE, 2003, ARCH INTERN MED, V163, P2674, DOI 10.1001/archinte.163.22.2674; DICK J, 2004, HIGH ALT MED BIOL, V5, P481; GERTLER JP, 1993, J VASC SURG, V18, P939, DOI 10.1016/0741-5214(93)90548-Z; GERTLER JP, 1991, J VASC SURG, V13, P428, DOI 10.1067/mva.1991.25767; Goodall Alison H, 2004, Methods Mol Biol, V272, P225; Harding RM, 1999, AVIATION MED, P43; Hodkinson PD, 2003, J THROMB HAEMOST, V1, P2131, DOI 10.1046/j.1538-7836.2003.00407.x; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; ISHII H, 1990, THROMB HAEMOSTASIS, V63, P157; Iversen PO, 2002, BRIT J HAEMATOL, V119, P1011, DOI 10.1046/j.1365-2141.2002.03953.x; Kapiotis S, 1997, CIRCULATION, V96, P19; LABRECQUE G, 1991, CHRONOBIOL INT, V8, P361, DOI 10.3109/07420529109059172; MACGREGOR I R, 1987, Fibrinolysis, V1, P247, DOI 10.1016/0268-9499(87)90044-0; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Muhm JM, 2004, AVIAT SPACE ENVIR MD, V75, P905; Rosing J, 1997, BRIT J HAEMATOL, V97, P233, DOI 10.1046/j.1365-2141.1997.192707.x; SANDSET PM, 1987, THROMB RES, V47, P389, DOI 10.1016/0049-3848(87)90454-3; Schreijer AJM, 2006, LANCET, V367, P832, DOI 10.1016/S0140-6736(06)68339-6; Senn S, 1993, CROSS OVER TRIALS CL, V2nd; SUDOH M, 2003, AVIAT SPACE ENV MED, V74, P423; SUDOH M, 2002, AVIAT SPACE ENV MED, V73, P278; Undar B, 1999, CHRONOBIOL INT, V16, P335, DOI 10.3109/07420529909116862; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6	30	97	104	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2006	295	19					2251	2261		10.1001/jama.295.19.2251	http://dx.doi.org/10.1001/jama.295.19.2251			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042UX	16705106	Bronze			2022-12-28	WOS:000237556600023
J	Baker, SG; Kaprio, J				Baker, Stuart G.; Kaprio, Jaakko			Cancer genetics - Common susceptibility genes for cancer: search for the end of the rainbow	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST; RISK		NCI, Bethesda, MD 20892 USA; Univ Helsinki, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Helsinki	Baker, SG (corresponding author), NCI, Bethesda, MD 20892 USA.	sb16i@nih.gov	Kaprio, Jaakko/A-1820-2008	Kaprio, Jaakko/0000-0002-3716-2455				Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Baker SG, 2005, J R STAT SOC C-APPL, V54, P941, DOI 10.1111/j.1467-9876.2005.00522.x; Baker SG, 2005, BIOMETRICS, V61, P55, DOI 10.1111/j.0006-341X.2005.030924.x; Begg CB, 2005, JNCI-J NATL CANCER I, V97, P1507, DOI 10.1093/jnci/dji312; Begg CB, 2001, AM J PUBLIC HEALTH, V91, P360, DOI 10.2105/AJPH.91.3.360; Berwick M, 1996, J NATL CANCER I, V88, P17, DOI 10.1093/jnci/88.1.17; CAIRNS J, 1981, NATURE, V289, P353, DOI 10.1038/289353a0; Calvert PM, 2002, ANN INTERN MED, V137, P603, DOI 10.7326/0003-4819-137-7-200210010-00012; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Hopper JL, 2001, BREAST CANCER RES, V3, P154, DOI 10.1186/bcr290; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; Soto AM, 2004, BIOESSAYS, V26, P1097, DOI 10.1002/bies.20087; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Tominaga S, 1985, Natl Cancer Inst Monogr, V69, P83; Tsao AS, 2004, CA-CANCER J CLIN, V54, P150, DOI 10.3322/canjclin.54.3.150; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	19	12	13	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2006	332	7550					1150	1152		10.1136/bmj.332.7550.1150	http://dx.doi.org/10.1136/bmj.332.7550.1150			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16690677	Green Published			2022-12-28	WOS:000237682700030
J	Irwig, L; McCaffery, K; Salkeld, G; Bossuyt, P				Irwig, Les; McCaffery, Kirsten; Salkeld, Glenn; Bossuyt, Patrick			Screening and choice - Informed choice for screening: implications for evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER; BENEFITS; MAMMOGRAPHY; WOMEN		Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; Univ Amsterdam, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands	University of Sydney; University of Amsterdam	Irwig, L (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Edward Ford Bldg,A27, Sydney, NSW 2006, Australia.	lesi@health.usyd.edu.au	Bossuyt, Patrick M/AAR-1183-2021; McCaffery, Kirsten/K-7945-2019; Bossuyt, Patrick M./B-4557-2016	Bossuyt, Patrick M/0000-0003-4427-0128; McCaffery, Kirsten/0000-0003-2696-5006; Bossuyt, Patrick M./0000-0003-4427-0128				Abelson J, 2003, SOC SCI MED, V57, P239, DOI 10.1016/S0277-9536(02)00343-X; Austoker J, 1999, BMJ-BRIT MED J, V319, P722, DOI 10.1136/bmj.319.7212.722; Barratt A, 2005, BMJ-BRIT MED J, V330, P936, DOI 10.1136/bmj.38398.469479.8F; Barratt A, 2004, BMJ-BRIT MED J, V329, P507, DOI 10.1136/bmj.329.7464.507; Cockburn J, 1999, AUST NZ J PUBL HEAL, V23, P318, DOI 10.1111/j.1467-842X.1999.tb01264.x; Dowie Jack, 2002, Health Expect, V5, P16, DOI 10.1046/j.1369-6513.2002.00160.x; Howard K, 2005, J MED SCREEN, V12, P96, DOI 10.1258/0969141053908276; IRWIG L, 2000, EFFECT CLIN PRACT, V2, P47; Jepson RG, 2005, J MED ETHICS, V31, P192, DOI 10.1136/jme.2003.005793; Jorgensen KJ, 2004, BMJ-BRIT MED J, V328, P148, DOI 10.1136/bmj.328.7432.148; Marteau T M, 2001, Health Expect, V4, P99, DOI 10.1046/j.1369-6513.2001.00140.x; *NHS CANC SCREEN P, CERV CANC FACTS; *NHS CANC SCREEN P, BREAST SCREEN FACTS; O'Connor A, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001431; Raffle A E, 2001, Health Expect, V4, P92, DOI 10.1046/j.1369-6513.2001.00138.x; Salkeld G, 1998, HEALTH CARE ANAL, V6, P106, DOI 10.1002/(SICI)1099-1042(199806)6:2<106::AID-HCA249>3.0.CO;2-4; Salkeld G, 2003, AUST NZ J PUBL HEAL, V27, P449, DOI 10.1111/j.1467-842X.2003.tb00425.x; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Slaytor EK, 1998, BRIT MED J, V317, P263, DOI 10.1136/bmj.317.7153.263; Strong K, 2005, J MED SCREEN, V12, P12, DOI 10.1258/0969141053279086; TORGERSON DJ, 1994, BMJ-BRIT MED J, V308, P117, DOI 10.1136/bmj.308.6921.117; UK National Screening Committee, CRIT APPR VIAB EFF A; Welch HG, 2004, SHOULD I BE TESTED C	23	71	71	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2006	332	7550					1148	1150		10.1136/bmj.332.7550.1148	http://dx.doi.org/10.1136/bmj.332.7550.1148			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044OT	16690676	Green Published, Green Submitted			2022-12-28	WOS:000237682700029
J	Gehring, GM; Schweinsberg, A; Barsi, C; Kostinski, N; Boyd, RW				Gehring, GM; Schweinsberg, A; Barsi, C; Kostinski, N; Boyd, RW			Observation of backward pulse propagation through a medium with a negative group velocity	SCIENCE			English	Article							SLOW LIGHT-PROPAGATION; ENERGY; SPEED	The nature of pulse propagation through a material with a negative value of the group velocity has been mysterious, as simple models seem to predict that pulses will propagate "backward'' through such a material. Using an erbium-doped optical fiber and measuring the time evolution of the pulse intensity at many points within the fiber, we demonstrate that the peak of the pulse does propagate backward inside the fiber, even though the energy flow is always in the forward direction.	Univ Rochester, Inst Opt, Rochester, NY 14627 USA; Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; Manhattan Coll, Dept Elect & Comp Engn, Bronx, NY 10471 USA; Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA	University of Rochester; University of Rochester; Manhattan College; University of Michigan System; University of Michigan	Gehring, GM (corresponding author), Univ Rochester, Inst Opt, Rochester, NY 14627 USA.	gehring@optics.rochester.edu	Schweinsberg, Aaron/D-7488-2012	Schweinsberg, Aaron/0000-0003-4710-0562				Agarwal GS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.203901; Baldit E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.143601; BASOV NG, 1966, SOV PHYS DOKL, V11, P222; Bigelow MS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.113903; Bigelow MS, 2003, SCIENCE, V301, P200, DOI 10.1126/science.1084429; BOYD RW, 1981, PHYS REV A, V24, P411, DOI 10.1103/PhysRevA.24.411; Boyd RW, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.023801; Boyd RW, 2002, PROG OPTICS, V43, P497, DOI 10.1016/S0079-6638(02)80030-0; Brillouin L., 1960, WAVE PROPAGATION GRO; Budker D, 1999, PHYS REV LETT, V83, P1767, DOI 10.1103/PhysRevLett.83.1767; CHIAO RY, 1993, PHYS REV A, V48, pR34, DOI 10.1103/PhysRevA.48.R34; CHU S, 1982, PHYS REV LETT, V49, P1293, DOI 10.1103/PhysRevLett.49.1293; CHU S, 1982, PHYS REV LETT, V48, P738, DOI 10.1103/PhysRevLett.48.738; GARRETT CGB, 1970, PHYS REV A, V1, P305, DOI 10.1103/PhysRevA.1.305; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; HILLMAN LW, 1983, OPT COMMUN, V45, P416, DOI 10.1016/0030-4018(83)90303-6; KASAPI A, 1995, PHYS REV LETT, V74, P2447, DOI 10.1103/PhysRevLett.74.2447; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Macke B, 2003, EUR PHYS J D, V23, P125, DOI 10.1140/epjd/e2003-00022-0; Milonni P. W., 2005, SER OPT OPTOELECTRON; Okawachi Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.153902; Schweinsberg A, 2006, EUROPHYS LETT, V73, P218, DOI 10.1209/epl/i2005-10371-0; SEGARD B, 1985, PHYS LETT A, V109, P213, DOI 10.1016/0375-9601(85)90305-6; SHERMAN GC, 1981, PHYS REV LETT, V47, P1451, DOI 10.1103/PhysRevLett.47.1451; SMITH RL, 1970, AM J PHYS, V38, P978, DOI 10.1119/1.1976551; Song KY, 2005, OPT EXPRESS, V13, P82, DOI 10.1364/OPEX.13.000082; Stenner MD, 2003, NATURE, V425, P695, DOI 10.1038/nature02016; Talukder MAI, 2001, PHYS REV LETT, V86, P3546, DOI 10.1103/PhysRevLett.86.3546; Wang LJ, 2000, NATURE, V406, P277, DOI 10.1038/35018520; Ware M, 2001, OPT EXPRESS, V9, P506, DOI 10.1364/OE.9.000506; Ware M, 2001, OPT EXPRESS, V9, P519, DOI 10.1364/OE.9.000519	31	203	214	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					895	897		10.1126/science.1124524	http://dx.doi.org/10.1126/science.1124524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690861				2022-12-28	WOS:000237452900042
J	Hoey, J				Hoey, J			Editorial independence and the Canadian Medical Association Journal	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Hoey J, 1999, CAN MED ASSOC J, V160, P507; Shuchman M, 2006, NEW ENGL J MED, V354, P1337, DOI 10.1056/NEJMp068056; WAKLEY T, 1855, LANCET, V1, P634; WOOLF V, 1929, TO THE LIGHTHOUSE, P235; 2006, CMAJ, V174, P9	5	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					1982	1983		10.1056/NEJMp068104	http://dx.doi.org/10.1056/NEJMp068104			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687710	Bronze			2022-12-28	WOS:000237413100002
J	Currie, GP; Legge, JS				Currie, Graeme P.; Legge, Joe S.			ABC of chronic obstructive pulmonary disease - Diagnosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							COPD		Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland	University of Aberdeen	Currie, GP (corresponding author), Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland.			Currie, Graeme P/0000-0002-5711-9147				Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; 2003, THORAX S1, V58, P1; 2004, THORAX S1, V59, P1	5	10	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2006	332	7552					1261	1263		10.1136/bmj.332.7552.1261	http://dx.doi.org/10.1136/bmj.332.7552.1261			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16735338	Green Published			2022-12-28	WOS:000237984100022
J	Hotopf, M; Hull, L; T Fear, N; Browne, T; Horn, O; Iversen, A; Jones, M; Murphy, D; Bland, D; Earnshaw, M; Greenberg, N; Hughes, JH; Tate, AR; Dandeker, C; Rona, R; Wessely, S				Hotopf, Matthew; Hull, Lisa; T Fear, Nicola; Browne, Tess; Horn, Oded; Iversen, Amy; Jones, Margaret; Murphy, Dominic; Bland, Duncan; Earnshaw, Mark; Greenberg, Neil; Hughes, Jamie Hacker; Tate, A. Rosemary; Dandeker, Christopher; Rona, Roberto; Wessely, Simon			The health of UK military personnel who deployed to the 2003 Iraq war: a cohort study	LANCET			English	Article							PERSIAN-GULF-WAR; MENTAL-HEALTH; VIETNAM VETERANS; ILLNESS; EPIDEMIOLOGY; AFGHANISTAN; CARE	Background Concerns have been raised about the mental and physical health of UK military personnel who deployed to the 2003 war in Iraq and subsequent tours of duty in the country. Methods We compared health outcomes in a random sample of UK armed forces personnel who were deployed to the 2003 Iraq war with those in personnel who were not deployed. Participants completed a questionnaire covering the nature of the deployment and health outcomes, which included symptoms of post-traumatic stress disorder, common mental disorders, general wellbeing, alcohol consumption, physical symptoms, and fatigue. Findings The participation rate was 62.3% (n=4722) in the deployed sample, and 56.3% (n=5550) in the non-deployed sample. Differences in health outcomes between groups were slight. There was a modest increase in the number of individuals with multiple physical symptoms (odds ratio 1.33; 95% Cl 1.15-1.54). No other differences between groups were noted. The effect of deployment was different for reservists compared with regulars. In regulars, only presence of multiple physical symptoms was weakly associated with deployment (1.32; 1.14-1.53), whereas for reservists deployment was associated with common mental disorders (2.47,1.35-4.52) and fatigue (1.78; 1.09-2.91). There was no evidence that later deployments, which were associated with escalating insurgency and UK casualties, were associated with poorer mental health outcomes. Interpretation For regular personnel in the UK armed forces, deployment to the Iraq war has not, so far, been associated with significantly worse health outcomes, apart from a modest effect on multiple physical symptoms. There is evidence of a clinically and statistically significant effect on health in reservists.	Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, London SE5 9RJ, England; Kings Coll London, Acad Ctr Def Mental Hlth, London SE5 9RJ, England; Kings Coll London, Dept Biostat, Inst Psychiat, London SE5 9RJ, England; Kings Coll London, Sch Social Sci & Publ Policy, London SE5 9RJ, England; Kings Coll London, Div Asthma Allergy & Lung Biol, London SE5 9RJ, England; Royal Hosp Haslar, Def Med Serv, Gosport, Hants, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Hotopf, M (corresponding author), Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, London SE5 9RJ, England.	m.hotopf@iop.kcl.ac.uk	Iversen, Amy/D-1112-2011; Rona, Roberto J/C-2348-2011; Tate, Anne Rosemary/AAK-4512-2020; Fear, Nicola/A-1917-2012; Hotopf, Matthew/E-4971-2010; Wessely, Simon C/A-8713-2008	Fear, Nicola/0000-0002-5792-2925; Hotopf, Matthew/0000-0002-3980-4466; greenberg, neil/0000-0003-4550-2971; Wessely, Simon Charles/0000-0002-6743-9929; Rona, Roberto/0000-0003-3739-5571				[Anonymous], 1988, JAMA, V259, P2701; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BLIESE PD, 2004, 2004002 US ARM MED R; BURKE J, 2004, OBSERVER LONDON 1128; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GREENE RA, 2005, UK TROOPS FACE TRAUM; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; HOGE CW, 2005, PSYHOL IMPACT MODERN; HORN O, 2006, LANCET          0516, DOI DOI 10.1016/S0140-6736(06)68661-3; Hotopf M, 2005, INT J EPIDEMIOL, V34, P791, DOI 10.1093/ije/dyi102; Hotopf M, 2003, BRIT MED J, V327, P1370, DOI 10.1136/bmj.327.7428.1370; Hughes JH, 2005, BRIT J PSYCHIAT, V186, P536, DOI 10.1192/bjp.186.6.536; Ismail K, 2002, BMJ-BRIT MED J, V325, P576, DOI 10.1136/bmj.325.7364.576; Iversen A, 2006, BRIT MED J, V332, P165, DOI 10.1136/bmj.332.7534.165; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Killgore WDS, 2006, J PSYCHOSOM RES, V60, P379, DOI 10.1016/j.jpsychores.2006.02.012; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; National Center for Medical Rehabilitation Research, 2006, RES FORC, P1; Pizarro J, 2006, ARCH GEN PSYCHIAT, V63, P193, DOI 10.1001/archpsyc.63.2.193; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; WOOD AM, IN PRESS J R STAT A	29	360	367	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 27	2006	367	9524					1731	1741		10.1016/S0140-6736(06)68662-5	http://dx.doi.org/10.1016/S0140-6736(06)68662-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731268				2022-12-28	WOS:000237854000028
J	Halpern, BS; Cottenie, K; Broitman, BR				Halpern, BS; Cottenie, K; Broitman, BR			Strong top-down control in southern California kelp forest ecosystems	SCIENCE			English	Article							BOTTOM-UP; FOOD WEBS; COMMUNITIES; HETEROGENEITY; CLIMATE; FORCES	Global-scale changes in anthropogenic nutrient input into marine ecosystems via terrestrial runoff, coupled with widespread predator removal via fishing, have created greater urgency for understanding the relative role of top-down versus bottom-up control of food web dynamics. Yet recent large-scale studies of community regulation in marine ecosystems have shown dramatically different results that leave this issue largely unresolved. We combined a multiyear, large-scale data set of species abundances for 46 species in kelp forests from the California Channel Islands with satellite-derived primary production and found that top-down control explains 7- to 10-fold more of the variance in abundance of bottom and mid-trophic levels than does bottom-up control. This top-down control was propagated via a variety of species-level direct and indirect responses to predator abundance. Management of top-down influences such as fishing may be more important in coastal marine ecosystems, particularly in kelp forest systems, than is commonly thought.	Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	National Center for Ecological Analysis & Synthesis; University of Guelph; University of California System; University of California Santa Barbara	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	halpern@nceas.ucsb.edu	Broitman, Bernardo R/D-6007-2013	Broitman, Bernardo R/0000-0001-6582-3188; Cottenie, Karl/0000-0001-9498-8483				BLANCHETTE CA, 2006, MAR BIOL; Broitman BR, 2005, LIMNOL OCEANOGR, V50, P1473, DOI 10.4319/lo.2005.50.5.1473; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Dayton PK, 1999, ECOL MONOGR, V69, P219, DOI 10.1890/0012-9615(1999)069[0219:TASSOK]2.0.CO;2; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; HALPERN BS, IN PRESS GLOBAL CHAN; HUNTER MD, 1992, ECOLOGY, V73, P724; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lafferty KD, 2004, ECOL APPL, V14, P1566, DOI 10.1890/03-5088; Legendre L., 1998, NUMERICAL ECOLOGY; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Mitsch W.J., 2001, WETLANDS; Otero MP, 2004, DEEP-SEA RES PT II, V51, P1129, DOI 10.1016/j.dsr2.2004.04.004; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Reed DC, 2000, ECOLOGY, V81, P2011; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Vinueza LR, 2006, ECOL MONOGR, V76, P111, DOI 10.1890/04-1957; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	25	85	90	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2006	312	5777					1230	1232		10.1126/science.1128613	http://dx.doi.org/10.1126/science.1128613			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728644				2022-12-28	WOS:000237957400059
J	Charles, C; Clements, P; Furst, DE				Charles, Christina; Clements, Philip; Furst, Daniel E.			Systemic sclerosis: hypothesis-driven treatment strategies	LANCET			English	Review							PULMONARY ARTERIAL-HYPERTENSION; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; CLINICAL-TRIALS; GENE-EXPRESSION; INTRAVENOUS EPOPROSTENOL; RHEUMATOID-ARTHRITIS; INCREASED PREVALENCE; DIFFUSE SCLERODERMA; RAYNAUDS-PHENOMENON	We review data from controlled trials and randomised controlled trials to examine the hypothesis for the pathogenesis of systemic sclerosis. Strategies used to treat the vascular complications in systemic sclerosis have so far shown the biggest successes, especially in the management of renal crisis and pulmonary arterial hypertension. Because these drugs have improved function and quality of life and have increased survival rates, they can truly be classified as disease-modifying compounds. Immunosuppressive therapy with cyclophosphamide in particular has also shown evidence of efficacy, and randomised controlled trials of autologous stem-cell transplantation are underway. So far, strategies to reduce or control fibrosis directly (bosentan, interferon gamma, and relaxin) have been disappointing but new strategies against fibrosis based on advanced understanding of the molecular biology of systemic sclerosis hold promise. Treatments against several cardinal features of the disorder simultaneously have not yet been examined but are being considered for future trials.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Furst, DE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, 1000 Vet Ave, Los Angeles, CA 90095 USA.	defurst@mednet.ucla.edu						Abraham DJ, 1997, AM J PATHOL, V151, P831; ALARCONSEGOVIA D, 1979, J RHEUMATOL, V6, P705; Arnett FC, 1996, ARTHRITIS RHEUM, V39, P1362, DOI 10.1002/art.1780390814; Arnett FC, 2001, ARTHRITIS RHEUM-US, V44, P1359, DOI 10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S; Artlett Carol M, 2003, Curr Rheumatol Rep, V5, P154, DOI 10.1007/s11926-003-0044-2; Badesch DB, 2004, J AM COLL CARDIOL, V43, p56S, DOI 10.1016/j.jacc.2004.02.036; Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; BECKETT VL, 1984, ARTHRITIS RHEUM, V27, P1137, DOI 10.1002/art.1780271009; BELCH JJF, 1983, LANCET, V1, P313; Black CM, 1999, ARTHRITIS RHEUM, V42, P299, DOI 10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R; BLACK CM, 1993, J INTERN MED, V234, P115, DOI 10.1111/j.1365-2796.1993.tb00719.x; BLOMBULOW B, 1981, ACTA MED SCAND, V210, P419; BLUESTONE R, 1970, ANN RHEUM DIS, V29, P153, DOI 10.1136/ard.29.2.153; CASAS JA, 1990, ANN RHEUM DIS, V49, P926, DOI 10.1136/ard.49.11.926; Christner PJ, 2000, ARTHRITIS RHEUM, V43, P2598, DOI 10.1002/1529-0131(200011)43:11<2598::AID-ANR30>3.0.CO;2-8; CLEGG DO, 1994, J RHEUMATOL, V21, P105; Clements P, 2005, ARTHRITIS RHEUM-US, V52, pS257; CLEMENTS PJ, 1993, ARTHRITIS RHEUM, V36, P75, DOI 10.1002/art.1780360113; Clements PJ, 1999, ARTHRITIS RHEUM-US, V42, P1194, DOI 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7; CLEMENTS PJ, 2004, SYSTEMIC SCLEROSIS, P129; Coustry F, 1998, BIOCHEM J, V331, P291, DOI 10.1042/bj3310291; Denton CP, 2004, ARTHRITIS RHEUM, V50, pS691; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Farge D, 2004, ANN RHEUM DIS, V63, P974, DOI 10.1136/ard.2003.011205; Feghali-Bostwick C, 2003, ARTHRITIS RHEUM, V48, P1956, DOI 10.1002/art.11173; Felinski EA, 1999, J BIOL CHEM, V274, P11672, DOI 10.1074/jbc.274.17.11672; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; FISCHER M, 1985, Z KARDIOL, V74, P298; FRANKS AG, 1982, LANCET, V1, P76; Fries R, 2005, CIRCULATION, V112, P2980, DOI 10.1161/CIRCULATIONAHA.104.523324; Furst, 2004, SYSTEMIC SCLEROSIS, P129; FURST DE, 1979, ANN RHEUM DIS, V38, P356, DOI 10.1136/ard.38.4.356; FURST DE, 1989, ARTHRITIS RHEUM, V32, P584, DOI 10.1002/anr.1780320512; FURST DE, 1996, SYSTEMIC SCLEROSIS, P275; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Ghofrani HA, 2004, J AM COLL CARDIOL, V44, P1488, DOI 10.1016/j.jacc.2004.06.060; GIBSON T, 1983, BRIT J RHEUMATOL, V22, P218; Grassegger A, 1998, BRIT J DERMATOL, V139, P639; GRUBER BL, 1991, ARTHRITIS RHEUM, V34, P362, DOI 10.1002/art.1780340315; Hamamdzic D, 2001, BMC Musculoskelet Disord, V2, P3, DOI 10.1186/1471-2474-2-3; Haustein UF, 1998, J RHEUMATOL, V25, P1917; Herrick Ariane L, 2003, Curr Rheumatol Rep, V5, P168, DOI 10.1007/s11926-003-0046-0; Hitraya EG, 1998, ARTHRITIS RHEUM-US, V41, P2048, DOI 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X; Hoyles RK, 2005, ARTHRITIS RHEUM, V52, P4110; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; IHN H, 2004, ARTHRITIS RHEUM, V44, P474; Jacobsen S, 1998, BRIT J RHEUMATOL, V37, P750; Jimenez SA, 2005, CURR OPIN RHEUMATOL, V17, P86, DOI 10.1097/01.bor.0000145516.45854.7b; Khanna D, 2005, ARTHRITIS RHEUM-US, V52, P592, DOI 10.1002/art.20787; King TE, 2005, CHEST, V127, P171, DOI 10.1378/chest.127.1.171; Korn JH, 2004, ARTHRITIS RHEUM-US, V50, P3985, DOI 10.1002/art.20676; Kucich U, 2002, AM J RESP CELL MOL, V26, P183, DOI 10.1165/ajrcmb.26.2.4666; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7; LEROY EC, 1988, J RHEUMATOL, V15, P202; Luzina IG, 2003, ARTHRITIS RHEUM-US, V48, P2262, DOI 10.1002/art.11080; MAYES MD, 2004, SYSTEMIC SCLEROSIS, P1; McLaughlin VV, 2004, ARTHRITIS RHEUM, V50, pS692; Medsger Jr T. A., 2001, ARTHRITIS ALLIED CON, P1590; Merkel PA, 2003, J RHEUMATOL, V30, P1630; Nelson J L, 2001, Curr Rheumatol Rep, V3, P222, DOI 10.1007/s11926-001-0022-5; Ohtsuka T, 2004, BRIT J DERMATOL, V150, P1091, DOI 10.1111/j.0007-0963.2004.05930.x; Oudiz RJ, 2004, CHEST, V126, P420, DOI 10.1378/chest.126.2.420; Parks CG, 1999, ENVIRON HEALTH PERSP, V107, P793, DOI 10.2307/3434342; PHILIPS N, 1995, J BIOL CHEM, V270, P9313, DOI 10.1074/jbc.270.16.9313; Pope JE, 2001, ARTHRITIS RHEUM-US, V44, P1351, DOI 10.1002/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I; REVEILLE JD, 1992, TISSUE ANTIGENS, V40, P45, DOI 10.1111/j.1399-0039.1992.tb01957.x; REVEILLE JD, 1992, J CLIN INVEST, V89, P1208, DOI 10.1172/JCI115704; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Sakkas LI, 2002, J IMMUNOL, V168, P3649, DOI 10.4049/jimmunol.168.7.3649; Schachna L, 2002, CURR OPIN RHEUMATOL, V14, P686, DOI 10.1097/00002281-200211000-00010; Seibold JR, 2005, ARTHRITIS RHEUM, V52, P4057; Seibold JR, 2000, ANN INTERN MED, V132, P871, DOI 10.7326/0003-4819-132-11-200006060-00004; Selva-O'Callaghan A, 2003, LUPUS, V12, P15, DOI 10.1191/0961203303lu248oa; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Steen V, 2003, ARTHRITIS RHEUM, V48, P516, DOI 10.1002/art.10775; Steen V, 2004, SYSTEMIC SCLEROSIS, P279; Steen V D, 2001, Am J Clin Dermatol, V2, P315, DOI 10.2165/00128071-200102050-00006; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; STEEN VD, 1984, AM J MED, V76, P779, DOI 10.1016/0002-9343(84)90986-0; Tsuji-Yamada J, 2001, J RHEUMATOL, V28, P1252; VandenHoogen FHJ, 1996, BRIT J RHEUMATOL, V35, P364; VANLAAR JM, 2002, CURR RHEUMATOL REP, V4, P275; WHITE B, 1995, ARTHRITIS RHEUM, V38, P351, DOI 10.1002/art.1780380309; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; Widom RL, 1997, GENE, V198, P407, DOI 10.1016/S0378-1119(97)00360-0; Wigley FM, 2000, ARCH INTERN MED, V160, P1101; WIGLEY FM, 1992, ARTHRITIS RHEUM, V35, P688, DOI 10.1002/art.1780350614; WIGLEY FM, 1994, ANN INTERN MED, V120, P199, DOI 10.7326/0003-4819-120-3-199402010-00004; WIGLEY FM, 2001, PRIMER RHEUMATIC DIS; WILLIAMS HJ, 1985, ARTHRITIS RHEUM, V28, P308, DOI 10.1002/art.1780280311; WILLIAMS MH, 2005, HEART           1209, DOI DOI 10.1136/HRT.2005.069484; ZARAFONETIS CJD, 1964, AM J MED SCI, V248, P550, DOI 10.1097/00000441-196411000-00006; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Ziesche R, 1999, NEW ENGL J MED, V341, P1264, DOI 10.1056/NEJM199910213411703	98	140	153	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2006	367	9523					1683	1691		10.1016/S0140-6736(06)68737-0	http://dx.doi.org/10.1016/S0140-6736(06)68737-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714190				2022-12-28	WOS:000237743100033
J	Workman, CT; Mak, HC; McCuine, S; Tagne, JB; Agarwal, M; Ozier, O; Begley, TJ; Samson, LD; Ideker, T				Workman, CT; Mak, HC; McCuine, S; Tagne, JB; Agarwal, M; Ozier, O; Begley, TJ; Samson, LD; Ideker, T			A systems approach to mapping DNA damage response pathways	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; REGULATORY NETWORKS; TRANSCRIPTION; DATABASE; GENOME; PROGRESSION; INHIBITION; REVEALS; REPAIR; AGENTS	Failure of cells to respond to DNA damage is a primary event associated with mutagenesis and environmental toxicity. To map the transcriptional network controlling the damage response, we measured genomewide binding locations for 30 damage-related transcription factors (TFs) after exposure of yeast to methyl-methanesulfonate (MMS). The resulting 5272 TF-target interactions revealed extensive changes in the pattern of promoter binding and identified damage-specific binding motifs. As systematic functional validation, we identified interactions for which the target changed expression in wild-type cells in response to MMS but was nonresponsive in cells lacking the TF. Validated interactions were assembled into causal pathway models that provide global hypotheses of how signaling, transcription, and phenotype are integrated after damage.	Univ Calif San Diego, La Jolla, CA 92093 USA; Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; SUNY Albany, Rensselaer, NY 12144 USA; MIT, Cambridge, MA 02139 USA	University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Whitehead Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Massachusetts Institute of Technology (MIT)	Ideker, T (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	trey@bioeng.ucsd.edu	Workman, Christopher T/K-1066-2015	Workman, Christopher T/0000-0002-2210-3743; Tagne, Jean-Bosco/0000-0003-1830-9156; Ideker, Trey/0000-0002-1708-8454	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070743] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES014811-01A1, R01 ES014811] Funding Source: Medline; NIGMS NIH HHS [R01 GM070743, R01 GM070743-01, R01 GM070743-02] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Begley TJ, 2004, MOL CELL, V16, P117, DOI 10.1016/j.molcel.2004.09.005; Begley TJ, 2002, MOL CANCER RES, V1, P103; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Friedberg EC, 2005, DNA REPAIR MUTAGENES; FRIEDBERG EC, 1991, MOL CELLULAR BIOL YE, V1, P147; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Habeler G, 2002, NUCLEIC ACIDS RES, V30, P80, DOI 10.1093/nar/30.1.80; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Workman C T, 2000, Pac Symp Biocomput, P467; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yeang CH, 2004, J COMPUT BIOL, V11, P243, DOI 10.1089/1066527041410382; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	29	197	204	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1054	1059		10.1126/science.1122088	http://dx.doi.org/10.1126/science.1122088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709784	Green Accepted			2022-12-28	WOS:000237628800046
J	Lovis, C; Mayor, M; Pepe, F; Alibert, Y; Benz, W; Bouchy, F; Correia, ACM; Laskar, J; Mordasini, C; Queloz, D; Santos, NC; Udry, S; Bertaux, JL; Sivan, JP				Lovis, C; Mayor, M; Pepe, F; Alibert, Y; Benz, W; Bouchy, F; Correia, ACM; Laskar, J; Mordasini, C; Queloz, D; Santos, NC; Udry, S; Bertaux, JL; Sivan, JP			An extrasolar planetary system with three Neptune-mass planets	NATURE			English	Article							SOLAR PLANETS; HARPS SEARCH; CORALIE SURVEY; MODELS; JUPITER; STARS	Over the past two years, the search for low-mass extrasolar planets has led to the detection of seven so-called 'hot Neptunes' or 'super-Earths' around Sun-like stars. These planets have masses 5 - 20 times larger than the Earth and are mainly found on close-in orbits with periods of 2 - 15 days. Here we report a system of three Neptune-mass planets with periods of 8.67, 31.6 and 197 days, orbiting the nearby star HD 69830. This star was already known to show an infrared excess possibly caused by an asteroid belt within 1 AU ( the Sun - Earth distance). Simulations show that the system is in a dynamically stable configuration. Theoretical calculations favour a mainly rocky composition for both inner planets, while the outer planet probably has a significant gaseous envelope surrounding its rocky/icy core; the outer planet orbits within the habitable zone of this star.	Observ Geneva, CH-1290 Sauverny, Switzerland; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Observ Haute Provence, F-04870 St Michel lObservatoire, France; Inst Astrophys, F-75014 Paris, France; Univ Aveiro, Dept Fis, P-3810193 Aveiro, Portugal; IMCCE, CNRS, UMR 8028, F-75014 Paris, France; Univ Lisbon, Ctr Astron & Astrofis, Observ Astron Lisboa, P-1349018 Lisbon, Portugal; Colegio Luis Verney, Ctr Geofis Evora, P-7002554 Evora, Portugal; CNRS, Serv Aeron, F-91371 Verrieres Le Buisson, France; Lab Astrophys Marseille, F-13013 Marseille, France	University of Geneva; University of Bern; UDICE-French Research Universities; Sorbonne Universite; Universidade de Aveiro; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universidade de Lisboa; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lovis, C (corresponding author), Observ Geneva, 51 Ch Maillettes, CH-1290 Sauverny, Switzerland.	christophe.lovis@obs.unige.ch; michel.mayor@obs.unige.ch	Laskar, Jacques/E-1098-2011; Santos, Nuno C/E-9957-2011; Correia, Alexandre C. M./J-4315-2013	Laskar, Jacques/0000-0003-2634-789X; Santos, Nuno C/0000-0003-4422-2919; Correia, Alexandre C. M./0000-0002-8946-8579; Alibert, Yann/0000-0002-4644-8818; Bouchy, Francois/0000-0002-7613-393X; udry, Stephane/0000-0001-7576-6236; Mordasini, Christoph/0000-0002-1013-2811; Pepe, Francesco/0000-0002-9815-773X				Alibert Y, 2005, ASTROPHYS J, V626, pL57, DOI 10.1086/431325; BARAFFE I, 2005, IN PRESS ASTRON ASTR; BARANNE A, 1996, A AS, V119, P390; Beckwith SVW, 1996, NATURE, V383, P139, DOI 10.1038/383139a0; Beichman CA, 2005, ASTROPHYS J, V626, P1061, DOI 10.1086/430059; Bouchy F, 2005, ASTRON ASTROPHYS, V440, P609, DOI 10.1051/0004-6361:20052697; Correia ACM, 2005, ASTRON ASTROPHYS, V440, P751, DOI 10.1051/0004-6361:20042376; des Etangs AL, 2004, ASTRON ASTROPHYS, V418, pL1, DOI 10.1051/0004-6361:20040106; Girardi L, 2000, ASTRON ASTROPHYS SUP, V141, P371, DOI 10.1051/aas:2000126; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Ida S, 2004, ASTROPHYS J, V604, P388, DOI 10.1086/381724; LASKAR J, 1993, PHYSICA D, V67, P257, DOI 10.1016/0167-2789(93)90210-R; Lovis C, 2005, ASTRON ASTROPHYS, V437, P1121, DOI 10.1051/0004-6361:20052864; Mayor M., 2003, MESSENGER, V114, P20; NOYES RW, 1984, ASTROPHYS J, V279, P763, DOI 10.1086/161945; Pepe F, 2004, ASTRON ASTROPHYS, V423, P385, DOI 10.1051/0004-6361:20040389; Perryman MAC, 1997, ASTRON ASTROPHYS, V323, pL49; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Queloz D, 2001, ASTRON ASTROPHYS, V379, P279, DOI 10.1051/0004-6361:20011308; Santos NC, 2002, ASTRON ASTROPHYS, V392, P215, DOI 10.1051/0004-6361:20020876; Santos NC, 2004, ASTRON ASTROPHYS, V426, pL19, DOI 10.1051/0004-6361:200400076; SCHALLER G, 1992, ASTRON ASTROPHYS SUP, V96, P269; Schneider J., 2006, EXTRASOLAR PLANETS E; Tanaka H, 2002, ASTROPHYS J, V565, P1257, DOI 10.1086/324713; Udry S, 2006, ASTRON ASTROPHYS, V447, P361, DOI 10.1051/0004-6361:20054084; UDRY S, IN PRESS PROTOSTARS, V5	30	291	294	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					305	309		10.1038/nature04828	http://dx.doi.org/10.1038/nature04828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710412	Green Submitted			2022-12-28	WOS:000237593200038
J	Usdin, M; Guillerm, M; Chirac, P				Usdin, M; Guillerm, M; Chirac, P			Neglected tests for neglected patients	NATURE			English	Editorial Material							CLINICAL-FEATURES; MALARIA; DIAGNOSIS; CHILDREN		MSF Campaign Access Essential Med, F-75011 Paris, France	Doctors Without Borders	Usdin, M (corresponding author), MSF Campaign Access Essential Med, 4 Rue St Sabin, F-75011 Paris, France.							Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109	5	13	13	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2006	441	7091					283	284		10.1038/441283a	http://dx.doi.org/10.1038/441283a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710396				2022-12-28	WOS:000237593200021
J	Bristow, RE; Berek, JS				Bristow, RE; Berek, JS			Surgery for ovarian cancer: how to improve survival	LANCET			English	Editorial Material							SPECIALIZATION; MANAGEMENT; CARCINOMA; CARE		Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Dept Gynecol & Obstet, Kelly Gynecol Oncol Serv, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Kelly Gynecol Oncol Serv, Baltimore, MD 21205 USA; Stanford Univ Hosp & Clin, Cooperat Ovarian Canc Grp Immunotherapy, Los Angeles, CA 90095 USA	Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Stanford University	Berek, JS (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	jberek@stanford.edu						Carney ME, 2002, GYNECOL ONCOL, V84, P36, DOI 10.1006/gyno.2001.6460; EISENKOP SM, 1992, GYNECOL ONCOL, V47, P203, DOI 10.1016/0090-8258(92)90107-T; Engelen MJA, 2006, CANCER-AM CANCER SOC, V106, P589, DOI 10.1002/cncr.21616; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; *IARC, 2006, GLOBOCAN 2002 ANC IN; JUNOR EJ, 1994, BRIT J CANCER, V70, P363, DOI 10.1038/bjc.1994.307; Junor EJ, 1999, BRIT J OBSTET GYNAEC, V106, P1130, DOI 10.1111/j.1471-0528.1999.tb08137.x; KEHOE S, 1994, BRIT J CANCER, V70, P1014, DOI 10.1038/bjc.1994.440; Paulsen T, 2006, INT J GYNECOL CANCER, V16, P11, DOI 10.1111/j.1525-1438.2006.00319.x; SELTZER V, 1995, JAMA-J AM MED ASSOC, V273, P491, DOI 10.1001/jama.1995.03520300065039; Woodman C, 1997, BRIT J OBSTET GYNAEC, V104, P135, DOI 10.1111/j.1471-0528.1997.tb11032.x	11	37	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1558	1560		10.1016/S0140-6736(06)68671-6	http://dx.doi.org/10.1016/S0140-6736(06)68671-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698396				2022-12-28	WOS:000237598000008
J	Hess, H				Hess, H			Materials science - Toward devices powered by biomolecular motors	SCIENCE			English	Editorial Material							TRANSPORT; DRIVEN; SURFACE		Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Hess, H (corresponding author), Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.	hhess@mse.ufl.edu	Hess, Henry/A-5224-2008; Hess, Henry/GPG-4092-2022	Hess, Henry/0000-0002-5617-606X; 				Bachand M, 2005, J NANOSCI NANOTECHNO, V5, P718, DOI 10.1166/jnn.2005.112; Baughman RH, 2005, SCIENCE, V308, P63, DOI 10.1126/science.1099010; Clemmens J, 2003, LANGMUIR, V19, P10967, DOI 10.1021/la035519y; Diez S, 2003, NANO LETT, V3, P1251, DOI 10.1021/nl034504h; Fletcher SP, 2005, SCIENCE, V310, P80, DOI 10.1126/science.1117090; Grove TJ, 2005, IEEE T ADV PACKAGING, V28, P556, DOI 10.1109/TADVP.2005.858341; Hess H, 2005, NANO LETT, V5, P629, DOI 10.1021/nl0478427; Hess H, 2004, CHEM-EUR J, V10, P2110, DOI 10.1002/chem.200305712; Hiratsuka Y, 2001, BIOPHYS J, V81, P1555, DOI 10.1016/S0006-3495(01)75809-2; Howard J., 2001, MECH MOTOR PROTEINS; Huang YM, 2005, IEEE T ADV PACKAGING, V28, P564, DOI 10.1109/TADVP.2005.858330; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Sailor MJ, 2005, CHEM COMMUN, P1375, DOI 10.1039/b417554a; Stracke R, 2000, NANOTECHNOLOGY, V11, P52, DOI 10.1088/0957-4484/11/2/302; van den Heuvel MGL, 2006, SCIENCE, V312, P910, DOI 10.1126/science.1124258	15	37	37	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					860	861		10.1126/science.1126399	http://dx.doi.org/10.1126/science.1126399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690850				2022-12-28	WOS:000237452900029
J	Stanley, GD				Stanley, GD			Ecology - Photosymbiosis and the evolution of modern coral reefs	SCIENCE			English	Editorial Material									Univ Montana, Paleontol Ctr, Missoula, MT 59812 USA	University of Montana System; University of Montana	Stanley, GD (corresponding author), Univ Montana, Paleontol Ctr, Missoula, MT 59812 USA.	george.stanley@umontana.edu						Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; COPPER P, 1989, CANADIAN SOC PETROLE, V13, P271; Fautin DG, 2004, HYDROBIOLOGIA, V530, P459, DOI 10.1007/s10750-004-2642-z; Flugel E., 2002, PHANEROZOIC REEF PAT, P391; HALLOCK P, 1986, Palaios, V1, P389, DOI 10.2307/3514476; HOEGHGULDBERG O, 2005, J GEOPHYS RES, V110, P1029; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Leinfelder RR, 2001, T GEOBIOL, V17, P251; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; Palliani RB, 2000, J MICROPALAEONTOL, V19, P133, DOI 10.1144/jm.19.2.133; Perrin Christine, 2002, P587, DOI 10.2110/pec.02.72.0587; Rosen B.R., 1989, Memoir of the Association of Australasian Palaeontologists, V8, P355; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sotka EE, 2005, TRENDS ECOL EVOL, V20, P59, DOI 10.1016/j.tree.2004.11.015; STANLEY GD, 1995, PALEOBIOLOGY, V21, P179, DOI 10.1017/S0094837300013191; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Talent J.A., 1988, Senckenbergiana Lethaea, V69, P315; Wood R., 1999, REEF EVOLUTION	19	105	108	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					857	858		10.1126/science.1123701	http://dx.doi.org/10.1126/science.1123701			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690848				2022-12-28	WOS:000237452900027
J	Annas, GJ				Annas, GJ			The patient's right to safety - Improving the quality of care through litigation against hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LIABILITY; REFORM		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Altman DE, 2004, NEW ENGL J MED, V351, P2041, DOI 10.1056/NEJMp048243; Annas GJ, 2004, RIGHTS PATIENTS; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Bovbjerg RR, 2005, J LAW MED ETHICS, V33, P478, DOI 10.1111/j.1748-720X.2005.tb00513.x; Budetti PP, 2005, JAMA-J AM MED ASSOC, V293, P2660, DOI 10.1001/jama.293.21.2660; Centers for Disease Control and Prevention (CDC), 2016, DEV WAT MAN PROGR RE; Entwistle VA, 2005, JT COMM J QUAL PATIE, V31, P483, DOI 10.1016/S1553-7250(05)31063-4; Hallinan J. T., 2005, WALL STREET J, pA1; Hyman DA, 2005, CORNELL LAW REV, V90, P893; *I MED COMM QUAL H, 1999, ERR IS HUM BUILD SAF; Jacobson PD, 2005, JAMA-J AM MED ASSOC, V294, P2083, DOI 10.1001/jama.294.16.2083; Katz J., 1984, SILENT WORLD DOCTOR; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Mariner WK., 2001, MED ERROR REPORTING; Mello MM, 2005, JAMA-J AM MED ASSOC, V294, P1817, DOI 10.1001/jama.294.14.1817; Mello MM, 2003, NEW ENGL J MED, V349, P1280, DOI 10.1056/NEJMhpr035095; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Mello MM, 2002, TEX LAW REV, V80, P1595; Morath J. M., 2005, DO NO HARM ENSURING; Romano PS, 2005, NEW ENGL J MED, V353, P302, DOI 10.1056/NEJMe058150; Sage WM, 2003, HEALTH AFFAIR, V22, P26, DOI 10.1377/hlthaff.22.4.26; Scholen MS, 2005, HLTH AFF MILLWOOD W, V3, P509; Wachter R.M., 2004, HEALTH AFFAIR; Weiler Paul C., 2005, DEPAUL LAW REV, V54, P205; Weinstein RA, 2005, NEW ENGL J MED, V353, P225, DOI 10.1056/NEJMp058073; Weinstein RA, 2005, NEW ENGL J MED, V353, P1869	26	36	37	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2063	2066		10.1056/NEJMsb053756	http://dx.doi.org/10.1056/NEJMsb053756			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040XA	16687721	Green Published			2022-12-28	WOS:000237413100015
J	Okie, S				Okie, S			Fighting HIV - Lessons from Brazil	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		BEYRER C, 2005, EVALUATION WORLD BAN; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; DOWNIE A, 2005, CHRISTIAN SCI M 0823, P4; *JOINT UN PROGR HI, 2005, AIDS EP UPD SPEC REP; *MIN HLTH BRAZ PRO, 2005, RESP MAG	5	100	104	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					1977	1981		10.1056/NEJMp068069	http://dx.doi.org/10.1056/NEJMp068069			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040XA	16687709	Bronze			2022-12-28	WOS:000237413100001
J	Wardlaw, JM; Chappell, FM; Best, JJK; Wartolowska, K; Berry, E				Wardlaw, JM; Chappell, FM; Best, JJK; Wartolowska, K; Berry, E		NHS Res Dev Hlth Technol Assessmen	Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis	LANCET			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; SPIRAL CT ANGIOGRAPHY; ENHANCED MR-ANGIOGRAPHY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ARTERY STENOSIS; DUPLEX ULTRASOUND; CONVENTIONAL ANGIOGRAPHY; ROTATIONAL ANGIOGRAPHY; CEREBRAL-ANGIOGRAPHY	Background Accurate carotid imaging is important for effective secondary stroke prevention. Non-invasive imaging, now widely available, is replacing intra-arterial angiography for carotid stenosis, but the accuracy remains uncertain despite an extensive literature. We systematically reviewed the accuracy of non-invasive imaging compared with intra-arterial angiography for diagnosing carotid stenosis in patients with carotid territory ischaemic symptoms. Methods We searched for articles published between 1980 and April 2004; included studies comparing non-invasive imaging with intra-arterial angiography that met Standards for Reporting of Diagnostic Accuracy (STARD) criteria; extracted data to calculate sensitivity and specificity of non-invasive imaging, to test for heterogeneity and to perform sensitivity analyses; and categorised percent stenosis by the North American Symptomatic Carotid Endarterectomy Trial (NASCET) method. Results In 41 included studies (2541 patients, 4876 arteries), contrast-enhanced MR angiography was more sensitive (0.94, 95% Cl 0.88-0.97) and specific (0.93, 95% CI 0.89-0.96) for 70-99% stenosis than Doppler ultrasound, MR angiography, and CT angiography (sensitivities 0.89, 0.88, 0.76; specificities 0.84, 0.84, 0.94, respectively). Data for 50-69% stenoses and combinations of non-invasive tests were sparse and unreliable. There was heterogeneity between studies and evidence of publication bias. Interpretation Non-invasive tests, used cautiously, could replace intra-arterial carotid angiography for 70-99% stenosis. However, more data are required to determine their accuracy, especially at 50-69% stenoses where the balance of risk and benefit for carotid endarterectomy is particularly narrow, and to explore and overcome heterogeneity. Methodology for evaluating imaging tests should be improved; blinded, prospective studies in clinically relevant patients are essential basic characteristics.	Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Oxford, Dept Neurol, Oxford OX1 2JD, England; Univ Leeds, Dept Med Phys, Leeds, W Yorkshire, England	University of Edinburgh; University of Oxford; University of Leeds	Wardlaw, JM (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	joanna.wardlaw@ed.ac.uk	Wartolowska, Karolina/D-3968-2015; Wardlaw, Joanna M/Y-3456-2019; Hernandez, María/GYU-3543-2022	Wardlaw, Joanna M/0000-0002-9812-6642; Wartolowska, Karolina A./0000-0003-4049-2364	National Institute for Health Research [01/37/03] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Alvarez-Linera J, 2003, AM J NEURORADIOL, V24, P1012; Anderson GB, 2000, STROKE, V31, P2168, DOI 10.1161/01.STR.31.9.2168; Anzalone N, 2005, RADIOLOGY, V236, P204, DOI 10.1148/radiol.2361032048; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; BERRY E, 2002, HLTH TECH ASSES, P6; BLAKELEY DD, 1995, ANN INTERN MED, V122, P360, DOI 10.7326/0003-4819-122-5-199503010-00007; BONE G, 1988, EUR NEUROL, V28, P73, DOI 10.1159/000116233; Bonig L, 2000, EUR J NEUROL, V7, P183, DOI 10.1046/j.1468-1331.2000.00031.x; Borisch I, 2003, AM J NEURORADIOL, V24, P1117; Bossuyt PM, 2003, CLIN RADIOL, V58, P575, DOI 10.1016/S0009-9260(03)00258-7; Catalano C, 2001, Radiol Med, V101, P54; Cosottini M, 2003, STROKE, V34, P660, DOI 10.1161/01.STR.0000057462.02141.6F; CUMMING MJ, 1994, AM J ROENTGENOL, V163, P517, DOI 10.2214/ajr.163.3.8079836; Dadachanji M C, 1995, J Assoc Physicians India, V43, P92; DAVIES KN, 1993, J NEUROL NEUROSUR PS, V56, P967, DOI 10.1136/jnnp.56.9.967; Deeks JJ., 2001, SYSTEMATIC REV HLTH, P248, DOI DOI 10.1002/9780470693926.CH14; DILLON EH, 1993, RADIOLOGY, V189, P211, DOI 10.1148/radiology.189.1.8372196; Dix J, 2000, AM J NEURORADIOL, V21, P639; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Elgersma OEH, 2000, RADIOLOGY, V216, P511, DOI 10.1148/radiology.216.2.r00au02511; Fairhead JF, 2005, NEUROLOGY, V65, P371, DOI 10.1212/01.WNL.0000170368.82460.b4; Feinstein AR, 2002, J EPIDEMIOL COMMUN H, V56, P330, DOI 10.1136/jech.56.5.330; FISHER CM, 1998, J VASC INVEST, V4, P91; Fleiss J., 2003, STAT METHODS RATES P, P212; Haynes RB, 2004, BMJ-BRIT MED J, V328, P1040, DOI 10.1136/bmj.38068.557998.EE; Heijenbrok-Kal MH, 2005, STROKE, V36, P2105, DOI 10.1161/01.STR.0000181753.40455.07; HUMPHREY P, 1990, J NEUROL NEUROSUR PS, V53, P966, DOI 10.1136/jnnp.53.11.966; HUSTON J, 1993, RADIOLOGY, V186, P339, DOI 10.1148/radiology.186.2.8421731; Hyde DE, 2004, STROKE, V35, P2776, DOI 10.1161/01.STR.0000147037.12223.d5; Jahromi AS, 2005, J VASC SURG, V41, P962, DOI 10.1016/j.jvs.2005.02.044; Kallmes DF, 1996, AM J NEURORADIOL, V17, P1501; Kelly S, 1997, BRIT J RADIOL, V70, P1028, DOI 10.1259/bjr.70.838.9404207; KENT DL, 1994, ANN INTERN MED, V120, P856, DOI 10.7326/0003-4819-120-10-199405150-00007; Knudsen L, 2002, EUR J VASC ENDOVASC, V24, P86, DOI 10.1053/ejvs.2002.1659; Koelemay MJW, 2004, STROKE, V35, P2306, DOI 10.1161/01.STR.0000141426.63959.cc; LASTER RE, 1993, AM J NEURORADIOL, V14, P681; LECLERC X, 1995, STROKE, V26, P1577, DOI 10.1161/01.STR.26.9.1577; Leclerc X, 1999, RADIOLOGY, V210, P673, DOI 10.1148/radiology.210.3.r99fe46673; Levi CR, 1996, CEREBROVASC DIS, V6, P231, DOI 10.1159/000108026; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lilford RJ, 2000, BRIT MED J, V320, P43, DOI 10.1136/bmj.320.7226.43; Link J, 1997, AM J ROENTGENOL, V168, P361, DOI 10.2214/ajr.168.2.9016207; Link J, 1996, AM J NEURORADIOL, V17, P89; Long A, 2002, EUR J VASC ENDOVASC, V24, P43, DOI 10.1053/ejvs.2002.1666; Magarelli N, 1998, NEURORADIOLOGY, V40, P367, DOI 10.1007/s002340050601; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Nederkoorn PJ, 2003, STROKE, V34, P1324, DOI 10.1161/01.STR.0000068367.08991.A2; Nederkoorn PJ, 2002, STROKE, V33, P2003, DOI 10.1161/01.STR.0000021900.58396.44; Osarumwense D, 2005, VASCULAR, V13, P173, DOI 10.2310/6670.2005.00067; PATEL MR, 1995, STROKE, V26, P1753, DOI 10.1161/01.STR.26.10.1753; Patel SG, 2002, J NEUROL NEUROSUR PS, V73, P21, DOI 10.1136/jnnp.73.1.21; Reed J F 3rd, 1991, Biomed Instrum Technol, V25, P465; REED JF, 1995, VASCULAR SURG, V29, P177, DOI 10.1177/153857449502900302; Remonda L, 1998, RADIOLOGY, V209, P95, DOI 10.1148/radiology.209.1.9769818; ROTHWELL PM, 1994, STROKE, V25, P2440, DOI 10.1161/01.STR.25.12.2440; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2005, LANCET, V365, P256; Rothwell PM, 2000, STROKE, V31, P1444, DOI 10.1161/01.STR.31.6.1444; Sardanelli F, 1999, J COMPUT ASSIST TOMO, V23, P208, DOI 10.1097/00004728-199903000-00008; Scarabino T, 1998, Radiol Med, V95, P170; Scarabino T, 1998, EUR J RADIOL, V28, P117, DOI 10.1016/S0720-048X(97)00121-6; Simeone A, 1997, J NEURORADIOLOGY, V24, P18; SITZER M, 1993, STROKE, V24, P1513, DOI 10.1161/01.STR.24.10.1513; Tang JL, 2000, J CLIN EPIDEMIOL, V53, P477, DOI 10.1016/S0895-4356(99)00204-8; Tetickovic E, 2001, COLLEGIUM ANTROPOL, V25, P511; TURNIPSEED WD, 1993, J VASC SURG, V17, P832, DOI 10.1016/0741-5214(93)90032-H; UEHARA T, 1995, CEREBROVASC DIS, V5, P199, DOI 10.1159/000107852; VANMERODE T, 1989, STROKE, V20, P1336, DOI 10.1161/01.STR.20.10.1336; VANNINEN R, 1995, AM J NEURORADIOL, V16, P1875; Wardlaw JM, 2001, J NEUROL NEUROSUR PS, V71, P155, DOI 10.1136/jnnp.71.2.155; Westwood ME, 2002, BRIT MED J, V324, P198, DOI 10.1136/bmj.324.7331.198; WHITE JE, 1994, AM SURGEON, V60, P340; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Winkelaar GB, 1999, J VASC SURG, V29, P986, DOI 10.1016/S0741-5214(99)70239-9; Worthy SA, 1997, NEURORADIOLOGY, V39, P122, DOI 10.1007/s002340050378; Young GR, 1996, STROKE, V27, P467, DOI 10.1161/01.STR.27.3.467; Zbornikova V, 1998, J NEUROIMAGING, V8, P132, DOI 10.1111/jon199883132	80	227	237	1	19	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 6	2006	367	9521					1503	1512		10.1016/S0140-6736(06)68650-9	http://dx.doi.org/10.1016/S0140-6736(06)68650-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679163				2022-12-28	WOS:000237324200030
J	Gupta, A; Gartner, JJ; Sethupathy, P; Hatzigeorgiou, AG; Fraser, NW				Gupta, A.; Gartner, J. J.; Sethupathy, P.; Hatzigeorgiou, A. G.; Fraser, N. W.			RETRACTED: Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript (Retracted Article. See vol 451, pg 600, 2008)	NATURE			English	Article; Retracted Publication							SIMPLEX-VIRUS TYPE-1	MicroRNAs (miRNAs) are a class of small RNA molecules that regulate the stability or the translational efficiency of target messenger RNAs (mRNAs)(1,2). The latency-associated transcript (LAT) of herpes simplex virus-1 (HSV-1) is the only viral gene expressed during latent infection in neurons(3). LAT inhibits apoptosis and maintains latency by promoting the survival of infected neurons(4). No protein product has been attributed to the LAT gene and the mechanism by which LAT protects cells from apoptosis is not yet known. Here we show that a miRNA encoded by the HSV-1 LAT gene confers resistance to apoptosis. Neuroblastoma cells transfected with a fragment of the LAT gene show reduced susceptibility to cell death. The anti-apoptotic function of LAT has been mapped to a region within the first exon(5,6). We have identified and characterized a microRNA (miR-LAT) generated from the exon 1 region of the HSV-1 LAT gene. The LAT miRNA was found to accumulate in cells transiently transfected with the LAT gene fragment or infected with a wild-type strain of HSV-1. A mutant virus in which a 372-nucleotide fragment encompassing the mature miRNA was deleted neither protected the infected cells from apoptosis nor generated an miRNA. miR-LAT exerts its antiapoptotic effect by downregulation of transforming growth factor (TGF)-beta 1 and SMAD3 expression, both of which are functionally linked in the TGF-beta pathway. Our results suggest that the miRNA encoded by the HSV-1 LAT gene regulates the induction of apoptosis in infected cells by modulation of TGF-beta signalling and thus contributes to the persistence of HSV in a latent form in sensory neurons.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Fraser, NW (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	nwfraser@mail.med.upenn.edu	Hatzigeorgiou, Artemis/Z-1976-2019					Ahmed M, 2002, J VIROL, V76, P717, DOI 10.1128/JVI.76.2.717-729.2002; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Inman M, 2001, J VIROL, V75, P3636, DOI 10.1128/JVI.75.8.3636-3646.2001; Jin L, 2005, J VIROL, V79, P12286, DOI 10.1128/JVI.79.19.12286-12295.2005; Jin L, 2003, J VIROL, V77, P6556, DOI 10.1128/JVI.77.11.6556-6561.2003; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jones C, 2003, CLIN MICROBIOL REV, V16, P79, DOI 10.1128/CMR.16.1.79-95.2003; LAFERRIERE A, 1994, COMPUT APPL BIOSCI, V10, P211; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Schuetz S, 2006, VIROLOGY, V344, P151, DOI 10.1016/j.virol.2005.09.034; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	22	209	252	1	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					82	85		10.1038/nature04836	http://dx.doi.org/10.1038/nature04836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16738545				2022-12-28	WOS:000238724500041
J	Patterson, N; Richter, DJ; Gnerre, S; Lander, ES; Reich, D				Patterson, Nick; Richter, Daniel J.; Gnerre, Sante; Lander, Eric S.; Reich, David			Genetic evidence for complex speciation of humans and chimpanzees	NATURE			English	Article							ANCESTRAL POPULATION SIZES; UPPER MIOCENE; DROSOPHILA-MAURITIANA; DIVERGENCE TIMES; DNA-SEQUENCES; GENOMIC DATA; EVOLUTION; HOMINID; PALEONTOLOGY; CHROMOSOMES	The genetic divergence time between two species varies substantially across the genome, conveying important information about the timing and process of speciation. Here we develop a framework for studying this variation and apply it to about 20 million base pairs of aligned sequence from humans, chimpanzees, gorillas and more distantly related primates. Human-chimpanzee genetic divergence varies from less than 84% to more than 147% of the average, a range of more than 4 million years. Our analysis also shows that human-chimpanzee speciation occurred less than 6.3 million years ago and probably more recently, conflicting with some interpretations of ancient fossils. Most strikingly, chromosome X shows an extremely young genetic divergence time, close to the genome minimum along nearly its entire length. These unexpected features would be explained if the human and chimpanzee lineages initially diverged, then later exchanged genes before separating permanently.	Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Reich, D (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02142 USA.	reich@genetics.med.harvard.edu		Richter, Daniel/0000-0002-9238-5571				Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BOAG PT, 1984, BIOL J LINN SOC, V22, P243, DOI 10.1111/j.1095-8312.1984.tb01679.x; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Coyne J.A., 1989, P180; Coyne J.A., 2004, SPECIATION; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; HALDANE JBS, 1962, J GENET, V58, P237; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MacLatchy L, 2000, J HUM EVOL, V39, P159, DOI 10.1006/jhev.2000.0407; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; O'hUigin C, 2002, MOL BIOL EVOL, V19, P1501, DOI 10.1093/oxfordjournals.molbev.a004213; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Osada N, 2005, GENETICS, V169, P259, DOI 10.1534/genetics.104.029231; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Pilbeam D, 2004, CR PALEVOL, V3, P305, DOI 10.1016/j.crpv.2004.01.006; Rannala B, 2003, GENETICS, V164, P1645; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Sarich V.M., 1983, P137; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Schwarz D, 2005, NATURE, V436, P546, DOI 10.1038/nature03800; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; Tao Y, 2003, GENETICS, V164, P1383; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; True JR, 1996, GENETICS, V142, P819; TUCKER PK, 1992, EVOLUTION, V46, P1146, DOI 10.1111/j.1558-5646.1992.tb00625.x; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wall JD, 2003, GENETICS, V163, P395; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	43	381	388	1	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1103	1108		10.1038/nature04789	http://dx.doi.org/10.1038/nature04789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16710306				2022-12-28	WOS:000238615500040
J	Manuel, DG; Kwong, K; Tanuseputro, P; Lim, J; Mustard, CA; Anderson, GM; Ardal, S; Alter, DA; Laupacis, A				Manuel, Douulas G.; Kwong, Kelvin; Tanuseputro, Peter; Lim, Jenny; Mustard, Cameron A.; Anderson, Geoffrey M.; Ardal, Sten; Alter, David A.; Laupacis, Andreas			Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; RISK; PREDICTION; MANAGEMENT; IMPACT	Objective To examine the potential effectiveness and efficiency of different guidelines for statin treatment to reduce deaths from coronary heart disease in the Canadian population. Design Modelled outcomes of screening and treatment recommendations of six national or international guidelines-from Canada, Australia, New Zealand, the United States,joint British societies, and European societies. Setting Canada. Data sources Details for 6760 men and women aged 20-74 years front the Canadian Heart Health Survey (weighted sample of 12 300 000 people) that included physical measurements including a lipid profile. Main outcome measures The number of people recommended for treatment with statins, die potential number of deaths from coronary heart disease avoided, and the number needed to treat to avoid one coronary heart disease death with five),cars of statin treatment if the recommendations from each guideline were frills implemented. Results When applied to the Canadian population, the Australian mid British guidelines were the most effective, potentially avoiding the most deaths over five years (> 15 000 deaths). The New Zealand guideline was the most efficient, potentially avoiding almost as many deaths (14 700) while recommending treatment to the fewest number of people (12.9% of people v 17.3% with the Australian and British guidelines). If their "optional" recommendations are g g included. the US guidelines recommended treating about twice as many people as the New Zealand guidelines (24.5% of the population, an additional 1.4 0 million people) with almost no increase in the number of deaths avoided. Conclusions By focusing recommendations on people with the highest risk of coronary heart disease, the Canadian, US, and European societies guidelines could improve either their effectiveness (in terms of hundreds of avoided deaths) or efficiency (in terms of thousands of fewer people recommended treatment) in the Canadian population.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Inst Work & Hlth, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Cent E Hlth Informat Partnership, Toronto, ON, Canada	University of Toronto; Institute for Work & Health; University of Toronto	Manuel, DG (corresponding author), Inst Clin Evaluat Sci, G-106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	doug.manuel@ices.on.ca	; Manuel, Doug/D-7100-2014	Tanuseputro, Peter/0000-0002-4409-0795; Kwong, Kelvin/0000-0001-6417-2432; Manuel, Doug/0000-0003-0912-0845				Alter DA, 2004, AM J MED, V116, P540, DOI 10.1016/j.amjmed.2003.10.039; Berger GMB, 2000, S AFR MED J, V90, P164; *BRIT HEART FDN, 2004, UPD GUID CARD DIS RI; Clemenson ND, 2000, JAMA-J AM MED ASSOC, V283, P2935, DOI 10.1001/jama.283.22.2935; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Genest J, 2003, CAN MED ASSOC J, V169, P921; Grover SA, 1999, J CLIN EPIDEMIOL, V52, P49, DOI 10.1016/S0895-4356(98)00139-5; Hata Yoshiya, 2002, J Atheroscler Thromb, V9, P1; Heller RF, 2000, BRIT MED J, V321, P950, DOI 10.1136/bmj.321.7266.950; Hense HW, 2004, INT J EPIDEMIOL, V33, P235, DOI 10.1093/ije/dyh118; Institute of Medicine, 1992, GUID CLIN PRACT DEV; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jackevicius CA, 2003, CAN J CARDIOL, V19, P1359; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; MACLEAN DR, 1992, CAN MED ASSOC J, V146, P1969; MacLean DR, 1999, CAN J CARDIOL, V15, P445; Mitka M, 2003, JAMA-J AM MED ASSOC, V290, P2243, DOI 10.1001/jama.290.17.2243; National Heart Foundation of Australia, 2001, MED J AUST S, V175, pS57; *NCEP, 2002, 025215 NIH NCEP US D; Tanuseputro P, 2003, CAN J CARDIOL, V19, P1249; TUGWELL P, 1985, J CHRON DIS, V38, P339, DOI 10.1016/0021-9681(85)90080-3; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	27	70	71	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1419	1422		10.1136/bmj.38849.487546.DE	http://dx.doi.org/10.1136/bmj.38849.487546.DE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16737980	Green Published, Bronze			2022-12-28	WOS:000238550800029
J	Nixon, J; Cranny, G; Iglesias, C; Nelson, EA; Hawkins, K; Phillips, A; Toraerson, D; Mason, S; Cullum, N				Nixon, Jane; Cranny, Gillian; Iglesias, Cynthia; Nelson, E. Andrea; Hawkins, Kim; Phillips, Angela; Torgerson, David; Mason, Su; Cullum, Nicky		PRESSURE Trial Grp	Randomised, controlled trial of alternating pressure mattresses compared with alternating pressure overlays for the prevention of pressure ulcers: PRESSURE (pressure relieving support surfaces) trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS	Objective To compare whether differences exist between alternating pressure overlays and alternating pressure mattresses in the development of new pressure ulcers, healing of existing pressure ulcers, and patient acceptability. Design Pragmatic, open, multicentre, randomised controlled trial. Setting 11 hospitals in six NHS trusts. Participants 1972 people admitted to hospital as acute or elective patients. Interventions Participants were randomised to an alternating pressure mattress (n = 982) of- an alternating pressure overlay (n = 990). Main outcome measures The proportion of participants developing a new pressure ulcer of grade 2 or worse; time to development of new pressure ulcers; proportions of participants developing a new ulcer within 30 days; healing of existing pressure ulcers; and patient acceptability Results Intention to treat analysis found no difference in the proportions of participants developing a new pressure ulcer of grade 2 or worse (10.7% overlay patients, 10.3% mattress patients; difference 0.4%, 95% confidence interval - 23% to 3.1%, P = 0.75). More overlay patients requested change owing to dissatisfaction (23.3%) than mattress patients (18.9%, P = 0.02). Conclusion No difference was found between alternating pressure mattresses and alternating pressure overlays in the proportion of people who develop a pressure ulcer.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Univ Leeds, Clin Trials Res Unit, Leeds LS2 9JT, W Yorkshire, England; Univ York, Ctr Rev & Disseminat, York YO10 5DD, N Yorkshire, England; Univ Leeds, Sch Healthcare Studies, Leeds LS2 9JT, W Yorkshire, England	University of York - UK; University of Leeds; University of York - UK; University of Leeds	Cullum, N (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	nac2@york.ac.uk	Cullum, Nicky/AAT-5888-2020; Nelson, Andrea/K-2733-2012; Cullum, Nicky A/F-2438-2011	Cullum, Nicky/0000-0003-2631-123X; Nelson, Andrea/0000-0001-6741-3078; Cullum, Nicky A/0000-0003-2631-123X; Cocks, Kim/0000-0003-2595-708X; Torgerson, David/0000-0002-1667-4275	Department of Health [97/06/14] Funding Source: Medline; National Institute for Health Research [97/06/14] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		ALLMAN RM, 1995, JAMA-J AM MED ASSOC, V273, P865, DOI 10.1001/jama.273.11.865; Baumgarten M, 2003, WOUND REPAIR REGEN, V11, P96, DOI 10.1046/j.1524-475X.2003.11204.x; BERGSTROM N, 1987, NURS RES, V36, P205, DOI 10.1097/00006199-198707000-00002; Berlowitz DR, 2001, J AM GERIATR SOC, V49, P866, DOI 10.1046/j.1532-5415.2001.49175.x; BRANDEIS GH, 1994, J AM GERIATR SOC, V42, P388, DOI 10.1111/j.1532-5415.1994.tb07486.x; Cullum N., 2004, COCHRANE DB SYST REV, V3, P1735, DOI DOI 10.1002/14651858.CD001735.PUB2; *EUR PRESS ULC ADV, 1999, PRESS ULC TREATM GUI; Iglesias C, 2006, BMJ-BRIT MED J, V332, P1416, DOI 10.1136/bmj.38850.711435.7C; Kaltenthaler E, 2001, J Wound Care, V10, P530; Nixon J, 2005, J ADV NURS, V50, P613, DOI 10.1111/j.1365-2648.2005.03439.x; Papanikolaou P, 2002, INT J NURS STUD, V39, P187, DOI 10.1016/S0020-7489(01)00011-6; Reed RL, 2003, GERONTOLOGY, V49, P255, DOI 10.1159/000070407; Theaker C, 2000, ANAESTHESIA, V55, P221, DOI 10.1046/j.1365-2044.2000.01216.x	13	84	89	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1413	1415		10.1136/bmj.38849.478299.7C	http://dx.doi.org/10.1136/bmj.38849.478299.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16740530	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000238550800023
J	Norskov, JK; Christensen, CH				Norskov, JK; Christensen, CH			Chemistry - Toward efficient hydrogen production at surfaces	SCIENCE			English	Editorial Material							CATALYSTS; WATER		Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark; Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Norskov, JK (corresponding author), Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark.	norskov@fysik.dtu.dk; chc@kemi.dtu.dk	Norskov, Jens K/D-2539-2017	Norskov, Jens K/0000-0002-4427-7728				Andersson MP, 2006, J CATAL, V239, P501, DOI 10.1016/j.jcat.2006.02.016; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Deluga GA, 2004, SCIENCE, V303, P993, DOI 10.1126/science.1093045; Filhol JS, 2006, ANGEW CHEM INT EDIT, V45, P402, DOI 10.1002/anie.200502540; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Greeley J, 2004, J AM CHEM SOC, V126, P3910, DOI 10.1021/ja037700z; Hinnemann B, 2005, J AM CHEM SOC, V127, P5308, DOI 10.1021/ja0504690; Jacobson MZ, 2005, SCIENCE, V308, P1901, DOI 10.1126/science.1109157; Lauritsen JV, 2006, CATAL TODAY, V111, P34, DOI 10.1016/j.cattod.2005.10.015; Ogasawara H, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.276102; Rostrup-Nielsen JR, 2004, CATAL REV, V46, P247, DOI 10.1081/CR-200036716; Siegbahn PEM, 2004, ADV INORG CHEM, V56, P101, DOI 10.1016/S0898-8838(04)56004-X	12	341	344	15	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1322	1323		10.1126/science.1127180	http://dx.doi.org/10.1126/science.1127180			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741103				2022-12-28	WOS:000237961600036
J	Saito, J; Miyamoto, H; Nakamura, R; Ishiguro, M; Michikami, T; Nakamura, AM; Demura, H; Sasaki, S; Hirata, N; Honda, C; Yamamoto, A; Yokota, Y; Fuse, T; Yoshida, F; Tholen, DJ; Gaskell, RW; Hashimoto, T; Kubota, T; Higuchi, Y; Nakamura, T; Smith, P; Hiraoka, K; Honda, T; Kobayashi, S; Furuya, M; Matsumoto, N; Nemoto, E; Yukishita, A; Kitazato, K; Dermawan, B; Sogame, A; Terazono, J; Shinohara, C; Akiyama, H				Saito, J; Miyamoto, H; Nakamura, R; Ishiguro, M; Michikami, T; Nakamura, AM; Demura, H; Sasaki, S; Hirata, N; Honda, C; Yamamoto, A; Yokota, Y; Fuse, T; Yoshida, F; Tholen, DJ; Gaskell, RW; Hashimoto, T; Kubota, T; Higuchi, Y; Nakamura, T; Smith, P; Hiraoka, K; Honda, T; Kobayashi, S; Furuya, M; Matsumoto, N; Nemoto, E; Yukishita, A; Kitazato, K; Dermawan, B; Sogame, A; Terazono, J; Shinohara, C; Akiyama, H			Detailed images of asteroid 25143 Itokawa from Hayabusa	SCIENCE			English	Article							GALILEO PHOTOMETRY; COLOR VARIATIONS; EJECTA BLOCKS; MUSES-C; EROS; REFLECTANCE; SIMULATION; REGOLITH; CAMERA; LUNAR	Rendezvous of the Japanese spacecraft Hayabusa with the near-Earth asteroid 25143 Itokawa took place during the interval September through November 2005. The onboard camera imaged the solid surface of this tiny asteroid ( 535 meters by 294 meters by 209 meters) with a spatial resolution of 70 centimeters per pixel, revealing diverse surface morphologies. Unlike previously explored asteroids, the surface of Itokawa reveals both rough and smooth terrains. Craters generally show unclear morphologies. Numerous boulders on Itokawa's surface suggest a rubble-pile structure.	Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Hayabusa Project Team, Kanagawa 2298510, Japan; Tokai Univ, Sch Engn, Kanagawa 2591292, Japan; Univ Tokyo, Dept Geosyst Engn, Tokyo 1138656, Japan; Planetary Sci Inst, Tucson, AZ 85719 USA; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; JAXA, ISAS, Dept Planetary Sci, Kanagawa 2298510, Japan; Fukushima Natl Coll Technol, Iwaki, Fukushima 9708034, Japan; Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; Univ Aizu, Sch Engn & Comp Sci, Fukushima 9658580, Japan; Natl Astron Observ Japan, Mizusawa Astrogeodynam Observ, Oshu, Iwate 0230861, Japan; Remote Sensing Technol Ctr Japan, Tokyo 1060032, Japan; NAOJ, Subaru Telescope, Hilo, HI 96720 USA; NAOJ, Opt & Infrared Astron Div, Tokyo 1818588, Japan; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; JAXA, ISAS, Dept Spacecraft Engn, Kanagawa 2298510, Japan; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85705 USA; Bandung Inst Technol, Dept Astron, Bandung 40132, Indonesia; Bandung Inst Technol, Bosscha Observ, Bandung 40132, Indonesia; JAXA, Publ Affairs Dept, Tokyo 1008260, Japan; Akita Univ, Fac Engn & Resource Sci, Akita 0108502, Japan	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Tokai University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Kobe University; University of Aizu; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Hawaii System; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Arizona; Institute Technology of Bandung; Institute Technology of Bandung; Japan Aerospace Exploration Agency (JAXA); Akita University	Saito, J (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Hayabusa Project Team, 3-1-1 Yoshinodai, Kanagawa 2298510, Japan.	saitoj@planeta.sci.isas.jaxa.jp	Miyamoto, Hideaki/B-9666-2008; Yoshida, Fumi/I-6389-2016; Nakamura, Akiko M/I-1993-2012; Sasaki, Sho/S-3845-2019; Miyamoto, Hideaki/E-3381-2012; Kubota, Takashi/GPP-4986-2022; Nakamura, Akiko/AAC-4191-2020	Miyamoto, Hideaki/0000-0001-8013-6124; Yoshida, Fumi/0000-0002-3286-911X; Nakamura, Akiko M/0000-0001-6990-8496; Sasaki, Sho/0000-0002-7646-5248; Nakamura, Akiko/0000-0001-6990-8496; Hirata, Naru/0000-0002-2435-604X; Michikami, Tatsuhiro/0000-0003-3096-5789; Dermawan, Budi/0000-0001-7663-5801				Binzel RP, 2001, METEORIT PLANET SCI, V36, P1167, DOI 10.1111/j.1945-5100.2001.tb01950.x; Cellino A, 2005, ICARUS, V179, P297, DOI 10.1016/j.icarus.2005.08.005; Chapman CR, 2002, ICARUS, V155, P104, DOI 10.1006/icar.2001.6744; Chapman CR, 1996, METEORIT PLANET SCI, V31, P699, DOI 10.1111/j.1945-5100.1996.tb02107.x; CINTALA MJ, 1982, P LUN PLAN SCI C, V13, P100; Clark BE, 2002, ASTEROIDS, P585, DOI DOI 10.1016/0273-1177(91)90551-T; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; HARTMANN WK, 1969, ICARUS, V10, P201, DOI 10.1016/0019-1035(69)90022-0; Helfenstein P, 1996, ICARUS, V120, P48, DOI 10.1006/icar.1996.0036; HELFENSTEIN P, 1994, ICARUS, V107, P37, DOI 10.1006/icar.1994.1005; HIROI T, 1994, METEORITICS, V29, P394, DOI 10.1111/j.1945-5100.1994.tb00603.x; Hiroi T, 2001, METEORIT PLANET SCI, V36, P1587, DOI 10.1111/j.1945-5100.2001.tb01850.x; MICHIKAMI T, 2005, 36 LUN PLAN SCI C; Murchie S, 2002, ICARUS, V155, P145, DOI 10.1006/icar.2001.6756; Nakamura T, 2001, EARTH PLANETS SPACE, V53, P1047, DOI 10.1186/BF03351703; Prockter L, 2002, ICARUS, V155, P75, DOI 10.1006/icar.2001.6770; Richardson JE, 2005, ICARUS, V179, P325, DOI 10.1016/j.icarus.2005.07.005; Sasaki S, 2001, NATURE, V410, P555, DOI 10.1038/35069013; TEDESCO EF, 1982, ASTRON J, V87, P1585, DOI 10.1086/113248; Thomas PC, 2002, ICARUS, V155, P18, DOI 10.1006/icar.2001.6755; Thomas PC, 2001, NATURE, V413, P394, DOI 10.1038/35096513; Thomas PC, 2000, J GEOPHYS RES-PLANET, V105, P15091, DOI 10.1029/1999JE001204; Veverka J, 1996, ICARUS, V120, P66, DOI 10.1006/icar.1996.0037	23	189	192	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1341	1344		10.1126/science.1125722	http://dx.doi.org/10.1126/science.1125722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741110				2022-12-28	WOS:000237961600043
J	Varmus, H				Varmus, Harold			The new era in cancer research	SCIENCE			English	Editorial Material							ADJUVANT CHEMOTHERAPY; LUNG ADENOCARCINOMAS; TRASTUZUMAB; RESISTANCE; ONCOGENES; MUTATION; THERAPY	For many years, discoveries about the genetic determinants of cancer appeared to be having only minor effects on efforts to control the disease in the clinic. Following advances made over the past decade, however, a description of cancer in molecular terms seems increasingly likely to improve the ways in which human cancers are detected, classified, monitored, and treated. Achieving the medical promise of this new era in cancer research will require a deeper understanding of the biology of cancer and imaginative application of new knowledge in the clinic, as well as political, social, and cultural changes.	Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Varmus, H (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	varmus@mskcc.org						Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Berenson Alex, 2006, N Y Times Web, pC2; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; BOS JL, 1989, CANCER RES, V49, P4682; BURCHENAL JH, 1956, PEDIATRICS, V18, P643; COUZIN J, 2006, SCIENCENOW DAIL 0315; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; PEARCE J, 2006, NY TIMES        0316, pA25; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Varmus H, 2005, COLD SH Q B, V70, P1, DOI 10.1101/sqb.2005.70.039; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; WEISS R, 2005, WASH POST, pA3; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	38	235	254	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1162	1165		10.1126/science.1126758	http://dx.doi.org/10.1126/science.1126758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728627				2022-12-28	WOS:000237957400038
J	Jager, M; Murienne, J; Clabaut, C; Deutsch, J; Le Guyader, H; Manuel, M				Jager, Muriel; Murienne, Jerome; Clabaut, Celine; Deutsch, Jean; Le Guyader, Herve; Manuel, Michael			Homology of arthropod anterior appendages revealed by Hox gene expression in a sea spider	NATURE			English	Article							APPENDICULAR ORIGIN; NERVOUS-SYSTEM; SEGMENT; HEAD; MORPHOLOGY; CHELICERATE; PHYLOGENY; EVOLUTION; POSITION; ANTENNAE	Arthropod head segments offer a paradigm for understanding the diversification of form during evolution, as a variety of morphologically diverse appendages have arisen from them. There has been long-running controversy, however, concerning which head appendages are homologous among arthropods, and from which ancestral arrangement they have been derived. This controversy has recently been rekindled by the proposition that the probable ancestral arrangement, with appendages on the first head segment, has not been lost in all extant arthropods as previously thought, but has been retained in the pycnogonids, or sea spiders(1). This proposal was based on the neuroanatomical analysis of larvae from the sea spider Anoplodactylus sp., and suggested that the most anterior pair of appendages, the chelifores, are innervated from the first part of the brain, the protocerebrum. Our examination of Hox gene expression in another sea spider, Endeis spinosa, refutes this hypothesis. The anterior boundaries of Hox gene expression domains place the chelifore appendages as clearly belonging to the second head segment, innervated from the second part of the brain, the deutocerebrum. The deutocerebrum must have been secondarily displaced towards the protocerebrum in pycnogonid ancestors. As anterior-most appendages are also deutocerebral in the other two arthropod groups, the Euchelicerata and the Mandibulata, we conclude that the protocerebral appendages have been lost in all extant arthropods.	Univ Paris 06, UMR CNRS UPMC MNHN ENS IRD 7138, F-75005 Paris, France; Univ Paris 06, UMR CNRS UPMC 7622, F-75005 Paris, France	Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Manuel, M (corresponding author), Univ Paris 06, UMR CNRS UPMC MNHN ENS IRD 7138, Case 05,9 Quai St Bernard, F-75005 Paris, France.	Michael.Manuel@snv.jussieu.fr	Murienne, Jerome/J-9015-2019; MURIENNE, Jerome/B-2416-2009	Murienne, Jerome/0000-0003-1474-7829; 				Babu K. S., 1965, Zoologische Jahrbuecher (Anatomie), V82, P1; Brusca RC, 2003, INVERTEBRATES; Budd GE, 2005, NATURE, V437, P1099, DOI 10.1038/4371099a; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Bullock T. H., 1965, STRUCTURE FUNCTION N, V2; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Dunlop JA, 2005, J ZOOL SYST EVOL RES, V43, P8, DOI 10.1111/j.1439-0469.2004.00284.x; Eriksson BJ, 2003, J MORPHOL, V255, P1, DOI 10.1002/jmor.10034; Gibert JM, 2000, EVOL DEV, V2, P194, DOI 10.1046/j.1525-142x.2000.00059.x; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; HENRY LAURA M., 1953, MICROENTOMOLOGY, V18, P16; Hughes AL, 1999, ADDICT BIOL, V4, P459; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Maxmen A, 2005, NATURE, V437, P1144, DOI 10.1038/nature03984; Mayer G, 2005, ARTHROPOD STRUCT DEV, V34, P471, DOI 10.1016/j.asd.2005.03.004; Meisenheimer J, 1902, Z WISS ZOOL ABT A, V72, P191; Mittmann B, 2003, DEV GENES EVOL, V213, P9, DOI 10.1007/s00427-002-0285-5; Morgan T.H, 1891, STUDIES BIOLOGICAL L, V5, P1; Popadic A, 1998, DEV GENES EVOL, V208, P142, DOI 10.1007/s004270050165; SANCHEZ S, 1959, DEV PYCNOGONIDES LEU; SANDEMAN DC, 1993, J EXP ZOOL, V265, P112, DOI 10.1002/jez.1402650204; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; Scholtz G, 2005, CRUSTACEAN ISS, V16, P139, DOI 10.1201/9781420037548.ch6; Scholtz G, 1997, ARTHROPOD RELATIONSH, P317; Simonnet F, 2004, DEV GENES EVOL, V214, P537, DOI 10.1007/s00427-004-0435-z; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; Weygoldt P., 1985, P20; WINTER G, 1980, Z ZOOL SYST EVOL, V18, P27; Wiren E, 1918, ZOOL BIDR UPPS, V6, P41	29	74	76	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					506	508		10.1038/nature04591	http://dx.doi.org/10.1038/nature04591			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724066				2022-12-28	WOS:000237778900049
J	Karin, M				Karin, Michael			Nuclear factor-kappa B in cancer development and progression	NATURE			English	Review							TUMOR-NECROSIS-FACTOR; INFLAMMATION-ASSOCIATED CANCER; TNF-ALPHA; INNATE IMMUNITY; JNK ACTIVATION; CELL-DEATH; CHROMOSOMAL TRANSLOCATION; SIGNALING PATHWAY; TRANSGENIC MICE; MAMMARY-GLAND	Nuclear factor-kappa B (NF-kappa B) transcription factors and the signalling pathways that activate them are central coordinators of innate and adaptive immune responses. More recently, it has become clear that NF-kappa B signalling also has a critical role in cancer development and progression. NF-kappa B provides a mechanistic link between inflammation and cancer, and is a major factor controlling the ability of both pre-neoplastic and malignant cells to resist apoptosis-based tumour-surveillance mechanisms. NF-kappa B might also regulate tumour angiogenesis and invasiveness, and the signalling pathways that mediate its activation provide attractive targets for new chemopreventive and chemotherapeutic approaches.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu						Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arnott CH, 2002, ONCOGENE, V21, P4728, DOI 10.1038/sj.onc.1205588; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; Dhala A, 2004, MED CLIN N AM, V88, P1535, DOI 10.1016/j.mcna.2004.06.005; Ekbom A, 1998, J Gastrointest Surg, V2, P312, DOI 10.1016/S1091-255X(98)80067-X; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holla VR, 2005, J BIOL CHEM, V280, P476, DOI 10.1074/jbc.M407403200; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Lind MH, 2004, P NATL ACAD SCI USA, V101, P4972, DOI 10.1073/pnas.0307106101; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Oshima M, 2005, CANCER RES, V65, P9147, DOI 10.1158/0008-5472.CAN-05-1936; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Roder David M, 2002, Gastric Cancer, V5 Suppl 1, P5, DOI 10.1007/s10120-002-0203-6; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Sun JL, 2005, JNCI-J NATL CANCER I, V97, P525, DOI 10.1093/jnci/dji070; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; VAN AD, 1996, SCIENCE, V274, P787; van Hogerlinden M, 1999, CANCER RES, V59, P3299; van Hogerlinden M, 2002, ONCOGENE, V21, P4969, DOI 10.1038/sj.onc.1205620; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zucca E, 2000, BLOOD, V96, P410	70	2814	2992	4	355	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					431	436		10.1038/nature04870	http://dx.doi.org/10.1038/nature04870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724054				2022-12-28	WOS:000237778900035
J	Kentsis, A				Kentsis, A			Correspondence patterns - Mechanisms and models of human dynamics	NATURE			English	Letter									NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University	Kentsis, A (corresponding author), NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA.	alex.kentsis@mssm.edu		Kentsis, Alex/0000-0002-8063-9191				Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Einstein A, 1919, SITZBER K PREUSS AKA, P349; EINSTEIN A, 1987, COLLECTED PAPERS A E; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; [No title captured]	6	15	15	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2006	441	7092					E5	E5		10.1038/nature04901	http://dx.doi.org/10.1038/nature04901			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724015				2022-12-28	WOS:000237778900031
J	Arnold, K; Zuberbuhler, K				Arnold, K; Zuberbuhler, K			Semantic combinations in primate calls	NATURE			English	Article							MONKEYS		Univ St Andrews, Sch Psychol, St Andrews KY16 9JP, Fife, Scotland	University of St Andrews	Arnold, K (corresponding author), Univ St Andrews, Sch Psychol, St Andrews KY16 9JP, Fife, Scotland.	kz3@st-and.ac.uk	Arnold, Kate/B-2021-2014; Zuberbühler, Klaus/A-9053-2011; Arnold, Kate/C-1129-2009	Arnold, Kate/0000-0002-5598-2174; Zuberbühler, Klaus/0000-0001-8378-088X; Arnold, Kate/0000-0002-5598-2174				ARNOLD K, IN PRESS ANIM BEHAV; CLEVELAND J, 1982, Z TIERPSYCHOL, V58, P231; Eckardt W, 2004, BEHAV ECOL, V15, P400, DOI 10.1093/beheco/arh032; Gautier J.-P., 1977, ANIMALS COMMUNICATE, P890; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Marler Peter, 1992, P66; MITANI JC, 1989, BEHAVIOUR, V109, P20, DOI 10.1163/156853989X00141; POHLNER Y, UNPUB BEHAV ECOL SOC; ROBINSON JG, 1984, BEHAVIOUR, V90, P46, DOI 10.1163/156853984X00551; Zuberbuhler K, 2002, ANIM BEHAV, V63, P293, DOI 10.1006/anbe.2001.1914	10	239	250	2	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					303	303		10.1038/441303a	http://dx.doi.org/10.1038/441303a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710411	Bronze			2022-12-28	WOS:000237593200035
J	Taniyasu, Y; Kasu, M; Makimoto, T				Taniyasu, Y; Kasu, M; Makimoto, T			An aluminium nitride light-emitting diode with a wavelength of 210 nanometres	NATURE			English	Article							SI-DOPED ALN; PHOTOLUMINESCENCE; SEMICONDUCTORS; CONDUCTION; EMISSION; GROWTH; GAN	Compact high-efficiency ultraviolet solid-state light sources(1) such as light-emitting diodes (LEDs) and laser diodes - are of considerable technological interest as alternatives to large, toxic, low-efficiency gas lasers and mercury lamps. Microelectronic fabrication technologies and the environmental sciences both require light sources with shorter emission wavelengths: the former for improved resolution in photolithography and the latter for sensors that can detect minute hazardous particles. In addition, ultraviolet solid-state light sources are also attracting attention for potential applications in high-density optical data storage, biomedical research, water and air purification, and sterilization. Wide-bandgap materials, such as diamond(2) and III - V nitride semiconductors (GaN, AlGaN and AlN; refs 3 - 10), are potential materials for ultraviolet LEDs and laser diodes, but suffer from difficulties in controlling electrical conduction. Here we report the successful control of both n-type and p-type doping in aluminium nitride ( AlN), which has a very wide direct bandgap(11) of 6 eV. This doping strategy allows us to develop an AlN PIN (p-type/intrinsic/n-type) homojunction LED with an emission wavelength of 210 nm, which is the shortest reported to date for any kind of LED. The emission is attributed to an exciton transition, and represents an important step towards achieving exciton-related light-emitting devices as well as replacing gas light sources with solid-state light sources.	NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan	Nippon Telegraph & Telephone Corporation	Taniyasu, Y (corresponding author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	taniyasu@will.brl.ntt.co.jp	Kasu, Makoto/N-4118-2018	Kasu, Makoto/0000-0002-0881-9454				Adivarahan V, 2004, APPL PHYS LETT, V85, P2175, DOI 10.1063/1.1796525; Akasaki I, 1997, JPN J APPL PHYS 1, V36, P5393, DOI 10.1143/JJAP.36.5393; Amano H, 2004, PHYS STATUS SOLIDI A, V201, P2679, DOI 10.1002/pssa.200405044; EDGAR JH, 1994, PROPERTIES GROUP 3 N; Han J, 1998, APPL PHYS LETT, V73, P1688, DOI 10.1063/1.122246; Hirayama H, 2005, J APPL PHYS, V97, DOI 10.1063/1.1899760; Koizumi S, 2001, SCIENCE, V292, P1899, DOI 10.1126/science.1060258; Kuokstis E, 2002, APPL PHYS LETT, V81, P2755, DOI 10.1063/1.1510586; Li J, 2003, APPL PHYS LETT, V83, P5163, DOI 10.1063/1.1633965; Mireles F, 1998, PHYS REV B, V58, P3879, DOI 10.1103/PhysRevB.58.3879; NAKAMURA S, 1992, JPN J APPL PHYS 2, V31, pL139, DOI 10.1143/JJAP.31.L139; NAKAMURA S, 1995, JPN J APPL PHYS 2, V34, pL1332, DOI 10.1143/JJAP.34.L1332; Nam KB, 2003, APPL PHYS LETT, V83, P878, DOI 10.1063/1.1594833; Ng HM, 1998, APPL PHYS LETT, V73, P821, DOI 10.1063/1.122012; Nishida T, 1999, PHYS STATUS SOLIDI A, V176, P45, DOI 10.1002/(SICI)1521-396X(199911)176:1<45::AID-PSSA45>3.0.CO;2-0; Pankove J. I., 1971, Journal of Luminescence, V4, P63, DOI 10.1016/0022-2313(71)90009-3; Ponce FA, 1997, NATURE, V386, P351, DOI 10.1038/386351a0; Rojo JC, 2001, J CRYST GROWTH, V231, P317, DOI 10.1016/S0022-0248(01)01452-X; Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712; SZE SM, 1981, PHYS SEMICONDUCTOR D, P63; Taniyasu Y, 2003, PHYS STATUS SOLIDI A, V200, P40, DOI 10.1002/pssa.200303409; Taniyasu Y, 2004, APPL PHYS LETT, V85, P4672, DOI 10.1063/1.1824181; Taniyasu Y, 2002, APPL PHYS LETT, V81, P1255, DOI 10.1063/1.1499738	23	1435	1508	27	878	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					325	328		10.1038/nature04760	http://dx.doi.org/10.1038/nature04760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710416				2022-12-28	WOS:000237593200042
J	Chirac, P; Torreele, E				Chirac, P; Torreele, E			Global framework on essential health R&D	LANCET			English	Editorial Material									Med Sans Frontieres, F-75544 Paris 11, France; Drugs Neglected Dis Initiat, Geneva, Switzerland	Doctors Without Borders	Chirac, P (corresponding author), Med Sans Frontieres, F-75544 Paris 11, France.	pierchir@club-internet.fr	Thorpe, Allison/A-2705-2011					ARRAL PE, 2005, 30 ANS RESULTATS REC; *DNDI, 2006, NEW HOP MAL PAT 2006; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Ropars AL, 2005, NEW LANDSCAPE NEGLEC; Trouiller P, 1998, Int J Infect Dis, V3, P61, DOI 10.1016/S1201-9712(99)90010-3; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; *WHO, 2005, PUBL HLTH INN INT PR; *WHO, 2002, MILT STOR SUCC PARTN; *WHO, 2000, DUTCH REG ART INJ; *WHO, 2001, ART SULPH PYRIM COMB; *WHO, 2003, LAPD NEW ANT AFR; WHO (World Health Organization), 2006, GLOB FRAM ESS HLTH R	12	114	120	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1560	1561		10.1016/S0140-6736(06)68672-8	http://dx.doi.org/10.1016/S0140-6736(06)68672-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698397				2022-12-28	WOS:000237598000009
J	Michel, CEC; Solomon, AW; Magbanua, JPV; Massae, PA; Huang, L; Mosha, J; West, SK; Nadala, ECB; Bailey, R; Wisniewski, C; Mabey, DCW; Lee, HH				Michel, CEC; Solomon, AW; Magbanua, JPV; Massae, PA; Huang, L; Mosha, J; West, SK; Nadala, ECB; Bailey, R; Wisniewski, C; Mabey, DCW; Lee, HH			Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study	LANCET			English	Article							CHLAMYDIA-TRACHOMATIS; MASS TREATMENT; STREPTOCOCCUS-PNEUMONIAE; AZITHROMYCIN; INFECTION; DIAGNOSIS; COMMUNITY; PCR; CARRIAGE; IMPACT	Background Trachoma results from repeated episodes of conjunctival infection with Chlamydia trachomatis and is the leading infectious cause of blindness. To eliminate trachoma, control programmes use the SAFE strategy (Surgery, Antibiotics, Face cleanliness, and Environmental improvement). The A component is designed to treat C trachomatis infection, and is initiated on the basis of the prevalence of the clinical sign trachomatous inflammation-follicular (TF). Unfortunately, TF correlates poorly with C trachomatis infection. We sought to assess a newly developed point-of-care (POC) assay compared with presence of TF for guiding the use of antibiotics for trachoma control. Methods We compared performance outcomes of the POC assay and presence of TF using commercial PCR as a comparator in 664 children aged 1-9 years in remote, trachoma-endemic villages in Tanzania. Signs of trachoma were graded according to the WHO simplified trachoma grading system. Findings Of 664 participants, 128 (19%) were positive for ocular C trachomatis infection by PCR. Presence of TF had a sensitivity of 64.1% (95% CI 55.8-72.4), specificity of 80.2% (76.8-83.6), and positive predictive value of 43.6% (36.5-50.7). By contrast, the POC assay had a sensitivity of 83.6% (77.2-90.0), specificity of 99.4% (98.8-100.0), and positive predictive value of 97.3% (94.2-100.3). Interagreements and intra-agreements between four novice operators were 0.988 (0.973-1.000) and 0.950 (0.894-1.000), respectively. Interpretation The POC assay is substantially more accurate than TF prevalence in identifying the presence or absence of infection. Additional studies should assess the use of the assay in the planning and monitoring of trachoma control activities.	Univ Cambridge, Dept Haematol, Diagnost Dev Unit, Cambridge, England; London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England; Tumaini Univ, Kilimanjaro Ctr Community Ophthalmol, Moshi, Tanzania; Johns Hopkins Univ, Dana Ctr Prevent Ophthalmol, Baltimore, MD USA	University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University	Lee, HH (corresponding author), Univ Cambridge, Dept Haematol, Diagnost Dev Unit, Cambridge, England.	hl207@cam.ac.uk		Nadala, Elpidio Cesar/0000-0002-8146-4397; Mabey, David/0000-0002-0031-8276; Solomon, Anthony/0000-0001-7101-6649				Bailey R, 2001, B WORLD HEALTH ORGAN, V79, P233; Baral K, 1999, B WORLD HEALTH ORGAN, V77, P461; Batt SL, 2003, ANTIMICROB AGENTS CH, V47, P2765, DOI 10.1128/AAC.47.9.2765-2769.2003; Brade H, 1997, J ENDOTOXIN RES, V4, P67, DOI 10.1177/096805199700400108; Burton MJ, 2003, INVEST OPHTH VIS SCI, V44, P4215, DOI 10.1167/iovs.03-0107; Emerson PM, 2004, LANCET, V363, P1093, DOI 10.1016/S0140-6736(04)15891-1; Frick KD, 2001, B WORLD HEALTH ORGAN, V79, P201; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; GRAYSTON JT, 1985, REV INFECT DIS, V7, P717; Koumans EH, 2003, J CLIN MICROBIOL, V41, P1507, DOI 10.1128/JCM.41.4.1507-1511.2003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; LEE HH, 2000, Patent No. 0105325; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Melese M, 2004, JAMA-J AM MED ASSOC, V292, P721, DOI 10.1001/jama.292.6.721; MICHEL CEE, 2000, 4 M EUR SOC CHLAM RE, P418; Miller K, 2004, OPHTHAL EPIDEMIOL, V11, P255, DOI 10.1080/09286580490514577; Miller K, 2004, BRIT J OPHTHALMOL, V88, P750, DOI 10.1136/bjo.2003.038661; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Sachse K, 2003, J MICROBIOL METH, V54, P233, DOI 10.1016/S0167-7012(03)00040-X; Schachter J, 1997, IMMUNOL INVEST, V26, P157, DOI 10.3109/08820139709048923; Solomon Anthony, 2004, Community Eye Health, V17, P54; Solomon AW, 2004, CLIN MICROBIOL REV, V17, P982, DOI 10.1128/CMR.17.4.982-1011.2004; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; West ES, 2005, INVEST OPHTH VIS SCI, V46, P83, DOI 10.1167/iovs.04-0327; West S K, 2001, Ophthalmic Epidemiol, V8, P137, DOI 10.1076/opep.8.2.137.4158; World Health Organization, 1997, 1 M WHO ALL GLOB EL	29	56	56	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1585	1590		10.1016/S0140-6736(06)68695-9	http://dx.doi.org/10.1016/S0140-6736(06)68695-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698411				2022-12-28	WOS:000237598000029
J	Cota, D; Proulx, K; Smith, KAB; Kozma, SC; Thomas, G; Woods, SC; Seeley, RJ				Cota, D; Proulx, K; Smith, KAB; Kozma, SC; Thomas, G; Woods, SC; Seeley, RJ			Hypothalamic mTOR signaling regulates food intake	SCIENCE			English	Article							MAMMALIAN TARGET; ARCUATE NUCLEUS; S6 KINASE; PATHWAY; TOR; PROTEIN; TRANSLATION; ACTIVATION; OBESITY; CNS	The mammalian Target of Rapamycin ( mTOR) protein is a serine-threonine kinase that regulates cell-cycle progression and growth by sensing changes in energy status. We demonstrated that mTOR signaling plays a role in the brain mechanisms that respond to nutrient availability, regulating energy balance. In the rat, mTOR signaling is controlled by energy status in specific regions of the hypothalamus and colocalizes with neuropeptide Y and proopiomelanocortin neurons in the arcuate nucleus. Central administration of leucine increases hypothalamic mTOR signaling and decreases food intake and body weight. The hormone leptin increases hypothalamic mTOR activity, and the inhibition of mTOR signaling blunts leptin's anorectic effect. Thus, mTOR is a cellular fuel sensor whose hypothalamic activity is directly tied to the regulation of energy intake.	Univ Cincinnati, Genome Res Inst, Dept Psychiat, Cincinnati, OH 45237 USA; Univ Cincinnati, Genome Res Inst, Dept Genome Sci, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Seeley, RJ (corresponding author), Univ Cincinnati, Genome Res Inst, Dept Psychiat, 2170 E Galbraith Rd, Cincinnati, OH 45237 USA.	Randy.Seeley@uc.edu	Thomas, George/K-9235-2014	Thomas, George/0000-0003-3518-8149; Cota, Daniela/0000-0002-6909-2156; Seeley, Randy/0000-0002-3721-5625	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017844, R37DK017844, R01DK054080, R01DK054890] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 54890, DK 54080, DK 17844] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gietzen DW, 2001, J NUTR, V131, p851S, DOI 10.1093/jn/131.3.851S; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Levin BE, 2002, INT REV NEUROBIOL, V51, P219, DOI 10.1016/S0074-7742(02)51007-2; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Meijer AJ, 2004, BIOCHEM BIOPH RES CO, V313, P397, DOI 10.1016/j.bbrc.2003.07.012; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Ritter S, 2001, J COMP NEUROL, V432, P197, DOI 10.1002/cne.1097; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	27	938	986	3	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					927	930		10.1126/science.1124147	http://dx.doi.org/10.1126/science.1124147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690869				2022-12-28	WOS:000237452900052
J	Douglas, T; Young, M				Douglas, T; Young, M			Viruses: Making friends with old foes	SCIENCE			English	Editorial Material							VIRAL NANOPARTICLES; BUILDING-BLOCKS; PROTEIN; PARTICLES; CAGE; SURFACE		Montana State Univ, Ctr Bioinspired Nanomat, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Douglas, T (corresponding author), Montana State Univ, Ctr Bioinspired Nanomat, Bozeman, MT 59717 USA.	tdouglas@chemistry.montana.edu; myoung@montana.edu	Douglas, Trevor/F-2748-2011; Douglas, Trevor/GRS-0012-2022	Douglas, Trevor/0000-0002-7882-2704	NIBIB NIH HHS [R21EB005364, R01EB000432] Funding Source: Medline; NIGMS NIH HHS [R01GM61340] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB005364, R01EB000432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061340] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen M, 2005, MAGN RESON MED, V54, P807, DOI 10.1002/mrm.20614; BANCROFT JB, 1967, VIROLOGY, V31, P354, DOI 10.1016/0042-6822(67)90180-8; Bothner B, 2005, VIROLOGY, V334, P17, DOI 10.1016/j.virol.2005.01.017; Chatterji A, 2004, BIOCONJUGATE CHEM, V15, P807, DOI 10.1021/bc0402888; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Douglas T, 2002, ADV MATER, V14, P415, DOI 10.1002/1521-4095(20020318)14:6<415::AID-ADMA415>3.0.CO;2-W; Flenniken ML, 2005, CHEM COMMUN, P447, DOI 10.1039/b413435d; Gillitzer E, 2002, CHEM COMMUN, P2390, DOI 10.1039/b207853h; Klem MT, 2005, ADV FUNCT MATER, V15, P1489, DOI 10.1002/adfm.200400453; Klem MT, 2003, J AM CHEM SOC, V125, P10806, DOI 10.1021/ja0363718; Knez M, 2003, NANO LETT, V3, P1079, DOI 10.1021/nl0342545; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; MELDRUM FC, 1991, NATURE, V349, P684, DOI 10.1038/349684a0; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Raja KS, 2003, BIOMACROMOLECULES, V4, P472, DOI 10.1021/bm025740+; Raja KS, 2003, CHEMBIOCHEM, V4, P1348, DOI 10.1002/cbic.200300759; Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101; Schlick TL, 2005, J AM CHEM SOC, V127, P3718, DOI 10.1021/ja046239n; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Strable E, 2004, NANO LETT, V4, P1385, DOI 10.1021/nl0493850; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Tang JH, 2006, J STRUCT BIOL, V154, P59, DOI 10.1016/j.jsb.2005.10.013; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wang Q, 2002, ANGEW CHEM INT EDIT, V41, P459; Wang Q, 2002, CHEM BIOL, V9, P813, DOI 10.1016/S1074-5521(02)00166-7; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Zhu YX, 2001, J STRUCT BIOL, V135, P302, DOI 10.1006/jsbi.2001.4415	29	468	484	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					873	875		10.1126/science.1123223	http://dx.doi.org/10.1126/science.1123223			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690856				2022-12-28	WOS:000237452900035
J	Madin, JS; Alroy, J; Aberhan, M; Fursich, FT; Kiessling, W; Kosnik, MA; Wagner, PJ				Madin, JS; Alroy, J; Aberhan, M; Fursich, FT; Kiessling, W; Kosnik, MA; Wagner, PJ			Statistical independence of escalatory ecological trends in phanerozoic marine invertebrates	SCIENCE			English	Article							FOSSIL RECORD; BRACHIOPODS; DIVERSITY; SELECTION; EVOLUTION; PATTERNS	Ecological interactions, such as predation and bioturbation, are thought to be fundamental determinants of macroevolutionary trends. A data set containing global occurrences of Phanerozoic fossils of benthic marine invertebrates shows escalatory trends in the relative frequency of ecological groups, such as carnivores and noncarnivorous infaunal or mobile organisms. Associations between these trends are either statistically insignificant or interpretable as preservational effects. Thus, there is no evidence that escalation drives macroecological trends at global and million-year time scales. We also find that taxonomic richness and occurrence data are cross-correlated, which justifies the traditional use of one as a proxy of the other.	Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Humboldt Univ, Museum Naturkunde, D-10115 Berlin, Germany; Univ Wurzburg, Inst Paleontol, D-97070 Wurzburg, Germany; James Cook Univ N Queensland, Sch Marine Biol & Aquaculture, Townsville, Qld 4811, Australia; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Wurzburg; James Cook University; Field Museum of Natural History (Chicago)	Madin, JS (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA.	madin@nceas.ucsb.edu	Alroy, John/B-4585-2009; Kosnik, Matthew/G-2312-2010; Kiessling, Wolfgang/E-2259-2015; Wagner, Peter/A-5514-2009; Kosnik, Matthew A./P-9632-2019	Alroy, John/0000-0002-9882-2111; Kosnik, Matthew/0000-0001-5380-7041; Kiessling, Wolfgang/0000-0002-1088-2014; Wagner, Peter/0000-0002-9083-9787; Kosnik, Matthew A./0000-0001-5380-7041; Madin, Joshua/0000-0002-5005-6227				Aberhan M, 2006, PALEOBIOLOGY, V32, P259, DOI 10.1666/05028.1; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; BAMBACH RK, 1983, BIOTIC INTERACTIONS, pCH15; Behrensmeyer AK, 2005, PALEOBIOLOGY, V31, P607, DOI 10.1666/0094-8373(2005)031[0607:ATMDST]2.0.CO;2; BUZAS MA, 1982, PALEOBIOLOGY, V8, P143, DOI 10.1017/S0094837300004486; GOULD SJ, 1980, PALEOBIOLOGY, V6, P383, DOI 10.1017/S0094837300003572; Kelley P.H., 2003, PREDATOR PREY INTERA; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; Kowalewski M, 2005, SCIENCE, V308, P1774, DOI 10.1126/science.1113408; Kowalewski M, 1998, GEOLOGY, V26, P1091, DOI 10.1130/0091-7613(1998)026<1091:AFRFOH>2.3.CO;2; Lupia R, 1999, PALEOBIOLOGY, V25, P305, DOI 10.1017/S009483730002131X; McKinney FK, 1998, SCIENCE, V281, P807, DOI 10.1126/science.281.5378.807; MORSE JW, 1980, GEOCHIM COSMOCHIM AC, V44, P85, DOI 10.1016/0016-7037(80)90178-7; PAWLIK JR, 1993, CHEM REV, V93, P1911, DOI 10.1021/cr00021a012; Sanders D, 2003, J AFR EARTH SCI, V36, P99, DOI 10.1016/S0899-5362(03)00027-7; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; THAYER CW, 1983, BIOTIC INTERACTIONS, pCH11; Vermeij G.J., 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; VRBA ES, 1986, PALEOBIOLOGY, V12, P217, DOI 10.1017/S0094837300013671	21	68	70	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					897	900		10.1126/science.1123591	http://dx.doi.org/10.1126/science.1123591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690862				2022-12-28	WOS:000237452900043
J	Bilous, J; Eggers, R; Gasse, F; Jarrett, S; Lydon, P; Magan, A; Okwo-Bele, JM; Salama, P; Vandelaer, J; Villeneuve, P; Wolfson, L				Bilous, J; Eggers, R; Gasse, F; Jarrett, S; Lydon, P; Magan, A; Okwo-Bele, JM; Salama, P; Vandelaer, J; Villeneuve, P; Wolfson, L			A new global immunisation vision and strategy	LANCET			English	Editorial Material									WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland; WHO, Family & Community Hlth Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland; UNICEF, Immunizat & Child Survival Team, New York, NY USA; UNICEF, Supply Div, New York, NY USA; UNICEF, Program Div, New York, NY USA; UNICEF, Hlth Sect, New York, NY USA	World Health Organization; World Health Organization; UNICEF; UNICEF; UNICEF; UNICEF	Okwo-Bele, JM (corresponding author), WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland.	okwobelej@who.int	Wolfson, Lara/AAC-1400-2019	Wolfson, Lara/0000-0002-6454-3368				[Anonymous], 2005, GIVS GLOB IMM VIS ST; Hadler SC, 2003, VACCINES, P1407; *UN, 2005, DRAFT GLOB IMM STRAT; UNICEF, 2002, WORLD FIT CHILDR MIL; United Nations, 2005, PROGR MILL DEV GOALS; *WHO, 2005, 5815 WHA WHO; *WHO, 2005, GLOB POL ER IN 2004; *WHO, 2004, 2004 GLOB IMM DAT; *WHO, 2002, EST DIS BURD COST EF; *WHO IVB, 2005, WHO VACC PREV DIS MO; World Health Organization, 2005, WORLD HLTH REP 2005; 2004, WKLY EPIDEMIOL REC, V79, P349; 2003, WKLY EPIDEMIOL REC, V78, P366	13	47	48	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1464	1466		10.1016/S0140-6736(06)68625-X	http://dx.doi.org/10.1016/S0140-6736(06)68625-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679143				2022-12-28	WOS:000237324200006
J	Kumar, R				Kumar, R			Boom to bust in the NHS - Questions on productivity	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Royal Manchester Childrens Hosp, Manchester M27 4HA, Lancs, England	Royal Manchester Children's Hospital	Kumar, R (corresponding author), Royal Manchester Childrens Hosp, Manchester M27 4HA, Lancs, England.	ram16k@yahoo.com.au						Lee P., 2006, PUBLIC SERVICE PRODU; Maynard A, 2006, BMJ-BRIT MED J, V332, P906, DOI 10.1136/bmj.332.7546.906	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1096	1096		10.1136/bmj.332.7549.1096-b	http://dx.doi.org/10.1136/bmj.332.7549.1096-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16675832	Green Published			2022-12-28	WOS:000237518400038
J	Chun, TH; Hotary, KB; Sabeh, F; Saltiel, AR; Allen, ED; Weiss, SJ				Chun, Tae-Hwa; Hotary, Kevin B.; Sabeh, Farideh; Saltiel, Alan R.; Allen, Edward D.; Weiss, Stephen J.			A pericellular collagenase directs the 3-dimensional development of white adipose tissue	CELL			English	Article							ISOLATED RAT ADIPOCYTES; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; INSULIN INCUBATION; GENE-EXPRESSION; MAMMARY-GLAND; CELL-SHAPE; ADIPOGENESIS; MICE; DIFFERENTIATION	White adipose tissue (WAT) serves as the primary energy depot in the body by storing fat. During development, fat cell precursors (i.e., preadipocytes) undergo a hypertrophic response as they mature into lipid-laden adipocytes. However, the mechanisms that regulate adipocyte size and mass remain undefined. Herein, we demonstrate that the membrane-anchored metal loproteinase, MT1-MMP, coordinates adipocyte differentiation in vivo. In the absence of the protease, WAT development is aborted, leaving tissues populated by mini-adipocytes which render null mice lipodystrophic. While MT1-MMP preadipocytes display a cell autonomous defect in vivo, null progenitors retain the ability to differentiate into functional adipocytes during 2-dimensional (2-D) culture. By contrast, within the context of the 3-dimensional (3-D) ECM, normal adipocyte maturation requires a burst in MT1-MMP-mediated proteolysis that modulates pericellular collagen rigidity in a fashion that controls adipogenesis. Hence, MT1-MMP acts as a 3-D-specific adipogenic factor that directs the dynamic adipocyte-ECM interactions critical to WAT development.	Univ Michigan, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weiss, SJ (corresponding author), Univ Michigan, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA.	sjweiss@umich.edu	Chun, Tae-Hwa/H-5959-2019; Saltiel, Alan/L-3632-2019	Chun, Tae-Hwa/0000-0001-9333-2589; Saltiel, Alan/0000-0002-9726-9828	NATIONAL CANCER INSTITUTE [R01CA088308] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA088308] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; BARNARD T, 1969, J ULTRA MOL STRUCT R, V29, P311, DOI 10.1016/S0022-5320(69)90109-9; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gentleman R, 2004, COMPSTAT 2004: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P171; Gonzalez FJ, 2005, CELL METAB, V1, P85, DOI 10.1016/j.cmet.2005.01.004; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Lazar MA, 2002, GENE DEV, V16, P1, DOI 10.1101/gad.964002; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Lijnen HR, 2002, THROMB HAEMOSTASIS, V88, P345; Lilla J, 2002, AM J PATHOL, V160, P1551, DOI 10.1016/S0002-9440(10)61100-5; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Maquoi E, 2003, THROMB HAEMOSTASIS, V89, P696, DOI 10.1055/s-0037-1613586; MARSHALL S, 1980, J CLIN INVEST, V66, P763, DOI 10.1172/JCI109914; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MORALES LM, 1992, BIOCHEM BIOPH RES CO, V188, P807, DOI 10.1016/0006-291X(92)91128-D; Morroni M, 2004, P NATL ACAD SCI USA, V101, P16801, DOI 10.1073/pnas.0407647101; NAPOLITANO L, 1963, J CELL BIOL, V18, P663, DOI 10.1083/jcb.18.3.663; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	43	295	306	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					577	591		10.1016/j.cell.2006.02.050	http://dx.doi.org/10.1016/j.cell.2006.02.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678100	Bronze			2022-12-28	WOS:000237506100022
J	Langowski, JL; Zhang, XQ; Wu, LL; Mattson, JD; Chen, TY; Smith, K; Basham, B; McClanahan, T; Kastelein, RA; Oft, M				Langowski, John L.; Zhang, Xueqing; Wu, Lingling; Mattson, Jeanine D.; Chen, Taiying; Smith, Kathy; Basham, Beth; McClanahan, Terrill; Kastelein, Robert A.; Oft, Martin			IL-23 promotes tumour incidence and growth	NATURE			English	Article							AUTOIMMUNE INFLAMMATION; ADAPTIVE IMMUNITY; T-CELLS; CANCER; SKIN; DISTINCT; INTERLEUKIN-12; RESISTANCE; CYTOKINE; IL-12	Chronic inflammation has long been associated with increased incidence of malignancy and similarities in the regulatory mechanisms have been suggested for more than a century(1). Infiltration of innate immune cells, elevated activities of matrix metalloproteases and increased angiogenesis and vasculature density are a few examples of the similarities between chronic and tumour-associated inflammation(2). Conversely, the elimination of early malignant lesions by immune surveillance, which relies on the cytotoxic activity of tumour-infiltrating T cells or intra-epithelial lymphocytes, is thought to be rate-limiting for the risk to develop cancer(3). Here we show a molecular connection between the rise in tumour-associated inflammation and a lack of tumour immune surveillance. Expression of the heterodimeric cytokine interleukin (IL)-23, but not of its close relative IL-12, is increased in human tumours. Expression of these cytokines antagonistically regulates local inflammatory responses in the tumour microenvironment and infiltration of intra-epithelial lymphocytes. Whereas IL-12 promotes infiltration of cytotoxic T cells, IL-23 promotes inflammatory responses such as upregulation of the matrix metalloprotease MMP9, and increases angiogenesis but reduces CD8 T-cell infiltration. Genetic deletion or antibody-mediated elimination of IL-23 leads to increased infiltration of cytotoxic T cells into the transformed tissue, rendering a protective effect against chemically induced carcinogenesis. Finally, transplanted tumours are growth-restricted in hosts depleted for IL-23 or in IL-23-receptor-deficient mice. Although many strategies for immune therapy of cancer attempt to stimulate an immune response against solid tumours, infiltration of effector cells into the tumour tissue often appears to be a critical hurdle(4-7). We show that IL-23 is an important molecular link between tumour-promoting pro-inflammatory processes and the failure of the adaptive immune surveillance to infiltrate tumours.	Schering Plough BioPharma, Palo Alto, CA 94304 USA	Merck & Company	Oft, M (corresponding author), Schering Plough BioPharma, 901 Calif Ave, Palo Alto, CA 94304 USA.	martin.oft@spcorp.com	Wu, Ling/GZN-2235-2022					Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; FUSENIG NE, 1978, B CANCER, V65, P271; Ganss R, 2004, EUR J IMMUNOL, V34, P2635, DOI 10.1002/eji.200425474; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; GUPTA JW, 1992, CANCER RES, V52, P2530; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Lo CH, 2003, J IMMUNOL, V171, P600, DOI 10.4049/jimmunol.171.2.600; Marincola FM, 2003, TRENDS IMMUNOL, V24, P335, DOI 10.1016/S1471-4906(03)00116-9; Mueller MM, 1999, AM J PATHOL, V155, P1557, DOI 10.1016/S0002-9440(10)65472-7; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Tiano HF, 2002, CANCER RES, V62, P3395; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307; Yee C, 2002, NAT REV CANCER, V2, P409, DOI 10.1038/nrc820	30	761	841	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					461	465		10.1038/nature04808	http://dx.doi.org/10.1038/nature04808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16688182				2022-12-28	WOS:000239278900045
J	Losev, E; Reinke, CA; Jellen, J; Strongin, DE; Bevis, BJ; Glick, BS				Losev, Eugene; Reinke, Catherine A.; Jellen, Jennifer; Strongin, Daniel E.; Bevis, Brooke J.; Glick, Benjamin S.			Golgi maturation visualized in living yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PICHIA-PASTORIS; PROTEIN-TRANSPORT; CISTERNAE; LOCALIZATION; APPARATUS; VESICLES; COMPLEX; LUMEN	The Golgi apparatus is composed of biochemically distinct early (cis, medial) and late ( trans, TGN) cisternae. There is debate about the nature of these cisternae(1-3). The stable compartments model predicts that each cisterna is a long-lived structure that retains a characteristic set of Golgi-resident proteins. In this view, secretory cargo proteins are transported by vesicles from one cisterna to the next. The cisternal maturation model predicts that each cisterna is a transient structure that matures from early to late by acquiring and then losing specific Golgi-resident proteins. In this view, secretory cargo proteins traverse the Golgi by remaining within the maturing cisternae. Various observations have been interpreted as supporting one or the other mechanism(4-9). Here we provide a direct test of the two models using three-dimensional time-lapse fluorescence microscopy of the yeast Saccharomyces cerevisiae. This approach reveals that individual cisternae mature, and do so at a consistent rate. In parallel, we used pulse - chase analysis to measure the transport of two secretory cargo proteins. The rate of cisternal maturation matches the rate of protein transport through the secretory pathway, suggesting that cisternal maturation can account for the kinetics of secretory traffic.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Glick, BS (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.	bsglick@midway.uchicago.edu						Abe M, 2004, J CELL SCI, V117, P5687, DOI 10.1242/jcs.01491; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Brigance WT, 2000, MOL BIOL CELL, V11, P171, DOI 10.1091/mbc.11.1.171; Cosson P, 2002, P NATL ACAD SCI USA, V99, P12831, DOI 10.1073/pnas.192460999; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; GRAHAM TR, 2000, CURRENT PROTOCOLS CE; Hammond AT, 2000, TRAFFIC, V1, P935, DOI 10.1034/j.1600-0854.2000.011203.x; HORAZDOVSKY BF, 1995, CURR OPIN CELL BIOL, V7, P544, DOI 10.1016/0955-0674(95)80012-3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; Martinez-Menarguez JA, 2001, J CELL BIOL, V155, P1213, DOI 10.1083/jcb.200108029; MATSUURATOKITA K, 2006, NATURE          0514; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Mogelsvang S, 2003, MOL BIOL CELL, V14, P2277, DOI 10.1091/mbc.E02-10-0697; Morin-Ganet MN, 2000, TRAFFIC, V1, P56, DOI 10.1034/j.1600-0854.2000.010109.x; PAYNE WE, 1995, GENE, V163, P19, DOI 10.1016/0378-1119(95)00379-K; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Reinke CA, 2004, P NATL ACAD SCI USA, V101, P18018, DOI 10.1073/pnas.0408256102; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Schekman R., 1997, GOLGI APPARATUS, P219, DOI 10.1007/978-3-0348-8876-9_8; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Volchuk A, 2000, CELL, V102, P335, DOI 10.1016/S0092-8674(00)00039-8; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667	31	259	267	4	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					1002	1006		10.1038/nature04717	http://dx.doi.org/10.1038/nature04717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16699524				2022-12-28	WOS:000238422300047
J	Bennett, BT				Bennett, B. Taylor			An easy way out? (vol 441, pg 570, 2006)	NATURE			English	Correction									Univ Illinois, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bennett, BT (corresponding author), Univ Illinois, Chicago, IL 60680 USA.							Bennett BT, 2006, NATURE, V441, P801, DOI 10.1038/441801a	1	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					801	801		10.1038/441801a	http://dx.doi.org/10.1038/441801a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16721917	Bronze			2022-12-28	WOS:000238254100012
J	Zhu, P; Liu, J; Bess, J; Chertova, E; Lifson, JD; Grise, H; Ofek, GA; Taylor, KA; Roux, KH				Zhu, Ping; Liu, Jun; Bess, Julian, Jr.; Chertova, Elena; Lifson, Jeffrey D.; Grise, Henry; Ofek, Gilad A.; Taylor, Kenneth A.; Roux, Kenneth H.			Distribution and three-dimensional structure of AIDS virus envelope spikes	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; GLYCOPROTEIN TRIMERS; ELECTRON TOMOGRAPHY; ATOMIC-STRUCTURE; TYPE-1 MATRIX; HIV; GP41; NEUTRALIZATION; FUSION; GP120	Envelope glycoprotein (Env) spikes on AIDS retroviruses initiate infection of host cells and are therefore targets for vaccine development. Though crystal structures for partial Env subunits are known, the structure and distribution of native Env spikes on virions is obscure. We applied cryoelectron microscopy tomography to define ultrastructural details of spikes. Virions of wild-type human immunodeficiency virus 1 (HIV-1) and a mutant simian immunodeficiency virus (SIV) had similar to 14 and similar to 73 spikes per particle, respectively, with some clustering of HIV-1 spikes. Three-dimensional averaging showed that the surface glycoprotein (gp120) 'head' of each subunit of the trimeric SIV spike contains a primary mass, with two secondary lobes. The transmembrane glycoprotein 'stalk' of each trimer is composed of three independent legs that project obliquely from the trimer head, tripod-like. Reconciling available atomic structures with the three-dimensional whole spike density map yields insights into the orientation of Env spike structural elements and possible structural bases of their functions.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; NCI, AIDS Vaccine Program, SAIC Frederick Inc, Frederick, MD 21702 USA; NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Roux, KH (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	roux@bio.fsu.edu	Ofek, Gilad/A-6965-2010; Bess, Jr., Julian/B-5343-2012; Abrams, William R/A-5782-2008		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055461] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI055461] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; CAVACINI LA, 1994, J IMMUNOL, V152, P2538; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chertova E, 2003, CURR MOL MED, V3, P265, DOI 10.2174/1566524033479889; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Forster MJ, 2000, J MOL BIOL, V298, P841, DOI 10.1006/jmbi.2000.3715; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Grundner C, 2002, J VIROL, V76, P3511, DOI 10.1128/JVI.76.7.3511-3521.2002; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Klasse PJ, 2001, CURR TOP MICROBIOL, V260, P87; KODAMA T, 1989, J VIROL, V63, P4709, DOI 10.1128/JVI.63.11.4709-4714.1989; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Qiao ZS, 2005, J BIOL CHEM, V280, P23138, DOI 10.1074/jbc.M414515200; RAO ZH, 1995, NATURE, V378, P743, DOI 10.1038/378743a0; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; West JT, 2001, J VIROL, V75, P9601, DOI 10.1128/JVI.75.20.9601-9612.2001; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Winkler H, 1999, ULTRAMICROSCOPY, V77, P141, DOI 10.1016/S0304-3991(99)00035-2; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Yuste E, 2005, J VIROL, V79, P12455, DOI 10.1128/JVI.79.19.12455-12463.2005; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	48	576	595	2	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					847	852		10.1038/nature04817	http://dx.doi.org/10.1038/nature04817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16728975	Bronze			2022-12-28	WOS:000238254100036
J	Underwood, M				Underwood, Martin			Diagnosis and management of gout	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PRACTICE RESEARCH DATABASE; HYPERURICEMIA; COLCHICINE; RISK; MEN; EPIDEMIOLOGY; ALLOPURINOL; INDICATORS; ARTHRITIS; DISEASE		Univ London, Dept Gen Practice & Primary Care, Ctr Hlth Sci, London E1 2AT, England	University of London	Underwood, M (corresponding author), Univ London, Dept Gen Practice & Primary Care, Ctr Hlth Sci, London E1 2AT, England.	m.underwood@qmul.ac.uk	Underwood, Martin/D-6364-2015	Underwood, Martin/0000-0002-0309-1708				AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; BELLAMY N, 1987, BRIT J CLIN PHARMACO, V24, P33, DOI 10.1111/j.1365-2125.1987.tb03132.x; Bieber JD, 2004, ARTHRITIS RHEUM-US, V50, P2400, DOI 10.1002/art.20438; Borstad GC, 2004, J RHEUMATOL, V31, P2429; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341; Giordano N, 2001, CLIN EXP RHEUMATOL, V19, P661; Janssens HJEM, 2003, FAM PRACT, V20, P413, DOI 10.1093/fampra/cmg413; Klemp P, 1997, ANN RHEUM DIS, V56, P22, DOI 10.1136/ard.56.1.22; Mikuls TR, 2005, RHEUMATOLOGY, V44, P1038, DOI 10.1093/rheumatology/keh679; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; Mikuls TR, 2004, ARTHRITIS RHEUM-US, V50, P937, DOI 10.1002/art.20102; Morris I, 2003, BRIT MED J, V327, P1275, DOI 10.1136/bmj.327.7426.1275; Rozenberg S, 1996, REV RHUM, V63, P255; SCHUMACHER HR, 2005, ANN SCI M AM COLL RH; SUTARIA S, 2006, RHEUMATOLOGY AD 0421, DOI DOI 10.1093/RHEUMATOLOGY/KE1071; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Wortmann RL, 2005, CURR OPIN RHEUMATOL, V17, P319, DOI 10.1097/01.bor.0000162060.25895.a5; YUE TF, 1961, ANN INTERN MED, V55, P179, DOI 10.7326/0003-4819-55-2-179; 2004, DRUG THER B, V42, P37	25	76	83	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1315	1319		10.1136/bmj.332.7553.1315	http://dx.doi.org/10.1136/bmj.332.7553.1315			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16740561	Green Published			2022-12-28	WOS:000238197000025
J	Asphaug, E				Asphaug, E			Perspective - Adventures in near-Earth object exploration	SCIENCE			English	Editorial Material							IMPACT; EROS	Asteroids, because of the hazard they pose to Earth, are compelling targets for robotic and human space exploration. Yet because of their exotic low-gravity environment, simply landing on an asteroid appears to be much more challenging than we had appreciated 5 or 10 years ago. Thanks to a bold new mission from Japan that has made the first asteroid sample return attempt, this goal is now within our reach.	Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Asphaug, E (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA.	asphaug@pmc.ucsc.edu	Asphaug, Erik/AAC-9455-2020					A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Abe S, 2006, SCIENCE, V312, P1344, DOI 10.1126/science.1126272; ASPHAUG E, 2001, LUN PLAN SCI C, V32; Demura H, 2006, SCIENCE, V312, P1347, DOI 10.1126/science.1126574; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; JONES TD, 2002, ASTR SOC P, V272, P141; Okada T, 2006, SCIENCE, V312, P1338, DOI 10.1126/science.1125731; Richardson JE, 2004, SCIENCE, V306, P1526, DOI 10.1126/science.1104731; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; Trombka JI, 2000, SCIENCE, V289, P2101, DOI 10.1126/science.289.5487.2101; Veverka J, 2000, SCIENCE, V289, P2088, DOI 10.1126/science.289.5487.2088; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164	13	9	9	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1328	1329		10.1126/science.1128496	http://dx.doi.org/10.1126/science.1128496			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741106	Green Published			2022-12-28	WOS:000237961600039
J	Rosenfeld, D				Rosenfeld, D			Atmosphere - Aerosols, clouds, and climate	SCIENCE			English	Editorial Material							PRECIPITATION; SPACE		Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Rosenfeld, D (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel.	daniel.rosenfeld@huji.ac.il	Rosenfeld, Daniel/F-6077-2016; Rosenfeld, Daniel/AAJ-4617-2021	Rosenfeld, Daniel/0000-0002-0784-7656; Rosenfeld, Daniel/0000-0002-0784-7656				Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Boucher O, 2000, GEOPHYS RES LETT, V27, P1103, DOI 10.1029/1999GL010963; Dusek U, 2006, SCIENCE, V312, P1375, DOI 10.1126/science.1125261; Ervens B, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005634; Givati A, 2004, J APPL METEOROL, V43, P1038, DOI [10.1175/1520-0450(2004)043<1038:QPSDTA>2.0.CO;2, 10.1175/1520-0450(2004)043&lt;1038:QPSDTA&gt;2.0.CO;2]; Mishchenko MI, 2004, J QUANT SPECTROSC RA, V88, P149, DOI 10.1016/j.jqsrt.2004.03.030; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Stephens GL, 2002, B AM METEOROL SOC, V83, P1771, DOI 10.1175/BAMS-83-12-1771	8	86	101	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1323	1324		10.1126/science.1128972	http://dx.doi.org/10.1126/science.1128972			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741104				2022-12-28	WOS:000237961600037
J	Spirito, P; Autore, C				Spirito, Paolo; Autore, Camillo			Management of hypertrophic cardiomyopathy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SUDDEN-DEATH; CLINICAL-COURSE; RISK; IDENTIFICATION; OBSTRUCTION; PREVALENCE; PROGNOSIS		Ente Osped Osped Galliera, Div Cardiol, I-16128 Genoa, Italy; Univ Roma La Sapienza, Osped SantAndrea, Unita Operat Cardiol, I-00189 Rome, Italy	Ente Ospedaliero Ospedali Galliera; Sapienza University Rome	Spirito, P (corresponding author), Ente Osped Osped Galliera, Div Cardiol, Via Volta 8, I-16128 Genoa, Italy.	paolo.spitito@galliera.it		autore, camillo/0000-0002-6542-7342				Autore C, 2005, J AM COLL CARDIOL, V45, P1076, DOI 10.1016/j.jacc.2004.12.067; Autore C, 2002, J AM COLL CARDIOL, V40, P1864, DOI 10.1016/S0735-1097(02)02495-6; Biagini E, 2005, J AM COLL CARDIOL, V46, P1543, DOI 10.1016/j.jacc.2005.04.062; Boriani G, 2004, CIRCULATION, V110, pE438, DOI 10.1161/01.CIR.0000144463.65977.C9; Cecchi F, 2003, NEW ENGL J MED, V349, P1027, DOI 10.1056/NEJMoa025050; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; HARRIS KM, IN PRESS CIRCULATION; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1994, J AM COLL CARDIOL, V24, P880, DOI 10.1016/0735-1097(94)90844-3; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Monserrat L, 2003, J AM COLL CARDIOL, V42, P873, DOI 10.1016/S0735-1097(03)00827-1; Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X; Nishimura RA, 2004, NEW ENGL J MED, V350, P1320, DOI 10.1056/NEJMcp030779; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Ommen SR, 2005, J AM COLL CARDIOL, V46, P470, DOI 10.1016/j.jacc.2005.02.090; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Spirito P, 1999, CIRCULATION, V99, P2132, DOI 10.1161/01.CIR.99.16.2132; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; SPIRITO P, 1987, AM J CARDIOL, V60, P123, DOI 10.1016/0002-9149(87)90998-2; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Woo A, 2005, CIRCULATION, V111, P2033, DOI 10.1161/01.CIR.0000162460.36735.71	27	58	68	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2006	332	7552					1251	1255		10.1136/bmj.332.7552.1251	http://dx.doi.org/10.1136/bmj.332.7552.1251			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16735335	Green Published, Green Submitted			2022-12-28	WOS:000237984100019
J	Jones, DC; Wein, MN; Oukka, M; Hofstaetter, JG; Glimcher, MJ; Glimcher, LH				Jones, Dallas C.; Wein, Marc N.; Oukka, Mohamed; Hofstaetter, Jochen G.; Glimcher, Melvin J.; Glimcher, Laurie H.			Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3	SCIENCE			English	Article							OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; UBIQUITIN LIGASE; CBFA1; RUNX2; GENE; WNT; OSF2/CBFA1; LRP5	Genetic mutations that disrupt osteoblast function can result in skeletal dysmorphogenesis or, more rarely, in increased postnatal bone formation. Here we show that Schnurri-3 (Shn3), a mammalian homolog of the Drosophila zinc finger adapter protein Shn, is an essential regulator of adult bone formation. Mice lacking Shn3 display adult-onset osteosclerosis with increased bone mass due to augmented osteobtast activity. Shn3 was found to control protein levels of Runx2, the principal transcriptional regulator of osteoblast differentiation, by promoting its degradation through recruitment of the E3 ubiquitin ligase WWP1 to Runx2. By this means, Runx2-mediated extracellular matrix mineralization was antagonized, revealing an essential role for Shn3 as a central regulator of postnatal bone mass.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Orthopaed Surg, Lab Study Skeletal Disorders & Rehabil, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Ludwig Boltzmann Inst Osteol, A-1120 Vienna, Austria	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Ludwig Boltzmann Institute	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu		Hofstatter, Jochen/0000-0001-7741-7187; Glimcher, Laurie/0000-0001-9537-3456	NIAID NIH HHS [AI29673] Funding Source: Medline; NIAMS NIH HHS [AR46983] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029673, R37AI029673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046983] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Oukka M, 2002, MOL CELL, V9, P121, DOI 10.1016/S1097-2765(01)00434-8; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Wein MN, 2005, IMMUNOL REV, V208, P66, DOI 10.1111/j.0105-2896.2005.00322.x; WU LC, 1993, NUCLEIC ACIDS RES, V21, P5067, DOI 10.1093/nar/21.22.5067; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200	25	167	184	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1223	1227		10.1126/science.1126313	http://dx.doi.org/10.1126/science.1126313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728642				2022-12-28	WOS:000237957400057
J	Lemaire, P				Lemaire, P			How many ways to make a chordate?	SCIENCE			English	Editorial Material							REGULATORY NETWORKS; GENE; INDUCTION; NOTOCHORD; EMBRYOS; XENOPUS; MODEL		Univ Mediterranee, Inst Biol Dev Marseille Luminy, CNRS, UMR6216, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lemaire, P (corresponding author), Univ Mediterranee, Inst Biol Dev Marseille Luminy, CNRS, UMR6216, Campus Luminy, F-13288 Marseille 9, France.	temaire@ibdm.univ-mrs.fr	Lemaire, Patrick/P-8228-2019; Lemaire, Patrick/D-4237-2009; Lemaire, Patrick/B-5560-2012	Lemaire, Patrick/0000-0003-4925-2009; Lemaire, Patrick/0000-0003-4925-2009				Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; Darras S, 2001, DEVELOPMENT, V128, P2629; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Imai KS, 2002, DEVELOPMENT, V129, P1729; Koide T, 2005, P NATL ACAD SCI USA, V102, P4943, DOI 10.1073/pnas.0408125102; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Nishida H, 2001, NATURE, V409, P724, DOI 10.1038/35055568; Pourquie O, 2001, NATURE, V409, P679, DOI 10.1038/35055657; Satoh N, 2003, TRENDS GENET, V19, P376, DOI 10.1016/S0168-9525(03)00144-6; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145	14	13	13	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2006	312	5777					1145	1146		10.1126/science.1128784	http://dx.doi.org/10.1126/science.1128784			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728621				2022-12-28	WOS:000237957400029
J	Miguel, MC; Zapperi, S				Miguel, M. -Carmen; Zapperi, Stefano			Fluctuations in plasticity at the microscale	SCIENCE			English	Editorial Material							FLOW		Univ Barcelona, Dept Fis Fonamental, E-08028 Barcelona, Spain; Univ Roma La Sapienza, Dipartimento Fis, Consiglio Nazl Ric, Ist Nazl Fis Mat, I-00185 Rome, Italy	University of Barcelona; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome	Miguel, MC (corresponding author), Univ Barcelona, Dept Fis Fonamental, Diagonal 647, E-08028 Barcelona, Spain.	stefano.zapperi@roma1.infn.it	Miguel, M. Carmen/I-3087-2014; Zapperi, Stefano/C-9473-2009	Miguel, M. Carmen/0000-0001-9050-1412; Zapperi, Stefano/0000-0001-5692-5465				Dimiduk DM, 2006, SCIENCE, V312, P1188, DOI 10.1126/science.1123889; Miguel MC, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.165501; Miguel MC, 2001, NATURE, V410, P667, DOI 10.1038/35070524; Puppin E, 2000, PHYS REV LETT, V84, P5415, DOI 10.1103/PhysRevLett.84.5415; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; Zaiser M, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/08/P08004; Zapperi S, 1998, PHYS REV B, V58, P6353, DOI 10.1103/PhysRevB.58.6353	8	27	27	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1151	1152		10.1126/science.1127729	http://dx.doi.org/10.1126/science.1127729			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16739254				2022-12-28	WOS:000237957400034
J	Weissleder, R				Weissleder, R			Molecular imaging in cancer	SCIENCE			English	Editorial Material							POSITRON-EMISSION-TOMOGRAPHY; ONCOLOGY DRUG DEVELOPMENT; IN-VIVO; LUNG-CANCER; END-POINTS; BREAST; REPORTERS; DISCOVERY; LOOKING; AGENTS		Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Weissleder, R (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA.	weissleder@helix.mgh.harvard.edu	Mullish, Benjamin H/O-9524-2017	Mullish, Benjamin H/0000-0001-6300-3100; /0000-0003-0828-4143				Alencar H, 2005, NEOPLASIA, V7, P977, DOI 10.1593/neo.05376; Anderson TS, 2004, COMPUT SCI ENG, V6, P22, DOI 10.1109/MCSE.2004.77; Avril N, 2005, J CLIN ONCOL, V23, P7445, DOI 10.1200/JCO.2005.06.965; Contag PR, 2002, DRUG DISCOV TODAY, V7, P555, DOI 10.1016/S1359-6446(02)02268-7; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Evans JA, 2005, CURR OPIN GASTROEN, V21, P578, DOI 10.1097/01.mog.0000174217.62214.10; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Guller U, 2002, BREAST CANCER RES TR, V71, P171, DOI 10.1023/A:1013828710301; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Heinrich S, 2005, ANN SURG, V242, P235, DOI 10.1097/01.sla.0000172095.97787.84; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Jaffer FA, 2005, JAMA-J AM MED ASSOC, V293, P855, DOI 10.1001/jama.293.7.855; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Keller M, 2006, BIOL PSYCHIAT, V59, P216, DOI 10.1016/j.biopsych.2005.07.013; Kelloff GJ, 2005, EUR J CANCER, V41, P491, DOI 10.1016/j.ejca.2004.12.006; Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7; Lappin G, 2003, NAT REV DRUG DISCOV, V2, P233, DOI 10.1038/nrd1037; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marten K, 2002, GASTROENTEROLOGY, V122, P406, DOI 10.1053/gast.2002.30990; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Meade TJ, 2003, CURR OPIN NEUROBIOL, V13, P597, DOI 10.1016/j.conb.2003.09.009; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; Ntziachristos V, 2000, P NATL ACAD SCI USA, V97, P2767, DOI 10.1073/pnas.040570597; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Park JW, 2004, CLIN CANCER RES, V10, P3885, DOI 10.1158/1078-0432.CCR-03-0785; Propper DJ, 2003, J CLIN ONCOL, V21, P203, DOI 10.1200/JCO.2003.02.008; Querol M, 2005, ORG LETT, V7, P1719, DOI 10.1021/ol050208v; Quon A, 2005, J CLIN ONCOL, V23, P1664, DOI 10.1200/JCO.2005.11.024; Rudin M, 2003, NAT REV DRUG DISCOV, V2, P123, DOI 10.1038/nrd1007; Saleem A, 2001, J CLIN ONCOL, V19, P1421, DOI 10.1200/JCO.2001.19.5.1421; Shah K, 2005, MOL THER, V11, P926, DOI 10.1016/j.ymthe.2005.01.017; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Wieder HA, 2004, J CLIN ONCOL, V22, P900, DOI 10.1200/JCO.2004.07.122; Wu KD, 2005, P NATL ACAD SCI USA, V102, P10640, DOI 10.1073/pnas.0504512102	40	902	948	4	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2006	312	5777					1168	1171		10.1126/science.1125949	http://dx.doi.org/10.1126/science.1125949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728630	Green Published			2022-12-28	WOS:000237957400040
J	Sambhara, S; Poland, GA				Sambhara, S; Poland, GA			Avian influenza vaccines: what's all the flap?	LANCET			English	Editorial Material							H5N1 INFLUENZA; ISCOM VACCINE; A H5N1; IMMUNOGENICITY; SAFETY; VIRUS; MICE		Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; Mayo Clin, Coll Med, Mayo Vaccine Res Grp, Program Translat Immunovirol & Biodefense, Rochester, MN USA; Mayo Clin, Coll Med, Dept Internal Med, Program Translat Immunovirol & Biodefense, Rochester, MN USA	Centers for Disease Control & Prevention - USA; Mayo Clinic; Mayo Clinic	Sambhara, S (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	ssambhara@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021					Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; *FOOD DRUG ADM CTR, 2006, GUID IND CLIN DAT NE; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Karaca K, 2005, CLIN DIAGN LAB IMMUN, V12, P1340, DOI 10.1128/CDLI.12.11.1340-1342.2005; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Poland GA, 2006, NEW ENGL J MED, V354, P1411, DOI 10.1056/NEJMe068047; Rimmelzwaan GF, 1999, VACCINE, V17, P1355, DOI 10.1016/S0264-410X(98)00390-9; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; World Health Organization, CUM NUMB CONF HUM CA	12	16	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2006	367	9523					1636	1638		10.1016/S0140-6736(06)68657-1	http://dx.doi.org/10.1016/S0140-6736(06)68657-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714169				2022-12-28	WOS:000237743100007
J	Mulcahy, NJ; Call, J				Mulcahy, NJ; Call, J			Apes save tools for future use	SCIENCE			English	Article							MENTAL TIME-TRAVEL; EVOLUTION	Planning for future needs, not just current ones, is one of the most formidable human cognitive achievements. Whether this skill is a uniquely human adaptation is a controversial issue. In a study we conducted, bonobos and orangutans selected, transported, and saved appropriate tools above baseline levels to use them 1 hour later ( experiment 1). Experiment 2 extended these results to a 14-hour delay between collecting and using the tools. Experiment 3 showed that seeing the apparatus during tool selection was not necessary to succeed. These findings suggest that the precursor skills for planning for the future evolved in great apes before 14 million years ago, when all extant great ape species shared a common ancestor.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Call, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	call@eva.mpg.de		Call Balaguer, Josep/0000-0002-8597-8336				Bailey WJ, 1992, MOL PHYLOGENET EVOL, V1, P97, DOI 10.1016/1055-7903(92)90024-B; BOESCH C, 1984, Primates, V25, P160, DOI 10.1007/BF02382388; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Clayton NS, 1999, J COMP PSYCHOL, V113, P403, DOI 10.1037/0735-7036.113.4.403; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; de Heinzelin J, 1999, SCIENCE, V284, P625; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; GARCIA J, 1955, SCIENCE, V122, P157; Gergely G., 2005, INTERACT STUD, V6, P463, DOI [10.1075/is.6.3.10ger, DOI 10.1075/IS.6.3.10GER]; Kano T., 1992, LAST APE; Kimble G. A, 1961, HILGARD MARQUISCONDI; Kohler W., 1927, MENTALITY APES, V2nd ed.; LIEBERMAN DA, 1979, J EXP PSYCHOL ANIM B, V5, P224, DOI 10.1037/0097-7403.5.3.224; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Schick K. D., 1993, MAKING SILENT STONES; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; TULVING E, 1984, BEHAV BRAIN SCI, V7, P223, DOI 10.1017/S0140525X0004440X; Tulving E., 2004, MISSING LINK COGNITI, P3; van Schaik CP, 2003, J HUM EVOL, V44, P11, DOI 10.1016/S0047-2484(02)00164-1; Vander Wall S.B., 1990, FOOD HOARDING ANIMAL	22	329	339	6	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1038	1040		10.1126/science.1125456	http://dx.doi.org/10.1126/science.1125456			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	043UX	16709782				2022-12-28	WOS:000237628800041
J	Wyithe, JSB; Loeb, A				Wyithe, JSB; Loeb, A			Suppression of dwarf galaxy formation by cosmic reionization	NATURE			English	Article							LY-ALPHA EMITTERS; REDSHIFT; UNIVERSE; MASS; PHOTOIONIZATION; FEEDBACK	A large number of faint galaxies, born less than a billion years after the Big Bang, have recently been discovered(1-6). Fluctuations in the distribution of these galaxies contributed to a scatter in the ionization fraction of cosmic hydrogen on scales of tens of megaparsecs, as observed along the lines of sight to the earliest known quasars(7-9). Theoretical simulations predict that the formation of dwarf galaxies should have been suppressed after cosmic hydrogen was reionized(10-13), leading to a drop in the cosmic star-formation rate(14). Here we report evidence for this suppression. We show that the post-reionization galaxies that produced most of the ionizing radiation at a redshift z approximate to 5.5 must have had a mass in excess of similar to 10(10.9+/-0.5) solar masses (M-.) or else the aforementioned scatter would have been smaller than observed. This limiting mass is two orders of magnitude larger than the galaxy mass that is thought to have dominated the reionization of cosmic hydrogen (similar to 10(8) M-.). We predict that future surveys with space-based infrared telescopes will detect a population of smaller galaxies that reionized the Universe at an earlier time, before the epoch of dwarf galaxy suppression.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Melbourne, Parkville, Vic 3010, Australia	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Melbourne	Loeb, A (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	swyithe@physics.unimelb.edu.au; aloeb@cfa.harvard.edu		Wyithe, Stuart/0000-0001-7956-9758				Barkana R, 2004, ASTROPHYS J, V609, P474, DOI 10.1086/421079; Barkana R, 2002, ASTROPHYS J, V578, P1, DOI 10.1086/342313; Barkana R, 2000, ASTROPHYS J, V539, P20, DOI 10.1086/309229; BOUWENS RJ, 2004, APJ, V616, P79; BOUWENS RJ, 2005, ORGASTROPH0509641; Bunker AJ, 2004, MON NOT R ASTRON SOC, V355, P374, DOI 10.1111/j.1365-2966.2004.08326.x; Dekel A, 2003, MON NOT R ASTRON SOC, V344, P1131, DOI 10.1046/j.1365-8711.2003.06923.x; Dijkstra M, 2004, ASTROPHYS J, V601, P666, DOI 10.1086/380603; Djorgovski SG, 2006, NEW ASTRON REV, V50, P140, DOI 10.1016/j.newar.2005.11.015; DJORGOVSKI SG, 2004, ORGASTROPH0409378; EFSTATHIOU G, 1992, MNRAS, V256, P43; Ellis R, 2001, ASTROPHYS J, V560, pL119, DOI 10.1086/324423; FAN X, 2005, ORGASTROPH0512082; FAN X, 2005, ORGASTROPH0405138; Kauffmann G, 2003, MON NOT R ASTRON SOC, V341, P54, DOI 10.1046/j.1365-8711.2003.06292.x; Kneib JP, 2004, ASTROPHYS J, V607, P697, DOI 10.1086/386281; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Lidz A, 2006, ASTROPHYS J, V639, pL47, DOI 10.1086/502678; Loeb A, 2005, ASTROPHYS J, V620, P553, DOI 10.1086/427229; Ouchi M, 2004, ASTROPHYS J, V611, P685, DOI 10.1086/422208; Pentericci L, 2002, ASTRON J, V123, P2151, DOI 10.1086/340077; QUINN T, 1996, MNRAS, V278, P49; Rhoads JE, 2003, ASTRON J, V125, P1006, DOI 10.1086/346272; Rhoads JE, 2001, ASTROPHYS J, V563, pL5, DOI 10.1086/338477; Santos MR, 2004, ASTROPHYS J, V606, P683, DOI 10.1086/383080; Sheth RK, 2001, MON NOT R ASTRON SOC, V323, P1, DOI 10.1046/j.1365-8711.2001.04006.x; Shimasaku K, 2003, ASTROPHYS J, V586, pL111, DOI 10.1086/374880; SPERGEL DN, 2006, UNPUB ASTROPHYS J; STARK DP, 2005, ORGASTROPH0508123; Thoul AA, 1996, ASTROPHYS J, V465, P608, DOI 10.1086/177446; White RL, 2003, ASTRON J, V126, P1, DOI 10.1086/375547; Wyithe JSB, 2004, NATURE, V427, P815, DOI 10.1038/nature02336; WYITHE JSB, 2006, ORGASTROPH0508604	33	42	42	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					322	324		10.1038/nature04748	http://dx.doi.org/10.1038/nature04748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710415	Green Submitted			2022-12-28	WOS:000237593200041
J	Coulehan, J				Coulehan, J			Shut-ins	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											Coulehan, J (corresponding author), No Org, Stony Brook, NY USA.	jcoulehan@notes.cc.sunysb.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2006	295	19					2225	2226		10.1001/jama.295.19.2225	http://dx.doi.org/10.1001/jama.295.19.2225			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042UX	16705095				2022-12-28	WOS:000237556600001
J	Chaudhry, B; Wang, J; Wu, SY; Maglione, M; Mojica, W; Roth, E; Morton, SC; Shekelle, PG				Chaudhry, Basit; Wang, Jerome; Wu, Shinyi; Maglione, Margaret; Mojica, Walter; Roth, Elizabeth; Morton, Sally C.; Shekelle, Paul G.			Systematic review: Impact of health information technology on quality, efficiency, and costs of medical care	ANNALS OF INTERNAL MEDICINE			English	Review							PHYSICIAN ORDER ENTRY; ADVERSE DRUG EVENTS; RANDOMIZED CONTROLLED-TRIALS; COMPUTER-BASED INTERVENTION; DECISION-SUPPORT-SYSTEMS; HOSPITALIZED-PATIENTS; PREVENTIVE CARE; CLINICAL GUIDELINES; IMPROVE TREATMENT; TIME UTILIZATION	Background: Experts consider health information technology key to improving efficiency and quality of health care. Purpose: To systematically review evidence on the effect of health information technology on quality, efficiency, and costs of health care. Data Sources: The authors systematically searched the English-language literature indexed in MEDLINE (1995 to January 2004), the Cochrane Central Register of Controlled Trials, the Cochrane Database of Abstracts of Reviews of Effects, and the Periodical Abstracts Database. We also added studies identified by experts up to April 2005. Study Selection: Descriptive and comparative studies and systematic reviews of health information technology. Data Extraction: Two reviewers independently extracted information on system capabilities, design, effects on quality, system acquisition, implementation context, and costs. Data Synthesis: 257 studies met the inclusion criteria. Most studies addressed decision support systems or electronic health records. Approximately 25% of the studies were from 4 academic institutions that implemented internally developed systems; only 9 studies evaluated multifunctional, commercially developed systems. Three major benefits on quality were demonstrated: increased adherence to guideline-based care, enhanced surveillance and monitoring, and decreased medication errors. The primary domain of improvement was preventive health. The major efficiency benefit shown was decreased utilization of care. Data on another efficiency measure, time utilization, were mixed. Empirical cost data were limited. Limitations: Available quantitative research was limited and was done by a small number of institutions. Systems were heterogeneous and sometimes incompletely described. Available financial and contextual data were limited. Conclusions: Four benchmark institutions have demonstrated the efficacy of health information technologies in improving quality and efficiency. Whether and how other institutions can achieve similar benefits, and at what costs, are unclear.	Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA 90095 USA; RAND Corp, So Calif Evidence Based Practice Ctr, Santa Monica, CA USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Greater Los Angeles Vet Affairs Syst, Los Angeles, CA 90048 USA	University of California System; University of California Los Angeles; RAND Corporation; Cedars Sinai Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Chaudhry, B (corresponding author), Univ Calif Los Angeles, Div Gen Internal Med, 911 Broxton Ave,2nd Floor, Los Angeles, CA 90095 USA.	BChaudhry@mednet.ucla.edu	Roth, Elizabeth/AAD-9380-2021; Greiver, Michelle/N-8764-2015; Tao, Youyou/D-2367-2014	Greiver, Michelle/0000-0001-8957-0285; 				Aarts J, 2004, J AM MED INFORM ASSN, V11, P207, DOI 10.1197/jamia.M1372; Abookire SA, 2000, J AM MED INFORM ASSN, P2; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Ash JS, 2004, J AM MED INFORM ASSN, V11, P95, DOI 10.1197/jamia.M1427; Ash JS, 2003, J AM MED INFORM ASSN, V10, P229, DOI 10.1197/jamia.M1204; Audet Anne-Marie, 2004, MedGenMed, V6, P2; BAIRD TK, 1984, AM J HOSP PHARM, V41, P2395, DOI 10.1093/ajhp/41.11.2395; Bateman R, 2001, PRECAMBRIAN RES, V108, P75, DOI 10.1016/S0301-9268(00)00148-0; Bates DW, 1999, AM J MED, V106, P144, DOI 10.1016/S0002-9343(98)00410-0; Bates DW, 1997, ARCH INTERN MED, V157, P2501, DOI 10.1001/archinte.157.21.2501; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bennett JW, 2003, MED J AUSTRALIA, V178, P217, DOI 10.5694/j.1326-5377.2003.tb05166.x; Berg M, 1998, INT J MED INFORM, V52, P243, DOI 10.1016/S1386-5056(98)00143-9; Berg M, 1999, INT J MED INFORM, V55, P87, DOI 10.1016/S1386-5056(99)00011-8; BURTON ME, 1991, CLIN PHARMACOL THER, V49, P685, DOI 10.1038/clpt.1991.86; Cannon DS, 2000, J AM MED INFORM ASSN, V7, P196, DOI 10.1136/jamia.2000.0070196; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Chen P, 2003, AM J CLIN PATHOL, V119, P432, DOI 10.1309/A96XU9YKU298HB2R; Chertow GM, 2001, JAMA-J AM MED ASSOC, V286, P2839, DOI 10.1001/jama.286.22.2839; Chin HL, 1999, J AM MED INFORM ASSN, P221; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Cordero Leandro, 2004, J Perinatol, V24, P88, DOI 10.1038/sj.jp.7211000; Day F, 1995, Proc Annu Symp Comput Appl Med Care, P576; Demakis JG, 2000, JAMA-J AM MED ASSOC, V284, P1411, DOI 10.1001/jama.284.11.1411; Dexter PR, 2004, JAMA-J AM MED ASSOC, V292, P2366, DOI 10.1001/jama.292.19.2366; Dexter PR, 1998, ANN INTERN MED, V128, P102, DOI 10.7326/0003-4819-128-2-199801150-00005; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Evans R S, 1993, Proc Annu Symp Comput Appl Med Care, P161; Evans R S, 1992, Proc Annu Symp Comput Appl Med Care, P437; Evans RS, 1999, ANN PHARMACOTHER, V33, P1026, DOI 10.1345/aph.18391; EVANS RS, 1986, JAMA-J AM MED ASSOC, V256, P1007, DOI 10.1001/jama.256.8.1007; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; EVANS RS, 1994, ARCH INTERN MED, V154, P878, DOI 10.1001/archinte.154.8.878; *FACCT, 2003, INN VIS STRAT CREAT; FIHN SD, 1994, J GEN INTERN MED, V9, P131, DOI 10.1007/BF02600026; FRIST B, 2004, WASHINGTON POST 0825, pA17; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; GARR DR, 1993, AM J PREV MED, V9, P55, DOI 10.1016/S0749-3797(18)30769-4; Garrido T, 2005, BMJ-BRIT MED J, V330, P581, DOI 10.1136/bmj.330.7491.581; GOLDMAN L, 1988, NEW ENGL J MED, V318, P797, DOI 10.1056/NEJM198803313181301; Honigman B, 2001, J AM MED INFORM ASSN, V8, P254, DOI 10.1136/jamia.2001.0080254; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2003, KEY CAP EL HLTH REC; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Jha AK, 1998, J AM MED INFORM ASSN, V5, P305, DOI 10.1136/jamia.1998.0050305; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kerr Eve A, 2002, Jt Comm J Qual Improv, V28, P555; Khoury A, 1997, Health Manag Technol, V18, P36; KHOURY A, 1997, HLTH MANAG TECHNOL, V18, P36; Khoury A T, 1998, Eff Clin Pract, V1, P73; Kilgore M L, 1998, J Cardiovasc Manag, V9, P31; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Krall M A, 1995, Proc Annu Symp Comput Appl Med Care, P708; Kramer Teresa L, 2003, Jt Comm J Qual Saf, V29, P479; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Kuperman G J, 1996, Proc AMIA Annu Fall Symp, P704; Kuperman GJ, 1999, J AM MED INFORM ASSN, V6, P512, DOI 10.1136/jamia.1999.0060512; LARSEN RA, 1989, INFECT CONT HOSP EP, V10, P316, DOI 10.2307/30146474; *LEAPFR GROUP, PURCH PRINC; LITZELMAN DK, 1993, J GEN INTERN MED, V8, P311, DOI 10.1007/BF02600144; MCDONALD CJ, 1992, M D COMPUT, V9, P304; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MCDONALD CJ, 1976, ANN INTERN MED, V84, P162, DOI 10.7326/0003-4819-84-2-162; MCDONALD CJ, 1980, JAMA-J AM MED ASSOC, V244, P1579, DOI 10.1001/jama.244.14.1579; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; Mekhjian HS, 2002, J AM MED INFORM ASSN, V9, P529, DOI 10.1197/jamia.M1038; Miller RH, 2004, HEALTH AFFAIR, V23, P116, DOI 10.1377/hlthaff.23.2.116; Mitchell E, 2001, BMJ-BRIT MED J, V322, P279, DOI 10.1136/bmj.322.7281.279; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Ornstein S M, 1995, Fam Med, V27, P260; Overhage J M, 2001, J Public Health Manag Pract, V7, P60; Overhage JM, 1997, J AM MED INFORM ASSN, V4, P364, DOI 10.1136/jamia.1997.0040364; Overhage JM, 2001, J AM MED INFORM ASSN, V8, P361, DOI 10.1136/jamia.2001.0080361; Overhage JM, 1996, ARCH INTERN MED, V156, P1551, DOI 10.1001/archinte.156.14.1551; PIERPONT GL, 1995, CRIT CARE MED, V23, P1067, DOI 10.1097/00003246-199506000-00012; Pizziferri L, 2005, J BIOMED INFORM, V38, P176, DOI 10.1016/j.jbi.2004.11.009; Poon EG, 2004, HEALTH AFFAIR, V23, P184, DOI 10.1377/hlthaff.23.4.184; Potts AL, 2004, PEDIATRICS, V113, P59, DOI 10.1542/peds.113.1.59; Rollman BL, 2002, J GEN INTERN MED, V17, P493, DOI 10.1046/j.1525-1497.2002.10421.x; Rollman BL, 2001, ARCH INTERN MED, V161, P189, DOI 10.1001/archinte.161.2.189; Rossi RA, 1997, J GEN INTERN MED, V12, P672, DOI 10.1046/j.1525-1497.1997.07140.x; SAFRAN C, 1995, LANCET, V346, P341, DOI 10.1016/S0140-6736(95)92226-1; Sanders DL, 2001, J AM MED INFORM ASSN, P583; Schriger DL, 2000, J AM MED INFORM ASSN, V7, P186, DOI 10.1136/jamia.2000.0070186; Schriger DL, 1997, JAMA-J AM MED ASSOC, V278, P1585, DOI 10.1001/jama.278.19.1585; Shojania KG, 1998, J AM MED INFORM ASSN, V5, P554, DOI 10.1136/jamia.1998.0050554; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; SMITH AF, 2004, ROADMAP 21 CENTURY H; STEELE MA, 1989, DICP ANN PHARMAC, V23, P497, DOI 10.1177/106002808902300612; Teich JM, 2000, ARCH INTERN MED, V160, P2741, DOI 10.1001/archinte.160.18.2741; TIERNEY WM, 1987, ANN INTERN MED, V107, P569, DOI 10.7326/0003-4819-107-4-569; TIERNEY WM, 1988, JAMA-J AM MED ASSOC, V259, P1194, DOI 10.1001/jama.259.8.1194; TIERNEY WM, 1990, NEW ENGL J MED, V322, P1499, DOI 10.1056/NEJM199005243222105; TIERNEY WM, 1993, JAMA-J AM MED ASSOC, V269, P379, DOI 10.1001/jama.269.3.379; TIERNEY WM, 1986, MED CARE, V24, P659, DOI 10.1097/00005650-198608000-00001; U.S. Department of Health and Human Services, 2004, DEC HLTH INF TECHN D; Valdes Ignacio, 2004, Inform Prim Care, V12, P3; Wang SJ, 2003, AM J MED, V114, P397, DOI 10.1016/S0002-9343(03)00057-3; Wells BJ, 2003, AM J MED QUAL, V18, P147, DOI 10.1177/106286060301800403; WHITE KS, 1984, J AM COLL CARDIOL, V4, P571, DOI 10.1016/S0735-1097(84)80104-7; WHITE RH, 1987, J GEN INTERN MED, V2, P141, DOI 10.1007/BF02596140; Willson D, 1995, Proc Annu Symp Comput Appl Med Care, P646; WILSON GA, 1982, AM J PUBLIC HEALTH, V72, P698, DOI 10.2105/AJPH.72.7.698; Wong DH, 2003, CRIT CARE MED, V31, P2488, DOI 10.1097/01.CCM.0000089637.53301.EF	106	1879	1904	4	419	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2006	144	10					742	752		10.7326/0003-4819-144-10-200605160-00125	http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00125			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043XO	16702590				2022-12-28	WOS:000237636400005
J	Taylor, HR; Wright, HR				Taylor, HR; Wright, HR			Dip-stick test for trachoma control programmes	LANCET			English	Editorial Material							OCULAR CHLAMYDIAL INFECTION; PREVALENCE; DIAGNOSIS; TANZANIA; IMPACT		Univ Melbourne, WHO Collaborating Ctr Prevent Blindness, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Univ New S Wales, Vis CRC, Sydney, NSW, Australia	Centre for Eye Research Australia; University of Melbourne; University of New South Wales Sydney	Taylor, HR (corresponding author), Univ Melbourne, WHO Collaborating Ctr Prevent Blindness, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia.	h.taylor@unimelb.edu.au		Taylor, Hugh/0000-0002-9437-784X				Bailey R, 1999, EPIDEMIOL INFECT, V123, P479, DOI 10.1017/S0950268899003076; Kuper H, 2003, LANCET INFECT DIS, V3, P372, DOI 10.1016/S1473-3099(03)00659-5; Michel CEC, 2006, LANCET, V367, P1585, DOI 10.1016/S0140-6736(06)68695-9; Miller K, 2004, OPHTHAL EPIDEMIOL, V11, P255, DOI 10.1080/09286580490514577; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Solomon AW, 2004, CLIN MICROBIOL REV, V17, P982, DOI 10.1128/CMR.17.4.982-1011.2004; TAYLOR HR, 1987, B WORLD HEALTH ORGAN, V65, P485; Thein J, 2002, OPHTHALMIC EPIDEMIOL, V9, P263, DOI 10.1076/opep.9.4.263.1508; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; WEST S, 1989, B WORLD HEALTH ORGAN, V67, P71; WEST S, 1995, LANCET, V345, P155, DOI 10.1016/S0140-6736(95)90167-1; *WHO, 1998, 5111 WHO; Wright HR, 2005, LANCET INFECT DIS, V5, P313, DOI 10.1016/S1473-3099(05)70116-X	14	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2006	367	9522					1553	1554		10.1016/S0140-6736(06)68668-6	http://dx.doi.org/10.1016/S0140-6736(06)68668-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698393				2022-12-28	WOS:000237598000005
J	Guilbert, TW; Morgan, WJ; Zeiger, RS; Mauger, DT; Boehmer, SJ; Szefler, SJ; Bacharier, LB; Lemanske, RF; Strunk, RC; Allen, DB; Bloomberg, GR; Heldt, G; Krawiec, M; Larsen, G; Liu, AH; Chinchilli, VM; Sorkness, CA; Taussig, LM; Martinez, FD				Guilbert, TW; Morgan, WJ; Zeiger, RS; Mauger, DT; Boehmer, SJ; Szefler, SJ; Bacharier, LB; Lemanske, RF; Strunk, RC; Allen, DB; Bloomberg, GR; Heldt, G; Krawiec, M; Larsen, G; Liu, AH; Chinchilli, VM; Sorkness, CA; Taussig, LM; Martinez, FD			Long-term inhaled corticosteroids in preschool children at high risk for asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FLUTICASONE PROPIONATE; CHILDHOOD ASTHMA; IMPULSE OSCILLOMETRY; PERSISTENT ASTHMA; BUDESONIDE; BECLOMETHASONE; SALMETEROL; SYMPTOMS	BACKGROUND: It is unknown whether inhaled corticosteroids can modify the subsequent development of asthma in preschool children at high risk for asthma. METHODS: We randomly assigned 285 participants two or three years of age with a positive asthma predictive index to treatment with fluticasone propionate (at a dose of 88 microg twice daily) or masked placebo for two years, followed by a one-year period without study medication. The primary outcome was the proportion of episode-free days during the observation year. RESULTS: During the observation year, no significant differences were seen between the two groups in the proportion of episode-free days, the number of exacerbations, or lung function. During the treatment period, as compared with placebo use, use of the inhaled corticosteroid was associated with a greater proportion of episode-free days (P=0.006) and a lower rate of exacerbations (P<0.001) and of supplementary use of controller medication (P<0.001). In the inhaled-corticosteroid group, as compared with the placebo group, the mean increase in height was 1.1 cm less at 24 months (P<0.001), but by the end of the trial, the height increase was 0.7 cm less (P=0.008). During treatment, the inhaled corticosteroid reduced symptoms and exacerbations but slowed growth, albeit temporarily and not progressively. CONCLUSIONS: In preschool children at high risk for asthma, two years of inhaled-corticosteroid therapy did not change the development of asthma symptoms or lung function during a third, treatment-free year. These findings do not provide support for a subsequent disease-modifying effect of inhaled corticosteroids after the treatment is discontinued.	Univ Arizona, Arizona Resp Ctr, Div Pediat Pulm Med, Tucson, AZ 85724 USA; Kaiser Permanente, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA; Penn State Univ, Hershey, PA USA; Natl Jewish Med & Res Ctr, Denver, CO USA; Washington Univ, St Louis, MO USA; Univ Wisconsin, Madison, WI USA	University of Arizona; Kaiser Permanente; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Jewish Health; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Guilbert, TW (corresponding author), Univ Arizona, Arizona Resp Ctr, Div Pediat Pulm Med, 1501 N Campbell Ave,POB 245073, Tucson, AZ 85724 USA.	guilbert@arc.arizona.edu		Guilbert, Theresa/0000-0002-6932-712X; Zeiger, Robert/0000-0001-5788-5063; Bacharier, Leonard/0000-0003-0432-2704	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051, M01RR000036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL064287, U10HL064307, K30HL004519, K08HL071742, U10HL064313, U10HL064288, U10HL064305, U10HL064295] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00036, M01 RR00051] Funding Source: Medline; NHLBI NIH HHS [5U10HL064295, 5U10HL064288, 5U10HL064287, 5U10HL064313, HL004519-04, HL071742-01, 5U10HL064307, 5U10HL064305] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; BARBEE RA, 1985, CHEST S, V87, P21; Bisgaard H, 1999, AM J RESP CRIT CARE, V160, P126, DOI 10.1164/ajrccm.160.1.9811024; Bisgaard H, 2005, J ALLERGY CLIN IMMUN, V115, P708, DOI 10.1016/j.jaci.2004.11.018; Bisgaard H, 2004, PEDIATRICS, V113, P87; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; DOLOVICH M, 1997, ASTHMA, V2, P1359; Goldman MD, 2002, PEDIATR PULM, V34, P312, DOI 10.1002/ppul.10168; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; Halonen M, 1999, AM J RESP CRIT CARE, V160, P564, DOI 10.1164/ajrccm.160.2.9809038; Marotta A, 2003, J ALLERGY CLIN IMMUN, V112, P317, DOI 10.1067/mai.2003.1627; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; *NAT ASTHM ED PREV, 1997, NIH PUBL; *NAT ASTHM ED PREV, 2002, NIH PUBL; *NAT TECHN INF SER, 1994, CHILDH ASTHM MAN PRO; Nielsen KG, 2000, AM J RESP CRIT CARE, V162, P1500, DOI 10.1164/ajrccm.162.4.2002019; Pao CS, 2002, AM J RESP CRIT CARE, V166, P945, DOI 10.1164/rccm.200203-265OC; PHELAN PD, 1995, CLIN PAEDIAT, V3; Roorda RJ, 2001, J ALLERGY CLIN IMMUN, V108, P540, DOI 10.1067/mai.2001.118789; Senturia YD, 2001, AMBUL PEDIATR, V1, P194, DOI 10.1367/1539-4409(2001)001<0194:TUOPRT>2.0.CO;2; Simons FER, 1997, NEW ENGL J MED, V337, P1659, DOI 10.1056/NEJM199712043372304; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Teper AM, 2004, PEDIATR PULM, V37, P111, DOI 10.1002/ppul.10400; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067; Verona E, 2003, ARCH DIS CHILD, V88, P503, DOI 10.1136/adc.88.6.503; WAALKENS HJ, 1993, AM REV RESPIR DIS, V148, P1252, DOI 10.1164/ajrccm/148.5.1252; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	31	723	783	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					1985	1997		10.1056/NEJMoa051378	http://dx.doi.org/10.1056/NEJMoa051378			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687711				2022-12-28	WOS:000237413100003
J	Kingsnorth, A; O'Reilly, D				Kingsnorth, A; O'Reilly, D			Acute pancreatitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MANAGEMENT; SEVERITY; GUIDELINES; NUTRITION; SURGERY		Derriford Hosp, Plymouth PL6 8DH, Devon, England; Aintree Univ Hosp NHS Fdn Trust, Dept Surg, Liverpool, Merseyside, England	Derriford Hospital; Aintree University Hospitals NHS Foundation Trust	Kingsnorth, A (corresponding author), Derriford Hosp, Plymouth PL6 8DH, Devon, England.	andrew.Kingsnorth@phnt.swest.nhs.uk						AYUH K, 2004, COCHRANE DB SYST REV; Bassi C, 2003, COCHRANE DB SYST REV; Buchler M, 1999, ACUTE PANCREATITIS N, P171; Connor S, 2005, SCAND J SURG, V94, P135, DOI 10.1177/145749690509400210; Dervenis C, 1999, INT J PANCREATOL, V25, P195; Eatock FC, 2005, AM J GASTROENTEROL, V100, P432, DOI 10.1111/j.1572-0241.2005.40587.x; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Isenmann R, 2004, GASTROENTEROLOGY, V126, P997, DOI 10.1053/j.gastro.2003.12.050; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; McKay CJ, 1999, BRIT J SURG, V86, P1302, DOI 10.1046/j.1365-2168.1999.01246.x; Meier R, 2002, CLIN NUTR, V21, P173, DOI 10.1054/clnu.2002.0543; Nathens AB, 2004, CRIT CARE MED, V32, P2524, DOI 10.1097/01.CCM.0000148222.09869.92; Neoptolemos JP, 2000, LANCET, V355, P1955, DOI 10.1016/S0140-6736(00)02327-8; O'Reilly DA, 2004, BMJ-BRIT MED J, V328, P968, DOI 10.1136/bmj.328.7446.968; Sargen K, 2001, JOP, V2, P317; Somogyi L, 2001, GASTROENTEROLOGY, V120, P708, DOI 10.1053/gast.2001.22333; Srivastava R, 2005, BRIT MED J, V331, P890, DOI 10.1136/bmj.331.7521.890; Toouli J, 2002, J GASTROEN HEPATOL, V17, pS15, DOI 10.1046/j.1440-1746.17.s1.2.x; Uhl W, 2003, PANCREATOLOGY, V3, DOI 10.1159/000067684; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Werner J, 2005, GUT, V54, P426, DOI 10.1136/gut.2003.035907; Whitcomb DC, 2004, GUT, V53, P1710, DOI 10.1136/gut.2003.015511; Windsor ACJ, 1998, GUT, V42, P431, DOI 10.1136/gut.42.3.431	23	75	81	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1072	1076		10.1136/bmj.332.7549.1072	http://dx.doi.org/10.1136/bmj.332.7549.1072			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16675814	Green Published			2022-12-28	WOS:000237518400020
J	He, P; Shan, L; Lin, NC; Martin, GB; Kemmerling, B; Nurnberger, T; Sheen, J				He, Ping; Shan, Libo; Lin, Nai-Chun; Martin, Gregory B.; Kemmerling, Birgit; Nuernberger, Thorsten; Sheen, Jen			Specific bacterial suppressors of MAMP signaling upstream of MAPKKK in Arabidopsis innate immunity	CELL			English	Article							PROGRAMMED CELL-DEATH; PTO-MEDIATED RESISTANCE; III EFFECTORS; NONHOST RESISTANCE; DEFENSE RESPONSES; KINASE; PLANT; GENE; DISEASE; PROTEIN	Plants and animals possess innate immune systems to prevent infections and are effectively "nonhosts" for most potential pathogens. The molecular mechanisms underlying nonhost immunity in plants remain obscure. In Arabidopsis, nonhost/nonpathogenic Pseudomonas syringae sustains but pathogenic P. syringae suppresses early MAMP (microbe-associated molecular pattern) marker-gene activation. We performed a cell-based genetic screen of virulence factors and identified AvrPto and AvrPtoB as potent and unique suppressors of early-defense gene transcription and MAP kinase (MAPK) signaling. Unlike effectors of mammalian pathogens, AvrPto and AvrPtoB intercept multiple MAMP-mediated signaling upstream of MAPKKK at the plasma membrane linked to the receptor. In transgenic Arabidopsis, AvrPto blocks early MAMP signaling and enables nonhost P. syringae growth. Deletions of avrPto and avrPtoB from pathogenic P. syringae reduce its virulence. The studies reveal a fundamental role of MAMP signaling in nonhost immunity, and a novel action of type III effectors from pathogenic bacteria.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; Eberhard Karls University of Tubingen	Sheen, J (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu	Martin, Gregory B/F-6262-2011	Martin, Gregory B/0000-0003-0044-6830; LIN, NAI-CHUN/0000-0002-6485-9776; He, Ping/0000-0002-5926-8349; Kemmerling, Birgit/0000-0003-1174-0189	NIGMS NIH HHS [R01 GM70567] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070567] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; Eastmond PJ, 2004, PLANT J, V37, P617, DOI 10.1111/j.1365-313X.2003.01989.x; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Galan JE, 2005, CURR OPIN MICROBIOL, V8, P1, DOI 10.1016/j.mib.2004.12.015; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2004, PLANT J, V37, P589, DOI 10.1111/j.1365-313X.2003.01986.x; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; McNellis TW, 1998, PLANT J, V14, P247, DOI 10.1046/j.1365-313X.1998.00106.x; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oh HS, 2005, PLANT J, V44, P348, DOI 10.1111/j.1365-313X.2005.02529.x; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Pedley KF, 2004, J BIOL CHEM, V279, P49229, DOI 10.1074/jbc.M410323200; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Shan LB, 2000, MOL PLANT MICROBE IN, V13, P592, DOI 10.1094/MPMI.2000.13.6.592; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	45	314	343	4	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					563	575		10.1016/j.cell.2006.02.047	http://dx.doi.org/10.1016/j.cell.2006.02.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678099	Bronze, Green Submitted			2022-12-28	WOS:000237506100021
J	Schwartz, RJ; Schneider, MD				Schwartz, RJ; Schneider, MD			CAMTA in cardiac hypertrophy	CELL			English	Editorial Material							TRANSCRIPTION; DISEASE; TINMAN; NKX2-5; FAMILY; HEART		Texas A&M Univ, Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine; Baylor College of Medicine	Schwartz, RJ (corresponding author), Texas A&M Univ, Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA.	rschwartz@ibt.tamhsc.edu		Schneider, Michael/0000-0001-9645-1938				Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; McKinsey TA, 2006, MOL BIOL CELL, V17, P438, DOI 10.1091/mbc.E05-07-0612; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Prall OWJ, 2002, ANN MED, V34, P148; SONG K, 2006, CELL; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200	10	7	10	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 5	2006	125	3					427	429		10.1016/j.cell.2006.04.015	http://dx.doi.org/10.1016/j.cell.2006.04.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678087	Bronze			2022-12-28	WOS:000237506100007
J	Shi, XB; Hong, T; Walter, KL; Ewalt, M; Michishita, E; Hung, T; Carney, D; Pena, P; Lan, F; Kaadige, MR; Lacoste, N; Cayrou, C; Davrazou, F; Saha, A; Cairns, BR; Ayer, DE; Kutateladze, TG; Shi, Y; Cote, J; Chua, KF; Gozani, O				Shi, Xiaobing; Hong, Tao; Walter, Kay L.; Ewalt, Mark; Michishita, Eriko; Hung, Tiffany; Carney, Dylan; Pena, Pedro; Lan, Fei; Kaadige, Mohan R.; Lacoste, Nicolas; Cayrou, Christelle; Davrazou, Foteini; Saha, Anjanabha; Cairns, Bradley R.; Ayer, Donald E.; Kutateladze, Tatiana G.; Shi, Yang; Cote, Jacques; Chua, Katrin F.; Gozani, Or			ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression	NATURE			English	Article							ACETYLATION; CHROMATIN; BINDING; ASSOCIATION; FINGER; YEAST	Dynamic regulation of diverse nuclear processes is intimately linked to covalent modifications of chromatin(1,2). Much attention has focused on methylation at lysine 4 of histone H3 (H3K4), owing to its association with euchromatic genomic regions(3,4). H3K4 can be mono-, di- or tri-methylated. Trimethylated H3K4 (H3K4me3) is preferentially detected at active genes, and is proposed to promote gene expression through recognition by transcription-activating effector molecules(5). Here we identify a novel class of methylated H3K4 effector domains-the PHD domains of the ING (for inhibitor of growth) family of tumour suppressor proteins. The ING PHD domains are specific and highly robust binding modules for H3K4me3 and H3K4me2. ING2, a native subunit of a repressive mSin3a-HDAC1 histone deacetylase complex(6), binds with high affinity to the trimethylated species. In response to DNA damage, recognition of H3K4me3 by the ING2 PHD domain stabilizes the mSin3a-HDAC1 complex at the promoters of proliferation genes. This pathway constitutes a new mechanism by which H3K4me3 functions in active gene repression. Furthermore, ING2 modulates cellular responses to genotoxic insults, and these functions are critically dependent on ING2 interaction with H3K4me3. Together, our findings establish a pivotal role for trimethylation of H3K4 in gene repression and, potentially, tumour suppressor mechanisms.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Laval, Ctr Canc Res, Quebec City, PQ G1R 2J6, Canada; VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA	Stanford University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Laval University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Gozani, O (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	ogozani@stanford.edu	Ewalt, Mark D/Y-4878-2019; Cote, Jacques/I-8901-2014; Gozani, Or P/I-6157-2013	Ewalt, Mark D/0000-0003-4245-752X; Cote, Jacques/0000-0001-6751-555X; Ayer, Donald/0000-0002-5595-3269; Cayrou, Christelle/0000-0002-6910-8023; Kutateladze, Tatiana/0000-0001-7375-6990; Shi, Xiaobing/0000-0001-5242-8189; Gozani, Or/0000-0002-1365-4463	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER; CIHR [64289-1] Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM060415-06, R01 GM060415] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CIHR(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; PENA PV, 2006, NATURE          0521; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; WYSOCKA J, 2006, NATURE          0521; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	23	712	752	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					96	99		10.1038/nature04835	http://dx.doi.org/10.1038/nature04835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16728974	Green Accepted			2022-12-28	WOS:000238724500044
J	Abe, M; Takagi, Y; Kitazato, K; Abe, S; Hiroi, T; Vilas, F; Clark, BE; Abell, PA; Lederer, SM; Jarvis, KS; Nimura, T; Ueda, Y; Fujiwara, A				Abe, M; Takagi, Y; Kitazato, K; Abe, S; Hiroi, T; Vilas, F; Clark, BE; Abell, PA; Lederer, SM; Jarvis, KS; Nimura, T; Ueda, Y; Fujiwara, A			Near-infrared spectral results of asteroid Itokawa from the Hayabusa spacecraft	SCIENCE			English	Article							C MISSION TARGET; REFLECTANCE SPECTROSCOPY; 1998 SF36; EROS; ALBEDO	The near-infrared spectrometer on board the Japanese Hayabusa spacecraft found a variation of more than 10% in albedo and absorption band depth in the surface reflectance of asteroid 25143 Itokawa. Spectral shape over the 1-micrometer absorption band indicates that the surface of this body has an olivine-rich mineral assemblage potentially similar to that of LL5 or LL6 chondrites. Diversity in the physical condition of Itokawa's surface appears to be larger than for other S-type asteroids previously explored by spacecraft, such as 433 Eros.	Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; Toho Gakuen Univ, Aichi 4658515, Japan; Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan; Kobe Univ, Grad Sch Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Arizona, Multiple Mirror Telescope Observ, Tucson, AZ 85721 USA; Ithaca Coll, Dept Phys, Ithaca, NY 14850 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Calif State Univ San Bernardino, Dept Phys, San Bernardino, CA 92407 USA; ESC Grp Hamilton Sundstrand, Houston, TX 77058 USA	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; Kobe University; Brown University; University of Arizona; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; California State University System; California State University San Bernardino	Abe, M (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Kanagawa 2298510, Japan.			Abe, Shinsuke/0000-0002-6247-4979; Vilas, Faith/0000-0003-4723-5870				ABELL PA, UNPUB; ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Al-Bassam K. S., 1978, Meteoritics, V13, P257, DOI 10.1111/j.1945-5100.1978.tb00815.x; Binzel RP, 2001, METEORIT PLANET SCI, V36, P1167, DOI 10.1111/j.1945-5100.2001.tb01950.x; CLARK BE, 1995, J GEOPHYS RES-PLANET, V100, P14443, DOI 10.1029/95JE00720; Clark BE, 2002, ICARUS, V155, P189, DOI 10.1006/icar.2001.6748; Clark BE, 2001, METEORIT PLANET SCI, V36, P1617, DOI 10.1111/j.1945-5100.2001.tb01853.x; GAFFEY MJ, 1990, LUNAR PLANET SCI, V21, P399; GRADIE J, 1980, P LUN PLAN SCI C, V11, P799; HAPKE B, 1986, ICARUS, V67, P264, DOI 10.1016/0019-1035(86)90108-9; HIROI T, 1994, J GEOPHYS RES-PLANET, V99, P10867, DOI 10.1029/94JE00841; Ishiguro M, 2003, PUBL ASTRON SOC JPN, V55, P691, DOI 10.1093/pasj/55.3.691; Izenberg NR, 2003, METEORIT PLANET SCI, V38, P1053, DOI 10.1111/j.1945-5100.2003.tb00298.x; Lederer SM, 2005, ICARUS, V173, P153, DOI 10.1016/j.icarus.2004.07.022; Li JY, 2004, ICARUS, V172, P415, DOI 10.1016/j.icarus.2004.07.024; McFadden LA, 2001, METEORIT PLANET SCI, V36, P1711, DOI 10.1111/j.1945-5100.2001.tb01858.x; Michel P, 2006, ASTRON ASTROPHYS, V449, P817, DOI 10.1051/0004-6361:20054319; Muinonen K., 2002, ASTEROID PHOTOMETRIC, P123; Muller TG, 2005, ASTRON ASTROPHYS, V443, P347, DOI 10.1051/0004-6361:20053862; Okada T, 2006, SCIENCE, V312, P1338, DOI 10.1126/science.1125731; Pieters C. M., 2004, LPI, V1720; Rivkin AS, 2004, ICARUS, V172, P408, DOI 10.1016/j.icarus.2004.07.006; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; Sekiguchi T, 2003, ASTRON ASTROPHYS, V397, P325, DOI 10.1051/0004-6361:20021437; Shkuratov Y, 1999, ICARUS, V137, P235, DOI 10.1006/icar.1998.6035; Sunshine JM, 1998, J GEOPHYS RES-PLANET, V103, P13675, DOI 10.1029/98JE01217; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164	27	118	122	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1334	1338		10.1126/science.1125718	http://dx.doi.org/10.1126/science.1125718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741108				2022-12-28	WOS:000237961600041
J	Wulff, K				Wulff, K			Examining knowledge of geometry	SCIENCE			English	Letter											Wulff, K (corresponding author), Geschamp 15, D-29640 Schneverdingen, Germany.	karl.ah.wulff@t-online.de						CULLEN C, 1996, ASTRONOMY MATH ANCIE, P77; Leibniz G. W., 1699, NOVISSIMA SINICA; NEEDHAM J., 1959, SCI CIVILISATION CHI, V3, P91	3	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1309	1309		10.1126/science.312.5778.1309c	http://dx.doi.org/10.1126/science.312.5778.1309c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741095				2022-12-28	WOS:000237961600018
J	Ashworth, J; Havranek, JJ; Duarte, CM; Sussman, D; Monnat, RJ; Stoddard, BL; Baker, D				Ashworth, Justin; Havranek, James J.; Duarte, Carlos M.; Sussman, Django; Monnat, Raymond J., Jr.; Stoddard, Barry L.; Baker, David			Computational redesign of endonuclease DNA binding and cleavage specificity	NATURE			English	Article							I-CREI; PREDICTION; SITE; RECOMBINATION; RECOGNITION; EVOLUTION	The reprogramming of DNA-binding specificity is an important challenge for computational protein design that tests current understanding of protein - DNA recognition, and has considerable practical relevance for biotechnology and medicine(1-6). Here we describe the computational redesign of the cleavage specificity of the intron-encoded homing endonuclease I-MsoI(7) using a physically realistic atomic-level forcefield(8,9). Using an in silico screen, we identified single base-pair substitutions predicted to disrupt binding by the wild-type enzyme, and then optimized the identities and conformations of clusters of amino acids around each of these unfavourable substitutions using Monte Carlo sampling(10). A redesigned enzyme that was predicted to display altered target site specificity, while maintaining wild-type binding affinity, was experimentally characterized. The redesigned enzyme binds and cleaves the redesigned recognition site similar to 10,000 times more effectively than does the wild-type enzyme, with a level of target discrimination comparable to the original endonuclease. Determination of the structure of the redesigned nuclease-recognition site complex by X-ray crystallography confirms the accuracy of the computationally predicted interface. These results suggest that computational protein design methods can have an important role in the creation of novel highly specific endonucleases for gene therapy and other applications.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Ashworth, J (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	ashwortj@u.washington.edu; dabaker@u.washington.edu	Duarte Quesada, Carlos Manuel/ABD-6208-2021; Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Ashworth, Justin/0000-0003-4835-6551	NATIONAL CANCER INSTITUTE [R01CA088942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA088942-05, R01 CA088942] Funding Source: Medline; NIGMS NIH HHS [R01 GM049857, R01 GM049857-12] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chevalier B, 2003, J MOL BIOL, V329, P253, DOI 10.1016/S0022-2836(03)00447-9; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Gouble A, 2006, J GENE MED, V8, P616, DOI 10.1002/jgm.879; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Heath PJ, 1997, NAT STRUCT BIOL, V4, P468, DOI 10.1038/nsb0697-468; Kono H, 1999, PROTEINS, V35, P114, DOI 10.1002/(SICI)1097-0134(19990401)35:1<114::AID-PROT11>3.0.CO;2-T; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pabo CO, 2000, J MOL BIOL, V301, P597, DOI 10.1006/jmbi.2000.3918; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; PRESS WH, 1992, NUMERICAL RECIPES; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Seligman LM, 2002, NUCLEIC ACIDS RES, V30, P3870, DOI 10.1093/nar/gkf495; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Sussman D, 2004, J MOL BIOL, V342, P31, DOI 10.1016/j.jmb.2004.07.031; Uil TG, 2003, NUCLEIC ACIDS RES, V31, P6064, DOI 10.1093/nar/gkg815; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Voigt CA, 2000, J MOL BIOL, V299, P789, DOI 10.1006/jmbi.2000.3758; Wickelgren I, 2003, SCIENCE, V300, P1646, DOI 10.1126/science.300.5626.1646	26	254	321	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					656	659		10.1038/nature04818	http://dx.doi.org/10.1038/nature04818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738662	Green Accepted			2022-12-28	WOS:000237920800052
J	Dixon, TH; Amelung, F; Ferretti, A; Novali, F; Rocca, F; Dokka, R; Sella, G; Kim, SW; Wdowinski, S; Whitman, D				Dixon, Timothy H.; Amelung, Falk; Ferretti, Alessandro; Novali, Fabrizio; Rocca, Fabio; Dokka, Roy; Sella, Giovanni; Kim, Sang-Wan; Wdowinski, Shimon; Whitman, Dean			Subsidence and flooding in New Orleans	NATURE			English	Article									Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; Tele Rilevamento Europa, I-20149 Milan, Italy; Politecn Milan, Dipartimento Elettron & Informaz, I-20133 Milan, Italy; Louisiana State Univ, Ctr Geoinformat, Baton Rouge, LA 70803 USA; Natl Geodet Survey, Silver Spring, MD 20910 USA; Florida Int Univ, Dept Earth Sci, Miami, FL 33199 USA	University of Miami; Polytechnic University of Milan; Louisiana State University System; Louisiana State University; National Oceanic Atmospheric Admin (NOAA) - USA; National Geodetic Survey, NOAA; State University System of Florida; Florida International University	Dixon, TH (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	tdixon@rsmas.miami.edu	Amelung, Falk/J-9042-2012; Wdowinski, Shimon/A-4118-2008; Ferretti, Alessandro/K-3811-2019	Rocca, Fabio/0000-0002-2266-6212; Wdowinski, Shimon/0000-0002-4969-0642; Ferretti, Alessandro/0000-0002-7802-5019				Burkett V.R., 2003, US GEOLOGICAL SURVEY, P63; Dokka RK, 2006, GEOLOGY, V34, P281, DOI 10.1130/G22264.1; *INT PERF EV TASK, 2006, 2 INT PERF EV TASK F; Miller L, 2004, NATURE, V428, P406, DOI 10.1038/nature02309; SHINKLE KD, 2004, NOAA TECH REP, V50, P135	5	255	257	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					587	588		10.1038/441587a	http://dx.doi.org/10.1038/441587a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738651				2022-12-28	WOS:000237920800033
J	Stafford, N				Stafford, Ned			Upending the zeitgeist	NATURE			English	News Item								Germany's best known stem-cell researcher, Oliver Brustle, is leading a charge to build up more commercial acumen on the nation's university campuses. He hopes that his company Life and Brain will incubate bright ideas from university academics.											0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					572	573		10.1038/441572a	http://dx.doi.org/10.1038/441572a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738631				2022-12-28	WOS:000237920800017
J	Baurle, I; Dean, C				Baurle, Isabel; Dean, Caroline			The timing of developmental transitions in plants	CELL			English	Review							FLOWERING-LOCUS-C; TRANS-ACTING SIRNAS; WINTER-ANNUAL HABIT; ARABIDOPSIS CIRCADIAN CLOCK; VEGETATIVE PHASE-CHANGE; RETRACTED ARTICLE. SEE; RNA-BINDING PROTEIN; MADS BOX GENE; MESSENGER-RNA; SHOOT APEX	Plants rely heavily on environmental cues to control the timing of developmental transitions. We are beginning to better understand what determines the timing of two of these transitions, the switch from juvenile to adult vegetative development and the transition to flowering. In this review, we discuss how RNA silencing mechanisms may influence the juvenile-to-adult vegetative switch. We also describe the discovery and regulation of a component of "florigen," the mobile flowering promotion signal that is involved in the transition to flowering. Parallel themes are beginning to emerge from a molecular comparison of these two developmental transitions.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	caroline.dean@bbsrc.ac.uk	Bäurle, Isabel/ABD-6356-2021	Bäurle, Isabel/0000-0001-5633-8068; Dean, Caroline/0000-0002-6555-3525	Natural Environment Research Council [NE/C507629/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/D010799/1, BB/E009662/1, BBS/E/J/000CA344, BBS/E/J/000CA355, BB/G009562/1, G20334, BBS/E/J/000CA369, BBS/E/J/000CA305, BBS/E/J/000CA376, BB/C517633/1, BBS/E/J/0000A219, BB/G01406X/1, BBS/E/J/00000581, BBS/E/J/000CA378, BBS/E/J/0000A199] Funding Source: Medline; BBSRC [BB/D010799/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Berardini TZ, 2001, SCIENCE, V291, P2405, DOI 10.1126/science.1057144; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Birve A, 2001, DEVELOPMENT, V128, P3371; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Bunning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; Choi K, 2005, PLANT CELL, V17, P2647, DOI 10.1105/tpc.105.035485; Clarke JH, 1999, PLANT J, V20, P493, DOI 10.1046/j.1365-313x.1999.00623.x; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deal RB, 2005, PLANT CELL, V17, P2633, DOI 10.1105/tpc.105.035196; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; DUDLEY M, 1991, DEVELOPMENT, V111, P733; DUDLEY M, 1993, GENETICS, V133, P389; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Foster TM, 2002, PLANT CELL, V14, P1497, DOI 10.1105/tpc.001685; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; He YH, 2004, GENE DEV, V18, P2774, DOI 10.1101/gad.1244504; Henderson IR, 2005, DEVELOPMENT, V132, P3597, DOI 10.1242/dev.01924; Huang T, 2005, SCIENCE, V309, P1694, DOI 10.1126/science.1117768; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; JACKSON D, 1994, DEVELOPMENT, V120, P405; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kim SY, 2005, PLANT CELL, V17, P3301, DOI 10.1105/tpc.105.034645; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Martin-Trillo M, 2006, DEVELOPMENT, V133, P1241, DOI 10.1242/dev.02301; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2004, P NATL ACAD SCI USA, V101, P3281, DOI 10.1073/pnas.0306778101; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; NAPPZINN K, 1969, INDUCTION FLOWERING, P291; Noh YS, 2003, PLANT CELL, V15, P1671, DOI 10.1105/tpc.012161; Oh S, 2004, PLANT CELL, V16, P2940, DOI 10.1105/tpc.104.026062; Orkwiszewski JAJ, 2000, P NATL ACAD SCI USA, V97, P10631, DOI 10.1073/pnas.180301597; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; PIRROTTA V, 1995, CURR OPIN GENET DEV, V5, P466, DOI 10.1016/0959-437X(95)90050-Q; POETHIG RS, 1988, GENETICS, V119, P959; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Rosonina E, 2005, MOL CELL, V20, P167, DOI 10.1016/j.molcel.2005.10.004; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schmitz RJ, 2005, DEVELOPMENT, V132, P5471, DOI 10.1242/dev.02170; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Stadler R, 2005, PLANT PHYSIOL, V139, P701, DOI 10.1104/pp.105.065607; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Swarup K, 1999, PLANT J, V20, P67, DOI 10.1046/j.1365-313X.1999.00577.x; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Telfer A, 1997, DEVELOPMENT, V124, P645; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Willmann MR, 2005, CURR OPIN PLANT BIOL, V8, P548, DOI 10.1016/j.pbi.2005.07.008; Wu XL, 2003, DEVELOPMENT, V130, P3735, DOI 10.1242/dev.00577; Wu XL, 2002, GENE DEV, V16, P151, DOI 10.1101/gad.952002; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541; ZEEVAART JAD, 1985, CRC HDB FLOWERING, P89; Zhao Z, 2005, NAT CELL BIOL, V7, P1256, DOI 10.1038/ncb1329	96	458	503	15	163	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 19	2006	125	4					655	664		10.1016/j.cell.2006.05.005	http://dx.doi.org/10.1016/j.cell.2006.05.005			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713560	Bronze			2022-12-28	WOS:000237886000012
J	Proctor, M; Farquhar, C				Proctor, Michelle; Farquhar, Cynthia			Diagnosis and management of dysmenorrhoea	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TOPICAL HEAT; LOW-LEVEL; ACETAMINOPHEN; ANTAGONIST		Univ Auckland, Dept Obstet & Gynaecol, Cochrane Menstrual Disorders & Subfertil Grp, Auckland 1, New Zealand; Univ Auckland, Natl Womens Hosp, Dept Obstet & Gynaecol, Auckland 1, New Zealand	University of Auckland; University of Auckland	Proctor, M (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Cochrane Menstrual Disorders & Subfertil Grp, Private Bag 92019, Auckland 1, New Zealand.	michelle.proctor@woosh.co.nz		Farquhar, Cynthia/0000-0002-3685-3553				Akin M, 2004, J REPROD MED, V49, P739; Akin MD, 2001, OBSTET GYNECOL, V97, P343, DOI 10.1016/S0029-7844(00)01163-7; Ali A, 1997, J INT MED RES, V25, P41; Baldaszti E, 2003, CONTRACEPTION, V67, P87, DOI 10.1016/S0010-7824(02)00482-1; BANDOLIER, VITAMIN E DYSMENORRH; Barnard ND, 2000, OBSTET GYNECOL, V95, P245, DOI 10.1016/S0029-7844(99)00525-6; BOLTON P, 2003, COCHRANE DB SYST REV; BRILL K, 1991, CONTRACEPTION, V43, P101, DOI 10.1016/0010-7824(91)90037-G; Brouard R, 2000, BRIT J OBSTET GYNAEC, V107, P614, DOI 10.1111/j.1471-0528.2000.tb13302.x; CHAN WY, 1981, AM J MED, V70, P535, DOI 10.1016/0002-9343(81)90576-3; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Coco AS, 1999, AM FAM PHYSICIAN, V60, P489; Davis AR, 2005, OBSTET GYNECOL, V106, P97, DOI 10.1097/01.AOG.0000165826.03915.65; Eccles NK, 2005, J ALTERN COMPLEM MED, V11, P681, DOI 10.1089/acm.2005.11.681; French L, 2005, AM FAM PHYSICIAN, V71, P285; GOLDZIEHER JW, 1971, FERTIL STERIL, V22, P609; Harel Zeev, 2004, J Pediatr Adolesc Gynecol, V17, P75, DOI 10.1016/j.jpag.2004.01.002; Harlow SD, 1996, BRIT J OBSTET GYNAEC, V103, P1134, DOI 10.1111/j.1471-0528.1996.tb09597.x; Hendrix SL, 2002, CONTRACEPTION, V66, P393, DOI 10.1016/S0010-7824(02)00414-6; Jeffcoate Sir Norman, 1975, PRINCIPLES GYNAECOLO; KLEIN JR, 1981, PEDIATRICS, V68, P661; Marjoribanks J., 2003, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD001751, DOI 10.1002/14651858.CD001751]; Prentice A, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858]; PRENTICE A, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002122; PROCTOR M, 2004, CLIN EVIDENCE; Proctor ML, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002248.pub3; Proctor ML, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001896.pub2; Proctor ML, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002120; Proctor ML., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002123; Proctor ML, 2001, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002124; SANDAHL B, 1979, ARCH GYNECOL, V227, P147, DOI 10.1007/BF02103289; SELAK V, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000068.PUB2; SUNDELL G, 1990, BRIT J OBSTET GYNAEC, V97, P588, DOI 10.1111/j.1471-0528.1990.tb02545.x; Vercellini P, 1996, AM J OBSTET GYNECOL, V175, P396, DOI 10.1016/S0002-9378(96)70152-7; Vercellini P, 2003, FERTIL STERIL, V80, P305, DOI 10.1016/S0015-0282(03)00608-3; VERCELLINI P, 1993, FERTIL STERIL, V60, P75; Wang L, 2004, OCCUP ENVIRON MED, V61, P1021, DOI 10.1136/oem.2003.012302; Weissman AM, 2004, BJOG-INT J OBSTET GY, V111, P345, DOI 10.1111/j.1471-0528.2004.00090.x; Wright JM, 2002, CAN MED ASSOC J, V167, P1131; Zhang WY, 1998, BRIT J OBSTET GYNAEC, V105, P780, DOI 10.1111/j.1471-0528.1998.tb10210.x; METAREGISTER CURRENT	41	227	242	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2006	332	7550					1134	1138B		10.1136/bmj.332.7550.1134	http://dx.doi.org/10.1136/bmj.332.7550.1134			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16690671	Green Published			2022-12-28	WOS:000237682700022
J	Rutten, FH; Moons, KGM; Hoes, AW				Rutten, FH; Moons, KGM; Hoes, AW			Commentary: Improving the quality and clinical relevance of diagnostic studies	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Rutten, FH (corresponding author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands.	F.H.Rutten@umcutrecht.nl						Bachmann LM, 2006, BRIT MED J, V332, P1127, DOI 10.1136/bmj.38793.637789.2F; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; Moons KGM, 2003, ACAD RADIOL, V10, P670, DOI 10.1016/S1076-6332(03)80087-9; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Rutten FH, 2005, BMJ-BRIT MED J, V331, P1379, DOI 10.1136/bmj.38664.661181.55	5	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 13	2006	332	7550					1129	1129		10.1136/bmj.332.7550.1129	http://dx.doi.org/10.1136/bmj.332.7550.1129			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044OT	16690669	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000237682700019
J	Gilchrist, M; Thorsson, V; Li, B; Rust, AG; Korb, M; Kennedy, K; Hai, T; Bolouri, H; Aderem, A				Gilchrist, M; Thorsson, V; Li, B; Rust, AG; Korb, M; Kennedy, K; Hai, T; Bolouri, H; Aderem, A			Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4	NATURE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; APOPTOSIS; IDENTIFICATION; EXPRESSION; CELLS; CREB; RNAS; P53	The innate immune system is absolutely required for host defence, but, uncontrolled, it leads to inflammatory disease. This control is mediated, in part, by cytokines that are secreted by macrophages. Immune regulation is extraordinarily complex, and can be best investigated with systems approaches ( that is, using computational tools to predict regulatory networks arising from global, high-throughput data sets). Here we use cluster analysis of a comprehensive set of transcriptomic data derived from Toll-like receptor (TLR)-activated macrophages to identify a prominent group of genes that appear to be regulated by activating transcription factor 3 (ATF3), a member of the CREB/ATF family of transcription factors. Network analysis predicted that ATF3 is part of a transcriptional complex that also contains members of the nuclear factor (NF)-kappa B family of transcription factors. Promoter analysis of the putative ATF3-regulated gene cluster demonstrated an over-representation of closely apposed ATF3 and NF-kappa B binding sites, which was verified by chromatin immunoprecipitation and hybridization to a DNA microarray. This cluster included important cytokines such as interleukin (IL)-6 and IL-12b. ATF3 and Rel ( a component of NF-kappa B) were shown to bind to the regulatory regions of these genes upon macrophage activation. A kinetic model of Il6 and Il12b messenger RNA expression as a function of ATF3 and NF-kappa B promoter binding predicted that ATF3 is a negative regulator of Il6 and Il12b transcription, and this hypothesis was validated using Atf3-null mice. ATF3 seems to inhibit Il6 and Il12b transcription by altering chromatin structure, thereby restricting access to transcription factors. Because ATF3 is itself induced by lipopolysaccharide, it seems to regulate TLR-stimulated inflammatory responses as part of a negative-feedback loop.	Inst Syst Biol, Seattle, WA 98103 USA; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Institute for Systems Biology (ISB); University System of Ohio; Ohio State University	Aderem, A (corresponding author), Inst Syst Biol, Seattle, WA 98103 USA.	aaderem@systemsbiology.org	Eckhardt, Erik/G-1567-2010; Hai, Tsonwin/E-3185-2011; Hai, Tsonwin/H-4480-2011	Hai, Tsonwin/0000-0003-4510-0315; Hai, Tsonwin/0000-0003-4510-0315; Rust, Alistair/0000-0001-7287-192X				Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Furumatsu T, 2005, J BIOL CHEM, V280, P35203, DOI 10.1074/jbc.M502409200; Gilchrist M, 2004, BLOOD, V104, P462, DOI 10.1182/blood-2003-08-2990; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Ishiguro T, 1996, CANCER RES, V56, P875; Ishiguro T, 2000, JPN J CANCER RES, V91, P833, DOI 10.1111/j.1349-7006.2000.tb01021.x; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; THORSSON VT, 2005, STAT APPL GEN MOL BI, V4, P1; Werner T, 2001, BIOMOL ENG, V17, P87, DOI 10.1016/S1389-0344(00)00071-X; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403	27	608	633	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					173	178		10.1038/nature04768	http://dx.doi.org/10.1038/nature04768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688168				2022-12-28	WOS:000237418800036
J	Olson, LE; Tollkuhn, J; Scafoglio, C; Krones, A; Zhang, J; Ohgi, KA; Wu, W; Taketo, MM; Kemler, R; Grosschedl, R; Rose, D; Li, X; Rosenfeld, MG				Olson, Lorin E.; Tollkuhn, Jessica; Scafoglio, Claudio; Krones, Anna; Zhang, Jie; Ohgi, Kenneth A.; Wu, Wei; Taketo, Makoto M.; Kemler, Rolf; Grosschedl, Rudolf; Rose, Dave; Li, Xue; Rosenfeld, Michael G.			Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination	CELL			English	Article							WNT SIGNALING PATHWAY; STEM-CELLS; PITUITARY DEVELOPMENT; COREPRESSOR COMPLEX; WNT/BETA-CATENIN; XENOPUS EMBRYOS; AXIS FORMATION; PIT-1 GENE; TRANSCRIPTION; MICE	While the biological roles of canonical Wnt/beta-catenin signaling in development and disease are well documented, understanding the molecular logic underlying the functionally distinct nuclear transcriptional programs mediating the diverse functions of beta-catenin remains a major challenge. Here, we report an unexpected strategy for beta-catenin-dependent regulation of cell-lineage determination based on interactions between beta-catenin and a specific homeodomain factor, Prop1, rather than Lef/Tcfs. beta-catenin acts as a binary switch to simultaneously activate expression of the critical lineage-determining transcription factor, Pit1, and to repress the gene encoding the lineage-inhibiting transcription factor, Hesx1, acting via TLE/Reptin/HDAC1 corepressor complexes. The strategy of functionally distinct actions of a homeodomain factor in response to Wnt signaling is suggested to be prototypic of a widely used mechanism for generating diverse cell types from pluripotent precursor cells in response to common signaling pathways during organogenesis.	Harvard Univ, Sch Med, Dept Pathol, Dept Surg Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Univ Calif San Diego, Sch Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Naples, Dottorato Ricerca Oncol Med & Chirurg & Immunol, I-80138 Naples, Italy; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego; Max Planck Society; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Naples Federico II; Kyoto University	Li, X (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Dept Surg Oncol, Boston, MA 02115 USA.	sean.li@childrens.harvard.edu; mrosenfeld@ucsd.edu	Scafoglio, Claudio/I-9489-2012	Scafoglio, Claudio/0000-0003-1188-8124; Tollkuhn, Jessica/0000-0001-5991-7620	NIDDK NIH HHS [DK 064744] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064744] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Brault V, 2001, DEVELOPMENT, V128, P1253; Brinkmeier ML, 2003, MOL ENDOCRINOL, V17, P2152, DOI 10.1210/me.2003-0225; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Cha KB, 2004, MECH DEVELOP, V121, P183, DOI 10.1016/j.mod.2003.12.002; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; Dasen JS, 2001, ANNU REV NEUROSCI, V24, P327, DOI 10.1146/annurev.neuro.24.1.327; DiMattia GE, 1997, DEV BIOL, V182, P180, DOI 10.1006/dbio.1996.8472; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gage PJ, 1996, MOL ENDOCRINOL, V10, P1570, DOI 10.1210/me.10.12.1570; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hermesz E, 1996, DEVELOPMENT, V122, P41; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; LEW D, 1993, GENE DEV, V7, P683, DOI 10.1101/gad.7.4.683; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Martinez-Barbera JP, 2000, DEV BIOL, V223, P422, DOI 10.1006/dbio.2000.9757; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Nasonkin IO, 2004, HUM MOL GENET, V13, P2727, DOI 10.1093/hmg/ddh311; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; RHODES SJ, 1993, GENE DEV, V7, P913, DOI 10.1101/gad.7.6.913; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	61	211	217	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					593	605		10.1016/j.cell.2006.02.046	http://dx.doi.org/10.1016/j.cell.2006.02.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678101	Bronze			2022-12-28	WOS:000237506100023
J	Matoba, S; Kang, JG; Patino, WD; Wragg, A; Boehm, M; Gavrilova, O; Hurley, PJ; Bunz, F; Hwang, PM				Matoba, Satoaki; Kang, Ju-Gyeong; Patino, Willmar D.; Wragg, Andrew; Boehm, Manfred; Gavrilova, Oksana; Hurley, Paula J.; Bunz, Fred; Hwang, Paul M.			p53 regulates mitochondrial respiration	SCIENCE			English	Article							CANCER-CELLS; LIFE-SPAN; DNA-DAMAGE; MICE; METABOLISM; GENES; IMPAIRMENT; DEFICIENCY; PATHWAYS; CAPACITY	The energy that sustains cancer cells is derived preferentially from glycolysis. This metabolic change, the Warburg effect, was one of the first alterations in cancer cells recognized as conferring a survival advantage. Here, we show that p53, one of the most frequently mutated genes in cancers, modulates the balance between the utilization of respiratory and glycolytic pathways. We identify Synthesis of Cytochrome c Oxidase 2 ( SCO2) as the downstream mediator of this effect in mice and human cancer cell lines. SCO2 is critical for regulating the cytochrome c oxidase ( COX) complex, the major site of oxygen utilization in the eukaryotic cell. Disruption of the SCO2 gene in human cancer cells with wild-type p53 recapitulated the metabolic switch toward glycolysis that is exhibited by p53-deficient cells. That SCO2 couples p53 to mitochondrial respiration provides a possible explanation for the Warburg effect and offers new clues as to how p53 might affect aging and metabolism.	NHLBI, Cardiol Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA; Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21231 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; Johns Hopkins Medicine	Hwang, PM (corresponding author), NHLBI, Cardiol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	hwangp@mail.nih.gov		Wragg, Andrew/0000-0002-8934-5712	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005101, ZIAHL005101, Z01HL005066, ZIAHL005066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002, Z01DK070002] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Attardi LD, 2005, MUTAT RES-FUND MOL M, V576, P4, DOI 10.1016/j.mrfmmm.2004.08.022; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Herrmann PC, 2003, PROTEOMICS, V3, P1801, DOI 10.1002/pmic.200300461; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Kondoh H, 2005, CANCER RES, V65, P177; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843; Papadopoulou LC, 1999, NAT GENET, V23, P333; Pecina P, 2004, PHYSIOL RES, V53, pS213; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Poyurovsky MV, 2006, GENE DEV, V20, P125, DOI 10.1101/gad.1397506; SARIBANSOHRABY S, 1983, CANCER RES, V43, P4662; Semenza G L, 2001, Novartis Found Symp, V240, P251; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WARBURG O, 1956, SCIENCE, V124, P269; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287	32	1246	1302	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1650	1653		10.1126/science.1126863	http://dx.doi.org/10.1126/science.1126863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16728594				2022-12-28	WOS:000238288600045
J	Farzaneh-Far, R; Schwarzberg, T; Mushlin, SB				Farzaneh-Far, Ramin; Schwarzberg, Talya; Mushlin, Stuart B.			Thinking outside the box	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE PULMONARY-EMBOLISM; DISEASE		Beth Israel Deaconess Med Ctr, Hematol Oncol Fellowship Program, Dept Hematol Oncol, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Schwarzberg, T (corresponding author), Beth Israel Deaconess Med Ctr, Hematol Oncol Fellowship Program, Dept Hematol Oncol, 330 Brookline Ave, Boston, MA 02215 USA.	tschwar1@bidmc.harvard.edu						Castelli R, 2003, VASC MED, V8, P257, DOI 10.1191/1358863x03vm510oa; COME PC, 1992, CHEST, V101, pS151, DOI 10.1378/chest.101.4_Supplement.151S; de Larranaga GF, 1999, THROMB RES, V96, P19, DOI 10.1016/S0049-3848(99)00059-6; Goldhaber SZ, 2002, ANN INTERN MED, V136, P691, DOI 10.7326/0003-4819-136-9-200205070-00012; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Kaczynska Anna, 2005, Kardiol Pol, V62, P119; Klein SK, 2005, NETH J MED, V63, P129; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Calvo-Romero JM, 2004, EUR J EMERG MED, V11, P208, DOI 10.1097/01.mej.0000136696.49343.8f; McConnell MV, 1996, AM J CARDIOL, V78, P469, DOI 10.1016/S0002-9149(96)00339-6; Schoepf UJ, 2004, CIRCULATION, V110, P3276, DOI 10.1161/01.CIR.0000147612.59751.4C; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; STEIN PD, 1991, CHEST, V100, P598, DOI 10.1378/chest.100.3.598; Yalamanchili K, 2004, AM J CARDIOL, V93, P263, DOI 10.1016/j.amjcard.2003.09.058	14	1	1	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2376	2381		10.1056/NEJMcps051436	http://dx.doi.org/10.1056/NEJMcps051436			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738275				2022-12-28	WOS:000237918500011
J	Marlovits, TC; Kubori, T; Lara-Tejero, M; Thomas, D; Unger, VM; Galan, JE				Marlovits, Thomas C.; Kubori, Tomoko; Lara-Tejero, Maria; Thomas, Dennis; Unger, Vinzenz M.; Galan, Jorge E.			Assembly of the inner rod determines needle length in the type III secretion injectisome	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; MOLECULAR CHARACTERIZATION; PROTEINS; CLONING; COMPLEX; GENES	Assembly of multi-component supramolecular machines is fundamental to biology, yet in most cases, assembly pathways and their control are poorly understood. An example is the type III secretion machine, which mediates the transfer of bacterial virulence proteins into host cells(1). A central component of this nanomachine is the needle complex or injectisome, an organelle associated with the bacterial envelope that is composed of a multi-ring base, an inner rod, and a protruding needle(2). Assembly of this organelle proceeds in sequential steps that require the reprogramming of the secretion machine. Here we provide evidence that, in Salmonella typhimurium, completion of the assembly of the inner rod determines the size of the needle substructure. Assembly of the inner rod, which is regulated by the InvJ protein, triggers conformational changes on the cytoplasmic side of the injectisome, reprogramming the secretion apparatus to stop secretion of the needle protein.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Brandeis Univ, Dept Biochem, Rosenstiel Basic Med Sci Res Ctr, Howard Hughes Med Inst, Waltham, MA 02454 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Brandeis University; Howard Hughes Medical Institute; Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Kubori, Tomoko/AAH-3609-2019; Marlovits, Thomas/A-3568-2019	Kubori, Tomoko/0000-0003-1098-6021; Marlovits, Thomas/0000-0001-8106-4038				Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; COLLAZO CM, 1995, MOL MICROBIOL, V15, P25, DOI 10.1111/j.1365-2958.1995.tb02218.x; Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J	16	163	168	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					637	640		10.1038/nature04822	http://dx.doi.org/10.1038/nature04822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738660				2022-12-28	WOS:000237920800048
J	Dharmasiri, S; Swarup, R; Mockaitis, K; Dharmasiri, N; Singh, SK; Kowalchyk, M; Marchant, A; Mills, S; Sandberg, G; Bennett, MJ; Estelle, M				Dharmasiri, S.; Swarup, R.; Mockaitis, K.; Dharmasiri, N.; Singh, S. K.; Kowalchyk, M.; Marchant, A.; Mills, S.; Sandberg, G.; Bennett, M. J.; Estelle, M.			AXR4 is required for localization of the auxin influx facilitator AUX1	SCIENCE			English	Article							ROOT GRAVITROPISM; RESISTANT MUTANTS; PERMEASE AUX1; ARABIDOPSIS; TRANSPORT; GROWTH; PROTEINS; MECHANISM; PATHWAYS	The AUX1 and PIN auxin influx and efflux facilitators are key regulators of root growth and development. For root gravitropism to occur, AUX1 and PIN2 must transport auxin via the lateral root cap to elongating epidermal cells. Genetic studies suggest that AXR4 functions in the same pathway as AUX1. Here we show that AXR4 is a previously unidentified accessory protein of the endoplasmic reticulum (ER) that regulates localization of AUX1 but not of PIN proteins. Loss of AXR4 resulted in abnormal accumulation of AUX1 in the ER of epidermal cells, indicating that the axr4 agravitropic phenotype is caused by defective AUX1 trafficking in the root epidermis.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; SLU, Umea Plant Sci Ctr, Umea, Sweden; Univ Nottingham, Sch Comp Sci & Informat Technol, Nottingham NG7 2UH, England	Indiana University System; Indiana University Bloomington; University of Nottingham; Swedish University of Agricultural Sciences; Umea University; University of Nottingham	Bennett, MJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	malcolm.bennett@nottingham.ac.uk; maestell@indiana.edu	Kowalczyk, Mariusz/ABD-2910-2020; Estelle, Mark/ABD-6742-2021; Marchant, Alan/I-4395-2012; Bennett, Malcolm/G-4004-2010	Kowalczyk, Mariusz/0000-0001-7454-4762; Marchant, Alan/0000-0002-8293-2332; Bennett, Malcolm/0000-0003-0475-390X; Singh, Sunil Kumar/0000-0001-6682-1512; Mills, Steven/0000-0002-4933-7777; swarup, Ranjan/0000-0002-6438-9188	Biotechnology and Biological Sciences Research Council [REI20541, BB/C514958/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Crofts AJ, 1998, PLANT CELL, V10, P813, DOI 10.1105/tpc.10.5.813; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; HOBBIE L, 1995, PLANT J, V7, P211, DOI 10.1046/j.1365-313X.1995.7020211.x; Kota J, 2005, J CELL BIOL, V168, P79, DOI 10.1083/jcb.200408106; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Mullen JL, 1998, PLANT PHYSIOL, V118, P1139, DOI 10.1104/pp.118.4.1139; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; SIMMONS C, 1995, PHYSIOL PLANTARUM, V93, P790, DOI 10.1111/j.1399-3054.1995.tb05133.x; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Swarup R, 2003, DEV CELL, V5, P824, DOI 10.1016/S1534-5807(03)00370-8; TIMPTE C, 1995, PLANT J, V8, P561, DOI 10.1046/j.1365-313X.1995.8040561.x; Yamamoto M, 1999, J PLANT RES, V112, P391, DOI 10.1007/PL00013892	23	138	158	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1218	1220		10.1126/science.1122847	http://dx.doi.org/10.1126/science.1122847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16690816				2022-12-28	WOS:000237957400055
J	Plevritis, SK; Kurian, AW; Sigal, BM; Daniel, BL; Ikeda, DM; Stockdale, FE; Garber, AM				Plevritis, Sylvia K.; Kurian, Allison W.; Sigal, Bronislava M.; Daniel, Bruce L.; Ikeda, Debra M.; Stockdale, Frank E.; Garber, Alan M.			Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OVARIAN-CANCER; CONSERVING TREATMENT; HIGH-RISK; WOMEN; MAMMOGRAPHY; MASTECTOMY; SURVIVAL; OUTCOMES; SURGERY; PERFORMANCE	Context Women with inherited BRCA1/2 mutations are at high risk for breast cancer, which mammography often misses. Screening with contrast-enhanced breast magnetic resonance imaging (MRI) detects cancer earlier but increases costs and results in more false-positive scans. Objective To evaluate the cost-effectiveness of screening BRCA1/2 mutation carriers with mammography plus breast MRI compared with mammography alone. Design, Setting, and Patients A computer model that simulates the life histories of individual BRCA1/2 mutation carriers, incorporating the effects of mammographic and MRI screening was used. The accuracy of mammography and breast MRI was estimated from published data in high-risk women. Breast cancer survival in the absence of screening was based on the Surveillance, Epidemiology and End Results database of breast cancer patients diagnosed in the prescreening period (1975-1981), adjusted for the current use of adjuvant therapy. Utilization rates and costs of diagnostic and treatment interventions were based on a combination of published literature and Medicare payments for 2005. Main Outcome Measures The survival benefit, incremental costs, and cost-effectiveness of MRI screening strategies, which varied by ages of starting and stopping MRI screening, were computed separately for BRCA1 and BRCA2 mutation carriers. Results Screening strategies that incorporate annual MRI as well as annual mammography have a cost per quality-adjusted life-year ( QALY) gained ranging from less than $45 000 to more than $700 000, depending on the ages selected for MRI screening and the specific BRCA mutation. Relative to screening with mammography alone, the cost per QALY gained by adding MRI from ages 35 to 54 years is $55 420 for BRCA1 mutation carriers, $130 695 for BRCA2 mutation carriers, and $98 454 for BRCA2 mutation carriers who have mammographically dense breasts. Conclusions Breast MRI screening is more cost-effective for BRCA1 than BRCA2 mutation carriers. The cost-effectiveness of adding MRI tomammography varies greatly by age.	Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Div Oncol, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Plevritis, SK (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	sylvia.plevritis@stanford.edu	Garber, Alan M/F-1476-2010; Kurian, Allison/A-4560-2019	Ikeda, Debra/0000-0002-8663-8448; Kurian, Allison/0000-0002-6175-9470	NCI NIH HHS [U01 CA088248, R01 CA829040, R01 CA66785] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA088248, R01CA066785] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; *AM MED ASS, 2005, MED RES BAS REL VAL; [Anonymous], SURVEILLANCE EPIDEMI; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Barlow WE, 2001, J NATL CANCER I, V93, P447, DOI 10.1093/jnci/93.6.447; Ben David Y, 2002, J CLIN ONCOL, V20, P463, DOI 10.1200/JCO.20.2.463; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chappuis PO, 2000, SEMIN SURG ONCOL, V18, P287, DOI 10.1002/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.3.CO;2-X; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; EASTON DF, 1995, AM J HUM GENET, V56, P265; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Grann VR, 2002, J CLIN ONCOL, V20, P2520, DOI 10.1200/JCO.2002.10.101; Grann VR, 1999, CANCER J, V5, P283; Gur D, 2005, RADIOLOGY, V235, P396, DOI 10.1148/radiol.2352040422; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hensley ML, 2005, BREAST CANCER RES TR, V91, P153, DOI 10.1007/s10549-004-6497-9; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Komenaka IK, 2004, CANCER, V100, P2079, DOI 10.1002/cncr.20221; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2000, RADIOLOGY, V215, P267, DOI 10.1148/radiology.215.1.r00ap01267; KURIAN AW, 2004, BREAST CANC RES TREA, V88, P5013; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lehman CD, 2005, CANCER, V103, P1898, DOI 10.1002/cncr.20971; Leung PP, 1999, J CLIN ONCOL, V17, P3082, DOI 10.1200/JCO.1999.17.10.3082; Max W, 2003, GYNECOL ONCOL, V88, P96, DOI 10.1016/S0090-8258(02)00101-4; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; Mock V, 1998, AAOHN J, V46, P425; Naeim A, 2005, CRIT REV ONCOL HEMAT, V53, P81, DOI 10.1016/j.critrevonc.2004.09.001; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; [National Comprehensive Cancer Network American Cancer Society], 2006, BREAST CANC TREATM G; National Comprehensive Cancer Network, NAT COMPR CANC NETW; Neubauer H, 2003, BRIT J RADIOL, V76, P3, DOI 10.1259/bjr/14883856; Palit TK, 2000, AM J SURG, V179, P441, DOI 10.1016/S0002-9610(00)00383-4; Peshkin BN, 2003, J CLIN ONCOL, V21, P4322, DOI 10.1200/JCO.2003.02.107; Pierce LJ, 2000, J CLIN ONCOL, V18, P3360, DOI 10.1200/JCO.2000.18.19.3360; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Plevritis SK, 2007, STAT MED, V26, P581, DOI 10.1002/sim.2550; Podo F, 2002, J EXP CLIN CANC RES, V21, P115; Rao S, 2004, BREAST CANCER RES TR, V83, P25, DOI 10.1023/B:BREA.0000010689.55559.06; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Robson M, 2005, CANCER, V103, P44, DOI 10.1002/cncr.20728; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; Stolier Alan J, 2004, Breast J, V10, P475, DOI 10.1111/j.1075-122X.2004.21543.x; Stoutjesdijk MJ, 2001, JNCI-J NATL CANCER I, V93, P1095, DOI 10.1093/jnci/93.14.1095; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Swisher Elizabeth, 2003, Curr Treat Options Oncol, V4, P105, DOI 10.1007/s11864-003-0011-1; Tilanus-Linthorst M, 2002, INT J CANCER, V102, P91, DOI 10.1002/ijc.10666; Tilanus-Linthorst MMA, 2000, BREAST CANCER RES TR, V63, P53, DOI 10.1023/A:1006480106487; TRECATE G, 2005, NEW ENGL J MED, V353, P1784; United States Bureau of Labor and Statistics, MED US WEEKL EARN FU; van Roosmalen MS, 2002, J CLIN ONCOL, V20, P2092, DOI 10.1200/jco.2002.08.035; Wainberg S, 2004, CANCER EPIDEM BIOMAR, V13, P1989; Weitzel JN, 2003, ARCH SURG-CHICAGO, V138, P1323, DOI 10.1001/archsurg.138.12.1323; BERKELEY MORTALITY D	59	190	193	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2374	2384		10.1001/jama.295.20.2374	http://dx.doi.org/10.1001/jama.295.20.2374			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720823	Bronze			2022-12-28	WOS:000237734400023
J	Queralt, E; Lehane, C; Novak, B; Uhlmann, F				Queralt, Ethel; Lehane, Chris; Novak, Bela; Uhlmann, Frank			Downregulation of PP2A(Cdc-95) phosphatase by separase initiates mitotic exit in budding yeast	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CDC14 PHOSPHATASE; MULTIPLE ROLES; ANAPHASE ONSET; MITOSIS; PHOSPHORYLATION; CLEAVAGE; COMPLEX; LOCALIZATION; CHECKPOINT	After anaphase, the high mitotic cyclin-dependent kinase (Cdk) activity is downregulated to promote exit from mitosis. To this end, in the budding yeast S. cerevisiae, the Cdk counteracting phosphatase Cdc14 is activated. In metaphase, Cdc14 is kept inactive in the nucleolus by its inhibitor Net1. During anaphase, Cdk- and Polo-dependent phosphorylation of Net1 is thought to release active Cdc14. How Netl is phosphorylated specifically in anaphase, when mitotic kinase activity starts to decline, has remained unexplained. Here, we show that PP2A(Cdc55) phosphatase keeps Netl under-phosphorylated in metaphase. The sister chromatid-separating protease separase, activated at anaphase onset, interacts with and down regulates PP2A(Cdc55) , thereby facilitating Cdk dependent Netl phosphorylation. PP2A(CdC55) downregulation also promotes phosphorylation of Bfa1, contributing to activation of the "mitotic exit network" that sustains Cdc14 as Cdk activity declines. These findings allow us to present a new quantitative model for mitotic exit in budding yeast.	Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Chromosome Segregat Lab, London WC2A 3PX, England; Hungarian Acad Sci, Mol Network Dynam Grp, H-1111 Budapest, Hungary; Budapest Univ Technol & Econ, H-1111 Budapest, Hungary	Cancer Research UK; Hungarian Academy of Sciences; Budapest University of Technology & Economics	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk	Queralt, Ethel/ABA-8640-2021; Novak, Bela/D-5365-2009; Queralt, Ethel/D-8090-2015	Queralt, Ethel/0000-0003-0045-0039; Novak, Bela/0000-0002-6961-1366; Queralt, Ethel/0000-0003-0045-0039; Uhlmann, Frank/0000-0002-3527-6619				Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; Cueille N, 2001, J CELL SCI, V114, P2649; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Evans DRH, 1997, GENETICS, V145, P227; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; McMillan JN, 1999, MOL CELL BIOL, V19, P5981; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Mortensen EM, 2005, CURR BIOL, V15, P2033, DOI 10.1016/j.cub.2005.10.046; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Novak B, 1998, PHILOS T ROY SOC B, V353, P2063, DOI 10.1098/rstb.1998.0352; Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663; Papi M, 2005, NAT CELL BIOL, V7, P1029, DOI 10.1038/ncb1303; Park CJ, 2003, GENETICS, V163, P21; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Saito RM, 2004, NAT CELL BIOL, V6, P777, DOI 10.1038/ncb1154; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-3; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Stegmeier F, 2004, CURR BIOL, V14, P467, DOI 10.1016/j.cub.2004.03.009; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Traverso EE, 2001, J BIOL CHEM, V276, P21924, DOI 10.1074/jbc.M011689200; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000; Yellman CM, 2006, MOL BIOL CELL, V17, P658, DOI 10.1091/mbc.E05-04-0336; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yoshida S, 2002, BIOCHEM BIOPH RES CO, V294, P687, DOI 10.1016/S0006-291X(02)00544-2; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	52	195	202	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					719	732		10.1016/j.cell.2006.03.038	http://dx.doi.org/10.1016/j.cell.2006.03.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713564	Bronze			2022-12-28	WOS:000237886000017
J	Emanuel, EJ; Wertheimer, A				Emanuel, EJ; Wertheimer, A			Public health - Who should get influenza vaccine when not all can?	SCIENCE			English	Editorial Material							AGE		NIH, Dept Clin Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	eemanuel@nih.gov						[Anonymous], 2005, HHS PAND INFL PLAN; COLLINS SD, 1945, PUBLIC HEALTH REP, V60, P853, DOI 10.2307/4585326; CROPPER ML, 1994, J RISK UNCERTAINTY, V8, P243, DOI 10.1007/BF01064044; DANIELS N, 1988, AM I MY PARENTS KEEP, P66; DWORKIN R, 1978, TAKING RIGHTS SERIOU, P150; Dworkin Ronald, 1993, LIFES DOMINION, P68; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Johannesson M, 1997, J HEALTH ECON, V16, P589, DOI 10.1016/S0167-6296(96)00516-4; Murray C. J. L., 1996, GLOBAL BURDEN DIS; MURRAY CJL, 1997, J HLTH EC, V16, P710; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; SIMONSEN L, 2004, THREAT PANDEMIC INFL; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B	13	119	123	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					854	855		10.1126/science.1125347	http://dx.doi.org/10.1126/science.1125347			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041JQ	16690847	Green Submitted			2022-12-28	WOS:000237452900026
J	Kono, M				Kono, M			Geophysics - Ships' logs and archeomagnetism	SCIENCE			English	Editorial Material							GEOMAGNETIC-FIELD; HISTORICAL RECORDS; SECULAR VARIATION; 4 CENTURIES		Tokyo Inst Technol, Tokyo 1528551, Japan; Okayama Univ, Okayama 7008530, Japan	Tokyo Institute of Technology; Okayama University	Kono, M (corresponding author), Tokyo Inst Technol, Tokyo 1528551, Japan.	masarukono@nifty.com						BLOXHAM J, 1989, PHILOS T R SOC A, V329, P415, DOI 10.1098/rsta.1989.0087; Gubbins D, 2006, SCIENCE, V312, P900, DOI 10.1126/science.1124855; GUBBINS D, 1983, GEOPHYS J ROY ASTR S, V73, P641, DOI 10.1111/j.1365-246X.1983.tb03336.x; Hatakeyama T, 2002, PHYS EARTH PLANET IN, V133, P181, DOI 10.1016/S0031-9201(02)00084-5; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; Johnson CL, 1997, GEOPHYS J INT, V131, P643, DOI 10.1111/j.1365-246X.1997.tb06604.x; Jonkers ART, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000115; Kelly P, 1997, GEOPHYS J INT, V128, P315, DOI 10.1111/j.1365-246X.1997.tb01557.x; Valet JP, 2003, REV GEOPHYS, V41, DOI 10.1029/2001RG000104	9	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					865	866		10.1126/science.1126665	http://dx.doi.org/10.1126/science.1126665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690853				2022-12-28	WOS:000237452900032
J	Attar, EC; Hasserjian, RP; Swartz, MN; Harris, NL				Attar, EC; Hasserjian, RP; Swartz, MN; Harris, NL			Case 14-2006: A 25-year-old woman with anemia and iron overload - delta beta-thalassemia and XmnI mutation in the G gamma hemoglobin promoter resulting in hereditary persistence of fetal hemoglobin.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIAMOND-BLACKFAN ANEMIA; SICKLE-CELL-ANEMIA; BONE-MARROW; GENE; HYDROXYUREA		Massachusetts Gen Hosp, Ctr Leukemia, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Attar, EC (corresponding author), Massachusetts Gen Hosp, Ctr Leukemia, Boston, MA 02114 USA.							Ball SE, 1996, BRIT J HAEMATOL, V94, P645, DOI 10.1046/j.1365-2141.1996.d01-1839.x; BERNARD J, 1962, NOUV REV FR HEMATOL, V2, P721; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; CRAIG JE, 1994, BLOOD, V83, P1673, DOI 10.1182/blood.V83.6.1673.1673; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; DUHOUX P, 1956, Sang, V27, P572; Ebert BL, 2005, BLOOD, V105, P4620, DOI 10.1182/blood-2004-08-3313; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; FOUCAR K, 2001, BONE MARROW PATHOLOG, P125; Gazda H, 2001, BLOOD, V97, P2145, DOI 10.1182/blood.V97.7.2145; GEORGIOU I, 1995, EUR J HAEMATOL, V54, P101; GILMAN JG, 1985, BLOOD, V66, P783; Giri N, 2000, BRIT J HAEMATOL, V108, P167; Hamaguchi I, 2002, BLOOD, V100, P2724, DOI 10.1182/blood.V100.8.2724; JANDL JH, 1987, BLOOD TXB HEMATOLOGY, P27; KEARNEY SL, IN PRESS PEDIAT BLOO; KRAUSE JR, 1988, HEMATOL ONCOL CLIN N, V2, P557, DOI 10.1016/S0889-8588(18)30584-7; Krijanovski OI, 1997, HEMATOL ONCOL CLIN N, V11, P1061, DOI 10.1016/S0889-8588(05)70483-4; LELONG M, 1951, Arch Fr Pediatr, V8, P473; Lipton JM, 2006, PEDIATR BLOOD CANCER, V46, P558, DOI 10.1002/pbc.20642; LOLIS D, 1995, EUR J OBSTET GYN R B, V60, P153, DOI 10.1016/0028-2243(95)02105-2; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; Roy V, 2005, BIOL BLOOD MARROW TR, V11, P600, DOI 10.1016/j.bbmt.2005.05.005; WICKRAMASINGHE SN, 2003, BLOOD BONE MARROW PA, P87; Willig TN, 2000, CURR OPIN HEMATOL, V7, P85, DOI 10.1097/00062752-200003000-00003	26	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2047	2056		10.1056/NEJMcpc069005	http://dx.doi.org/10.1056/NEJMcpc069005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687718				2022-12-28	WOS:000237413100012
J	Takahashi, KS; Gabay, M; Jaccard, D; Shibuya, K; Ohnishi, T; Lippmaa, M; Triscone, JM				Takahashi, KS; Gabay, M; Jaccard, D; Shibuya, K; Ohnishi, T; Lippmaa, M; Triscone, JM			Local switching of two-dimensional superconductivity using the ferroelectric field effect	NATURE			English	Article							ELECTROSTATIC MODULATION; TRANSITION-TEMPERATURES; SRTIO3	Correlated oxides display a variety of extraordinary physical properties including high-temperature superconductivity(1) and colossal magnetoresistance(2). In these materials, strong electronic correlations often lead to competing ground states that are sensitive to many parameters - in particular the doping level so that complex phase diagrams are observed. A flexible way to explore the role of doping is to tune the electron or hole concentration with electric fields, as is done in standard semiconductor field effect transistors(3). Here we demonstrate a model oxide system based on high-quality heterostructures in which the ferroelectric field effect approach can be studied. We use a single-crystal film of the perovskite superconductor Nb-doped SrTiO3 as the superconducting channel and ferroelectric Pb(Zr, Ti) O-3 as the gate oxide. Atomic force microscopy is used to locally reverse the ferroelectric polarization, thus inducing large resistivity and carrier modulations, resulting in a clear shift in the superconducting critical temperature. Field-induced switching from the normal state to the ( zero resistance) superconducting state was achieved at a well-defined temperature. This unique system could lead to a field of research in which devices are realized by locally defining in the same material superconducting and normal regions with `perfect' interfaces, the interface being purely electronic. Using this approach, one could potentially design one-dimensional superconducting wires, superconducting rings and junctions, superconducting quantum interference devices ( SQUIDs) or arrays of pinning centres.	Univ Geneva, DPMC, CH-1211 Geneva 4, Switzerland; Univ Paris 11, Phys Solides Lab, F-91405 Orsay, France; Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan	University of Geneva; UDICE-French Research Universities; Universite Paris Saclay; University of Tokyo	Triscone, JM (corresponding author), Univ Geneva, DPMC, 24 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	Jean-Marc.Triscone@physics.unige.ch	Shibuya, Keisuke/K-2079-2012; OHNISHI, Tsuyoshi/H-2670-2011; Kim, Yu Jin/A-2433-2012; TAKAHASHI, Kei/B-2498-2013	Shibuya, Keisuke/0000-0001-5067-5952; OHNISHI, Tsuyoshi/0000-0002-2333-7752; 				Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; Ahn CH, 1997, SCIENCE, V276, P1100, DOI 10.1126/science.276.5315.1100; Aidam R, 1999, PHYSICA C, V328, P21, DOI 10.1016/S0921-4534(99)00526-2; BEASLEY MR, 1979, PHYS REV LETT, V42, P1165, DOI 10.1103/PhysRevLett.42.1165; BEDNORZ JG, 1986, Z PHYS B, V64, P193; Cassinese A, 2004, APPL PHYS LETT, V84, P3933, DOI 10.1063/1.1745103; GABAY M, 1993, PHYS REV LETT, V71, P2138, DOI 10.1103/PhysRevLett.71.2138; KOONCE CS, 1967, PHYS REV, V163, P380, DOI 10.1103/PhysRev.163.380; KOSTERLI.JM, 1972, J PHYS PART C SOLID, V5, pL124, DOI 10.1088/0022-3719/5/11/002; LEE C, 1975, PHYS REV B, V11, P2299, DOI 10.1103/PhysRevB.11.2299; Leitner A, 1998, APPL PHYS LETT, V72, P3065, DOI 10.1063/1.121542; MINNHAGEN P, 1987, REV MOD PHYS, V59, P1001, DOI 10.1103/RevModPhys.59.1001; MULLER KA, 1979, PHYS REV B, V19, P3593, DOI 10.1103/PhysRevB.19.3593; Ohashi S, 1999, REV SCI INSTRUM, V70, P178, DOI 10.1063/1.1149562; Parendo KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197004; PFEIFFER ER, 1969, PHYS LETT A, VA 29, P589, DOI 10.1016/0375-9601(69)91110-4; SCHOOLEY JF, 1964, PHYS REV LETT, V12, P474, DOI 10.1103/PhysRevLett.12.474; Takahashi KS, 2004, APPL PHYS LETT, V84, P1722, DOI 10.1063/1.1667279; TAKAHASHI KS, 2005, P SOC PHOTO-OPT INS, V5932, P267; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Tokura Y., 2000, ADV CONDENSED MATTER, V2; TUFTE ON, 1967, PHYS REV, V155, P796, DOI 10.1103/PhysRev.155.796; WERTHAME.NR, 1966, PHYS REV, V147, P295, DOI 10.1103/PhysRev.147.295	24	80	83	1	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					195	198		10.1038/nature04731	http://dx.doi.org/10.1038/nature04731			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688171				2022-12-28	WOS:000237418800040
J	Berns, GS; Chappelow, J; Cekic, M; Zink, CF; Pagnoni, G; Martin-Skurski, ME				Berns, GS; Chappelow, J; Cekic, M; Zink, CF; Pagnoni, G; Martin-Skurski, ME			Neurobiological substrates of dread	SCIENCE			English	Article							SOMATOSENSORY CORTEX; HUMAN BRAIN; PAIN; ANTICIPATION; FMRI; LOCALIZATION; EXPERIENCE; MODULATION; MECHANISMS; EMOTION	Given the choice of waiting for an adverse outcome or getting it over with quickly, many people choose the latter. Theoretical models of decision-making have assumed that this occurs because there is a cost to waiting - i.e., dread. Using functional magnetic resonance imaging, we measured the neural responses to waiting for a cutaneous electric shock. Some individuals dreaded the outcome so much that, when given a choice, they preferred to receive more voltage rather than wait. Even when no decision was required, these extreme dreaders were distinguishable from those who dreaded mildly by the rate of increase of neural activity in the posterior elements of the cortical pain matrix. This suggests that dread derives, in part, from the attention devoted to the expected physical response and not simply from fear or anxiety. Although these differences were observed during a passive waiting procedure, they correlated with individual behavior in a subsequent choice paradigm, providing evidence for a neurobiological link between the experienced disutility of dread and subsequent decisions about unpleasant outcomes.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Emory University	Berns, GS (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 101 Woodruff Circle,Suite 4000, Atlanta, GA 30322 USA.	gberns@emory.edu	Pagnoni, Giuseppe/F-3398-2015	Pagnoni, Giuseppe/0000-0002-8272-8091	NATIONAL INSTITUTE ON DRUG ABUSE [K08DA000367, R01DA016434] Funding Source: NIH RePORTER; NIDA NIH HHS [DA016434, DA00367, K08 DA000367, R01 DA016434] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bentley DE, 2004, CLIN NEUROPHYSIOL, V115, P1846, DOI 10.1016/j.clinph.2004.03.010; Bentley DE, 2003, PAIN, V102, P265, DOI 10.1016/S0304-3959(02)00405-0; Berridge K.C., 1999, WELL BEING FDN HEDON, P525; Bingel U, 2004, NEUROIMAGE, V23, P224, DOI 10.1016/j.neuroimage.2004.05.021; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Ferretti A, 2004, NEUROIMAGE, V23, P1217, DOI 10.1016/j.neuroimage.2004.08.003; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Morewedge CK, 2005, PSYCHOL SCI, V16, P626, DOI 10.1111/j.1467-9280.2005.01585.x; Petrovic P, 2002, NEUROIMAGE, V16, P1142, DOI 10.1006/nimg.2002.1069; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Raij TT, 2005, P NATL ACAD SCI USA, V102, P2147, DOI 10.1073/pnas.0409542102; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Salomons TV, 2004, J NEUROSCI, V24, P7199, DOI 10.1523/JNEUROSCI.1315-04.2004; Samuelson Paul, 1937, REV ECON STUD, V4, P155, DOI [DOI 10.2307/2967612, 10.2307/2967612]; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Varian H.R., 2002, INTERMEDIATE MICROEC; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065	31	152	158	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2006	312	5774					754	758		10.1126/science.1123721	http://dx.doi.org/10.1126/science.1123721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039NF	16675703	Green Accepted			2022-12-28	WOS:000237312100053
J	Doi, M; Hirayama, J; Sassone-Corsi, P				Doi, Masao; Hirayama, Jun; Sassone-Corsi, Paolo			Circadian regulator CLOCK is a histone acetyltransferase	CELL			English	Article							PERIPHERAL CLOCK; GENE-EXPRESSION; PROTEIN SIR2; TRANSCRIPTION; ACETYLATION; CHROMATIN; MOUSE; MECHANISM; ACTIVATION; PHOSPHORYLATION	The molecular machinery that governs circadian rhythmicity comprises proteins whose interplay generates time-specific transcription of clock genes. The role of chromatin remodeling in a physiological setting such as the circadian clock is yet unclear. We show that the protein CLOCK, a central component of the circadian pacemaker, has histone acetyltransferase (HAT) activity. CLOCK shares homology with acetylcoenzyme A binding motifs within the MYST family of HATs. CLOCK displays high sequence similarity to ACTR, a member of SRC family of HATs, with which it shares also enzymatic specificity for histones H3 and H4. BMAL1, the heterodimerization partner of CLOCK, enhances HAT function. The HAT activity of CLOCK is essential to rescue circadian rhythmicity and activation of clock genes in Clock mutant cells. Identification of CLOCK as a novel type of DNA binding HAT reveals that chromatin remodeling is crucial for the core clock mechanism and identifies unforeseen links between histone acetylation and cellular physiology.	Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	paolosc@igbmc.u-strasbg.fr	Doi, Masao/J-9267-2019; Sassone-Corsi, Paolo/H-6182-2011	Doi, Masao/0000-0001-6264-9217; Hirayama, Jun/0000-0002-8485-3320				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brownell JE, 1999, METH MOL B, V119, P343; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Doi M, 2004, CURR BIOL, V14, P975, DOI 10.1016/j.cub.2004.05.043; Doi M, 2001, P NATL ACAD SCI USA, V98, P8089, DOI 10.1073/pnas.141090998; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Loury R, 2004, METHOD ENZYMOL, V377, P197; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WADE PA, 1997, CURR BIOL, V7, P82; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	68	619	644	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					497	508		10.1016/j.cell.2006.03.033	http://dx.doi.org/10.1016/j.cell.2006.03.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678094	Bronze			2022-12-28	WOS:000237506100016
J	Haemmerle, G; Lass, A; Zimmermann, R; Gorkiewicz, G; Meyer, C; Rozman, J; Heldmaier, G; Maier, R; Theussl, C; Eder, S; Kratky, D; Wagner, EF; Klingenspor, M; Hoefler, G; Zechner, R				Haemmerle, G; Lass, A; Zimmermann, R; Gorkiewicz, G; Meyer, C; Rozman, J; Heldmaier, G; Maier, R; Theussl, C; Eder, S; Kratky, D; Wagner, EF; Klingenspor, M; Hoefler, G; Zechner, R			Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase	SCIENCE			English	Article							HORMONE-SENSITIVE LIPASE; INSULIN; EXPRESSION; OBESITY; TISSUE; MOBILIZATION; ACCUMULATION; DEFICIENCY; MECHANISMS	Fat tissue is the most important energy depot in vertebrates. The release of free fatty acids (FFAs) from stored fat requires the enzymatic activity of lipases. We showed that genetic inactivation of adipose triglyceride lipase (ATGL) in mice increases adipose mass and leads to triacylglycerol deposition in multiple tissues. ATGL-deficient mice accumulated large amounts of lipid in the heart, causing cardiac dysfunction and premature death. Defective cold adaptation indicated that the enzyme provides FFAs to fuel thermogenesis. The reduced availability of ATGL-derived FFAs leads to increased glucose use, increased glucose tolerance, and increased insulin sensitivity. These results indicate that ATGL is rate limiting in the catabolism of cellular fat depots and plays an important role in energy homeostasis.	Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; Univ Marburg, Fac Biol, Dept Anim Physiol, D-35032 Marburg, Germany; Res Inst Mol Pathol, A-1030 Vienna, Austria	University of Graz; Medical University of Graz; Philipps University Marburg; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at	Gorkiewicz, Gregor/ABF-1602-2021; Meyer, Carola/N-5874-2014; Rozman, Jan/A-2540-2010; Klingenspor, Martin/D-6930-2011; Hoefler, Gerald/B-7006-2008; Kratky, Dagmar/ABF-5699-2021; Klingenspor, Martin/K-5033-2019; Lass, Achim/C-3332-2008; Heldmaier, Gerhard/AAI-3286-2020; Hoefler, Gerald/H-1796-2016	Gorkiewicz, Gregor/0000-0003-1149-4782; Meyer, Carola/0000-0001-7959-1218; Rozman, Jan/0000-0002-8035-8904; Klingenspor, Martin/0000-0002-4502-6664; Lass, Achim/0000-0002-8190-7151; Wagner, Erwin F/0000-0001-7872-0196; Zechner, Rudolf/0000-0001-5483-1182; Zimmermann, Robert/0000-0002-7354-870X; Hoefler, Gerald/0000-0002-9056-3063; Haemmerle, Guenter/0000-0001-9900-5896; Kratky, Dagmar/0000-0003-1357-7573	Austrian Science Fund FWF [F 3001, F 3002] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Large V, 1998, J LIPID RES, V39, P1688; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Mulder H, 1999, DIABETES, V48, P228, DOI 10.2337/diabetes.48.1.228; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Raben DM, 2005, TRENDS ENDOCRIN MET, V16, P35, DOI 10.1016/j.tem.2005.01.009; RANDLE PJ, 1963, LANCET, V1, P785; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; SCHOENBORN V, IN PRESS DIABETES; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	27	973	1027	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					734	737		10.1126/science.1123965	http://dx.doi.org/10.1126/science.1123965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675698				2022-12-28	WOS:000237312100047
J	Macara, IG; Spang, A				Macara, IG; Spang, A			Closing the GAP between polarity and vesicle transport	CELL			English	Editorial Material									Univ Virginia, Ctr Cell Signalling, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Basel, Bioctr, CH-4056 Basel, Switzerland	University of Virginia; University of Basel	Macara, IG (corresponding author), Univ Virginia, Ctr Cell Signalling, Dept Microbiol, Charlottesville, VA 22908 USA.	imacara@virginia.edu; anne.spang@unibas.ch	Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203				Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; Lee OK, 2003, NAT CELL BIOL, V5, P987, DOI 10.1038/ncb1055; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; TERAI T, 2006, MOL BIOL CELL, V8, P8; Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007; WELLS CD, 2006, CELL; Zhang XY, 2005, J CELL BIOL, V170, P273, DOI 10.1083/jcb.200502055	10	14	14	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 5	2006	125	3					419	421		10.1016/j.cell.2006.04.011	http://dx.doi.org/10.1016/j.cell.2006.04.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678084	Bronze			2022-12-28	WOS:000237506100004
J	Wilson, CW; Chuang, PT				Wilson, Christopher W.; Chuang, Pao-Tien			New "hogs" in hedgehog transport and signal reception	CELL			English	Review							DROSOPHILA ORTHOLOG; MECHANISMS; GRADIENT		Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Chuang, PT (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	pao-tien.chuang@ucsf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066600, R01HL067822] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66600, HL67822] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Glise B, 2005, DEV CELL, V8, P255, DOI 10.1016/j.devcel.2005.01.003; Gorfinkiel N, 2005, DEV CELL, V8, P241, DOI 10.1016/j.devcel.2004.12.018; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; JIA J, 2006, CELL MOL LIFE SCI; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; TENZEN T, 2006, DEV CELL; Torroja C, 2005, J NEUROBIOL, V64, P334, DOI 10.1002/neu.20168; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; ZHANG W, 2006, DEV CELL	18	20	21	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 5	2006	125	3					435	438		10.1016/j.cell.2006.04.016	http://dx.doi.org/10.1016/j.cell.2006.04.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678090	Green Submitted, Bronze			2022-12-28	WOS:000237506100010
J	Deleris, A; Gallego-Bartolome, J; Bao, JS; Kasschau, KD; Carrington, JC; Voinnet, O				Deleris, Angelique; Gallego-Bartolome, Javier; Bao, Jinsong; Kasschau, Kristin D.; Carrington, James C.; Voinnet, Olivier			Hierarchical action and inhibition of plant Dicer-like proteins in antiviral defense	SCIENCE			English	Article							CELL-TO-CELL; RNA INTERFERENCE; SILENCING SIGNAL; INITIATION STEP; DICER-LIKE-4; ARABIDOPSIS; BIOGENESIS; VIRUSES	The mechanisms underlying induction and suppression of RNA silencing in the ongoing plant-virus arms race are poorly understood. We show here that virus-derived small RNAs produced by Arabidopsis Dicer-like 4 (DCL4) program an effector complex conferring antiviral immunity. Inhibition of DCL4 by a viral-encoded suppressor revealed the subordinate antiviral activity of DCL2. Accordingly, inactivating both DCL2 and DCL4 was necessary and sufficient to restore systemic infection of a suppressor-deficient virus. The effects of DCL2 were overcome by increasing viral dosage in inoculated leaves, but this could not surmount additional, non - cell autonomous effects of DCL4 specifically preventing viral unloading from the vasculature. These findings define a molecular framework for studying antiviral silencing and defense in plants.	CNRS, Unite Propre Rech 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Oregon State University	Voinnet, O (corresponding author), CNRS, Unite Propre Rech 2357, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr	Bao, Jinsong/A-7413-2008; Carrington, James C/A-4656-2012; Gallego-Bartolomé, Javier/AAV-7369-2020	Bao, Jinsong/0000-0002-9606-6615; Carrington, James C/0000-0003-3572-129X; Gallego-Bartolome, Javier/0000-0003-2225-7168; Voinnet, Olivier/0000-0001-6982-9544; DELERIS, Angelique/0000-0001-7600-9480	NIAID NIH HHS [AI43288] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043288, R37AI043288, R21AI043288] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Cohen Y, 2000, VIROLOGY, V273, P258, DOI 10.1006/viro.2000.0441; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Gasciolli V, 2005, CURR BIOL; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Scholthof HB, 2005, TRENDS PLANT SCI, V10, P376, DOI 10.1016/j.tplants.2005.07.002; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	19	648	699	5	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					68	71		10.1126/science.1128214	http://dx.doi.org/10.1126/science.1128214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16741077				2022-12-28	WOS:000238850200030
J	Li, HT; Ilin, S; Wang, WK; Duncan, EM; Wysocka, J; Allis, CD; Patel, DJ				Li, Haitao; Ilin, Serge; Wang, Wooikoon; Duncan, Elizabeth M.; Wysocka, Joanna; Allis, C. David; Patel, Dinshaw J.			Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF	NATURE			English	Article							TRANSCRIPTION FACTOR; LYSINE METHYLATION; STRUCTURAL BASIS; H3 TAIL; CHROMODOMAIN; CHROMATIN; BROMODOMAIN; BINDING; DOMAIN; RECOGNIZE	Mono-, di- and trimethylated states of particular histone lysine residues are selectively found in different regions of chromatin, thereby implying specialized biological functions for these marks ranging from heterochromatin formation to X-chromosome inactivation and transcriptional regulation(1-3). A major challenge in chromatin biology has centred on efforts to define the connection between specific methylation states and distinct biological readouts impacting on function(4). For example, histone H3 trimethylated at lysine 4 (H3K4me3) is associated with transcription start sites of active genes(5-7), but the molecular 'effectors' involved in specific recognition of H3K4me3 tails remain poorly understood. Here we demonstrate the molecular basis for specific recognition of H3(1-15)K4me3 (residues 1-15 of histone H3 trimethylated at K4) by a plant homeodomain (PHD) finger of human BPTF (bromodomain and PHD domain transcription factor), the largest subunit of the ATP-dependent chromatin-remodelling complex, NURF (nucleosome remodelling factor). We report on crystallographic and NMR structures of the bromodomain-proximal PHD finger of BPTF in free and H3(1-15)K4me3-bound states. H3(1-15)K4me3 interacts through anti-parallel beta-sheet formation on the surface of the PHD finger, with the long side chains of arginine 2 (R2) and K4me3 fitting snugly in adjacent pre-formed surface pockets, and bracketing an invariant tryptophan. The observed stapling role by non-adjacent R2 and K4me3 provides a molecular explanation for H3K4me3 site specificity. Binding studies establish that the BPTF PHD finger exhibits a modest preference for K4me3- over K4me2-containing H3 peptides, and discriminates against monomethylated and unmodified counterparts. Furthermore, we identified key specificity-determining residues from binding studies of H3(1-15)K4me3 with PHD finger point mutants. Our findings call attention to the PHD finger as a previously uncharacterized chromatin-binding module found in a large number of chromatin-associated proteins.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Allis, CD (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	alliscd@rockefeller.edu; pateld@mskcc.org	Hu, Ruogu/B-2203-2008; Duncan, Elizabeth/AAJ-3351-2020; Li, Haitao/B-2668-2012	Li, Haitao/0000-0001-6741-293X; Duncan, Elizabeth/0000-0003-2003-6417	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Bottomley MJ, 2004, EMBO REP, V5, P464, DOI 10.1038/sj.embor.7400146; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; WYSOCKA J, 2006, NATURE          0521; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	31	574	602	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					91	95		10.1038/nature04802	http://dx.doi.org/10.1038/nature04802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16728978	Green Accepted			2022-12-28	WOS:000238724500043
J	Al-Ruzzeh, S; George, S; Bustami, M; Wray, J; Ilsley, C; Athanasiou, T; Amrani, M				Al-Ruzzeh, Sharif; George, Shane; Bustami, Mahmoud; Wray, Jo; Ilsley, Charles; Athanasiou, Thanos; Amrani, Mohamed			Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; GRAFT-SURGERY; REVASCULARIZATION; MORBIDITY; OPERATION; RISK	Objective To compare the clinical, angiographic, neurocognitive, and quality of life outcomes of off-pump coronary artery bypass surgery with conventional coronary artery bypass grafting surgery using cardiopulmonary bypass. Design Randomised controlled clinical trial. Setting Tertiary cardiothoracic centre in Middlesex, England. Participants 168 patients (27 women) requiring primary isolated coronary artery bypass grafting surgery. Interventions Patients were randomised to conventional coronary artery bypass grafting surgery using cardiopulmonary bypass (n = 84) or off-pump coronary artery bypass surgery (n = 84), carried out by one surgeon. Angiographic examination was carried out at three months postoperatively. Neurocognitive tests were carried out at baseline and at six weeks and six months postoperatievely. Main outcome measures Clinical outcome, graft patency at three months, neurocognitive function at six weeks and six months, and health related quality of life. Results Graft patency was evaluated by angiography in 151 (89.9%) patients and was similar between the cardiopulmonary bypass and off-pump groups (risk difference - 1%, 95% confidence interval - 5% to 4% with the off-pump group considered the treatment group. Patients in the off-pump group required fewer blood transfusions (1.7 units v 1.0 unit, P = 0.02), shorter duration of mechanical ventilation (7.7 hours v 3.9 hours, P = 0.03), and shorter hospital stay (10.8 days v 8.9 days). Scores for neurocognitive function showed * significant difference in three memory subtests at six weeks and two memory subtests at six months in favour of the off-pump group. Conclusions Patients who underwent off-pump coronary artery bypass surgery showed similar patency of grafts, better clinical outcome, shorter hospital stay, and better neurocognitive function than patients who underwent conventional coronary artery bypass grafting surgery using cardiopulmonary bypass.	Harefield Hosp, Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield UB9 6JH, Middx, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Amrani, M (corresponding author), Harefield Hosp, Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield UB9 6JH, Middx, England.	mohamedamrani@hotmail.co.uk	Al-Ruzzeh, Sharif/AAB-4687-2021	Wray, Jo/0000-0002-4769-1211				Al-Ruzzeh S, 2005, J CARDIAC SURG, V20, P1, DOI 10.1111/j.0886-0440.2005.05003.x; Al-Ruzzeh S, 2002, ANN THORAC SURG, V73, P1431, DOI 10.1016/S0003-4975(02)03399-4; Al-Ruzzeh S, 2002, J THORAC CARDIOV SUR, V123, P525, DOI 10.1067/mtc.2002.119059; Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8; Anyanwu AC, 2002, ANN THORAC SURG, V73, P798, DOI 10.1016/S0003-4975(01)03415-4; Browne SM, 1999, J THORAC CARDIOV SUR, V117, P481, DOI 10.1016/S0022-5223(99)70327-2; BUCHER H, 2002, USERS GUIDE MED LIT, P393; Collie A, 2002, ANN THORAC SURG, V73, P2005, DOI 10.1016/S0003-4975(01)03375-6; Cox CM, 2000, ANN THORAC SURG, V69, P140, DOI 10.1016/S0003-4975(99)01196-0; Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X; Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5; Grigore AM, 2002, ANESTH ANALG, V94, P4, DOI 10.1097/00000539-200201000-00002; Grigore AM, 2001, ANESTHESIOLOGY, V95, P1110, DOI 10.1097/00000542-200111000-00014; Gundry SR, 1998, J THORAC CARDIOV SUR, V115, P1273, DOI 10.1016/S0022-5223(98)70209-0; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D; McKhann GM, 1997, ANN THORAC SURG, V63, P516; MOODY DM, 1990, ANN NEUROL, V28, P477, DOI 10.1002/ana.410280403; MURKIN JM, 1995, J THORAC CARDIOV SUR, V110, P349, DOI 10.1016/S0022-5223(95)70230-X; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Omeroglu SN, 2000, ANN THORAC SURG, V70, P844, DOI 10.1016/S0003-4975(00)01567-8; Onorati F, 2005, ANN THORAC SURG, V79, P837, DOI 10.1016/j.athoracsur.2004.07.060; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324; Snapinn Steven M, 2000, Curr Control Trials Cardiovasc Med, V1, P19, DOI 10.1186/CVM-1-1-019; Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039; Taggart DP, 2001, CURR OPIN CARDIOL, V16, P271, DOI 10.1097/00001573-200109000-00003; van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036; Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405; van Dijk D, 2004, HEART, V90, P431, DOI 10.1136/hrt.2003.010173; Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	140	156	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2006	332	7554					1365	1368		10.1136/bmj.38852.479907.7C	http://dx.doi.org/10.1136/bmj.38852.479907.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057HN	16740529	Bronze, Green Published			2022-12-28	WOS:000238587000018
J	Mkhoyan, KA; Batson, PE; Cha, J; Schaff, WJ; Silcox, J				Mkhoyan, KA; Batson, PE; Cha, J; Schaff, WJ; Silcox, J			Direct determination of local lattice polarity in crystals	SCIENCE			English	Article							SUB-ANGSTROM RESOLUTION		Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Cornell University; International Business Machines (IBM)	Mkhoyan, KA (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	kam55@cornell.edu	Batson, Philip E/C-3107-2012; Cha, Judy/H-5483-2011; j, j/GQP-4038-2022	Mkhoyan, Andre/0000-0003-3568-5452				Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; Kisielowski C, 2001, ULTRAMICROSCOPY, V89, P243, DOI 10.1016/S0304-3991(01)00090-0; Krivanek O. L., 1997, I PHYS C SER, V153, P35; Kudera S, 2005, NANO LETT, V5, P445, DOI 10.1021/nl048060g; MCGIBBON AJ, 1995, SCIENCE, V269, P519, DOI 10.1126/science.269.5223.519; Milliron DJ, 2004, NATURE, V430, P190, DOI 10.1038/nature02695; Nellist PD, 2004, SCIENCE, V305, P1741, DOI 10.1126/science.1100965; TAFTO J, 1982, J APPL CRYSTALLOGR, V15, P60, DOI 10.1107/S0021889882011352	9	48	48	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1354	1354		10.1126/science.1124511	http://dx.doi.org/10.1126/science.1124511			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741114				2022-12-28	WOS:000237961600047
J	Muller-Wodarg, ICF				Mueller-Wodarg, Ingo C. F.			Planetary science - Exploring other worlds to learn more about our own	SCIENCE			English	Editorial Material									Imperial Coll London, Space & Atmospher Phys Grp, London SW7 2BW, England	Imperial College London	Muller-Wodarg, ICF (corresponding author), Imperial Coll London, Space & Atmospher Phys Grp, London SW7 2BW, England.	i.mueller-wodarg@imperial.ac.uk	Mueller-Wodarg, Ingo C. F./M-9945-2014	Mueller-Wodarg, Ingo C. F./0000-0001-6308-7826				Forbes JM, 2006, SCIENCE, V312, P1366, DOI 10.1126/science.1126389; Mendillo M, 2006, SCIENCE, V311, P1135, DOI 10.1126/science.1122099; Mendillo M, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009961; Prange R, 2004, NATURE, V432, P78, DOI 10.1038/nature02986; Rishbeth H, 2004, PLANET SPACE SCI, V52, P849, DOI 10.1016/j.pss.2004.02.007	5	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1319	1320		10.1126/science.1128497	http://dx.doi.org/10.1126/science.1128497			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048QM	16741101				2022-12-28	WOS:000237961600034
J	Sun, L; Banhart, F; Krasheninnikov, AV; Rodriguez-Manzo, JA; Terrones, M; Ajayan, PM				Sun, L.; Banhart, F.; Krasheninnikov, A. V.; Rodriguez-Manzo, J. A.; Terrones, M.; Ajayan, P. M.			Carbon nanotubes as high-pressure cylinders and nanoextruders	SCIENCE			English	Article							MECHANICAL-PROPERTIES; ELASTIC PROPERTIES; YOUNGS MODULUS; SINGLE; COMPRESSION; MIGRATION; STRENGTH; ONIONS	Closed-shell carbon nanostructures, such as carbon onions, have been shown to act as self-contracting high-pressure cells under electron irradiation. We report that controlled irradiation of multiwalled carbon nanotubes can cause large pressure buildup within the nanotube cores that can plastically deform, extrude, and break solid materials that are encapsulated inside the core. We further showed by atomistic simulations that the internal pressure inside nanotubes can reach values higher than 40 gigapascals. Nanotubes can thus be used as robust nanoscale jigs for extruding and deforming hard nanomaterials and for modifying their properties, as well as templates for the study of individual nanometer-sized crystals under high pressure.	Johannes Gutenberg Univ Mainz, Inst Phys Chem, D-55099 Mainz, Germany; Univ Helsinki, Accelerator Lab, FIN-00014 Helsinki, Finland; Aalto Univ, Phys Lab, Helsinki 02015, Finland; Inst Potosino Invest Cient & Tecnol, Adv Mat Dept, San Luis Potosi 78216, Mexico; Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA	Johannes Gutenberg University of Mainz; University of Helsinki; Aalto University; Instituto Potosino Investigacion Cientifica y Tecnologica; Rensselaer Polytechnic Institute	Banhart, F (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys Chem, D-55099 Mainz, Germany.	Banhart@uni-mainz.de	Sun, Litao/D-4289-2013; Krasheninnikov, Arkady/M-3020-2013; Banhart, Florian/I-1118-2016; Terrones, Mauricio/B-3829-2014; Krasheninnikov, Arkady/L-3866-2016; Krasheninnikov, Arkady V./X-7552-2019	Sun, Litao/0000-0002-2750-5004; Krasheninnikov, Arkady/0000-0003-0074-7588; Banhart, Florian/0000-0001-5911-9418; Terrones, Mauricio/0000-0003-0010-2851; Krasheninnikov, Arkady/0000-0003-0074-7588; Krasheninnikov, Arkady V./0000-0003-0074-7588				Ajayan PM, 1998, PHYS REV LETT, V81, P1437, DOI 10.1103/PhysRevLett.81.1437; AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0; Banhart F, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.241408; Banhart F, 2005, SMALL, V1, P953, DOI 10.1002/smll.200500162; Banhart F, 1999, REP PROG PHYS, V62, P1181, DOI 10.1088/0034-4885/62/8/201; Banhart F, 1996, NATURE, V382, P433, DOI 10.1038/382433a0; Barber AH, 2003, APPL PHYS LETT, V82, P4140, DOI 10.1063/1.1579568; Cadek M, 2002, APPL PHYS LETT, V81, P5123, DOI 10.1063/1.1533118; Chopra NG, 1996, CHEM PHYS LETT, V256, P241, DOI 10.1016/0009-2614(96)00475-7; Dalton A.B., 2003, NATURE, P423; Gogotsi Y, 2002, CHEM PHYS LETT, V365, P354, DOI 10.1016/S0009-2614(02)01496-3; Hernandez E, 1998, PHYS REV LETT, V80, P4502, DOI 10.1103/PhysRevLett.80.4502; Kamalakaran R, 2000, APPL PHYS LETT, V77, P3385, DOI 10.1063/1.1327611; Krasheninnikov AV, 2006, CHEM PHYS LETT, V418, P132, DOI 10.1016/j.cplett.2005.10.106; Krasheninnikov AV, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125428; Krishnan A, 1998, PHYS REV B, V58, P14013, DOI 10.1103/PhysRevB.58.14013; Li J, 2002, PHYS CHEM MINER, V29, P166, DOI 10.1007/s00269-001-0224-4; Li JX, 2005, ADV MATER, V17, P1539, DOI 10.1002/adma.200401917; Li JX, 2004, NANO LETT, V4, P1143, DOI 10.1021/nl049705f; Lu JP, 1997, PHYS REV LETT, V79, P1297, DOI 10.1103/PhysRevLett.79.1297; Lupo F, 2005, CHEM PHYS LETT, V410, P384, DOI 10.1016/j.cplett.2005.05.116; Maniwa Y, 2002, J PHYS SOC JPN, V71, P2863, DOI 10.1143/JPSJ.71.2863; Mayne M, 2001, CHEM PHYS LETT, V338, P101, DOI 10.1016/S0009-2614(01)00278-0; Motta M, 2005, NANO LETT, V5, P1529, DOI 10.1021/nl050634+; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; TSANG SC, 1994, NATURE, V372, P159, DOI 10.1038/372159a0; Wang ZW, 2004, P NATL ACAD SCI USA, V101, P13699, DOI 10.1073/pnas.0405877101; Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971; Xiao T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.153407; Yakobson BI, 1996, PHYS REV LETT, V76, P2511, DOI 10.1103/PhysRevLett.76.2511; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637; Zaiser M, 1999, MATER RES SOC SYMP P, V540, P243; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311	34	263	271	28	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1199	1202		10.1126/science.1124594	http://dx.doi.org/10.1126/science.1124594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728637				2022-12-28	WOS:000237957400049
J	Campbell, IA; Bah-Sow, O				Campbell, IA; Bah-Sow, O			Pulmonary tuberculosis: diagnosis and treatment	BRITISH MEDICAL JOURNAL			English	Review							GLOBAL EPIDEMIOLOGY; UNITED-KINGDOM; CHEMOTHERAPY; MANAGEMENT		Llandough Hosp, Cardiff CF64 2XX, S Glam, Wales; Conakry Univ, Teaching Hosp, Dept Pneumophtisiol, Conakry, Guinea		Campbell, IA (corresponding author), Llandough Hosp, Cardiff CF64 2XX, S Glam, Wales.	Ian.Campbell@cardiffandvale.wales.nhs.uk						Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; CANTWELL MF, 1994, JAMA-J AM MED ASSOC, V272, P535, DOI 10.1001/jama.272.7.535; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Crampin AC, 2001, INT J TUBERC LUNG D, V5, P994; Crofton J., 1999, CLIN TUBERCULOSIS, V2nd; Dormandy Thomas, 1999, WHITE DEATH; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Enarson RM, 2005, INT J TUBERC LUNG D, V9, P1299; FOX W, 1959, B WORLD HEALTH ORGAN, V21, P51; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1109; National Institute for Health and Clinical Excellence (NICE), 2006, TUB CLIN DIAGN MAN T; Ormerod P, 2000, THORAX, V55, P887; Ormerod P, 1998, THORAX, V53, P536; POZNIAK AL, 2005, BRIT HIV ASS TREATME; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; SCHAAF HS, 1995, PEDIATR INFECT DIS J, V14, P189, DOI 10.1097/00006454-199503000-00004; SNIDER DE, 1992, NEW ENGL J MED, V326, P703, DOI 10.1056/NEJM199203053261011; Volmink J, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; *WHO STOP TB DEP, 2003, TREATM TUB GUID NAT; 2005, LANCET, V366, P2063	23	45	46	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 20	2006	332	7551					1194	1197		10.1136/bmj.332.7551.1194	http://dx.doi.org/10.1136/bmj.332.7551.1194			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048GJ	16709993	Green Published			2022-12-28	WOS:000237935300020
J	Evans, WD				Evans, W. Douglas			How social marketing works in health care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Hlth Promot Res, Washington, DC 20036 USA	Research Triangle Institute	Evans, WD (corresponding author), RTI Int, Hlth Promot Res, Washington, DC 20036 USA.	devans@rti.org						Aaker D., 1996, BUILDING STRONG BRAN; Andreasen AlanR., 1995, MARKETING SOCIAL CHA; [Anonymous], 1992, DESIGNING HLTH COMMU; Bandura A., 1986, SOCIAL FDN THOUGHT A; BORDEN NH, 1964, J ADVERTISING RES, V4, P2; Evans WD, 2005, J HEALTH COMMUN, V10, P181, DOI 10.1080/10810730590915137; Farrelly MC, 2005, AM J PUBLIC HEALTH, V95, P425, DOI 10.2105/AJPH.2004.049692; Grilli R, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000389; Hornik R, 2003, COMMUN THEOR, V13, P204, DOI 10.1111/j.1468-2885.2003.tb00289.x; Hornik R, 1997, ADVERT CONS, P45; Hornik R., 2002, PUBLIC HLTH COMMUNIC; Huhman Marian, 2004, Prev Chronic Dis, V1, pA11; Kreuter M, 2000, TAILORED HLTH MESSAG; NCI, 2002, MAK HLTH COMM PROGR; PACT Agencies, 1982, J ADVERTIS, V11, P3; Petty R.E., 1986, COMMUN PERSUATION, P1; Prochaska James O., 1992, STAGES CHANGE MODIFI; Snyder L., 2003, INT COMM ASS ANN M S; Snyder LB, 2002, LEA COMMUN SER, P357; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND	20	111	112	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2006	332	7551					1207	1210		10.1136/bmj.332.7551.1207-a	http://dx.doi.org/10.1136/bmj.332.7551.1207-a			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048GJ	16710002	Green Published			2022-12-28	WOS:000237935300028
J	Hastings, G; McDermott, L				Hastings, G; McDermott, L			Putting social marketing into practice	BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING-CESSATION		Inst Social Mkt, Stirling, Scotland; Open Univ, Stirling FK9 4LA, Scotland	University of Stirling; Open University - UK	Hastings, G (corresponding author), Inst Social Mkt, Stirling, Scotland.	gerard.hastings@stir.ac.uk						Department of Health, 2004, CHOOS HLTH MAK HLTH; Evans WD, 2006, BMJ-BRIT MED J, V332, P1207, DOI 10.1136/bmj.332.7551.1207-a; Gordon R, 2006, REV EFFECTIVENESS SO; Hastings G, 2006, ADDICTION, V101, P303, DOI 10.1111/j.1360-0443.2006.01371.x; Hastings G, 2005, J PUBLIC HEALTH POL, V26, P296, DOI 10.1057/palgrave.jphp.3200039; Hastings G, 2011, REV RES EFFECTS FOOD; Hastings G, 2004, TOBACCO HLTH EUROPEA; Lovato C, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003439; Lowry RJ, 2004, PUBLIC HEALTH, V118, P239, DOI 10.1016/j.puhe.2003.09.010; Maguire A, 1999, COMMUNITY DENT HLTH, V16, P138; McDermott L., 2005, SYSTEMATIC REV EFFEC; McGinnis J.M., 2006, FOOD MARKETING CHILD; *NHS ARG CLYD, 2005, W SCOTL CANC AW PROJ; Stead M., 2006, REV EFFECTIVENESS SO	14	23	23	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 20	2006	332	7551					1210	1212		10.1136/bmj.332.7551.1210	http://dx.doi.org/10.1136/bmj.332.7551.1210			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048GJ	16710004	Green Submitted, Green Published			2022-12-28	WOS:000237935300029
J	Sharp, D				Sharp, D			Modern physics for the modern physician	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 1989, LANCET, Vii, P426; Mitton S, 2000, LANCET, V356, P1460; Mitton S, 2001, LANCET, V357, P824, DOI 10.1016/S0140-6736(00)04194-5; Mitton S., 2005, F HOYLE LIFE SCI; Mitton S, 2006, LANCET, V367, P1692, DOI 10.1016/S0140-6736(06)68738-2; ROBERTSON AJB, 1964, LANCET, V1, P1229	6	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2006	367	9523					1641	1642		10.1016/S0140-6736(06)68713-8	http://dx.doi.org/10.1016/S0140-6736(06)68713-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714172				2022-12-28	WOS:000237743100010
J	Walker, D; Gutierrez, JP; Torres, P; Bertozzi, SM				Walker, Dilys; Gutierrez, J. Pablo; Torres, Pilar; Bertozzi, Stefano M.			HIV prevention in Mexican schools: prospective randomised evaluation of intervention	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EMERGENCY CONTRACEPTION; CONTROLLED-TRIAL; VIRGINITY PLEDGES; SEXUAL-BEHAVIOR; PREGNANCY; HEALTH; ADOLESCENTS; EDUCATION; STD	Objective To assess effects on condom use and other sexual behaviour of an HIV prevention programme at school that promotes the use of condoms with and without emergency contraception. Design Cluster randomised controlled trial. Setting 40 public high schools in the state of Morelos, Mexico. Participants 10 954 first year high school students. Intervention Schools were randomised to one of three arms: an HIV prevention course that promoted condom use, the same course with emergency contraception as back-up, or the existing sex education course. Self administered anonymous questionnaires were completed at baseline, four months, and 16 months. Students at intervention schools received a 30 hour course (over 15 weeks) on HIV prevention and life skills, designed in accordance with guidelines of the joint United Nations programme on HIV/AIDS. Two extra hours of education on emergency contraception were given to students in the condom promotion with contraception arm. Main outcome measures Primary outcome measure was reported condom use. Other outcomes were reported sexual activity; knowledge and attitudes about HIV and emergency contraception; and attitudes and confidence about condom use. Results Intervention did not affect reported condom use. Knowledge of HIV improved in both intervention arms and knowledge of emergency contraception improved in the condom promotion with contraception arm. Reported sexual behaviour was similar in the intervention arms and the control group. Conclusion A rigorously designed, implemented, mid evaluated HIV education course based in public high schools did not reduce risk behaviour, so such courses need to be redesigned and evaluated. Addition of emergency contraception did not decrease reported condom use or increase risky sexual behaviour but did increase reported use of emergency contraception.	Natl Inst Publ Hlth, Div Hlth Econ & Evaluat, Cuernavaca, Morelos, Mexico; Natl Inst Publ Hlth, Div Reprod Hlth, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Gutierrez, JP (corresponding author), Natl Inst Publ Hlth, Div Hlth Econ & Evaluat, Cuernavaca, Morelos, Mexico.	jpgutier@correo.insp.mx	Gutierrez, Juan Pablo/A-4253-2010	Gutierrez, Juan Pablo/0000-0002-0557-5562; Bertozzi, Stefano M/0000-0002-1723-7085; Torres, Pilar/0000-0003-1869-2044				Bersamin MM, 2005, J ADOLESCENT HEALTH, V36, P428, DOI 10.1016/j.jadohealth.2004.09.016; Bruckner H, 2005, J ADOLESCENT HEALTH, V36, P271, DOI 10.1016/j.jadohealth.2005.01.005; DiCenso A., 2002, BRIT MED J, V324, P1; Dupont S, 2002, INT J STD AIDS, V13, P482, DOI 10.1258/09564620260079644; Ellertson C, 2001, OBSTET GYNECOL, V98, P570, DOI 10.1016/S0029-7844(01)01506-X; Gayet C, 2003, SALUD PUBLICA MEXICO, V45, pS632, DOI 10.1590/s0036-36342003001100008; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Gold MA, 1997, FAM PLANN PERSPECT, V29, P15, DOI 10.2307/2953348; Graham A, 2002, BRIT MED J, V324, P1179, DOI 10.1136/bmj.324.7347.1179; Grimes DA, 2004, OBSTET GYNECOL, V104, P220, DOI 10.1097/01.AOG.0000135804.89369.59; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; *I NAT EST GEOGR I, 2005, PERC REG BIRTHS AD M; Jackson RA, 2003, OBSTET GYNECOL, V102, P8, DOI 10.1016/S0029-7844(03)00478-2; JEEMMOU JB, 1998, JAMA-J AM MED ASSOC, V279, P1529; Jemmott JB, 1998, JAMA-J AM MED ASSOC, V279, P1529, DOI 10.1001/jama.279.19.1529; *JOINT UN PROGR HI, 2005, RES NEEDS EXP RESP A; KAINE T, 2000, OBSTET GYNECOL, V96, P1; Kirby D, 2002, J SEX RES, V39, P51, DOI 10.1080/00224490209552120; KIRBY D, 1995, REV ED PROGRAMS DESI; Langer A, 1999, CONTRACEPTION, V60, P233, DOI 10.1016/S0010-7824(99)00088-8; Lonczak HS, 2002, ARCH PEDIAT ADOL MED, V156, P438, DOI 10.1001/archpedi.156.5.438; MAGMUSSEN L, 2004, INT J ADOLESC MED HL, V16, P303; Magnussen Lesley, 2004, Int J Adolesc Med Health, V16, P303; OAKLEY A, 1995, BRIT MED J, V310, P158, DOI 10.1136/bmj.310.6973.158; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Robin L, 2004, J ADOLESCENT HEALTH, V34, P3, DOI 10.1016/S1054-139X(03)00244-1; Schaalma HP, 1996, HEALTH EDUC QUART, V23, P469, DOI 10.1177/109019819602300407; *SECR ED PUBL, 2005, EST BAS SIST ED NAC; Siegel DM, 1998, ARCH PEDIAT ADOL MED, V152, P961; Stern C, 1997, SALUD PUBLICA MEXICO, V39, P137; The Joint United Nations Programme on HIV/AIDS, 1997, IMP HIV SEX HLTH ED; TORRES MP, IN PRESS PUBLICA MEX; *UN POP FUND, 2003, 23 UNFPA; *UNICEF JOINT UN P, 2002, JOV VIH SIDA OP MOM	34	40	40	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2006	332	7551					1189	1192A		10.1136/bmj.38796.457407.80	http://dx.doi.org/10.1136/bmj.38796.457407.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048GJ	16682420	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000237935300018
J	Brune, H				Brune, H			Assembly and probing of spin chains of finite size	SCIENCE			English	Editorial Material							FERROMAGNETISM		Ecole Polytech Fed Lausanne, Inst Phys Nanostruct, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Brune, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Phys Nanostruct, CH-1015 Lausanne, Switzerland.	harald.brune@epfl.ch	Brune, Harald/E-7284-2017	Brune, Harald/0000-0003-4459-3111				Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Bruno P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.137203; Caneschi A, 2001, ANGEW CHEM INT EDIT, V40, P1760, DOI 10.1002/1521-3773(20010504)40:9<1760::AID-ANIE17600>3.0.CO;2-U; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Dender DC, 1996, PHYS REV B, V53, P2583, DOI 10.1103/PhysRevB.53.2583; Enderle M, 2000, PHYSICA B, V276, P560, DOI 10.1016/S0921-4526(99)01737-8; Gambardella P, 2002, NATURE, V416, P301, DOI 10.1038/416301a; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Hirjibehedin CF, 2006, SCIENCE, V312, P1021, DOI 10.1126/science.1125398; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133	10	20	20	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2006	312	5776					1005	1006		10.1126/science.1127387	http://dx.doi.org/10.1126/science.1127387			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709772	Green Submitted			2022-12-28	WOS:000237628800029
J	Ikeda, F; Dikic, I				Ikeda, Fumiyo; Dikic, Ivan			CYLD in ubiquitin signaling and tumor pathogenesis	CELL			English	Editorial Material							KAPPA; ONCOPROTEIN	Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-kappa B and activates transcription of proliferation genes in response to growth signals.	Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Ikeda, Fumiyo/AAD-3770-2020; Dikic, Ivan/O-4650-2015	Ikeda, Fumiyo/0000-0003-0407-2768; Dikic, Ivan/0000-0001-8156-9511				Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Watanabe N, 1997, EMBO J, V16, P3609, DOI 10.1093/emboj/16.12.3609	9	20	22	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					643	645		10.1016/j.cell.2006.05.003	http://dx.doi.org/10.1016/j.cell.2006.05.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713556	Bronze			2022-12-28	WOS:000237886000008
J	Gregory, SG; Barlow, KF; Mclay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; Howe, KL; Woodfine, K; Spencer, CCA; Jones, MC; Gillson, C; Searle, S; Zhou, Y; Kokocinski, F; McDonald, L; Evans, R; Phillips, K; Atkinson, A; Cooper, R; Jones, C; Hall, RE; Andrews, TD; Lloyd, C; Ainscough, R; Almeida, JP; Ambrose, KD; Anderson, F; Andrew, RW; Ashwell, RIS; Aubin, K; Babbage, AK; Bagguley, CL; Bailey, J; Beasley, H; Bethel, G; Bird, CP; Bray-Allen, S; Brown, JY; Brown, AJ; Buckley, D; Burton, J; Bye, J; Carder, C; Chapman, JC; Clark, SY; Clarke, G; Clee, C; Cobley, V; Collier, RE; Corby, N; Coville, GJ; Davies, J; Deadman, R; Dunn, M; Earthrowl, M; Ellington, AG; Errington, H; Frankish, A; Frankland, J; French, L; Garner, P; Garnett, J; Gay, L; Ghori, MRJ; Gibson, R; Gilby, LM; Gillett, W; Glithero, RJ; Grafham, DV; Griffiths, C; Griffiths-Jones, S; Grocock, R; Hammond, S; Harrison, ESI; Hart, E; Haugen, E; Heath, PD; Holmes, S; Holt, K; Howden, PJ; Hunt, AR; Hunt, SE; Hunter, G; Isherwood, J; James, R; Johnson, C; Johnson, D; Joy, A; Kay, M; Kershaw, JK; Kibukawa, M; Kimberley, AM; King, A; Knights, AJ; Lad, H; Laird, G; Lawlor, S; Leongamornlert, DA; Lloyd, DM; Loveland, J; Lovell, J; Lush, MJ; Lyne, R; Martin, S; Mashreghi-Mohammadi, M; Matthews, L; Matthews, NSW; McLaren, S; Milne, S; Mistry, S; Moore, MJF; Nickerson, T; O'Dell, CN; Oliver, K; Palmeiri, A; Palmer, SA; Parker, A; Patel, D; Pearce, AV; Peck, AI; Pelan, S; Phelps, K; Phillimore, BJ; Plumb, R; Rajan, J; Raymond, C; Rouse, G; Saenphimmachak, C; Sehra, HK; Sheridan, E; Shownkeen, R; Sims, S; Skuce, CD; Smith, M; Steward, C; Subramanian, S; Sycamore, N; Tracey, A; Tromans, A; Van Helmond, Z; Wall, M; Wallis, JM; White, S; Whitehead, SL; Wilkinson, JE; Willey, DL; Williams, H; Wilming, L; Wray, PW; Wu, Z; Coulson, A; Vaudin, M; Sulston, JE; Durbin, R; Hubbard, T; Wooster, R; Dunham, I; Carter, NP; McVean, G; Ross, MT; Harrow, J; Olson, MV; Beck, S; Rogers, J; Bentley, DR				Gregory, SG; Barlow, KF; Mclay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; Howe, KL; Woodfine, K; Spencer, CCA; Jones, MC; Gillson, C; Searle, S; Zhou, Y; Kokocinski, F; McDonald, L; Evans, R; Phillips, K; Atkinson, A; Cooper, R; Jones, C; Hall, RE; Andrews, TD; Lloyd, C; Ainscough, R; Almeida, JP; Ambrose, KD; Anderson, F; Andrew, RW; Ashwell, RIS; Aubin, K; Babbage, AK; Bagguley, CL; Bailey, J; Beasley, H; Bethel, G; Bird, CP; Bray-Allen, S; Brown, JY; Brown, AJ; Buckley, D; Burton, J; Bye, J; Carder, C; Chapman, JC; Clark, SY; Clarke, G; Clee, C; Cobley, V; Collier, RE; Corby, N; Coville, GJ; Davies, J; Deadman, R; Dunn, M; Earthrowl, M; Ellington, AG; Errington, H; Frankish, A; Frankland, J; French, L; Garner, P; Garnett, J; Gay, L; Ghori, MRJ; Gibson, R; Gilby, LM; Gillett, W; Glithero, RJ; Grafham, DV; Griffiths, C; Griffiths-Jones, S; Grocock, R; Hammond, S; Harrison, ESI; Hart, E; Haugen, E; Heath, PD; Holmes, S; Holt, K; Howden, PJ; Hunt, AR; Hunt, SE; Hunter, G; Isherwood, J; James, R; Johnson, C; Johnson, D; Joy, A; Kay, M; Kershaw, JK; Kibukawa, M; Kimberley, AM; King, A; Knights, AJ; Lad, H; Laird, G; Lawlor, S; Leongamornlert, DA; Lloyd, DM; Loveland, J; Lovell, J; Lush, MJ; Lyne, R; Martin, S; Mashreghi-Mohammadi, M; Matthews, L; Matthews, NSW; McLaren, S; Milne, S; Mistry, S; Moore, MJF; Nickerson, T; O'Dell, CN; Oliver, K; Palmeiri, A; Palmer, SA; Parker, A; Patel, D; Pearce, AV; Peck, AI; Pelan, S; Phelps, K; Phillimore, BJ; Plumb, R; Rajan, J; Raymond, C; Rouse, G; Saenphimmachak, C; Sehra, HK; Sheridan, E; Shownkeen, R; Sims, S; Skuce, CD; Smith, M; Steward, C; Subramanian, S; Sycamore, N; Tracey, A; Tromans, A; Van Helmond, Z; Wall, M; Wallis, JM; White, S; Whitehead, SL; Wilkinson, JE; Willey, DL; Williams, H; Wilming, L; Wray, PW; Wu, Z; Coulson, A; Vaudin, M; Sulston, JE; Durbin, R; Hubbard, T; Wooster, R; Dunham, I; Carter, NP; McVean, G; Ross, MT; Harrow, J; Olson, MV; Beck, S; Rogers, J; Bentley, DR			The DNA sequence and biological annotation of human chromosome 1	NATURE			English	Article							COPY NUMBER POLYMORPHISM; REPLICATION; GENE; GENOME; TRANSCRIPTION; CHROMATIN; MAP; DUPLICATIONS; ORGANIZATION; EVOLUTION	The reference sequence for each human chromosome provides the framework for understanding genome function, variation and evolution. Here we report the finished sequence and biological annotation of human chromosome 1. Chromosome 1 is gene-dense, with 3,141 genes and 991 pseudogenes, and many coding sequences overlap. Rearrangements and mutations of chromosome 1 are prevalent in cancer and many other diseases. Patterns of sequence variation reveal signals of recent selection in specific genes that may contribute to human fitness, and also in regions where no function is evident. Fine-scale recombination occurs in hotspots of varying intensity along the sequence, and is enriched near genes. These and other studies of human biology and disease encoded within chromosome 1 are made possible with the highly accurate annotated sequence, as part of the completed set of chromosome sequences that comprise the reference human genome.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Duke Univ, Ctr Human Genet, Durham, NC 27708 USA; Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England; Solexa Ltd, Saffron Walden CB10 1XL, Essex, England	Wellcome Trust Sanger Institute; Duke University; University of Washington; University of Washington Seattle; University of London; King's College London; University of Oxford; University of London; University College London	Gregory, SG (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	sgregory@chg.duhs.duke.edu	Andrews, Dan/ABG-4815-2020; Johnson, David/A-3907-2011; Frankish, Adam/G-6545-2011; Lyne, Rachel/AAE-2189-2020; Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Durbin, Richard/AAE-7178-2019; Griffiths-Jones, Sam/H-2998-2014	Johnson, David/0000-0003-0887-3343; Lyne, Rachel/0000-0001-8050-402X; Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Durbin, Richard/0000-0002-9130-1006; Martin, Sancha/0000-0001-6213-5259; Griffiths-Jones, Sam/0000-0001-6043-807X; Wass, Elizabeth/0000-0002-8605-9921; Dunham, Ian/0000-0003-2525-5598; Loveland, Jane/0000-0002-7669-2934; Andrews, Dan/0000-0003-3922-6376; Steward, Charles/0000-0001-8829-5349; Kokocinski, Felix/0000-0002-8472-9207; Hunt, Adrienne/0000-0002-1227-0310; Gibson, Richard Charles/0000-0001-5412-1965; Frankish, Adam/0000-0002-4333-628X; Wilming, Laurens/0000-0002-4154-7358; Swarbreck, David/0000-0002-5453-1013; Kay, Mike/0000-0002-3282-0834; Leongamornlert, Daniel/0000-0002-3486-3168; Davidson, Claire/0000-0002-4910-8202; Fosker, Christine/0000-0002-3799-9474; Harrow, Jennifer/0000-0003-0338-3070; Rajan, Jeena/0000-0002-3613-0013; Gregory, Simon/0000-0002-7805-1743; Haugen, Eric/0000-0001-7444-8981; Hunt, Sarah/0000-0002-8350-1235; Howe, Kevin/0000-0002-1751-9226	Medical Research Council [G0000107] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0000107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams SH, 2001, BIOCHEM J, V360, P135, DOI 10.1042/bj3600135; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Buckley PG, 2005, CANCER RES, V65, P2653, DOI 10.1158/0008-5472.CAN-04-3651; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Duan ZJ, 2004, MOL CELL BIOL, V24, P58, DOI 10.1128/MCB.24.1.58-70.2004; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gilbert DM, 2002, NAT GENET, V32, P336, DOI 10.1038/ng1102-336; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HASSAN AB, 1994, J CELL SCI, V107, P425; HASSAN AB, 1994, J CELL SCI, V107, P1381; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; HOLMQUIST GP, 1987, AM J HUM GENET, V40, P151; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Jarbo C, 2006, INT J CANCER, V118, P1159, DOI 10.1002/ijc.21385; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kresse SH, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-39; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Maresco DL, 1998, CYTOGENET CELL GENET, V82, P71, DOI 10.1159/000015067; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Redon R, 2005, J MED GENET, V42, P166, DOI 10.1136/jmg.2004.023861; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schermelleh L, 2001, CHROMOSOME RES, V9, P77, DOI 10.1023/A:1026799818566; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; STRANGE RC, 1991, CARCINOGENESIS, V12, P25, DOI 10.1093/carcin/12.1.25; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; VANPOPPEL G, 1992, CARCINOGENESIS, V13, P303, DOI 10.1093/carcin/13.2.303; Weise A, 2005, CYTOGENET GENOME RES, V108, P217, DOI 10.1159/000080819; Woodfine K, 2005, CELL CYCLE, V4, P172, DOI 10.4161/cc.4.1.1350; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016	50	156	2081	3	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					315	321		10.1038/nature04727	http://dx.doi.org/10.1038/nature04727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710414	Bronze			2022-12-28	WOS:000237593200040
J	Kennedy, CR; McCann, DC; Campbell, MJ; Law, CM; Mullee, M; Petrou, S; Watkin, P; Worsfold, S; Yuen, HM; Stevenson, J				Kennedy, CR; McCann, DC; Campbell, MJ; Law, CM; Mullee, M; Petrou, S; Watkin, P; Worsfold, S; Yuen, HM; Stevenson, J			Language ability after early detection of permanent childhood hearing impairment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN; OUTCOMES	Background: Children with bilateral permanent hearing impairment often have impaired language and speech abilities. However, the effects of universal newborn screening for permanent bilateral childhood hearing impairment and the effects of confirmation of hearing impairment by nine months of age on subsequent verbal abilities are uncertain. Methods: We studied 120 children with bilateral permanent hearing impairment identified from a large birth cohort in southern England, at a mean of 7.9 years of age. Of the 120 children, 61 were born during periods with universal newborn screening and 57 had hearing impairment that was confirmed by nine months of age. The primary outcomes were language as compared with nonverbal ability and speech expressed as z scores (the number of standard deviations by which the score differed from the mean score among 63 age-matched children with normal hearing), adjusted for the severity of the hearing impairment and for maternal education. Results: Confirmation of hearing impairment by nine months of age was associated with higher adjusted mean z scores for language as compared with nonverbal ability (adjusted mean difference for receptive language, 0.82; 95 percent confidence interval, 0.31 to 1.33; and adjusted mean difference for expressive language, 0.70; 95 percent confidence interval, 0.13 to 1.26). Birth during periods with universal newborn screening was also associated with higher adjusted z scores for receptive language as compared with nonverbal ability (adjusted mean difference, 0.60; 95 percent confidence interval, 0.07 to 1.13), although the z scores for expressive language as compared with nonverbal ability were not significantly higher. Speech scores did not differ significantly between those who were exposed to newborn screening or early confirmation and those who were not. Conclusions: Early detection of childhood hearing impairment was associated with higher scores for language but not for speech in midchildhood.	Univ Southampton, Dept Child Hlth, Southampton, Hants, England; Univ Southampton, Dept Publ Hlth Sci & Med Stat, Southampton, Hants, England; Univ Southampton, Dept Psychol, Southampton, Hants, England; Univ Sheffield, Inst Primary Care & Gen Practice, Sheffield, S Yorkshire, England; UCL, Inst Child Hlth, London, England; Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; Whipps Cross Univ Hosp, Dept Audiol, London, England	University of Southampton; University of Southampton; University of Southampton; University of Sheffield; University of London; University College London; University of Oxford; University of London; Queen Mary University London	Kennedy, CR (corresponding author), Southampton Gen Hosp, Mailpoint 21, Southampton SO16 6YD, Hants, England.	crk1@soton.ac.uk	Campbell, Michael J/I-4253-2014; Law, Catherine/A-1353-2009; Petrou, Stavros/ABD-8323-2021	Campbell, Michael J/0000-0003-3529-2739; Petrou, Stavros/0000-0003-3121-6050; Law, Catherine/0000-0002-1777-9386	MRC [G0501681] Funding Source: UKRI; Medical Research Council [G0501681] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allen T., 1986, DEAF CHILDREN AM, P161, DOI DOI 10.1177/15257401050270010201; BALDWIN M, 2005, THESIS U MANCHESTER; Bishop D. V. M., 1983, TEST RECEPTION GRAMM; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; BYRNE JM, 1995, CAN PSYCHOL, V36, P115, DOI 10.1037/0708-5591.36.2.115; CALDERON R, 2000, LANGUAGE SPEECH SOCI, P53; Dalzell L, 2000, EAR HEARING, V21, P118, DOI 10.1097/00003446-200004000-00006; DAVIS A, 1992, British Journal of Audiology, V26, P77, DOI 10.3109/03005369209077875; DAVIS A, 1997, HEALTH TECHNOL ASSES, V1, P1, DOI DOI 10.3310/HTA1100; Dunn L.M., 2009, PEABODY PICTURE VOCA; Harrison Melody, 2003, Ear and Hearing, V24, P89, DOI 10.1097/01.AUD.0000051749.40991.1F; Kennedy C, 2005, LANCET, V366, P660, DOI 10.1016/S0140-6736(05)67138-3; Kennedy CR, 1998, LANCET, V352, P1957; Lutman ME, 1999, EUR J PEDIATR, V158, P95, DOI 10.1007/s004310051025; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; *NAT BREAST CANC C, 1994, Q NEWSL NAT BREAST C, V1, P1; *NIH, 1993, EARL ID HEAR IMP INF; *OFF NAT STAT, 2000, STAND OCC CLASS; RAVEN C, 1998, MANUAL RAVENS PROGR; RENFREW C, 1995, RENFREW BUS STORY MA; Schroeder L, 2006, PEDIATRICS, V117, P1101, DOI 10.1542/peds.2005-1335; *STAT CORP, 2003, STAT STAT SOFTW REL; STEVENSON J, IN PRESS J SPEECH LA; Thompson DC, 2001, JAMA-J AM MED ASSOC, V286, P2000, DOI 10.1001/jama.286.16.2000; TUCKER SM, 1992, ARCH DIS CHILD, V67, P911, DOI 10.1136/adc.67.7.911; Wake M, 2005, ARCH DIS CHILD, V90, P238, DOI 10.1136/adc.2003.039354; Wake M, 2004, EAR HEARING, V25, P1, DOI 10.1097/01.AUD.0000111262.12219.2F; Watkin PM, 1999, ARCH DIS CHILD, V81, P380, DOI 10.1136/adc.81.5.380; WATKIN W, 2005, AUDIOL MED, V3, P175; Yoshinaga-Itano C, 2001, Semin Neonatol, V6, P521, DOI 10.1053/siny.2001.0075; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	31	321	332	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2131	2141		10.1056/NEJMoa054915	http://dx.doi.org/10.1056/NEJMoa054915			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707750	Green Published			2022-12-28	WOS:000237575400007
J	Newell-Price, J; Bertagna, X; Grossman, AB; Nieman, LK				Newell-Price, J; Bertagna, X; Grossman, AB; Nieman, LK			Cushing's syndrome	LANCET			English	Review							GASTRIC-INHIBITORY POLYPEPTIDE; CORTICOTROPIN-RELEASING HORMONE; MACRONODULAR ADRENAL-HYPERPLASIA; DEXAMETHASONE-SUPPRESSION TEST; TERM-FOLLOW-UP; NIGHTTIME SALIVARY CORTISOL; MIDNIGHT SERUM CORTISOL; QUALITY-OF-LIFE; ECTOPIC ADRENOCORTICOTROPIN SYNDROME; SOMATOSTATIN RECEPTOR SCINTIGRAPHY	Cushing's syndrome results from lengthy and inappropriate exposure to excessive glucocorticoids. Untreated, it has significant morbidity and mortality. The syndrome remains a challenge to diagnose and manage. Here, we review the current understanding of pathogenesis, clinical features, diagnostic, and differential diagnostic approaches. We provide diagnostic algorithms and recommendations for management.	Univ Sheffield, No Gen Hosp, Div Clin Sci, Sheffield S5 7AU, S Yorkshire, England; Royal Hallamshire Hosp, Dept Endocrinol, Sheffield S10 2JF, S Yorkshire, England; Univ Paris 05, Fac Med Rene Descartes, INSERM, U567,Inst Cochin,Dept Endocrinol, Paris, France; Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Dept Endocrinol, London, England; NICHHD, Reprod Endocrinol & Med Branch, NIH, Bethesda, MD 20891 USA	Northern General Hospital; University of Sheffield; University of Sheffield; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Newell-Price, J (corresponding author), Univ Sheffield, No Gen Hosp, Div Clin Sci, Sheffield S5 7AU, S Yorkshire, England.	j.newellprice@sheffield.ac.uk			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000638, ZIAHD008833] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000638, Z01HD008833] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ambrosi B, 1990, Clin Endocrinol (Oxf), V33, P809; Ambrosi B, 2004, EUR J ENDOCRINOL, V151, P173, DOI 10.1530/eje.0.1510173; Aniszewski JP, 2001, WORLD J SURG, V25, P934, DOI 10.1007/s00268-001-0032-5; Arlt W, 1997, CLIN ENDOCRINOL, V47, P623, DOI 10.1046/j.1365-2265.1997.3091129.x; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; Arnaldi G, 1998, J CLIN ENDOCR METAB, V83, P2029, DOI 10.1210/jc.83.6.2029; Aron DC, 1997, J CLIN ENDOCR METAB, V82, P1780, DOI 10.1210/jc.82.6.1780; Assie Guillaume, 2004, Pituitary, V7, P209, DOI 10.1007/s11102-005-1403-y; Atkinson AB, 2005, CLIN ENDOCRINOL, V63, P549, DOI 10.1111/j.1365-2265.2005.02380.x; Batista D, 2005, J CLIN ENDOCR METAB, V90, P5134, DOI 10.1210/jc.2004-1778; Benbassat Carlos A, 2004, Harefuah, V143, P636; BERTAGNA X, 2002, CUSHINS DIS; BERTAGNA XR, 2002, CUSHINGS DIS; Bertherat J, 2005, J CLIN ENDOCR METAB, V90, P1302, DOI 10.1210/jc.2004-1256; Bertherat J, 2003, CANCER RES, V63, P5308; BILODEAU SSV, 2005, END SOC 87 ANN M 200; BOSCARO M, 2005, END SOC 87 ANN M JUN; Bourdeau I, 2003, J CLIN ENDOCR METAB, V88, P3931, DOI 10.1210/jc.2002-022001; Bourdeau I, 2002, J CLIN ENDOCR METAB, V87, P1949, DOI 10.1210/jc.87.5.1949; Bourdeau I, 2001, J CLIN ENDOCR METAB, V86, P5534, DOI 10.1210/jc.86.11.5534; Brunt LM, 2001, SURGERY, V130, P629, DOI 10.1067/msy.2001.116920; Cannavo S, 2005, CLIN ENDOCRINOL, V63, P118, DOI 10.1111/j.1365-2265.2005.02285.x; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; Castro M, 1999, J CLIN ENDOCR METAB, V84, P878, DOI 10.1210/jc.84.3.878; Castro M, 2003, CLIN ENDOCRINOL, V59, P800, DOI 10.1046/j.1365-2265.2003.01908.x; Catargi B, 2003, J CLIN ENDOCR METAB, V88, P5808, DOI 10.1210/jc.2003-030254; Chabre O, 1998, J CLIN ENDOCR METAB, V83, P3134, DOI 10.1210/jc.83.9.3134; Chavez-Rodriguez J, 2005, AM J SURG, V189, P581, DOI 10.1016/j.amjsurg.2005.02.003; Chee GH, 2001, CLIN ENDOCRINOL, V54, P617, DOI 10.1046/j.1365-2265.2001.01261.x; Coiro V, 2000, J INTERN MED, V247, P667, DOI 10.1046/j.1365-2796.2000.00676.x; Colombo P, 2000, EUR J ENDOCRINOL, V143, P227, DOI 10.1530/eje.0.1430227; Contreras LN, 2000, MEDICINA-BUENOS AIRE, V60, P326; CRAPO L, 1979, METABOLISM, V28, P955, DOI 10.1016/0026-0495(79)90097-0; Dackiw APB, 2001, WORLD J SURG, V25, P914, DOI 10.1007/s00268-001-0030-7; Dahia PLM, 1996, J CLIN ENDOCR METAB, V81, P1768, DOI 10.1210/jc.81.5.1768; Dahia PLM, 1999, ENDOCR REV, V20, P136, DOI 10.1210/er.20.2.136; DALLASTA C, 2005, PITUITARY, DOI DOI 10.1007/S11102-005-0008-9; Davies JH, 2005, CLIN ENDOCRINOL, V62, P466, DOI 10.1111/j.1365-2265.2005.02244.x; deKeyzer Y, 1997, HORM RES, V47, P259, DOI 10.1159/000185473; deKeyzer Y, 1996, J CLIN INVEST, V97, P1311, DOI 10.1172/JCI118547; Devin JK, 2004, STEREOT FUNCT NEUROS, V82, P254, DOI 10.1159/000083476; Di Somma C, 2002, CLIN ENDOCRINOL, V56, P153, DOI 10.1046/j.0300-0664.2001.01454.doc.x; Drake WM, 1998, J CLIN ENDOCR METAB, V83, P3542, DOI 10.1210/jc.83.10.3542; Erickson D, 2004, CLIN ENDOCRINOL, V60, P413, DOI 10.1111/j.1365-2265.2004.01990.x; Estrada J, 2001, J CLIN ENDOCR METAB, V86, P5695, DOI 10.1210/jc.86.12.5695; Estrada J, 1997, NEW ENGL J MED, V336, P172, DOI 10.1056/NEJM199701163360303; ETXABE J, 1994, CLIN ENDOCRINOL, V40, P479, DOI 10.1111/j.1365-2265.1994.tb02486.x; Faggiano A, 2003, J CLIN ENDOCR METAB, V88, P2076, DOI 10.1210/jc.2002-021494; Faggiano A, 2003, J CLIN ENDOCR METAB, V88, P2527, DOI 10.1210/jc.2002-021558; Findling JW, 2004, J CLIN ENDOCR METAB, V89, P6005, DOI 10.1210/jc.2004-1378; Findling JW, 2004, J CLIN ENDOCR METAB, V89, P1222, DOI 10.1210/jc.2003-030207; Forget H, 2002, PSYCHONEUROENDOCRINO, V27, P367, DOI 10.1016/S0306-4530(01)00059-2; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Gafni RI, 2000, J PEDIATR-US, V137, P30, DOI 10.1067/mpd.2000.106226; Gibson S, 1996, J CLIN ENDOCR METAB, V81, P497, DOI 10.1210/jc.81.2.497; Gicquel C, 2001, CANCER RES, V61, P6762; Giordano TJ, 2003, AM J PATHOL, V162, P521, DOI 10.1016/S0002-9440(10)63846-1; Giraldi FP, 2003, J CLIN ENDOCR METAB, V88, P1554, DOI 10.1210/jc.2002-021518; Granberg D, 2003, CLIN ENDOCRINOL, V59, P793, DOI 10.1046/j.1365-2265.2003.01931.x; Greening JE, 2005, HORM RES, V64, P140, DOI 10.1159/000088587; Groussin L, 2002, J CLIN ENDOCR METAB, V87, P1980, DOI 10.1210/jc.87.5.1980; Groussin L, 2002, J CLIN ENDOCR METAB, V87, P4324, DOI 10.1210/jc.2002-020592; Hague K, 2000, SURG NEUROL, V53, P77, DOI 10.1016/S0090-3019(99)00159-7; HALL WA, 1994, ANN INTERN MED, V120, P817, DOI 10.7326/0003-4819-120-10-199405150-00001; Hammer GD, 2004, J CLIN ENDOCR METAB, V89, P6348, DOI 10.1210/jc.2003-032180; Heald AH, 2004, CLIN ENDOCRINOL, V61, P458, DOI 10.1111/j.1365-2265.2004.02118.x; Heaney AP, 2002, NAT MED, V8, P1281, DOI 10.1038/nm784; Heaney AP, 2003, J CLIN INVEST, V111, P1381, DOI 10.1172/JCI200316575; Hofland LJ, 2005, EUR J ENDOCRINOL, V152, P645, DOI 10.1530/eje.1.01876; HORIBA N, 1995, J CLIN ENDOCR METAB, V80, P2336, DOI 10.1210/jc.80.8.2336; Iacobone M, 2005, J ENDOCRINOL INVEST, V28, P327; Ilias I, 2004, J CLIN ENDOCR METAB, V89, P3795, DOI 10.1210/jc.2003-032014; Ilias I, 2005, J CLIN ENDOCR METAB, V90, P4955, DOI 10.1210/jc.2004-2527; Invitti C, 1999, J CLIN ENDOCR METAB, V84, P440, DOI 10.1210/jc.84.2.440; Isidori AM, 2003, J CLIN ENDOCR METAB, V88, P5299, DOI 10.1210/jc.2003-030510; Isidori AM, 2006, J CLIN ENDOCR METAB, V91, P371, DOI 10.1210/jc.2005-1542; JENKINS PJ, 1995, J CLIN ENDOCR METAB, V80, P165, DOI 10.1210/jc.80.1.165; Jordan S, 2000, EUR J ENDOCRINOL, V143, pR1, DOI 10.1530/eje.0.143R001; KAYE TB, 1990, ANN INTERN MED, V112, P434, DOI 10.7326/0003-4819-76-3-112-6-434; Kelly PA, 2002, J CLIN ENDOCR METAB, V87, P5465, DOI 10.1210/jc.2002-020299; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Korbonits M, 2001, J CLIN ENDOCR METAB, V86, P2728, DOI 10.1210/jc.86.6.2728; Krakoff J, 2001, J CLIN ENDOCR METAB, V86, P4104, DOI 10.1210/jc.86.9.4104; Lacroix A, 2001, ENDOCR REV, V22, P75, DOI 10.1210/er.22.1.75; LACROIX A, 1992, NEW ENGL J MED, V327, P974, DOI 10.1056/NEJM199210013271402; Lacroix A, 1999, NEW ENGL J MED, V341, P1577, DOI 10.1056/NEJM199911183412104; Lacroix A, 1997, J CLIN ENDOCR METAB, V82, P2414, DOI 10.1210/jc.82.8.2414; Lacroix A, 1997, NEW ENGL J MED, V337, P1429, DOI 10.1056/NEJM199711133372004; LAMBERTS SWJ, 1994, J CLIN ENDOCR METAB, V78, P17, DOI 10.1210/jc.78.1.17; Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970; Lebrethon MC, 1998, J CLIN ENDOCR METAB, V83, P4514, DOI 10.1210/jc.83.12.4514; Leibowitz G, 1996, CLIN ENDOCRINOL, V44, P717, DOI 10.1046/j.1365-2265.1996.737558.x; Lidhar K, 1999, J CLIN ENDOCR METAB, V84, P3823, DOI 10.1210/jc.84.10.3823; Lienhardt A, 2001, J CLIN ENDOCR METAB, V86, P5711, DOI 10.1210/jc.86.12.5711; Lindholm J, 2001, J CLIN ENDOCR METAB, V86, P117, DOI 10.1210/jc.86.1.117; Lindsay JR, 2006, J CLIN ENDOCR METAB, V91, P447, DOI 10.1210/jc.2005-1058; Lindsay JR, 2005, ENDOCR REV, V26, P775, DOI 10.1210/er.2004-0025; Lindsay JR, 2005, J CLIN ENDOCR METAB, V90, P3077, DOI 10.1210/jc.2004-2361; Lindsay JR, 2005, ENDOCRIN METAB CLIN, V34, P403, DOI 10.1016/j.ecl.2005.01.009; Liu CY, 2004, CLIN ENDOCRINOL, V61, P478, DOI 10.1111/j.1365-2265.2004.02115.x; Locatelli M, 2005, J CLIN ENDOCR METAB, V90, P5478, DOI 10.1210/jc.2004-2436; MAGIAKOU MA, 1994, NEW ENGL J MED, V331, P629, DOI 10.1056/NEJM199409083311002; Mancini T, 2004, CLIN ENDOCRINOL, V61, P768, DOI 10.1111/j.1365-2265.2004.02168.x; Martinelli CE, 1999, CLIN ENDOCRINOL, V51, P67, DOI 10.1046/j.1365-2265.1999.00749.x; Mazzuco TL, 2006, ENDOCRINOLOGY, V147, P782, DOI 10.1210/en.2005-0921; MCNALLY PG, 1993, CLIN ENDOCRINOL, V39, P681, DOI 10.1111/j.1365-2265.1993.tb02427.x; Meyer A, 2004, DIGEST SURG, V21, P363, DOI 10.1159/000081353; Minetto M, 2004, OSTEOPOROSIS INT, V15, P855, DOI 10.1007/s00198-004-1616-3; Mircescu H, 2000, J CLIN ENDOCR METAB, V85, P3531, DOI 10.1210/jc.85.10.3531; Moro M, 2000, J CLIN ENDOCR METAB, V85, P3569, DOI 10.1210/jc.85.10.3569; Morris DG, 2003, J CLIN ENDOCR METAB, V88, P6080, DOI 10.1210/jc.2002-022048; MUNIR A, 2005, SOC END 194 ANN M 20; N'Diaye N, 1998, J CLIN ENDOCR METAB, V83, P2781, DOI 10.1210/jc.83.8.2781; Newell-Price J, 2002, J CLIN ENDOCR METAB, V87, P1640, DOI 10.1210/jc.87.4.1640; Newell-Price J, 1998, ENDOCR REV, V19, P647, DOI 10.1210/er.19.5.647; Newell-Price J, 2001, MOL ENDOCRINOL, V15, P338, DOI 10.1210/me.15.2.338; NEWELLPRICE J, 1995, CLIN ENDOCRINOL, V43, P545, DOI 10.1111/j.1365-2265.1995.tb02918.x; NewellPrice J, 1997, CLIN ENDOCRINOL, V47, P173; NewellPrice J, 1997, J CLIN ENDOCR METAB, V82, P176, DOI 10.1210/jc.82.1.176; NIEMAN LK, 1993, J CLIN ENDOCR METAB, V77, P1308, DOI 10.1210/jc.77.5.1308; NIEMAN LK, 2001, CUSHINGS SYNDROME; Nieman Lynnette K, 2002, Pituitary, V5, P77, DOI 10.1023/A:1022308429992; O'Boyle CJ, 2003, SURG ENDOSC, V17, P1905, DOI 10.1007/s00464-002-8878-7; Ohmori N, 2003, ENDOCR J, V50, P1, DOI 10.1507/endocrj.50.1; OLDFIELD EH, 1991, NEW ENGL J MED, V325, P897, DOI 10.1056/NEJM199109263251301; Orlefors H, 2005, J CLIN ENDOCR METAB, V90, P3392, DOI 10.1210/jc.2004-1938; Pacak K, 2004, J CLIN ENDOCR METAB, V89, P2214, DOI 10.1210/jc.2003-031812; Paez-Pereda M, 2001, J CLIN INVEST, V108, P1123, DOI 10.1172/JCI11098; Papanicolaou DA, 2002, J CLIN ENDOCR METAB, V87, P4515, DOI 10.1210/jc.2002-020534; Papanicolaou DA, 1998, J CLIN ENDOCR METAB, V83, P1163, DOI 10.1210/jc.83.4.1163; Pascual-Le Tallec L, 2002, J CLIN ENDOCR METAB, V87, P5015, DOI 10.1210/jc.2002-020598; Patronas N, 2003, J CLIN ENDOCR METAB, V88, P1565, DOI 10.1210/jc.2002-021438; Pereira AM, 2003, J CLIN ENDOCR METAB, V88, P5858, DOI 10.1210/jc.2003-030751; PERRAUDIN V, 1995, J CLIN ENDOCR METAB, V80, P2661, DOI 10.1210/jc.80.9.2661; PHLIPPONNEAU M, 1994, J CLIN ENDOCR METAB, V78, P20, DOI 10.1210/jc.78.1.20; Picon A, 1999, ONCOGENE, V18, P2627, DOI 10.1038/sj.onc.1202635; PICON A, 1995, J MOL ENDOCRINOL, V15, P187, DOI 10.1677/jme.0.0150187; Pimentel FR, 2005, J ENDOCRINOL INVEST, V28, P502, DOI 10.1007/BF03347237; Pivonello R, 2005, NEW ENGL J MED, V352, P2457, DOI 10.1056/NEJM200506093522322; Pivonello R, 2004, J CLIN ENDOCR METAB, V89, P2452, DOI 10.1210/jc.2003-030837; Porpiglia F, 2004, J ENDOCRINOL INVEST, V27, P654, DOI 10.1007/BF03347498; Poulose BK, 2005, SURG ENDOSC, V19, P379, DOI 10.1007/s00464-004-8914-x; Pralong FP, 1999, J CLIN ENDOCR METAB, V84, P3817, DOI 10.1210/jc.84.10.3817; Putignano P, 2003, J CLIN ENDOCR METAB, V88, P4153, DOI 10.1210/jc.2003-030312; Putignano P, 1998, HORM METAB RES, V30, P389, DOI 10.1055/s-2007-978903; Raff H, 1998, J CLIN ENDOCR METAB, V83, P2681, DOI 10.1210/jc.83.8.2681; Raffin-Sanson ML, 2003, EUR J ENDOCRINOL, V149, P79, DOI 10.1530/eje.0.1490079; RAY DW, 1995, J CLIN ENDOCR METAB, V80, P2430, DOI 10.1210/jc.80.8.2430; Rees DA, 2002, CLIN ENDOCRINOL, V56, P541, DOI 10.1046/j.1365-2265.2002.01511.x; Reimondo G, 2005, EUR J ENDOCRINOL, V153, P803, DOI 10.1530/eje.1.02042; Reimondo G, 2003, CLIN ENDOCRINOL, V58, P718, DOI 10.1046/j.1365-2265.2003.01776.x; REZNIK Y, 1992, NEW ENGL J MED, V327, P981, DOI 10.1056/NEJM199210013271403; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Rockall AG, 2004, RADIOGRAPHICS, V24, P435, DOI 10.1148/rg.242035092; Rockall AG, 2003, EUR J ENDOCRINOL, V149, P561, DOI 10.1530/eje.0.1490561; Rockall AG, 2003, EUR J ENDOCRINOL, V149, P543, DOI 10.1530/eje.0.1490543; Rollin GAFS, 2004, J CLIN ENDOCR METAB, V89, P1131, DOI 10.1210/jc.2003-031170; Salenave S, 2004, J CLIN ENDOCR METAB, V89, P3371, DOI 10.1210/jc.2003-031908; Savage MO, 2001, HORM RES, V56, P19, DOI 10.1159/000048129; Savage MO, 2001, HORM RES, V55, P24, DOI 10.1159/000063459; Scommegna S, 2005, J ENDOCRINOL INVEST, V28, P231, DOI 10.1007/BF03345378; Sheehan JM, 2000, J NEUROSURG, V93, P738, DOI 10.3171/jns.2000.93.5.0738; Sheehan JM, 2000, NEUROSURGERY, V47, P33, DOI 10.1097/00006123-200007000-00008; Shimon I, 2002, NEUROSURGERY, V51, P57, DOI 10.1097/00006123-200207000-00008; Sohaib SA, 1999, AM J ROENTGENOL, V172, P997, DOI 10.2214/ajr.172.4.10587135; STEWART PM, 1995, J CLIN ENDOCR METAB, V80, P3617, DOI 10.1210/jc.80.12.3617; Storr HL, 2004, CLIN ENDOCRINOL, V61, P553, DOI 10.1111/j.1365-2265.2004.02124.x; Storr HL, 2004, J CLIN ENDOCR METAB, V89, P3818, DOI 10.1210/jc.2003-031531; Storr HL, 2003, J CLIN ENDOCR METAB, V88, P34, DOI 10.1210/jc.2002-021032; Stratakis CA, 2001, J CLIN ENDOCR METAB, V86, P4041, DOI 10.1210/jc.86.9.4041; Suri D, 2005, J CLIN ENDOCR METAB, V90, P1340, DOI 10.1210/jc.2004-1746; Swearingen B, 2004, J CLIN ENDOCR METAB, V89, P3752, DOI 10.1210/jc.2003-032249; Swords FM, 2005, J CLIN ENDOCR METAB, V90, P3009, DOI 10.1210/jc.2004-0946; Swords FM, 2002, MOL ENDOCRINOL, V16, P2746, DOI 10.1210/me.2002-0099; Terzolo M, 2004, J CLIN ENDOCR METAB, V89, P3745, DOI 10.1210/jc.2004-0079; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; TRAINER PJ, 1993, CLIN ENDOCRINOL, V38, P73, DOI 10.1111/j.1365-2265.1993.tb00975.x; Trilck M, 2005, EXP CLIN ENDOCR DIAB, V113, P225, DOI 10.1055/s-2005-837667; Tsagarakis S, 2003, J CLIN ENDOCR METAB, V88, P4754, DOI 10.1210/jc.2003-030525; Tsagarakis S, 2002, J CLIN ENDOCR METAB, V87, P1646, DOI 10.1210/jc.87.4.1646; Tsagarakis S, 2000, CLIN ENDOCRINOL, V52, P355, DOI 10.1046/j.1365-2265.2000.00943.x; Valero R, 2004, EUR J ENDOCRINOL, V151, P727, DOI 10.1530/eje.0.1510727; van Aken MO, 2005, J CLIN ENDOCR METAB, V90, P3279, DOI 10.1210/jc.2004-1375; VANCE ML, 2005, END SOC 87 ANN M JUN; Vella A, 2001, J CLIN ENDOCR METAB, V86, P1596, DOI 10.1210/jc.86.4.1596; Viardot A, 2005, J CLIN ENDOCR METAB, V90, P5730, DOI 10.1210/jc.2004-2264; WAJCHENBERG BL, 1994, ENDOCR REV, V15, P752, DOI 10.1210/er.15.6.752; WEBER A, 1995, CLIN ENDOCRINOL, V43, P19, DOI 10.1111/j.1365-2265.1995.tb01888.x; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Willenberg HS, 1998, NEW ENGL J MED, V339, P27, DOI 10.1056/NEJM199807023390105; Woo YS, 2005, J CLIN ENDOCR METAB, V90, P4963, DOI 10.1210/jc.2005-0070; Yaneva M, 2004, J CLIN ENDOCR METAB, V89, P3345, DOI 10.1210/jc.2003-031790; YANOVSKI JA, 1993, JAMA-J AM MED ASSOC, V269, P2232, DOI 10.1001/jama.269.17.2232; YANOVSKI JA, 1994, ENDOCRIN METAB CLIN, V23, P487, DOI 10.1016/S0889-8529(18)30080-X; Yanovski JA, 1998, J CLIN ENDOCR METAB, V83, P348, DOI 10.1210/jc.83.2.348; Yap LB, 2002, CLIN ENDOCRINOL, V56, P25, DOI 10.1046/j.0300-0664.2001.01444.x; Zacharieva S, 2005, HORM METAB RES, V37, P36, DOI 10.1055/s-2005-861031; Zeh HJ, 2003, ANN SURG ONCOL, V10, P1012, DOI 10.1245/ASO.2003.06.001	198	883	925	5	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1605	1617		10.1016/S0140-6736(06)68699-6	http://dx.doi.org/10.1016/S0140-6736(06)68699-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698415				2022-12-28	WOS:000237598000033
J	Singer, PA; Guyatt, GH				Singer, PA; Guyatt, GH			Deeper lessons from the CMAJ debacle	LANCET			English	Editorial Material									Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada; McMaster Univ, Hamilton, ON, Canada	University of Toronto; McMaster University	Singer, PA (corresponding author), Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada.	peter.singer@utoronto.ca						BRANSWELL H, 2006, CMA PRESIDENT SAYS C; COLLINSNAKAI RL, 2006, COMMUNICATION   0317; FRKETICH J, 2006, HAMILTON SPECTA 0331; Kassirer JP, 2006, CAN MED ASSOC J, V174, P945, DOI 10.1503/cmaj.060290; Shuchman M, 2006, NEW ENGL J MED, V354, P1337, DOI 10.1056/NEJMp068056; 2006, CMAJ EDITORIAL GOVER; 2006, LANCET, V367, P704	7	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2006	367	9522					1551	1553		10.1016/S0140-6736(06)68667-4	http://dx.doi.org/10.1016/S0140-6736(06)68667-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698392				2022-12-28	WOS:000237598000004
J	Arita, I; Nakane, M; Fenner, F				Arita, I; Nakane, M; Fenner, F			Public health - Is polio eradication realistic?	SCIENCE			English	Editorial Material									Agcy Cooperat Int Hlth, Kumamoto 8620901, Japan; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Arita, I (corresponding author), Agcy Cooperat Int Hlth, Kumamoto 8620901, Japan.	arita@acih.com						ARITA I, 1998, ERADICATION INFECT D, pCH15; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; FENNER F, 1982, REV INFECT DIS, V4, P916; Heymann DL, 2005, NATURE, V434, P699, DOI 10.1038/434699a; Jezek Z, 1988, HUMAN MONKEYPOX; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Nomoto A, 2002, NAT IMMUNOL, V3, P205, DOI 10.1038/ni0302-205; SACHS JD, 2005, END POVERTY EC POSSI, pCH10; *WHO, 2005, WHOVB0505; *WHO UNICEF, 2005, WHOVB0505 UNICEF IVB; World Bank, 2004, WORLD DEV IND 2004; 2005, ECONOMIST       0122, P67	14	66	71	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					852	854		10.1126/science.1124959	http://dx.doi.org/10.1126/science.1124959			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041JQ	16690846				2022-12-28	WOS:000237452900025
J	Jacobsen, RS; Andersen, KN; Borel, PI; Fage-Pedersen, J; Frandsen, LH; Hansen, O; Kristensen, M; Lavrinenko, AV; Moulin, G; Ou, H; Peucheret, C; Zsigri, B; Bjarklev, A				Jacobsen, RS; Andersen, KN; Borel, PI; Fage-Pedersen, J; Frandsen, LH; Hansen, O; Kristensen, M; Lavrinenko, AV; Moulin, G; Ou, H; Peucheret, C; Zsigri, B; Bjarklev, A			Strained silicon as a new electro-optic material	NATURE			English	Article							WAVE-GUIDES; OPTICAL MODULATOR; PHOTONIC CRYSTALS	For decades, silicon has been the material of choice for mass fabrication of electronics. This is in contrast to photonics, where passive optical components in silicon have only recently been realized(1,2). The slow progress within silicon optoelectronics, where electronic and optical functionalities can be integrated into monolithic components based on the versatile silicon platform, is due to the limited active optical properties of silicon(3). Recently, however, a continuous-wave Raman silicon laser was demonstrated(4); if an effective modulator could also be realized in silicon, data processing and transmission could potentially be performed by all-silicon electronic and optical components. Here we have discovered that a significant linear electro-optic effect is induced in silicon by breaking the crystal symmetry. The symmetry is broken by depositing a straining layer on top of a silicon waveguide, and the induced nonlinear coefficient, chi(2) approximate to 15 pm V-1, makes it possible to realize a silicon electro-optic modulator. The strain-induced linear electro-optic effect may be used to remove a bottleneck(5) in modern computers by replacing the electronic bus with a much faster optical alternative.	Tech Univ Denmark, Nano DTU, Dept Commun Opt & Mat, COM DTU, DK-2800 Lyngby, Denmark; Tech Univ Denmark, Nano DTU, MIC Dept Micro & Nanotechnol, CINF, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Jacobsen, RS (corresponding author), Tech Univ Denmark, Nano DTU, Dept Commun Opt & Mat, COM DTU, Bldg 345V, DK-2800 Lyngby, Denmark.	Rune@com.dtu.dk	Frandsen, Lars Hagedorn/ABE-3741-2021; Ou, Haiyan/D-8728-2011; Lavrinenko, Andrei V/E-4099-2015; Frandsen, Lars Hagedorn/B-4535-2012; Kristensen, Martin/R-5257-2018; Hansen, Ole/C-4480-2011; Peucheret, Christophe/C-1359-2011	Ou, Haiyan/0000-0002-0538-8230; Frandsen, Lars Hagedorn/0000-0001-9145-2210; Kristensen, Martin/0000-0003-4133-1693; Hansen, Ole/0000-0002-6090-8323; Peucheret, Christophe/0000-0002-1655-9293; Lavrinenko, Andrei/0000-0001-8853-2033				Bogaerts W, 2005, J LIGHTWAVE TECHNOL, V23, P401, DOI 10.1109/JLT.2004.834471; BUTCHER PN, 1990, ELEMENTS NONLINEAR O, V5; Gibbs WW, 2004, SCI AM, V291, P96, DOI 10.1038/scientificamerican1104-96; Jacobsen RS, 2005, OPT EXPRESS, V13, P7861, DOI 10.1364/OPEX.13.007861; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; Kondo J, 2002, J LIGHTWAVE TECHNOL, V20, P2110, DOI 10.1109/JLT.2002.806766; Krauss TF, 1996, NATURE, V383, P699, DOI 10.1038/383699a0; Lee KK, 2001, OPT LETT, V26, P1888, DOI 10.1364/OL.26.001888; Li GL, 2003, J LIGHTWAVE TECHNOL, V21, P2010, DOI 10.1109/JLT.2003.815654; Liao L, 2005, OPT EXPRESS, V13, P3129, DOI 10.1364/OPEX.13.003129; Liao Weijun, 2004, OPT LASER TECHNOL, V36, P603; Liu AS, 2004, NATURE, V427, P615, DOI 10.1038/nature02310; MADOU MJ, 2002, FUNDAMENTALS MICROFA, P299; MYERS RA, 1991, OPT LETT, V16, P1732, DOI 10.1364/OL.16.001732; Nakamura H, 2004, OPT EXPRESS, V12, P6606, DOI 10.1364/OPEX.12.006606; Notomi M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.253902; Pavesi L., 2004, SILICON PHOTONICS; RASMUSSEN FE, 2003, THESIS TU DENMARK; Reed GT, 2005, MATER TODAY, V8, P40, DOI 10.1016/S1369-7021(04)00678-9; Rong HS, 2005, NATURE, V433, P725, DOI 10.1038/nature03346; Soljacic M, 2004, NAT MATER, V3, P211, DOI 10.1038/nmat1097; SOREF RA, 1987, IEEE J QUANTUM ELECT, V23, P123, DOI 10.1109/JQE.1987.1073206; SOREF RA, 1993, P IEEE, V81, P1687, DOI 10.1109/5.248958; Trinh PD, 1997, IEEE PHOTONIC TECH L, V9, P940, DOI 10.1109/68.593358; Vlasov YA, 2004, OPT EXPRESS, V12, P1622, DOI 10.1364/OPEX.12.001622	26	523	541	5	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					199	202		10.1038/nature04706	http://dx.doi.org/10.1038/nature04706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688172				2022-12-28	WOS:000237418800041
J	Crickmore, MA; Mann, RS				Crickmore, Michael A.; Mann, Richard S.			Hox control of organ size by regulation of morphogen production and mobility	SCIENCE			English	Article							WING IMAGINAL DISC; DPP MORPHOGEN; CELL-PROLIFERATION; GRADIENT FORMATION; DARWINS FINCHES; DROSOPHILA; GENES; PATTERN; HEDGEHOG; RECEPTORS	Selector genes modify developmental pathways to sculpt animal body parts. Although body parts differ in size, the ways in which selector genes create size differences are unknown. We have studied how the Drosophila Hox gene Ultrabithorax (Ubx) limits the size of the haltere, which, by the end of larval development, has similar to fivefold fewer cells than the wing. We find that Ubx controls haltere size by restricting both the transcription and the mobility of the morphogen Decapentaplegic (Dpp). Ubx restricts Dpp's distribution in the haltere by increasing the amounts of the Dpp receptor, thickveins. Because morphogens control tissue growth in many contexts, these findings provide a potentially general mechanism for how selector genes modify organ sizes.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, HHSC 1104,701 W 168th St, New York, NY 10032 USA.	rsm10@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058575, R01GM054510] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054510, R01 GM054510-12, R01 GM054510-13, R01 GM058575, R01 GM054510-14] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke R, 1996, DEVELOPMENT, V122, P2261; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; CASANOVA J, 1993, NATURE, V362, P152, DOI 10.1038/362152a0; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cohen S. M., 1993, DEV DROSOPHILA MELAN, P747; Day SJ, 2000, DEVELOPMENT, V127, P2977; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Funakoshi Y, 2001, DEVELOPMENT, V128, P67; Grant PR, 2005, CURR BIOL, V15, pR614, DOI 10.1016/j.cub.2005.08.014; GUILLEN I, 1995, DEVELOPMENT, V121, P3447; Haerry TE, 1998, DEVELOPMENT, V125, P3977; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MARTIN PF, 1982, J EXP ZOOL, V222, P97, DOI 10.1002/jez.1402220113; MORATA G, 1976, ROUX ARCH DEV BIOL, V179, P125, DOI 10.1007/BF00848298; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Roch F, 2000, DEVELOPMENT, V127, P97; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; SEKELSKY JJ, 1995, GENETICS, V139, P1347; TABATA T, 1995, DEVELOPMENT, V121, P3359; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; ZECCA M, 1995, DEVELOPMENT, V121, P2265	39	120	120	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					63	68		10.1126/science.1128650	http://dx.doi.org/10.1126/science.1128650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16741075	Green Accepted			2022-12-28	WOS:000238850200029
J	Iglesias, C; Nixon, J; Cranny, G; Nelson, EA; Hawkins, K; Phillips, A; Torgerson, D; Mason, S; Cullum, N				Iglesias, Cynthia; Nixon, Jane; Cranny, Gillian; Nelson, E. Andrea; Hawkins, Kim; Phillips, Angela; Torgerson, David; Mason, Su; Cullum, Nicky		PRESSURE Trial Grp	Pressure relieving support surfaces (PRESSURE) trial: Cost effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; ULCERS	Objective To assess tire cost effectiveness of alternating pressure mattresses compared with alternating pressure overlays for the prevention of pressure ulcers in patients admitted to hospital. Design Cost effectiveness analysis carried out alongside the pressure relieving support surfaces (PRESSURE) trial; a multicentre UK based pragmatic randomised controlled trial. Setting 11 hospitals in six UK NHS trusts. Participants Intention to treat population comprising 1971 participants. Main outcome measures Kaplan Meier estimates of restricted mean time to development of pressure ulcers and total costs for treatment in hospital. Results Alternating pressure mattresses were associated with lower overall costs (283.6 pound per patient on average, 95% confidence interval -377.59 pound to. 976.79) pound mainly due to reduced length of stay in hospital, and greater benefits (a delay in time to ulceration of 10.64 days on average, - 24.40 to 3.09). The differences in health benefits and total costs for hospital stay between alternating pressure mattresses and alternating pressure overlays were not statistically significant; however, a cost effectiveness acceptability curve indicated that on average alternating pressure mattresses compared with alternating pressure overlays were associated with air 80% probability of being cost saving. Conclusion Alternating pressure mattresses for the prevention of pressure ulcers are more likely to be cost effective and are more acceptable to patients than alternating pressure overlays.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Univ Leeds, Clin Trials Res Unit, Leeds LS2 9JT, W Yorkshire, England; Univ York, Ctr Rev & Disseminat, York YO10 5DD, N Yorkshire, England; Univ Leeds, Sch Healthcare Studies, Leeds LS2 9JT, W Yorkshire, England	University of York - UK; University of Leeds; University of York - UK; University of Leeds	Cullum, N (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	nac2@york.ac.uk	Cullum, Nicky A/F-2438-2011; Cullum, Nicky/AAT-5888-2020; Torgerson, David/L-4566-2019; Nelson, Andrea/K-2733-2012	Cullum, Nicky A/0000-0003-2631-123X; Cullum, Nicky/0000-0003-2631-123X; Torgerson, David/0000-0002-1667-4275; Nelson, Andrea/0000-0001-6741-3078; Cocks, Kim/0000-0003-2595-708X	National Institute for Health Research [97/06/14] Funding Source: researchfish; Department of Health [97/06/14] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		ALLMAN RM, 1995, JAMA-J AM MED ASSOC, V273, P865, DOI 10.1001/jama.273.11.865; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Baumgarten M, 2003, WOUND REPAIR REGEN, V11, P96, DOI 10.1046/j.1524-475X.2003.11204.x; Bennett G, 2004, AGE AGEING, V33, P230, DOI 10.1093/ageing/afh086; Brandeis G H, 2001, Adv Skin Wound Care, V14, P245, DOI 10.1097/00129334-200109000-00011; Brandeis GH, 2001, ADV SKIN WOUND CARE, V14, P245; BRANDEIS GH, 2001, ADV SKIN WOUND CARE, V14, P248; *CIPFA, 2003, HLTH SERV DAT 2003; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fleurence RL, 2005, INT J TECHNOL ASSESS, V21, P334, DOI 10.1017/S0266462305050440; Lindsey JK, 1998, STAT MED, V17, P59, DOI 10.1002/(SICI)1097-0258(19980115)17:1<59::AID-SIM733>3.3.CO;2-Z; Mihaylova B, 2005, LANCET, V365, P1779, DOI 10.1016/S0140-6736(05)63014-0; *NAT I HLTH CLIN E, 2003, NICE CLIN GUIDELINE, V7; *NICE, 2004, TECHN GUID MAN SPONS; *NIH CLIN EXC, 2003, NICE CLIN GUIDELINE, V7; NIXON J, 2006, IN PRESS HLTH TECHNO; NIXON J, 2006, BMJ, V332; Nixon J, 2006, BMJ-BRIT MED J, V332, P1413, DOI 10.1136/bmj.38849.478299.7C; Reed RL, 2003, GERONTOLOGY, V49, P255, DOI 10.1159/000070407; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197	21	45	48	3	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1416	1418B		10.1136/bmj.38850.711435.7C	http://dx.doi.org/10.1136/bmj.38850.711435.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16740528	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000238550800024
J	Hayes, JM				Hayes, JM			The pathway of carbon in nature	SCIENCE			English	Editorial Material							SEDIMENTS		Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Hayes, JM (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	jhayes@whoi.edu						ADAM P, 1993, GEOCHIM COSMOCHIM AC, V57, P3395, DOI 10.1016/0016-7037(93)90547-A; BEIER JA, 1991, NATURE, V351, P642, DOI 10.1038/351642a0; CALVIN M, 1969, CHEM EVOLUTION; EGLINTON G, 1991, PHILOS T ROY SOC B, V333, P315, DOI 10.1098/rstb.1991.0081; GAGOSIAN RB, 1978, GEOCHIM COSMOCHIM AC, V42, P1091, DOI 10.1016/0016-7037(78)90106-0; Hebting Y, 2006, SCIENCE, V312, P1627, DOI 10.1126/science.1126372; KOHNEN MEL, 1989, NATURE, V341, P640, DOI 10.1038/341640a0; MAKENZIE AS, 1982, SCIENCE, V217, P491; REPETA DJ, 1988, ORG GEOCHEM, V12, P469, DOI 10.1016/0146-6380(88)90156-8	9	5	7	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1605	1606		10.1126/science.1128966	http://dx.doi.org/10.1126/science.1128966			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16690818	Green Submitted			2022-12-28	WOS:000238288600030
J	Pisitkun, P; Deane, JA; Difilippantonio, MJ; Tarasenko, T; Satterthwaite, AB; Bolland, S				Pisitkun, Prapaporn; Deane, Jonathan A.; Difilippantonio, Michael J.; Tarasenko, Tatyana; Satterthwaite, Anne B.; Bolland, Silvia			Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication	SCIENCE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; DEFICIENT MICE; YAA MUTATION; Y-CHROMOSOME; DISEASE; ENGAGEMENT; BTK	Antibodies against nuclear self-antigens are characteristic of systemic autoimmunity, although mechanisms promoting their generation and selection are unclear. Here, we report that B cells containing the Y-linked autoimmune accelerator (Yaa) locus are intrinsically biased toward nucleolar antigens because of increased expression of TLR7, a single-stranded RNA-binding innate immune receptor. The TLR7 gene is duplicated in Yaa mice because of a 4-Megabase expansion of the pseudoautosomal region. These results reveal high divergence in mouse Y chromosomes and represent a good example of gene copy number qualitatively altering a polygenic disease manifestation.	NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; NCI, Sect Canc Genom, Henet Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; Univ Texas SW, Dept Internal Med, Dallas, TX 75390 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Southwestern Medical Center Dallas	Bolland, S (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	sbolland@nih.gov	Difilippantonio, Michael/AAF-2839-2021	Difilippantonio, Michael/0000-0002-4676-7034	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000912] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amano H, 2003, J IMMUNOL, V170, P2293, DOI 10.4049/jimmunol.170.5.2293; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Dal Zotto L, 1998, HUM MOL GENET, V7, P489, DOI 10.1093/hmg/7.3.489; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; FOSSATI L, 1995, EUR J IMMUNOL, V25, P166, DOI 10.1002/eji.1830250128; IZUI S, 1995, IMMUNOL REV, V144, P137, DOI 10.1111/j.1600-065X.1995.tb00068.x; IZUI S, 1988, EUR J IMMUNOL, V18, P911, DOI 10.1002/eji.1830180612; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leslie D, 2001, J CLIN INVEST, V108, P1417, DOI 10.1172/JCI14452; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mary C, 2000, J IMMUNOL, V165, P2987, DOI 10.4049/jimmunol.165.6.2987; Moll T, 2005, J IMMUNOL, V174, P702, DOI 10.4049/jimmunol.174.2.702; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; MURPHY ED, 1979, ARTHRITIS RHEUM, V22, P1188, DOI 10.1002/art.1780221105; Nadeau JH, 2006, NATURE, V439, P798, DOI 10.1038/439798a; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; WEINER ES, 1991, ARTHRITIS RHEUM, V34, P68, DOI 10.1002/art.1780340111	23	639	667	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1669	1672		10.1126/science.1124978	http://dx.doi.org/10.1126/science.1124978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16709748				2022-12-28	WOS:000238288600051
J	Abe, S; Mukai, T; Hirata, N; Barnouin-Jha, OS; Cheng, AF; Demura, H; Gaskell, RW; Hashimoto, T; Hiraoka, K; Honda, T; Kubota, T; Matsuoka, M; Mizuno, T; Nakamura, R; Scheeres, DJ; Yoshikawa, M				Abe, Shinsuke; Mukai, Tadashi; Hirata, Naru; Barnouin-Jha, Olivier S.; Cheng, Andrew F.; Demura, Hirohide; Gaskell, Robert W.; Hashimoto, Tatsuaki; Hiraoka, Kensuke; Honda, Takayuki; Kubota, Takashi; Matsuoka, Masatoshi; Mizuno, Takahide; Nakamura, Ryosuke; Scheeres, Daniel J.; Yoshikawa, Makoto			Mass and local topography measurements of Itokawa by Hayabusa	SCIENCE			English	Article							LASER ALTIMETRY; NEAR-SHOEMAKER; MUSES-C; 433-EROS; MISSION; SURFACE; TARGET; SHAPE; LIDAR	The ranging instrument aboard the Hayabusa spacecraft measured the surface topography of asteroid 25143 Itokawa and its mass. A typical rough area is similar in roughness to debris located on the interior wall of a large crater on asteroid 433 Eros, which suggests a surface structure on Itokawa similar to crater ejecta on Eros. The mass of Itokawa was estimated as (3.58 +/- 0.18) x 1010 kilograms, implying a bulk density of (1.95 +/- 0.14) grams per cubic centimeter for a volume of ( 1.84 +/- 0.09) x 10(7) cubic meters and a bulk porosity of similar to 40%, which is similar to that of angular sands, when assuming an LL ( low iron chondritic) meteorite composition. Combined with surface observations, these data indicate that Itokawa is the first subkilometer-sized small asteroid showing a rubble-pile body rather than a solid monolithic asteroid.	Kobe Univ, Grad Sch Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Aizu, Dept Comp Software, Fukushima 9658580, Japan; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; JAXA, ISAS, Kanagawa 2298510, Japan; NEC Aerosp Syst Co Ltd, Tokyo 1818551, Japan; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA	Kobe University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Aizu; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institute of Advanced Industrial Science & Technology (AIST); University of Michigan System; University of Michigan	Abe, S (corresponding author), Kobe Univ, Grad Sch Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan.	avell@kobe-u.ac.jp	Barnouin, Olivier S/I-7475-2015; Kubota, Takashi/GPP-4986-2022	Barnouin, Olivier S/0000-0002-3578-7750; Abe, Shinsuke/0000-0002-6247-4979; SCHEERES, DANIEL/0000-0003-0558-3842; Hirata, Naru/0000-0002-2435-604X				Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Asphaug E, 2002, ASTEROIDS, P463; Benz W, 1999, ICARUS, V142, P5, DOI 10.1006/icar.1999.6204; Britt D. T., 2002, ASTEROIDS 3, VIII, P485; Cheng AF, 2002, ICARUS, V155, P51, DOI 10.1006/icar.2001.6750; Cheng AF, 2001, SCIENCE, V292, P488, DOI 10.1126/science.1058330; Demura H, 2006, SCIENCE, V312, P1347, DOI 10.1126/science.1126574; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Hashimoto T, 2003, ACTA ASTRONAUT, V52, P381, DOI 10.1016/S0094-5765(02)00178-9; Michel P, 2006, ASTRON ASTROPHYS, V449, P817, DOI 10.1051/0004-6361:20054319; Mukai T, 2006, ADV SPACE RES-SERIES, V37, P138, DOI 10.1016/j.asr.2005.07.086; Mukai T, 2002, ADV SPACE RES, V29, P1231, DOI 10.1016/S0273-1177(02)00141-2; Okada T, 2006, SCIENCE, V312, P1338, DOI 10.1126/science.1125731; Pravec P., 2002, ASTEROIDS 3, P113; RICHARDSON DC, 2002, ASTEROIDS, V3, P501; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; Werner R. A., 1996, Celestial Mechanics and Dynamical Astronomy, V65, P313, DOI 10.1007/BF00053511; Zuber MT, 2000, SCIENCE, V289, P2097, DOI 10.1126/science.289.5487.2097	18	160	160	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1344	1347		10.1126/science.1126272	http://dx.doi.org/10.1126/science.1126272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741111				2022-12-28	WOS:000237961600044
J	Imai, KS; Levine, M; Satoh, N; Satou, Y				Imai, Kaoru S.; Levine, Michael; Satoh, Nori; Satou, Yutaka			Regulatory blueprint for a chordate embryo	SCIENCE			English	Article							CIONA-SAVIGNYI EMBRYOS; INTESTINALIS EMBRYOS; ASCIDIAN EMBRYOS; BETA-CATENIN; GENE; NOTOCHORD; DIFFERENTIATION; EXPRESSION; INDUCTION; MUSCLE	Ciona is an emerging model system for elucidating gene networks in development. Comprehensive in situ hybridization assays have identified 76 regulatory genes with localized expression patterns in the early embryo, at the time when naive blastomeres are determined to follow specific cell fates. Systematic gene disruption assays provided more than 3000 combinations of gene expression profiles in mutant backgrounds. Deduced gene circuit diagrams describing the formation of larval tissues were computationally visualized. These diagrams constitute a blueprint for the Ciona embryo and provide a foundation for understanding the evolutionary origins of the chordate body plan.	Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; Univ Calif Berkeley, Dept Mol & Cellular Biol, Div Genet & Dev, Berkeley, CA 94720 USA	Kyoto University; University of California System; University of California Berkeley	Satou, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.	yutaka@ascidian.zool.kyoto-u.ac.jp	Satou, Yutaka/AAJ-2194-2021; Satou, Yutaka/K-7131-2012; Satoh, Nori/C-4123-2009	Satou, Yutaka/0000-0001-5193-0708; Satou, Yutaka/0000-0001-5193-0708; Satoh, Nori/0000-0002-4480-3572; Levine, Michael/0000-0001-7629-0081; Imai, Kaoru/0000-0001-9113-6074				Agius E, 2000, DEVELOPMENT, V127, P1173; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; Corbo JC, 1997, DEVELOPMENT, V124, P2335; Corbo JC, 1997, DEVELOPMENT, V124, P589; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Fujiwara S, 1998, DEVELOPMENT, V125, P2511; Hudson C, 2005, DEVELOPMENT, V132, P1199, DOI 10.1242/dev.01688; Imai K, 2000, DEVELOPMENT, V127, P3009; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Imai KS, 2002, DEVELOPMENT, V129, P2723; Imai KS, 2002, DEVELOPMENT, V129, P1729; Imai KS, 2002, DEVELOPMENT, V129, P3441; Katsube KI, 2005, INT J DEV BIOL, V49, P369, DOI 10.1387/ijdb.041950kk; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Nishida H, 2001, NATURE, V409, P724, DOI 10.1038/35055568; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Satou Y, 2002, DEV GENES EVOL, V212, P87, DOI 10.1007/s00427-002-0218-3; Satou Y, 2001, DEVELOPMENT, V128, P3559; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Takahashi H, 1999, GENE DEV, V13, P1519, DOI 10.1101/gad.13.12.1519; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Tokuoka M, 2005, DEV BIOL, V288, P387, DOI 10.1016/j.ydbio.2005.09.018; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Yagi K, 2005, DEV BIOL, V282, P535, DOI 10.1016/j.ydbio.2005.03.029; Yamada L, 2003, DEVELOPMENT, V130, P6485, DOI 10.1242/dev.00847	27	280	285	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1183	1187		10.1126/science.1123404	http://dx.doi.org/10.1126/science.1123404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728634				2022-12-28	WOS:000237957400045
J	Fischer, SA; Graham, MB; Kuehnert, MJ; Kotton, CN; Srinivasan, A; Marty, FM; Comer, JA; Guarner, J; Paddock, CD; DeMeo, DL; Shieh, WJ; Erickson, BR; Bandy, U; DeMaria, A; Davis, JP; Delmonico, FL; Pavlin, B; Likos, A; Vincent, MJ; Sealy, TK; Goldsmith, CS; Jernigan, DB; Rollin, PE; Packard, MM; Patel, M; Rowland, C; Helfand, RF; Nichol, ST; Fishman, JA; Ksiazek, T; Zaki, SR				Fischer, Staci A.; Graham, Mary Beth; Kuehnert, Matthew J.; Kotton, Camille N.; Srinivasan, Arjun; Marty, Francisco M.; Comer, James A.; Guarner, Jeannette; Paddock, Christopher D.; DeMeo, Dawn L.; Shieh, Wun-Ju; Erickson, Bobbie R.; Bandy, Utpala; DeMaria, Alfred, Jr.; Davis, Jeffrey P.; Delmonico, Francis L.; Pavlin, Boris; Likos, Anna; Vincent, Martin J.; Sealy, Tara K.; Goldsmith, Cynthia S.; Jernigan, Daniel B.; Rollin, Pierre E.; Packard, Michelle M.; Patel, Mitesh; Rowland, Courtney; Helfand, Rita F.; Nichol, Stuart T.; Fishman, Jay A.; Ksiazek, Thomas; Zaki, Sherif R.		LCMV Transplant Recipient	Transmission of lymphocytic choriomeningitis virus by organ transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTION; OUTBREAK; HAMSTERS; MENINGOENCEPHALITIS; MENINGITIS; DIAGNOSIS; PERSONNEL; DONOR	Background: In December 2003 and April 2005, signs and symptoms suggestive of infection developed in two groups of recipients of solid-organ transplants. Each cluster was investigated because diagnostic evaluations were unrevealing, and in each a common donor was recognized. Methods: We examined clinical specimens from the two donors and eight recipients, using viral culture, electron microscopy, serologic testing, molecular analysis, and histopathological examination with immunohistochemical staining to identify a cause. Epidemiologic investigations, including interviews, environmental assessments, and medical-record reviews, were performed to characterize clinical courses and to determine the cause of the illnesses. Results: Laboratory testing revealed lymphocytic choriomeningitis virus (LCMV) in all the recipients, with a single, unique strain of LCMV identified in each cluster. In both investigations, LCMV could not be detected in the organ donor. In the 2005 cluster, the donor had had contact in her home with a pet hamster infected with an LCMV strain identical to that detected in the organ recipients; no source of LCMV infection was found in the 2003 cluster. The transplant recipients had abdominal pain, altered mental status, thrombocytopenia, elevated aminotransferase levels, coagulopathy, graft dysfunction, and either fever or leukocytosis within three weeks after transplantation. Diarrhea, peri-incisional rash, renal failure, and seizures were variably present. Seven of the eight recipients died, 9 to 76 days after transplantation. One recipient, who received ribavirin and reduced levels of immunosuppressive therapy, survived. Conclusions: We document two clusters of LCMV infection transmitted through organ transplantation.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Rhode Isl Hosp, Providence, RI USA; Brown Med Sch, Providence, RI USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Rhode Isl Dept Hlth, Providence, RI 02908 USA; Massachusetts Dept Publ Hlth, Boston, MA USA; Wisconsin Dept Hlth & Family Serv, Madison, WI USA; New England Organ Bank Inc, Newton, MA USA	Centers for Disease Control & Prevention - USA; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Medical College of Wisconsin; Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Massachusetts Department of Public Health	Kuehnert, MJ (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop A-30, Atlanta, GA 30333 USA.	mkuehnert@cdc.gov	Guarner, Jeannette/B-8273-2013	Guarner, Jeannette/0000-0001-5610-3541; Kotton, Camille/0000-0001-7320-2234; Helfand, Rita/0000-0001-5734-0258; Rollin, Pierre/0000-0002-4608-2641; Marty, Francisco/0000-0002-3708-8734				ARMSTRONG D, 1969, J AMER MED ASSOC, V209, P265, DOI 10.1001/jama.209.2.265; Barton LL, 2002, AM J OBSTET GYNECOL, V187, P1715, DOI 10.1067/mob.2002.126297; BAUM SG, 1966, NEW ENGL J MED, V274, P934, DOI 10.1056/NEJM196604282741704; Bechtel RT, 1997, ARCH OPHTHALMOL-CHIC, V115, P680, DOI 10.1001/archopht.1997.01100150682027; Besselsen DG, 2003, COMPARATIVE MED, V53, P65; BIGGAR RJ, 1975, JAMA-J AM MED ASSOC, V232, P494, DOI 10.1001/jama.232.5.494; BIGGAR RJ, 1975, LANCET, V1, P856; BIGGAR RJ, 1977, J AM VET MED ASSOC, V171, P829; BOWEN GS, 1975, AM J EPIDEMIOL, V102, P233, DOI 10.1093/oxfordjournals.aje.a112152; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P210; CHILDS JE, 1991, AM J TROP MED HYG, V44, P117, DOI 10.4269/ajtmh.1991.44.117; DEIBEL R, 1976, J CLIN MICROBIOL, V3, P397; DYKEWICZ CA, 1992, JAMA-J AM MED ASSOC, V267, P1349; DYKEWICZ CA, 1992, JAMA-J AM MED ASSOC, V268, P874; Enders G, 1999, PEDIATR INFECT DIS J, V18, P652, DOI 10.1097/00006454-199907000-00020; ENRIA DA, 1994, ANTIVIR RES, V23, P23, DOI 10.1016/0166-3542(94)90030-2; GREGG MB, 1975, B WORLD HEALTH ORGAN, V52, P549; HIRSCH MS, 1974, NEW ENGL J MED, V291, P610, DOI 10.1056/NEJM197409192911206; HORTON J, 1971, CANCER RES, V31, P1066; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; LEHMANNGRUBE F, 1979, J MED VIROL, V4, P125, DOI 10.1002/jmv.1890040207; LEWIS JM, 1961, NEW ENGL J MED, V265, P776, DOI 10.1056/NEJM196110192651604; MAETZ HM, 1976, AM J PUBLIC HEALTH, V66, P1082, DOI 10.2105/AJPH.66.11.1082; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; *OPTN SRTR, 2004, 2004 ANN REP; Paddock C, 2005, MODERN PATHOL, V18, p263A; Park JY, 1997, J MED VIROL, V51, P107, DOI 10.1002/(SICI)1096-9071(199702)51:2&lt;107::AID-JMV4&gt;3.0.CO;2-B; PETERS CJ, 1995, EXOTIC VIRAL INFECT, P227; Puglielli MT, 1999, NAT MED, V5, P1370; ROEBROEK RMJA, 1994, CLIN NEUROL NEUROSUR, V96, P178, DOI 10.1016/0303-8467(94)90058-2; Rousseau MC, 1997, EUR J EPIDEMIOL, V13, P817, DOI 10.1023/A:1007434521082; SKINNER HH, 1979, J SMALL ANIM PRACT, V20, P145, DOI 10.1111/j.1748-5827.1979.tb07023.x; Srinivasan A, 2005, NEW ENGL J MED, V352, P1103, DOI 10.1056/NEJMoa043018; STEPHENSEN CB, 1992, J MED VIROL, V38, P27, DOI 10.1002/jmv.1890380107; Teperman L. W., 2005, Morbidity and Mortality Weekly Report, V54, P1021; *UN NETW ORG SHAR, 2004, ACQ IMM DEF SYNDR AI; VANZEE BE, 1975, AM J MED, V58, P803, DOI 10.1016/0002-9343(75)90635-X; WARKEL RL, 1973, NEUROLOGY, V23, P198, DOI 10.1212/WNL.23.2.198; Wright R, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e9; ZAKI SR, 1995, AM J PATHOL, V146, P552; 2005, MMWR MORB MORTAL WHL, V54, P537	42	346	355	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2235	2249		10.1056/NEJMoa053240	http://dx.doi.org/10.1056/NEJMoa053240			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045RF	16723615	Bronze			2022-12-28	WOS:000237758900005
J	Moss, RL; Dimmitt, RA; Barnhart, DC; Sylvester, KG; Brown, RL; Powell, DM; Islam, S; Langer, JC; Sato, TT; Brandt, ML; Lee, H; Blakely, ML; Lazar, EL; Hirschl, RB; Kenney, BD; Hackam, DJ; Zelterman, D; Silverman, BL				Moss, R. Lawrence; Dimmitt, Reed A.; Barnhart, Douglas C.; Sylvester, Karl G.; Brown, Rebeccah L.; Powell, David M.; Islam, Saleem; Langer, Jacob C.; Sato, Thomas T.; Brandt, Mary L.; Lee, Hanmin; Blakely, Martin L.; Lazar, Eric L.; Hirschl, Ronald B.; Kenney, Brian D.; Hackam, David J.; Zelterman, Daniel; Silverman, Bonnie L.			Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BIRTH-WEIGHT; ISOLATED INTESTINAL PERFORATION; DEFINITIVE TREATMENT; LOCAL-ANESTHESIA; INFANTS; MANAGEMENT; OUTCOMES; GROWTH; EXPERIENCE	Background: Perforated necrotizing enterocolitis is a major cause of morbidity and mortality in premature infants, and the optimal treatment is uncertain. We designed this multicenter randomized trial to compare outcomes of primary peritoneal drainage with laparotomy and bowel resection in preterm infants with perforated necrotizing enterocolitis. Methods: We randomly assigned 117 preterm infants (delivered before 34 weeks of gestation) with birth weights less than 1500 g and perforated necrotizing enterocolitis at 15 pediatric centers to undergo primary peritoneal drainage or laparotomy with bowel resection. Postoperative care was standardized. The primary outcome was survival at 90 days postoperatively. Secondary outcomes included dependence on parenteral nutrition 90 days postoperatively and length of hospital stay. Results: At 90 days postoperatively, 19 of 55 infants assigned to primary peritoneal drainage had died (34.5 percent), as compared with 22 of 62 infants assigned to laparotomy (35.5 percent, P=0.92). The percentages of infants who depended on total parenteral nutrition were 17 of 36 (47.2 percent) in the peritoneal-drainage group and 16 of 40 (40.0 percent) in the laparotomy group (P=0.53). The mean (+/-SD) length of hospitalization for the 76 infants who were alive 90 days after operation was similar in the primary peritoneal-drainage and laparotomy groups (126+/-58 days and 116+/-56 days, respectively; P=0.43). Subgroup analyses stratified according to the presence or absence of radiographic evidence of extensive necrotizing enterocolitis (pneumatosis intestinalis), gestational age of less than 25 weeks, and serum pH less than 7.30 at presentation showed no significant advantage of either treatment in any group. Conclusions: The type of operation performed for perforated necrotizing enterocolitis does not influence survival or other clinically important early outcomes in preterm infants.	Yale Univ, Sch Med, Pediat Surg Sect, New Haven, CT 06520 USA; Univ Alabama Birmingham, Div Neonatol, Birmingham, AL USA; Univ Alabama Birmingham, Div Pediat Surg, Birmingham, AL USA; Stanford Univ, Sch Med, Div Pediat Surg, Stanford, CA 94305 USA; Cincinnati Childrens Hosp & Med Ctr, Div Pediat Surg, Cincinnati, OH USA; Childrens Natl Med Ctr, Div Pediat Surg, Washington, DC 20010 USA; Univ Mississippi, Sch Med, Div Pediat Surg, Jackson, MS 39216 USA; Univ Toronto, Fac Med, Div Pediat Surg, Toronto, ON, Canada; Childrens Hosp Wisconsin, Div Pediat Surg, Milwaukee, WI 53201 USA; Texas Childrens Hosp, Div Pediat Surg, Houston, TX 77030 USA; Univ Calif San Francisco, Sch Med, Div Pediat Surg, San Francisco, CA USA; Univ Tennessee, Ctr Hlth Sci, Div Pediat Surg, Memphis, TN 38163 USA; Morristown Mem Hosp, Div Pediat Surg, Morristown, NJ USA; Univ Michigan, Sch Med, Div Pediat Surg, Ann Arbor, MI USA; Columbus Childrens Hosp, Div Pediat Surg, Columbus, OH USA; Univ Pittsburgh, Sch Med, Div Pediat Surg, Pittsburgh, PA USA; Yale Univ, Sch Epidemiol & Publ Hlth, Div Pediat Surg, New Haven, CT USA	Yale University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Stanford University; Cincinnati Children's Hospital Medical Center; Children's National Health System; University of Mississippi; University of Toronto; Children's Hospital of Wisconsin; Baylor College of Medicine; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Health Science Center; Atlantic Health System; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University	Moss, RL (corresponding author), Yale Univ, Sch Med, Pediat Surg Sect, 333 Cedar St,FMB 132,POB 208062, New Haven, CT 06520 USA.	larry.moss@yale.edu	Islam, Saleem/AAE-5987-2020; Islam, Saleem/Y-2091-2019	kenney, brian/0000-0001-7491-1999; Hackam, David/0000-0001-5195-8807; Sylvester, Karl G./0000-0002-8559-0155; Zelterman, Daniel/0000-0003-0711-8688; Sato, Thomas/0000-0001-6547-6403	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD042480, R01HD038462] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD 38462, K24 HD 42480] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Azarow KS, 1997, PEDIATR SURG INT, V12, P137, DOI 10.1007/BF01349981; Blakely ML, 2006, PEDIATRICS, V117, pE680, DOI 10.1542/peds.2005-1273; Blakely ML, 2005, ANN SURG, V241, P984, DOI 10.1097/01.sla.0000164181.67862.7f; Calisti A, 2004, Minerva Pediatr, V56, P335; Cass DL, 2000, J PEDIATR SURG, V35, P1531, DOI 10.1053/jpsu.2000.18299; CHEU HW, 1988, J PEDIATR SURG, V23, P557, DOI 10.1016/S0022-3468(88)80368-3; Dimmitt RA, 2000, J PEDIATR SURG, V35, P856, DOI 10.1053/jpsu.2000.6865; EHRLICH PF, 2003, AM SURGEON, V67, P752; EIN SH, 1990, J PEDIATR SURG, V25, P1034, DOI 10.1016/0022-3468(90)90213-S; EIN SH, 1977, J PEDIATR SURG, V12, P963, DOI 10.1016/0022-3468(77)90607-8; Gollin G, 2003, J PEDIATR SURG, V38, P1814, DOI 10.1016/j.jpedsurg.2003.08.029; Harrison MR, 1997, J PEDIATR SURG, V32, P1637, DOI 10.1016/S0022-3468(97)90472-3; Harrison MR, 2003, NEW ENGL J MED, V349, P1916, DOI 10.1056/NEJMoa035005; Henry Marion C W, 2005, Semin Pediatr Surg, V14, P181, DOI 10.1053/j.sempedsurg.2005.05.007; Henry MCW, 2004, SEMIN PERINATOL, V28, P221, DOI 10.1053/j.semperi.2004.03.010; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Lessin MS, 1998, J PEDIATR SURG, V33, P370, DOI 10.1016/S0022-3468(98)90465-1; Michel JL, 2004, EUR J PEDIATR SURG, V14, P85, DOI 10.1055/s-2004-815853; MORGAN LJ, 1994, J PEDIATR SURG, V29, P310, DOI 10.1016/0022-3468(94)90338-7; Moss RL, 2001, J PEDIATR SURG, V36, P1210, DOI 10.1053/jpsu.2001.25764; Noble HGS, 2001, AM J SURG, V181, P416, DOI 10.1016/S0002-9610(01)00612-2; Rangel SJ, 2005, PRINCIPLES PRACTICE, P1251; Salhab Walid A, 2004, J Perinatol, V24, P534, DOI 10.1038/sj.jp.7211165; Snyder CL, 1997, J PEDIATR SURG, V32, P434, DOI 10.1016/S0022-3468(97)90599-6; Sonntag J, 2000, ACTA PAEDIATR, V89, P528, DOI 10.1080/080352500750027790; STEVENSON DK, 1980, PEDIATRICS, V66, P925; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; TAKAMATSU H, 1992, J PEDIATR SURG, V27, P741, DOI 10.1016/S0022-3468(05)80105-8	28	229	244	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2225	2234		10.1056/NEJMoa054605	http://dx.doi.org/10.1056/NEJMoa054605			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045RF	16723614				2022-12-28	WOS:000237758900004
J	Sebolt-Leopold, JS; English, JM				Sebolt-Leopold, Judith S.; English, Jessie M.			Mechanisms of drug inhibition of signalling molecules	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; CELL LUNG-CANCER; ANTITUMOR-ACTIVITY; FACTOR RECEPTOR; MAP KINASE; PROTEIN-KINASES; IN-VITRO; RESISTANCE; GENE	The emergence of tumour-specific, molecularly targeted agents signifies a paradigm shift in cancer therapy, with less reliance on drugs that non-discriminately kill tumour and host cells. Although the diversity of targets giving rise to this new generation of anticancer drugs has expanded, many challenges persist in the design of effective treatment regimens. The complex interplay of signal-transduction pathways further complicates the customization of cancer treatments to target single mechanisms. However, despite uncertainty over precise or dominant mechanisms of action, especially for compounds targeting multiple gene products, emerging agents are producing significant therapeutic advances against a broad range of human cancers.	Pfizer Global Res & Dev, Michigan Labs, Ann Arbor, MI 48105 USA; Pfizer Res Technol Ctr, Cambridge, MA 02139 USA	Pfizer; Pfizer	Sebolt-Leopold, JS (corresponding author), Pfizer Global Res & Dev, Michigan Labs, 2800 Plymouth Rd, Ann Arbor, MI 48105 USA.	judith.leopold@pfizer.com						Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cherrington JM, 2000, ADV CANCER RES, V79, P1, DOI 10.1016/S0065-230X(00)79001-4; Cohen MH, 2003, ONCOLOGIST, V8, P303, DOI 10.1634/theoncologist.8-4-303; COLLETT MS, 1978, P NATL ACAD SCI USA, V75, P2021, DOI 10.1073/pnas.75.4.2021; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Downward J, 2006, NATURE, V439, P274, DOI 10.1038/439274a; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Ebos JML, 2004, MOL CANCER RES, V2, P315; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gilliland DG, 2002, CURR OPIN HEMATOL, V9, P274, DOI 10.1097/00062752-200207000-00003; Goldberg Richard M, 2005, Nat Rev Drug Discov, VSuppl, pS10; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; Hainsworth JD, 2005, J CLIN ONCOL, V23, P7889, DOI 10.1200/JCO.2005.01.8234; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Herbst RS, 2005, J CLIN ONCOL, V23, P2544, DOI 10.1200/JCO.2005.02.477; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Johnson JR, 2005, CLIN CANCER RES, V11, P6414, DOI 10.1158/1078-0432.CCR-05-0790; Kerr DJ, 2004, NAT CLIN PRACT ONCOL, V1, P39, DOI 10.1038/ncponc0026; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kostich M, 2002, GENOME BIOL, V3; LEVINSON AD, 1978, CELL, V15, P561, DOI 10.1016/0092-8674(78)90024-7; Lyons JF, 2001, ENDOCR-RELAT CANCER, V8, P219, DOI 10.1677/erc.0.0080219; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Nelson MH, 2006, ANN PHARMACOTHER, V40, P261, DOI 10.1345/aph.1G387; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Satyamoorthy K, 2003, CANCER RES, V63, P756; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Sheinerman FB, 2005, J MOL BIOL, V352, P1134, DOI 10.1016/j.jmb.2005.07.074; Shimizu A, 1999, CANCER RES, V59, P3719; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wallace EM, 2005, CURR TOP MED CHEM, V5, P215, DOI 10.2174/1568026053507723; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang YL, 2005, NEOPLASIA, V7, P336, DOI 10.1593/neo.04532; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; Wilhelm S, 2002, CURR PHARM DESIGN, V8, P2255, DOI 10.2174/1381612023393026; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yeon CH, 2005, INVEST NEW DRUG, V23, P391, DOI 10.1007/s10637-005-2899-8	58	251	269	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					457	462		10.1038/nature04874	http://dx.doi.org/10.1038/nature04874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724058				2022-12-28	WOS:000237778900039
J	Fuyuno, I				Fuyuno, I			Japanese spin-offs face struggle for survival	NATURE			English	News Item																			0	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2006	441	7091					280	281		10.1038/441280a	http://dx.doi.org/10.1038/441280a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710389				2022-12-28	WOS:000237593200016
J	Schmidt, B; Roberts, RS; Davis, P; Doyle, LW; Barrington, KJ; Ohlsson, A; Solimano, A; Tin, W				Schmidt, B; Roberts, RS; Davis, P; Doyle, LW; Barrington, KJ; Ohlsson, A; Solimano, A; Tin, W		Caffeine Apnea Prematurity Trial G	Caffeine therapy for apnea of prematurity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; METABOLIC-RATE; BRONCHOPULMONARY DYSPLASIA; METHYLXANTHINE THERAPY; OXYGEN-CONSUMPTION; IDIOPATHIC APNEA; THEOPHYLLINE; AMINOPHYLLINE; RETINOPATHY; POPULATION	Background: Methylxanthines reduce the frequency of apnea of prematurity and the need for mechanical ventilation during the first seven days of therapy. It is uncertain whether methylxanthines have other short- and long-term benefits or risks in infants with very low birth weight. Methods: We randomly assigned 2006 infants with birth weights of 500 to 1250 g during the first 10 days of life to receive either caffeine or placebo, until drug therapy for apnea of prematurity was no longer needed. We evaluated the short-term outcomes before the first discharge home. Results: Of 963 infants who were assigned to caffeine and who remained alive at a postmenstrual age of 36 weeks, 350 (36 percent) received supplemental oxygen, as did 447 of the 954 infants (47 percent) assigned to placebo (adjusted odds ratio, 0.63; 95 percent confidence interval, 0.52 to 0.76; P < 0.001). Positive airway pressure was discontinued one week earlier in the infants assigned to caffeine (median postmenstrual age, 31.0 weeks; interquartile range, 29.4 to 33.0) than in the infants in the placebo group (median postmenstrual age, 32.0 weeks; interquartile range, 30.3 to 34.0; P < 0.001). Caffeine reduced weight gain temporarily. The mean difference in weight gain between the group receiving caffeine and the group receiving placebo was greatest after two weeks (mean difference, -23 g; 95 percent confidence interval, -32 to -13; P < 0.001). The rates of death, ultrasonographic signs of brain injury, and necrotizing enterocolitis did not differ significantly between the two groups. Conclusions: Caffeine therapy for apnea of prematurity reduces the rate of bronchopulmonary dysplasia in infants with very low birth weight. (ClinicalTrials.gov number, NCT00182312.).	McMaster Univ, Med Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; James Cook Univ, Dept Pediat, Middlesbrough, Cleveland, England	McMaster University; McMaster University; University of Melbourne; McGill University; University of Toronto; University of British Columbia	Schmidt, B (corresponding author), McMaster Univ, Med Ctr, Dept Clin Epidemiol & Biostat, Rm 3N11E,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	schmidt@mcmaster.ca	Herlenius, Eric/B-7260-2008; Pfister, Riccardo E/N-7082-2014; Doyle, Lex/AAJ-5205-2021	Herlenius, Eric/0000-0002-6859-0620; Pfister, Riccardo E/0000-0002-7395-0512; Doyle, Lex/0000-0002-7667-7312; Barrington, Keith/0000-0001-9669-5094; Ringstedt, Thomas/0000-0003-0294-9351				Allen MC, 2002, MENT RETARD DEV D R, V8, P221, DOI 10.1002/mrdd.10044; Ambalavanan N, 2003, CLIN PERINATOL, V30, P305, DOI 10.1016/S0095-5108(03)00021-6; BARRINGTON K, 1991, PEDIATR RES, V29, P372, DOI 10.1038/pr.1991.72500; Bauer J, 2001, PEDIATRICS, V107, P660, DOI 10.1542/peds.107.4.660; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Carnielli VP, 2000, ARCH DIS CHILD-FETAL, V83, pF39, DOI 10.1136/fn.83.1.F39; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Eichenwald EC, 1997, PEDIATRICS, V100, P354, DOI 10.1542/peds.100.3.354; Erenberg A, 2000, PHARMACOTHERAPY, V20, P644, DOI 10.1592/phco.20.7.644.35167; *FOOD DRUG ADM, 2000, 020793 CAFCIT NDA FO; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; GARNER A, 1984, PEDIATRICS, V74, P127; GERHARDT T, 1979, PEDIATRICS, V63, P537; Henderson-Smart D, 2004, COCHRANE DB SYST REV, V4; Henderson-Smart DJ, 2001, COCHRANE DB SYST REV, V3; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Martin Richard J, 2004, Paediatr Respir Rev, V5 Suppl A, pS377, DOI 10.1016/S1526-0542(04)90067-X; Millar David, 2004, Semin Neonatol, V9, P239, DOI 10.1016/j.siny.2003.11.008; MILSAP RL, 1980, CLIN PHARMACOL THER, V28, P536, DOI 10.1038/clpt.1980.199; Pesce AJ, 1998, CLIN CHEM, V44, P1124; Pinto-Martin JA, 2001, PEDIATRICS, V108, P238; PINTOMARTIN JA, 1995, PEDIATRICS, V95, P249; Schmidt B, 2005, BIOL NEONATE, V88, P208, DOI 10.1159/000087584; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schmidt B, 1999, J PEDIATR-US, V135, P526, DOI 10.1016/S0022-3476(99)70180-0; SHENNAN AT, 1988, PEDIATRICS, V82, P527; THURSTON JH, 1978, SCIENCE, V201, P649, DOI 10.1126/science.209541; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; 1987, ARCH OPHTHALMOL, V105, P1498; 1987, ARCH OPHTHALMOL, V105, P906	30	669	717	2	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2112	2121		10.1056/NEJMoa054065	http://dx.doi.org/10.1056/NEJMoa054065			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707748	Green Published			2022-12-28	WOS:000237575400005
J	Douglas, L; Akil, M				Douglas, L; Akil, M			Sodium in soluble paracetamol may be linked to raised blood pressure	BRITISH MEDICAL JOURNAL			English	Article									Royal Hallamshire Hosp, Dept Rheumatol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Douglas, L (corresponding author), Royal Hallamshire Hosp, Dept Rheumatol, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	lucydouglas@doctors.org.uk						Chobanian AV, 2000, HYPERTENSION, V35, P858, DOI 10.1161/01.HYP.35.4.858; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; Scientific Advisory Committee on Nutrition, 2003, SALT HLTH; World Health Organization, 2004, GLOB STRAT DIET PHYS	4	10	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 13	2006	332	7550					1133	1133		10.1136/bmj.332.7550.1133	http://dx.doi.org/10.1136/bmj.332.7550.1133			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16690670	Green Published, Bronze			2022-12-28	WOS:000237682700021
J	Callahan, CM; Boustani, MA; Unverzagt, FW; Austrom, MG; Damush, TM; Perkins, AJ; Fultz, BA; Hui, SL; Counsell, SR; Hendrie, HC				Callahan, CM; Boustani, MA; Unverzagt, FW; Austrom, MG; Damush, TM; Perkins, AJ; Fultz, BA; Hui, SL; Counsell, SR; Hendrie, HC			Effectiveness of collaborative care for older adults with Alzheimer disease in primary care - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED-TRIAL; MILD COGNITIVE IMPAIRMENT; NURSING-HOME PLACEMENT; NEUROPSYCHIATRIC SYMPTOMS; CLINICAL-TRIALS; DOUBLE-BLIND; DEMENTIA; DEPRESSION; DONEPEZIL; EFFICACY	Context Most older adults with dementia will be cared for by primary care physicians, but the primary care practice environment presents important challenges to providing quality care. Objective To test the effectiveness of a collaborative care model to improve the quality of care for patients with Alzheimer disease. Design, Setting, and Patients Controlled clinical trial of 153 older adults with Alzheimer disease and their caregivers who were randomized by physician to receive collaborative care management (n= 84) or augmented usual care ( n= 69) at primary care practices within 2 US university-affiliated health care systems from January 2002 through August 2004. Eligible patients ( identified via screening or medical record) met diagnostic criteria for Alzheimer disease and had a self-identified caregiver. Intervention Intervention patients received 1 year of care management by an interdisciplinary team led by an advanced practice nurse working with the patient's family caregiver and integrated within primary care. The team used standard protocols to initiate treatment and identify, monitor, and treat behavioral and psychological symptoms of dementia, stressing nonpharmacological management. Main Outcome Measures Neuropsychiatric Inventory (NPI) administered at baseline and at 6, 12, and 18 months. Secondary outcomes included the Cornell Scale for Depression in Dementia (CSDD), cognition, activities of daily living, resource use, and caregiver's depression severity. Results Initiated by caregivers' reports, 89% of intervention patients triggered at least 1 protocol for behavioral and psychological symptoms of dementia with a mean of 4 per patient from a total of 8 possible protocols. Intervention patients were more likely to receive cholinesterase inhibitors (79.8% vs 55.1%; P=. 002) and antidepressants (45.2% vs 27.5%; P=. 03). Intervention patients had significantly fewer behavioral and psychological symptoms of dementia as measured by the total NPI score at 12 months ( mean difference, - 5.6; P=. 01) and at 18 months ( mean difference, - 5.4; P=. 01). Intervention caregivers also reported significant improvements in distress as measured by the caregiver NPI at 12 months; at 18 months, caregivers showed improvement in depression as measured by the Patient Health Questionnaire-9. No group differences were found on the CSDD, cognition, activities of daily living, or on rates of hospitalization, nursing home placement, or death. Conclusions Collaborative care for the treatment of Alzheimer disease resulted in significant improvement in the quality of care and in behavioral and psychological symptoms of dementia among primary care patients and their caregivers. These improvements were achieved without significantly increasing the use of antipsychotics or sedative-hypnotics.	Indiana Univ, Sch Med, Ctr Aging Res, Regenstrief Inst Inc, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; Richard L Roudebush VA Med Ctr, Ctr Excellence Evidence Based Practices, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Callahan, CM (corresponding author), Indiana Univ, Sch Med, Ctr Aging Res, Regenstrief Inst Inc, 1050 Wishard Blvd,RG 6th, Indianapolis, IN 46202 USA.	ccallaha@iupui.edu		Perkins, Anthony/0000-0003-1278-5397	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010884] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS10884] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Aparasu RR, 1998, CLIN THER, V20, P603, DOI 10.1016/S0149-2918(98)80069-6; Association A. P., 1992, DIAGN STAT MAN MENT; Austrom MG, 2004, GERONTOLOGIST, V44, P548, DOI 10.1093/geront/44.4.548; Ballard C, 2000, J AFFECT DISORDERS, V59, P97, DOI 10.1016/S0165-0327(99)00057-9; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; CALLAHAN CM, 1995, ANN INTERN MED, V122, P422, DOI 10.7326/0003-4819-122-6-199503150-00004; Clarfield AM, 2003, ARCH INTERN MED, V163, P2219, DOI 10.1001/archinte.163.18.2219; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Clegg A, 2001, Health Technol Assess, V5, P1; COHENMANSFIELD J, 1995, J GERIATR PSYCH NEUR, V8, P52; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Ferris SH, 1997, ALZ DIS ASSOC DIS, V11, pS1; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Ganguli M, 2004, J AM GERIATR SOC, V52, P1668, DOI 10.1111/j.1532-5415.2004.52459.x; Hall KS, 2000, INT J GERIATR PSYCH, V15, P521, DOI 10.1002/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F; Haupt M, 2000, DEMENT GERIATR COGN, V11, P147, DOI 10.1159/000017228; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; Kmietowicz Z, 2005, BRIT MED J, V330, P495, DOI 10.1136/bmj.330.7490.495-a; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Landefeld CS, 2003, ANN INTERN MED, V139, P609, DOI 10.7326/0003-4819-139-7-200310070-00034; LOGSDON RG, 1995, J AM GERIATR SOC, V43, P150, DOI 10.1111/j.1532-5415.1995.tb06380.x; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Matthews HP, 2000, INT J GERIATR PSYCH, V15, P713, DOI 10.1002/1099-1166(200008)15:8<713::AID-GPS187>3.0.CO;2-I; MITTELMAN MS, 1995, GERONTOLOGIST, V35, P792, DOI 10.1093/geront/35.6.792; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Murman DL, 2005, PHARMACOECONOMICS, V23, P227, DOI 10.2165/00019053-200523030-00004; OKAGAKI JF, 1994, NEUROLOGY, V44, P2203; Perkins AJ, 2004, J CLIN EPIDEMIOL, V57, P1040, DOI 10.1016/j.jclinepi.2004.03.002; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Reuben DB, 2003, J AM GERIATR SOC, V51, P1787, DOI 10.1046/j.1532-5415.2003.51565.x; RIMMER J, 1997, EXERCISE MANAGEMENT; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Sachs GA, 2004, J GEN INTERN MED, V19, P1057, DOI 10.1111/j.1525-1497.2004.30329.x; Seltzer B, 2004, ARCH NEUROL-CHICAGO, V61, P1852, DOI 10.1001/archneur.61.12.1852; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; Trinh NH, 2003, JAMA-J AM MED ASSOC, V289, P210, DOI 10.1001/jama.289.2.210; [U.S. Department of Health and Human Services Public Health Service Agency], 1996, AHCPR PUBL; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; *US DEP VET AFF U, 1997, DEM ID ASS GUID PRIM; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G	50	528	532	6	69	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2006	295	18					2148	2157		10.1001/jama.295.18.2148	http://dx.doi.org/10.1001/jama.295.18.2148			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040OW	16684985				2022-12-28	WOS:000237391300024
J	Colvin, L; Forbes, K; Fallon, M				Colvin, L; Forbes, K; Fallon, M			ABC of palliative care - Difficult pain	BRITISH MEDICAL JOURNAL			English	Editorial Material									Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; Bristol Oncol Ctr, Bristol, Avon, England; Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh; Bristol Haematology & Oncology Centre; University of Edinburgh	Colvin, L (corresponding author), Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland.			Colvin, Lesley/0000-0002-1563-8600; Fallon, Marie/0000-0001-9214-0091				Hanks GW, 2001, BRIT J CANCER, V84, P587, DOI 10.1054/bjoc.2001.1680; Mercadante S, 2002, CANCER, V94, P832, DOI 10.1002/cncr.10249; World Health Organization, 1996, CANC PAIN REL	3	22	23	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 6	2006	332	7549					1081	1083		10.1136/bmj.332.7549.1081	http://dx.doi.org/10.1136/bmj.332.7549.1081			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16675817	Green Published, Green Submitted			2022-12-28	WOS:000237518400023
J	Boudreau, N; Weaver, V				Boudreau, Nancy; Weaver, Valerie			Forcing the third dimension	CELL			English	Editorial Material									Univ Calif San Francisco, Dept Surg, Surg Res Lab, San Francisco, CA 94143 USA; Univ Penn, Dept Pathol, Inst Med & Engn, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine	Weaver, V (corresponding author), Univ Calif San Francisco, Dept Surg, Surg Res Lab, San Francisco, CA 94143 USA.	vmweaver@mail.med.upenn.edu		Weaver, Valerie marie/0000-0003-4786-6752				Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; CHUN TH, 2006, CELL; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463	10	13	14	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					429	431		10.1016/j.cell.2006.04.019	http://dx.doi.org/10.1016/j.cell.2006.04.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678088	Bronze			2022-12-28	WOS:000237506100008
J	Healton, CG; Vallone, D; McCausland, KL; Xiao, HJ; Green, MP				Healton, CG; Vallone, D; McCausland, KL; Xiao, HJ; Green, MP			Smoking, obesity, and their co-occurrence in the United States: cross sectional analysis	BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; CESSATION; PREVALENCE; OVERWEIGHT; ADULTS	Objectives To describe the prevalence of obesity, smoking, and both health risk factors together among adults in the United States. Design Cross sectional analysis of a national health interview survey. Setting United States. Participants 29 305 adults (aged >= 18) in 2002. Main outcome measures Prevalence of adults who are obese (body mass index >= 30), who smoke, and who are obese and smoke. Prevalence was stratified by age, sex, ethnic group, education, and income. Results 23.5% of adults were obese, 22.7% smoked, and 4.7% smoked and were obese. Conclusions Although die proportion of adults who smoke and are obese is relatively low, this subgroup is concentrated among lower socioeconomic groups.	Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA; Amer Legacy Fdn, Washington, DC 20036 USA	Columbia University	Healton, CG (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.	chealton@americanlegacy.org						Centers for Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P427; Copeland AL, 2006, ADDICT BEHAV, V31, P115, DOI 10.1016/j.addbeh.2005.04.020; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Greenlund KJ, 2004, ARCH INTERN MED, V164, P181, DOI 10.1001/archinte.164.2.181; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106	8	63	64	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 1	2006	333	7557					25	26		10.1136/bmj.38840.608704.80	http://dx.doi.org/10.1136/bmj.38840.608704.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16698804	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000238922900023
J	Dally, JM; Emery, NJ; Clayton, NS				Dally, Joanna M.; Emery, Nathan J.; Clayton, Nicola S.			Food-caching western scrub-jays keep track of who was watching when	SCIENCE			English	Article							OBSERVATIONAL SPATIAL MEMORY; MENTAL TIME-TRAVEL; APHELOCOMA-CALIFORNICA; CORVUS-CORAX; STRATEGIES; CONSPECIFICS; COMPETITORS; CACHES; RAVENS	Western scrub-jays (Aphelocoma californica) hide food caches for future consumption, steal others' caches, and engage in tactics to minimize the chance that their own caches will be stolen. We show that scrub-jays remember which individual watched them during particular caching events and alter their recaching behavior accordingly. We found no evidence to suggest that a storer's use of cache protection tactics is cued by the observer's behavior.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England	University of Cambridge; University of Cambridge	Clayton, NS (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	nsc22@cam.ac.uk	Clayton, Nicola s/A-2891-2010	Clayton, Nicola/0000-0003-1835-423X	Biotechnology and Biological Sciences Research Council [BB/D000335/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bednekoff PA, 1996, ANIM BEHAV, V52, P833, DOI 10.1006/anbe.1996.0228; Bednekoff PA, 1996, BEHAVIOUR, V133, P807, DOI 10.1163/156853996X00251; Bugnyar T, 2005, P ROY SOC B-BIOL SCI, V272, P1641, DOI 10.1098/rspb.2005.3144; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Byrne R., 1988, MACHIAVELLIAN INTELL; CHENEY D, 1996, ANIM BEHAV, V34, P1722; CLARKSON K, 1986, J ANIM ECOL, V55, P111, DOI 10.2307/4696; CLAYTON N, 2001, PHILOS T R SOC LOND, V0356, P00001; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; CONNOR R, 2000, P ROY SOC LOND B BIO, V268, P263; DALLY J, 2001, P ROY SOC LOND B BIO, V271, pS387; Dally JM, 2005, ANIM BEHAV, V70, P1251, DOI 10.1016/j.anbehav.2005.02.009; Dally JM, 2005, BEHAVIOUR, V142, P961, DOI 10.1163/1568539055010084; Emery NJ, 2004, ANIM COGN, V7, P37, DOI 10.1007/s10071-003-0178-7; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; Engh AL, 2005, ANIM BEHAV, V69, P209, DOI 10.1016/j.anbehav.2004.04.013; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Heinrich B, 1998, ANIM BEHAV, V56, P1083, DOI 10.1006/anbe.1998.0906; Humphrey N. K., 1988, MACHIAVELLIAN INTELL, P13; Povinelli DJ, 2003, TRENDS COGN SCI, V7, P157, DOI 10.1016/S1364-6613(03)00053-6; Silk JB, 1999, ANIM BEHAV, V58, P45, DOI 10.1006/anbe.1999.1129; Suddendorf T, 2005, LEARN MOTIV, V36, P110, DOI 10.1016/j.lmot.2005.02.010; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6	23	221	227	3	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1662	1665		10.1126/science.1126539	http://dx.doi.org/10.1126/science.1126539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16709747				2022-12-28	WOS:000238288600049
J	Kearney, PM; Baigent, C; Godwin, J; Halls, H; Emberson, JR; Patrono, C				Kearney, Patricia M.; Baigent, Colin; Godwin, Jon; Halls, Heather; Emberson, Jonathan R.; Patrono, Carlo			Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPLICATIONS; PREVENTION; VALDECOXIB; PARECOXIB; ROFECOXIB; NAPROXEN; ASPIRIN; THERAPY; DISEASE	Objective To assess the effects of selective cyclo-oxygenase-2 (COX 2) inhibitors and traditional non-steroidal anti-inflammatory drugs (NSAIDs) on the risk of vascular events. Design Meta-analysis of published and unpublished tabular data from randomised trials, with indirect estimation of the effects of traditional NSAIDs. Data sources Medline and Embase (January 1966 to April 2005); Food and Drug Administration records, and data on file from Novartis, Pfizer, and Merck. Review methods Eligible studies were randomised trials that included a comparison of a selective COX 2 inhibitor versus placebo or a selective COX 2 inhibitor versus a traditional NSAID, of at least four weeks' duration, with information on serious vascular events (defined as myocardial infarction, stroke, or vascular death). Individual investigators and manufacturers provided information on the number of patients randomised, numbers of vascular events, and the person time of follow-up for each randomised group. Results In placebo comparisons, allocation to a selective COX 2 inhibitor was associated with a 42% relative increase in the incidence of serious vascular events (1.2%/year v 0.9%/year; rate ratio 1.42, 95% confidence interval 1.13 to 1.78; P = 0.003), with no significant heterogeneity among the different selective COX 2 inhibitors. This was chiefly attributable to an increased risk of myocardial infarction (0.6%/year v 0.3%/year; 1.86, 1.33 to 2.59; P = 0.0003), with little apparent difference in other vascular outcomes. Among trials of at least one year's duration (mean 2.7 years), the rate ratio for vascular events was 1.45 (1.12 to 1.89; P = 0.005). Overall, the incidence of serious vascular events was similar between a selective COX 2 inhibitor and any traditional NSAID (1.0%/year v 0.9/%year; 1.16,0.97 to 1.38; P = 0.1). However, statistical heterogeneity (P = 0.001) was found between trials of a selective COX 2 inhibitor versus naproxen (1.67,1.21 to 2.03) and of a selective COX 2 inhibitor versus non-naproxen NSAIDs (0.88,0.69 to 1.12). The summary rate ratio for vascular events, compared with placebo, was 0.92 (0.67 to 1.26) for naproxen, 1.51 (0.96 to 2.37) for ibuprofen, and 1.63 (1.12 to 2.37) for diclofenac. Conclusions Selective COX 2 inhibitors are associated with a moderate increase in the risk of vascular events, as are high dose regimens of ibuprofen and diclofenac, but high dose naproxen is not associated with such an excess.	Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England; Univ Roma La Sapienza, Dept Pharmacol, Rome, Italy	University of Oxford; University of Oxford; Sapienza University Rome	Baigent, C (corresponding author), Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England.	colin.baigent@ctsu.ox.ac.uk	Kearney, Patricia M/AAE-8501-2020; Bannuru, Raveendhara/G-2601-2011	Bannuru, Raveendhara/0000-0002-8069-5783; Kearney, Patricia/0000-0001-9599-3540; Patrono, Carlo/0000-0002-6447-2424; Emberson, Jonathan/0000-0001-7792-9422				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2003, ARTHRITIS RHEUM, V48, P12, DOI 10.1002/art.10738; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; BROCHIER ML, 1993, EUR HEART J, V14, P951, DOI 10.1093/eurheartj/14.7.951; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; FORNARO G, 1993, CIRCULATION, V87, P162, DOI 10.1161/01.CIR.87.1.162; Furberg CD, 2005, CIRCULATION, V111, P249, DOI 10.1161/01.CIR.0000155081.76164.17; LEVIN B, 2005, M FDA ADV COMM COX2; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(03)00125-9; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405	16	983	1023	0	57	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1302	1305		10.1136/bmj.332.7553.1302	http://dx.doi.org/10.1136/bmj.332.7553.1302			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16740558	Green Published			2022-12-28	WOS:000238197000020
J	Christofori, G				Christofori, G			New signals from the invasive front	NATURE			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER METASTASIS; E-CADHERIN; TUMOR PROGRESSION; GROWTH-FACTOR; TGF-BETA; SCATTER-FACTOR; CELL-ADHESION; FGF-RECEPTOR; COLON-CANCER	Approximately 90% of all cancer deaths arise from the metastatic spread of primary tumours. Of all the processes involved in carcinogenesis, local invasion and the formation of metastases are clinically the most relevant, but they are the least well understood at the molecular level. Revealing their mechanisms is one of the main challenges for exploratory and applied cancer research. Recent experimental progress has identified a number of molecular pathways and cellular mechanisms that underlie the multistage process of metastasis formation: these include tumour invasion, tumour-cell dissemination through the bloodstream or the lymphatic system, colonization of distant organs and, finally, fatal outgrowth of metastases.	Univ Basel, Ctr Biomed, Dept Clin Biol Sci, CH-4058 Basel, Switzerland	University of Basel	Christofori, G (corresponding author), Univ Basel, Ctr Biomed, Dept Clin Biol Sci, Mattenstr 28, CH-4058 Basel, Switzerland.	gerhard.christofori@unibas.ch						Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Aharinejad S, 2002, CANCER RES, V62, P5317; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Boccaccio C, 2005, NATURE, V434, P396, DOI 10.1038/nature03357; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Conacci-Sorrell ME, 2002, GENE DEV, V16, P2058, DOI 10.1101/gad.227502; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hayward SW, 2001, CANCER RES, V61, P8135; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Matteucci E, 2005, EXP CELL RES, V310, P176, DOI 10.1016/j.yexcr.2005.07.008; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stella MC, 2005, MOL CELL BIOL, V25, P3982, DOI 10.1128/MCB.25.10.3982-3996.2005; Strathdee G, 2002, SEMIN CANCER BIOL, V12, P373, DOI 10.1016/S1044-579X(02)00057-3; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	75	776	834	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2006	441	7092					444	450		10.1038/nature04872	http://dx.doi.org/10.1038/nature04872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724056				2022-12-28	WOS:000237778900037
J	Hirschtick, RE				Hirschtick, Robert E.			Copy-and-paste	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											No Org, Chicago, IL USA.	rober@northwestern.edu							0	108	109	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2335	2336		10.1001/jama.295.20.2335	http://dx.doi.org/10.1001/jama.295.20.2335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720812				2022-12-28	WOS:000237734400001
J	Viskin, S				Viskin, S			Prediction versus prevention of sudden cardiac death	LANCET			English	Editorial Material							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; HEART-RATE-VARIABILITY; EJECTION FRACTION; RISK STRATIFICATION; PROPHYLACTIC USE; MORTALITY; FAILURE; BENEFIT		Tel Aviv Med Ctr & Sch Med, Sackler Sch Med, Tel Aviv Sourasky Med Ctr, Dept Cardiol, IL-64239 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Viskin, S (corresponding author), Tel Aviv Med Ctr & Sch Med, Sackler Sch Med, Tel Aviv Sourasky Med Ctr, Dept Cardiol, IL-64239 Tel Aviv, Israel.	saviskin@tasmc.health.gov.il						Barthel P, 2003, CIRCULATION, V108, P1221, DOI 10.1161/01.CIR.0000088783.34082.89; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Buxton AE, 2000, NEW ENGL J MED, V342, P1937, DOI 10.1056/NEJM200006293422602; Buxton AE, 2005, CIRCULATION, V111, P2537, DOI 10.1161/01.CIR.0000165057.88551.2C; Copie X, 1996, J AM COLL CARDIOL, V27, P270, DOI 10.1016/0735-1097(95)00454-8; ELSHERIF N, 1995, J AM COLL CARDIOL, V25, P908, DOI 10.1016/0735-1097(94)00504-J; Hjalmarson A, 1999, LANCET, V353, P2001; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; Kron J, 2001, AM HEART J, V141, P92, DOI 10.1067/mhj.2001.111261; La Rovere MT, 1998, LANCET, V351, P478; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2000, CIRCULATION, V101, P1638; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07	18	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2006	367	9523					1639	1641		10.1016/S0140-6736(06)68712-6	http://dx.doi.org/10.1016/S0140-6736(06)68712-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714171				2022-12-28	WOS:000237743100009
J	Bisgaard, H; Hermansen, MN; Loland, L; Halkjaer, LB; Buchvald, F				Bisgaard, H; Hermansen, MN; Loland, L; Halkjaer, LB; Buchvald, F			Intermittent inhaled corticosteroids in infants with episodic wheezing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							1ST 6 YEARS; CHILDHOOD ASTHMA; LUNG-FUNCTION; PRESCHOOL-CHILDREN; FLUTICASONE PROPIONATE; AIRWAY-RESISTANCE; YOUNG-CHILDREN; BUDESONIDE; SYMPTOMS; RESPONSIVENESS	BACKGROUND: We hypothesized that asthma is preceded by a stage of recurrent episodes of wheezing during the first years of life and that inhaled corticosteroid therapy during symptomatic episodes in this early phase may delay progression to persistent wheezing. METHODS: We assigned one-month-old infants to treatment with two-week courses of inhaled budesonide (400 microg per day) or placebo, initiated after a three-day episode of wheezing, in this single-center, randomized, double-blind, prospective study of three years' duration. The primary outcome was the number of symptom-free days; key secondary outcomes were the time to discontinuation due to persistent wheezing and safety, as evaluated by height and bone mineral density at the end of the study. RESULTS: We enrolled 411 infants and randomly assigned 294 to receive budesonide at a first episode of wheezing. The proportion of symptom-free days was 83 percent in the budesonide group and 82 percent in the placebo group (absolute difference, 1 percent; 95 percent confidence interval, -4.8 to 6.9 percent). Twenty-four percent of children in the budesonide group had persistent wheezing, as compared with 21 percent in the placebo group (hazard ratio, 1.22; 95 percent confidence interval, 0.71 to 2.13) -- a finding that was unaffected by the presence or absence of atopic dermatitis. The mean duration of the acute episodes was 10 days in both groups and was independent of respiratory viral status. Height and bone mineral density were not affected by treatment. CONCLUSIONS: Intermittent inhaled corticosteroid therapy had no effect on the progression from episodic to persistent wheezing and no short-term benefit during episodes of wheezing in the first three years of life.	Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Gentofte, Denmark	University of Copenhagen	Bisgaard, H (corresponding author), Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Gentofte, Denmark.		Kronow, Joern/B-1054-2011; Bisgaard, Hans/N-4761-2016	Bisgaard, Hans/0000-0003-4131-7592				AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; BISGAARD H, 1990, LANCET, V336, P649, DOI 10.1016/0140-6736(90)92147-A; Bisgaard H, 1999, AM J RESP CRIT CARE, V160, P126, DOI 10.1164/ajrccm.160.1.9811024; Bisgaard H, 2005, CHEST, V128, P355, DOI 10.1378/chest.128.1.355; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 1995, EUR RESPIR J, V8, P2067, DOI 10.1183/09031936.95.08122067; Bisgaard H, 2001, AM J RESP CRIT CARE, V163, P1290, DOI 10.1164/ajrccm.163.6.ed1801b; BLAIR H, 1977, ARCH DIS CHILD, V52, P613, DOI 10.1136/adc.52.8.613; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Cane RS, 2001, ARCH DIS CHILD, V84, P31, DOI 10.1136/adc.84.1.31; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; deBlic J, 1996, J ALLERGY CLIN IMMUN, V98, P14, DOI 10.1016/S0091-6749(96)70221-X; GERRITSEN J, 1989, AM REV RESPIR DIS, V140, P1325, DOI 10.1164/ajrccm/140.5.1325; Global Initiative for Asthma, 2005, NIH PUBL; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hofhuis W, 2005, AM J RESP CRIT CARE, V171, P328, DOI 10.1164/rccm.200402-227OC; Klug B, 1998, PEDIATR PULM, V25, P322, DOI 10.1002/(SICI)1099-0496(199805)25:5<322::AID-PPUL6>3.0.CO;2-K; Krawiec ME, 2001, AM J RESP CRIT CARE, V163, P1338, DOI 10.1164/ajrccm.163.6.2005116; Le Bourgeois M, 2002, CHEST, V122, P791, DOI 10.1378/chest.122.3.791; Loland L, 2006, CHEST, V129, P669, DOI 10.1378/chest.129.3.669; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; National Asthma Education and Prevention Program, 2003, J ALLERGY CLIN IMMUN, V111, P466, DOI DOI 10.1542/PEDS.2007-3825; Nielsen KG, 2000, AM J RESP CRIT CARE, V162, P1500, DOI 10.1164/ajrccm.162.4.2002019; Oswald H, 1997, PEDIATR PULM, V23, P14, DOI 10.1002/(SICI)1099-0496(199701)23:1<14::AID-PPUL2>3.0.CO;2-P; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Roorda RJ, 2001, J ALLERGY CLIN IMMUN, V108, P540, DOI 10.1067/mai.2001.118789; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Selroos O, 2004, RESP MED, V98, P254, DOI 10.1016/j.rmed.2003.10.007; SELROOS O, 1995, CHEST, V108, P1228, DOI 10.1378/chest.108.5.1228; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; Zeiger RS, 1999, J ALLERGY CLIN IMMUN, V103, P376, DOI 10.1016/S0091-6749(99)70460-4	41	398	419	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					1998	2005		10.1056/NEJMoa054692	http://dx.doi.org/10.1056/NEJMoa054692			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687712				2022-12-28	WOS:000237413100004
J	Davies, L; Welch, HG				Davies, L; Welch, HG			Increasing incidence of thyroid cancer in the United States, 1973-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARCINOMA; AUTOPSY; ULTRASONOGRAPHY; PREVALENCE; MANAGEMENT; PALPATION; COUNTY; TRENDS	Context Increasing cancer incidence is typically interpreted as an increase in the true occurrence of disease but may also reflect changing pathological criteria or increased diagnostic scrutiny. Changes in the diagnostic approach to thyroid nodules may have resulted in an increase in the apparent incidence of thyroid cancer. Objective To examine trends in thyroid cancer incidence, histology, size distribution, and mortality in the United States. Methods Retrospective cohort evaluation of patients with thyroid cancer, 19732002, using the Surveillance, Epidemiology, and End Results ( SEER) program and data on thyroid cancer mortality from the National Vital Statistics System. Main Outcome Measures Thyroid cancer incidence, histology, size distribution, and mortality. Results The incidence of thyroid cancer increased from 3.6 per 100 000 in 1973 to 8.7 per 100 000 in 2002 - a 2.4-fold increase (95% confidence interval [CI], 2.2-2.6; P <. 001 for trend). There was no significant change in the incidence of the less common histological types: follicular, medullary, and anaplastic ( P >. 20 for trend). Virtually the entire increase is attributable to an increase in incidence of papillary thyroid cancer, which increased from 2.7 to 7.7 per 100 000 - a 2.9-fold increase ( 95% CI, 2.6-3.2; P <. 001 for trend). Between 1988 ( the first year SEER collected data on tumor size) and 2002, 49% ( 95% CI, 47%-51%) of the increase consisted of cancers measuring 1 cm or smaller; 87% ( 95% CI, 85%-89%) consisted of cancers measuring 2 cm or smaller. Mortality from thyroid cancer was stable between 1973 and 2002 ( approximately 0.5 deaths per 100 000). Conclusions The increasing incidence of thyroid cancer in the United States is predominantly due to the increased detection of small papillary cancers. These trends, combined with the known existence of a substantial reservoir of subclinical cancer and stable overall mortality, suggest that increasing incidence reflects increased detection of subclinical disease, not an increase in the true occurrence of thyroid cancer.	White River Junct Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; Dartmouth Med Sch, Div Otolaryngol, Hanover, NH USA; Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA; Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH USA	VA Outcomes Group; Dartmouth College; Dartmouth College; Dartmouth College	Davies, L (corresponding author), White River Junct Dept Vet Affairs Med Ctr, VA Outcomes Grp, 215 N Main St,111B, White River Jct, VT 05009 USA.	louise.davies@dartmouth.edu		Welch, H. Gilbert/0000-0002-3448-1207				BONDESON L, 1981, CANCER-AM CANCER SOC, V47, P319, DOI 10.1002/1097-0142(19810115)47:2<319::AID-CNCR2820470218>3.0.CO;2-A; Burke JP, 2005, MAYO CLIN PROC, V80, P753; DAVIES L, IN PRESS OTOLARYNGOL; Etzioni R, 2002, J NATL CANCER I, V94, P981; EZZAT S, 1994, ARCH INTERN MED, V154, P1838; FASSINA AS, 1993, TUMORI J, V79, P314, DOI 10.1177/030089169307900506; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Haselkorn T, 2000, CANCER CAUSE CONTROL, V11, P163, DOI 10.1023/A:1008932123830; HEITZ P, 1976, CANCER, V37, P2329, DOI 10.1002/1097-0142(197605)37:5<2329::AID-CNCR2820370523>3.0.CO;2-7; Hodgson NC, 2004, ANN SURG ONCOL, V11, P1093, DOI 10.1245/ASO.2004.03.066; Mangano JJ, 1996, EUR J CANCER PREV, V5, P75; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; Mulla ZD, 2000, ANN EPIDEMIOL, V10, P24, DOI 10.1016/S1047-2797(99)00044-7; ROJESKI MT, 1985, NEW ENGL J MED, V313, P428, DOI 10.1056/NEJM198508153130707; Ron E, 1996, OTOLARYNG HEAD NECK, V115, P403, DOI 10.1016/S0194-5998(96)70073-6; SOBRINHOSIMOES MA, 1979, CANCER-AM CANCER SOC, V43, P1702, DOI 10.1002/1097-0142(197905)43:5<1702::AID-CNCR2820430521>3.0.CO;2-S; Solares CA, 2005, AM J OTOLARYNG, V26, P87, DOI 10.1016/j.amjoto.2004.08.003; VANDERLAAN WP, 1947, NEW ENGL J MED, V237, P221, DOI [10.1056/NEJM194708142370703, 10.1056/NEJM194702132360702]; Wenig B, 1997, ATLAS ENDOCRINE PATH; Wiest PW, 1998, J ULTRAS MED, V17, P487; World Health Organization, 2000, INT CLASS DIS ONC; 2003, AJCC CANC STAGING MA	22	2462	2612	4	134	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2006	295	18					2164	2167		10.1001/jama.295.18.2164	http://dx.doi.org/10.1001/jama.295.18.2164			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040OW	16684987	Bronze			2022-12-28	WOS:000237391300026
J	Moore, AK				Moore, AK			The otoscope	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												Anisa.Moore@HealthONEcares.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2006	295	18					2115	2116		10.1001/jama.295.18.2115	http://dx.doi.org/10.1001/jama.295.18.2115			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040OW	16684972				2022-12-28	WOS:000237391300001
J	Sargolini, F; Fyhn, M; Hafting, T; McNaughton, BL; Witter, MP; Moser, MB; Moser, EI				Sargolini, F; Fyhn, M; Hafting, T; McNaughton, BL; Witter, MP; Moser, MB; Moser, EI			Conjunctive representation of position, direction, and velocity in entorhinal cortex	SCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; HIPPOCAMPAL PLACE CELLS; LAYER-V NEURONS; HEAD-DIRECTION; PATH-INTEGRATION; RAT; PRESUBICULUM; ORGANIZATION; PROJECTIONS; SYSTEM	Grid cells in the medial entorhinal cortex (MEC) are part of an environment-independent spatial coordinate system. To determine how information about location, direction, and distance is integrated in the grid-cell network, we recorded from each principal cell layer of MEC in rats that explored two-dimensional environments. Whereas layer II was predominated by grid cells, grid cells colocalized with head-direction cells and conjunctive grid x head-direction cells in the deeper layers. All cell types were modulated by running speed. The conjunction of positional, directional, and translational information in a single MEC cell type may enable grid coordinates to be updated during self-motion-based navigation.	Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway; Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA; Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Neurosci Res Inst, Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); University of Arizona; Vrije Universiteit Amsterdam	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Hafting, Torkel/0000-0002-0928-3487; Sargolini, Francesca/0000-0002-5038-3746				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; CABALLEROBLEDA M, 1994, EXP BRAIN RES, V101, P93; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; FYHN M, 2005, SOC NEUR ABSTR, V31; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hamam BN, 2000, J COMP NEUROL, V418, P457; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Honda Y, 2004, J COMP NEUROL, V473, P463, DOI 10.1002/cne.20093; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; Johnson A, 2005, HIPPOCAMPUS, V15, P86, DOI 10.1002/hipo.20033; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; McNaughton BL, 1996, J EXP BIOL, V199, P173; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Parron C, 2004, EXP BRAIN RES, V159, P349, DOI 10.1007/s00221-004-1960-8; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P420; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; vanHaeften T, 1997, J NEUROSCI, V17, P862; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Wouterlood FG, 2004, BRAIN RES, V1013, P1, DOI 10.1016/j.brainres.2004.03.017; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Zhang K, 1996, J NEUROSCI, V16, P2112	36	846	872	7	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					758	762		10.1126/science.1125572	http://dx.doi.org/10.1126/science.1125572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675704				2022-12-28	WOS:000237312100054
J	Keele, BF; Van Heuverswyn, F; Li, YY; Bailes, E; Takehisa, J; Santiago, ML; Bibollet-Ruche, F; Chen, YL; Wain, LV; Liegeois, F; Loul, S; Ngole, EM; Bienvenue, Y; Delaporte, E; Brookfield, JFY; Sharp, PM; Shaw, GM; Peeters, M; Hahn, BH				Keele, Brandon F.; Van Heuverswyn, Fran; Li, Yingying; Bailes, Elizabeth; Takehisa, Jun; Santiago, Mario L.; Bibollet-Ruche, Frederic; Chen, Yalu; Wain, Louise V.; Liegeois, Florian; Loul, Severin; Ngole, Eitel Mpoudi; Bienvenue, Yanga; Delaporte, Eric; Brookfield, John F. Y.; Sharp, Paul M.; Shaw, George M.; Peeters, Martine; Hahn, Beatrice H.			Chimpanzee reservoirs of pandemic and nonpandemic HIV-1	SCIENCE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; GROUP-N; ORIGIN; CAMEROON; IDENTIFICATION; TROGLODYTES; SEQUENCES; AIDS	Human immunodeficiency virus type 1 (HIV-1), the cause of human acquired immunodeficiency syndrome ( AIDS), is a zoonotic infection of staggering proportions and social impact. Yet uncertainty persists regarding its natural reservoir. The virus most closely related to HIV-1 is a simian immunodeficiency virus ( SIV) thus far identified only in captive members of the chimpanzee subspecies Pan troglodytes troglodytes. Here we report the detection of SIVcpz antibodies and nucleic acids in fecal samples from wild-living P.t. troglodytes apes in southern Cameroon, where prevalence rates in some communities reached 29 to 35%. By sequence analysis of endemic SIVcpz strains, we could trace the origins of pandemic ( group M) and nonpandemic ( group N) HIV-1 to distinct, geographically isolated chimpanzee communities. These findings establish P. t. troglodytes as a natural reservoir of HIV-1.	Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Montpellier 1, Lab Retrovirus, UMR 145, Inst Rech Dev, F-34394 Montpellier, France; Univ Montpellier 1, Dept Int Hlth, F-34394 Montpellier 5, France; Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England; Projet Prevent Sida Cameroun PRESICA, Yaounde, Cameroon; Howard Hughes Med Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Nottingham; Howard Hughes Medical Institute	Hahn, BH (corresponding author), Univ Alabama, Dept Med, Birmingham, AL 35294 USA.	bhahn@uab.edu	Delaporte, Eric/J-5397-2018; Sharp, Paul/Y-3787-2019; Sharp, Paul M/GPX-1497-2022; Sharp, Paul M/F-5783-2010; Florian, Liegeois/D-3798-2013	Delaporte, Eric/0000-0002-1822-9853; Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Florian, Liegeois/0000-0003-1048-0661; Wain, Louise/0000-0003-4951-1867; Hahn, Beatrice/0000-0002-9400-9887; Santiago, Mario L./0000-0001-7792-2706	NIAID NIH HHS [P30 AI 27767, R01 AI58715, R01 AI058715, R01 AI058715-05, R01 AI50529] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058715, P30AI027767, R01AI050529] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Groves Colin P., 1993, P243; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Nerrienet E, 2005, J VIROL, V79, P1312, DOI 10.1128/JVI.79.2.1312-1319.2005; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; Santiago ML, 2005, J VIROL, V79, P12515, DOI 10.1128/JVI.79.19.12515-12527.2005; Santiago ML, 2003, J VIROL, V77, P7545, DOI 10.1128/JVI.77.13.7545-7562.2003; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Sharp PM, 2001, PHILOS T R SOC B, V356, P867, DOI 10.1098/rstb.2001.0863; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; VandenHaesevelde MM, 1996, VIROLOGY, V221, P346, DOI 10.1006/viro.1996.0384; VANHEUSERSWYN F, 2006, 13 C RETR OPP INF, V132; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Worobey M, 2004, NATURE, V428, P820, DOI 10.1038/428820a; Yamaguchi J, 2006, AIDS RES HUM RETROV, V22, P83, DOI 10.1089/aid.2006.22.83	20	559	601	1	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					523	526		10.1126/science.1126531	http://dx.doi.org/10.1126/science.1126531			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16728595	Green Accepted			2022-12-28	WOS:000239308600063
J	Sui, HX; Downing, KH				Sui, Haixin; Downing, Kenneth H.			Molecular architecture of axonemal microtubule doublets revealed by cryo-electron tomography	NATURE			English	Article							DYNEIN-REGULATORY-COMPLEX; INTERMEDIATE-FILAMENT PROTEINS; URCHIN SPERM FLAGELLA; CHLAMYDOMONAS-FLAGELLA; COMPONENTS; TUBULIN; TEKTINS; ARMS; HETEROGENEITY; MUTATIONS	The axoneme, which forms the core of eukaryotic flagella and cilia, is one of the largest macromolecular machines, with a structure that is largely conserved from protists to mammals(1). Microtubule doublets are structural components of axonemes that contain a number of proteins besides tubulin, and are usually found in arrays of nine doublets arranged around two singlet microtubules. Coordinated sliding of adjacent doublets, which involves a host of other proteins in the axoneme, produces periodic beating movements of the axoneme. We have obtained a three-dimensional density map of intact microtubule doublets using cryo-electron tomography and image averaging. Our map, with a resolution of about 3 nm, provides insights into locations of particular proteins within the doublets and the structural features of the doublets that define their mechanical properties. We identify likely candidates for several of these non-tubulin components of the doublets. This work offers insight on how tubulin protofilaments and accessory proteins attach together to form the doublets and provides a structural basis for understanding doublet function in axonemes.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Downing, KH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	khdowning@lbl.gov	Sui, Haixin/L-4265-2017	Sui, Haixin/0000-0002-5560-4325				BOZKURT HH, 1993, CELL MOTIL CYTOSKEL, V24, P109; CHANG XJ, 1987, J CELL BIOL, V104, P1563, DOI 10.1083/jcb.104.6.1563; CHEN R, 1993, J CELL SCI, V106, P909; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; Hinchcliffe EH, 1998, J CELL SCI, V111, P585; HOOPS HJ, 1983, J CELL BIOL, V97, P902, DOI 10.1083/jcb.97.3.902; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Ikeda K, 2003, J BIOL CHEM, V278, P7725, DOI 10.1074/jbc.M210751200; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; LINCK RW, 1985, J CELL BIOL, V100, P126, DOI 10.1083/jcb.100.1.126; LINCK RW, 1982, J CELL SCI, V58, P1; Linck RW, 2003, PROTIST, V154, P299, DOI 10.1078/143446103322454086; LINCK RW, 1987, J CELL BIOL, V104, P1069, DOI 10.1083/jcb.104.4.1069; LINCK RW, 1976, J CELL SCI, V20, P405; Lindemann CB, 2004, BIOL CELL, V96, P681, DOI 10.1016/j.biolcel.2004.08.001; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; MEZA I, 1972, EXP CELL RES, V74, P535, DOI 10.1016/0014-4827(72)90413-2; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; NORRANDER JM, 1992, P NATL ACAD SCI USA, V89, P8567, DOI 10.1073/pnas.89.18.8567; Patel-King RS, 2002, J BIOL CHEM, V277, P34271, DOI 10.1074/jbc.M204137200; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; PIRNER MA, 1994, J BIOL CHEM, V269, P31800; STEFFEN W, 1989, CELL MOTIL CYTOSKEL, V14, P359, DOI 10.1002/cm.970140306; Waterman-Storer C, 1998, CURRENT PROTOCOLS CE; WITMAN GB, 1972, J CELL BIOL, V54, P540, DOI 10.1083/jcb.54.3.540; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Woolley DM, 1997, J CELL SCI, V110, P85; [No title captured]	30	119	124	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					475	478		10.1038/nature04816	http://dx.doi.org/10.1038/nature04816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16738547	Green Submitted			2022-12-28	WOS:000239278900048
J	Matsuura-Tokita, K; Takeuchi, M; Ichihara, A; Mikuriya, K; Nakano, A				Matsuura-Tokita, Kumi; Takeuchi, Masaki; Ichihara, Akira; Mikuriya, Kenta; Nakano, Akihiko			Live imaging of yeast Golgi cisternal maturation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; PICHIA-PASTORIS; APPARATUS; MICROSCOPY; TRANSPORT; COMPLEX; SEC7; CONTINUITIES	There is a debate over how protein trafficking is performed through the Golgi apparatus(1-4). In the secretory pathway, secretory proteins that are synthesized in the endoplasmic reticulum enter the early compartment of the Golgi apparatus called cis cisternae, undergo various modifications and processing, and then leave for the plasma membrane from the late ( trans) cisternae. The cargo proteins must traverse the Golgi apparatus in the cis-totrans direction. Two typical models propose either vesicular transport or cisternal progression and maturation for this process. The vesicular transport model predicts that Golgi cisternae are distinct stable compartments connected by vesicular traffic, whereas the cisternal maturation model predicts that cisternae are transient structures that form de novo, mature from cis to trans, and then dissipate. Technical progress in live-cell imaging has long been awaited to address this problem. Here we show, by the use of high-speed three-dimensional confocal microscopy, that yeast Golgi cisternae do change the distribution of resident membrane proteins from the cis nature to the trans over time, as proposed by the maturation model, in a very dynamic way.	RIKEN, Discovery Res Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan; Yokogawa Elect Corp, Bioctr, Tokyo 1808750, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan	RIKEN; Yokogawa Electric Corporation; University of Tokyo	Nakano, A (corresponding author), RIKEN, Discovery Res Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan.	nakano@riken.jp	Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/C-6185-2009; Nakano, Akihiko/A-6420-2016	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X				ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LOSEV E, 2006, NATURE          0514; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; Nakano A, 2004, CELL MOL LIFE SCI, V61, P186, DOI 10.1007/s00018-003-3356-5; Nakano A, 2002, CELL STRUCT FUNCT, V27, P349, DOI 10.1247/csf.27.349; Pelham H, 2000, TRAFFIC, V1, P191, DOI 10.1034/j.1600-0854.2000.010213.x; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Pelham HRB, 2001, J CELL BIOL, V155, P1099, DOI 10.1083/jcb.200110160; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; RAMBOURG A, 1993, ANAT REC, V237, P441, DOI 10.1002/ar.1092370402; RAMBOURG A, 1995, ANAT REC, V243, P283, DOI 10.1002/ar.1092430302; Rambourg A, 2001, J CELL SCI, V114, P2231; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Sata M, 1998, P NATL ACAD SCI USA, V95, P4204, DOI 10.1073/pnas.95.8.4204; Sato K, 1997, P NATL ACAD SCI USA, V94, P9693, DOI 10.1073/pnas.94.18.9693; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667	24	247	256	4	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					1007	1010		10.1038/nature04737	http://dx.doi.org/10.1038/nature04737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16699523				2022-12-28	WOS:000238422300048
J	Doebley, J				Doebley, J			Plant science - Unfallen grains: How ancient farmers turned weeds into crops	SCIENCE			English	Editorial Material							EVOLUTION; DOMESTICATION; MAIZE; RICE		Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Doebley, J (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	jdoebley@wisc.edu						DOEBLEY J, 1993, CURR OPIN GENET DEV, V3, P865, DOI 10.1016/0959-437X(93)90006-B; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Paterson AH, 2002, NEW PHYTOL, V154, P591, DOI 10.1046/j.1469-8137.2002.00420.x; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6	11	53	56	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1318	1319		10.1126/science.1128836	http://dx.doi.org/10.1126/science.1128836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741100				2022-12-28	WOS:000237961600033
J	Grunbaum, D				Grunbaum, D			Behavior - Align in the sand	SCIENCE			English	Editorial Material							PHASE-TRANSITION; PARTICLES		Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Grunbaum, D (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	grunbaum@ocean.washington.edu						[Anonymous], PROVERBS, V30, P24; Baron S., 1972, DESERT LOCUST; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Czirok A, 1999, PHYS REV LETT, V82, P209, DOI 10.1103/PhysRevLett.82.209; Kumar V, 2005, LECT NOTES CONTROL I, V309; Lovejoy NR, 2006, P ROY SOC B-BIOL SCI, V273, P767, DOI 10.1098/rspb.2005.3381; OKUBO A, 2001, DIFFUSION ECOLOGICAL; PARR ALBERT EIDE, 1927, OCC PAPERS BINGHAM OCEANOGRAPHIC COLL, VNo. 1., P1; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; RAINEY RC, 1989, MIGRATION METEOROLOG; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226	12	20	21	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1320	1322		10.1126/science.1127548	http://dx.doi.org/10.1126/science.1127548			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741102				2022-12-28	WOS:000237961600035
J	Goncharov, AF; Struzhkin, VV; Jacobsen, SD				Goncharov, Alexander F.; Struzhkin, Viktor V.; Jacobsen, Steven D.			Reduced radiative conductivity of low-spin (Mg,Fe)O in the lower mantle	SCIENCE			English	Article							THERMAL-CONDUCTIVITY; EARTHS MANTLE; ELECTRONIC-STRUCTURE; OPTICAL-ABSORPTION; CONVECTION MODEL; HEAT-TRANSFER; HIGH-PRESSURE; OLIVINE; IRON; HETEROGENEITY	Optical absorption spectra have been measured at pressures up to 80 gigapascals (GPa) for the tower-mantle oxide magnesiowustite (Mg,Fe)O. Upon reaching the high-spin to tow-spin transition of Fe2+ at about 60 GPa, we observed enhanced absorption in the mid- and near-infrared spectral range, whereas absorption in the visible-ultraviolet was reduced. The observed changes in absorption are in contrast to prediction and are attributed to d-d orbital charge transfer in the Fe2+ ion. The results indicate that low-spin (Mg,Fe)O will exhibit lower radiative thermal conductivity than high-spin (Mg,Fe)O, which needs to be considered in future geodynamic models of convection and plume stabilization in the lower mantle.	Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Goncharov, AF (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	goncharov@gl.ciw.edu	Jacobsen, Steven/F-3443-2013; Struzhkin, Viktor V/J-9847-2013; Goncharov, Alexander F./AAX-9943-2020	Jacobsen, Steven/0000-0002-9746-958X; Struzhkin, Viktor V/0000-0002-3468-0548; Goncharov, Alexander F./0000-0002-6422-8819				ABUEID RM, 1978, NATURWISSENSCHAFTEN, V65, P256, DOI 10.1007/BF00368568; Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; Burns R. G, 1993, MINERALOGICAL APPL C; Dubuffet F, 2002, NONLINEAR PROC GEOPH, V9, P311, DOI 10.5194/npg-9-311-2002; Dubuffet F, 2000, GEOPHYS RES LETT, V27, P17, DOI 10.1029/1999GL008338; DZIEWONSKI AM, 1984, J GEOPHYS RES, V89, P5929, DOI 10.1029/JB089iB07p05929; Figgis BN., 1966, INTRO LIGAND FIELDS; GOTO T, 1980, PHYS EARTH PLANET IN, V22, P277, DOI 10.1016/0031-9201(80)90044-8; Hofmeister AM, 2005, J GEODYN, V40, P51, DOI 10.1016/j.jog.2005.06.001; Hofmeister AM, 1999, SCIENCE, V283, P1699, DOI 10.1126/science.283.5408.1699; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; Lin JF, 2005, NATURE, V436, P377, DOI 10.1038/nature03825; Lorenz CD, 1998, PHYS REV E, V57, P230, DOI 10.1103/PhysRevE.57.230; MAO HK, 1972, SCIENCE, V176, P403, DOI 10.1126/science.176.4033.403; MAO HK, 1972, CARNEGIE I YB, V72, P554; Matyska C, 2005, EARTH PLANET SC LETT, V234, P71, DOI 10.1016/j.epsl.2004.10.040; SHANKLAND TJ, 1974, J GEOPHYS RES, V79, P3273, DOI 10.1029/JB079i023p03273; SHANKLAND TJ, 1979, J GEOPHYS RES, V84, P1603, DOI 10.1029/JB084iB04p01603; SHERMAN DM, 1991, J GEOPHYS RES-SOLID, V96, P14299, DOI 10.1029/91JB01202; Shukla A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.081101; Speziale S, 2005, P NATL ACAD SCI USA, V102, P17918, DOI 10.1073/pnas.0508919102; SU WJ, 1991, NATURE, V352, P121, DOI 10.1038/352121a0; Tackley PJ, 2000, SCIENCE, V288, P2002, DOI 10.1126/science.288.5473.2002; TANABE Y, 1954, J PHYS SOC JPN, V9, P753, DOI 10.1143/JPSJ.9.753; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Yanagawa TKB, 2004, PHYS EARTH PLANET IN, V146, P163, DOI 10.1016/j.pepi.2003.07.031; ZAANEN J, 1985, PHYS REV LETT, V55, P418, DOI 10.1103/PhysRevLett.55.418	29	140	146	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1205	1208		10.1126/science.1125622	http://dx.doi.org/10.1126/science.1125622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728639				2022-12-28	WOS:000237957400051
J	Grimm, D; Streetz, KL; Jopling, CL; Storm, TA; Pandey, K; Davis, CR; Marion, P; Salazar, F; Kay, MA				Grimm, Dirk; Streetz, Konrad L.; Jopling, Catherine L.; Storm, Theresa A.; Pandey, Kusum; Davis, Corrine R.; Marion, Patricia; Salazar, Felix; Kay, Mark A.			Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways	NATURE			English	Article							NUCLEAR EXPORT; VIRUS; INTERFERENCE; TRANSDUCTION; VECTORS; EXPRESSION; PROTEIN	RNA interference (RNAi) is a universal and evolutionarily conserved phenomenon of post-transcriptional gene silencing by means of sequence-specific mRNA degradation, triggered by small double-stranded RNAs1,2. Because this mechanism can be efficiently induced in vivo by expressing target-complementary short hairpin RNA (shRNA) from non-viral and viral vectors, RNAi is attractive for functional genomics and human therapeutics(3,4). Here we systematically investigate the long-term effects of sustained high-level shRNA expression in livers of adult mice. Robust shRNA expression in all the hepatocytes after intravenous infusion was achieved with an optimized shRNA delivery vector based on duplex-DNA-containing adeno-associated virus type 8 (AAV8). An evaluation of 49 distinct AAV/shRNA vectors, unique in length and sequence and directed against six targets, showed that 36 resulted in dose-dependent liver injury, with 23 ultimately causing death. Morbidity was associated with the downregulation of liver-derived microRNAs (miRNAs), indicating possible competition of the latter with shRNAs for limiting cellular factors required for the processing of various small RNAs. In vitro and in vivo shRNA transfection studies implied that one such factor, shared by the shRNA/miRNA pathways and readily saturated, is the nuclear karyopherin exportin-5. Our findings have fundamental consequences for future RNAi-based strategies in animals and humans, because controlling intracellular shRNA expression levels will be imperative. However, the risk of oversaturating endogenous small RNA pathways can be minimized by optimizing shRNA dose and sequence, as exemplified here by our report of persistent and therapeutic RNAi against human hepatitis B virus in vivo.	Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; Hepadnavirus Testing Inc, Mountain View, CA 94043 USA	Stanford University; Stanford University; Stanford University; Stanford University	Kay, MA (corresponding author), Stanford Univ, Sch Med, Dept Pediat, 300 Pasteur Dr, Stanford, CA 94305 USA.	markay@stanford.edu		Jopling, Catherine/0000-0001-6046-1456; Kay, Mark/0000-0002-2799-2615				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Cao Wen, 2005, Journal of Applied Genetics, V46, P217; Dykxhoorn DM, 2005, ANNU REV MED, V56, P401, DOI 10.1146/annurev.med.56.082103.104606; Grimm D., 2003, Current Gene Therapy, V3, P281, DOI 10.2174/1566523034578285; Grimm D, 2002, METHODS, V28, P146, DOI 10.1016/S1046-2023(02)00219-0; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jenkins DD, 2004, TRANSPLANTATION, V78, P530, DOI 10.1097/01.TP.0000130180.42573.B1; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Marion PL, 2003, FRONTIERS IN VIRAL HEPATITIS, P197, DOI 10.1016/B978-044450986-4/50069-2; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	30	1295	1445	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					537	541		10.1038/nature04791	http://dx.doi.org/10.1038/nature04791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724069				2022-12-28	WOS:000237778900056
J	Ohtsuki, H; Hauert, C; Lieberman, E; Nowak, MA				Ohtsuki, Hisashi; Hauert, Christoph; Lieberman, Erez; Nowak, Martin A.			A simple rule for the evolution of cooperation on graphs and social networks	NATURE			English	Article							FINITE POPULATIONS; ALTRUISM; DYNAMICS; GAME; STABILITY; EMERGENCE	A fundamental aspect of all biological systems is cooperation. Cooperative interactions are required for many levels of biological organization ranging from single cells to groups of animals(1-4). Human society is based to a large extent on mechanisms that promote cooperation(5-7). It is well known that in unstructured populations, natural selection favours defectors over cooperators. There is much current interest, however, in studying evolutionary games in structured populations and on graphs(8-17). These efforts recognize the fact that who-meets-whom is not random, but determined by spatial relationships or social networks(18-24). Here we describe a surprisingly simple rule that is a good approximation for all graphs that we have analysed, including cycles, spatial lattices, random regular graphs, random graphs and scale-free networks(25,26): natural selection favours cooperation, if the benefit of the altruistic act, b, divided by the cost, c, exceeds the average number of neighbours, k, which means b/c > k. In this case, cooperation can evolve as a consequence of 'social viscosity' even in the absence of reputation effects or strategic complexity.	Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan; Harvard Univ, Dept Appl Math, Cambridge, MA 02138 USA	Harvard University; Kyushu University; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Nowak, Martin A/A-6977-2008; Hauert, Christoph/E-5369-2011; Aiden, Erez Lieberman/A-2908-2010	Hauert, Christoph/0000-0002-1239-281X; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078986-01, R01 GM078986] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Ifti M, 2004, J THEOR BIOL, V231, P97, DOI 10.1016/j.jtbi.2004.06.003; Killingback T, 1996, P ROY SOC B-BIOL SCI, V263, P1135, DOI 10.1098/rspb.1996.0166; Le Galliard JF, 2003, EVOLUTION, V57, P1; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Mitteldorf J, 2000, J THEOR BIOL, V204, P481, DOI 10.1006/jtbi.2000.2007; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; Szabo G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036107; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wild G, 2004, P ROY SOC B-BIOL SCI, V271, P2345, DOI 10.1098/rspb.2004.2862; Wilson E.O., 1975, P1	30	1334	1373	28	498	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					502	505		10.1038/nature04605	http://dx.doi.org/10.1038/nature04605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724065	Green Accepted			2022-12-28	WOS:000237778900048
J	Horton, R				Horton, Richard			Trial registers: protecting patients, advancing trust	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; PARKER N, 2006, SUN             0316, P1; Rockhold FW, 2006, LANCET, V367, P1635, DOI 10.1016/S0140-6736(06)68710-2; SEAMARK M, 2006, DAILY MAIL      0317, P1; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Sim I, 2000, MED DECIS MAKING, V20, P440, DOI 10.1177/0272989X0002000408	6	21	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2006	367	9523					1633	1635		10.1016/S0140-6736(06)68709-6	http://dx.doi.org/10.1016/S0140-6736(06)68709-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714167				2022-12-28	WOS:000237743100005
J	Baughman, RH				Baughman, RH			Dangerously seeking linear carbon	SCIENCE			English	Editorial Material							CONJUGATED POLYMER		Univ Texas, Nanotech Inst, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas	Baughman, RH (corresponding author), Univ Texas, Nanotech Inst, Richardson, TX 75080 USA.	ray.baughman@utdallas.edu	Baughman, Ray/A-8628-2018	Baughman, Ray/0000-0001-5845-5137				BAUGHMAN RH, 1978, ANN NY ACAD SCI, V313, P705; BLOOR D, 1985, NATO ADV STUDY I E, V102; Curtis SM, 2005, CRYST GROWTH DES, V5, P2313, DOI 10.1021/cg050204x; Gibtner T, 2002, CHEM-EUR J, V8, P408, DOI 10.1002/1521-3765(20020118)8:2<408::AID-CHEM408>3.0.CO;2-L; Goroff NS, 2005, ORG LETT, V7, P1891, DOI 10.1021/ol050184s; Heimann R.B., 1999, CARBYNE CARBYNOID ST; Hlavaty J, 2001, CARBON, V39, P53, DOI 10.1016/S0008-6223(00)00072-5; Okawa Y, 2001, NATURE, V409, P683, DOI 10.1038/35055625; Patel G. N., 1976, United States Patent Publication US, Patent No. 3999946; Sarkar A, 2000, J MATER CHEM, V10, P819, DOI 10.1039/a907438d; Sun AW, 2006, SCIENCE, V312, P1030, DOI 10.1126/science.1124621; Szczepanski J, 2001, SPECTROCHIM ACTA A, V57, P775, DOI 10.1016/S1386-1425(00)00443-1; Wang ZX, 2000, PHYS REV B, V61, pR2472, DOI 10.1103/PhysRevB.61.R2472; WEGNER G, 1969, Z NATURFORSCH PT B, VB 24, P824; Zhao XL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.187401	15	98	98	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1009	1010		10.1126/science.1125999	http://dx.doi.org/10.1126/science.1125999			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709775				2022-12-28	WOS:000237628800032
J	Diamond, JS				Diamond, JS			Astrocytes put down the broom and pick up the baton	CELL			English	Editorial Material							D-SERINE; NEURONS; GLYCINE; RELEASE	In this issue of Cell, Panatier et al. (2006) show that D-serine released by astrocytes, a type of glial cell in the brain, promotes NMDA receptor activity at synapses in the hypothalamus. These results confirm that glial cells participate in synaptic signaling and show that they can dictate the tenor of synaptic plasticity.	NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Diamond, JS (corresponding author), NINDS, NIH, Bethesda, MD 20892 USA.	diamondj@ninds.nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002986, ZIANS002986] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Danysz W, 1998, PHARMACOL REV, V50, P597; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Piet R, 2004, P NATL ACAD SCI USA, V101, P2151, DOI 10.1073/pnas.0308408100; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948	9	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 19	2006	125	4					639	641		10.1016/j.cell.2006.05.006	http://dx.doi.org/10.1016/j.cell.2006.05.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713554	Bronze			2022-12-28	WOS:000237886000006
J	Kurland, CG; Collins, LJ; Penny, D				Kurland, CG; Collins, LJ; Penny, D			Genomics and the irreducible nature of eukaryote cells	SCIENCE			English	Review							MITOCHONDRIAL ENDOSYMBIOSIS; PHYLOGENETIC-RELATIONSHIPS; EARLY EVOLUTION; PROTEIN; ORIGIN; ANCESTRY; BACTERIA; SEQUENCE; PROVIDES; REMNANT	Large-scale comparative genomics in harness with proteomics has substantiated fundamental features of eukaryote cellular evolution. The evolutionary trajectory of modern eukaryotes is distinct from that of prokaryotes. Data from many sources give no direct evidence that eukaryotes evolved by genome fusion between archaea and bacteria. Comparative genomics shows that, under certain ecological settings, sequence loss and cellular simplification are common modes of evolution. Subcellular architecture of eukaryote cells is in part a physical-chemical consequence of molecular crowding; subcellular compartmentation with specialized proteomes is required for the efficient functioning of proteins.	Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand; Lund Univ, Dept Microbial Ecol, Lund, Sweden	Massey University; Lund University	Penny, D (corresponding author), Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand.	d.penny@massey.ac.nz	Penny, David/E-9410-2011					Akhmanova A, 1998, MOL MICROBIOL, V30, P1017, DOI 10.1046/j.1365-2958.1998.01130.x; Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Berg OG, 2000, MOL BIOL EVOL, V17, P951, DOI 10.1093/oxfordjournals.molbev.a026376; Berg OG, 2002, MOL BIOL EVOL, V19, P2265, DOI 10.1093/oxfordjournals.molbev.a004050; Bowler Peter, 1988, NONDARWINIAN REVOLUT, P94; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Cai JP, 1996, INT J SYST BACTERIOL, V46, P542, DOI 10.1099/00207713-46-2-542; Canback B, 2002, P NATL ACAD SCI USA, V99, P6097, DOI 10.1073/pnas.082112499; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; CAVALIERSMITH T, 1987, NATURE, V326, P332, DOI 10.1038/326332a0; CLARK CG, 1995, P NATL ACAD SCI USA, V92, P6518, DOI 10.1073/pnas.92.14.6518; Collins L, 2006, MOL BIOL EVOL, V23, P901, DOI 10.1093/molbev/msj084; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Copley RR, 1999, CURR OPIN STRUC BIOL, V9, P408, DOI 10.1016/S0959-440X(99)80055-4; Dacks JB, 2003, P ROY SOC B-BIOL SCI, V270, pS168, DOI 10.1098/rsbl.2003.0058; DARNELL JE, 1978, SCIENCE, V202, P1257, DOI 10.1126/science.364651; DEDUVE C, 1982, ANN NY ACAD SCI, V386, P1, DOI 10.1111/j.1749-6632.1982.tb21402.x; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Fedorov A, 2004, J MOL EVOL, V59, P695, DOI 10.1007/s00239-003-0085-1; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Gabaldon T, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bti1124; Germot A, 1996, P NATL ACAD SCI USA, V93, P14614, DOI 10.1073/pnas.93.25.14614; Gogarten JP, 1996, SCIENCE, V274, P1750; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Karlberg O, 2000, YEAST, V17, P170, DOI 10.1002/1097-0061(20000930)17:3<170::AID-YEA25>3.0.CO;2-V; Keeling PJ, 2005, CURR OPIN GENET DEV, V15, P601, DOI 10.1016/j.gde.2005.09.003; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Korbel JO, 2002, TRENDS GENET, V18, P158, DOI 10.1016/S0168-9525(01)02597-5; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lopez-Garcia P, 1999, TRENDS BIOCHEM SCI, V24, P88, DOI 10.1016/S0968-0004(98)01342-5; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Padovan ACB, 2005, J MOL EVOL, V60, P726, DOI 10.1007/s00239-004-0164-y; Penny D, 1999, CURR OPIN GENET DEV, V9, P672, DOI 10.1016/S0959-437X(99)00020-9; Pielak GJ, 2005, P NATL ACAD SCI USA, V102, P5901, DOI 10.1073/pnas.0501812102; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Poole A, 1999, BIOESSAYS, V21, P880, DOI 10.1002/(SICI)1521-1878(199910)21:10<880::AID-BIES11>3.0.CO;2-P; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Ribeiro S, 1998, MOL BIOL EVOL, V15, P779, DOI 10.1093/oxfordjournals.molbev.a025983; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; STANIER RY, 1962, ARCH MIKROBIOL, V42, P17, DOI 10.1007/BF00425185; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102	73	152	164	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1011	1014		10.1126/science.1121674	http://dx.doi.org/10.1126/science.1121674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709776				2022-12-28	WOS:000237628800033
J	Rosi, NL; Giljohann, DA; Thaxton, CS; Lytton-Jean, AKR; Han, MS; Mirkin, CA				Rosi, NL; Giljohann, DA; Thaxton, CS; Lytton-Jean, AKR; Han, MS; Mirkin, CA			Oligonucleotide-modified gold nanoparticles for intracellular gene regulation	SCIENCE			English	Article							ANTISENSE OLIGONUCLEOTIDES; ULTRASENSITIVE DETECTION; MAMMALIAN-CELLS; IN-VIVO; DNA; DELIVERY; TRANSFECTION; THERAPEUTICS; GLUTATHIONE; INHIBITION	We describe the use of gold nanoparticle-oligonucleotide complexes as intracellular gene regulation agents for the control of protein expression in cells. These oligonucleotide-modified nanoparticles have affinity constants for complementary nucleic acids that are higher than their unmodified oligonucleotide counterparts, are less susceptible to degradation by nuclease activity, exhibit greater than 99% cellular uptake, can introduce oligonucleotides at a higher effective concentration than conventional transfection agents, and are nontoxic to the cells under the conditions studied. By chemically tailoring the density of DNA bound to the surface of gold nanoparticles, we demonstrated a tunable gene knockdown.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010; Han, Min Su/S-4827-2016	Han, Min Su/0000-0001-9588-6980; Lytton-Jean, Abigail/0000-0002-1582-0066; Mirkin, Chad/0000-0002-6634-7627				Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Bergen JM, 2005, MRS BULL, V30, P663, DOI 10.1557/mrs2005.194; Bertrand JR, 2002, BIOCHEM BIOPH RES CO, V296, P1000, DOI 10.1016/S0006-291X(02)02013-2; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Bielinska AU, 1999, BIOCONJUGATE CHEM, V10, P843, DOI 10.1021/bc990036k; Dulkeith E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.203002; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Han G, 2005, BIOCONJUGATE CHEM, V16, P1356, DOI 10.1021/bc050173j; He L, 2000, J AM CHEM SOC, V122, P9071, DOI 10.1021/ja001215b; Jason TLH, 2004, TOXICOL APPL PHARM, V201, P66, DOI 10.1016/j.taap.2004.04.017; Jen CP, 2004, LANGMUIR, V20, P1369, DOI 10.1021/la036154k; Jin RC, 2003, J AM CHEM SOC, V125, P1643, DOI 10.1021/ja021096v; Lebedeva I, 2001, ANNU REV PHARMACOL, V41, P403, DOI 10.1146/annurev.pharmtox.41.1.403; Letsinger RL, 2000, BIOCONJUGATE CHEM, V11, P289, DOI 10.1021/bc990152n; Li Z, 2002, NUCLEIC ACIDS RES, V30, P1558, DOI 10.1093/nar/30.7.1558; Lytton-Jean AKR, 2005, J AM CHEM SOC, V127, P12754, DOI 10.1021/ja052255o; Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Patil SD, 2005, AAPS J, V7, pE61, DOI 10.1208/aapsj070109; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; STEPHENSON ML, 1978, P NATL ACAD SCI USA, V75, P285, DOI 10.1073/pnas.75.1.285; Sullivan MMO, 2003, GENE THER, V10, P1882, DOI 10.1038/sj.gt.3302083; Sundaram P, 1996, NUCLEIC ACIDS RES, V24, P1375, DOI 10.1093/nar/24.7.1375; Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100; Tkachenko AG, 2004, BIOCONJUGATE CHEM, V15, P482, DOI 10.1021/bc034189q; Wang ZX, 2004, J MATER CHEM, V14, P578, DOI 10.1039/b314328g; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159; ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280	31	1617	1686	8	715	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1027	1030		10.1126/science.1125559	http://dx.doi.org/10.1126/science.1125559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709779				2022-12-28	WOS:000237628800038
J	Siegel, R; Kim, U; Patke, A; Yu, X; Ren, XD; Tarakhovsky, A; Roeder, RG				Siegel, Rachael; Kim, Unkyu; Patke, Alina; Yu, Xin; Ren, Xiaodi; Tarakhovsky, Alexander; Roeder, Robert G.			Nontranscriptional regulation of SYK by the coactivator OCA-B is required at multiple stages of B cell development	CELL			English	Article							ADAPTER PROTEIN SLP-65; TYROSINE KINASE; LYMPHOCYTE DEVELOPMENT; MICE LACKING; TRANSCRIPTION; RECEPTOR; DIFFERENTIATION; SELECTION; IDENTIFICATION; ACTIVATION	OCA-B was originally identified as a nuclear transcriptional coactivator that is essential for antigen-driven immune responses. The later identification of a membrane bound, myristoylated form of OCA-B suggested additional, unique functions in B cell signaling pathways. This study has shown that OCA-B also functions in the pre-B1-to-pre-B2 cell transition and, most surprisingly, that it directly interacts with SYK, a tyrosine kinase critical for pre-BCR and BCR signaling. This unprecedented type of interaction-a transcriptional coactivator with a signaling kinase-occurs in the cytoplasm and directly regulates SYK stability. This study indicates that OCA-B is required for pre-BCR and BCR signaling at multiple stages of B cell development through its nontranscriptional regulation of SYK. Combined with the deregulation of OCA-B target genes, this may help explain the multitude of defects observed in B cell development and immune responses of Oca-b(-/-) mice.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	roeder@rockefeller.edu			NCI NIH HHS [CA 113872] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113872] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fleming HE, 2002, SEMIN IMMUNOL, V14, P423, DOI 10.1016/S1044532302000775; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Hess J, 2001, MOL CELL BIOL, V21, P1531, DOI 10.1128/MCB.21.5.1531-1539.2001; Jankovic M, 2003, INT IMMUNOL, V15, P1099, DOI 10.1093/intimm/dxg109; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kim U, 2003, P NATL ACAD SCI USA, V100, P8868, DOI 10.1073/pnas.1033108100; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Kim U, 2000, J IMMUNOL, V165, P6825, DOI 10.4049/jimmunol.165.12.6825; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Malone CS, 2002, J IMMUNOL, V168, P3369, DOI 10.4049/jimmunol.168.7.3369; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Ray RJ, 1998, J IMMUNOL, V160, P5886; ROLINK A, 1991, BIOCHEM SOC T, V19, P275, DOI 10.1042/bst0190275; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Stevens S, 2000, J IMMUNOL, V164, P5306, DOI 10.4049/jimmunol.164.10.5306; Tang H, 1999, IMMUNITY, V11, P517, DOI 10.1016/S1074-7613(00)80127-2; Teitell MA, 2003, TRENDS IMMUNOL, V24, P546, DOI 10.1016/j.it.2003.08.002; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; Wang L, 2003, CANCER RES, V63, P4724; Wang LD, 2003, IMMUNOLOGY, V110, P411, DOI 10.1111/j.1365-2567.2003.01756.x; Yu X, 2001, IMMUNITY, V14, P157, DOI 10.1016/S1074-7613(09)00090-9	34	31	32	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					761	774		10.1016/j.cell.2006.03.036	http://dx.doi.org/10.1016/j.cell.2006.03.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713566	Bronze			2022-12-28	WOS:000237886000020
J	Dolling, G; Enkrich, C; Wegener, M; Soukoulis, CM; Linden, S				Dolling, G; Enkrich, C; Wegener, M; Soukoulis, CM; Linden, S			Simultaneous negative phase and group velocity of light in a metamaterial	SCIENCE			English	Article							OPTICAL METAMATERIALS; PROPAGATION; INDEX; REFRACTION; PULSE	We investigated the propagation of femtosecond laser pulses through a metamaterial that has a negative index of refraction for wavelengths around 1.5 micrometers. From the interference fringes of a Michelson interferometer with and without the sample, we directly inferred the phase time delay. From the pulse-envelope shift, we determined the group time delay. In a spectral region, phase and group velocity are negative simultaneously. This means that both the carrier wave and the pulse envelope peak of the output pulse appear at the rear side of the sample before their input pulse counterparts have entered the front side of the sample.	Univ Karlsruhe TH, Ctr Funct Nanostruct, Inst Angew Phys & Deutsch Forschungsgemeinschaft, D-76131 Karlsruhe, Germany; Forschungszentrum KarlsruheHelmholtz Gemeinschaft, Inst Nanotechnol, D-76021 Karlsruhe, Germany; Iowa State Univ, Ames Lab, Ames, IA 50011 USA; Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; Univ Crete, Dept Mat Sci & Technol, Iraklion 71110, Crete, Greece; Fdn Res & Technol Hellas, Inst Elect Struct, Iraklion 71110, Crete, Greece	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Dolling, G (corresponding author), Univ Karlsruhe TH, Ctr Funct Nanostruct, Inst Angew Phys & Deutsch Forschungsgemeinschaft, Wolfgang Gaede Str 1, D-76131 Karlsruhe, Germany.	gunnar.dolling@physik.uni-karlsruhe.de	Wegener, Martin/S-5456-2016; Soukoulis, Costas M./A-5295-2008; Wegener, Martin/ABD-5353-2021	Wegener, Martin/0000-0002-9770-2441; Wegener, Martin/0000-0002-9770-2441				Bigelow MS, 2003, SCIENCE, V301, P200, DOI 10.1126/science.1084429; Brillouin L., 1960, WAVE PROPAGATION GRO; CHU S, 1982, PHYS REV LETT, V48, P738, DOI 10.1103/PhysRevLett.48.738; Dolling G, 2005, OPT LETT, V30, P3198, DOI 10.1364/OL.30.003198; GARRETT CGB, 1970, PHYS REV A, V1, P305, DOI 10.1103/PhysRevA.1.305; Grigorenko AN, 2005, NATURE, V438, P335, DOI 10.1038/nature04242; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Koschny T, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.245105; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Stenner MD, 2003, NATURE, V425, P695, DOI 10.1038/nature02016; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Wang LJ, 2000, NATURE, V406, P277, DOI 10.1038/35018520; Woodley JF, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046603; Zhang S, 2005, OPT EXPRESS, V13, P4922, DOI 10.1364/OPEX.13.004922; Zhang S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137404	18	633	647	13	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					892	894		10.1126/science.1126021	http://dx.doi.org/10.1126/science.1126021			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690860	Green Published			2022-12-28	WOS:000237452900041
J	Tariq, SM; Sadaf, T				Tariq, SM; Sadaf, T			Reexpansion pulmonary edema after treatment of pneumothorax	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Sultan Qaboos Univ Hosp, Muscat, Oman	Sultan Qaboos University	Tariq, SM (corresponding author), Sultan Qaboos Univ Hosp, Muscat, Oman.								0	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2046	2046		10.1056/NEJMicm050849	http://dx.doi.org/10.1056/NEJMicm050849			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687717				2022-12-28	WOS:000237413100010
J	Bukau, B; Weissman, J; Horwich, A				Bukau, Bernd; Weissman, Jonathan; Horwich, Arthur			Molecular chaperones and protein quality control	CELL			English	Review							UBIQUITIN-PROTEASOME SYSTEM; MISFOLDED GLYCOPROTEINS; HSP70 CHAPERONES; UNFOLDED PROTEIN; MECHANISM; AUTOPHAGY; ATP; DEGRADATION; IMPAIRMENT; BINDING		Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Ruprecht Karls University Heidelberg; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Scripps Research Institute; Howard Hughes Medical Institute; Yale University; Yale University	Bukau, B (corresponding author), Heidelberg Univ, Zentrum Mol Biol, Kirschnerstr 1, D-69120 Heidelberg, Germany.	horwich@csb.yale.edu	Gimenez, Luis E Diaz/D-9291-2011	Weissman, Jonathan/0000-0003-2445-670X; Bukau, Bernd/0000-0003-0521-7199				Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cormier JH, 2005, MOL CELL, V19, P717, DOI 10.1016/j.molcel.2005.08.029; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Romisch K, 2006, TRENDS BIOCHEM SCI, V31, P24, DOI 10.1016/j.tibs.2005.11.004; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200	48	1146	1195	0	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					443	451		10.1016/j.cell.2006.04.014	http://dx.doi.org/10.1016/j.cell.2006.04.014			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678092	hybrid			2022-12-28	WOS:000237506100012
J	Lonard, DM; O'Malley, BW				Lonard, David M.; O'Malley, Bert W.			The expanding cosmos of nuclear receptor coactivators	CELL			English	Editorial Material							TRANSCRIPTIONAL ACTIVATION; METHYLATION; SUPERFAMILY; COMPLEX; SRC-1; RNA		Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.tmc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD007857] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 07857, HD 08818] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; ANZICK SL, 1997, SCIENCE, V277, P955; Glass CK, 2000, GENE DEV, V14, P121; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; ONATE SA, 1995, SCIENCE, V270, P1354; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xu W, 2003, METHOD ENZYMOL, V364, P205; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	20	249	255	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					411	414		10.1016/j.cell.2006.04.021	http://dx.doi.org/10.1016/j.cell.2006.04.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678083	Bronze			2022-12-28	WOS:000237506100002
J	Lebwohl, M; Callen, JP				Lebwohl, M; Callen, JP			Obesity, smoking, and psoriasis - Commentary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONALCOHOLIC STEATOHEPATITIS; MORTALITY; ALCOHOL; RISK		Mt Sinai Sch Med, Dept Dermatol, New York, NY USA; Univ Louisville, Sch Med, Div Dermatol, Louisville, KY 40292 USA	Icahn School of Medicine at Mount Sinai; University of Louisville	Callen, JP (corresponding author), 310 E Broadway, Louisville, KY 40202 USA.	jefca@aol.com						Buslau M, 1999, ACTA DERM-VENEREOL, V79, P234; Fortes C, 2005, ARCH DERMATOL, V141, P1580, DOI 10.1001/archderm.141.12.1580; Herron MD, 2005, ARCH DERMATOL, V141, P1527, DOI 10.1001/archderm.141.12.1527; Langman G, 2001, J GASTROEN HEPATOL, V16, P1395, DOI 10.1046/j.1440-1746.2001.02644.x; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; Matsumoto T, 2004, J GASTROENTEROL, V39, P1102, DOI 10.1007/s00535-004-1451-5; McGowan JW, 2005, ARCH DERMATOL, V141, P1601, DOI 10.1001/archderm.141.12.1601; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; National Psoriasis Foundation, PSOR STAT; Poikolainen K, 1999, ARCH DERMATOL, V135, P1490, DOI 10.1001/archderm.135.12.1490; Zhang XJ, 2002, INT J DERMATOL, V41, P659, DOI 10.1046/j.1365-4362.2002.01595.x	11	15	15	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2006	295	2					208	210		10.1001/jama.295.2.208	http://dx.doi.org/10.1001/jama.295.2.208			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001NT	16715548				2022-12-28	WOS:000234544300028
J	Hahne, SJM; Charlett, A; Purcell, B; Samuelsson, S; Camaroni, I; Ehrhard, I; Heuberger, S; Santamaria, M; Stuart, JM				Hahne, SJM; Charlett, A; Purcell, B; Samuelsson, S; Camaroni, I; Ehrhard, I; Heuberger, S; Santamaria, M; Stuart, JM			Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: systematic review	BRITISH MEDICAL JOURNAL			English	Article							CASE-FATALITY RATE; HEALTH-CARE; PENICILLIN; MENINGITIS; MANAGEMENT	Objective To review the evidence for effectiveness of treatment with antibiotics before admission in reducing case fatality from meningococcal disease. Design Systematic review Data sources Cochrane register of trials and systematic reviews, database of abstracts of reviews of effectiveness, health technology assessment, and national research register in England and Wales, Medline, Embase, and CAB Health. Included studies Studies describing vital outcome of at least 10 cases of meningococcal disease classified by whether or not antibiotics were given before admission to hospital. Results 14 observational studies met the review criteria. Oral antibiotic treatment given before admission was associated with reduced mortality among cases (combined risk ratio 0.17, 95% confidence interval 0.07 to 0.44). In seven studies in which all included patients were seen in primary care, the association between parenteral antibiotics before admission and Outcome was inconsistent (chi(2) for heterogeneity 11.02, P = 0.09). After adjustment for the proportion given parenteral antibiotics before admission, there was no residual heterogeneity. A higher proportion of patients given parenteral antibiotics before admission was associated with reduced mortality after such treatment and vice versa (P = 0.04). Conclusion Confounding by severity is die most likely explanation both for the beneficial effect of oral antibiotics and the harmful effect observed in some studies of parenteral antibiotics. We cannot conclude whether or not antibiotics given before admission have an effect on case fatality. The data are consistent with benefit when a substantial proportion of cases are treated.	Hlth Protect Agcy, Stat Modelling & Bioinformat Dept, Ctr Infect, London, England; Hlth Protect Agcy, Sussex Hlth Protect Unit, Lewes, E Sussex, England; Statens Serum Inst, DK-2300 Copenhagen, Denmark; Smittskyddsinst, Dept Epidemiol, Stockholm, Sweden; Publ Hlth Lab Saxony, Dresden, Germany; Austrian Agcy Food & Hlth Safety, Austria Natl Reference Ctr Meningococci, Graz, Austria; Communicable Dis Surveillance & Response CSR, Geneva, Switzerland; Hlth Protect Agcy SW, Stonehouse, Glos, England	Health Protection Agency; Health Protection Agency; Statens Serum Institut; Swedish Institute for Infectious Disease Control	Hahne, SJM (corresponding author), Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands.	susan.hahne@rivm.nl						Barquet N, 1997, JAMA-J AM MED ASSOC, V278, P491, DOI 10.1001/jama.278.6.491; Barquet N, 2000, ARCH INTERN MED, V160, P2221; BOHR V, 1983, J INFECTION, V7, P193, DOI 10.1016/S0163-4453(83)96980-3; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; BRADBURN MJ, 1998, STATA TECHNICAL B, V44, P4; BRANDTZAEG P, 1995, MENINGOCOCCAL DIS, P79; CARTWRIGHT K, 1992, BMJ-BRIT MED J, V305, P143, DOI 10.1136/bmj.305.6846.143; Cartwright K, 1997, BRIT MED J, V315, P757; Cartwright K., 1995, MENINGOCOCCAL DIS; DOMINGO P, 1995, LANCET, V345, P460, DOI 10.1016/S0140-6736(95)90446-8; *EUR UN INV BACT I, 2002, INV NEISS MEN EUR 20; Flexner S, 1913, J EXP MED, V17, P553, DOI 10.1084/jem.17.5.553; GIMENO AM, 1999, AN ESP PEDIATR, V50, P17; Gunnell D J, 1994, Commun Dis Rep CDR Rev, V4, pR101; HALSTENSEN A, 1987, SCAND J INFECT DIS, V19, P35, DOI 10.3109/00365548709032375; Harnden A, 2006, BRIT MED J, V332, P1295, DOI 10.1136/bmj.38789.723611.55; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IDSOE O, 1968, B WORLD HEALTH ORGAN, V38, P159; Jefferies C, 1999, NEW ZEAL MED J, V112, P115; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Jolly K, 2001, Commun Dis Public Health, V4, P124; MARTIN D, 1999, EPIDEMIOLOGY MENINGO; MUNOZ MTG, 1986, AN ESP PEDIATR, V24, P213; Nadel S, 1998, J ACCID EMERG MED, V15, P298; Norgard B, 2002, J INFECTION, V45, P144, DOI 10.1053/jinf.2002.1037; PALMER SR, 1992, J INFECTION, V25, P321, DOI 10.1016/0163-4453(92)91699-C; Prins JM, 1997, J ANTIMICROB CHEMOTH, V39, P13, DOI 10.1093/jac/39.1.13; *PUBL HLTH LAB SER, PREADM BENZ PEN SUSP; PURCELL B, 2006, BRIT MED J, V328, P1339; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); SORENSEN HT, 1992, J CLIN EPIDEMIOL, V45, P1289; Sorensen HT, 1998, J CLIN EPIDEMIOL, V51, P717, DOI 10.1016/S0895-4356(98)00064-X; STRANG JR, 1992, BRIT MED J, V305, P141, DOI 10.1136/bmj.305.6846.141; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Wood AL, 1996, PUBLIC HEALTH, V110, P237, DOI 10.1016/S0033-3506(96)80109-0; Woodward C M, 1995, Commun Dis Rep CDR Rev, V5, pR135	36	26	28	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 3	2006	332	7553					1299	1301		10.1136/bmj.332.7553.1299	http://dx.doi.org/10.1136/bmj.332.7553.1299			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16740557	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000238197000019
J	Forbes, JM; Bruinsma, S; Lemoine, FG				Forbes, Jeffrey M.; Bruinsma, Sean; Lemoine, Frank G.			Solar rotation effects on the thermospheres of Mars and Earth	SCIENCE			English	Article							DENSITIES; IONOSPHERE; MODEL; FLUX	The responses of Earth's and Mars' thermospheres to the quasi-periodic (27-day) variation of solar flux due to solar rotation were measured contemporaneously, revealing that this response is twice as large for Earth as for Mars. Per typical 20-unit change in 10.7-centimeter radio flux ( used as a proxy for extreme ultraviolet flux) reaching each planet, we found temperature changes of 42.0 +/- 8.0 kelvin and 19.2 +/- 3.6 kelvin for Earth and Mars, respectively. Existing data for Venus indicate values of 3.6 +/- 0.6 kelvin. Our observational result constrains comparative planetary thermosphere simulations and may help resolve existing uncertainties in thermal balance processes, particularly CO2 cooling.	Univ Colorado, Dept Aerosp Engn Sci, Boulder, CO 80309 USA; CNES, Dept Terr & Planetary Geodesy, F-31401 Toulouse, France; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Forbes, JM (corresponding author), Univ Colorado, Dept Aerosp Engn Sci, Boulder, CO 80309 USA.	forbes@colorado.edu	Forbes, Jeffrey M/B-7234-2016; Lemoine, Frank/D-1215-2013	Forbes, Jeffrey M/0000-0001-6937-0796; Lemoine, Frank G./0000-0002-3051-1456				Bruinsma S, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001508; Bruinsma S, 2004, PLANET SPACE SCI, V52, P297, DOI 10.1016/j.pss.2003.11.004; Bruinsma S, 2003, J ATMOS SOL-TERR PHY, V65, P1053, DOI 10.1016/S1364-6826(03)00137-8; Bruinsma S, 2003, J SPACECRAFT ROCKETS, V40, P230, DOI 10.2514/2.3937; Emmert JT, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010176; HEDIN AE, 1983, J GEOPHYS RES-SPACE, V88, P73, DOI 10.1029/JA088iA01p00073; Keating G.M., 1985, ADV SPACE RES, V5, P117, DOI [10.1016/0273-1177(85)90200-5, DOI 10.1016/0273-1177(85)90200-5]; KEATING GM, 1992, J GEOPHYS RES-SPACE, V97, P4189, DOI 10.1029/91JA02444; Keating GM, 2000, GEOPHYS RES LETT, V27, P1523, DOI 10.1029/2000GL003771; MAHAJAN KK, 1990, J GEOPHYS RES-SPACE, V95, P1091, DOI 10.1029/JA095iA02p01091; Marcos FA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021269; Mendillo M, 2006, SCIENCE, V311, P1135, DOI 10.1126/science.1122099; Roble R. G., 1995, GEOPHYS MONOGRAPH SE, V87, P1; ROBLE RG, 1989, GEOPHYS RES LETT, V16, P1441, DOI 10.1029/GL016i012p01441; Withers P, 2005, PLANET SPACE SCI, V53, P1401, DOI 10.1016/j.pss.2005.07.010	15	62	65	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1366	1368		10.1126/science.1126389	http://dx.doi.org/10.1126/science.1126389			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741117				2022-12-28	WOS:000237961600051
J	Boye, E				Boye, E			DisA, a busy bee that monitors chromosome integrity	CELL			English	Editorial Material							CHECKPOINT	When nutrients are limited many prokaryotic and some eukaryotic cells tuck their chromosomes safely away in resistant spores. However, before starting the sporulation process, the prokaryote Bacillus subtilis wisely ensures that its chromosome is intact. In this issue of Cell, Bejerano-Sagie et al. (2006) describe a protein, DisA, that is responsible for the surveillance of chromosome integrity during sporulation.	Norwegian Radium Hosp, Rikshosp, Med Ctr, Dept Cell Biol, N-0310 Oslo, Norway	University of Oslo; National Hospital Norway	Boye, E (corresponding author), Norwegian Radium Hosp, Rikshosp, Med Ctr, Dept Cell Biol, N-0310 Oslo, Norway.	erik.boye@labmed.uio.no						Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; DEFAIS M, 1971, VIROLOGY, V43, P495, DOI 10.1016/0042-6822(71)90321-7; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; IRETON K, 1994, EMBO J, V13, P1566, DOI 10.1002/j.1460-2075.1994.tb06419.x; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015	6	3	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 19	2006	125	4					641	643		10.1016/j.cell.2006.05.004	http://dx.doi.org/10.1016/j.cell.2006.05.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713555	Bronze			2022-12-28	WOS:000237886000007
J	Wilme, L; Goodman, SM; Ganzhorn, JU				Wilme, L; Goodman, SM; Ganzhorn, JU			Biogeographic evolution of Madagascar's microendemic biota	SCIENCE			English	Article							LEMURS	The endemic species richness on Madagascar, relative to landmass area, is unparalleled in the world. Many organisms on the island have restricted geographical ranges. A comprehensive hypothesis explaining the evolution of this microendemism has yet to be developed. Using an analysis of watersheds in the context of Quaternary climatic shifts, we provide a new mechanistic model to explain the process of explosive speciation on the island. River catchments with sources at relatively low elevations were zones of isolation and hence led to the speciation of locally endemic taxa, whereas those at higher elevations were zones of retreat and dispersion and hence contain proportionately lower levels of microendemism. These results provide a framework for biogeographic and phylogeographic studies, as well as a basis for prioritizing conservation actions of the remaining natural forest habitats on the island.	Field Museum Nat Hist, Chicago, IL 60605 USA; Missouri Bot Garden, Antananarivo 101, Madagascar; WWF, Antananarivo 101, Madagascar; Univ Hamburg, Dept Anim Ecol & Conservat, D-20146 Hamburg, Germany	Field Museum of Natural History (Chicago); Missouri Botanical Gardens; World Wildlife Fund; University of Hamburg	Goodman, SM (corresponding author), Field Museum Nat Hist, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	sgoodman@fieldmuseum.org	Wilmé, Lucienne/A-3818-2016; Wilmé, Lucienne/AAQ-6653-2020; Ganzhorn, Joerg/AAO-6955-2020	Wilmé, Lucienne/0000-0002-8344-1957; Wilmé, Lucienne/0000-0002-8344-1957; Ganzhorn, Joerg/0000-0003-1395-9758				Andreone F, 2005, MOL PHYLOGENET EVOL, V34, P315, DOI 10.1016/j.ympev.2004.10.013; [Anonymous], 2003, NATURAL HIST MADAGAS; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Burney David A., 1997, P75; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; Krause David W., 1997, P3; Lynch-Stieglitz J, 2004, SCIENCE, V304, P1919, DOI 10.1126/science.1100374; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Rasoloarison RM, 2000, INT J PRIMATOL, V21, P963, DOI 10.1023/A:1005511129475; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Straka H, 1996, COLLOQ SEMI, P37; Thalmann Urs, 2000, P191; *WORLD CONS UN IUC, 2005, P 5 IUCN WORLD WORLD, P25; Yoder AD, 2005, P NATL ACAD SCI USA, V102, P6587, DOI 10.1073/pnas.0502092102	21	316	328	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1063	1065		10.1126/science.1122806	http://dx.doi.org/10.1126/science.1122806			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709785				2022-12-28	WOS:000237628800048
J	Schievink, WI				Schievink, WI			Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							THORACIC DISC HERNIATION; SPONTANEOUS CSF LEAKS; EPIDURAL BLOOD PATCH; MARFAN-SYNDROME; ORTHOSTATIC HEADACHES; SURGICAL-TREATMENT; SKELETAL FEATURES; POSTURAL HEADACHE; DURAL ENHANCEMENT; HYPOVOLEMIA	Context Spontaneous intracranial hypotension is caused by spontaneous spinal cerebrospinal fluid (CSF) leaks and is known for causing orthostatic headaches. It is an important cause of new headaches in young and middle-aged individuals, but initial misdiagnosis is common. Objective To summarize existing evidence regarding the epidemiology, pathophysiology, diagnosis, and management of spontaneous spinal CSF leaks and intracranial hypotension. Evidence Acquisition MEDLINE (1966-2005) and OLDMEDLINE (1950-1965) were searched using the terms intracranial hypotension, CSF leak, low pressure headache, and CSF hypovolemia. Reference lists of these articles and ongoing investigations in this area were used as well. Evidence Synthesis Spontaneous intracranial hypotension is caused by single or multiple spinal CSF leaks. The incidence has been estimated at 5 per 100 000 per year, with a peak around age 40 years. Women are affected more commonly than men. Mechanical factors combine with an underlying connective tissue disorder to cause the CSF leaks. An orthostatic headache is the prototypical manifestation but other headache patterns occur as well, and associated symptoms are common. Typical magnetic resonance imaging findings include subdural fluid collections, enhancement of the pachymeninges, engorgement of venous structures, pituitary hyperemia, and sagging of the brain ( mnemonic: SEEPS). Myelography is the study of choice to identify the spinal CSF leak. Treatments include bed rest, epidural blood patching, percutaneous placement of fibrin sealant, and surgical CSF leak repair, but outcomes have been poorly studied and no management strategies have been studied in properly controlled randomized trials. Conclusions Spontaneous intracranial hypotension is not rare but it remains underdiagnosed. The spectrum of clinical and radiographic manifestations is varied, with diagnosis largely based on clinical suspicion, cranial magnetic resonance imaging, and myelography. Numerous treatment options are available, but much remains to be learned about this disorder.	Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Schievink, WI (corresponding author), Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, 8631 W 3rd St,Suite 800E, Los Angeles, CA 90048 USA.	schievinkw@cshs.org						Alvarez-Linera J, 2000, NEUROLOGY, V55, P1895, DOI 10.1212/WNL.55.12.1895; Baryshnik DB, 2004, NEUROLOGY, V62, P1445, DOI 10.1212/01.WNL.0000120750.40453.64; Beck CE, 1998, J NEUROSURG, V89, P470, DOI 10.3171/jns.1998.89.3.0470; BELL WE, 1960, NEUROLOGY, V10, P512, DOI 10.1212/WNL.10.5.512; Berroir S, 2004, CEREBROVASC DIS, V17, P9, DOI 10.1159/000073892; Berroir S, 2004, NEUROLOGY, V63, P1950, DOI 10.1212/01.WNL.0000144339.34733.E9; BILLINGS J J, 1975, Proceedings of the Australian Association of Neurologists, V12, P31; Binder DK, 2005, J NEUROSURG-SPINE, V2, P614, DOI 10.3171/spi.2005.2.5.0614; Binder DK, 2002, NEUROSURGERY, V51, P830, DOI 10.1227/01.NEU.0000024286.95876.2F; Brady-McCreery Kathryn M, 2002, Binocul Vis Strabismus Q, V17, P43; Burtis MT, 2005, AM J NEURORADIOL, V26, P34; Chiapparini L, 2002, NEURORADIOLOGY, V44, P143, DOI 10.1007/s002340100685; Chung SJ, 2000, NEUROLOGY, V55, P1321, DOI 10.1212/WNL.55.9.1321; DAVENPORT RJ, 1995, J NEUROL NEUROSUR PS, V59, P516, DOI 10.1136/jnnp.59.5.516; de Noronha RJ, 2003, J NEUROL NEUROSUR PS, V74, P752, DOI 10.1136/jnnp.74.6.752; Dillon WP, 1998, AM J NEURORADIOL, V19, P1001; Dillon WP, 2001, AM J NEURORADIOL, V22, P1233; ERKULVRAWATR S, 1979, ARCH NEUROL-CHICAGO, V36, P557, DOI 10.1001/archneur.1979.00500450051008; Eross EJ, 2002, CEPHALALGIA, V22, P769, DOI 10.1046/j.1468-2982.2002.00487.x; Eross EJ, 2002, CEPHALALGIA, V22, P439, DOI 10.1046/j.1468-2982.2002.00385.x; Ferrante E, 1998, J Neurosurg Sci, V42, P177; FISHMAN RA, 1993, NEUROLOGY, V43, P609, DOI 10.1212/WNL.43.3_Part_1.609; Fukutake T, 1997, HEADACHE, V37, P291, DOI 10.1046/j.1526-4610.1997.3705291.x; Garcia-Morales I, 2001, CEPHALALGIA, V21, P703, DOI 10.1046/j.1468-2982.2001.00226.x; HOLMES JM, 1953, BMJ-BRIT MED J, V20, P1363; Hong M, 2002, NEUROLOGY, V58, P1285, DOI 10.1212/WNL.58.8.1285; HORTON JC, 1994, OPHTHALMOLOGY, V101, P244; Kashmere JL, 2004, CAN J NEUROL SCI, V31, P565, DOI 10.1017/S0317167100003826; Koss SA, 2003, AM J NEURORADIOL, V24, P704; LASATER G M, 1970, Headache, V10, P63, DOI 10.1111/j.1526-4610.1970.hed1002063.x; LEHMAN RAW, 1977, J PEDIATR-US, V90, P49, DOI 10.1016/S0022-3476(77)80763-4; Levine DN, 2001, J NEUROL SCI, V192, P1, DOI 10.1016/S0022-510X(01)00601-3; LINDQVIST T, 1949, ACTA MED SCAND, V132, P556; Mamelak AN, 1996, J NEUROSURG, V85, P192; MILES J, 1969, J NEUROL NEUROSUR PS, V32, P99, DOI 10.1136/jnnp.32.2.99; Milledge JT, 2005, J PAEDIATR CHILD H, V41, P68, DOI 10.1111/j.1440-1754.2005.00541.x; Miyazawa K, 2003, NEUROLOGY, V60, P941, DOI 10.1212/01.WNL.0000049933.51044.81; Moayeri NN, 1998, J NEUROSURG, V88, P912, DOI 10.3171/jns.1998.88.5.0912; Mokri B, 1999, MAYO CLIN PROC, V74, P1113, DOI 10.4065/74.11.1113; Mokri B, 1997, MAYO CLIN PROC, V72, P400, DOI 10.4065/72.5.400; Mokri B, 2004, CEPHALALGIA, V24, P883, DOI 10.1111/j.1468-2982.2004.00763.x; Mokri B, 2003, NEUROLOGY, V61, P980, DOI 10.1212/01.WNL.0000085868.37963.7D; Mokri B, 2002, CEPHALALGIA, V22, P780, DOI 10.1046/j.1468-2982.2002.00400.x; Mokri B, 2002, NEUROLOGY, V58, P814, DOI 10.1212/WNL.58.5.814; MOKRI B, 1991, ANN NEUROL, V30, P294; Mokri B, 2000, NEUROLOGY, V55, P573, DOI 10.1212/WNL.55.4.573; Moriyama E, 2004, J NEUROSURG, V101, P421, DOI 10.3171/jns.2004.101.3.0421; MURROS K, 1983, J NEUROL NEUROSUR PS, V46, P1149, DOI 10.1136/jnnp.46.12.1149; NOSIK WA, 1955, JAMA-J AM MED ASSOC, V157, P1110, DOI 10.1001/jama.1955.02950300038008; O'Leary DH, 1998, NEW ENGL J MED, V338, P180, DOI 10.1056/NEJM199801153380308; Pakiam ASI, 1999, ARCH NEUROL-CHICAGO, V56, P869, DOI 10.1001/archneur.56.7.869; PANNULLO SC, 1993, NEUROLOGY, V43, P919, DOI 10.1212/WNL.43.5.919; PHILIP N, 1995, CLIN DYSMORPHOL, V4, P347, DOI 10.1097/00019605-199510000-00011; Pleasure SJ, 1998, NEUROLOGY, V50, P1854, DOI 10.1212/WNL.50.6.1854; Portier F, 2002, ANN OTO RHINOL LARYN, V111, P817, DOI 10.1177/000348940211100910; Rabin BM, 1998, AM J NEURORADIOL, V19, P1034; RANDO TA, 1992, NEUROLOGY, V42, P481, DOI 10.1212/WNL.42.3.481; Rapport RL, 2003, J NEUROSURG, V98, P282, DOI 10.3171/spi.2003.98.3.0282; RENOWDEN SA, 1995, J NEUROL NEUROSUR PS, V59, P511, DOI 10.1136/jnnp.59.5.511; Roll JD, 2003, AM J NEURORADIOL, V24, P707; Rosser T, 2005, J CHILD NEUROL, V20, P153, DOI 10.1177/08830738050200021701; Sato Y, 1997, CEPHALALGIA, V17, P42, DOI 10.1046/j.1468-2982.1997.1701042.x; Schaltenbrand G., 1938, ZENTRALBL NEUROCHIR, V3, P290; Schievink W I, 2000, Neurosurg Focus, V9, pe8, DOI 10.3171/foc.2000.9.1.8; SCHIEVINK WI, 1994, J NEUROSURG, V80, P736, DOI 10.3171/jns.1994.80.4.0736; Schievink WI, 2005, J NEUROSURG, V103, P608, DOI 10.3171/jns.2005.103.4.0608; Schievink WI, 2005, NEUROLOGY, V65, P135, DOI 10.1212/01.wnl.0000167192.86419.15; Schievink WI, 2005, HEADACHE, V45, P607, DOI 10.1111/j.1526-4610.2005.05117_2.x; Schievink WI, 2005, NEUROLOGY, V64, P1282, DOI 10.1212/01.WNL.0000156906.84165.C0; Schievink WI, 2004, J NEUROSURG, V100, P1098, DOI 10.3171/jns.2004.100.6.1098; Schievink WI, 2004, J NEUROSURG, V100, P639, DOI 10.3171/jns.2004.100.4.0639; Schievink WI, 2004, NEUROSURGERY, V54, P65, DOI 10.1227/01.NEU.0000097200.18478.7B; Schievink WI, 2003, ARCH NEUROL-CHICAGO, V60, P1713, DOI 10.1001/archneur.60.12.1713; Schievink WI, 2003, NEUROSURGERY, V53, P1216, DOI 10.1227/01.NEU.0000089483.30857.11; Schievink WI, 2003, J NEUROSURG, V99, P840, DOI 10.3171/jns.2003.99.5.0840; Schievink WI, 1998, NEUROLOGY, V51, P1768, DOI 10.1212/WNL.51.6.1768; Schievink WI, 1998, J NEUROSURG, V88, P243, DOI 10.3171/jns.1998.88.2.0243; Schievink WI, 2000, J NEUROSURG, V92, P475, DOI 10.3171/jns.2000.92.3.0475; Schievink WI, 1996, LANCET, V347, P1409, DOI 10.1016/S0140-6736(96)91048-X; Schievink WI, 1996, J NEUROSURG, V84, P598, DOI 10.3171/jns.1996.84.4.0598; Schievink WI, 1997, LANCET, V349, P1223, DOI 10.1016/S0140-6736(05)62417-8; Schievink WI, 1998, ANN NEUROL, V44, P458; Schievink WI, 2001, NEUROSURGERY, V48, P513, DOI 10.1097/00006123-200103000-00009; SCHIEVINK WI, 2005, HDB CEREBRAL ARTERY, P12; SCHIEVINK WI, IN PRESS NEUROLOGY; Schoffer KL, 2002, CAN J NEUROL SCI, V29, P253, DOI 10.1017/S0317167100002031; Schrijver I, 2002, J NEUROSURG, V96, P483, DOI 10.3171/jns.2002.96.3.0483; Sencakova D, 2001, NEUROLOGY, V57, P1921, DOI 10.1212/WNL.57.10.1921; Sharma P, 2001, J NEUROSURG, V95, P905, DOI 10.3171/jns.2001.95.5.0905; Shimazu Noriko, 1998, Nippon Acta Radiologica, V58, P349; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SIPE JC, 1981, NEUROLOGY, V31, P334, DOI 10.1212/WNL.31.3.334; TENG P, 1968, Bulletin of the Los Angeles Neurological Societies, V33, P121; Vishteh AG, 1998, J NEUROSURG, V89, P483, DOI 10.3171/jns.1998.89.3.0483; Warner GTA, 2002, CEPHALALGIA, V22, P822, DOI 10.1046/j.1468-2982.2002.00433.x; WEBER WEJ, 1991, CLIN NEUROL NEUROSUR, V93, P55, DOI 10.1016/0303-8467(91)90010-M; Weisfelt M, 2005, Ned Tijdschr Geneeskd, V149, P1001; Whiteley W, 2003, BRIT J NEUROSURG, V17, P456, DOI 10.1080/02688690310001611251; Winter SCA, 2002, J NEUROSURG, V96, P343, DOI 10.3171/spi.2002.96.3.0343; YAMAMOTO M, 1993, INTERNAL MED, V32, P228, DOI 10.2169/internalmedicine.32.228; Yousry I, 2001, AM J NEURORADIOL, V22, P1239	101	624	658	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2006	295	19					2286	2296		10.1001/jama.295.19.2286	http://dx.doi.org/10.1001/jama.295.19.2286			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042UX	16705110	Bronze			2022-12-28	WOS:000237556600027
J	Lau, S; Matricardi, PM				Lau, S; Matricardi, PM			Worms, asthma, and the hygiene hypothesis	LANCET			English	Editorial Material							ALLERGIC REACTIVITY; ATOPY; CHILDREN; SCHOOLCHILDREN; ASSOCIATION; INFECTIONS; PARASITES; SYMPTOMS; EXPOSURE; TRIAL		Charite Univ Med Ctr, Dept Paediat Pneumol & Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lau, S (corresponding author), Charite Univ Med Ctr, Dept Paediat Pneumol & Immunol, D-13353 Berlin, Germany.	susanne.lau@charite.de						BUIJS J, 1994, AM J EPIDEMIOL, V140, P839, DOI 10.1093/oxfordjournals.aje.a117332; Cooper PJ, 2006, LANCET, V367, P1598, DOI 10.1016/S0140-6736(06)68697-2; Cooper PJ, 2002, CLIN EXP IMMUNOL, V128, P398, DOI 10.1046/j.1365-2249.2002.01908.x; Cooper PJ, 2003, AM J RESP CRIT CARE, V168, P313, DOI 10.1164/rccm.200211-1320OC; Falcone FH, 2005, TRENDS PARASITOL, V21, P157, DOI 10.1016/j.pt.2005.02.002; GROVE DI, 1982, ALLERGY, V37, P139, DOI 10.1111/j.1398-9995.1982.tb01889.x; ISHIZAKA K, 1967, J IMMUNOL, V99, P1187; JOHANSSO.SG, 1967, LANCET, V2, P951; JOHANSSON SG, 1968, LANCET, V1, P1118; LYNCH NR, 1993, J ALLERGY CLIN IMMUN, V92, P404, DOI 10.1016/0091-6749(93)90119-Z; LYNCH NR, 1987, CLIN ALLERGY, V17, P199, DOI 10.1111/j.1365-2222.1987.tb02004.x; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Nyan OA, 2001, CLIN EXP ALLERGY, V31, P1672, DOI 10.1046/j.1365-2222.2001.00987.x; *PAN AM HLTH ORG, 2001, EC HLTH SIT AN TREND; Pelosi U, 2005, ALLERGY, V60, P626, DOI 10.1111/j.1398-9995.2005.00747.x; Schafer T, 2005, ALLERGY, V60, P1014, DOI 10.1111/j.1398-9995.2005.00801.x; Scrivener S, 2001, LANCET, V358, P1493, DOI 10.1016/S0140-6736(01)06579-5; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Tedeschi A, 2003, CLIN EXP ALLERGY, V33, P449, DOI 10.1046/j.1365-2222.2003.01628.x; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	23	13	14	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2006	367	9522					1556	1558		10.1016/S0140-6736(06)68670-4	http://dx.doi.org/10.1016/S0140-6736(06)68670-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698395				2022-12-28	WOS:000237598000007
J	Berman, E; Nicolaides, M; Maki, RG; Fleisher, M; Chanel, S; Scheu, K; Wilson, BA; Heller, G; Sauter, NP				Berman, E; Nicolaides, M; Maki, RG; Fleisher, M; Chanel, S; Scheu, K; Wilson, BA; Heller, G; Sauter, NP			Altered bone and mineral metabolism in patients receiving imatinib mesylate	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; PDGF-BB; RESORPTION; CELLS	BACKGROUND: Imatinib mesylate inhibits several tyrosine kinases, including BCR-ABL, the C-KIT receptor, and the platelet-derived growth factor receptors (alpha) and (beta), all of which are associated with disease. We observed that hypophosphatemia developed in some patients with either chronic myelogenous leukemia or gastrointestinal stromal tumors who were receiving imatinib. METHODS: We identified 16 patients who had low serum phosphate levels and 8 patients who had normal serum phosphate levels, all of whom were receiving imatinib. We performed the following biochemical measurements: whole-blood levels of ionized calcium, plasma levels of intact parathyroid hormone, and serum levels of total calcium, phosphate, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, magnesium, and markers of bone formation (bone alkaline phosphatase and osteocalcin) and bone resorption (N-telopeptide of collagen cross-links); urinalysis; and phosphate, calcium, and creatinine levels in ``spot'' urine specimens. RESULTS: Patients in the low-phosphate group (median serum phosphate level, 2.0 mg per deciliter [0.6 mmol per liter]; normal level, >2.5 mg per deciliter [0.8 mmol per liter]) had elevated parathyroid hormone levels and low-to-normal serum calcium levels, were younger, and were receiving a higher dose of imatinib than patients in the normal-phosphate group (median level, 3.2 mg per deciliter [1.0 mmol per liter]). Both groups had high levels of phosphate excreted in the urine and markedly decreased serum levels of osteocalcin and N-telopeptide of collagen cross-links. CONCLUSIONS: Hypophosphatemia, with associated changes in bone and mineral metabolism, develops in a proportion of patients taking imatinib for either chronic myelogenous leukemia or gastrointestinal stromal tumors. The drug may inhibit bone remodeling (formation and resorption), even in patients with normal serum phosphate levels.	Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Clin Labs, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Berman, E (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA.	bermane@mskcc.org	Maki, Robert G./AAI-2793-2020; Maki, Robert G/J-9145-2019	Maki, Robert G/0000-0002-9853-2528				BOUILLON R, 1975, J CLIN ENDOCR METAB, V41, P1130, DOI 10.1210/jcem-41-6-1130; Brame LA, 2004, SEMIN NEPHROL, V24, P39, DOI 10.1053/j.semnephrol.2003.08.016; Chaudhary LR, 2001, J CELL BIOCHEM, V81, P304, DOI 10.1002/1097-4644(20010501)81:2<304::AID-JCB1045>3.3.CO;2-L; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Efron B., 1994, MONOGRAPHS STAT APPL; El-Hajj Fuleihan G, 1997, J CLIN ENDOCR METAB, V82, P281, DOI 10.1210/jc.82.1.281; Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219; Gertz BJ, 1998, CALCIFIED TISSUE INT, V63, P102, DOI 10.1007/s002239900497; Gottardi M, 2005, NEW ENGL J MED, V353, P2722, DOI 10.1056/NEJMc052500; HALEVY J, 1988, ARCH INTERN MED, V148, P153, DOI 10.1001/archinte.148.1.153; Hannon R, 2000, OSTEOPOROSIS INT, V11, P30, DOI 10.1007/s001980070004; Herbst RS, 2006, J CLIN ONCOL, V24, P190, DOI 10.1200/JCO.2005.04.8678; HICKEY L, 2004, CURR OPIN ENDOCRINOL, V11, P18, DOI DOI 10.1097/00060793-200402000-00006; HOCK JM, 1994, ENDOCRINOLOGY, V134, P1423, DOI 10.1210/en.134.3.1423; Kronenberg HM, 2002, NEW ENGL J MED, V347, P1022, DOI 10.1056/NEJMe020098; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mitlak BH, 1996, J BONE MINER RES, V11, P238; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; SHAYMAN JA, 1995, RENAL PATHOPHYSIOLOG, P27; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; WIKTORJEDRZEJCZAK W, 1991, P NATL ACAD SCI USA, V88, P5937; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Zhang ZM, 1998, BIOCHEM BIOPH RES CO, V251, P190, DOI 10.1006/bbrc.1998.9412	27	224	229	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2006	2013		10.1056/NEJMoa051140	http://dx.doi.org/10.1056/NEJMoa051140			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687713				2022-12-28	WOS:000237413100005
J	Larson, AM; Curtis, JR				Larson, AM; Curtis, JR			Integrating palliative care for liver transplant candidates - "Too well for transplant, too sick for life"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CIRRHOSIS TYPE-B; HEPATITIS-B; CANCER-PATIENTS; HEPATOCELLULAR-CARCINOMA; DYING PATIENTS; PHYSICIAN COMMUNICATION; PROGNOSTIC FACTORS; EMOTIONAL SUPPORT; FAMILY-MEMBERS	Chronic liver disease results in more than 1 million physician visits and more than 300 000 hospitalizations per year in the United States. More than 27 000 patients annually progress to end-stage liver disease (ESLD), liver failure, or death. Patients with ESLD experience such complications as encephalopathy, malnutrition, muscle wasting, ascites, esophagogastric variceal hemorrhage, spontaneous bacterial peritonitis, fatigue, and depression. Despite significant improvements in palliation, patients' quality of life diminishes and their disease will often inexorably progress. Liver transplantation, a valid treatment option, increases life and reduces many symptoms. With the current shortage of organs, up to 10% to 15% of these patients die without receiving an organ. Many patients also are not candidates for transplantation due to comorbid illness. In addition, some patients receive a transplant but succumb to complications of the transplant itself. Such patients and families face the conundrum of a potentially treatable yet often fatal illness. Through the case of a 55-year-old woman with a life-long history of hepatitis B virus infection who is awaiting transplant, we discuss the transplant eligibility process and the struggle with maintaining hope for a cure in the face a life-threatening illness. In all of these circumstances, the health care team must combine elements of palliative care with life-sustaining therapy to maximize the patient's quality and quantity of life.	Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Larson, AM (corresponding author), Univ Washington, Hepatol Div, UW Box 356174,NE Pacific St, Seattle, WA 98195 USA.	amlarson@u.washington.edu	Larson, Anne/I-2087-2019		NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR008016] Funding Source: NIH RePORTER; NINR NIH HHS [R01-NR-008016] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Arguedas MR, 2003, DIGEST DIS SCI, V48, P1622, DOI 10.1023/A:1024784327783; Azoulay E, 2002, AM J RESP CRIT CARE, V165, P438, DOI 10.1164/ajrccm.165.4.200108-006oc; Back Anthony L, 2005, J Palliat Med, V8, P26, DOI 10.1089/jpm.2005.8.26; Back Anthony L, 2003, Ann Intern Med, V138, P439; Bavdekar Ashish, 2002, Indian Journal of Pediatrics, V69, P427, DOI 10.1007/BF02722636; BENNER KG, 1992, GASTROENTEROLOGY, V103, P1307, DOI 10.1016/0016-5085(92)91521-5; Benzein E, 2001, PALLIATIVE MED, V15, P117, DOI 10.1191/026921601675617254; Bianchi G, 2003, DIGEST LIVER DIS, V35, P46, DOI 10.1016/S1590-8658(02)00011-7; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; BLOCK SD, 2000, MANAGING DEATH INTEN; Brown R, 1997, ANN ONCOL, V8, P877, DOI 10.1023/A:1008213630112; BRUHN JG, 1984, SOUTH MED J, V77, P215, DOI 10.1097/00007611-198402000-00020; Bryce CL, 2004, QUAL LIFE RES, V13, P773, DOI 10.1023/B:QURE.0000021685.83961.88; Buehler J A, 1975, Am J Nurs, V75, P1353, DOI 10.2307/3423622; Cardenas A, 2005, J HEPATOL, V42, pS124, DOI 10.1016/j.jhep.2004.12.007; Carline JD, 2003, J PAIN SYMPTOM MANAG, V25, P19, DOI 10.1016/S0885-3924(02)00537-7; Carson J L, 1993, Drugs, V46 Suppl 1, P243; Child C G, 1964, Major Probl Clin Surg, V1, P1; Collie A, 2005, LIVER INT, V25, P1, DOI 10.1111/j.1478-3231.2005.01012.x; Conn H O, 1981, Hepatology, V1, P673, DOI 10.1002/hep.1840010617; Cordoba J, 2003, J HEPATOL, V39, P231, DOI 10.1016/S0168-8278(03)00189-2; COUSINS N, 1989, BIOL HOPE HEALING PO; *CTR MED MED SERV, MED HOSP BEN SPEC WA; Curtis JR, 1997, J GEN INTERN MED, V12, P736, DOI 10.1046/j.1525-1497.1997.07158.x; Curtis JR, 2004, EUR RESPIR J, V24, P200, DOI 10.1183/09031936.04.00010104; DAVIES SE, 1991, HEPATOLOGY, V13, P150, DOI 10.1002/hep.1840130122; DEJONGH FE, 1992, GASTROENTEROLOGY, V103, P1630, DOI 10.1016/0016-5085(92)91188-A; Devulder J, 2005, CURR MED RES OPIN, V21, P1555, DOI 10.1185/030079905X65321; Edwards E B, 2001, Clin Transpl, P19; FALLOWFIELD L, 1993, LANCET, V341, P476, DOI 10.1016/0140-6736(93)90219-7; Fallowfield L, 1998, J CLIN ONCOL, V16, P1961, DOI 10.1200/JCO.1998.16.5.1961; FATTOVICH G, 1995, HEPATOLOGY, V21, P77; FATTOVICH G, 1991, GUT, V32, P294, DOI 10.1136/gut.32.3.294; Ford S, 1996, SOC SCI MED, V42, P1511, DOI 10.1016/0277-9536(95)00265-0; Forman LM, 2001, HEPATOLOGY, V33, P473, DOI 10.1053/jhep.2001.22481; Freeman RB, 2005, LIVER TRANSPLANT, V11, P134, DOI 10.1002/lt.20322; Gulberg V, 2002, DIGESTION, V66, P127, DOI 10.1159/000065593; HERTH K, 1990, J ADV NURS, V15, P1250, DOI 10.1111/j.1365-2648.1990.tb01740.x; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Hough CL, 2005, J CRIT CARE, V20, P20, DOI 10.1016/j.jcrc.2004.09.006; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kanwal F, 2004, AM J GASTROENTEROL, V99, P1726, DOI 10.1111/j.1572-0241.2004.30300.x; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; LANDRY FJ, 1992, ARCH INTERN MED, V152, P2305, DOI 10.1001/archinte.152.11.2305; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; LIAW YF, 1989, LIVER, V9, P235; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; MACMAHON BJ, 1997, VIRAL HEPATITIS, P315; Maguire P, 1996, EUR J CANCER, V32A, P1486, DOI 10.1016/0959-8049(96)00059-7; Maguire P, 1999, EUR J CANCER, V35, P2058, DOI 10.1016/S0959-8049(99)00301-9; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; McCaughan GW, 2001, HEPATOLOGY, V34, P215, DOI 10.1053/jhep.2001.26164; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x; Miller J F, 1989, Appl Nurs Res, V2, P23; Montalbano M, 2005, Minerva Gastroenterol Dietol, V51, P109; National Comprehensive Cancer Network, 2014, CLIN PRACT GUID ONC; Nekolaichuk CL, 1998, J PALLIAT CARE, V14, P36, DOI 10.1177/082585979801400107; *NIH CONS DEV C LI, 1984, HEPATOLOGY, V4, pS1; *ORG PROC TRANSPL, TRANSPL US REC ABO; Parle M, 1997, SOC SCI MED, V44, P231, DOI 10.1016/S0277-9536(96)00148-7; Per?kyl? Annsi., 1991, QUALITATIVE HLTH RES, V1, P407, DOI DOI 10.1177/104973239100100402; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; REALDI G, 1994, J HEPATOL, V21, P656, DOI 10.1016/S0168-8278(94)80115-0; Redinbaugh EM, 2003, BMJ-BRIT MED J, V327, P185, DOI 10.1136/bmj.327.7408.185; ROBERTS CS, 1994, CANCER, V74, P336, DOI 10.1002/cncr.2820741319; Saab S, 2005, LIVER TRANSPLANT, V11, P218, DOI 10.1002/lt.20345; Schafer D, 2001, TRANSPLANTATION LIVE, P1; Schomerus H, 2001, METAB BRAIN DIS, V16, P37, DOI 10.1023/A:1011610427843; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Singh N, 1997, DIGEST DIS SCI, V42, P1421, DOI 10.1023/A:1018898106656; Slevin ML, 1996, BRIT J CANCER, V74, P1275, DOI 10.1038/bjc.1996.529; Smith Thomas J, 2003, J Palliat Med, V6, P699, DOI 10.1089/109662103322515202; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14; Srivastava Nandini, 2003, Trop Gastroenterol, V24, P59; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; TATTERSALL MHN, 1994, J CLIN ONCOL, V12, P1305, DOI 10.1200/JCO.1994.12.6.1305; Tegeder I, 1999, CLIN PHARMACOKINET, V37, P17, DOI 10.2165/00003088-199937010-00002; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; van der Plas SM, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-33; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Weir MR, 2002, CLEV CLIN J MED, V69, P53; Wenrich MD, 2003, J PAIN SYMPTOM MANAG, V25, P236, DOI 10.1016/S0885-3924(02)00694-2; Wenrich MD, 2001, ARCH INTERN MED, V161, P868, DOI 10.1001/archinte.161.6.868; Westphal JF, 1997, DRUG SAFETY, V17, P47, DOI 10.2165/00002018-199717010-00004; WHIPPEN DA, 1991, J CLIN ONCOL, V9, P1916, DOI 10.1200/JCO.1991.9.10.1916; Wiesinger GF, 2001, J REHABIL MED, V33, P260; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879; WongWylie G, 1997, QUAL HEALTH RES, V7, P32, DOI 10.1177/104973239700700103; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Younossi ZM, 2001, AM J GASTROENTEROL, V96, P2199, DOI 10.1016/S0002-9270(01)02519-9	96	70	70	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2006	295	18					2168	2176		10.1001/jama.295.18.2168	http://dx.doi.org/10.1001/jama.295.18.2168			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040OW	16684988				2022-12-28	WOS:000237391300027
J	Crubezy, E; Magnaval, JF; Francfort, HP; Ludes, B; Larrouy, G				Crubezy, E; Magnaval, JF; Francfort, HP; Ludes, B; Larrouy, G			Herodotus, the Scythes and hookworm infection	LANCET			English	Editorial Material									Univ Toulouse 3, Fac Med, Dept Parasitol, F-31073 Toulouse 07, France; Univ Toulouse 3, CNRS, UMR 8555, F-31062 Toulouse, France; Univ Strasbourg 1, Inst Med Legale, Strasbourg, France; Maison Rene Ginouves, Archeol Asie Cent, Nanterre, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Magnaval, JF (corresponding author), Univ Toulouse 3, Fac Med, Dept Parasitol, 37 Allees Jules Guesde, F-31073 Toulouse 07, France.	magnaval@cict.fr	LUDES, Bertrand/AAB-6309-2022; Magnaval, Jean-Francois/AAA-7549-2022; Crubézy, Eric/AAB-5165-2022	Crubézy, Eric/0000-0001-9417-9053				Clisson I, 2002, INT J LEGAL MED, V116, P304, DOI 10.1007/s00414-002-0295-x; FRANCFORT HP, 2000, ACAD INSCRIP BELLES, P755; Rudenko S. I, 1970, FROZEN TOMBS SIBERIA	3	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1520	1520		10.1016/S0140-6736(06)68652-2	http://dx.doi.org/10.1016/S0140-6736(06)68652-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679165				2022-12-28	WOS:000237324200032
J	Liu, ZL; Xiong, TB; Meads, C				Liu, Zulian; Xiong, Tengbin; Meads, Catherine			Clinical effectiveness of treatment with hyperbaric oxygen for neonatal hypoxic-ischaemic encephalopathy: systematic review of Chinese literature	BRITISH MEDICAL JOURNAL			English	Review								Objectives To investigate the clinical effectiveness of treatment with hyperbaric oxygen for neonates with hypoxic-ischaemic encephalopathy. This treatment is frequently used in China but much less often in the West. Data sources Western (Cochrane controlled trials register and database of systematic reviews, Medline, Embase, CINAHL, and HealthSTAR) and Chinese (China Hospital Digital Library, Chinese Medical journal Network) databases and hand search of Chinese journals. No language restrictions. Review methods Randomised or quasi-randomised controlled trials of treatment with hyperbaric oxygen compared with "usual care" in term neonates with hypoxic-ischaemic encephalopathy. Outcomes included mortality and long term neurological sequelae. Standardised forms were used to extract and compare data. Criteria of York Centre for Reviews and Dissemination were used to assess quality. Analysis was mainly qualitative but included meta-analysis. Results 20 trials were found, mainly from Chinese sources. The reporting quality of trials was poor by Western (CONSORT) standards. Treatment with hyperbaric oxygen had better outcomes than the comparator in almost all trials. The odds ratios of the meta-analyses were 0.26 (95% confidence interval 0.14 to 0.46) for mortality and 0.41 (0.27 to 0.6 1) for neurological sequelae. Conclusion Treatment with hyperbaric oxygen possibly reduces mortality and neurological sequelae in term neonates with hypoxic-ischaemic encephalopathy. Because of the poor quality of reporting in all trials and the possibility of publication bias, an adequately powered, high quality randomised controlled trial is needed to investigate these findings. The Chinese medical literature may be a rich source of evidence to inform clinical practice and other systematic reviews.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Meads, C (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	c.a.meads@bham.ac.uk		Meads, Catherine/0000-0002-2368-0665				AKSENOW I, 2004, UND HYP MED SOC ANN; CHEN ZL, 1995, CHIN J PRACTICAL PED, V2, P86; CHEN ZP, 2000, HUA XIA MED, V2, P155; DING YY, 2003, CHIN J MOD CLIN MED, P1; HE KM, 2000, CHIN J CONT PEDIAT, V2, P345; JACOBS S, 2003, COCHRANE DB SYST REV, V4; KENT A, 2003, COCHRANE DB SYST REV, V2, DOI UNSP CD004494; KHAN KS, 2001, 4 NHS CRD; LI HY, 2004, CHIN J MODERN CHINES, V2; LIN XZ, 2000, J NEONATAL, V15, P172; LIU HL, 2003, CHIN J PRACT CHIN MO, V3, P770; LU DF, 2001, J CHIN PHYS, V29, P38; LU HY, 2003, J XIANNING COLL MED, V17, P115; LU JF, 1999, J GUANGXI MED U, V16, P703; Ramaswami R. A., 2000, Hong Kong Medical Journal, V6, P108; *RICHM HYP HLTH CT, SUMM INT IND HYP OXY; SI AH, 1999, J HYPERBARIC OXYGENA, P8; SONG XM, 2000, CHIN J PRACTICAL PED, V15, P762; SUN JH, 2000, J APPL CLIN PEDIAT, V15, P266; SUN XJ, 1998, CHIN J BIRTH HLTH HE, V6, P79; WANG AH, 2002, CHIN J PRIMARY MED P, V9, P503; WANG MM, 1999, NINGXIA MED J, V21, P113; WANG SL, 2001, SHANGDONG MED J, V41, P38; WANG XJ, 2001, CHIN J CONT PEDIAT, V3, P273; Wei X, 2004, BRAIN, V127, P2629, DOI 10.1093/brain/awh316; WEN R, 2001, CHIN MED J METALLURG, V18, P304; Whitelaw A, 2000, Semin Neonatol, V5, P33, DOI 10.1053/siny.1999.0113; YUAN XW, 1999, MOD DIAGN TREAT, V10, P174; ZHANG XH, 2000, CHIN J BIRTH HLTH HE, V8, P35	29	20	29	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 19	2006	333	7564					374	376		10.1136/bmj.38776.731655.2F	http://dx.doi.org/10.1136/bmj.38776.731655.2F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OD	16690641	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000240112200016
J	Wiedemann, HP; Wheeler, AP; Bernard, GR; Thompson, BT; Hayden, D; deBoisblanc, B; Connors, AF; Hite, RD; Harabin, AL				Wiedemann, HP; Wheeler, AP; Bernard, GR; Thompson, BT; Hayden, D; deBoisblanc, B; Connors, AF; Hite, RD; Harabin, AL		Natl Heart Lung Blood Inst Acute	Comparison of two fluid-management strategies in acute lung injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY ILL PATIENTS; PRESSURE PULMONARY-EDEMA; GOAL-DIRECTED THERAPY; OXYGEN DELIVERY; SEPTIC SHOCK; SUPRANORMAL VALUES; PROSPECTIVE TRIAL; PATIENT SAFETY; FUROSEMIDE	BACKGROUND: Optimal fluid management in patients with acute lung injury is unknown. Diuresis or fluid restriction may improve lung function but could jeopardize extrapulmonary-organ perfusion. METHODS In a randomized study, we compared a conservative and a liberal strategy of fluid management using explicit protocols applied for seven days in 1000 patients with acute lung injury. The primary end point was death at 60 days. Secondary end points included the number of ventilator-free days and organ-failure-free days and measures of lung physiology. RESULTS: The rate of death at 60 days was 25.5 percent in the conservative-strategy group and 28.4 percent in the liberal-strategy group (P=0.30; 95 percent confidence interval for the difference, -2.6 to 8.4 percent). The mean (+/-SE) cumulative fluid balance during the first seven days was -136+/-491 ml in the conservative-strategy group and 6992+/-502 ml in the liberal-strategy group (P<0.001). As compared with the liberal strategy, the conservative strategy improved the oxygenation index ([mean airway pressure x the ratio of the fraction of inspired oxygen to the partial pressure of arterial oxygen] x 100) and the lung injury score and increased the number of ventilator-free days (14.6+/-0.5 vs. 12.1+/-0.5, P<0.001) and days not spent in the intensive care unit (13.4+/-0.4 vs. 11.2+/-0.4, P<0.001) during the first 28 days but did not increase the incidence or prevalence of shock during the study or the use of dialysis during the first 60 days (10 percent vs. 14 percent, P=0.06). CONCLUSIONS: Although there was no significant difference in the primary outcome of 60-day mortality, the conservative strategy of fluid management improved lung function and shortened the duration of mechanical ventilation and intensive care without increasing nonpulmonary-organ failures. These results support the use of a conservative strategy of fluid management in patients with acute lung injury.	Cleveland Clin, Dept Pulm Allergy & Crit Care Med, Cleveland, OH 44195 USA; Vanderbilt Univ, Nashville, TN USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA; Wake Forest Univ, Hlth Sci Ctr, Winston Salem, NC 27109 USA; NHLBI, NIH, Bethesda, MD 20892 USA	Cleveland Clinic Foundation; Vanderbilt University; Harvard University; Massachusetts General Hospital; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Case Western Reserve University; MetroHealth System; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wiedemann, HP (corresponding author), Cleveland Clin, Dept Pulm Allergy & Crit Care Med, 9500 Euclid Ave,Desk A-90, Cleveland, OH 44195 USA.	wiedemh@ccf.org		Wiedemann, Herbert/0000-0002-4587-4401; Connors, Alfred F./0000-0001-7123-3360; NOIRI, Eisei/0000-0002-9515-7582	NHLBI NIH HHS [N01-HR-16146-54, N01-HR-46046-64] Funding Source: Medline; DIVISION OF LUNG DISEASES [N01HR016146] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALI J, 1979, J CLIN INVEST, V64, P1494, DOI 10.1172/JCI109608; Barnes Kathleen C, 2005, Proc Am Thorac Soc, V2, P195, DOI 10.1513/pats.200502-013AC; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Drazen JM, 2003, NEW ENGL J MED, V348, P1377, DOI 10.1056/NEJMe030031; FLEMING A, 1992, ARCH SURG-CHICAGO, V127, P1175; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; HUDSON LD, 1992, AM REV RESPIR DIS, V146, P540; HUMPHREY H, 1990, CHEST, V97, P1176, DOI 10.1378/chest.97.5.1176; HYERS TM, 1990, CHEST, V97, P1025, DOI 10.1378/chest.97.5.1025; Landis E.M., 1963, HDB PHYSL SECTION 2, P961; LONG R, 1988, J APPL PHYSIOL, V65, P1736, DOI 10.1152/jappl.1988.65.4.1736; MARTIN C, 1990, ACTA ANAESTH SCAND, V34, P413, DOI 10.1111/j.1399-6576.1990.tb03114.x; Martin GS, 2002, CRIT CARE MED, V30, P2175, DOI 10.1097/00003246-200210000-00001; MITCHELL JP, 1992, AM REV RESPIR DIS, V145, P990, DOI 10.1164/ajrccm/145.5.990; MOLLOY WD, 1985, CIRCULATION, V72, P1365, DOI 10.1161/01.CIR.72.6.1365; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001; MURRAY JF, 1989, AM REV RESPIR DIS, V139, P1065; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PREWITT RM, 1981, J CLIN INVEST, V67, P409, DOI 10.1172/JCI110049; Reising CA, 1999, J SURG RES, V82, P56, DOI 10.1006/jsre.1998.5513; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rizvi K, 2005, CRIT CARE MED, V33, P98, DOI 10.1097/01.CCM.0000150650.70142.E9; SCHULLER D, 1991, CHEST, V100, P1068, DOI 10.1378/chest.100.4.1068; Schuster D P, 1993, New Horiz, V1, P478; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SIBBALD WJ, 1985, CHEST, V87, P585, DOI 10.1378/chest.87.5.585; SIMMONS RS, 1987, AM REV RESPIR DIS, V135, P924, DOI 10.1164/arrd.1987.135.4.924; Steinbrook R, 2003, NEW ENGL J MED, V349, P629, DOI 10.1056/NEJMp038133; Steinbrook R, 2003, NEW ENGL J MED, V348, P1393, DOI 10.1056/NEJMhpr030349; TUCHSCHMIDT J, 1992, CHEST, V102, P216, DOI 10.1378/chest.102.1.216; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; YU MH, 1993, CRIT CARE MED, V21, P830, DOI 10.1097/00003246-199306000-00009	37	2274	2392	2	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2564	2575						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16714767				2022-12-28	WOS:000238233400006
J	Lu, J; Sherman, D; Devor, M; Saper, CB				Lu, Jun; Sherman, David; Devor, Marshall; Saper, Clifford B.			A putative flip-flop switch for control of REM sleep	NATURE			English	Article							EYE-MOVEMENT SLEEP; PARADOXICAL SLEEP; LOCUS-COERULEUS; WAKING CYCLE; TEGMENTAL NUCLEUS; PONTINE LESIONS; NEURONS; RAT; CAT; GENERATION	Rapid eye movement ( REM) sleep consists of a dreaming state in which there is activation of the cortical and hippocampal electroencephalogram ( EEG), rapid eye movements, and loss of muscle tone. Although REM sleep was discovered more than 50 years ago, the neuronal circuits responsible for switching between REM and non-REM (NREM) sleep remain poorly understood. Here we propose a brainstem flip - flop switch, consisting of mutually inhibitory REM-off and REM-on areas in the mesopontine tegmentum. Each side contains GABA (gamma-aminobutyric acid)- ergic neurons that heavily innervate the other. The REM- on area also contains two populations of glutamatergic neurons. One set projects to the basal forebrain and regulates EEG components of REM sleep, whereas the other projects to the medulla and spinal cord and regulates atonia during REM sleep. The mutually inhibitory interactions of the REM- on and REM- off areas may form a flip - flop switch that sharpens state transitions and makes them vulnerable to sudden, unwanted transitions - for example, in narcolepsy.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Hebrew Univ Jerusalem, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Hebrew University of Jerusalem	Lu, J (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA.	jlu@bidmc.harvard.edu; csaper@bidmc.harvard.edu						Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Braak H, 2000, ACTA NEUROPATHOL, V99, P489, DOI 10.1007/s004010051150; CHASE MH, 1989, J NEUROSCI, V9, P743; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou WB, 2002, ACTA PHARMACOL SIN, V23, P691; Coleman CG, 2004, NEUROSCIENCE, V126, P821, DOI 10.1016/j.neuroscience.2004.04.029; Gerashchenko D, 2001, BRAIN RES, V913, P106, DOI 10.1016/S0006-8993(01)02792-5; HOBSON JA, 1983, J NEUROPHYSIOL, V50, P770, DOI 10.1152/jn.1983.50.4.770; JONES BE, 1977, BRAIN RES, V124, P473, DOI 10.1016/0006-8993(77)90948-9; Kapas L, 1996, BRAIN RES, V712, P53, DOI 10.1016/0006-8993(95)01431-4; KAYAMA Y, 1992, BRAIN RES, V569, P210, DOI 10.1016/0006-8993(92)90632-J; Kimura K, 2000, NEUROLOGY, V55, P894, DOI 10.1212/WNL.55.6.894; Kubin L, 2001, ARCH ITAL BIOL, V139, P147; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lu J, 2002, J NEUROSCI, V22, P4568, DOI 10.1523/JNEUROSCI.22-11-04568.2002; Manford M, 1998, BRAIN, V121, P1819, DOI 10.1093/brain/121.10.1819; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; McCarley RW, 2004, ARCH ITAL BIOL, V142, P429; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; MOURET J, 1980, BRAIN RES, V186, P273, DOI 10.1016/0006-8993(80)90975-0; ONOE H, 1995, NEUROREPORT, V6, P353, DOI 10.1097/00001756-199501000-00031; Plazzi G, 1996, NEUROLOGY, V46, P1250, DOI 10.1212/WNL.46.5.1250; RYE DB, 1988, J COMP NEUROL, V269, P315, DOI 10.1002/cne.902690302; Sakai K, 2001, ARCH ITAL BIOL, V139, P93; SANFORD LD, 1994, J SLEEP RES, V3, P233; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; SASTRE JP, 1981, BRAIN RES, V229, P147, DOI 10.1016/0006-8993(81)90752-6; SASTRE JP, 1979, PHYSIOL BEHAV, V22, P979; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; SHOUSE MN, 1992, BRAIN RES, V571, P50, DOI 10.1016/0006-8993(92)90508-7; STERIADE M, 1990, J NEUROSCI, V10, P2560; TAAL W, 1994, NEUROREPORT, V5, P2225, DOI 10.1097/00001756-199411000-00005; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Wilson S, 2005, DRUGS, V65, P927, DOI 10.2165/00003495-200565070-00003; Wu MF, 2004, J PHYSIOL-LONDON, V554, P202, DOI 10.1113/jphysiol.2003.052134	39	771	810	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					589	594		10.1038/nature04767	http://dx.doi.org/10.1038/nature04767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16688184				2022-12-28	WOS:000237920800037
J	Benson, JD; Chen, YNP; Cornell-Kennon, SA; Dorsch, M; Kim, S; Leszczyniecka, M; Sellers, WR; Lengauer, C				Benson, John D.; Chen, Ying-Nan P.; Cornell-Kennon, Susan A.; Dorsch, Marion; Kim, Sunkyu; Leszczyniecka, Magdalena; Sellers, William R.; Lengauer, Christoph			Validating cancer drug targets	NATURE			English	Review							CELL LUNG-CANCER; HIGH-FREQUENCY; ESTROGEN-RECEPTOR; PML/RAR-ALPHA; MUTANT-CELLS; MICE REVEALS; PIK3CA GENE; MUTATIONS; GROWTH; EXPRESSION	A cancer drug target is only truly validated by demonstrating that a given therapeutic agent is clinically effective and acts through the target against which it was designed. Nevertheless, it is desirable to declare an early-stage drug target as 'validated' before investing in a full-scale drug discovery programme dedicated to it. Although the outcome of validation studies can guide cancer research programmes, strictly defined universal validation criteria have not been established.	Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Novartis	Lengauer, C (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	christoph.lengauer@novartis.com						Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Beeram M, 2005, J CLIN ONCOL, V23, P6771, DOI 10.1200/JCO.2005.08.036; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Cool M, 2006, GENE CHROMOSOME CANC, V45, P191, DOI 10.1002/gcc.20276; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Early E, 1996, P NATL ACAD SCI USA, V93, P7900, DOI 10.1073/pnas.93.15.7900; Emens Leisha A, 2005, Am J Ther, V12, P243; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Jensen EV, 2003, CLIN CANCER RES, V9, P1980; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamb A, 2005, NAT REV DRUG DISCOV, V4, P161, DOI 10.1038/nrd1635; Kang CS, 2005, J NEURO-ONCOL, V74, P267, DOI 10.1007/s11060-004-8322-z; Kim H, 1999, EXP CELL RES, V253, P78, DOI 10.1006/excr.1999.4706; Kitayama H, 1996, BLOOD, V88, P995; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Lefevre G, 2004, J BIOL CHEM, V279, P31769, DOI 10.1074/jbc.M403907200; Lengauer C, 2005, NAT REV DRUG DISCOV, V4, P375, DOI 10.1038/nrd1722; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Marx J, 2005, SCIENCE, V308, P1248, DOI 10.1126/science.308.5726.1248; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mills GB, 2001, P NATL ACAD SCI USA, V98, P10031, DOI 10.1073/pnas.191379498; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Nair HB, 2005, CANCER RES, V65, P11164, DOI 10.1158/0008-5472.CAN-05-1087; O'Neill J, 2004, BBA-REV CANCER, V1705, P43, DOI 10.1016/j.bbcan.2004.09.004; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; Patel JD, 2004, CRIT REV ONCOL HEMAT, V50, P175, DOI 10.1016/j.critrevonc.2004.02.004; Pitha-Rowe I, 2003, LEUKEMIA, V17, P1723, DOI 10.1038/sj.leu.2403065; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; RAO W, 2004, P NATL ACAD SCI USA, V101, P13306; Ratliff Timothy L, 2005, J Urol, V174, P1149; Salloukh HF, 2000, ONCOGENE, V19, P4362, DOI 10.1038/sj.onc.1203804; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sausville EA, 2004, J CHEMOTHERAPY, V16, P16, DOI 10.1179/joc.2004.16.Supplement-1.16; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; Silva J, 2004, ONCOGENE, V23, P8401, DOI 10.1038/sj.onc.1208176; Simon M, 2001, AM J ROENTGENOL, V177, P195, DOI 10.2214/ajr.177.1.1770195; Tao J, 2005, BRIT J DERMATOL, V153, P715, DOI 10.1111/j.1365-2133.2005.06765.x; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; vanElsas A, 1996, AM J PATHOL, V149, P883; Walker K, 2005, CURR OPIN GENET DEV, V15, P62, DOI 10.1016/j.gde.2004.11.001; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yue W, 2005, CLIN CANCER RES, V11, p925S	57	116	127	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					451	456		10.1038/nature04873	http://dx.doi.org/10.1038/nature04873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724057				2022-12-28	WOS:000237778900038
J	Xiang, J; Lu, W; Hu, YJ; Wu, Y; Yan, H; Lieber, CM				Xiang, Jie; Lu, Wei; Hu, Yongjie; Wu, Yue; Yan, Hao; Lieber, Charles M.			Ge/Si nanowire heterostructures as high-performance field-effect transistors	NATURE			English	Article							CARBON-NANOTUBE TRANSISTORS	Semiconducting carbon nanotubes(1,2) and nanowires(3) are potential alternatives to planar metal-oxide-semiconductor field-effect transistors (MOSFETs)(4) owing, for example, to their unique electronic structure and reduced carrier scattering caused by one-dimensional quantum confinement effects(1,5). Studies have demonstrated long carrier mean free paths at room temperature in both carbon nanotubes1,6 and Ge/Si core/shell nanowires(7). In the case of carbon nanotube FETs, devices have been fabricated that work close to the ballistic limit(8). Applications of high-performance carbon nanotube FETs have been hindered, however, by difficulties in producing uniform semiconducting nanotubes, a factor not limiting nanowires, which have been prepared with reproducible electronic properties in high yield as required for large-scale integrated systems(3,9,10). Yet whether nanowire field-effect transistors (NWFETs) can indeed outperform their planar counterparts is still unclear(4). Here we report studies on Ge/Si core/shell nanowire heterostructures configured as FETs using high-kappa dielectrics in a top-gate geometry. The clean one-dimensional hole-gas in the Ge/Si nanowire heterostructures(7) and enhanced gate coupling with high-kappa dielectrics give high-performance FETs values of the scaled transconductance (3.3 mS mu m(-1)) and on-current (2.1 mA mu m(-1)) that are three to four times greater than state-of-the-art MOSFETs and are the highest obtained on NWFETs. Furthermore, comparison of the intrinsic switching delay, tau = CV/I, which represents a key metric for device applications(4,11), shows that the performance of Ge/Si NWFETs is comparable to similar length carbon nanotube FETs and substantially exceeds the length-dependent scaling of planar silicon MOSFETs.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu	Lu, Wei D./E-8388-2011; Chu, Yung-Ming/C-6318-2009; Hu, Yongjie/A-8308-2013; Lu, Wei/AAE-2921-2022	Lu, Wei D./0000-0003-4731-1976; Lu, Wei/0000-0002-4150-8674; Hu, Yongjie/0000-0001-7225-1130				Aberg I, 2004, IEEE INTERNATIONAL ELECTRON DEVICES MEETING 2004, TECHNICAL DIGEST, P173, DOI 10.1109/IEDM.2004.1419099; Avouris P, 2002, ACCOUNTS CHEM RES, V35, P1026, DOI 10.1021/ar010152e; Chau R, 2005, IEEE T NANOTECHNOL, V4, P153, DOI 10.1109/TNANO.2004.842073; Chau R, 2004, IEEE ELECTR DEVICE L, V25, P408, DOI 10.1109/LED.2004.828570; Cui Y, 2003, NANO LETT, V3, P149, DOI 10.1021/nl025875l; Friedman RS, 2005, NATURE, V434, P1085, DOI 10.1038/4341085a; Greytak AB, 2004, APPL PHYS LETT, V84, P4176, DOI 10.1063/1.1755846; Guo J, 2004, IEEE INTERNATIONAL ELECTRON DEVICES MEETING 2004, TECHNICAL DIGEST, P703; Guo J, 2003, IEEE T NANOTECHNOL, V2, P329, DOI 10.1109/TNANO.2003.820518; Guo J, 2002, APPL PHYS LETT, V80, P3192, DOI 10.1063/1.1474604; Javey A, 2004, NANO LETT, V4, P447, DOI 10.1021/nl035185x; Javey A, 2002, NAT MATER, V1, P241, DOI 10.1038/nmat769; Javey A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.106804; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Jin S, 2004, NANO LETT, V4, P915, DOI 10.1021/nl049659j; Lieber CM, 2003, MRS BULL, V28, P486, DOI 10.1557/mrs2003.144; Lin YM, 2004, NANO LETT, V4, P947, DOI 10.1021/nl049745j; Lu W, 2005, P NATL ACAD SCI USA, V102, P10046, DOI 10.1073/pnas.0504581102; Martel R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.256805; McEuen PL, 2002, IEEE T NANOTECHNOL, V1, P78, DOI 10.1109/TNANO.2002.1005429; McEuen PL, 1999, PHYS REV LETT, V83, P5098, DOI 10.1103/PhysRevLett.83.5098; Patolsky F, 2005, MATER TODAY, V8, P20, DOI 10.1016/S1369-7021(05)00791-1; Ritenour A, 2003, 2003 IEEE INTERNATIONAL ELECTRON DEVICES MEETING, TECHNICAL DIGEST, P433; Taur Y., 2021, FUNDAMENTALS MODERN, DOI 10.1017/9781108847087; Wallace RM, 2002, MRS BULL, V27, P192, DOI 10.1557/mrs2002.70; Wang DW, 2003, APPL PHYS LETT, V83, P2432, DOI 10.1063/1.1611644; Wang J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2001158; Wang J, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P707, DOI 10.1109/IEDM.2002.1175936; Yeo YC, 2002, J APPL PHYS, V92, P7266, DOI 10.1063/1.1521517; Zheng GF, 2004, ADV MATER, V16, P1890, DOI 10.1002/adma.200400472	30	1260	1340	7	545	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					489	493		10.1038/nature04796	http://dx.doi.org/10.1038/nature04796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724062				2022-12-28	WOS:000237778900045
J	Bekkelund, SI; Lilleng, H; Tonseth, S				Bekkelund, SI; Lilleng, H; Tonseth, S			Drug points - Gabapentin may cause reversible visual field constriction	BRITISH MEDICAL JOURNAL			English	Article							VIGABATRIN; TIAGABINE		Univ Hosp N Norway, Dept Neurol, Tromso, Norway; Ctr Ophthalmol, Sortland, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway	Bekkelund, SI (corresponding author), Univ Hosp N Norway, Dept Neurol, Tromso, Norway.	svein.ivar.bekkelond@unn.no						Eke T, 1997, BRIT MED J, V314, P180, DOI 10.1136/bmj.314.7075.180; Kalviainen R, 1999, NEUROLOGY, V53, P922, DOI 10.1212/WNL.53.5.922; Lawden MC, 2003, J NEUROL NEUROSUR PS, V74, P286, DOI 10.1136/jnnp.74.3.286; Sills GJ, 2001, NEUROLOGY, V57, P196, DOI 10.1212/WNL.57.2.196	4	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 20	2006	332	7551					1193	1193		10.1136/bmj.332.7551.1193	http://dx.doi.org/10.1136/bmj.332.7551.1193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048GJ	16709992	Bronze, Green Published			2022-12-28	WOS:000237935300019
J	Norrving, B				Norrving, Bo			Dipyridamole with aspirin for secondary stroke prevention	LANCET			English	Editorial Material							ISCHEMIC-STROKE; CLOPIDOGREL		Univ Hosp, Dept Neurol, S-22185 Lund, Sweden	Lund University; Skane University Hospital	Norrving, B (corresponding author), Univ Hosp, Dept Neurol, S-22185 Lund, Sweden.	bo.norrving@neurol.lu.se		Norrving, Bo/0000-0002-8024-5096				*ANT TRIAL COLL, 2000, BMJ-BRIT MED J, V324, P71; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; De Schryver ELLM, 2003, STROKE, V34, P2339, DOI 10.1161/01.STR.0000090346.45784.C3; DESCHRYVER E, 2006, COCHRANE DB SYST REV, V2; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Donnan GA, 2002, STROKE, V33, P2139, DOI 10.1161/01.STR.0000023100.96778.1E; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Halkes PHA, 2006, LANCET, V367, P1665; Jones L, 2004, HEALTH TECHNOL ASSES, V8, P1; Leonardi-Bee J, 2005, STROKE, V36, P162, DOI 10.1161/01.STR.0000149621.95215.ea; Weyrich AS, 2005, CIRCULATION, V111, P633, DOI 10.1161/01.CIR.0000154607.90506.45	13	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2006	367	9523					1638	1639		10.1016/S0140-6736(06)68711-4	http://dx.doi.org/10.1016/S0140-6736(06)68711-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714170				2022-12-28	WOS:000237743100008
J	Liu, ZH; Feldman, LC; Tolk, NH; Zhang, ZY; Cohen, PI				Liu, ZH; Feldman, LC; Tolk, NH; Zhang, ZY; Cohen, PI			RETRACTED: Desorption of H from Si(111) by resonant excitation of the Si-H vibrational stretch mode (Retracted article. See vol. 333, pg. 1824, 2011)	SCIENCE			English	Article; Retracted Publication							SCANNING-TUNNELING-MICROSCOPY; LASER-INDUCED DESORPTION; SILICON SURFACES; VICINAL SI(111); X 7; HYDROGEN; MECHANISMS; KINETICS; ENERGY; STATE	Past efforts to achieve selective bond scission by vibrational excitation have been thwarted by energy thermalization. Here we report resonant photodesorption of hydrogen from a Si(111) surface using tunable infrared radiation. The wavelength dependence of the desorption yield peaks at 0.26 electron volt: the energy of the Si-H vibrational stretch mode. The desorption yield is quadratic in the infrared intensity. A strong H/D isotope effect rules out thermal desorption mechanisms, and electronic effects are not applicable in this low-energy regime. A molecular mechanism accounting for the desorption event remains elusive.	Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA; Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA	University of Minnesota System; University of Minnesota Twin Cities; Vanderbilt University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Cohen, PI (corresponding author), Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA.	picohen@umn.edu						AVOURIS P, 1989, ANNU REV PHYS CHEM, V40, P173; Buehler EJ, 2000, SCIENCE, V290, P506, DOI 10.1126/science.290.5491.506; Chuang TJ, 1983, SURF SCI REP, V3, P1, DOI 10.1016/0167-5729(83)90005-5; CHUANG TJ, 1981, J CHEM PHYS, V74, P1453, DOI 10.1063/1.441132; Corcelli SA, 2002, J PHYS CHEM A, V106, P10849, DOI 10.1021/jp0205012; Durr M, 2002, SCIENCE, V296, P1838, DOI 10.1126/science.1070859; GORTEL ZW, 1983, PHYS REV B, V28, P2119, DOI 10.1103/PhysRevB.28.2119; GUPTA P, 1988, PHYS REV B, V37, P8234, DOI 10.1103/PhysRevB.37.8234; HEIDBERG J, 1982, PHYS REV LETT, V49, P666, DOI 10.1103/PhysRevLett.49.666; Herring C, 1997, PHYS REV B, V55, P13314, DOI 10.1103/PhysRevB.55.13314; Hudson LT, 2000, PHYS REV B, V62, P10535, DOI 10.1103/PhysRevB.62.10535; JAKOB P, 1991, J CHEM PHYS, V95, P2897, DOI 10.1063/1.460892; KOEHLER BG, 1991, SURF SCI, V248, P158, DOI 10.1016/0039-6028(91)90069-5; Lyding JW, 1998, APPL SURF SCI, V130, P221, DOI 10.1016/S0169-4332(98)00054-3; RAGHAVACHARI K, 1993, CHEM PHYS LETT, V206, P156, DOI 10.1016/0009-2614(93)85533-T; REIDER GA, 1991, PHYS REV LETT, V66, P1994, DOI 10.1103/PhysRevLett.66.1994; REIDER GA, 1991, J CHEM PHYS, V94, P4080, DOI 10.1063/1.460660; SHEN TC, 1995, SCIENCE, V268, P1590, DOI 10.1126/science.268.5217.1590; Vondrak T, 1999, PHYS REV LETT, V82, P1967, DOI 10.1103/PhysRevLett.82.1967; Williams PA, 1997, PHYS REV LETT, V79, P3459, DOI 10.1103/PhysRevLett.79.3459; Wu B, 2004, APPL PHYS LETT, V84, P2175, DOI 10.1063/1.1687452; ZHU XY, 1994, ANNU REV PHYS CHEM, V45, P113, DOI 10.1146/annurev.pc.45.100194.000553; ZIMMERMANN FM, 1995, SURF SCI REP, V22, P127, DOI 10.1016/0167-5729(96)80001-X	23	72	74	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1024	1026		10.1126/science.1124529	http://dx.doi.org/10.1126/science.1124529			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709778				2022-12-28	WOS:000237628800037
J	Nogue, S; Culla, A				Nogue, S; Culla, A			Burton's line	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hosp Clin Barcelona, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona	Nogue, S (corresponding author), Hosp Clin Barcelona, E-08036 Barcelona, Spain.								0	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					E21	E21		10.1056/NEJMicm050064	http://dx.doi.org/10.1056/NEJMicm050064			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707743				2022-12-28	WOS:000237575400011
J	Garcia-Sastre, A; Biron, CA				Garcia-Sastre, A; Biron, CA			Type 1 interferons and the virus-host relationship: A lesson in detente	SCIENCE			English	Review							DOUBLE-STRANDED-RNA; NF-KAPPA-B; TOLL-LIKE RECEPTOR-3; HEPATITIS-C VIRUS; IFN-ALPHA-BETA; RIG-I; VIRAL-INFECTION; ADAPTER PROTEIN; CELL RESPONSES; T-LYMPHOCYTES	The interface between an infectious agent and its host represents the ultimate battleground for survival: The microbe must secure a niche for replication, whereas the host must limit the pathogen's advance. Among the host's arsenal of antimicrobial factors, the type 1 interferons (IFNs) induce potent defense mechanisms against viruses and are key in the host-virus standoff. Viruses have evolved multiple tricks to avoid the immediate antiviral effects of IFNs and, in turn, hosts have adapted use of this innate cytokine system to galvanize multiple additional layers of immune defense. The plasticity that exists in these interactions provides us with a lesson in detente.	Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA	Brown University; Icahn School of Medicine at Mount Sinai	Biron, CA (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA.	Christine_Biron@brown.edu	Li, Chia Cheng/D-9906-2015	Garcia-Sastre, Adolfo/0000-0002-6551-1827	NCI NIH HHS [R01CA41268] Funding Source: Medline; NIAID NIH HHS [U54AI57158, R01AI55677, R01AI46954, P01AI58113, P01AI52106, U19AI62623] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062623, U54AI057158, P01AI052106, R01AI046954, P01AI058113, R01AI055677] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Biron C.A., 2001, FIELDS VIROLOGY, P321; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Cho SS, 1996, J IMMUNOL, V157, P4781; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Gil MP, 2006, BLOOD, V107, P987, DOI 10.1182/blood-2005-07-2834; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Karp CL, 2000, IMMUNOL TODAY, V21, P24, DOI 10.1016/S0167-5699(99)01541-8; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lee CK, 2000, J IMMUNOL, V164, P1286, DOI 10.4049/jimmunol.164.3.1286; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Unterstab G, 2005, P NATL ACAD SCI USA, V102, P13640, DOI 10.1073/pnas.0502883102; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	55	681	720	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					879	882		10.1126/science.1125676	http://dx.doi.org/10.1126/science.1125676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690858				2022-12-28	WOS:000237452900037
J	Wileman, T				Wileman, T			Aggresomes and autophagy generate sites for virus replication	SCIENCE			English	Review							SWINE-FEVER VIRUS; DOUBLE-MEMBRANE VESICLES; ACTIN-BASED MOTILITY; VACCINIA VIRUS; ENDOPLASMIC-RETICULUM; CELLULAR AUTOPHAGY; ASSEMBLY SITES; VIRAL REPLICATION; RNA REPLICATION; PLASMA-MEMBRANE	The replication of many viruses is associated with specific intracellular compartments called virus factories or virioplasm. These are thought to provide a physical scaffold to concentrate viral components and thereby increase the efficiency of replication. The formation of virus replication sites often results in rearrangement of cellular membranes and reorganization of the cytoskeleton. Similar rearrangements are seen in cells in response to protein aggregation, where aggresomes and autophagosomes are produced to facilitate protein degradation. Here I review the evidence that some viruses induce aggresomes and autophagosomes to generate sites of replication.	Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Wileman, T (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	t.wileman@uea.ac.uk						Andres G, 2001, J VIROL, V75, P6758, DOI 10.1128/JVI.75.15.6758-6768.2001; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; CHEN M, 1986, J GEN VIROL, V67, P915, DOI 10.1099/0022-1317-67-5-915; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Everett RD, 2006, CELL MICROBIOL, V8, P365, DOI 10.1111/j.1462-5822.2005.00677.x; Everett RD, 2005, J VIROL, V79, P5078, DOI 10.1128/JVI.79.8.5078-5089.2005; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jouvenet N, 2004, J VIROL, V78, P7990, DOI 10.1128/JVI.78.15.7990-8001.2004; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Monaghan P, 2003, J MICROSC-OXFORD, V212, P62, DOI 10.1046/j.1365-2818.2003.01245.x; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Risco C, 2002, J VIROL, V76, P1839, DOI 10.1128/JVI.76.4.1839-1855.2002; Rust RC, 2001, J VIROL, V75, P9808, DOI 10.1128/JVI.75.20.9808-9818.2001; Sanderson CM, 2000, J GEN VIROL, V81, P47, DOI 10.1099/0022-1317-81-1-47; Schepis A, 2006, TRAFFIC, V7, P308, DOI 10.1111/j.1600-0854.2005.00381.x; Schwartz M, 2004, P NATL ACAD SCI USA, V101, P11263, DOI 10.1073/pnas.0404157101; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sodeik B, 2002, J CELL BIOL, V159, P393, DOI 10.1083/jcb.200210024; Stefanovic S, 2005, J VIROL, V79, P11766, DOI 10.1128/JVI.79.18.11766-11775.2005; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Ward BM, 2004, J VIROL, V78, P2486, DOI 10.1128/JVI.78.5.2486-2493.2004; WILLIS DB, 1979, VIROLOGY, V98, P328, DOI 10.1016/0042-6822(79)90556-7; Zhang HY, 2006, AUTOPHAGY, V2, P91, DOI 10.4161/auto.2.2.2297	47	180	195	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					875	878		10.1126/science.1126766	http://dx.doi.org/10.1126/science.1126766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690857				2022-12-28	WOS:000237452900036
J	Bennett, J; Whale, R				Bennett, J; Whale, R			Galactorrhoea may be associated with methadone use	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROLACTIN		Univ Brighton, Postgrad Med Sch, Brighton BN1 9PH, E Sussex, England; Southdowns Hlth NHS Trust, Brighton BN2 3EW, E Sussex, England	University of Brighton	Whale, R (corresponding author), Univ Brighton, Postgrad Med Sch, Brighton BN1 9PH, E Sussex, England.	Richard.whale@brighton.ac.uk						Bart G, 2005, NEUROPSYCHOPHARMACOL, V30, P2254, DOI 10.1038/sj.npp.1300811; BILLERBECK W, 2001, P 36 INT EN CONV ENG, V1, P1; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; TOLIS G, 1978, J CLIN ENDOCR METAB, V47, P200, DOI 10.1210/jcem-47-1-200	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1071	1071		10.1136/bmj.332.7549.1071	http://dx.doi.org/10.1136/bmj.332.7549.1071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16675813	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000237518400019
J	Hoare, Z; Lim, WS				Hoare, Z; Lim, WS			BMJ learning - Pneumonia: update on diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; SEVERITY	Prompt diagnosis and management of community acquired pneumonia saves lives. This article summarises the latest key recommendations in the management of pneumonia and is intended for junior doctors managing this common condition.	City Hosp Nottingham, Dept Resp Med, Nottingham NG5 1PB, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital	Hoare, Z (corresponding author), City Hosp Nottingham, Dept Resp Med, Hucknall Rd, Nottingham NG5 1PB, England.	Zara.Hoare@nottingham.ac.uk						Ewig S, 2006, EUR RESPIR J, V27, P6, DOI 10.1183/09031936.06.00130205; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Halm EA, 2002, ARCH INTERN MED, V162, P1278, DOI 10.1001/archinte.162.11.1278; Hansson LO, 1997, SCAND J CLIN LAB INV, V57, P111, DOI 10.1080/00365519709056378; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Macfarlane JT, 2004, THORAX, V59, P364, DOI 10.1136/thx.2004.024992; Metlay JP, 1997, ARCH INTERN MED, V157, P1453, DOI 10.1001/archinte.157.13.1453; Metlay JP, 2003, ANN INTERN MED, V138, P109, DOI 10.7326/0003-4819-138-2-200301210-00012; SMITH RP, 1995, CHEST, V108, P1288, DOI 10.1378/chest.108.5.1288; Weber SG, 2003, EMERG INFECT DIS, V9, P1415, DOI 10.3201/eid0911.030284; WOODHEAD MA, 1987, LANCET, V1, P671; WOODHEAD MA, 1991, RESP MED, V85, P313, DOI 10.1016/S0954-6111(06)80103-4	14	61	67	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1077	1079		10.1136/bmj.332.7549.1077	http://dx.doi.org/10.1136/bmj.332.7549.1077			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16675815	Green Published			2022-12-28	WOS:000237518400021
J	Pena, PV; Davrazou, F; Shi, XB; Walter, KL; Verkhusha, VV; Gozani, O; Zhao, R; Kutateladze, TG				Pena, Pedro V.; Davrazou, Foteini; Shi, Xiaobing; Walter, Kay L.; Verkhusha, Vladislav V.; Gozani, Or; Zhao, Rui; Kutateladze, Tatiana G.			Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2	NATURE			English	Article							TUMOR-SUPPRESSOR P33(ING1); LYSINE-4 METHYLATION; H3 TAIL; BINDING; CHROMODOMAIN; BROMODOMAIN; PROTEINS; ACETYLATION; FINGER; GROWTH	Covalent modifications of histone tails have a key role in regulating chromatin structure and controlling transcriptional activity. In eukaryotes, histone H3 trimethylated at lysine 4 (H3K4me3) is associated with active chromatin and gene expression(1-4). We recently found that plant homeodomain (PHD) finger of tumour suppressor ING2 (inhibitor of growth 2) binds H3K4me3 and represents a new family of modules that target this epigenetic mark(5). The molecular mechanism of H3K4me3 recognition, however, remains unknown. Here we report a 2.0 angstrom resolution structure of the mouse ING2 PHD finger in complex with a histone H3 peptide trimethylated at lysine 4. The H3K4me3 tail is bound in an extended conformation in a deep and extensive binding site consisting of elements that are conserved among the ING family of proteins. The trimethylammonium group of Lys 4 is recognized by the aromatic side chains of Y215 and W238 residues, whereas the intermolecular hydrogen-bonding and complementary surface interactions, involving Ala 1, Arg 2, Thr 3 and Thr 6 of the peptide, account for the PHD finger's high specificity and affinity. Substitution of the binding site residues disrupts H3K4me3 interaction in vitro and impairs the ability of ING2 to induce apoptosis in vivo. Strong binding of other ING and YNG PHD fingers suggests that the recognition of H3K4me3 histone code is a general feature of the ING/YNG proteins. Elucidation of the mechanisms underlying this novel function of PHD fingers provides a basis for deciphering the role of the ING family of tumour suppressors in chromatin regulation and signalling.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; Yeshiva University; Albert Einstein College of Medicine	Kutateladze, TG (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA.	Tatiana.Kutateladze@uchsc.edu	Hu, Ruogu/B-2203-2008; Verkhusha, Vladislav/AAU-7784-2020; Gozani, Or P/I-6157-2013	Verkhusha, Vladislav/0000-0002-2083-8121; Gozani, Or/0000-0002-1365-4463; Shi, Xiaobing/0000-0001-5242-8189; Kutateladze, Tatiana/0000-0001-7375-6990	NCI NIH HHS [R01 CA113472] Funding Source: Medline; NIGMS NIH HHS [R01 GM071424] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071424] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campos EI, 2004, CELL MOL LIFE SCI, V61, P2597, DOI 10.1007/s00018-004-4199-4; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SHI X, 2006, NATURE; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412	27	533	544	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					100	103		10.1038/nature04814	http://dx.doi.org/10.1038/nature04814			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16728977	Green Accepted			2022-12-28	WOS:000238724500045
J	Wysocka, J; Swigut, T; Xiao, H; Milne, TA; Kwon, SY; Landry, J; Kauer, M; Tackett, AJ; Chait, BT; Badenhorst, P; Wu, C; Allis, CD				Wysocka, Joanna; Swigut, Tomek; Xiao, Hua; Milne, Thomas A.; Kwon, So Yeon; Landry, Joe; Kauer, Monika; Tackett, Alan J.; Chait, Brian T.; Badenhorst, Paul; Wu, Carl; Allis, C. David			A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling	NATURE			English	Article							TRANSCRIPTION FACTOR; COMPLEX NURF; METHYLATION; H3; BINDING; METHYLTRANSFERASE; ACETYLATION; ASSOCIATION; BROMODOMAIN; DOMAIN	Lysine methylation of histones is recognized as an important component of an epigenetic indexing system demarcating transcriptionally active and inactive chromatin domains. Trimethylation of histone H3 lysine 4 (H3K4me3) marks transcription start sites of virtually all active genes(1-4). Recently, we reported that the WD40-repeat protein WDR5 is important for global levels of H3K4me3 and control of HOX gene expression(5). Here we show that a plant homeodomain (PHD) finger of nucleosome remodelling factor (NURF), an ISWI-containing ATP-dependent chromatin-remodelling complex, mediates a direct preferential association with H3K4me3 tails. Depletion of H3K4me3 causes partial release of the NURF subunit, BPTF (bromodomain and PHD finger transcription factor), from chromatin and defective recruitment of the associated ATPase, SNF2L (also known as ISWI and SMARCA1), to the HOXC8 promoter. Loss of BPTF in Xenopus embryos mimics WDR5 loss-of-function phenotypes, and compromises spatial control of Hox gene expression. These results strongly suggest that WDR5 and NURF function in a common biological pathway in vivo, and that NURF-mediated ATP-dependent chromatin remodelling is directly coupled to H3K4 trimethylation to maintain Hox gene expression patterns during development. We also identify a previously unknown function for the PHD finger as a highly specialized methyl-lysine-binding domain.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Vertebrate Embryol, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20814 USA; Univ Birmingham, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England	Rockefeller University; Rockefeller University; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Birmingham	Wu, C (corresponding author), Rockefeller Univ, Lab Chromatin Biol, 1230 York Ave, New York, NY 10021 USA.	carlwu@helix.nih.gov	Milne, Tom/E-1872-2016; Kwon, So Yeon/M-5625-2014	Milne, Tom/0000-0002-0413-4271; Kwon, So Yeon/0000-0002-8490-9101; /0000-0002-2542-0250; Swigut, Tomek/0000-0002-7649-6781	Biotechnology and Biological Sciences Research Council [BB/D522470/1] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; LI H, 2006, NATURE          0521; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SHI X, 2006, NATURE          0521; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	28	831	864	2	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					86	90		10.1038/nature04815	http://dx.doi.org/10.1038/nature04815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16728976				2022-12-28	WOS:000238724500042
J	Lander, GC; Tang, L; Casjens, SR; Gilcrease, EB; Prevelige, P; Poliakov, A; Potter, CS; Carragher, B; Johnson, JE				Lander, Gabriel C.; Tang, Liang; Casjens, Sherwood R.; Gilcrease, Eddie B.; Prevelige, Peter; Poliakov, Anton; Potter, Clinton S.; Carragher, Bridget; Johnson, John E.			The structure of an infectious P22 virion shows the signal for headful DNA packaging	SCIENCE			English	Article							SALMONELLA PHAGE-P22; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; PROTEIN; BACTERIOPHAGE-P22; ENCAPSULATION; MATURATION; MECHANISM	Bacteriophages, herpesviruses, and other large double-stranded DNA (dsDNA) viruses contain molecular machines that pump DNA into preassembled procapsids, generating internal capsid pressures exceeding, by 10-fold, that of bottled champagne. A 17 angstrom resolution asymmetric reconstruction of the infectious P22 virion reveals that tightly spooled DNA about the portal dodecamer forces a conformation that is significantly different from that observed in isolated portals assembled from ectopically expressed protein. We propose that the tight dsDNA spooling activates the switch that signals the headful chromosome packing density to the particle exterior.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Scripps Research Institute; Scripps Research Institute; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham	Johnson, JE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jackj@scripps.edu	Johnson, Johnson/HDL-9124-2022	Lander, Gabriel C./0000-0003-4921-1135; Carragher, Bridget/0000-0002-0624-5020	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NCRR NIH HHS [RR17573] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Anderson Dwight, 2005, P102; BOTSTEIN D, 1973, J MOL BIOL, V80, P669, DOI 10.1016/0022-2836(73)90204-0; CASJENS S, 1974, Journal of Supramolecular Structure, V2, P202, DOI 10.1002/jss.400020215; CASJENS S, 1992, J MOL BIOL, V224, P1055, DOI 10.1016/0022-2836(92)90469-Z; Casjens S, 1988, BACTERIOPHAGES, P15; Casjens Sherwood, 2005, P80; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; HOFFMAN B, 1975, J VIROL, V16, P1547, DOI 10.1128/JVI.16.6.1547-1559.1975; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; KING J, 1973, J MOL BIOL, V80, P697, DOI 10.1016/0022-2836(73)90205-2; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; Prevelige PEJ, 2005, BACTERIOPHAGES, P457; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Tang L, 2005, EMBO J, V24, P2087, DOI 10.1038/sj.emboj.7600695; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0	23	241	246	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1791	1795		10.1126/science.1127981	http://dx.doi.org/10.1126/science.1127981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16709746				2022-12-28	WOS:000238452800057
J	Sturmer, T; Hasselbach, P; Amelang, M				Sturmer, T; Hasselbach, P; Amelang, M			Personality, lifestyle, and risk of cardiovascular disease and cancer: follow-up of population based cohort	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; A BEHAVIOR; MYOCARDIAL-INFARCTION; BREAST-CANCER; 52 COUNTRIES; STRESS; ASSOCIATION; INTERHEART; COMPONENTS; MORTALITY	Objective To study the relation between measures of personality and risk of cardiovascular disease and cancer in a large cohort. Design Follow-up of population based cohort. Setting Heidelberg, Germany. Participants 5114 women and men aged 40-65 in 1992-5. Main outcome measures Psychological traits assessed by several standardised personality questionnaires in 1992-5, related to cause of death (to 2002-3) or reported incidence of cardiovascular diseases and cancer (validated by treating doctors). Relative risks (and 95% confidence intervals) for combined morbidity and mortality according to five important personality traits were estimated using multivariable Cox proportional hazards models. Results During median follow-up of 8.5 years, 257 participants died and 72 participants were diagnosed with a heart attack, 62 with stroke, and 240 with cancer. (morbidity and mortality combined). A high internal locus of control over disease was associated with a decreased risk of myocardial infarction (adjusted relative risk for an increase of 1 SD = 0.75; 95% confidence interval 0.58 to 0.96). An increase of 1 SD in time urgency was associated with a decreased risk of cancer (adjusted relative risk 0.83; 0.73 to 0.95). Other major personality traits-anger control, psychoticism, and symptoms of depression-were not consistently associated with myocardial infarction, stroke, or cancer. Conclusion Internal locus of control over disease and time urgency seem to be associated with reduced risk for common chronic diseases, probably by affecting unmeasured health related behaviour. The other personality traits assessed had no major impact on cardiovascular disease and cancer.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02120 USA; Univ Heidelberg, Dept Psychol, D-6900 Heidelberg, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ruprecht Karls University Heidelberg	Sturmer, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA.	til.sturmer@post.harvard.edu	Stürmer, Til/AAB-5459-2022					Amelang M., 2004, Z GESUNDHEITSPSYCHOL, V12, P102; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Borkenau P, 2001, J PERS SOC PSYCHOL, V80, P655, DOI 10.1037/0022-3514.80.4.655; Brayne C, 1998, PERS INDIV DIFFER, V25, P889, DOI 10.1016/S0191-8869(98)00071-3; Butow PN, 2000, J PSYCHOSOM RES, V49, P169, DOI 10.1016/S0022-3999(00)00156-2; Carmelli D, 1996, J PSYCHOSOM RES, V40, P475, DOI 10.1016/0022-3999(95)00637-0; Duijts SFA, 2003, INT J CANCER, V107, P1023, DOI 10.1002/ijc.11504; Garssen B, 2004, CLIN PSYCHOL REV, V24, P315, DOI 10.1016/j.cpr.2004.01.002; Glynn RJ, 2004, J CLIN EPIDEMIOL, V57, P113, DOI 10.1016/j.jclinepi.2003.02.001; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247; Merz CNB, 2002, BEHAV MED, V27, P141, DOI 10.1080/08964280209596039; RAGLAND DR, 1988, NEW ENGL J MED, V318, P65, DOI 10.1056/NEJM198801143180201; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; SHEKELLE RB, 1985, AM J EPIDEMIOL, V122, P559, DOI 10.1093/oxfordjournals.aje.a114135; Sutton S.R., 2004, SAGE HDB HLTH PSYCHO; Vaidya JG, 2002, J PERS SOC PSYCHOL, V83, P1469, DOI 10.1037//0022-3514.83.6.1469; Weitkunat R, 2002, J CLIN EPIDEMIOL, V55, P436, DOI 10.1016/S0895-4356(01)00507-8; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	19	75	76	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 10	2006	332	7554					1359	1362		10.1136/bmj.38833.479560.80	http://dx.doi.org/10.1136/bmj.38833.479560.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	057HN	16687457	Green Published, Bronze			2022-12-28	WOS:000238587000016
J	Leopold, P; Layalle, S				Leopold, P; Layalle, S			Development biology - Linking nutrition and tissue growth	SCIENCE			English	Editorial Material							DROSOPHILA; METAMORPHOSIS		Univ Nice, CNRS, UMR 6543, F-06108 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Leopold, P (corresponding author), Univ Nice, CNRS, UMR 6543, Parc Valrose, F-06108 Nice 2, France.	pierre.leopold@unice.fr	Layalle, Sophie/N-3815-2017	Layalle, Sophie/0000-0002-3650-0598				Allee JP, 2006, J INSECT PHYSIOL, V52, P450, DOI 10.1016/j.jinsphys.2005.12.006; Britton JS, 1998, DEVELOPMENT, V125, P2149; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Day SJ, 2000, DEVELOPMENT, V127, P2977; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; MacWhinnie SGB, 2005, DEV BIOL, V285, P285, DOI 10.1016/j.ydbio.2005.06.021; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737	9	4	4	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1317	1318		10.1126/science.1128343	http://dx.doi.org/10.1126/science.1128343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741099				2022-12-28	WOS:000237961600032
J	Myerburg, RJ; Feigal, DW; Lindsay, BD				Myerburg, Robert J.; Feigal, David W., Jr.; Lindsay, Bruce D.			Life-threating malfunction of implantable cadiac devices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Miami, Miller Sch Med, Miami, FL 33152 USA; NDA Partners, Phoenix, AZ USA; US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA; Washington Univ, Sch Med, St Louis, MO 63130 USA	University of Miami; US Food & Drug Administration (FDA); Washington University (WUSTL)	Myerburg, RJ (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33152 USA.							*HEART RHYTHM SOC, 2005, POL C PAC ICD PERF; *HEART RHYTHM SOC, IN PRESS HEART RHYTH; MAIER B, 2005, NY TIMES        0524, pA1; MYERBURG RJ, 2006, REPORT INDEPENDENT P; Steinbrook R, 2005, NEW ENGL J MED, V353, P221, DOI 10.1056/NEJMp058158	5	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2309	2311		10.1056/NEJMp068112	http://dx.doi.org/10.1056/NEJMp068112			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16702187				2022-12-28	WOS:000237918500001
J	Bardia, A; Williamson, EE; Bauer, BA				Bardia, Aditya; Williamson, Eric E.; Bauer, Brent A.			Scarring moxibustion and religious scarification resulting in hepatitis C and hepatocellular carcinoma	LANCET			English	Editorial Material							RISK-FACTORS; TRANSMISSION; INFECTION; VIRUS		Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Bauer, BA (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA.	bauer.brent@mayo.edu						Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; KIYOSAWA K, 1994, GASTROENTEROLOGY, V106, P1596, DOI 10.1016/0016-5085(94)90416-2; Murphy EL, 2000, HEPATOLOGY, V31, P756, DOI 10.1002/hep.510310329; REFETOFF S, 1994, THYROID, V4, P249, DOI 10.1089/thy.1994.4.249; Zeuzem S, 1996, J HEPATOL, V24, P3	5	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1790	1790		10.1016/S0140-6736(06)68775-8	http://dx.doi.org/10.1016/S0140-6736(06)68775-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731275				2022-12-28	WOS:000237854000035
J	Raftery, J				Raftery, J			Review of NICE's recommendations, 1999-2005	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Southampton, Wessex Inst Hlth Res & Dev, Southampton SO16 7PX, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Wessex Inst Hlth Res & Dev, Southampton SO16 7PX, Hants, England.	j.p.raftery@soton.ac.uk						CORVARI R, 2005, CANADA PHARM PRICING; *DEP HLTH, 2002004 HSC; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Devlin N, 2002, COST EFFECTIVENESS T; Duckett SJ, 2004, HEALTH CARE FINANC R, V25, P55; HADHORN D, 1991, JAMA-J AM MED ASSOC, V265, P2218; Ham C., 2003, REASONABLE RATIONING, P141; *HC HLTH COMM, 2002, REV NAT I CLIN EXC; Hill S, 2003, TECHNOLOGY APPRAISAL; Miners AH, 2005, BMJ-BRIT MED J, V330, P65, DOI 10.1136/bmj.38285.482350.82; *NAT I CLIN EXC, 2002, GUID US TRAST TREATM; *NAT I CLIN EXC, 2001, GUID US RIL MOT NEUR; *NAT I CLIN EXC, 2003, TECHN APPR GUID 70 U; *NAT I CLIN EXC, 2005, NICE ISS FAST DRUGS; *NAT I CLIN EXC, 2002, TECHN APPR GUID 50 U; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; Newdick C., 2005, WHO SHOULD WE TREAT; Porter R, 2002, NEW ZEAL MED J, V115, P274; Raftery J, 2001, BRIT MED J, V323, P1300, DOI 10.1136/bmj.323.7324.1300; Robert G, 2003, REASONABLE RATIONING, P64; STIFTUNG B, 2004, CTR QUALITY MED POLI; 2004, ECONOMIST       0515, P40	22	73	73	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2006	332	7552					1266	1268		10.1136/bmj.332.7552.1266	http://dx.doi.org/10.1136/bmj.332.7552.1266			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16735341	Green Submitted, Green Published			2022-12-28	WOS:000237984100024
J	Robinson, DP; Das, S; Watts, AB				Robinson, D. P.; Das, S.; Watts, A. B.			Earthquake rupture stalled by a subducting fracture zone	SCIENCE			English	Article							HISTORY; PLATE; ASPERITIES; INVERSION; BARRIERS; STRESS; MODEL; SLIP	We showed that the rupture produced by the great Peru earthquake (moment magnitude 8.4) on 23 June 2001 propagated for similar to 70 kilometers before encountering a 6000-square-kilometer area of fault that acted as a barrier. The rupture continued around this barrier, which remained unbroken for similar to 30 seconds and then began to break when the main rupture front was similar to 200 kilometers from the epicenter. The barrier had relatively low rupture speed, slip, and aftershock density as compared to its surroundings, and the time of the main energy release in the earthquake coincided with the barrier's rupture. We associate this barrier with a fracture zone feature on the subducting oceanic plate.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Oxford	Robinson, DP (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	David.Robinson@earth.ox.ac.uk			Natural Environment Research Council [NE/C518806/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bilham R, 2005, SCIENCE, V308, P1126, DOI 10.1126/science.1113363; British Oceanographic Data Centre, 2003, GEBCO DIG ATL; CLOETINGH S, 1986, TECTONOPHYSICS, V132, P49, DOI 10.1016/0040-1951(86)90024-7; CLOOS M, 1992, GEOLOGY, V20, P601, DOI 10.1130/0091-7613(1992)020<0601:TTSZEA>2.3.CO;2; Comte D., 1991, Natural Hazards, V4, P23, DOI 10.1007/BF00126557; Das S, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000119; DAS S, 1990, J GEOPHYS RES-SOLID, V95, P6899, DOI 10.1029/JB095iB05p06899; DAS S, 1994, PHYS EARTH PLANET IN, V85, P293, DOI 10.1016/0031-9201(94)90119-8; DAS S, 1977, J GEOPHYS RES, V82, P5658, DOI 10.1029/JB082i036p05658; FREUND LB, 1990, DYNAMIC FRACTURE MCH; HANDSCHUMACHER DW, 1976, GEOPHYSICS PACIFIC O, P177; Henry C, 2000, J GEOPHYS RES-SOL EA, V105, P16097, DOI 10.1029/2000JB900077; HERRON EM, 1972, GEOL SOC AM BULL, V83, P1671, DOI 10.1130/0016-7606(1972)83[1671:SSATCH]2.0.CO;2; JUDGE AV, 1991, J GEOPHYS RES-SOL EA, V96, P16625, DOI 10.1029/90JB01772; KELLEHER J, 1976, J GEOPHYS RES, V81, P4885, DOI 10.1029/JB081i026p04885; Kostrov B., 1988, PRINCIPLES EARTHQUAK; MADARIAGA R, 1977, GEOPHYS J ROY ASTR S, V51, P625, DOI 10.1111/j.1365-246X.1977.tb04211.x; Olsen KB, 1997, SCIENCE, V278, P834, DOI 10.1126/science.278.5339.834; Page MT, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003736; RODRIGUEZMAREK A, 2003, EARTHQUAKE SPECTRA, V19; Scholz CH, 1997, GEOLOGY, V25, P487, DOI 10.1130/0091-7613(1997)025<0487:TEOSSO>2.3.CO;2; SCHWELLER WJ, 1981, NAZCA PLATE CRUSTAL, P323	22	85	84	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1203	1205		10.1126/science.1125771	http://dx.doi.org/10.1126/science.1125771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728638				2022-12-28	WOS:000237957400050
J	Tai, RH; Liu, CQ; Maltese, AV; Fan, XT				Tai, Robert H.; Liu, Christine Qi; Maltese, Adam V.; Fan, Xitao			Planning early for careers in science	SCIENCE			English	Editorial Material									Univ Virginia, Curry Sch Educ, Charlottesville, VA 22904 USA	University of Virginia	Tai, RH (corresponding author), Univ Virginia, Curry Sch Educ, 405 Emmet St S, Charlottesville, VA 22904 USA.	rht6h@virginia.edu	Fan, Xitao/D-1533-2013; Maltese, Adam V/G-6011-2014; Maltese, Adam/M-1018-2019	Maltese, Adam V/0000-0001-8422-9395; Maltese, Adam/0000-0001-8422-9395				DILLON S, 2006, NY TIMES        0306; HATIVA N, 1995, DISCIPLINARY DIFFERE; Long S., 2001, REGRESSION MODELS CA; National Research Council, 2005, RIS GATH STORM EN EM; National Science Board, 2004, EM CRIT PROBL SCI EN; *NCES, 2004, US MAN NAT ED LONG S; ROCK DA, 1991, 91468 NCES	7	517	520	8	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1143	1144		10.1126/science.1128690	http://dx.doi.org/10.1126/science.1128690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048OW	16728620				2022-12-28	WOS:000237957400028
J	Frydman, HM; Li, JM; Robson, DN; Wieschaus, E				Frydman, Horacio M.; Li, Jennifer M.; Robson, Drew N.; Wieschaus, Eric			Somatic stem cell niche tropism in Wolbachia	NATURE			English	Article							HORIZONTAL TRANSFER; TRICHOGRAMMA-WASPS; DROSOPHILA OVARIAN; HOST; INFECTIONS; BACTERIA; BEHAVIOR; INSECTS	Wolbachia are intracellular bacteria found in the reproductive tissue of all major groups of arthropods(1,2). They are transmitted vertically from the female hosts to their offspring, in a pattern analogous to mitochondria inheritance. But Wolbachia phylogeny does not parallel that of the host, indicating that horizontal infectious transmission must also occur(3-5). Insect parasitoids are considered the most likely vectors, but the mechanism for horizontal transfer is largely unknown(4,6,7). Here we show that newly introduced Wolbachia cross several tissues and infect the germline of the adult Drosophila melanogaster female. Through investigation of bacterial migration patterns during the course of infection, we found that Wolbachia reach the germline through the somatic stem cell niche in the D. melanogaster germarium. In addition, our data suggest that Wolbachia are highly abundant in the somatic stem cell niche of long-term infected hosts, implying that this location may also contribute to efficient vertical transmission. This is, to our knowledge, the first report of an intracellular parasite displaying tropism for a stem cell niche.	Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08540 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA	Howard Hughes Medical Institute; Princeton University; Princeton University	Frydman, HM (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08540 USA.	hfrydman@princeton.edu		Robson, Drew/0000-0002-0150-1515; Frydman, Horacio/0000-0003-0191-7948				Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Grenier S, 1998, P ROY SOC B-BIOL SCI, V265, P1441, DOI 10.1098/rspb.1998.0455; Hadfield SJ, 1999, NATURE, V402, P482, DOI 10.1038/45002; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kang L, 2003, HEREDITY, V90, P71, DOI 10.1038/sj.hdy.6800180; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Rigaud T, 2001, J INVERTEBR PATHOL, V77, P251, DOI 10.1006/jipa.2001.5026; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	27	155	160	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					509	512		10.1038/nature04756	http://dx.doi.org/10.1038/nature04756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724067				2022-12-28	WOS:000237778900050
J	Senecal, E; Thomas, SH; Lev, MH; Schwamm, LH; Milne, LW; Gordon, J; Harris, NL; Brown, DF				Senecal, Emily; Thomas, Stephen H.; Lev, Michael H.; Schwamm, Lee H.; Milne, Leslie W.; Gordon, James; Harris, Nancy Lee; Brown, David F.			A 72-year-old woman admitted to the emergency department because of a sudden change in mental status - Acute ischemic stroke.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; INTRAARTERIAL THROMBOLYSIS; HYPERACUTE STROKE; CT ANGIOGRAPHY; PERFUSION; INTUBATION; PREDICTION; ACCURACY; EFFICACY; THERAPY		Massachusetts Gen Hosp, Emergency Serv, Boston, MA 02114 USA; Massachusetts Gen Hosp, Telestroke & Acute Stroke Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Thomas, SH (corresponding author), Massachusetts Gen Hosp, Emergency Serv, Boston, MA 02114 USA.			Thomas, Stephen/0000-0003-4153-3965				*2005 AM HEART ASS, 2005, CIRCULATION S, V112, P111; Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; Becker KJ, 2005, STROKE, V36, P400, DOI 10.1161/01.STR.0000153056.25397.ff; Berzin TM, 2001, STROKE, V32, P317; Chalela JA, 1999, STROKE, V30, P2366, DOI 10.1161/01.STR.30.11.2366; *COMM MASS DEP HLT, 2004, ADV B PRIM STROK SER; *COMM MASS DEP HLT, AM HOSP LIC REG; Conroy MB, 1999, STROKE, V30, P2580, DOI 10.1161/01.STR.30.12.2580; *FOOD DRUG ADM, 2004, IND US CONC MERC RET; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P3204; Hacke W, 2005, STROKE, V36, P66, DOI 10.1161/01.STR.0000149938.08731.2c; Hacke W, 2004, LANCET, V363, P768; Harrison TH, 2004, PEDIATR EMERG CARE, V20, P101, DOI 10.1097/01.pec.0000113879.10140.7f; Hunter GJ, 1998, AM J NEURORADIOL, V19, P29; Ingall TJ, 2004, STROKE, V35, P2418, DOI 10.1161/01.STR.0000140891.70547.56; Kirchhof K, 2003, RADIOLOGY, V228, P126, DOI 10.1148/radiol.2273020530; Kothari RU, 1999, ANN EMERG MED, V33, P373, DOI 10.1016/S0196-0644(99)70299-4; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Kwiatkowski T, 2005, ANN EMERG MED, V45, P377, DOI 10.1016/j.annemergmed.2004.06.021; Lev MH, 1999, RADIOLOGY, V213, P150, DOI 10.1148/radiology.213.1.r99oc10150; Lev MH, 2001, J COMPUT ASSIST TOMO, V25, P520, DOI 10.1097/00004728-200107000-00003; Lev MH, 2001, STROKE, V32, P2021, DOI 10.1161/hs0901.095680; Liferidge Aisha T, 2004, Prehosp Emerg Care, V8, P384; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Reeves MJ, 2005, STROKE, V36, P1820, DOI 10.1161/01.STR.0000178108.54612.9e; Rosamond Wayne D, 2005, Prehosp Emerg Care, V9, P19, DOI 10.1080/10903120590891985; Schramm P, 2002, STROKE, V33, P2426, DOI 10.1161/01.STR.0000032244.03134.37; Schwamm LH, 2005, STROKE, V36, P690, DOI 10.1161/01.STR.0000158165.42884.4F; Schwamm LH, 2004, ACAD EMERG MED, V11, P1193, DOI 10.1197/j.aem.2004.08.014; Silliman SL, 2003, STROKE, V34, P729, DOI 10.1161/01.STR.0000056529.29515.B2; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Thomas S H, 1999, Prehosp Emerg Care, V3, P310, DOI 10.1080/10903129908958960; Thomas Stephen H, 2002, Prehosp Emerg Care, V6, P210, DOI 10.1080/10903120290938562; Thomson David P, 2003, Prehosp Emerg Care, V7, P265, DOI 10.1080/10903120390936923; TOMSICK TA, 1990, AM J NEURORADIOL, V11, P473; Wang H E, 2000, Prehosp Emerg Care, V4, P14, DOI 10.1080/10903120090941560; Wang Henry E, 2004, Prehosp Emerg Care, V8, P366; Wayne M A, 1999, Prehosp Emerg Care, V3, P107, DOI 10.1080/10903129908958916; Wintermark M, 2002, ANN NEUROL, V51, P417, DOI 10.1002/ana.10136	45	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2263	2271		10.1056/NEJMcpc069007	http://dx.doi.org/10.1056/NEJMcpc069007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045RF	16723618				2022-12-28	WOS:000237758900010
J	Wheeler, AP; Bernard, GR; Thompson, BT; Schoenfeld, D; Wiedemann, HP; deBoisblanc, B; Connors, AF; Hite, D; Harabin, AL				Wheeler, AP; Bernard, GR; Thompson, BT; Schoenfeld, D; Wiedemann, HP; deBoisblanc, B; Connors, AF; Hite, D; Harabin, AL		Natl Heart Lung Blood Inst	Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RIGHT-HEART CATHETERIZATION; CRITICALLY-ILL PATIENTS; RESPIRATORY-DISTRESS-SYNDROME; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; RISK SURGICAL PATIENTS; PATIENT SAFETY; PRESSURE; OUTCOMES; CARE	Background: The balance between the benefits and the risks of pulmonary-artery catheters (PACs) has not been established. Methods: We evaluated the relationship of benefits and risks of PACs in 1000 patients with established acute lung injury in a randomized trial comparing hemodynamic management guided by a PAC with hemodynamic management guided by a central venous catheter (CVC) using an explicit management protocol. Mortality during the first 60 days before discharge home was the primary outcome. Results: The groups had similar baseline characteristics. The rates of death during the first 60 days before discharge home were similar in the PAC and CVC groups (27.4 percent and 26.3 percent, respectively; P=0.69; absolute difference, 1.1 percent; 95 percent confidence interval, -4.4 to 6.6 percent), as were the mean (+/-SE) numbers of both ventilator-free days (13.2+/-0.5 and 13.5+/-0.5; P=0.58) and days not spent in the intensive care unit (12.0+/-0.4 and 12.5+/-0.5; P=0.40) to day 28. PAC-guided therapy did not improve these measures for patients in shock at the time of enrollment. There were no significant differences between groups in lung or kidney function, rates of hypotension, ventilator settings, or use of dialysis or vasopressors. Approximately 90 percent of protocol instructions were followed in both groups, with a 1 percent rate of crossover from CVC- to PAC-guided therapy. Fluid balance was similar in the two groups, as was the proportion of instructions given for fluid and diuretics. Dobutamine use was uncommon. The PAC group had approximately twice as many catheter-related complications (predominantly arrhythmias). Conclusions: PAC-guided therapy did not improve survival or organ function but was associated with more complications than CVC-guided therapy. These results, when considered with those of previous studies, suggest that the PAC should not be routinely used for the management of acute lung injury.	Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Cleveland Clin, Cleveland, OH 44106 USA; Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA; Wake Forest Univ Hlth Sci, Winston Salem, NC USA; NHLBI, NIH, Bethesda, MD 20892 USA	Vanderbilt University; Harvard University; Massachusetts General Hospital; Cleveland Clinic Foundation; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Case Western Reserve University; MetroHealth System; Wake Forest University; Wake Forest University School of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wheeler, AP (corresponding author), Vanderbilt Univ, Med Ctr, T-1217 MCN, Nashville, TN 37232 USA.	art.wheeler@vanderbilt.edu		Connors, Alfred F./0000-0001-7123-3360; Wiedemann, Herbert/0000-0002-4587-4401	NHLBI NIH HHS [N01-HR-16146-54, N01-HR-46054-64] Funding Source: Medline; DIVISION OF LUNG DISEASES [N01HR046054, N01HR016146] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Afessa B, 2001, CRIT CARE MED, V29, P1145, DOI 10.1097/00003246-200106000-00010; Angus D, 2001, BRIT MED J, V322, P446, DOI 10.1136/bmj.322.7284.446; Bernard GR, 2000, JAMA-J AM MED ASSOC, V283, P2568, DOI 10.1001/jama.283.19.2568; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Burns D, 1996, Am J Crit Care, V5, P49; Chalfin D B, 1997, New Horiz, V5, P292; CIVETTA JM, 1972, ANN SURG, V176, P753, DOI 10.1097/00000658-197212000-00014; Cohen MG, 2005, AM J MED, V118, P482, DOI 10.1016/j.amjmed.2004.12.018; CONNORS AF, 1983, NEW ENGL J MED, V308, P263, DOI 10.1056/NEJM198302033080508; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Dalen JE, 1996, JAMA-J AM MED ASSOC, V276, P916, DOI 10.1001/jama.276.11.916; Dalen JE, 2001, JAMA-J AM MED ASSOC, V286, P348, DOI 10.1001/jama.286.3.348; Drazen JM, 2003, NEW ENGL J MED, V348, P1377, DOI 10.1056/NEJMe030031; EISENBERG PR, 1984, CRIT CARE MED, V12, P549, DOI 10.1097/00003246-198407000-00001; Ferguson ND, 2002, INTENS CARE MED, V28, P1073, DOI 10.1007/s00134-002-1354-y; FORRESTE.JS, 1971, NEW ENGL J MED, V285, P190, DOI 10.1056/NEJM197107222850402; FULLER H, 1992, CRIT CARE MED, V20, P928, DOI 10.1097/00003246-199207000-00006; Gnaegi A, 1997, CRIT CARE MED, V25, P213, DOI 10.1097/00003246-199702000-00003; GORE JM, 1987, CHEST, V92, P721, DOI 10.1378/chest.92.4.721; Guyatt G, 1991, J Intensive Care Med, V6, P91; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; IBERTI TJ, 1990, JAMA-J AM MED ASSOC, V264, P2928, DOI 10.1001/jama.264.22.2928; Ivanov R I, 1997, New Horiz, V5, P268; Jacka MJ, 2002, CRIT CARE MED, V30, P1197, DOI 10.1097/00003246-200206000-00003; Jain M, 2003, INTENS CARE MED, V29, P2059, DOI 10.1007/s00134-003-1924-7; Marinelli WA, 1999, AM J RESP CRIT CARE, V160, P69, DOI 10.1164/ajrccm.160.1.9711079; MIMOZ O, 1994, CRIT CARE MED, V22, P573, DOI 10.1097/00003246-199404000-00011; Morris AH, 2000, ANN INTERN MED, V132, P373, DOI 10.7326/0003-4819-132-5-200003070-00007; Morris Alan H, 2003, Curr Opin Crit Care, V9, P236, DOI 10.1097/00075198-200306000-00012; *NAT HEART LUNG BL, COMP 2 FLUID MAN STR; Polanczyk CA, 2001, JAMA-J AM MED ASSOC, V286, P309, DOI 10.1001/jama.286.3.309; Rhodes A, 2002, INTENS CARE MED, V28, P256, DOI 10.1007/s00134-002-1206-9; Richard C, 2003, JAMA-J AM MED ASSOC, V290, P2713, DOI 10.1001/jama.290.20.2713; Rizvi K, 2005, CRIT CARE MED, V33, P98, DOI 10.1097/01.CCM.0000150650.70142.E9; ROBIN ED, 1985, ANN INTERN MED, V103, P445, DOI 10.7326/0003-4819-103-3-445; Sakr Y, 2005, CHEST, V128, P2722, DOI 10.1378/chest.128.4.2722; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; SCHULTZ RJ, 1985, J TRAUMA, V25, P309, DOI 10.1097/00005373-198504000-00005; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; Steinbrook R, 2003, NEW ENGL J MED, V349, P629, DOI 10.1056/NEJMp038133; Steinbrook R, 2003, NEW ENGL J MED, V348, P1393, DOI 10.1056/NEJMhpr030349; STEINGRUB JS, 1991, CHEST, V99, P1451, DOI 10.1378/chest.99.6.1451; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Walker M B, 1994, Clin Intensive Care, V5, P15; ZION MM, 1990, CHEST, V98, P1331, DOI 10.1378/chest.98.6.1331	47	616	634	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2213	2224						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045RF	16714768				2022-12-28	WOS:000237758900003
J	Steinbrook, R				Steinbrook, R			Health care reform in Massachusetts - A work in progress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						*KAIS COMM MED UN, 2005, STAT FISC COND MED; McDonough JE, 1997, NEW ENGL J MED, V336, P148, DOI 10.1056/NEJM199701093360222; Schroeder SA, 1996, NEW ENGL J MED, V334, P1130, DOI 10.1056/NEJM199604253341713; 2006, HLTH CARE ACCESS AFF	4	20	20	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2095	2098		10.1056/NEJMp068097	http://dx.doi.org/10.1056/NEJMp068097			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707745				2022-12-28	WOS:000237575400002
J	Trotta, CR; Paushkin, SV; Patel, M; Li, H; Peltz, SW				Trotta, CR; Paushkin, SV; Patel, M; Li, H; Peltz, SW			Cleavage of pre-tRNAs by the splicing endonuclease requires a composite active site	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ARCHAEAL; INTRON; ENZYME; RECOGNITION; SUBSTRATE; EVOLUTION; SUBUNITS; MOTIFS	Splicing is required for the removal of introns from a subset of transfer RNAs in all eukaryotic organisms. The first step of splicing, intron recognition and cleavage, is performed by the tRNA-splicing endonuclease, a tetrameric enzyme composed of the protein subunits Sen54, Sen2, Sen34 and Sen15. It has previously been demonstrated that the active sites for cleavage at the 5' and 3' splice sites of precursor tRNA are contained within Sen2 and Sen34, respectively(1-3). A recent structure of an archaeal endonuclease complexed with a bulge - helix - bulge RNA has led to the unexpected hypothesis that catalysis requires a critical 'cation-pi sandwich' composed of two arginine residues that serve to position the RNA substrate within the active site(4). This motif is derived from a cross-subunit interaction between the two catalytic subunits. Here we test the role of this interaction within the eukaryotic endonuclease and show that catalysis at the 50 splice site requires the conserved cation-pi sandwich derived from the Sen34 subunit in addition to the catalytic triad of Sen2. The catalysis of pre-tRNA by the eukaryotic tRNA-splicing endonuclease therefore requires a previously unrecognized composite active site.	PTC Therapeut, S Plainfield, NJ 07080 USA; Florida State Univ, Inst Mol Biophys, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Trotta, CR (corresponding author), PTC Therapeut, 100 Corp Court, S Plainfield, NJ 07080 USA.	ctrotta@ptcbio.com		Li, Hong/0000-0003-2046-9861	NIGMS NIH HHS [F32 GM018893] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABELSON J, 1992, SCIENCE, V255, P1390, DOI 10.1126/science.1542787; Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; BALDI MI, 1992, SCIENCE, V255, P1404, DOI 10.1126/science.1542788; Belfort M, 1997, CELL, V89, P1003, DOI 10.1016/S0092-8674(00)80287-1; Bujnicki JM, 2000, FEBS LETT, V486, P328, DOI 10.1016/S0014-5793(00)02322-X; DINICOLA NE, 1997, CELL, V89, P859; Fruscoloni P, 2001, EMBO REP, V2, P217, DOI 10.1093/embo-reports/kve040; HO CK, 1990, EMBO J, V9, P1245, DOI 10.1002/j.1460-2075.1990.tb08232.x; KlemanLeyer K, 1997, CELL, V89, P839, DOI 10.1016/S0092-8674(00)80269-X; LEE MC, 1985, J BIOL CHEM, V260, P3108; Li H, 2000, J MOL BIOL, V302, P639, DOI 10.1006/jmbi.2000.3941; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; LykkeAndersen J, 1997, EMBO J, V16, P6290, DOI 10.1093/emboj/16.20.6290; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Randau L, 2005, P NATL ACAD SCI USA, V102, P17934, DOI 10.1073/pnas.0509197102; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; REYES VM, 1987, ANAL BIOCHEM, V166, P90, DOI 10.1016/0003-2697(87)90551-3; REYES VM, 1988, CELL, V55, P719, DOI 10.1016/0092-8674(88)90230-9; Tocchini-Valentini GD, 2005, P NATL ACAD SCI USA, V102, P15418, DOI 10.1073/pnas.0506750102; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; Volta V, 2005, BIOCHEM BIOPH RES CO, V337, P89, DOI 10.1016/j.bbrc.2005.09.012; XUE S, IN PRESS SCIENCE	22	45	46	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2006	441	7091					375	377		10.1038/nature04741	http://dx.doi.org/10.1038/nature04741			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710424				2022-12-28	WOS:000237593200054
J	Ridker, PM; Torres, J				Ridker, PM; Torres, J			Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIALS; CORONARY-HEART-DISEASE; PRIMARY PREVENTION; UNCERTAINTY PRINCIPLE; SECONDARY PREVENTION; STATIN THERAPY; DRUG TRIALS; OF-INTEREST; EVENTS; ASSOCIATION	Context In surveys based on data available prior to 2000, clinical trials funded by for-profit organizations appeared more likely to report positive findings than those funded by not-for-profit organizations. Whether this situation has changed over the past 5 years or whether similar effects are present among jointly funded trials is unknown. Objective To determine in contemporary randomized cardiovascular trials the association between funding source and the likelihood of reporting positive findings. Design We reviewed 324 consecutive superiority trials of cardiovascular medicine published between January 1, 2000, and July 30, 2005, in JAMA, The Lancet, and the New England Journal of Medicine. Main Outcome Measure The proportion of trials favoring newer treatments over the standard of care was evaluated by funding source. Results Of the 324 superiority trials, 21 cited no funding source. Of the 104 trials funded solely by not-for-profit organizations, 51 (49%) reported evidence significantly favoring newer treatments over the standard of care, whereas 53 (51%) did not (P=. 80). By contrast, 92 (67.2%) of 137 trials funded solely by for-profit organizations favored newer treatments over standard of care ( P <. 001). Among 62 jointly funded trials, 35 (56.5%), an intermediate proportion, favored newer treatments. For 205 randomized trials evaluating drugs, the proportions favoring newer treatments were 39.5%, not-for-profit; 54.4%, jointly funded; and 65.5%, for-profit trials ( P for trend across groups =. 002). For the 39 randomized trials evaluating cardiovascular devices, the proportions favoring newer treatments were 50.0%, not-for-profit; 69.2%, jointly funded; and 82.4%, for-profit trials ( P for trend across groups=. 07). Regardless of funding source, trials using surrogate end points, such as quantitative angiography, intravascular ultrasound, plasma biomarkers, and functional measures were more likely to report positive findings (67%) than trials using clinical end points (54.1%; P=. 02). Conclusions Recent cardiovascular trials funded by for-profit organizations are more likely to report positive findings than trials funded by not-for-profit organizations, as are trials using surrogate rather than clinical end points. Trials jointly funded by not-for-profit and for-profit organizations appear to report positive findings at a rate approximately midway between rates observed in trials supported solely by one or the other of these entities.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org						Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Curfman GD, 2000, NEW ENGL J MED, V343, P1520; De Angelis C, 2004, ANN INTERN MED, V141, P477, DOI 10.7326/0003-4819-141-6-200409210-00109; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Djulbegovic B, 1999, BLOOD, V94, p399A; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Fries JF, 2004, ARTHRITIS RES THER, V6, pR250, DOI 10.1186/ar1170; GIFFORD F, 1995, BIOETHICS, V9, P127, DOI 10.1111/j.1467-8519.1995.tb00306.x; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kjaergard LL, 1999, HEPATOLOGY, V30, P1134, DOI 10.1002/hep.510300510; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Miller PB, 2003, KENNEDY INST ETHIC J, V13, P93, DOI 10.1353/ken.2003.0014; Montaner JSG, 2001, LANCET, V358, P1893, DOI 10.1016/S0140-6736(01)06891-X; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Olson L G, 2002, Monash Bioeth Rev, V21, pS55; PEDERSEN TR, 1994, LANCET, V344, P1383; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; Wahlbeck K, 1999, BRIT MED J, V318, P465; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	41	212	215	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2006	295	19					2270	2274		10.1001/jama.295.19.2270	http://dx.doi.org/10.1001/jama.295.19.2270			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042UX	16705108	Bronze			2022-12-28	WOS:000237556600025
J	McGuire, BM; Julian, BA; Bynon, JS; Cook, WJ; King, SJ; Curtis, JJ; Accortt, NA; Eckhoff, DE				McGuire, Brendan M.; Julian, Bruce A.; Bynon, J. Steve, Jr.; Cook, William J.; King, Steven J.; Curtis, John J.; Accortt, Neil A.; Eckhoff, Devin E.			Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation	ANNALS OF INTERNAL MEDICINE			English	Article							RENAL-DISEASE	Background: Patients infected with hepatitis C virus (HCV) frequently develop renal failure after liver transplantation. Objective: To describe renal histologic characteristics and concomitant clinical features in HCV-infected patients with end-stage cirrhosis. Design: Case series. Setting: Single-center liver transplant program in the United States. Patients: 30 patients who received liver transplants for HCV-induced cirrhosis. Intervention: Kidney biopsy during liver engraftment. Measurements: Clinical data and laboratory tests of renal function within 6 months before liver transplantation. Results: Twenty-five patients had immune-complex glomerulonephritis: membranoproliferative glomerulonephritis type 1 (n = 12), IgA nelphropathy (n = 7), and mesangial glomerulonephritis (n 6). Of these patients, 10 had normal serum creatinine levels, normal urinalysis results, and normal quantitative proteinuria. For 5 others, the only renal abnormality was an increased serum creatinine level. No patient had cryoglobulins in the blood or kidney. Limitations: This small observational study did not include patients with nonviral cirrhosis and did not document post-transplantation outcomes. Conclusions: immune-complex glomerulonephritis was common in patients with end-stage HCV-induced cirrhosis and was often clinically silent. Its potential to cause renal failure after liver transplantation may be underappreciated.	Univ Alabama Birmingham, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	McGuire, BM (corresponding author), Univ Alabama Birmingham, 1530 3rd Ave S,MCLM 262A, Birmingham, AL 35294 USA.	bmcguire@uab.edu						Arase Y, 1998, INTERNAL MED, V37, P836, DOI 10.2169/internalmedicine.37.836; Belgiojoso G B, 1976, Clin Nephrol, V6, P303; D'Amico G, 1998, KIDNEY INT, V54, P650, DOI 10.1046/j.1523-1755.1998.00028.x; Giclas PC, 1997, MANUAL CLIN LAB IMMU, V5, P181; GONWA TA, 1995, TRANSPLANTATION, V59, P361, DOI 10.1097/00007890-199502150-00010; Gorevic PD, 1997, MANUAL CLIN LAB IMMU, P217; JENNETTE JC, 1988, AM J KIDNEY DIS, V12, P348, DOI 10.1016/S0272-6386(88)80022-2; JINDAL RM, 1995, POSTGRAD MED J, V71, P513, DOI 10.1136/pgmj.71.839.513; JOHNSON RJ, 1993, NEW ENGL J MED, V328, P465, DOI 10.1056/NEJM199302183280703; Kendrick EA, 1997, TRANSPLANTATION, V63, P1287, DOI 10.1097/00007890-199705150-00016; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1016/S0272-6386(03)00828-X; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Pillebout E, 2005, AM J TRANSPLANT, V5, P1120, DOI 10.1111/j.1600-6143.2005.00852.x; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3	15	125	134	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2006	144	10					735	741		10.7326/0003-4819-144-10-200605160-00007	http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043XO	16702589				2022-12-28	WOS:000237636400004
J	de Winter, S; van Buchem, MA; Vermeer, MH				de Winter, S; van Buchem, MA; Vermeer, MH			Annular erythema of Sjogren's syndrome	LANCET			English	Editorial Material									Leiden Univ, Med Ctr, Dept Dermatol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Vermeer, MH (corresponding author), Leiden Univ, Med Ctr, Dept Dermatol, POB 9600, NL-2300 RC Leiden, Netherlands.	M.H.Vermeer@lumc.nl	Vermeer, Maarten/AAO-5381-2021; van Buchem, Mark/AAC-9843-2022	Vermeer, Maarten/0000-0002-5872-4613; van Buchem, Mark/0000-0003-1881-1998					0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1604	1604		10.1016/S0140-6736(06)68698-4	http://dx.doi.org/10.1016/S0140-6736(06)68698-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698414				2022-12-28	WOS:000237598000032
J	Kehlet, H; Jensen, TS; Woolf, CJ				Kehlet, H; Jensen, TS; Woolf, CJ			Persistent postsurgical pain: risk factors and prevention	LANCET			English	Review							DORSAL-ROOT GANGLION; ACUTE POSTOPERATIVE PAIN; INGUINAL-HERNIA; BREAST SURGERY; NERVE INJURY; PREEMPTIVE ANALGESIA; RANDOMIZED-TRIAL; CARDIAC-SURGERY; UP-REGULATION; BACK-PAIN	Acute postoperative pain is followed by persistent pain in 10-50% of individuals after common operations, such as groin hernia repair, breast and thoracic surgery, leg amputation, and coronary artery bypass surgery. Since chronic pain can be severe in about 2-10% of these patients, persistent postsurgical pain represents a major, largely unrecognised clinical problem. Iatrogenic neuropathic pain is probably the most important cause of long-term postsurgical pain. Consequently, surgical techniques that avoid nerve damage should be applied whenever possible. Also, the effect of aggressive, early therapy for postoperative pain should be investigated, since the intensity of acute postoperative pain correlates with the risk of developing a persistent pain state. Finally, the role of genetic factors should be studied, since only a proportion of patients with intraoperative nerve damage develop chronic pain. Based on information about the molecular mechanisms that affect changes to the peripheral and central nervous system in neuropathic pain, several opportunities exist for multimodal pharmacological intervention. Here, we outline strategies for identification of patients at risk and for prevention and possible treatment of this important entity of chronic pain.	Rigshosp, Sect Surg Pathophysiol 4074, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark; Massachusetts Gen Hosp, Dept Anaesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA USA; Harvard Univ, Sch Med, Charlestown, MA USA	Rigshospitalet; University of Copenhagen; Aarhus University; Harvard University; Massachusetts General Hospital; Harvard University	Kehlet, H (corresponding author), Rigshosp, Sect Surg Pathophysiol 4074, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark.	henrik.kehlet@rh.dk	Jensen, Troels Staehelin/A-3418-2009; Woolf, Clifford/A-9784-2010	Jensen, Troels Staehelin/0000-0002-3487-6380; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 38253] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aasvang E, 2005, BRIT J ANAESTH, V95, P69, DOI 10.1093/bja/aei019; ANDERSEN G, 1995, PAIN, V61, P187, DOI 10.1016/0304-3959(94)00144-4; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Bay-Nielsen M, 2004, BRIT J SURG, V91, P1372, DOI 10.1002/bjs.4502; Benedetti F, 1998, J THORAC CARDIOV SUR, V115, P841, DOI 10.1016/S0022-5223(98)70365-4; Bhave G, 2004, J NEUROBIOL, V61, P88, DOI 10.1002/neu.20083; Bisgaard T, 2001, PAIN, V90, P261, DOI 10.1016/S0304-3959(00)00406-1; Bisgaard T, 2005, SCAND J GASTROENTERO, V40, P1358, DOI 10.1080/00365520510023675; Brennan TJ, 2005, ANESTHESIOLOGY, V103, P681, DOI 10.1097/00000542-200510000-00004; Bruce J, 2003, PAIN, V104, P265, DOI 10.1016/S0304-3959(03)00017-4; Callesen T, 1999, BRIT J SURG, V86, P1528, DOI 10.1046/j.1365-2168.1999.01320.x; Caumo W, 2002, ACTA ANAESTH SCAND, V46, P1265, DOI 10.1034/j.1399-6576.2002.461015.x; Cerfolio RJ, 2003, ANN THORAC SURG, V76, P407, DOI 10.1016/S0003-4975(03)00447-8; Coderre TJ, 1997, BEHAV BRAIN SCI, V20, P404, DOI 10.1017/S0140525X97251484; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Dahl JB, 2004, ACTA ANAESTH SCAND, V48, P1130, DOI 10.1111/j.1399-6576.2004.00484.x; DEVOR M, 1990, PAIN, V42, P51, DOI 10.1016/0304-3959(90)91092-W; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; DWORKIN RH, 1992, J ABNORM PSYCHOL, V101, P200, DOI 10.1037/0021-843X.101.1.200; Fassoulaki A, 2000, REGION ANESTH PAIN M, V25, P350, DOI 10.1053/rapm.2000.7812; Fassoulaki A, 2005, ANESTH ANALG, V101, P1427, DOI 10.1213/01.ANE.0000180200.11626.8E; Fassoulaki A, 2002, ANESTH ANALG, V95, P985, DOI 10.1097/00000539-200210000-00036; Gardell LR, 2003, J NEUROSCI, V23, P8370; Gold MS, 2003, J NEUROSCI, V23, P158; Gotoda Y, 2001, EUR J PAIN-LONDON, V5, P89, DOI 10.1053/eujp.2001.0225; Gottrup H, 2000, PAIN, V87, P275, DOI 10.1016/S0304-3959(00)00291-8; Gottschalk A, 2004, ANESTHESIOLOGY, V101, P1063, DOI 10.1097/00000542-200411000-00004; Gottschalk A, 1998, JAMA-J AM MED ASSOC, V279, P1076, DOI 10.1001/jama.279.14.1076; Granot M, 2003, ANESTHESIOLOGY, V98, P1422, DOI 10.1097/00000542-200306000-00018; Grant AM, 2004, BRIT J SURG, V91, P1570, DOI 10.1002/bjs.4799; Haanpaa M, 1999, CLIN J PAIN, V15, P78, DOI 10.1097/00002508-199906000-00003; Hakim AJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P275, DOI 10.1002/art.10395; Hanley M, 2004, DISABIL REHABIL, V26, P882, DOI 10.1080/09638280410001708896; Hartvigsen J, 2004, SPINE, V29, P897, DOI 10.1097/00007632-200404150-00015; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Jaaskelainen SK, 2004, NEUROLOGY, V62, P1951, DOI 10.1212/01.WNL.0000129490.67954.C2; JENSEN TS, 1985, PAIN, V21, P267, DOI 10.1016/0304-3959(85)90090-9; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jin SX, 2003, J NEUROSCI, V23, P4017; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Jung BF, 2004, NEUROLOGY, V62, P1545, DOI 10.1212/01.WNL.0000123261.00004.29; Jung BF, 2003, PAIN, V104, P1, DOI 10.1016/S0304-3959(03)00241-0; Kalkman CJ, 2003, PAIN, V105, P415, DOI 10.1016/S0304-3959(03)00252-5; Kalso E, 2001, ACTA ANAESTH SCAND, V45, P935, DOI 10.1034/j.1399-6576.2001.450803.x; Katz J, 2005, PAIN, V119, P16, DOI 10.1016/j.pain.2005.09.008; Katz J, 2004, ANESTHESIOLOGY, V101, P169, DOI 10.1097/00000542-200407000-00026; Katz J, 1996, CLIN J PAIN, V12, P50, DOI 10.1097/00002508-199603000-00009; Koltzenburg M, 1998, CURR OPIN NEUROL, V11, P515, DOI 10.1097/00019052-199810000-00014; Lai J, 2004, ANNU REV PHARMACOL, V44, P371, DOI 10.1146/annurev.pharmtox.44.101802.121627; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Linton Steven J., 2002, Cognitive Behaviour Therapy, V31, P49, DOI 10.1080/16506070252959481; Liu CN, 2001, NEUROSCIENCE, V105, P265, DOI 10.1016/S0306-4522(01)00161-0; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Macrae WA, 2001, BRIT J ANAESTH, V87, P88, DOI 10.1093/bja/87.1.88; McCartney CJL, 2004, ANESTH ANALG, V98, P1385, DOI 10.1213/01.ANE.0000108501.57073.38; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Mikkelsen T, 2004, ANESTH ANALG, V99, P146, DOI 10.1213/01.ANE.0000115147.14626.C5; Mogil JS, 2000, ANNU REV NEUROSCI, V23, P777, DOI 10.1146/annurev.neuro.23.1.777; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Moiniche S, 2002, ANESTHESIOLOGY, V96, P725, DOI 10.1097/00000542-200203000-00032; Nikolajsen L, 2004, ACTA ANAESTH SCAND, V48, P111, DOI 10.1111/j.1399-6576.2004.00271.x; Nikolajsen L, 1997, LANCET, V350, P1353, DOI 10.1016/S0140-6736(97)06315-0; Nikolajsen L, 1997, PAIN, V72, P393, DOI 10.1016/S0304-3959(97)00061-4; Nikolajsen L, 2001, BRIT J ANAESTH, V87, P107, DOI 10.1093/bja/87.1.107; O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833; Obata H, 1999, CAN J ANAESTH, V46, P1127, DOI 10.1007/BF03015520; Ochroch EA, 2002, ANESTHESIOLOGY, V97, P1234, DOI 10.1097/00000542-200211000-00029; Ong CKS, 2005, ANESTH ANALG, V100, P757, DOI 10.1213/01.ANE.0000144428.98767.0E; Perkins FM, 2000, ANESTHESIOLOGY, V93, P1123, DOI 10.1097/00000542-200010000-00038; Picchio MC, 2004, ARCH SURG-CHICAGO, V139, P755, DOI 10.1001/archsurg.139.7.755; Poobalan AS, 2003, CLIN J PAIN, V19, P48, DOI 10.1097/00002508-200301000-00006; Rasmussen PV, 2004, PAIN, V110, P461, DOI 10.1016/j.pain.2004.04.034; Reuben SS, 2004, ANESTHESIOLOGY, V101, P1215, DOI 10.1097/00000542-200411000-00023; Reuben SS, 2004, J PAIN SYMPTOM MANAG, V27, P133, DOI 10.1016/j.jpainsymman.2003.06.004; Rogers ML, 2002, EUR J CARDIO-THORAC, V21, P298, DOI 10.1016/S1010-7940(01)01104-6; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Senturk M, 2002, ANESTH ANALG, V94, P11; Sharma AD, 2000, ANESTH ANALG, V91, P1358, DOI 10.1097/00000539-200012000-00010; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Subramaniam K, 2004, ANESTH ANALG, V99, P482, DOI 10.1213/01.ANE.0000118109.12855.07; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Tasmuth T, 1996, PAIN, V68, P343, DOI 10.1016/S0304-3959(96)03219-8; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Turk DC, 1996, J BEHAV MED, V19, P435, DOI 10.1007/BF01857677; Turk DC., 1999, PSYCHOSOCIAL FACTORS, P18; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Werner MU, 2004, ANESTHESIOLOGY, V100, P115, DOI 10.1097/00000542-200401000-00020; WOOLF CJ, 1990, J NEUROSCI, V10, P2717; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; Woolf CJ, 2004, ANN INTERN MED, V140, P441, DOI 10.7326/0003-4819-140-8-200404200-00010; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	95	2330	2449	10	217	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1618	1625		10.1016/S0140-6736(06)68700-X	http://dx.doi.org/10.1016/S0140-6736(06)68700-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698416				2022-12-28	WOS:000237598000034
J	Sieberer, T; Leyser, O				Sieberer, T; Leyser, O			Plant science - Auxin transport, but in which direction?	SCIENCE			English	Editorial Material							ARABIDOPSIS-THALIANA; EFFLUX; PIN; PROTEINS		Univ York, Dept Biol, York Y010 4YW, N Yorkshire, England	University of York - UK	Sieberer, T (corresponding author), Univ York, Dept Biol, York Y010 4YW, N Yorkshire, England.	ts20@york.ac.uk; hmol1@york.ac.uk	Leyser, Ottoline/AAC-5577-2019	Leyser, Ottoline/0000-0003-2161-3829	Biotechnology and Biological Sciences Research Council [BBS/B/09392] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; DHARMASIRI S, 2006, SCIENCE         0511; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Grebe M, 2002, CURR BIOL, V12, P329, DOI 10.1016/S0960-9822(02)00654-1; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; MORRIS DA, 2004, BIOSYNTHESIS SIGNAL, P437; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; YANG Y, IN PRESS CURR BIOL	17	27	27	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					858	860		10.1126/science.1127659	http://dx.doi.org/10.1126/science.1127659			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690849				2022-12-28	WOS:000237452900028
J	Thompson, RJ; Zhou, N; MacVicar, BA				Thompson, RJ; Zhou, N; MacVicar, BA			Ischemia opens neuronal gap junction hemichannels	SCIENCE			English	Article							CONNEXIN HEMICHANNELS; ATP RELEASE; BRAIN; DEPOLARIZATION; INHIBITION; MECHANISMS; DEATH; COMMUNICATION; ASTROCYTES; CHANNELS	Neuronal excitotoxicity during stroke is caused by activation of unidentified large-conductance channels, leading to swelling and calcium dysregulation. We show that ischemic-like conditions [O-2/glucose deprivation (OGD)] open hemichannels, or half gap junctions, in neurons. Hemichannel opening was indicated by a large linear current and flux across the membrane of small fluorescent molecules. Single-channel openings of hemichannels ( 530 picosiemens) were observed in OGD. Both the current and dye flux were blocked by inhibitors of hemichannels. Therefore, hemichannel opening contributes to the profound ionic dysregulation during stroke and may be a ubiquitous component of ischemic neuronal death.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia	MacVicar, BA (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada.	bmacvica@interchange.ubc.ca	MacVicar, Brian/P-1553-2015; Thompson, Roger/A-3029-2012; MacVicar, Brian/AAI-7729-2020; Thompson, Roger/L-3930-2016	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Thompson, Roger/0000-0002-7019-7246; Zhou, Ning/0000-0003-4693-0679				Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fung ML, 1997, BRAIN RES, V762, P97, DOI 10.1016/S0006-8993(97)00371-5; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Thompson RJ, 2002, BIOPHYS J, V83, P278, DOI 10.1016/S0006-3495(02)75168-0; TOMASETTO C, 1993, J CELL BIOL, V122, P157, DOI 10.1083/jcb.122.1.157; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	23	424	443	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					924	927		10.1126/science.1126241	http://dx.doi.org/10.1126/science.1126241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690868				2022-12-28	WOS:000237452900051
J	Macilwain, C				Macilwain, C			Challengers in the field	NATURE			English	News Item																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2006	441	7090					149	149		10.1038/441149a	http://dx.doi.org/10.1038/441149a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688145	Bronze			2022-12-28	WOS:000237418800013
J	Popescu, I; Vaughan-Sarrazin, MS; Rosenthal, GE				Popescu, I; Vaughan-Sarrazin, MS; Rosenthal, GE			Certificate of need regulations and use of coronary revascularization after acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GEOGRAPHIC-VARIATION; ADMINISTRATIVE DATA; CLAIMS DATA; ANGIOPLASTY; MEDICARE; OUTCOMES; VOLUME; ANGIOGRAPHY; HOSPITALS; PERSPECTIVE	Context Certificate of need regulations were enacted to control health care costs by limiting unnecessary expansion of services. While many states have repealed certificate of need regulations in recent years, few analyses have examined relationships between certificate of need regulations and outcomes of care. Objective To compare rates of coronary revascularization and mortality after acute myocardial infarction in states with and without certificate of need regulations. Design, Setting, and Participants Retrospective cohort study of 1 139 792 Medicare beneficiaries aged 68 years or older with AMI who were admitted to 4587 US hospitals during 2000-2003. Main Outcome Measures Thirty-day risk-adjusted rates of coronary revascularization with either coronary artery bypass graft surgery or percutaneous coronary intervention and 30-day all-cause mortality. Results The 624 421 patients in states with certificate of need regulations were less likely to be admitted to hospitals with coronary revascularization services ( 321 573 [51.5%] vs 323 695 [62.8%]; P <. 001) or to undergo revascularization at the admitting hospital ( 163 120 [26.1%] vs 163 877 [31.8%]; P <. 001) than patients in states without certificates of need but were more likely to undergo revascularization at a transfer hospital ( 73 379 [11.7%] vs 45 907 [8.9%]; P <. 001). Adjusting for demographic and clinical risk factors, patients in states with highly and moderately stringent certificate of need regulations, respectively, were less likely to undergo revascularization within the first 2 days ( adjusted hazard ratios, 0.68; 95% confidence interval [CI], 0.54-0.87; P =.002 and 0.80; 95% CI, 0.71-0.90; P <. 001) relative to patients in states without certificates of need, although no differences in the likelihood of revascularization were observed during days 3 through 30. Unadjusted 30-day mortality was similar in states with and without certificates of need ( 109 304 [17.5%] vs 90 104 [ 17.5%]; P=.76), as was adjusted mortality ( odds ratio, 1.00; 95% CI, 0.97-1.03; P=.90). Conclusions Patients with acute myocardial infarction were less likely to be admitted to hospitals offering coronary revascularization and to undergo early revascularization in states with certificate of need regulations. However, differences in the availability and use of revascularization therapies were not associated with mortality.	Iowa City VA Med Ctr, CRIISP, Iowa City, IA USA; Univ Iowa, Carver Coll Med, Dept Internal Med, Div Gen Internal Med, Iowa City, IA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Popescu, I (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, 200 Hawkins Dr,SE615-GH, Iowa City, IA 52240 USA.	ioana-popescu@uiowa.edu		Vaughan Sarrazin, Mary/0000-0001-8717-1061				*AM HLTH PLANN ASS, 2004, IMPR HLTH CAR DOS CO; *AM HLTH PLANN ASS, 2000, NAT DIR HLTH PLANN P; [Anonymous], 2004, IMPROVING HLTH CARE; Ash AS, 2003, HEALTH SERV RES, V38, P1253, DOI 10.1111/1475-6773.00175; BURDA D, 1991, MOD HLTH, V21, P28; BURDA D, 1991, MOD HEALTHCARE, V21, P32; BURDA D, 1991, MOD HEALTHCARE, V21, P36; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; Canto JG, 2000, NEW ENGL J MED, V342, P1094, DOI 10.1056/NEJM200004133421505; Conover CS, 2003, EVALUATION CERTIFICA, V2; Cram P, 2005, NEW ENGL J MED, V352, P1454, DOI 10.1056/NEJMsa042325; *CTR EV CLIN SCI D, DARTM ATL HEALTHC 19; *CTR MED MED SERV, 2003, MED PRESCR DRUG IMPR; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; *GEN ACC OFF, 2003, PUBL GEN ACC OFF; Guadagnoli E, 2001, MED CARE, V39, P446, DOI 10.1097/00005650-200105000-00005; Hannan EL, 1997, HEALTH SERV RES, V31, P659; HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Ho V, 2004, AM HEART J, V147, P442, DOI 10.1016/j.ahj.2003.05.002; Krumholz HM, 1998, CIRCULATION, V98, P2010, DOI 10.1161/01.CIR.98.19.2010; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MANARD BB, 1995, GEORGIA CERTIFICATE; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Pilote L, 2003, MED CARE, V41, P813, DOI 10.1097/00005650-200307000-00005; Robinson JL, 2001, AM J MED QUAL, V16, P155, DOI 10.1177/106286060101600502; ROMANO M, 2003, MOD HEALTHCARE, V33, P1; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; SARRAZIN MSV, 2002, JAMA-J AM MED ASSOC, V288, P1859; SHORTELL SM, 1988, NEW ENGL J MED, V318, P1100, DOI 10.1056/NEJM198804283181705; SLOAN FA, 1988, COST QUALITY ACCESS; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Woods KL, 1998, EUR HEART J, V19, P1348, DOI 10.1053/euhj.1998.1027	40	42	42	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2006	295	18					2141	2147		10.1001/jama.295.18.2141	http://dx.doi.org/10.1001/jama.295.18.2141			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040OW	16684984				2022-12-28	WOS:000237391300023
J	Klose, RJ; Yamane, K; Bae, YJ; Zhang, DZ; Erdjument-Bromage, H; Tempst, P; Wong, JM; Zhang, Y				Klose, Robert J.; Yamane, Kenichi; Bae, Yangjin; Zhang, Dianzheng; Erdjument-Bromage, Hediye; Tempst, Paul; Wong, Jiemin; Zhang, Yi			The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36	NATURE			English	Article							METHYLATION; BINDING; PROTEIN; DOMAIN; JMJC; CHROMODOMAIN; RECOGNITION; FAMILY; SETDB1; JMJD2A	Post-translational modification of chromatin has profound effects on many biological processes including transcriptional regulation, heterochromatin organization, and X-chromosome inactivation(1,2). Recent studies indicate that methylation on specific histone lysine ( K) residues participates in many of these processes(3). Lysine methylation occurs in three distinct states, having either one (me1), two (me2) or three (me3) methyl groups attached to the amine group of the lysine side chain. These differences in modification state have an important role in defining how methylated chromatin is recognized and interpreted(4-6). Until recently, histone lysine methylation was considered a stable modification(7,8), but the identification of histone demethylase enzymes has demonstrated the reversibility of this epigenetic mark(9-11). So far, all characterized histone demethylases show enzymatic activity towards lysine residues modified in the me1 or me2 state(9-11), leaving open the possibility that me3 constitutes an irreversible modification. Here we demonstrate that JHDM3A ( jumonji C (JmjC)- domain-containing histone demethylase 3A; also known as JMJD2A) is capable of removing the me3 group from modified H3 lysine 9 (H3K9) and H3 lysine 36 (H3K36). Overexpression of JHDM3A abrogates recruitment of HP1 ( heterochromatin protein 1) to heterochromatin, indicating a role for JHDM3A in antagonizing methylated H3K9 nucleated events. siRNA-mediated knockdown of JHDM3A leads to increased levels of H3K9 methylation and upregulation of a JHDM3A target gene, ASCL2, indicating that JHDM3A may function in euchromatin to remove histone methylation marks that are associated with active transcription(12).	Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Bae, Yangjin/AAO-1866-2021	Bae, Yangjin/0000-0003-2397-0192; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Wong, Jiemin/0000-0002-5311-842X; Zhang, Yi/0000-0002-2789-0811				Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; DUERRE JA, 1974, J NEUROCHEM, V23, P541, DOI 10.1111/j.1471-4159.1974.tb06057.x; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katoh M, 2004, INT J ONCOL, V24, P1623; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	28	484	513	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					312	316		10.1038/nature04853	http://dx.doi.org/10.1038/nature04853			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16732292				2022-12-28	WOS:000239122100041
J	Pendry, JB; Schurig, D; Smith, DR				Pendry, J. B.; Schurig, D.; Smith, D. R.			Controlling electromagnetic fields	SCIENCE			English	Article							NEGATIVE INDEX; MAGNETIC RESPONSE; REFRACTION; METAMATERIALS	Using the freedom of design that metamaterials provide, we show how electromagnetic fields can be redirected at will and propose a design strategy. The conserved fields-electric displacement field D, magnetic induction field B, and Poynting vector B-are all displaced in a consistent manner. A simple illustration is given of the cloaking of a proscribed volume of space to exclude completely all electromagnetic fields. Our work has relevance to exotic lens design and to the cloaking of objects from electromagnetic fields.	Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, London SW7 2AZ, England; Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	Imperial College London; Duke University	Pendry, JB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, Prince Consort Rd, London SW7 2AZ, England.	j.pendry@imperial.ac.uk	Smith, David R/E-4710-2012; Schurig, David A/A-3647-2008	Pendry, John/0000-0001-5145-5441	Engineering and Physical Sciences Research Council [GR/S49537/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; CHIAO RY, 2002, OPTICS PHOTONICS NEW; Cubukcu E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.207401; Cubukcu E, 2003, NATURE, V423, P604, DOI 10.1038/423604b; Driscoll T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2174088; Grbic A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.117403; Greegor RB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037202; Houck AA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.137401; Leonhardt U, 2003, IEEE J SEL TOP QUANT, V9, P102, DOI 10.1109/JSTQE.2002.807968; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Smith DR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036617; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Ward AJ, 1996, J MOD OPTIC, V43, P773, DOI 10.1080/09500349608232782; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025	21	6621	6863	100	1895	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1780	1782		10.1126/science.1125907	http://dx.doi.org/10.1126/science.1125907			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16728597				2022-12-28	WOS:000238452800053
J	Madhok, V; Fahey, T				Madhok, Vishnu; Fahey, Tom			Commentary: Cardiovascular risk estimation: important but may be inaccurate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACCURACY; SCORE		Univ Dundee, Div Community Hlth Sci, Dundee DD2 4BF, Scotland	University of Dundee	Fahey, T (corresponding author), Univ Dundee, Div Community Hlth Sci, Mackenzie Bldg, Dundee DD2 4BF, Scotland.	t.p.fahey@chs.dundee.ac.uk	Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; BRINDLE P, 2006, HEART           0418; Brindle PM, 2005, BRIT J GEN PRACT, V55, P838; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE	5	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1422	1422		10.1136/bmj.38849.517257.DE	http://dx.doi.org/10.1136/bmj.38849.517257.DE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16737981	Green Published, Bronze			2022-12-28	WOS:000238550800030
J	Tonelli, M; Jose, P; Curhan, G; Sacks, F; Braunwald, E; Pfeffer, M				Tonelli, Marcello; Jose, Powell; Curhan, Gary; Sacks, Frank; Braunwald, Eugene; Pfeffer, Marc		CARE Trial Investigators	Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							URINARY ALBUMIN EXCRETION; CARDIOVASCULAR-DISEASE; RENAL-INSUFFICIENCY; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RISK-FACTOR; PROGRESSION; MORTALITY; EVENTS; MICROALBUMINURIA	Objectives To determine whether data on proteinuria are useful for refining estimates of risk based on kidney function alone, and whether the results of kidney function tests can be a useful adjunct to data on proteinuria. Design Analysis of data from a randomised trial. Impaired kidney function was defined as low glomerular filtration rate (< 60 ml/min/1.73 m(2)) and proteinuria ( >= 1+ protein) on dipstick urinalysis. Setting Study of cholesterol and recurrent events: a randomised trial of pravastatin 40 mg daily versus placebo. Participants 4098 men and women with previous myocardial infarction. Main outcome measures All cause mortality and cardiovascular events. Results 371 participants died in nearly 60 months of follow-up. Compared with participants without proteinuria or impaired kidney function, patients with both characteristics were at high risk (hazard ratio 2.39, 95% confidence interval 1.72 to 3.30), and those with only proteinuria or only impaired kidney function were at intermediate risk (1.69, 1.32 to 2.16; 1.41, 1.12 to 1.79, respectively) of dying from any cause. The results were similar for cardiovascular outcomes, including new cases of heart failure, stroke, and coronary death or non-fatal myocardial infarction. A graded increase in the risk of all cause mortality was seen for severity of renal impairment and degree of proteinuria by dipstick. Conclusions The presence or absence of proteinuria on dipstick urinalysis may be used to refine estimates of risk based on kidney function alone.	Univ Alberta, Dept Med, Edmonton, AB T6G 2C3, Canada; Yale Univ, Sch Med, New Haven, CT USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Alberta; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Tonelli, M (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2C3, Canada.	mtonelli@ualberta.ca	Tonelli, Marcello/B-3028-2009	Tonelli, Marcello/0000-0002-0846-3187				Anavekar NS, 2004, KIDNEY INT, V66, pS50, DOI 10.1111/j.1523-1755.2004.09213.x; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Clausen P, 2001, CIRCULATION, V103, P1869; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Culleton BF, 2000, AM J MED, V109, P1, DOI 10.1016/S0002-9343(00)00444-7; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Garg AX, 2001, KIDNEY INT, V60, P1867, DOI 10.1046/j.1523-1755.2001.00001.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grimm RH, 1997, KIDNEY INT, pS10; HAKIM RM, 1989, AM J KIDNEY DIS, V14, P396, DOI 10.1016/S0272-6386(89)80173-8; HANNEDOUCHE T, 1993, AM J KIDNEY DIS, V21, P131, DOI 10.1016/0272-6386(93)70104-7; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Kasiske BI, 2001, ANN INTERN MED, V134, P707, DOI 10.7326/0003-4819-134-8-200104170-00014; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; Locatelli F, 1997, MINER ELECTROL METAB, V23, P301; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McCullough PA, 2002, AM HEART J, V144, P226, DOI 10.1067/mhj.2002.125513; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; *NKF K DOQI, 2002, AM J KIDNEY DIS S, V39, pS76; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SACKS FM, 1991, AM J CARDIOL, V68, P1436, DOI 10.1016/0002-9149(91)90276-Q; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; SBLIPAK MG, 2002, ANN INTERN MED, V137, P555; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2002, KIDNEY INT, V62, P997, DOI 10.1046/j.1523-1755.2002.00522.x; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; Stenvinkel P, 2002, KIDNEY INT, V62, P1791, DOI 10.1046/j.1523-1755.2002.00637.x; Stuveling EM, 2004, ATHEROSCLEROSIS, V172, P107, DOI 10.1016/S0021-9150(03)00252-1; Tonelli M, 2001, AM J KIDNEY DIS, V37, P484, DOI 10.1053/ajkd.2001.22070; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008	36	150	160	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1426	1429		10.1136/bmj.38814.566019.2F	http://dx.doi.org/10.1136/bmj.38814.566019.2F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16714328	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000238550800032
J	Baker, J				Baker, J			The falcon has landed - Introduction	SCIENCE			English	Editorial Material																			0	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1327	1327		10.1126/science.312.5778.1327	http://dx.doi.org/10.1126/science.312.5778.1327			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741105				2022-12-28	WOS:000237961600038
J	Schafer, T; Maco, B; Petfalski, E; Tollervey, D; Bottcher, B; Aebi, U; Hurt, E				Schafer, Thorsten; Maco, Bohumil; Petfalski, Elisabeth; Tollervey, David; Boettcher, Bettina; Aebi, Ueli; Hurt, Ed			Hrr25-dependent phosphorylation state regulates organization of the pre-40S subunit	NATURE			English	Article							PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROGRAPHS; NUCLEAR EXPORT; COMPLEX; YEAST; IDENTIFICATION; TRANSCRIPTION; BIOGENESIS; MATURATION	The formation of eukaryotic ribosomes is a multistep process that takes place successively in the nucleolar, nucleoplasmic and cytoplasmic compartments(1-4). Along this pathway, multiple preribosomal particles are generated, which transiently associate with numerous non-ribosomal factors before mature 60S and 40S subunits are formed(5-12). However, most mechanistic details of ribosome biogenesis are still unknown. Here we identify a maturation step of the yeast pre-40S subunit that is regulated by the protein kinase Hrr25 and involves ribosomal protein Rps3. A high salt concentration releases Rps3 from isolated pre-40S particles but not from mature 40S subunits. Electron microscopy indicates that pre-40S particles lack a structural landmark present in mature 40S subunits, the 'beak'. The beak is formed by the protrusion of 18S ribosomal RNA helix 33, which is in close vicinity to Rps3. Two protein kinases Hrr25 and Rio2 are associated with pre-40S particles. Hrr25 phosphorylates Rps3 and the 40S synthesis factor Enp1. Phosphorylated Rsp3 and Enp1 readily dissociate from the pre-ribosome, whereas subsequent dephosphorylation induces formation of the beak structure and salt-resistant integration of Rps3 into the 40S subunit. In vivo depletion of Hrr25 inhibits growth and leads to the accumulation of immature 40S subunits that contain unstably bound Rps3. We conclude that the kinase activity of Hrr25 regulates the maturation of 40S ribosomal subunits.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; European Mol Biol Lab, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Basel; University of Edinburgh; European Molecular Biology Laboratory (EMBL)	Hurt, E (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz.uni-heidelberg.de	Bottcher, Bettina/E-9397-2010; Tollervey, David/AAR-6662-2020; Ed Hurt, Dr./AAE-8874-2019	Bottcher, Bettina/0000-0002-7962-4849; Tollervey, David/0000-0003-2894-2772; Ed Hurt, Dr./0000-0002-4535-8255; Schaefer, Thorsten/0000-0003-4867-8374; Maco, Bohumil/0000-0001-8444-313X	Natural Environment Research Council [NE/C516928/1] Funding Source: researchfish; Wellcome Trust Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BELTRAME M, 1992, EMBO J, V11, P1531, DOI 10.1002/j.1460-2075.1992.tb05198.x; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; FRANK J, 1982, J MOL BIOL, V161, P107, DOI 10.1016/0022-2836(82)90281-9; FRANK J, 1981, SCIENCE, V214, P1353, DOI 10.1126/science.7313694; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	27	171	174	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					651	655		10.1038/nature04840	http://dx.doi.org/10.1038/nature04840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738661				2022-12-28	WOS:000237920800051
J	Fruchter, AS; Levan, AJ; Strolger, L; Vreeswijk, PM; Thorsett, SE; Bersier, D; Burud, I; Ceron, JMC; Castro-Tirado, AJ; Conselice, C; Dahlen, T; Ferguson, HC; Fynbo, JPU; Garnavich, PM; Gibbons, RA; Gorosabel, J; Gull, TR; Hjorth, J; Holland, ST; Kouveliotou, C; Levay, Z; Livio, M; Metzger, MR; Nugent, PE; Petro, L; Pian, E; Rhoads, JE; Riess, AG; Sahu, KC; Smette, A; Tanvir, NR; Wijers, RAMJ; Woosley, SE				Fruchter, A. S.; Levan, A. J.; Strolger, L.; Vreeswijk, P. M.; Thorsett, S. E.; Bersier, D.; Burud, I.; Castro Ceron, J. M.; Castro-Tirado, A. J.; Conselice, C.; Dahlen, T.; Ferguson, H. C.; Fynbo, J. P. U.; Garnavich, P. M.; Gibbons, R. A.; Gorosabel, J.; Gull, T. R.; Hjorth, J.; Holland, S. T.; Kouveliotou, C.; Levay, Z.; Livio, M.; Metzger, M. R.; Nugent, P. E.; Petro, L.; Pian, E.; Rhoads, J. E.; Riess, A. G.; Sahu, K. C.; Smette, A.; Tanvir, N. R.; Wijers, R. A. M. J.; Woosley, S. E.			Long gamma-ray bursts and core-collapse supernovae have different environments	NATURE			English	Article							HOST GALAXIES; MASSIVE STARS; REDSHIFT; AFTERGLOW; SPECTROSCOPY; CONSTRAINTS; PROGENITOR; EMISSION; SEARCH	When massive stars exhaust their fuel, they collapse and often produce the extraordinarily bright explosions known as core-collapse supernovae. On occasion, this stellar collapse also powers an even more brilliant relativistic explosion known as a long-duration gamma-ray burst. One would then expect that these long gamma-ray bursts and core-collapse supernovae should be found in similar galactic environments. Here we show that this expectation is wrong. We find that the gamma-ray bursts are far more concentrated in the very brightest regions of their host galaxies than are the core-collapse supernovae. Furthermore, the host galaxies of the long gamma-ray bursts are significantly fainter and more irregular than the hosts of the core-collapse supernovae. Together these results suggest that long-duration gamma-ray bursts are associated with the most extremely massive stars and may be restricted to galaxies of limited chemical evolution. Our results directly imply that long gamma-ray bursts are relatively rare in galaxies such as our own Milky Way.	Space Telescope Sci Inst, Baltimore, MD 21218 USA; Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; Western Kentucky Univ, Bowling Green, KY 42101 USA; European So Observ, Santiago 19, Chile; Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; Norwegian Meteorol Inst, N-0313 Oslo, Norway; Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark; CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; CALTECH, Pasadena, CA 91125 USA; Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Extraterr Planets & Stellar Astrophys Explorat Un, Greenbelt, MD 20771 USA; NASA, George C Marshall Space Flight Ctr, Natl Space Sci & Technol Ctr, Huntsville, AL 35805 USA; Renaissance Technol Corp, E Setauket, NY 11733 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Osserv Astron Trieste, INAF, I-34131 Trieste, Italy; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands	Space Telescope Science Institute; University of Leicester; University of Hertfordshire; Western Kentucky University; European Southern Observatory; University of California System; University of California Santa Cruz; Liverpool John Moores University; Norwegian Meteorological Institute; University of Copenhagen; Niels Bohr Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); California Institute of Technology; University of Nottingham; Stockholm University; University of Notre Dame; Vanderbilt University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Istituto Nazionale Astrofisica (INAF); University of Amsterdam	Fruchter, AS (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	fruchter@stsci.edu	Riess, Adam/ABF-2480-2020; Gull, Theodore R/D-2753-2012; Conselice, Christopher J/B-4348-2013; Hjorth, Jens/M-5787-2014; Fynbo, Johan P. U./L-8496-2014; Nugent, Peter Edward/AGG-8472-2022	Gull, Theodore R/0000-0002-6851-5380; Hjorth, Jens/0000-0002-4571-2306; Fynbo, Johan P. U./0000-0002-8149-8298; Conselice, Christopher/0000-0003-1949-7638; Pian, Elena/0000-0001-8646-4858; Fruchter, Andrew/0000-0002-6652-9279; Thorsett, Stephen/0000-0002-2025-9613; Wijers, Ralph/0000-0002-3101-1808; Castro-Tirado, A. J./0000-0003-2999-3563	STFC [PP/D000920/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000920/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BERSIER D, UNPUB ASTROPHYS J; Bloom JS, 2002, ASTRON J, V123, P1111, DOI 10.1086/338893; Bloom JS, 1999, NATURE, V401, P453, DOI 10.1038/46744; BLOOM JS, 1998, APJ, V507, P25; BRANCH D, 1995, PUBL ASTRON SOC PAC, V107, P1019, DOI 10.1086/133657; Chapman SC, 2005, ASTROPHYS J, V622, P772, DOI 10.1086/428082; Chen HW, 2005, ASTROPHYS J, V634, pL25, DOI 10.1086/498646; Christensen L, 2004, ASTRON ASTROPHYS, V425, P913, DOI 10.1051/0004-6361:20040361; Conselice CJ, 2005, ASTROPHYS J, V633, P29, DOI 10.1086/432829; Crowther PA, 2006, ASTRON ASTROPHYS, V449, P711, DOI 10.1051/0004-6361:20054298; Della Valle M, 2003, ASTRON ASTROPHYS, V406, pL33, DOI 10.1051/0004-6361:20030855; Figer DF, 2005, ASTROPHYS J, V622, pL49, DOI 10.1086/429159; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; Fynbo JPU, 2003, ASTRON ASTROPHYS, V406, pL63, DOI 10.1051/0004-6361:20030931; Galama TJ, 2000, ASTROPHYS J, V536, P185, DOI 10.1086/308909; Gehrels N, 2005, NATURE, V437, P851, DOI 10.1038/nature04142; Giavalisco M, 2004, ASTROPHYS J, V600, pL93, DOI 10.1086/379232; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; Klose S, 2004, ASTRON J, V128, P1942, DOI 10.1086/424539; Kobulnicky HA, 2004, ASTROPHYS J, V617, P240, DOI 10.1086/425299; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; Le Floc'h E, 2003, ASTRON ASTROPHYS, V400, P499, DOI 10.1051/0004-6361:20030001; Levan A, 2005, ASTROPHYS J, V624, P880, DOI 10.1086/428657; MacFadyen AI, 2001, ASTROPHYS J, V550, P410, DOI 10.1086/319698; MALESANI D, 2004, APJ, V609, P5; Mannucci F, 2005, ASTRON ASTROPHYS, V433, P807, DOI 10.1051/0004-6361:20041411; Mirabal N, 2003, ASTROPHYS J, V595, P935, DOI 10.1086/377471; Panaitescu A, 2001, ASTROPHYS J, V560, pL49, DOI 10.1086/324061; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Prochaska JX, 2004, ASTROPHYS J, V611, P200, DOI 10.1086/421988; PROCHASKA JX, IN PRESS ASTROPHYS J; Riess AG, 2004, ASTROPHYS J, V600, pL163, DOI 10.1086/378311; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Soderberg AM, 2006, ASTROPHYS J, V638, P930, DOI 10.1086/499121; Sokolov VV, 2001, ASTRON ASTROPHYS, V372, P438, DOI 10.1051/0004-6361:20010512; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; van den Bergh S, 2005, PUBL ASTRON SOC PAC, V117, P773, DOI 10.1086/431435; VanDyk SD, 1996, ASTRON J, V111, P2017, DOI 10.1086/117937; Vreeswijk PM, 2004, ASTRON ASTROPHYS, V419, P927, DOI 10.1051/0004-6361:20040086; Vreeswijk PM, 2001, ASTROPHYS J, V546, P672, DOI 10.1086/318308; WEIDNER C, 2005, INITIAL MASS FUNCTIO, P125; WOOSLEY S, 2005, BURSTS ASTROPHYS J, V637, P914; Yoon SC, 2005, ASTRON ASTROPHYS, V443, P643, DOI 10.1051/0004-6361:20054030; Zeh A, 2004, ASTROPHYS J, V609, P952, DOI 10.1086/421100; [No title captured]	50	649	653	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					463	468		10.1038/nature04787	http://dx.doi.org/10.1038/nature04787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16688183	Green Submitted, Green Accepted			2022-12-28	WOS:000237778900040
J	Pulikal, G; Marshall, A				Pulikal, G; Marshall, A			Complete calcification of a rheumatic left atrium	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Derriford Hosp, Plymouth PL6 8DH, Devon, England	Derriford Hospital	Pulikal, G (corresponding author), Derriford Hosp, Plymouth PL6 8DH, Devon, England.								0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2262	2262		10.1056/NEJMicm050044	http://dx.doi.org/10.1056/NEJMicm050044			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045RF	16723617				2022-12-28	WOS:000237758900008
J	Atwood, HL				Atwood, HL			Gatekeeper at the synapse	SCIENCE			English	Editorial Material							RELEASE; BRUCHPILOT; CHANNEL		Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Atwood, HL (corresponding author), Univ Toronto, Dept Physiol, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	h.atwood@utoronto.ca						Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Feeney CJ, 1998, J COMP NEUROL, V402, P197, DOI 10.1002/(SICI)1096-9861(19981214)402:2&lt;197::AID-CNE5&gt;3.0.CO;2-Q; Hagiwara A, 2005, J COMP NEUROL, V489, P195, DOI 10.1002/cne.20633; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2918, DOI 10.1073/pnas.73.8.2918; PFENNINGER K, 1972, J NEUROCYTOL, V1, P129, DOI 10.1007/BF01099180; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008	18	17	17	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1008	1009		10.1126/science.1128445	http://dx.doi.org/10.1126/science.1128445			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709774				2022-12-28	WOS:000237628800031
J	Lim, J; Hao, T; Shaw, C; Patel, AJ; Szabo, G; Rual, JF; Fisk, CJ; Li, N; Smolyar, A; Hill, DE; Barabasi, AL; Vidal, M; Zoghbi, HY				Lim, Janghoo; Hao, Tong; Shaw, Chad; Patel, Akash J.; Szabo, Gabor; Rual, Jean-Francois; Fisk, C. Joseph; Li, Ning; Smolyar, Alex; Hill, David E.; Barabasi, Albert-Laszlo; Vidal, Marc; Zoghbi, Huda Y.			A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration	CELL			English	Article							MEDIATES NEURODEGENERATION; CEREBELLAR-ATAXIA; GENE; MOUSE; TOXICITY; MUTATION; MODELS; SCALE; MAP; SPECIFICITY	Many human inherited neurodegenerative disorders are characterized by loss of balance due to cerebellar Purkinje cell (PC) degeneration. Although the disease-causing mutations have been identified for a number of these disorders, the normal functions of the proteins involved remain, in many cases, unknown. To gain insight into the function of proteins involved in PC degeneration, we developed an interaction network for 54 proteins involved in 23 inherited ataxias and expanded the network by incorporating literature-curated and evolutionarily conserved interactions. We identified 770 mostly novel protein-protein interactions using a stringent yeast two-hybrid screen; of 75 pairs tested, 83% of the interactions were verified in mammalian cells. Many ataxia-causing proteins share interacting partners, a subset of which have been found to modify neurodegeneration in animal models. This interactome thus provides a tool for understanding pathogenic mechanisms common for this class of neuroclegenerative disorders and for identifying candidate genes for inherited ataxias.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA; Harvard Univ, Sch Med, Ctr Canc Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Notre Dame; University of Notre Dame	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu	Barabasi, Albert-Laszlo/S-6474-2017; Hill, David E/B-6617-2011	Zoghbi, Huda/0000-0002-0700-3349; Shaw, Chad/0000-0001-7267-5398; Rual, Jean-Francois/0000-0003-4465-8819; Barabasi, Albert/0000-0002-4028-3522	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS27699] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kaytor MD, 2005, HUM MOL GENET, V14, P1095, DOI 10.1093/hmg/ddi122; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matsuda J, 2004, HUM MOL GENET, V13, P2709, DOI 10.1093/hmg/ddh281; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Noveroske JK, 2005, MAMM GENOME, V16, P672, DOI 10.1007/s00335-005-0035-x; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun XZ, 2001, J NEUROSCI RES, V64, P348, DOI 10.1002/jnr.1085; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yoshida H, 2002, NEUROBIOL DIS, V10, P88, DOI 10.1006/nbdi.2002.0502; Young A, 2005, BIOINFORMATICS, V21, P275, DOI 10.1093/bioinformatics/bth495; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zoghbi HY, 2002, TRENDS GENET, V18, P463, DOI 10.1016/S0168-9525(02)02729-4	56	596	626	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					801	814		10.1016/j.cell.2006.03.032	http://dx.doi.org/10.1016/j.cell.2006.03.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713569	Bronze			2022-12-28	WOS:000237886000023
J	Lorentzen, E; Conti, E				Lorentzen, Esben; Conti, Elena			The exosome and the proteasome: Nano-compartments for degradation	CELL			English	Review							HEXAMERIC RING STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; POLY(A) POLYMERASE; ARCHAEAL EXOSOME; QUALITY-CONTROL; 20S PROTEASOME; RNASE PH; COMPLEX; RECOGNITION	Exosomes and proteasomes are macromolecular complexes that posttranscriptionally regulate gene expression by degrading mRNAs and proteins, respectively. Although the two complexes act on different substrates and are composed of different subunits, they share a similar barrel-like architecture that appears to have evolved to restrict substrate access and prevent indiscriminate degradation.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Conti, E (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	elena.conti@embl.de	Lorentzen, Esben/AAX-8077-2020	Lorentzen, Esben/0000-0001-6493-7220; Conti, Elena/0000-0003-1254-5588				Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Choi JM, 2004, J BIOL CHEM, V279, P755, DOI 10.1074/jbc.M309628200; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	20	66	66	1	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 19	2006	125	4					651	654		10.1016/j.cell.2006.05.002	http://dx.doi.org/10.1016/j.cell.2006.05.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713559	Bronze			2022-12-28	WOS:000237886000011
J	Sutton, MA; Ito, HT; Cressy, P; Kempf, C; Woo, JC; Schuman, EM				Sutton, Michael A.; Ito, Hiroshi T.; Cressy, Paola; Kempf, Christian; Woo, Jessica C.; Schuman, Erin M.			Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis	CELL			English	Article							GLUTAMATE-RECEPTOR CHANNELS; HIPPOCAMPAL PYRAMIDAL NEURONS; OPTICAL QUANTAL ANALYSIS; HOMEOSTATIC PLASTICITY; NEOCORTICAL NEURONS; CA2+ PERMEABILITY; SPINES; SYNAPSES; EVENTS; TRANSMISSION	Activity deprivation in neurons induces a slow compensatory scaling up of synaptic strength, reflecting a homeostatic mechanism for stabilizing neuronal activity. Prior studies have focused on the loss of action potential (AP) driven neurotransmission in synaptic homeostasis. Here, we show that the miniature synaptic transmission that persists during AP blockade profoundly shapes the time course and mechanism of homeostatic scaling. A brief blockade of NMDA receptor (NMDAR) mediated miniature synaptic events ("minis") rapidly scales up synaptic strength, over an order of magnitude faster than with AP blockade alone. The rapid scaling induced by NMDAR mini blockade is mediated by increased synaptic expression of surface GluR1 and the transient incorporation of Ca2+-permeable AMPA receptors at synapses; both of these changes are implemented locally within dendrites and require dendritic protein synthesis. These results indicate that NMDAR signaling during miniature synaptic transmission serves to stabilize synaptic function through active suppression of dendritic protein synthesis.	CALTECH, Div Biol 11496, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Div Biol 11496, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011; Sutton, Michael/C-6264-2011	Sutton, Michael/0000-0002-0692-6459				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; AXELSSON J, 1959, J PHYSIOL-LONDON, V147, P178, DOI 10.1113/jphysiol.1959.sp006233; Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Dravid SM, 2003, NEUROSCI LETT, V351, P145, DOI 10.1016/j.neulet.2003.07.017; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Horton AC, 2003, J NEUROSCI, V23, P6188; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; LERMA J, 1994, EUR J NEUROSCI, V6, P1080, DOI 10.1111/j.1460-9568.1994.tb00605.x; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pierce JP, 2000, NAT NEUROSCI, V3, P311, DOI 10.1038/73868; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Scheenen WJJM, 1996, CHEM BIOL, V3, P765, DOI 10.1016/S1074-5521(96)90253-7; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Stewart JJ, 2000, J CLIN PHARMACOL, V40, P347, DOI 10.1177/00912700022009044; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Torre ER, 1996, J NEUROSCI, V16, P5967; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Wang S, 1999, CAN J PHYSIOL PHARM, V77, P651, DOI 10.1139/cjpp-77-9-651; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Yin HZ, 1999, J COMP NEUROL, V409, P250; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang JC, 2005, BRAIN RES, V1050, P110, DOI 10.1016/j.brainres.2005.05.032	42	460	465	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					785	799		10.1016/j.cell.2006.03.040	http://dx.doi.org/10.1016/j.cell.2006.03.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713568	Bronze			2022-12-28	WOS:000237886000022
J	Altman, SH; Doonan, M				Altman, SH; Doonan, M			Can Massachusetts lead the way in health care reform?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA; Brandeis Univ, Massachusetts Hlth Policy Forum, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Altman, SH (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA.								0	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2093	2095		10.1056/NEJMp068103	http://dx.doi.org/10.1056/NEJMp068103			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707744				2022-12-28	WOS:000237575400001
J	Berlinger, NT				Berlinger, NT			Robotic surgery - Squeezing into tight places	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Minnesota, Sch Med, Dept Lab Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Berlinger, NT (corresponding author), Univ Minnesota, Sch Med, Dept Lab Med, Minneapolis, MN 55455 USA.							Camarillo DB, 2004, AM J SURG, V188, p2S, DOI 10.1016/j.amjsung.2004.08.025; Kant AJ, 2004, PEDIATR RADIOL, V34, P454, DOI 10.1007/s00247-003-1130-3; Menon M, 2004, UROL CLIN N AM, V31, P701, DOI 10.1016/j.ucl.2004.06.011	3	45	67	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2099	2101		10.1056/NEJMp058233	http://dx.doi.org/10.1056/NEJMp058233			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707746				2022-12-28	WOS:000237575400003
J	Bongartz, T; Sutton, AJ; Sweeting, MJ; Buchan, I; Matteson, EL; Montori, V				Bongartz, T; Sutton, AJ; Sweeting, MJ; Buchan, I; Matteson, EL; Montori, V			Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TUMOR-NECROSIS-FACTOR; ALPHA MONOCLONAL-ANTIBODY; RECEIVING CONCOMITANT METHOTREXATE; LYMPHOTOXIN-ALPHA; ADALIMUMAB D2E7; DOUBLE-BLIND; INFLIXIMAB; PLACEBO; ETANERCEPT; EFFICACY	Context Tumor necrosis factor (TNF) plays an important role in host defense and tumor growth control. Therefore, anti-TNF antibody therapies may increase the risk of serious infections and malignancies. Objective To assess the extent to which anti-TNF antibody therapies may increase the risk of serious infections and malignancies in patients with rheumatoid arthritis by performing a meta-analysis to derive estimates of sparse harmful events occurring in randomized trials of anti-TNF therapy. Data Sources A systematic literature search of EMBASE, MEDLINE, Cochrane Library, and electronic abstract databases of the annual scientific meetings of both the European League Against Rheumatism and the American College of Rheumatology was conducted through December 2005. This search was complemented with interviews of the manufacturers of the 2 licensed anti-TNF antibodies. Study Selection We included randomized, placebo-controlled trials of the 2 licensed anti-TNF antibodies ( infliximab and adalimumab) used for 12 weeks or more in patients with rheumatoid arthritis. Nine trials met our inclusion criteria, including 3493 patients who received anti-TNF antibody treatment and 1512 patients who received placebo. Data Extraction Data on study characteristics to assess study quality and intention-to-treat data for serious infections and malignancies were abstracted. Published information from the trials was supplemented by direct contact between principal investigators and industry sponsors. Data Synthesis We calculated a pooled odds ratio (Mantel-Haenszel methods with a continuity correction designed for sparse data) for malignancies and serious infections ( infection that requires antimicrobial therapy and/or hospitalization) in anti-TNF treated patients vs placebo patients. We estimated effects for high and low doses separately. The pooled odds ratio for malignancy was 3.3 (95% confidence interval [CI], 1.2-9.1) and for serious infection was 2.0 ( 95% CI, 1.3-3.1). Malignancies were significantly more common in patients treated with higher doses compared with patients who received lower doses of anti-TNF antibodies. For patients treated with anti-TNF antibodies in the included trials, the number needed to harm was 154 ( 95% CI, 91500) for 1 additional malignancy within a treatment period of 6 to 12 months. For serious infections, the number needed to harm was 59 ( 95% CI, 39-125) within a treatment period of 3 to 12 months. Conclusions There is evidence of an increased risk of serious infections and a dose-dependent increased risk of malignancies in patients with rheumatoid arthritis treated with anti-TNF antibody therapy. The formal meta-analysis with pooled sparse adverse events data from randomized controlled trials serves as a tool to assess harmful drug effects.	Mayo Clin, Coll Med, Div Rheumatol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Univ Manchester, NW Inst Biohlth Informat, Manchester, Lancs, England; Mayo Clin, Coll Med, Knowledge & Encounter Res Unit, Rochester, MN USA; Mayo Clin, Coll Med, Dept Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Leicester; MRC Biostatistics Unit; University of Cambridge; University of Manchester; Mayo Clinic; Mayo Clinic	Bongartz, T (corresponding author), Mayo Clin, Coll Med, Div Rheumatol, 200 1st St SW, Rochester, MN 55905 USA.	bongartz.tim@mayo.edu	Sweeting, Michael John/U-3917-2019; Buchan, Iain E/H-5767-2013	Sweeting, Michael John/0000-0003-0980-8965; Buchan, Iain E/0000-0003-3392-1650; Sutton, Alexander/0000-0002-8934-9940; Montori, Victor/0000-0003-0595-2898				ARNETT FC, 1989, B RHEUM DIS, V38, P1; Askling J, 2005, ANN RHEUM DIS, V64, P1421, DOI 10.1136/ard.2004.033993; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Beauparlant P, 1999, SEMIN ARTHRITIS RHEU, V29, P148, DOI 10.1016/S0049-0172(99)80026-2; Berlin JA, 1999, JAMA-J AM MED ASSOC, V281, P830, DOI 10.1001/jama.281.9.830; BREEDVELD F, 2004, AM COLL RHEUM ANN SC; Catrina AI, 2005, ARTHRITIS RHEUM-US, V52, P61, DOI 10.1002/art.20764; Chakravarty EF, 2005, J RHEUMATOL, V32, P2130; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; den Broeder A, 2002, J RHEUMATOL, V29, P2288; Dobrzanski MJ, 2004, CANCER RES, V64, P406, DOI 10.1158/0008-5472.CAN-03-2580; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Furst DE, 2003, J RHEUMATOL, V30, P2563; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gudbrandsdottir S, 2004, CLIN EXP RHEUMATOL, V22, P118; Haraoui B, 2005, SEMIN ARTHRITIS RHEU, V34, P7, DOI 10.1016/j.semarthrit.2005.01.003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213; KATO K, 1989, MED MICROBIOL IMMUN, V178, P337; Kavanaugh A, 2000, J RHEUMATOL, V27, P841; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kirchner S, 2004, CYTOKINE, V28, P67, DOI 10.1016/j.cyto.2004.06.008; Kroesen S, 2003, RHEUMATOLOGY, V42, P617, DOI 10.1093/rheumatology/keg263; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; MASTROENI P, 1993, MICROB PATHOGENESIS, V14, P473, DOI 10.1006/mpat.1993.1046; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W; Moher D, 2000, ONKOLOGIE, V23, P597, DOI 10.1159/000055014; NAKANE A, 1988, INFECT IMMUN, V56, P2563, DOI 10.1128/IAI.56.10.2563-2569.1988; Nestorov I, 2005, SEMIN ARTHRITIS RHEU, V34, P12, DOI 10.1016/j.semarthrit.2005.01.004; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; QIN ZH, 1995, BLOOD, V85, P2779, DOI 10.1182/blood.V85.10.2779.bloodjournal85102779; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Rau R, 2004, SCAND J RHEUMATOL, V33, P145, DOI 10.1080/03009740410005467; Roach DR, 2005, INFECT IMMUN, V73, P4787, DOI 10.1128/IAI.73.8.4787-4792.2005; ROBINS J, 1986, BIOMETRICS, V42, P311, DOI 10.2307/2531052; Smeeth L, 1999, BMJ-BRIT MED J, V318, P1548, DOI 10.1136/bmj.318.7197.1548; Stone JH, 2005, NEW ENGL J MED, V352, P351; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van de Putte LBA, 2003, ANN RHEUM DIS, V62, P1168, DOI 10.1136/ard.2003.009563; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; Wallis RS, 2005, SEMIN ARTHRITIS RHEU, V34, P34, DOI 10.1016/j.semarthrit.2005.01.009; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Weisman MH, 2003, CLIN THER, V25, P1700, DOI 10.1016/S0149-2918(03)80164-9; WESTHOVENS R, 2004, EUR LEAG RHEUM ANN S; Wolfe F, 2004, ARTHRITIS RHEUM-US, V50, P1740, DOI 10.1002/art.20311	58	1840	1933	4	186	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2006	295	19					2275	2285		10.1001/jama.295.19.2275	http://dx.doi.org/10.1001/jama.295.19.2275			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042UX	16705109				2022-12-28	WOS:000237556600026
J	Abu-Laban, RB; McIntyre, CM; Christenson, JM; van Beek, CA; Innes, GD; O'Brien, RK; Wanger, KP; McKnight, RD; Gin, KG; Zed, PJ; Watts, J; Puskaric, J; MacPhail, IA; Berringer, RG; Milner, RA				Abu-Laban, RB; McIntyre, CM; Christenson, JM; van Beek, CA; Innes, GD; O'Brien, RK; Wanger, KP; McKnight, RD; Gin, KG; Zed, PJ; Watts, J; Puskaric, J; MacPhail, IA; Berringer, RG; Milner, RA			Aminophylline in bradyasystolic cardiac arrest: a randomised placebo-controlled trial	LANCET			English	Article							CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; ADENOSINE; ATROPINE; ANTAGONISM; CONDUCTION; ASYSTOLE	Background Endogenous adenosine might cause or perpetuate bradyasystole. Our aim was to determine whether aminophylline, an adenosine antagonist, increases the rate of return of spontaneous circulation (ROSC) after out-of-hospital cardiac arrest. Methods In a double-blind trial, we randomly assigned 971 patients older than 16 years with asystole or pulseless electrical activity at fewer than 60 beats per minute, and who were unresponsive to initial treatment with epinephrine and atropine, to receive intravenous aminophylline (250 mg, and an additional 250 mg if necessary) (n=486) or placebo (n=485). The patients were enrolled between January, 2001 and September, 2003, from 1886 people who had had cardiac arrests. Standard resuscitation measures were used for at least 10 mins after the study drug was administered. Analysis was by intention-to-treat. This trial is registered with the ClinicalTrials.gov registry with the number NCT00312273. Findings Baseline characteristics and survival predictors were similar in both groups. The median time from the arrival of the advanced life-support paramedic team to study drug administration was 13 min. The proportion of patients who had an ROSC was 24.5% in the aminophylline group and 23.7% in the placebo group (difference 0.8%; 95% CI -4.6% to 6.2%; p=0.778). The proportion of patients with non-sinus tachyarrhythmias after study drug administration was 34.6% in the aminophylline group and 26.2% in the placebo group (p=0.004). Survival to hospital admission and survival to hospital discharge were not significantly different between the groups. A multivariate logistic regression analysis showed no evidence of a significant subgroup or interactive effect from aminophylline. Interpretation Although aminophylline increases non-sinus tachyarrhythmias, we noted no evidence that it significantly increases the proportion of patients who achieve ROSC after bradyasystolic cardiac arrest.	Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; British Columbia Ambulance Serv, Victoria, BC, Canada; Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada	University of British Columbia	Abu-Laban, RB (corresponding author), Vancouver Gen Hosp, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada.	abulaban@interchange.ubc.ca						Abu-Laban RB, 2002, NEW ENGL J MED, V346, P1522, DOI 10.1056/NEJMoa012885; AbuLaban RB, 2003, NEW ENGL J MED, V349, P1487; ABULABAN RB, 2004, ACAD EMERG MED, V11, P601; [Anonymous], 1986, Am J Emerg Med, V4, P72; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; BARDENHEUER H, 1986, AM J PHYSIOL, V250, pH173, DOI 10.1152/ajpheart.1986.250.2.H173; BERNE RM, 1963, AM J PHYSIOL, V204, P317, DOI 10.1152/ajplegacy.1963.204.2.317; Burton JH, 1997, ANN EMERG MED, V30, P154, DOI 10.1016/S0196-0644(97)70134-3; CUMMINS RO, 1993, ANN EMERG MED, V22, P37, DOI 10.1016/S0196-0644(05)80247-1; DIMARCO JP, 1985, J AM COLL CARDIOL, V6, P417, DOI 10.1016/S0735-1097(85)80181-9; DOBSON JG, 1983, AM J PHYSIOL, V245, pH468, DOI 10.1152/ajpheart.1983.245.3.H468; DOBSON JG, 1983, CIRC RES, V52, P151, DOI 10.1161/01.RES.52.2.151; FAVALE S, 1985, J AM COLL CARDIOL, V5, P1212, DOI 10.1016/S0735-1097(85)80027-9; Gray J D, 2001, CJEM, V3, P213; HERLITZ J, 1994, RESUSCITATION, V28, P27, DOI 10.1016/0300-9572(94)90051-5; JENNETT B, 1975, LANCET, V1, P480; JETTE AM, 1986, J GEN INTERN MED, V1, P143, DOI 10.1007/BF02602324; Kaplan JL, 2003, ACAD EMERG MED, V10, P923, DOI 10.1197/S1069-6563(03)00309-9; Lee C C, 2001, Prehosp Emerg Care, V5, P304, DOI 10.1080/10903120190939878; Lee CC, 2000, AM J EMERG MED, V18, P350, DOI 10.1016/S0735-6757(00)90143-8; LEWIS RJ, 1993, ANN EMERG MED, V22, P1463, DOI 10.1016/S0196-0644(05)81997-3; LITTMANN L, 1994, J AM COLL CARDIOL, V23, P1708, DOI 10.1016/0735-1097(94)90679-3; Mader TJ, 1999, RESUSCITATION, V41, P39, DOI 10.1016/S0300-9572(99)00029-5; Mader TJ, 2000, RESUSCITATION, V47, P105, DOI 10.1016/S0300-9572(00)00234-3; Mader TJ, 1997, RESUSCITATION, V35, P3, DOI 10.1016/S0300-9572(97)01097-6; Mader TJ, 2003, ACAD EMERG MED, V10, P192, DOI 10.1111/j.1553-2712.2003.tb01989.x; MALCOLM AD, 1993, CARDIOVASC DRUG THER, V7, P139, DOI 10.1007/BF00878323; Ornato JP, 1996, ANN EMERG MED, V27, P576, DOI 10.1016/S0196-0644(96)70160-9; PELLEG A, 1990, AM J PHYSIOL, V258, pH1815, DOI 10.1152/ajpheart.1990.258.6.H1815; PEPE PE, 1993, CRIT CARE MED, V21, P1838, DOI 10.1097/00003246-199312000-00009; Perouansky M, 1998, RESUSCITATION, V38, P39, DOI 10.1016/S0300-9572(98)00079-3; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; SCHRADER J, 1977, PFLUG ARCH EUR J PHY, V372, P29, DOI 10.1007/BF00582203; SEDGWICK ML, 1994, RESUSCITATION, V27, P55, DOI 10.1016/0300-9572(94)90022-1; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; URTHALER F, 1972, J LAB CLIN MED, V79, P96; VISKIN S, 1993, ANN INTERN MED, V118, P279, DOI 10.7326/0003-4819-118-4-199302150-00006; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Willerson JT, 2000, CIRCULATION, V102, P1	41	25	28	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1577	1584		10.1016/S0140-6736(06)68694-7	http://dx.doi.org/10.1016/S0140-6736(06)68694-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698410				2022-12-28	WOS:000237598000028
J	Wardle, J; Brodersen, NH; Cole, TJ; Jarvis, MJ; Boniface, R				Wardle, Jane; Brodersen, Naomi Henning; Cole, Tim J.; Jarvis, Martin J.; Boniface, David R.			Development of adiposity in adolescence: five year longitudinal study of an ethnically and socioeconomically diverse sample of young people in Britain	BRITISH MEDICAL JOURNAL			English	Article							OBESITY; CHILDHOOD; CHILDREN; OVERWEIGHT; POPULATION; ADULTS; TRENDS; BMI	Objective To examine the developmental trajectory of obesity in adolescence in relation to sex, ethnicity, and socioeconomic status. Design Five year longitudinal cohort study of a socioeconomically and ethnically diverse sample of school students aged 11-12 years at baseline. Setting 36 London schools recruited to the study in 1999 by a stratified random sampling procedure. Participants 5863 students participated in one or more years. Main outcome measures Weight, height, and waist circumference measured annually by trained researchers; overweight and obesity defined according to International Obesity Task Force criteria; adiposity and central adiposity indexed by body mass index (BMI) and waist standard deviation scores relative to 1990 British reference values. Results In school year 7 (age 11-12), the prevalence of overweight and obesity combined was almost 25%, with higher rates in girls (29%) and students from lower socioeconomic backgrounds (31%) and the highest rates in black girls (38%). Prevalence of obesity increased over the five years of the study at the expense of overweight, but no reduction occurred in the proportion of students with BMIs in the healthy range. Waist circumferences were high compared with 1990 norms at age 11 (by 0.79 SD in boys and by 1.15 SD in girls) and increased further over time. Both BMI and waist circumference tracked strongly over the five years. Conclusions Prevalence of overweight and obesity was high in London school students, with significant socioeconomic and ethnic inequalities. Little evidence was found of new cases of overweight or obesity emerging over adolescence, but few obese or overweight adolescents reduced to a healthy weight. The results indicate that persistent obesity is established before age 11 and highlight the need to target efforts to prevent obesity in the early years.	UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Unit, London WC1E 6BT, England; Inst Child Hlth, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England	University of London; University College London; University of London; University College London	Wardle, J (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Unit, Mortimer St, London WC1E 6BT, England.	j.wardle@ucl.ac.uk	Jarvis, Martin J/B-1034-2008; Cole, Tim J/B-7883-2008	Jarvis, Martin J/0000-0001-9238-8038; Cole, Tim J/0000-0001-5711-8200; Boniface, David/0000-0002-0320-5234	MRC [G9827821] Funding Source: UKRI; Medical Research Council [G9827821, G9827821(62595)] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Hulens M, 2001, INT J OBESITY, V25, P395, DOI 10.1038/sj.ijo.0801513; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Romon M, 2005, INT J OBESITY, V29, P54, DOI 10.1038/sj.ijo.0802788; Saxena S, 2004, ARCH DIS CHILD, V89, P30; TOWNSEND P, 1998, HLTH DEPRIVATION INE; Vanhala M, 1998, BRIT MED J, V317, P319, DOI 10.1136/bmj.317.7154.319; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wardle J, 2002, ADDICT BEHAV, V27, P561, DOI 10.1016/S0306-4603(01)00193-9	11	193	200	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 13	2006	332	7550					1130	1132A		10.1136/bmj.38807.594792.AE	http://dx.doi.org/10.1136/bmj.38807.594792.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16679329	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000237682700020
J	Altman, DG; Royston, P				Altman, DG; Royston, P			Statistics notes - The cost of dichotomising continuous variables	BRITISH MEDICAL JOURNAL			English	Article							PROGNOSTIC-FACTORS; REGRESSION; DICHOTOMIZATION		Univ Oxford Wolfson Coll, Canc Res UK NHS Ctr Stat Med, Oxford OX2 6UD, England; MRC, Clin Trials Unit, London NW1 2DA, England	Cancer Research UK; University of Oxford; Medical Research Council Clinical Trials Unit	Altman, DG (corresponding author), Univ Oxford Wolfson Coll, Canc Res UK NHS Ctr Stat Med, Oxford OX2 6UD, England.	doug.altman@cancer.org.uk			Medical Research Council [MC_U122861386] Funding Source: Medline; MRC [MC_U122861386] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Austin PC, 2004, STAT MED, V23, P1159, DOI 10.1002/sim.1687; Buettner P, 1997, J CLIN EPIDEMIOL, V50, P1201, DOI 10.1016/S0895-4356(97)00155-8; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; DelPriore G, 1997, OBSTET GYNECOL, V89, P351, DOI 10.1016/S0029-7844(96)00504-2; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Royston P, 2005, METHOD INFORM MED, V44, P561	8	1304	1310	3	42	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 6	2006	332	7549					1080	1080		10.1136/bmj.332.7549.1080	http://dx.doi.org/10.1136/bmj.332.7549.1080			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16675816	Bronze, Green Published			2022-12-28	WOS:000237518400022
J	Lorenz, RD; Wall, S; Radebaugh, J; Boubin, G; Reffet, E; Janssen, M; Stofan, E; Lopes, R; Kirk, R; Elachi, C; Lunine, J; Mitchell, K; Paganelli, F; Soderblom, L; Wood, C; Wye, L; Zebker, H; Anderson, Y; Ostro, S; Allison, M; Boehmer, R; Callahan, P; Encrenaz, P; Ori, GG; Francescetti, G; Gim, Y; Hamilton, G; Hensley, S; Johnson, W; Kelleher, K; Muhleman, D; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Stiles, B; Vetrella, S; Flamini, E; West, R				Lorenz, RD; Wall, S; Radebaugh, J; Boubin, G; Reffet, E; Janssen, M; Stofan, E; Lopes, R; Kirk, R; Elachi, C; Lunine, J; Mitchell, K; Paganelli, F; Soderblom, L; Wood, C; Wye, L; Zebker, H; Anderson, Y; Ostro, S; Allison, M; Boehmer, R; Callahan, P; Encrenaz, P; Ori, GG; Francescetti, G; Gim, Y; Hamilton, G; Hensley, S; Johnson, W; Kelleher, K; Muhleman, D; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Stiles, B; Vetrella, S; Flamini, E; West, R			The sand seas of Titan: Cassini RADAR observations of longitudinal dunes	SCIENCE			English	Article							SURFACE; WINDS	The most recent Cassini RADAR images of Titan show widespread regions ( up to 1500 kilometers by 200 kilometers) of near-parallel radar-dark linear features that appear to be seas of longitudinal dunes similar to those seen in the Namib desert on Earth. The Ku-band (2.17-centimeter wavelength) images show similar to 100-meter ridges consistent with duneforms and reveal flow interactions with underlying hills. The distribution and orientation of the dunes support a model of fluctuating surface winds of similar to 0.5 meter per second resulting from the combination of an eastward flow with a variable tidal wind. The existence of dunes also requires geological processes that create sand-sized (100- to 300-micrometer) particulates and a lack of persistent equatorial surface liquids to act as sand traps.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Proxemy Res, Bowie, MD 20715 USA; Planetary Sci Inst, Tucson, AZ 85719 USA; Wheeling Jesuit Coll, Wheeling, WV 26003 USA; Stanford Univ, Stanford, CA 94305 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Observ Paris, F-92195 Meudon, France; Univ G DAnnunzio, Int Res Sch Planetary Sci, I-65127 Pescara, Italy; Fac Ingn, I-80125 Naples, Italy; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Roma La Sapienza, I-00184 Rome, Italy; Politecn Bari, Dipartimento Interateneo Fis, I-70126 Bari, Italy; INFM, I-70126 Bari, Italy; Agenzia Spaziale Italiana, I-00131 Rome, Italy	University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; Wheeling University; Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; G d'Annunzio University of Chieti-Pescara; California Institute of Technology; Sapienza University Rome; Politecnico di Bari; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Agenzia Spaziale Italiana (ASI)	Lorenz, RD (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	rlorenz@lpl.arizona.edu	Lorenz, Ralph D/B-8759-2016; Mitchell, Karl Leon/AAG-3821-2020; Mitchell, Karl Leon/AGL-9516-2022; Lopes, Rosaly M.C./D-1608-2016	Lorenz, Ralph D/0000-0001-8528-4644; Mitchell, Karl Leon/0000-0003-1093-8441; Lopes, Rosaly M.C./0000-0002-7928-3167; Lunine, Jonathan/0000-0003-2279-4131; zebker, howard/0000-0001-9931-5237; ORI, Gian Gabriele/0000-0002-6460-1476				ALLISON M, 1992, P S TIT TOUL FRANC 9, P113; Bagnold R. A., 1941, PHYS WIND BLOWN SAND; Bird MK, 2005, NATURE, V438, P800, DOI 10.1038/nature04060; EDGETT KS, 2000, LUNAR PLANET SCI, V31, P1070; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; ELACHI C, IN PRESS NATURE; FRYBERGER SG, 1979, US GEOLOGICAL SURVEY, V1052, P137; Greeley R., 1985, WIND GEOLOGICAL PROC, DOI 10.1017/CBO9780511573071; Hartung M, 2004, ASTRON ASTROPHYS, V421, pL17, DOI 10.1051/0004-6361:20040171; HUTHNANCE JM, 1982, ESTUAR COAST SHELF S, V14, P79, DOI 10.1016/S0302-3524(82)80068-6; Lancaster N., 1995, GEOMORPHOLOGY DESERT; LEE P, 1995, J GEOPHYS RES-PLANET, V100, P5381, DOI 10.1029/95JE00225; Lorenz R. D., 2002, LIFTING TITANS VEIL; Lorenz RD, 2005, PLANET SPACE SCI, V53, P557, DOI 10.1016/j.pss.2004.06.004; LORENZ RD, 1992, ESA, P119; LORENZ RD, IN PRESS ICARUS; LORENZ RD, 1995, J GEOPHYS RES-PLANET, V88, P26377; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019871; RUBIN DM, 1990, SEDIMENTOLOGY, V37, P673, DOI 10.1111/j.1365-3091.1990.tb00628.x; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; Tokano T, 2002, ICARUS, V158, P499, DOI 10.1006/icar.2002.6883; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; West RA, 2005, NATURE, V436, P670, DOI 10.1038/nature03824; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; [No title captured]	27	271	278	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2006	312	5774					724	727		10.1126/science.1123257	http://dx.doi.org/10.1126/science.1123257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675695				2022-12-28	WOS:000237312100044
J	Brauer, SL; Cadillo-Quiroz, H; Yashiro, E; Yavitt, JB; Zinder, SH				Braeuer, Suzanna L.; Cadillo-Quiroz, Hinsby; Yashiro, Erika; Yavitt, Joseph B.; Zinder, Stephen H.			Isolation of a novel acidiphilic methanogen from an acidic peat bog	NATURE			English	Article							OLIGOTROPHIC FEN; NEW-YORK; BACTERIA; COMMUNITIES; POPULATIONS; PEATLANDS; DIVERSITY	Acidic peatlands are among the largest natural sources of atmospheric methane and harbour a large diversity of methanogenic Archaea(1). Despite the ubiquity of methanogens in these peatlands, indigenous methanogens capable of growth at acidic pH values have resisted culture and isolation(2-4); these recalcitrant methanogens include members of an uncultured family-level clade in the Methanomicrobiales prevalent in many acidic peat bogs in the Northern Hemisphere(1,5,6). However, we recently succeeded in obtaining a mixed enrichment culture of a member of this clade(7). Here we describe its isolation and initial characterization. We demonstrate that the optimum pH for methanogenesis by this organism is lower than that of any previously described methanogen.	Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA	Cornell University; Cornell University	Zinder, SH (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	shz1@cornell.edu	Yashiro, Erika/G-6234-2016	Yashiro, Erika/0000-0002-2364-9908; Cadillo-Quiroz, Hinsby/0000-0002-4908-4597				Angert ER, 2005, NAT REV MICROBIOL, V3, P214, DOI 10.1038/nrmicro1096; Basiliko N, 2003, GEOMICROBIOL J, V20, P563, DOI 10.1080/713851165; Brauer SL, 2004, GEOMICROBIOL J, V21, P433, DOI 10.1080/01490450490505400; BRAUER SL, IN PRESS FEMS MICROB; Brook EJ, 2005, SCIENCE, V310, P1285, DOI 10.1126/science.1121535; CADILLOQUIROZ H, IN PRESS ENV MICROBI; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; Dedysh SN, 1998, SCIENCE, V282, P281, DOI 10.1126/science.282.5387.281; Franzmann PD, 1997, INT J SYST BACTERIOL, V47, P1068, DOI 10.1099/00207713-47-4-1068; Galand PE, 2003, ENVIRON MICROBIOL, V5, P1133, DOI 10.1046/j.1462-2920.2003.00520.x; Galand PE, 2002, FEMS MICROBIOL ECOL, V42, P441, DOI 10.1111/j.1574-6941.2002.tb01033.x; GOODWIN S, 1987, APPL ENVIRON MICROB, V53, P57, DOI 10.1128/AEM.53.1.57-64.1987; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Horn MA, 2003, APPL ENVIRON MICROB, V69, P74, DOI 10.1128/AEM.69.1.74-83.2003; Juottonen H, 2005, ENVIRON MICROBIOL, V7, P1547, DOI 10.1111/j.1462-2920.2005.00838.x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; MAESTROJUAN GM, 1991, INT J SYST BACTERIOL, V41, P267, DOI 10.1099/00207713-41-2-267; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; PATEL GB, 1990, INT J SYST BACTERIOL, V40, P12, DOI 10.1099/00207713-40-1-12; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Sizova MV, 2003, FEMS MICROBIOL ECOL, V45, P301, DOI 10.1016/S0168-6496(03)00165-X; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; WILLIAMS RT, 1985, APPL ENVIRON MICROB, V50, P1542, DOI 10.1128/AEM.50.6.1542-1544.1985	25	121	134	5	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					192	194		10.1038/nature04810	http://dx.doi.org/10.1038/nature04810			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16699521	Green Submitted			2022-12-28	WOS:000238979700045
J	Truby, H; Baic, S; Delooy, A; Fox, KR; Livingstone, MBE; Logan, CM; Macdonald, IA; Morgan, LM; Taylor, MA; Millward, DJ				Truby, Helen; Baic, Sue; deLooy, Anne; Fox, Kenneth R.; Livingstone, M. Barbara E.; Logan, Catherine M.; Macdonald, Ian A.; Morgan, Linda M.; Taylor, Moira A.; Millward, D. J.			Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC "diet trials"	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; STRATEGIES	Objective To compare the effectiveness of four commercial weight loss diets available to adults in the United Kingdom. Design Six month multicentre randomised unblinded controlled trial. Setting Community based sample of otherwise healthy overweight and obese adults. Interventions Dr Atkins' new diet revolution, Slim-Fast plan, Weight Watchers pure points programme, and Rosemary Conley's eat yourself slim diet and fitness plan. Main outcome measures Weight and body fat changes over six months. Results All diets resulted in significant loss of body fat and weight over six months. Groups did not differ significantly but loss of body fat and weight was greater in all groups compared with the control group. In an intention to treat analysis, average weight loss was 5.9 kg and average fat loss was 4.4 kg over six months. The Atkins diet resulted in significantly higher weight loss during the first four weeks, but by the end was no more or less effective than the other diets. Conclusions Clinically useful weight loss and fat loss can be achieved in adults who are motivated to follow commercial diets for a substantial period. Given the limited resources for weight management in the NHS, healthcare practitioners should discuss with their patients programmes known to be effective.	Univ Surrey, Sch Biomed & Mol Sci, Ctr Nutr Dietet & Food, Surrey GU2 7XH, England; Univ Bristol, Dept Exercise & Hlth Sci, Ctr Sports Exercise & Hlth Sci, Bristol BS8 1TP, Avon, England; Univ Plymouth, Fac Hlth & Social Work, Plymouth PL4 8AA, Devon, England; Univ Ulster, No Ireland Ctr Food & Hlth, Coleraine BT52 1SA, Londonderry, North Ireland; Univ Nottingham, Sch Med, Integrated Syst Biol & Med, Inst Clin Res,Queens Med Ctr, Nottingham NG7 2UH, England; Univ Nottingham, Sch Med, Integrated Syst Biol & Med, Sch Biomed Sci,Queens Med Ctr, Nottingham NG7 2UH, England	University of Surrey; University of Bristol; University of Plymouth; Ulster University; University of Nottingham; University of Nottingham	Truby, H (corresponding author), Univ Surrey, Sch Biomed & Mol Sci, Ctr Nutr Dietet & Food, Surrey GU2 7XH, England.	h.truby@surrey.ac.uk	Fox, Kenneth/B-5897-2014	Taylor, Moira/0000-0003-4100-8343; Fox, Kenneth/0000-0003-2216-4287; Macdonald, Ian/0000-0002-7540-9850; Truby, Helen/0000-0002-1992-1649				ATKINS RC, 1999, ATKINS NEW DIET REVO; Crowe TC, 2005, OBES REV, V6, P235, DOI 10.1111/j.1467-789X.2005.00196.x; *DEP HLTH, 1999, WHIT PAP PUBL HLTH S; Foster GD, 1997, J CONSULT CLIN PSYCH, V65, P79, DOI 10.1037/0022-006X.65.1.79; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; FREEDMAN M, 2001, OBESITY REV S1, V9, P1, DOI DOI 10.1038/0BY.2001.113; French SA, 1999, INT J OBESITY, V23, P320, DOI 10.1038/sj.ijo.0800822; Harvey-Berino J, 1998, OBES RES, V6, P202, DOI 10.1002/j.1550-8528.1998.tb00338.x; KARVETTI RL, 1992, EUR J CLIN NUTR, V46, P743; Lean MEJ, 1997, EUR J CLIN NUTR, V51, P243, DOI 10.1038/sj.ejcn.1600391; Newman DJ, 2002, ANN CLIN BIOCHEM, V39, P89, DOI 10.1258/0004563021901847; Offer A, 2001, SOC HIST MED, V14, P79, DOI 10.1093/shm/14.1.79; Perri MG, 1998, CLIN PSYCHOL-SCI PR, V5, P526, DOI 10.1111/j.1468-2850.1998.tb00172.x; Royal College of Physicians, 2004, STOR PROBL MED CAS S; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; STERN I, ANN INT MED, V140, P769; STERN L, ANN INTERN MED, V140, P769; Vlad Ioana, 2003, BMJ, V327, P1308, DOI 10.1136/bmj.327.7427.1308-d	18	158	160	0	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1309	1311		10.1136/bmj.38833.411204.80	http://dx.doi.org/10.1136/bmj.38833.411204.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16720619	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000238197000022
J	Jacque, JM; Stevenson, M				Jacque, Jean-Marc; Stevenson, Mario			The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-AUTOINTEGRATION FACTOR; PREINTEGRATION COMPLEXES; PRIMARY MACROPHAGES; CDNA INTEGRATION; TYPE-1; DNA; BAF; REPLICATION; CHROMATIN	Primate lentiviruses such as human immunodeficiency type 1 (HIV-1) have the capacity to infect non-dividing cells such as tissue macrophages(1). In the process, viral complementary DNA traverses the nuclear envelope to integrate within chromatin(2). Given the intimate association between chromatin and the nuclear envelope(3), we examined whether HIV-1 appropriates nuclear envelope components during infection. Here we show that emerin, an integral inner-nuclear-envelope protein, is necessary for HIV-1 infection. Infection of primary macrophages lacking emerin was abortive in that viral cDNA localized to the nucleus but integration into chromatin was inefficient, and conversion of viral cDNA to non-functional episomal cDNA increased. HIV-1 cDNA associated with emerin in vivo, and the interaction of viral cDNA with chromatin was dependent on emerin. Barrier-to-autointegration factor (BAF), the LEM ( LAP, emerin, MAN) binding partner of emerin, was required for the association of viral cDNA with emerin and for the ability of emerin to support virus infection. Therefore emerin, which bridges the interface between the inner nuclear envelope and chromatin, may be necessary for chromatin engagement by viral cDNA before integration.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Stevenson, M (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Suite 319, Worcester, MA 01605 USA.	mario.stevenson@umassmed.edu	Jacque, Jean-Marc/B-6875-2008					Beitzel B, 2003, NUCLEIC ACIDS RES, V31, P5025, DOI 10.1093/nar/gkg684; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Lau A, 2004, EMBO J, V23, P3421, DOI 10.1038/sj.emboj.7600348; Lee KK, 2001, J CELL SCI, V114, P4567; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Li L, 2000, J VIROL, V74, P10965, DOI 10.1128/JVI.74.23.10965-10974.2000; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; Mansharamani M, 2003, J VIROL, V77, P13084, DOI 10.1128/JVI.77.24.13084-13092.2003; Miccoli L, 2003, NUCLEIC ACIDS RES, V31, P4162, DOI 10.1093/nar/gkg459; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; STEVENSON M, 1990, J VIROL, V64, P2421, DOI 10.1128/JVI.64.5.2421-2425.1990; Suzuki Y, 2004, EMBO J, V23, P4670, DOI 10.1038/sj.emboj.7600452; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102; Zielske SP, 2005, J VIROL, V79, P11541, DOI 10.1128/JVI.79.17.11541-11546.2005	27	80	98	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					641	645		10.1038/nature04682	http://dx.doi.org/10.1038/nature04682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16680152				2022-12-28	WOS:000237920800049
J	Bhardwaj, VR; Metcalfe, N; Innes, E; Harrison, E; Jenkins, D				Bhardwaj, Vishal Rai; Metcalfe, Neil; Innes, Emma; Harrison, Esther; Jenkins, David			Lesson of the week - Recurrent diabetic ketoacidosis after changing pen devices for insulin injection	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Worcestershire Royal Hosp, S Worcestershire Ctr Diabet & Metab, Worcester, England		Jenkins, D (corresponding author), Worcestershire Royal Hosp, S Worcestershire Ctr Diabet & Metab, Worcester, England.	david.jenkins@worcsacute.wmids.nhs.uk						*AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS94; BASU A, 1993, DIABETIC MED, V10, P282, DOI 10.1111/j.1464-5491.1993.tb00060.x; Department of Health, 2002, NAT SERV FRAM DIAB D; Dunger DB, 2004, PEDIATRICS, V113, P133; KRENTZ A, 2003, TXB DIABETES, V1	5	9	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2006	332	7552					1259	1260		10.1136/bmj.332.7552.1259	http://dx.doi.org/10.1136/bmj.332.7552.1259			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16735337	Green Published			2022-12-28	WOS:000237984100021
J	Freemantle, CJ; Read, AW; de Klerk, NH; McAullay, D; Anderson, IP; Stanley, FJ				Freemantle, C. Jane; Read, Anne W.; de Klerk, Nicholas H.; McAullay, Daniel; Anderson, Ian P.; Stanley, Fiona J.			Patterns, trends, and increasing disparities in mortality for Aboriginal and non-Aboriginal infants born in Western Australia, 1980-2001: population database study	LANCET			English	Article							PRENATAL-CARE; WOMEN	Background Since there are known disparities between Aboriginal and non-Aboriginal populations in Australia, trends in infant mortality rates can be used to assess the effectiveness of programmes designed to improve the health of Aboriginal populations. We have examined mortality rates in these populations in Western Australia. Method We used the most comprehensive and valid total population data available for an Australian state to determine all-cause and cause-specific mortality for Aboriginal and non-Aboriginal infants born in Western Australia from 1980 to 2001. Findings Overall, infant mortality rates fell in both populations, but less so in Aboriginal (from 25.0 in 1980-84 to 16.1 in 1998-2001) than in non-Aboriginal infants (from 8.4 in 1980-84 to 3.7 in 1998-2001) such that disparities between the two groups increased for all major causes of infant death. The relative risk for Aboriginal compared with non-Aboriginal infants rose from 3.0 (95% CI 2.5-3.6) to 4.4 (3.5-5.5), and there were significantly more potentially preventable deaths, such as those caused by infections (5.9 per 1000 livebirths vs 0.7 per 1000 livebirths, RR 8.5, 95% CI 7.1-10.2). Additionally, for Aboriginal infants, postneonatal mortality rates were higher than neonatal mortality rates (11.2 per 1000 livebirths vs 9.7 per 1000 livebirths), trend analyses showed that previous reductions in deaths due to preterm. birth (4.3 per 1000 livebirths-1.4 per 1000 livebirths from 1980-97) were not sustained in the most recent years studied (3.5 per 1000 livebirths), and rates of sudden infant death syndrome did not fall significantly (4.9 per 1000 livebirths vs 4.7 per 1000 livebirths). Interpretation These increasing disparities between Aboriginal and non-Aboriginal infants, especially in remote areas, demand immediate action in partnership with Aboriginal communities, focusing on both access to primary health care and better living conditions. Implementation and assessment of policies to reduce the continuing social and economic disadvantage faced by Aboriginal families are vital.	Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; Dept Hlth, Off Aboriginal Hlth, Perth, WA, Australia; Univ Melbourne, Koori Hlth Unit, Onemda VicHlth, Ctr Hlth & Soc, Melbourne, Vic, Australia	Telethon Kids Institute; University of Western Australia; University of Melbourne	Freemantle, CJ (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	janef@ichr.uwa.edu.au	de Klerk, Nicholas H/D-8388-2016; Anderson, Ian PS/C-1498-2008	de Klerk, Nicholas H/0000-0001-9223-0767; McAullay, Daniel/0000-0002-0651-899X				Alessandri LM, 2001, MED J AUSTRALIA, V175, P185, DOI 10.5694/j.1326-5377.2001.tb143092.x; ANDERSON I, 2002, NEW RURAL HLTH, P116; *AUSTR BUR STAT, 1999, NAT HLTH SURV AB TOR; *AUSTR I HLTH WELF, 1998, HLTH RUR REM AUSTR, P104; Australian Bureau of Statistics, 1998, INF PAP 1996 CENS PO; Australian Institute of Health and Welfare, 2019, NO TERR REM AB INV O; Blair E, 1996, J PAEDIATR CHILD H, V32, P498, DOI 10.1111/j.1440-1754.1996.tb00962.x; Bower C, 2000, J PAEDIATR CHILD H, V36, P574, DOI 10.1046/j.1440-1754.2000.00575.x; BOWER C, 1998, REPORT BIRTH DEFECTS; Craig ED, 2004, AUST NZ J OBSTET GYN, V44, P545, DOI 10.1111/j.1479-828X.2004.00312.x; ElamEvans LD, 1997, OBSTET GYNECOL, V90, P71, DOI 10.1016/S0029-7844(97)00138-5; ElamEvans LD, 1996, OBSTET GYNECOL, V87, P575, DOI 10.1016/0029-7844(95)00474-2; FREEMANTLE CJ, 2003, THESIS U W AUSTR, P475; FREEMANTLE CJ, 2004, 1 GOV W AUSTR, P220; FREEMANTLE CJ, 2003, THESIS U W AUSTR; FREEMANTLE CJ, IN PRESS J PAEDIAT C; Gee V, 1994, VALIDATION STUDY W A; GEE V, 1998, PERINATAL STAT W AUS; Gracey M, 1997, AUST NZ J PUBL HEAL, V21, P511, DOI 10.1111/j.1467-842X.1997.tb01744.x; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Kleinman J C, 1990, MMWR CDC Surveill Summ, V39, P31; Luo ZC, 2004, INT J EPIDEMIOL, V33, P1252, DOI 10.1093/ije/dyh290; MAHONY A, 1995, IMMUNISATION DELAY 0; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; *NAT HLTH MRC, 2003, NHMRC ROAD MAP STRAT; *NGUN TJITJ PIRN C, 1998, EV REP; READ AW, 1999, COMP INDIGENOUS STAT; Reid J., 1991, HLTH ABORIGINAL AUST; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P149; STANLEY F, 2001, 2001 YB AUSTR; Stanley F. J., 1997, SEMIN NEONATOL, V2, P195; THOMSON N, 1997, HLTH ABORIGINAL AUST, P37; Zubrick SR, 2004, W AUSTR AB CHILD HLT	33	71	71	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1758	1766		10.1016/S0140-6736(06)68771-0	http://dx.doi.org/10.1016/S0140-6736(06)68771-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047BE	16731271				2022-12-28	WOS:000237854000031
J	Heukelbach, J; Feldmeier, H				Heukelbach, Joerg; Feldmeier, Herman			Scabies	LANCET			English	Review							PARASITIC SKIN DISEASES; PERMETHRIN 5-PERCENT CREAM; MITE SARCOPTES-SCABIEI; BENZYL BENZOATE; ACUTE GLOMERULONEPHRITIS; NORWEGIAN SCABIES; CRUSTED SCABIES; VAR. HOMINIS; IN-VITRO; RESISTANT SCABIES	Scabies is a neglected parasitic disease that is a major public health problem in many resource-poor regions. It causes substantial morbidity from secondary infections and post-infective complications such as acute post-streptococcal glomerulonephritis. Disease control requires treatment of the affected individual and all people they have been in contact with, but is often hampered by inappropriate or delayed diagnosis, poor treatment compliance, and improper use of topical compounds such as permethrin, lindane, or benzyl benzoate. In addition to concerns over toxicity with such compounds, parasite resistance seems to be increasing. Oral ivermectin is an alter-native that has been used successfully in community control programmes. Plant derivatives such as turmeric, neem, and tea tree oil are also promising future treatments. The disease is strongly associated with poverty and overcrowding, and the associated stigma can ostracise affected individuals. Treatment of scabies in poor countries needs to integrate drug treatment programmes with efforts to improve the socioeconomic conditions and education programmes to reduce stigma. We expect the future to bring more sensitive and specific clinical and laboratory-based diagnostic methods, as well as new therapeutic strategies.	Charite, Dept Med Microbiol & Immunol Infect, Berlin, Germany; Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidade Federal do Ceara	Feldmeier, H (corresponding author), Charite, Dept Med Microbiol & Immunol Infect, Campus Benjamin Franklin, Berlin, Germany.	hermann.feldmeier@charite.de		Heukelbach, Jorg/0000-0002-7845-5510				Alberici F, 2000, BRIT J DERMATOL, V142, P969, DOI 10.1046/j.1365-2133.2000.03480.x; Alexander NDE, 1998, T ROY SOC TROP MED H, V92, P342, DOI 10.1016/S0035-9203(98)91035-5; Amerio PL, 2003, EUR J DERMATOL, V13, P69; ANDREWS JRH, 1989, J ROY SOC HEALTH, V109, P199, DOI 10.1177/146642408910900607; ANDREWS JRH, 1979, INT J DERMATOL, V18, P545, DOI 10.1111/j.1365-4362.1979.tb01966.x; [Anonymous], 2003, FDA Consum, V37, P6; Arlian LG, 2004, J MED ENTOMOL, V41, P74, DOI 10.1603/0022-2585-41.1.74; ARLIAN LG, 1984, J AM ACAD DERMATOL, V10, P979, DOI 10.1016/S0190-9622(84)80318-7; ARLIAN LG, 1984, J AM ACAD DERMATOL, V11, P210, DOI 10.1016/S0190-9622(84)70151-4; ARLIAN LG, 1989, ANNU REV ENTOMOL, V34, P139, DOI 10.1146/annurev.en.34.010189.001035; ARLIAN LG, 1989, EXP APPL ACAROL, V6, P181, DOI 10.1007/BF01193978; Barkwell R, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63020-6; Bastian HM, 1997, AM J MED, V102, P305, DOI 10.1016/S0002-9343(99)80272-1; Berrios X, 1990, Rev Chil Pediatr, V61, P109; Bezold G, 2001, BRIT J DERMATOL, V144, P614, DOI 10.1046/j.1365-2133.2001.04096.x; Bhalla M, 2004, PEDIATR DERMATOL, V21, P597, DOI 10.1111/j.0736-8046.2004.21515.x; Bigby M, 2000, ARCH DERMATOL, V136, P387, DOI 10.1001/archderm.136.3.387; Bockarie MJ, 2000, ACTA TROP, V75, P127, DOI 10.1016/S0001-706X(99)00087-X; Boffa MJ, 1995, BRIT J DERMATOL, V133, P1013, DOI 10.1111/j.1365-2133.1995.tb06950.x; Brar BK, 2003, J DERMATOL, V30, P694, DOI 10.1111/j.1346-8138.2003.tb00460.x; Brites C, 2002, AIDS, V16, P1292, DOI 10.1097/00002030-200206140-00015; Brooks PA, 2002, J PAEDIATR CHILD H, V38, P401, DOI 10.1046/j.1440-1754.2002.00015.x; Buczek A, 2006, ANN EPIDEMIOL, V16, P423, DOI 10.1016/j.annepidem.2005.06.058; Buffet M, 2003, FUND CLIN PHARMACOL, V17, P217, DOI 10.1046/j.1472-8206.2003.00173.x; Burch JM, 2004, PEDIATR DERMATOL, V21, P58, DOI 10.1111/j.0736-8046.2004.21113.x; BURGESS I, 1994, ADV PARASIT, V33, P235, DOI 10.1016/S0065-308X(08)60414-5; Burkhart KM, 1998, INT J DERMATOL, V37, P76; Carapetis JR, 1997, PEDIATR INFECT DIS J, V16, P494, DOI 10.1097/00006454-199705000-00008; Cestari TF, 2005, CLIN DERMATOL, V23, P545, DOI 10.1016/j.clindermatol.2005.01.013; CHAKRABARTI A, 1985, INT J ZOONOSES, V12, P39; Chambliss ML, 2000, ARCH FAM MED, V9, P473, DOI 10.1001/archfami.9.5.473; CHARLES V, 1992, TROP GEOGR MED, V44, P178; Chosidow O, 2000, LANCET, V355, P819, DOI 10.1016/S0140-6736(99)09458-1; Chouela EN, 1999, ARCH DERMATOL, V135, P651, DOI 10.1001/archderm.135.6.651; CHRISTOPHERSEN J, 1978, ARCH DERMATOL, V114, P747, DOI 10.1001/archderm.114.5.747; Corbett EL, 1996, GENITOURIN MED, V72, P115; Coyne PE, 1997, LANCET, V350, P215, DOI 10.1016/S0140-6736(05)62378-1; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; CURRIE BJ, 1994, MED J AUSTRALIA, V161, P636, DOI 10.5694/j.1326-5377.1994.tb127655.x; Currie BJ, 2002, J PAEDIATR CHILD H, V38, P223, DOI 10.1046/j.1440-1754.2002.00850.x; DAVIES JE, 1983, ARCH DERMATOL, V119, P142, DOI 10.1001/archderm.119.2.142; DEGELAU J, 1992, INFECT CONT HOSP EP, V13, P421; del Giudice P, 1999, ARCH DERMATOL, V135, P351, DOI 10.1001/archderm.135.3.351; del Giudice Pascal, 2003, J Drugs Dermatol, V2, P13; Downs AMR, 1999, EPIDEMIOL INFECT, V122, P471, DOI 10.1017/S0950268899002277; Downs AMR, 2004, BRIT J DERMATOL, V150, P602, DOI 10.1046/j.1365-2133.2004.05823.x; DURAN C, 1993, PEDIATR DERMATOL, V10, P136, DOI 10.1111/j.1525-1470.1993.tb00039.x; Elgart GW, 2003, DERMATOL CLIN, V21, P277, DOI 10.1016/S0733-8635(02)00095-5; Elgart M L, 1999, Skin Therapy Lett, V5, P1; Elgart ML, 1996, DRUG SAFETY, V14, P386, DOI 10.2165/00002018-199614060-00004; Estrada Benjamin, 2003, Semin Pediatr Infect Dis, V14, P20, DOI 10.1053/spid.2003.127213; FAIN A, 1978, INT J DERMATOL, V17, P20, DOI 10.1111/j.1365-4362.1978.tb06040.x; Feldmeier H, 2005, TROP MED INT HEALTH, V10, P713, DOI 10.1111/j.1365-3156.2005.01457.x; Figueroa JI, 1998, INT J DERMATOL, V37, P752, DOI 10.1046/j.1365-4362.1998.00425.x; Fischer K, 2003, AM J TROP MED HYG, V68, P61, DOI 10.4269/ajtmh.2003.68.1.0680061; Franz TJ, 1996, ARCH DERMATOL, V132, P901, DOI 10.1001/archderm.132.8.901; Gach JE, 2000, LANCET, V356, P650, DOI 10.1016/S0140-6736(00)02608-8; Gibbs S, 1996, INT J DERMATOL, V35, P633, DOI 10.1111/j.1365-4362.1996.tb03687.x; GLAZIOU P, 1993, TROP MED PARASITOL, V44, P331; GREEN MS, 1989, EPIDEMIOL REV, V11, P126, DOI 10.1093/oxfordjournals.epirev.a036033; Haas N, 2005, ARCH DERMATOL RES, V296, P327, DOI 10.1007/s00403-004-0524-x; Haas N, 2001, ARCH DERMATOL, V137, P1656; Harumal P, 2003, AM J TROP MED HYG, V68, P54, DOI 10.4269/ajtmh.2003.68.54; Hegazy AA, 1999, INT J DERMATOL, V38, P291, DOI 10.1046/j.1365-4362.1999.00630.x; Heilesen B., 1946, ACTA DERM-VENEREOL, V26, P26; HERRMANN WP, 1969, HAUTARZT, V20, P467; Heukelbach J, 2005, BRIT J DERMATOL, V153, P150, DOI 10.1111/j.1365-2133.2005.06591.x; Heukelbach J, 2004, B WORLD HEALTH ORGAN, V82, P563; Heukelbach J, 2004, LANCET, V363, P889, DOI 10.1016/S0140-6736(04)15738-3; Heukelbach J, 2003, TROP MED INT HEALTH, V8, P368, DOI 10.1046/j.1365-3156.2003.01038.x; Heukelbach Jorg, 2005, Curr Infect Dis Rep, V7, P373, DOI 10.1007/s11908-005-0012-2; Heukelbach Jörg, 2003, Cad. Saúde Pública, V19, P1535, DOI 10.1590/S0102-311X2003000500032; Holt DC, 2004, J INVEST DERMATOL, V123, P240, DOI 10.1111/j.0022-202X.2004.22716.x; Holt DC, 2003, J INVEST DERMATOL, V121, P1419, DOI 10.1046/j.1523-1747.2003.12621.x; HULBERT TV, 1992, CLIN INFECT DIS, V14, P1164, DOI 10.1093/clinids/14.5.1164; Johnston G, 2005, BMJ-BRIT MED J, V331, P619, DOI 10.1136/bmj.331.7517.619; JUDD LE, 1993, NEW ZEAL MED J, V106, P61; Karthikeyan K, 2005, POSTGRAD MED J, V81, P7, DOI 10.1136/pgmj.2003.018390; Kissmeyer A, 1937, LANCET, V1, P21; KRISTENSEN JK, 1991, INT J DERMATOL, V30, P699, DOI 10.1111/j.1365-4362.1991.tb02612.x; Lacarrubba F, 2001, PEDIATR DERMATOL, V18, P439, DOI 10.1046/j.1525-1470.2001.01973.x; Lalli PN, 2004, J PARASITOL, V90, P711, DOI 10.1645/GE-214R; Lawrence G, 2005, B WORLD HEALTH ORGAN, V83, P34; Leppard B, 2000, BRIT J DERMATOL, V143, P520, DOI 10.1111/j.1365-2133.2000.03704.x; Ljunggren EL, 2003, PARASITOLOGY, V127, P139, DOI 10.1017/S003118200300338X; Lonc E, 2000, J PARASITOL, V86, P170, DOI 10.1645/0022-3395(2000)086[0170:SAHLII]2.0.CO;2; Madan V, 2001, J DERMATOL, V28, P481, DOI 10.1111/j.1346-8138.2001.tb00015.x; Mattsson JG, 2001, PARASITOLOGY, V122, P555, DOI 10.1017/S0031182001007648; Mauleon-Fernandez C, 2005, CLIN EXP DERMATOL, V30, P595, DOI 10.1111/j.1365-2230.2005.01832.x; McCarthy JS, 2004, POSTGRAD MED J, V80, P382, DOI 10.1136/pgmj.2003.014563; Mellanby K, 1941, BRIT MED J, V1941, P405; Mellanby K., 1985, CUTANEOUS INFESTATIO, P9; MELLANBY K, 1985, CUTANEOUS INFESTATIO, P71; Mellanby Kenneth, 1944, PARASITOLOGY, V35, P197, DOI 10.1017/S0031182000021612; Micali G, 2004, J EUR ACAD DERMATOL, V18, P153, DOI 10.1111/j.1468-3083.2004.00858.x; Micali G, 1999, ACTA DERM-VENEREOL, V79, P396, DOI 10.1080/000155599750010427; Millership S, 2002, Commun Dis Public Health, V5, P144; Mimouni D, 2003, BRIT J DERMATOL, V149, P157, DOI 10.1046/j.1365-2133.2003.05329.x; MITRA M, 1993, TROP GEOGR MED, V45, P142; Morsy Tosson A., 1994, Journal of the Egyptian Society of Parasitology, V24, P305; Nnoruka EN, 2001, TROP DOCT, V31, P15, DOI 10.1177/004947550103100105; Odueko O M, 2001, Niger J Med, V10, P64; Oladimeji FA, 2000, J ETHNOPHARMACOL, V72, P305, DOI 10.1016/S0378-8741(00)00229-4; Patel A, 1999, Australas J Dermatol, V40, P37, DOI 10.1046/j.1440-0960.1999.00314.x; Pence DB, 2002, REV SCI TECH OIE, V21, P385, DOI 10.20506/rst.21.2.1335; Pettersson EU, 2005, INT J PARASITOL, V35, P39, DOI 10.1016/j.ijpara.2004.09.006; POONKING T, 1973, LANCET, V1, P475; PORTER MJ, 1980, T ROY SOC TROP MED H, V74, P162, DOI 10.1016/0035-9203(80)90237-0; POTTER EV, 1985, CUTANEOUS INFESTATIO, P49; PURVIS RS, 1991, J AM ACAD DERMATOL, V25, P1015, DOI 10.1016/0190-9622(91)70300-Q; QUARTERMAN MJ, 1994, PEDIATR DERMATOL, V11, P264, DOI 10.1111/j.1525-1470.1994.tb00600.x; Rajajee S, 1990, Indian J Pediatr, V57, P775, DOI 10.1007/BF02722275; Ramos-e-Silva M, 1998, INT J DERMATOL, V37, P625, DOI 10.1046/j.1365-4362.1998.00400_1.x; Rehbein S, 2003, VET PARASITOL, V114, P267, DOI 10.1016/S0304-4017(03)00140-7; REID HFM, 1990, T ROY SOC TROP MED H, V84, P298, DOI 10.1016/0035-9203(90)90296-Q; REID HFM, 1990, J MED MICROBIOL, V32, P111, DOI 10.1099/00222615-32-2-111; Reintjes R, 1997, LANCET, V350, P215, DOI 10.1016/S0140-6736(05)62377-X; Richard-Lenoble D, 2003, FUND CLIN PHARMACOL, V17, P199, DOI 10.1046/j.1472-8206.2003.00170.x; Roberts LJ, 2005, J INFECTION, V50, P375, DOI 10.1016/j.jinf.2004.08.033; Roos TC, 2001, DRUGS, V61, P1067, DOI 10.2165/00003495-200161080-00004; SOLOMON LM, 1977, ARCH DERMATOL, V113, P353, DOI 10.1001/archderm.113.3.353; STANTON B, 1987, J TROP MED HYG, V90, P219; SVARTMAN M, 1973, J LAB CLIN MED, V81, P182; SVARTMAN M, 1972, LANCET, V1, P249; TAPLIN D, 1991, LANCET, V337, P1016, DOI 10.1016/0140-6736(91)92669-S; Terry BC, 2001, PUBLIC HEALTH, V115, P208, DOI 10.1016/S0033-3506(01)00445-0; TUZUN Y, 1980, INT J DERMATOL, V19, P41, DOI 10.1111/j.1365-4362.1980.tb01993.x; Usha V, 2000, J AM ACAD DERMATOL, V42, P236, DOI 10.1016/S0190-9622(00)90131-2; VERMA KC, 1983, INDIAN J MED RES, V77, P447; WALKER GJ, 2000, COCHRANE DB SYST REV, V2; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; Walton SF, 2000, T ROY SOC TROP MED H, V94, P92, DOI 10.1016/S0035-9203(00)90454-1; Walton SF, 2004, ARCH DERMATOL, V140, P563, DOI 10.1001/archderm.140.5.563; WHITTLE HC, 1973, T ROY SOC TROP MED H, V67, P349, DOI 10.1016/0035-9203(73)90112-0; Wong LCF, 2001, MED J AUSTRALIA, V175, P367, DOI 10.5694/j.1326-5377.2001.tb143620.x; 2005, MMWR MORB MORTAL WKL, V54, P533	137	220	228	1	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1767	1774		10.1016/S0140-6736(06)68772-2	http://dx.doi.org/10.1016/S0140-6736(06)68772-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047BE	16731272				2022-12-28	WOS:000237854000032
J	Horton, R				Horton, R			Indigenous peoples: time to act now for equity and health	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; Bramley Dale, 2004, N Z Med J, V117, pU1215; Freemantle CJ, 2006, LANCET, V367, P1758, DOI 10.1016/S0140-6736(06)68771-0; Kunitz SJ, 2000, AM J PUBLIC HEALTH, V90, P1531, DOI 10.2105/AJPH.90.10.1531; Kuper A, 2005, LANCET, V366, P983, DOI 10.1016/S0140-6736(05)67374-6; Stephens C, 2005, LANCET, V366, P10, DOI 10.1016/S0140-6736(05)66801-8; STEPHENS C, IN PRESS LANCET	7	25	25	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY-JUN	2006	367	9524					1705	1707		10.1016/S0140-6736(06)68745-X	http://dx.doi.org/10.1016/S0140-6736(06)68745-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731249				2022-12-28	WOS:000237854000004
J	Middleton, JF; McKinley, RK; Gillies, CL				Middleton, J. F.; McKinley, R. K.; Gillies, C. L.			Effect of patient completed agenda forms and doctors' education about the agenda on the outcome of consultations: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; PATIENTS SATISFACTION; COMMUNICATION-SKILLS; MINUTE; CARE	Objective To assess the effect of patient completed agenda forms for the consultation and doctors' education on identifying patients' agendas on the outcome of consultations. Design Randomised controlled trial. Setting General practices in Leicestershire and Nottinghamshire, United Kingdom. Participants 46 general practitioners and 976 patients. Interventions Education for general practitioners, with an embedded clustered randomised controlled trial of a patient agenda form. Main outcome measures Number of problems identified, time required to manage each problem, duration of consultations, number of problems raised after the doctor considered the consultation finished ("by the way" questions), and patient satisfaction. Results Data were available from 45 doctors (98%) and 857 patients (88%). The number of problems, identified in each consultation increased by 0.2 (95% confidence interval 0.1 to 0.4) with the agenda form, by 0.3 (0.1 to 0.6) with education, and by 0.5 (0.3 to 0.7) with both interventions. The time required to manage each problem was not affected. The duration of consultations with the agenda form was increased by 0.9 minutes (0.3 to 1.5 minutes) and with the combined intervention by 1.9 minutes (1.0 to 2.8 minutes). Patient satisfaction with the depth of the doctor-patient relationship was increased with the agenda form. The occurrence of "by the way" presentations did not change. Conclusion A patient completed agenda form before the consultation or general practitioner education about the agenda form, or both enabled the identification of more problems in consultations although consultations were longer.	Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester LE5 4PW, Leics, England; Univ Leicester, Leics Northants & Rutland Deanery, Leicester LE1 7RH, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leicester	McKinley, RK (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester LE5 4PW, Leics, England.	rkm@le.ac.uk	McKinley, Robert Kee/H-9211-2013	McKinley, Robert Kee/0000-0002-3684-3435; Gillies, Clare/0000-0002-8417-9700				Baker R, 1992, Qual Health Care, V1, P104, DOI 10.1136/qshc.1.2.104; BAKER R, 1990, BRIT J GEN PRACT, V40, P487; BERGER J, 1976, FORTUNATE MAN; Byrne P.S., 1976, DOCTORS TALKING PATI; Cartwright A., 1981, GEN PRACTICE REVISIT; EGBERT LD, 1964, NEW ENGL J MED, V270, P825, DOI 10.1056/NEJM196404162701606; EVANS BJ, 1987, BRIT J MED PSYCHOL, V60, P373, DOI 10.1111/j.2044-8341.1987.tb02756.x; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Hulsman RL, 1999, MED EDUC, V33, P655, DOI 10.1046/j.1365-2923.1999.00519.x; JOHNSON JE, 1988, CANCER-AM CANCER SOC, V61, P46, DOI 10.1002/1097-0142(19880101)61:1<46::AID-CNCR2820610109>3.0.CO;2-2; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; MAGUIRE P, 1988, BRIT MED J, V297, P907, DOI 10.1136/bmj.297.6653.907; McCann S, 1996, PATIENT EDUC COUNS, V27, P227, DOI 10.1016/0738-3991(95)00830-6; MCCORMICK A, 1995, MORBIDITY STAT GEN P; MCCORMICK A, 1995, CHARLTON J MORBIDITY; MIDDLETON JF, 1995, BRIT MED J, V311, P34, DOI 10.1136/bmj.311.6996.34; MIDDLETON JF, 2000, ED GEN PRACT, V11, P307; MIDDLETON JF, 1997, THESIS U LEICESTER; Middleton JF, 1998, ED GEN PRACT, V9, P231; MIDDLETON JF, 1991, MODERN MED       APR, P183; MORRELL DC, 1986, BMJ-BRIT MED J, V292, P870, DOI 10.1136/bmj.292.6524.870; Postlethwaite RJ, 1997, BRIT MED J, V314, P755, DOI 10.1136/bmj.314.7082.755; RIDSDALE L, 1989, J ROY COLL GEN PRACT, V39, P488; Spence J, 1960, PURPOSE PRACTICE MED, P271; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; THOMPSON SC, 1990, HEALTH PSYCHOL, V9, P390, DOI 10.1037/0278-6133.9.4.390; Tuckett D., 1985, M EXPERTS APPROACH S; UKOUMUNNE OC, 1999, HEALTH TECHNOL ASSES, V3, P27; WEBBER V, 1994, BRIT J GEN PRACT, V44, P175; Williams TL, 2001, ASSESSMENT, V8, P37, DOI 10.1177/107319110100800104; Wilson A, 2002, BRIT J GEN PRACT, V52, P1012; WILSON A, 1992, BMJ-BRIT MED J, V304, P227, DOI 10.1136/bmj.304.6821.227	33	50	53	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2006	332	7552					1238	1241		10.1136/bmj.38841.444861.7C	http://dx.doi.org/10.1136/bmj.38841.444861.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048ZC	16707508	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000237984100015
J	Bauer, A; Kantelhardt, JW; Barthel, P; Schneider, R; Makikallio, T; Ulm, K; Hnatkova, K; Schornig, A; Huikuri, H; Bunde, A; Malik, M; Schmidt, G				Bauer, Axel; Kantelhardt, Jan W.; Barthel, Petra; Schneider, Raphael; Makikallio, Timo; Ulm, Kurt; Hnatkova, Katerina; Schornig, Albert; Huikuri, Heikki; Bunde, Armin; Malik, Marek; Schmidt, Georg			Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study	LANCET			English	Article							SUDDEN CARDIAC DEATH; RISK STRATIFICATION; RATE-VARIABILITY; DEFIBRILLATOR; REFLEX	Background Decreased vagal activity after myocardial infarction results in reduced heart-rate variability and increased risk of death. To distinguish between vagal and sympathetic factors that affect heart-rate variability, we used a signal-processing algorithm to separately characterise deceleration and acceleration of heart rate. We postulated that diminished deceleration-related modulation of heart rate is an important prognostic marker. Our prospective hypotheses were that deceleration capacity is a better predictor of risk than left-ventricular ejection fraction (LVEF) and standard deviation of normal-to-normal intervals (SDNN). Methods We quantified heart rate deceleration capacity by assessing 24-h Holter recordings from a post-infarction cohort in Munich (n=1455). We blindly validated the prognostic power of deceleration capacity in post-infarction populations in London, UK (n=656), and Oulu, Finland (n=600). We tested our hypotheses by assessment of the area under the receiver-operator characteristics curve (AUC). Findings During a median follow-up of 24 months, 70 people died in the Munich cohort and 66 in the London cohort. The Oulu cohort was followed-up for 38 months and 77 people died. In the London cohort, mean AUC of deceleration capacity was 0.80 (SD 0.03) compared with 0.67 (0.04) for LVEF and 0.69 (0.04) for SDNN. In the Oulu cohort, mean AUC of deceleration capacity was 0.74 (0.03) compared with 0.60 (0.04) for LVEF and 0.64 (0.03) for SDNN (p<0.0001 for all comparisons). Stratification by dichotomised deceleration capacity was especially powerful in patients with preserved LVEF (p<0.0001 in all cohorts). Interpretation Impaired heart rate deceleration capacity is a powerful predictor of mortality after myocardial infarction and is more accurate than LVEF and the conventional measures of heart-rate variability.	Tech Univ Munich, Klinikum Rechts Isar, Erste Med Klin, D-8000 Munich, Germany; Tech Univ Munich, Klinikum Rechts Isar, Deutsch Herzzentrum Munchen, D-8000 Munich, Germany; Tech Univ Munich, Klinikum Rechts Isar, Inst Stat & Epidemiol, D-8000 Munich, Germany; Univ Giessen, Inst Theoret Phys 3, D-35390 Giessen, Germany; Univ Halle Wittenberg, Fachbereich Phys, D-4010 Halle, Germany; Univ Oulu, Dept Med, Oulu, Finland; Univ London, London WC1E 7HU, England	Technical University of Munich; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Justus Liebig University Giessen; Martin Luther University Halle Wittenberg; University of Oulu; University of London	Schmidt, G (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Erste Med Klin, D-8000 Munich, Germany.	gschmidt@tum.de	Schmidt, Georg/D-3711-2009; Kantelhardt, Jan/AAF-7955-2019	Schmidt, Georg/0000-0003-3692-5243; Kantelhardt, Jan/0000-0002-9293-0293; Schneider, Raphael/0000-0001-7754-5840; Malik, Marek/0000-0002-3792-1407; Bauer, Axel/0000-0001-9201-8555				Barthel P, 2003, CIRCULATION, V108, P1221, DOI 10.1161/01.CIR.0000088783.34082.89; Bauer A, 2006, PHYSICA A, V364, P423, DOI 10.1016/j.physa.2005.08.080; BILLMAN GE, 1982, CIRCULATION, V66, P874, DOI 10.1161/01.CIR.66.4.874; Camm AJ, 1996, CIRCULATION, V93, P1043; Copie X, 1996, J AM COLL CARDIOL, V27, P270, DOI 10.1016/0735-1097(95)00454-8; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Efron B, 1993, INTRO BOOTSTRAP MONO; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hartikainen JEK, 1996, J AM COLL CARDIOL, V28, P296, DOI 10.1016/0735-1097(96)00169-6; HNATKOVA K, 1994, COMPUT METH PROG BIO, V42, P147, DOI 10.1016/0169-2607(94)90125-2; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; La Rovere MT, 1998, LANCET, V351, P478; LOWN B, 1976, NEW ENGL J MED, V294, P1165; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824; Schmidt G, 1999, LANCET, V353, P1390, DOI 10.1016/S0140-6736(98)08428-1; SCHWARTZ PJ, 1988, CIRCULATION, V78, P969, DOI 10.1161/01.CIR.78.4.969; SCHWARTZ PJ, 1973, CIRC RES, V32, P215, DOI 10.1161/01.RES.32.2.215; SCHWARTZ PJ, 1992, CIRCULATION, V85, P77	21	402	450	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2006	367	9523					1674	1681		10.1016/S0140-6736(06)68735-7	http://dx.doi.org/10.1016/S0140-6736(06)68735-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714188				2022-12-28	WOS:000237743100031
J	Mitton, S				Mitton, Simon			Astroparticle physics and cosmology	LANCET			English	Review							PROBE WMAP OBSERVATIONS; SUPERNOVAE; UNIVERSE; MAPS	Astroparticle physics is an interdisciplinary field that explores the connections between the physics of elementary particles and the large-scale properties of the universe. Particle physicists have developed a standard model to describe the properties of matter in the quantum world. This model explains the bewildering array of particles in terms of constructs made from two or three quarks. Quarks, leptons, and three of the fundamental forces of physics are the main components of this standard model. Cosmologists have also developed a standard model to describe the bulk properties of the universe. In this new framework, ordinary matter, such as stars and galaxies, makes up only around 4% of the material universe. The bulk of the universe is dark matter (roughly 23%) and dark energy (about 73%). This dark energy drives an acceleration that means that the expanding universe will grow ever larger. String theory, in which the universe has several invisible dimensions, might offer an opportunity to unite the quantum description of the particle world with the gravitational properties of the large-scale universe.	St Edmunds Coll, Cambridge CB3 0BN, England	University of Cambridge	Mitton, S (corresponding author), St Edmunds Coll, Cambridge CB3 0BN, England.	smitton@cambridge.org	Mitton, Simon A/A-5899-2012	Mitton, Simon A/0000-0003-3695-9806				Adelberger E, 2005, PHYS WORLD, V18, P41; Bennett CL, 2005, SCIENCE, V307, P879, DOI 10.1126/science.1106444; Bennett CL, 2003, ASTROPHYS J SUPPL S, V148, P1, DOI 10.1086/377253; Bennett CL, 2003, ASTROPHYS J, V583, P1, DOI 10.1086/345346; Chiaverini J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.151101; de Bernardis P, 2000, NATURE, V404, P955, DOI 10.1038/35010035; DICKE RH, 1965, ASTROPHYS J, V142, P414, DOI 10.1086/148306; Einstein A, 1917, SITZBER K PREUSS AKA, P142; FILIPPENKO AV, 2000, TYPE 1A SUPERNOVAE, pCH1; Fukuda Y, 1998, PHYS REV LETT, V81, P1562, DOI 10.1103/PhysRevLett.81.1562; HOYLE F, 1965, ENCOUNTER FUTURE, P74; Hubble E, 1929, P NATL ACAD SCI USA, V15, P168, DOI 10.1073/pnas.15.3.168; KRAGH H, 1996, COSMOLOGY CONTROVERS, P355; Lampton M. L., 2004, Proceedings of the SPIE - The International Society for Optical Engineering, V5166, P113, DOI 10.1117/12.502333; MATHER JC, 1990, ASTROPHYS J, V354, pL37, DOI 10.1086/185717; *NAT RES COUNC BOA, 2004, ECONOMIST       0525; Perlmutter S, 2003, PHYS TODAY, V56, P53, DOI 10.1063/1.1580050; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Randall L, 1999, PHYS REV LETT, V83, P3370, DOI 10.1103/PhysRevLett.83.3370; Rebolo R, 2004, MON NOT R ASTRON SOC, V353, P747, DOI 10.1111/j.1365-2966.2004.08102.x; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Tauber JA, 2004, ADV SPACE RES, V34, P491, DOI 10.1016/j.asr.2003.05.025; Weinberg S, 1999, SCI AM, V281, P68, DOI 10.1038/scientificamerican1299-68	27	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2006	367	9523					1692	1697		10.1016/S0140-6736(06)68738-2	http://dx.doi.org/10.1016/S0140-6736(06)68738-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714191				2022-12-28	WOS:000237743100034
J	Holman, C				Holman, C			Clearing a path through the patent thicket	CELL			English	Editorial Material								Patents do not always promote innovation, particularly when they restrict access to fundamental scientific discoveries and the tools of basic research. However, there are legal and policy approaches that may help to ameliorate problems associated with patenting these sorts of inventions.	Univ Missouri, Sch Law, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Holman, C (corresponding author), Univ Missouri, Sch Law, Kansas City, MO 64110 USA.	holmancm@umkc.edu						Broothaerts W, 2005, NATURE, V433, P629, DOI 10.1038/nature03309; Garber K, 2006, SCIENCE, V311, P1855, DOI 10.1126/science.311.5769.1855; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; *NIH, 1999, PRINCP GUID REC NIH; RAI AK, 2002, BAYH DOLE REFORM PRO, V66; Walsh J.P., 2005, PATENTS MAT TRANSFER; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303	7	10	10	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 19	2006	125	4					629	633		10.1016/j.cell.2006.05.009	http://dx.doi.org/10.1016/j.cell.2006.05.009			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713553	Bronze			2022-12-28	WOS:000237886000004
J	Alfonso, I; Yaylali, I				Alfonso, I; Yaylali, I			Sympathetic-nerve damage in brachial-plexus palsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Miami Childrens Hosp, Miami, FL 33155 USA		Alfonso, I (corresponding author), Miami Childrens Hosp, Miami, FL 33155 USA.								0	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2165	2165		10.1056/NEJMicm050048	http://dx.doi.org/10.1056/NEJMicm050048			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707753				2022-12-28	WOS:000237575400010
J	Viotti, R; Vigliano, C; Lococo, B; Bertocchi, G; Petti, M; Alvarez, MG; Postan, M; Armenti, A				Viotti, Rodolfo; Vigliano, Carlos; Lococo, Bruno; Bertocchi, Graciela; Petti, Marcos; Alvarez, Maria Gabriela; Postan, Miriam; Armenti, Alejandro			Long-term cardiac outcomes of treating chronic chagas disease with benznidazole versus no treatment - A nonrandomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							TRYPANOSOMA-CRUZI DNA; HEART-DISEASE; ELECTROCARDIOGRAPHIC ABNORMALITIES; CHEMOTHERAPY; MORTALITY; PREDICTORS; EFFICACY; LESIONS; RISK	Background: Benznidazole is effective for treating acute-stage Chagas disease, but its effectiveness for treating indeterminate and chronic stages remains uncertain. Objective: To compare long-term outcomes of patients with nonacute Chagas disease treated with benznidazole versus outcomes of those who did not receive treatment. Design: Clinical trial with unblinded, nonrandom assignment of patients to intervention or control groups. Setting: Chagas disease center in Buenos Aires, Argentina. Patients: 566 patients 30 to 50 years of age with 3 positive results on serologic tests and without heart failure. Measurements: The primary outcome was disease progression, defined as a change to a more advanced Kuschnir group or death. Secondary outcomes included new abnormalities on electrocardiography and serologic reactivity. Intervention: Oral benznidazole, 5 mg/kg of body weight per day for 30 days (283 patients), or no treatment (283 patients). Results: Fewer treated patients had progression of disease (12 of 283 [4%] vs. 40 of 283 [14%]; adjusted hazard ratio, 0.24 [95% CI, 0.10 to 0.59]; P = 0.002) or developed abnormalities on electrocardiography (15 of 283 [5%] vs. 45 of 283 [16%]; adjusted hazard ratio, 0.27 [CI, 0.13 to 0.57]; P = 0.001) compared with untreated patients. Left ventricular ejection fraction (hazard ratio, 0.97 [CI, 0.94 to 0.99]; P < 0.002) and left ventricular diastolic diameter (hazard ratio, 2.45 [CI, 1.53 to 3.95]; P < 0.001) were also associated with disease progression. Conversion to negative results on serologic testing was more frequent in treated patients than in untreated patients (32 of 218 [15%] vs. 12 of 212 [6%]; adjusted hazard ratio, 2.1 [CI, 1.06 to 4.06]; P = 0.034). Limitations: Nonrandom, unblinded treatment assignment was used, and follow-up data were missing for 20% of patients. Loss to follow-up was more common among patients who were less sick. Two uncontrolled interim analyses were conducted. Conclusions: Compared with no treatment, benznidazole treatment was associated with reduced progression of Chagas disease and increased negative seroconversion for patients presenting with nonacute disease and no heart failure. These observations indicate that a randomized, controlled trial should now be conducted.	Hosp Interzonal Gen Agudos Eva Peron, Buenos Aires, DF, Argentina; Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina		Viotti, R (corresponding author), Jose Hernandez 3440,Villa Ballester,Gral San Mart, RA-1653 Buenos Aires ZC, DF, Argentina.	peron@millicom.com.ar	Alvarez, Maria/GZH-1345-2022					ANDRADE SG, 1985, B WORLD HEALTH ORGAN, V63, P721; ANDRADE ZA, 1978, AM HEART J, V95, P316, DOI 10.1016/0002-8703(78)90362-9; Apt W, 2003, ANN TROP MED PARASIT, V97, P23, DOI 10.1179/000349803125002751; BARRETT PA, 1981, PROG CARDIOVASC DIS, V23, P299, DOI 10.1016/0033-0620(81)90018-9; Bellotti G, 1996, AM HEART J, V131, P301, DOI 10.1016/S0002-8703(96)90358-0; BESTETTI RB, 1994, CARDIOLOGY, V84, P261, DOI 10.1159/000176409; BRANDARIZ S, 1995, LANCET, V346, P1370, DOI 10.1016/S0140-6736(95)92388-8; Cancado J. R., 1985, CARDIOPATIA CHAGASIC, P327; CANÇADO J. Romeu, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P29, DOI 10.1590/S0036-46652002000100006; Cancado JR, 1999, MEM I OSWALDO CRUZ, V94, P331, DOI 10.1590/S0074-02761999000700064; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; ESPINOSA RA, 1991, INT J CARDIOL, V30, P195, DOI 10.1016/0167-5273(91)90095-7; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Fabbro de Suasnabar D, 2000, REV INST MED TROP SP, V42, P99; Feigenbaum H., 1994, ECHOCARDIOGR-J CARD, P68; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Francolino Sonia S., 2003, Rev. Soc. Bras. Med. Trop., V36, P103, DOI 10.1590/S0037-86822003000100014; FRELIJ H, 1994, ENFERMEDAD CHAGAS, P343; Gallerano R R, 2000, Rev Fac Cien Med Univ Nac Cordoba, V57, P135; HIGUCHI MD, 1993, CARDIOVASC PATHOL, V2, P101, DOI 10.1016/1054-8807(93)90021-S; JONES EM, 1993, AM J TROP MED HYG, V48, P348, DOI 10.4269/ajtmh.1993.48.348; Kierszenbaum F, 1999, CLIN MICROBIOL REV, V12, P210, DOI 10.1128/CMR.12.2.210; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; LARANJA FS, 1956, CIRCULATION, V14, P1035, DOI 10.1161/01.CIR.14.6.1035; Lauria-Pires L, 2000, AM J TROP MED HYG, V63, P111, DOI 10.4269/ajtmh.2000.63.111; Machado CRS, 2000, HUM PATHOL, V31, P3, DOI 10.1016/S0046-8177(00)80191-4; Maguire J H, 1982, Bull Pan Am Health Organ, V16, P47; MAGUIRE JH, 1987, CIRCULATION, V75, P1140, DOI 10.1161/01.CIR.75.6.1140; Manzullo EC, 1999, MEM I OSWALDO CRUZ, V94, P317, DOI 10.1590/S0074-02761999000700060; OROURKE RA, 1995, CURR PROB CARDIOLOGY, V20, P829, DOI 10.1016/S0146-2806(06)80001-0; Pinto Dias J C, 1995, Arq Bras Cardiol, V65, P359; Rodriguez-Salas LA, 1998, ECHOCARDIOGR-J CARD, V15, P271, DOI 10.1111/j.1540-8175.1998.tb00607.x; ROSENBAUM MB, 1964, PROG CARDIOVASC DIS, V7, P199, DOI 10.1016/S0033-0620(64)80020-7; Schijman AG, 2004, AM J TROP MED HYG, V70, P210, DOI 10.4269/ajtmh.2004.70.210; Sosa-Estani S, 2004, MEDICINA-BUENOS AIRE, V64, P1; STEINER RM, 1992, HEART DIS TXB CARDIO, P204; STORINO R, 1994, ENFERMEDAD CHAGAS, P59; Streiger Mirtha L., 2004, Rev. Soc. Bras. Med. Trop., V37, P365; Sundararajan V, 2002, ANN INTERN MED, V136, P349, DOI 10.7326/0003-4819-136-5-200203050-00007; Urbina JA, 2002, CURR PHARM DESIGN, V8, P287, DOI 10.2174/1381612023396177; VIOTTI R, 1994, AM HEART J, V127, P151, DOI 10.1016/0002-8703(94)90521-5; Viotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960; VOLLER A, 1975, LANCET, V1, P426; World Health Organization (WHO), 2002, WHO TECH REP SER, V905, P1; Zhang L, 1999, J INFECT DIS, V180, P480, DOI 10.1086/314889	47	422	447	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2006	144	10					724	733		10.7326/0003-4819-144-10-200605160-00006	http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043XO	16702588				2022-12-28	WOS:000237636400003
J	Chen, BE; Kondo, M; Garnier, A; Watson, FL; Puettmann-Holgado, R; Lamar, DR; Schmucker, D				Chen, Brian E.; Kondo, Masahiro; Garnier, Amelie; Watson, Fiona L.; Puettmann-Holgado, Roland; Lamar, David R.; Schmucker, Dietmar			The molecular diversity of Dscam is functionally required for neuronal wiring specificity in Drosophila	CELL			English	Article							AXON GUIDANCE; NEURAL DEVELOPMENT; SENSORY NEURONS; ALPHA-NEUREXINS; NERVOUS-SYSTEM; BINDING; RECEPTORS; FAMILY; SUPERFAMILY; PROJECTIONS	Alternative splicing of Dscam generates an enormous molecular diversity with maximally 38,016 different receptors. Whether this large diversity is required in vivo is currently unclear. We examined the role of Dscam in neuron-target recognition of single mechanosensory neurons, which connect with different target cells through multiple axonal branches' Analysis of Dscam null neurons demonstrated an essential role of Dscam for growth and directed extension of axon branches. Expression of randomly chosen single isoforms could not rescue connectivity but did restore basic axonal extension and rudimentary branching. Moreover, two Dscam alleles were generated that each reduced the maximally possible Dscam diversity to 22,176 isoforms. Reduction of Dscam diversity resulted in specific connectivity defects of mechanosensory neurons. Furthermore, the observed allele-specific phenotypes suggest functional differences among isoforms. Our findings provide evidence that a very large number of structurally unique receptor isoforms is required to ensure fidelity and precision of neuronal connectivity.	Harvard Univ, Sch Med, Dept Neurobiol, Dana Farber Canc Inst,Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Schmucker, D (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Dana Farber Canc Inst,Dept Canc Biol, Boston, MA 02115 USA.	dietmar_schmucker@dfci.harvard.edu			NCI NIH HHS [T32CA09361] Funding Source: Medline; NINDS NIH HHS [R01-NS46747] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046747] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Canal I, 1998, J NEUROSCI, V18, P999; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GHYSEN A, 1980, DEV BIOL, V78, P521, DOI 10.1016/0012-1606(80)90351-6; GHYSEN A, 1978, NATURE, V274, P869, DOI 10.1038/274869a0; Grillenzoni N, 1998, DEVELOPMENT, V125, P3563; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kreahling JM, 2005, MOL CELL BIOL, V25, P10251, DOI 10.1128/MCB.25.23.10251-10260.2005; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Takeichi M, 1997, DEV NEUROSCI-BASEL, V19, P86, DOI 10.1159/000111189; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Williams DW, 2002, DEVELOPMENT, V129, P617; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5	39	145	150	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					607	620		10.1016/j.cell.2006.03.034	http://dx.doi.org/10.1016/j.cell.2006.03.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678102	Bronze			2022-12-28	WOS:000237506100024
J	Newman, JRS; Ghaemmaghami, S; Ihmels, J; Breslow, DK; Noble, M; DeRisi, JL; Weissman, JS				Newman, John R. S.; Ghaemmaghami, Sina; Ihmels, Jan; Breslow, David K.; Noble, Matthew; DeRisi, Joseph L.; Weissman, Jonathan S.			Single-cell proteomic analysis of S-cerevisiae reveals the architecture of biological noise	NATURE			English	Article							STOCHASTIC GENE-EXPRESSION; MESSENGER-RNA; FLUORESCENT PROTEIN; EUKARYOTIC GENOME; GLOBAL ANALYSIS; YEAST PROTEOME; SYSTEM; LOCALIZATION; DYNAMICS; SWITCH	A major goal of biology is to provide a quantitative description of cellular behaviour. This task, however, has been hampered by the difficulty in measuring protein abundances and their variation. Here we present a strategy that pairs high-throughput flow cytometry and a library of GFP-tagged yeast strains to monitor rapidly and precisely protein levels at single-cell resolution. Bulk protein abundance measurements of >2,500 proteins in rich and minimal media provide a detailed view of the cellular response to these conditions, and capture many changes not observed by DNA microarray analyses. Our single-cell data argue that noise in protein expression is dominated by the stochastic production/destruction of messenger RNAs. Beyond this global trend, there are dramatic protein-specific differences in noise that are strongly correlated with a protein's mode of transcription and its function. For example, proteins that respond to environmental changes are noisy whereas those involved in protein synthesis are quiet. Thus, these studies reveal a remarkable structure to biological noise and suggest that protein noise levels have been selected to reflect the costs and potential benefits of this variation.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94107 USA; Calif Inst Quantitat Biomed Res, San Francisco, CA 94107 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Newman, JRS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 1700 4th St, San Francisco, CA 94107 USA.	weissman@cmp.ucsf.edu		Breslow, David/0000-0003-0245-3348; Weissman, Jonathan/0000-0003-2445-670X; Ghaemmaghami, Sina/0000-0002-8696-2950				Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Edwards BS, 1999, CYTOMETRY, V37, P156, DOI 10.1002/(SICI)1097-0320(19991001)37:2<156::AID-CYTO9>3.0.CO;2-T; EITZMAN PD, 1989, CYTOMETRY, V10, P475, DOI 10.1002/cyto.990100417; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fagarasanu M, 2005, J CELL BIOL, V169, P765, DOI 10.1083/jcb.200503083; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2005, NAT GENET, V37, P925, DOI 10.1038/ng0905-925; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Wei J, 2005, J PROTEOME RES, V4, P801, DOI 10.1021/pr0497632; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	45	1119	1132	3	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					840	846		10.1038/nature04785	http://dx.doi.org/10.1038/nature04785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16699522				2022-12-28	WOS:000238254100035
J	Okada, T; Shirai, K; Yamamoto, Y; Arai, T; Ogawa, K; Hosono, K; Kato, M				Okada, Tatsuaki; Shirai, Kei; Yamamoto, Yukio; Arai, Takehiko; Ogawa, Kazunori; Hosono, Kozue; Kato, Manabu			X-ray fluorescence spectrometry of asteroid Itokawa by Hayabusa	SCIENCE			English	Article							MUSES-C; ELEMENTAL COMPOSITION; 433 EROS; MISSION; MERCURY	X-ray fluorescence spectrometry of asteroid 25143 Itokawa was performed by the x-ray spectrometer onboard Hayabusa during the first touchdown on 19 November 2005. We selected those data observed during relatively enhanced solar activity and determined average elemental mass ratios of Mg/Si =0.78 +/- 0.09 and Al/Si = 0.07 +/- 0.03. Our preliminary results suggest that Itokawa has a composition consistent with that of ordinary chondrites, but primitive achondrites cannot be ruled out. Among ordinary chondrites, LL- or L-chondrites appear to be more likely than H-chondrites. No substantial regional difference was found on the asteroid surface, indicating its homogeneity in composition.	Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; Grad Univ Adv Studies, Dept Space & Astronaut Sci, Kanagawa 2298510, Japan; Tokyo Inst Technol, Dept Earth & Planetary Sci, Tokyo 1528550, Japan	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; Graduate University for Advanced Studies - Japan; Tokyo Institute of Technology	Okada, T (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa 2298510, Japan.	okada@planeta.sci.isas.jaxa.jp		Arai, Takehiko/0000-0002-5711-7731				Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; ABELL PA, 2006, LUN PLAN SCI C, V37, P1513; ADLER I, 1972, ANAL CHEM, V44, pA28; ADLER I, 1977, PHYS CHEM EARTH, V10, P17, DOI 10.1016/0079-1946(77)90004-0; ARAI T, 2003, P ISAS LUN PLAN S, V36, P282; Binzel RP, 2001, METEORIT PLANET SCI, V36, P1167, DOI 10.1111/j.1945-5100.2001.tb01950.x; Demura H, 2006, SCIENCE, V312, P1347, DOI 10.1126/science.1126574; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; GAFFEY MJ, 1993, ICARUS, V106, P573, DOI 10.1006/icar.1993.1194; Grande M, 2003, PLANET SPACE SCI, V51, P427, DOI 10.1016/S0032-0633(03)00020-5; Grard R, 2001, PLANET SPACE SCI, V49, P1395, DOI 10.1016/S0032-0633(01)00081-2; JAROSEWICH E, 1990, METEORITICS, V25, P323, DOI 10.1111/j.1945-5100.1990.tb00717.x; Kaasalainen M, 2003, ASTRON ASTROPHYS, V405, pL29, DOI 10.1051/0004-6361:20030819; Kawaguchi J, 2003, ESA SP PUBL, V542, P25; KUWADA Y, 1997, P ISAS LUN PLAN S, V30, P212; MASUDA E, 2002, THESIS TOKYO I TECHN; McCoy TJ, 2001, METEORIT PLANET SCI, V36, P1661, DOI 10.1111/j.1945-5100.2001.tb01855.x; Miyaguchi K, 1999, NUCL INSTRUM METH A, V436, P24, DOI 10.1016/S0168-9002(99)00595-1; Nagano I, 2000, ADV SPACE RES-SERIES, V25, P33, DOI 10.1016/S0273-1177(99)00894-7; Nittler LR, 2001, METEORIT PLANET SCI, V36, P1673, DOI 10.1111/j.1945-5100.2001.tb01856.x; Okada T, 2000, ADV SPACE RES-SERIES, V25, P345, DOI 10.1016/S0273-1177(99)00942-4; OKADA T, 2005, LUN PLAN SCI C, V36, P1175; OKADA T, IN PRESS ADV GEOSCI; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; Solomon SC, 2001, PLANET SPACE SCI, V49, P1445, DOI 10.1016/S0032-0633(01)00085-X; Trombka JI, 2000, SCIENCE, V289, P2101, DOI 10.1126/science.289.5487.2101; Trombka JI, 1997, J GEOPHYS RES-PLANET, V102, P23729, DOI 10.1029/97JE00270; YAMAMOTO Y, 2003, P ISAS LUN PLAN S, V36, P286	28	74	75	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1338	1341		10.1126/science.1125731	http://dx.doi.org/10.1126/science.1125731			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741109				2022-12-28	WOS:000237961600042
J	Hsu, J; Price, M; Huang, J; Brand, R; Fung, V; Hui, R; Fireman, B; Newhouse, JP; Selby, JV				Hsu, John; Price, Mary; Huang, Jie; Brand, Richard; Fung, Vicki; Hui, Rita; Fireman, Bruce; Newhouse, Joseph P.; Selby, Joseph V.			Unintended consequences of caps on medicare drug benefits	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRESCRIPTION DRUGS; HEALTH-INSURANCE; CHRONICALLY ILL; COST; BENEFICIARIES; COVERAGE; ADMISSION; OUTCOMES; RISK	Background: Little information exists about the consequences of limits on prescription-drug benefits for Medicare beneficiaries. Methods: We compared the clinical and economic outcomes in 2003 among 157,275 Medicare+Choice beneficiaries whose annual drug benefits were capped at $1,000 and 41,904 beneficiaries whose drug benefits were unlimited because of employer supplements. Results: After adjusting for individual characteristics, we found that subjects whose benefits were capped had pharmacy costs for drugs applicable to the cap that were lower by 31 percent than subjects whose benefits were not capped (95 percent confidence interval, 29 to 33 percent) but had total medical costs that were only 1 percent lower (95 percent confidence interval, -4 to 6 percent). Subjects whose benefits were capped had higher relative rates of visits to the emergency department (relative rate, 1.09 [95 percent confidence interval, 1.04 to 1.14]), nonelective hospitalizations (relative rate, 1.13 [1.05 to 1.21]), and death (relative rate, 1.22 [1.07 to 1.38]; difference, 0.68 per 100 person-years [0.30 to 1.07]). Among subjects who used drugs for hypertension, hyperlipidemia, or diabetes in 2002, those whose benefits were capped were more likely to be nonadherent to long-term drug therapy in 2003; the respective odds ratios were 1.30 (95 percent confidence interval, 1.23 to 1.38), 1.27 (1.19 to 1.34), and 1.33 (1.18 to 1.48) for subjects using drugs for hypertension, hyperlipidemia, and diabetes. In each subgroup, the physiological outcomes were worse for subjects whose drug benefits were capped than for those whose benefits were not capped; the odds ratios were 1.05 (95 percent confidence interval, 1.00 to 1.09), 1.13 (1.03 to 1.25), and 1.23 (1.03 to 1.46), respectively, for subjects with a systolic blood pressure of 140 mm Hg or more, a serum low-density-lipoprotein cholesterol level of 130 mg per deciliter or more, and a glycated hemoglobin level of 8 percent or more. Conclusions: A cap on drug benefits was associated with lower drug consumption and unfavorable clinical outcomes. In patients with chronic disease, the cap was associated with poorer adherence to drug therapy and poorer control of blood pressure, lipid levels, and glucose levels. The savings in drug costs from the cap were offset by increases in the costs of hospitalization and emergency department care.	Kaiser Permanente, Div Res, Oakland, CA 94612 USA; Kaiser Permanente, Pharm Outcomes Res Grp, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Kaiser Permanente; Kaiser Permanente; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Hsu, J (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway,3rd Fl, Oakland, CA 94612 USA.	jth@dor.kaiser.org	Newhouse, Joseph/AGJ-5632-2022; Newhouse, Joseph/AAD-9763-2019		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS010803, R01HS013902] Funding Source: NIH RePORTER; AHRQ HHS [P01-HS-10803, R01-HS-013902] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ACHMAN L, 2004, COMMONWEALTH FUND PU, V795; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; Cox ER, 2001, MED CARE, V39, P296, DOI 10.1097/00005650-200103000-00009; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Freemantle N, 1996, BRIT MED J, V312, P1469, DOI 10.1136/bmj.312.7044.1469; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P2409; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; *KAIS FAM FDN HEW, 2004, CURR TRENDS FUT OUTL; Krieger N, 1999, AM J EPIDEMIOL, V150, P892; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; Mayes R, 2004, HEALTH AFFAIR, V23, P282, DOI 10.1377/hlthaff.23.2.282; MCARDLE FB, 2004, HLTH AFF MILLWOOD S; Mojtabai R, 2003, HEALTH AFFAIR, V22, P220, DOI 10.1377/hlthaff.22.4.220; Morgan S, 2004, HEALTH AFFAIR, V23, P269, DOI 10.1377/hlthaff.23.3.269; Newhouse JP, 2004, HEALTH AFFAIR, V23, P89, DOI 10.1377/hlthaff.23.1.89; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; PHELPS CE, 1992, HLTH EC; Piette JD, 2004, AM J PUBLIC HEALTH, V94, P1782, DOI 10.2105/AJPH.94.10.1782; Rector TS, 2004, HEALTH AFFAIR, V23, P213, DOI 10.1377/hlthaff.23.4.213; Reed M, 2005, MED CARE, V43, P810, DOI 10.1097/01.mlr.0000170416.68260.78; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; RUBIN RJ, 1995, NEW ENGL J MED, V333, P733; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; Soumerai SB, 1999, NEW ENGL J MED, V340, P722, DOI 10.1056/NEJM199903043400909; Soumerai SB, 1999, NEW ENGL J MED, V340, P976; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steinman MA, 2001, J GEN INTERN MED, V16, P793, DOI 10.1046/j.1525-1497.2001.10412.x; STUART B, 2005, HLTH AFF MILLWOOD S; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tseng CW, 2004, JAMA-J AM MED ASSOC, V292, P952, DOI 10.1001/jama.292.8.952; Tseng CW, 2003, JAMA-J AM MED ASSOC, V290, P222, DOI 10.1001/jama.290.2.222; Valenstein M, 2002, MED CARE, V40, P630, DOI 10.1097/00005650-200208000-00002; Zhao Y, 2001, Health Serv Res, V36, P180; ZWEIFEL P, 2000, HDB HLTH EC, P409	37	287	287	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2349	2359		10.1056/NEJMsa054436	http://dx.doi.org/10.1056/NEJMsa054436			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047ZZ	16738271				2022-12-28	WOS:000237918500007
J	Nimmo, F; Pappalardo, RT				Nimmo, Francis; Pappalardo, Robert T.			Diapir-induced reorientation of Saturn's moon Enceladus	NATURE			English	Article							EUROPA; MIRANDA; TOPOGRAPHY; TECTONICS; MODELS; ORIGIN	Enceladus is a small icy satellite of Saturn. Its south polar region consists of young, tectonically deformed terrain and has an anomalously high heat flux(1,2). This heat flux is probably due to localized tidal dissipation within either the ice shell(3) or the underlying silicate core(4). The surface deformation is plausibly due to upwelling of low-density material (diapirism(5)) as a result of this tidal heating. Here we show that the current polar location of the hotspot can be explained by reorientation of the satellite's rotation axis because of the presence of a low-density diapir. If the diapir is in the ice shell, then the shell must be relatively thick and maintain significant rigidity (elastic thickness greater than similar to 0.5 km); if the diapir is in the silicate core, then Enceladus cannot possess a global subsurface ocean, because the core must be coupled to the overlying ice for reorientation to occur. The reorientation generates large (similar to 10 MPa) tectonic stress patterns(6) that are compatible with the observed deformation of the south polar region(2). We predict that the distribution of impact craters on the surface will not show the usual leading hemisphere trailing hemisphere asymmetry. A low-density diapir also yields a potentially observable negative gravity anomaly.	Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of California System; University of California Santa Cruz; University of Colorado System; University of Colorado Boulder	Nimmo, F (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, 1156 High St, Santa Cruz, CA 95064 USA.	fnimmo@es.ucsc.edu	Pappalardo, Robert/AAP-8953-2021	Pappalardo, Robert/0000-0003-2571-4627; Nimmo, Francis/0000-0003-3573-5915				Gaidos EJ, 2000, NATURE, V405, P637, DOI 10.1038/35015170; GREENBERG R, 1991, URANUS, P693; JANES DM, 1988, J GEOPHYS RES-SOLID, V93, P3127, DOI 10.1029/JB093iB04p03127; LISSAUER JJ, 1984, ICARUS, V58, P159, DOI 10.1016/0019-1035(84)90034-4; MATSON DL, 2006, LUNAR PLANET SCI C, V37; Matsuyama I, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002447; McKinnon WB, 1998, ASTROPHYS SPACE SC L, V227, P525, DOI 10.1007/978-94-011-5252-5_22; McNamara AK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021082; MELOSH HJ, 1980, ICARUS, V44, P745, DOI 10.1016/0019-1035(80)90141-4; Moore WB, 2000, ICARUS, V147, P317, DOI 10.1006/icar.2000.6460; MORRISON D, 1986, SATELLITES, P764; Moser J, 1997, PHYS EARTH PLANET IN, V102, P153, DOI 10.1016/S0031-9201(97)00012-5; Nimmo F, 2003, ICARUS, V166, P21, DOI 10.1016/j.icarus.2003.08.002; NIMMO F, 2002, GEOPHYS RES LETT, V29; OJAKANGAS GW, 1986, ICARUS, V66, P341, DOI 10.1016/0019-1035(86)90163-6; OJAKANGAS GW, 1989, ICARUS, V81, P242, DOI 10.1016/0019-1035(89)90053-5; Palguta J, 2006, ICARUS, V180, P428, DOI 10.1016/j.icarus.2005.08.020; Pappalardo RT, 1997, J GEOPHYS RES-PLANET, V102, P13369, DOI 10.1029/97JE00802; PLESCIA JB, 1988, ICARUS, V73, P442, DOI 10.1016/0019-1035(88)90055-3; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Richards MA, 1999, GEOPHYS RES LETT, V26, P1777, DOI 10.1029/1999GL900331; ROSS MN, 1989, ICARUS, V78, P90, DOI 10.1016/0019-1035(89)90071-7; Sotin C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013844; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; SQUYRES SW, 1983, ICARUS, V53, P319, DOI 10.1016/0019-1035(83)90152-5; TSAI VC, 2005, EOS, V86; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; TURCOTTE DL, 1981, J GEOPHYS RES, V86, P3951, DOI 10.1029/JB086iB05p03951; WILLEMANN RJ, 1984, ICARUS, V60, P701, DOI 10.1016/0019-1035(84)90174-X; Wisdom J, 2004, ASTRON J, V128, P484, DOI 10.1086/421360	30	91	91	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2006	441	7093					614	616		10.1038/nature04821	http://dx.doi.org/10.1038/nature04821			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738654				2022-12-28	WOS:000237920800042
J	Anderson, I; Crengle, S; Kamaka, ML; Chen, TH; Palafox, N; Jackson-Pulver, L				Anderson, Ian; Crengle, Sue; Kamaka, Martina Leialoho; Chen, Tai-Ho; Palafox, Neal; Jackson-Pulver, Lisa			Indigenous Health 1 - Indigenous health in Australia, New Zealand, and the Pacific	LANCET			English	Article								We survey Indigenous health issues across the Pacific with a case study approach that focuses on Australia, New Zealand, Hawai'i, and US Associated Micronesia. For each case study, we provide an overview of the Indigenous population, its colonial history, and current health and social outcomes. In the discussion that follows, we flag some of the key policy initiatives that have been developed to address Indigenous health disadvantage, albeit within the context of continuing debates about Indigenous rights and policy.	Univ Melbourne, Sch Populat Hlth, Ctr Hlth & Soc, Onemda VicHlth Koori Hlth Unit, Parkville, Vic 3010, Australia; Univ Auckland, Sch Populat Hlth, Dept Maori & Pacific Hlth, Auckland 1, New Zealand; Univ Hawaii, John A Burns Sch Med, Dept Native Hawaiian Hlth, Honolulu, HI 96822 USA; Univ Hawaii, John A Burns Sch Med, Dept Family Med & Community Hlth, Honolulu, HI 96822 USA; Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Muru Marri Indigenous Hlth Unit, Kensington, NSW 2033, Australia	University of Melbourne; University of Auckland; University of Hawaii System; University of Hawaii System; University of New South Wales Sydney	Anderson, I (corresponding author), Univ Melbourne, Sch Populat Hlth, Ctr Hlth & Soc, Onemda VicHlth Koori Hlth Unit, Parkville, Vic 3010, Australia.	ipa@unimelb.edu.au	Crengle, Sue/E-6774-2010; lehmann, jennifer/AAB-8110-2019; Anderson, Ian PS/C-1498-2008	Crengle, Sue/0000-0001-9367-1492; Jackson Pulver, Lisa/0000-0001-8809-511X				*AB TORR STRAIT IS, 1994, NAT AB HLTH STRAT EV; *AB TORR STRAIT IS, 2005, SOC JUST REP 2004, P197; Ajwani S, 2004, NZ MED J, V116, P6; Ajwani S., 2003, DECADES DISPARITY ET; Anderson I., 2005, GEN PRACTICE AUSTR 2, P303; ANDERSON I, 2005, ABORIGINAL TORRES ST, P303; ANDERSON I, 2004, HONOUR NATIONS TREAT, P254; ANDERSON I, 2000, ABORIGINAL PRIMARY H; [Anonymous], WHO WORLD HLTH REP 2; *AS DEV BANK, 2005, KEY IND 2005 LAB MAR; *ASS NAT HAW PHYS, AL WELC AH NA KAUK; Attwood Bain, 1997, 1967 REFERENDUM ABOR; Attwood Bain, 2003, RIGHTS ABORIGINES; *AUSTR BUR STAT, 2003, POP CHAR AB TORR STR; *AUSTR BUR STAT, 2003, HLTH WELF AUSTR AB T; *AUSTR BUR STAT, 1999, HLTH WELF AUSTR AB T; *AUSTR BURS STAT A, 2005, HLTH WELF AUSTR AB T; *AUSTR COUNC TRAD, 2002, HIST TRAD UN SUPP IN; BEARDEN D, ANAL ENV POLICY C RE; BLAISDELL R, 1993, SOCIAL PROCESS HAWAI; Blaisdell R K, 2001, Hawaii Med J, V60, P295; Blaisdell R. K, 1993, ASIAN AM PACIFIC ISL, V1, P117; Blaisdell Richard Kekuni, 1996, Asian Am Pac Isl J Health, V4, P160; Blakely T, 2002, NEW ZEAL MED J, V115, P39; Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011; Braun K L, 1995, Hawaii Med J, V54, P723; Braun K L, 1996, Hawaii Med J, V55, P278; Broome R., 2005, ABORIGINAL VICTORIAN; Burgmann V, 1993, POWER PROTEST MOVEME; Bushnell O. A., 1993, GIFTS CIVILIZATION G; Butlin N.G., 1983, OUR ORIGINAL AGGRESS; *CDCP, 2004, DEATHS FIN DAT 2002; Chesterman J, 1997, CITIZENS RIGHTS ABOR, DOI 10.1017/CBO9780511518249; Coates KS, 2004, GLOBAL HISTORY OF INDIGENOUS PEOPLES: STRUGGLE AND SURVIVAL, P1, DOI 10.1057/9780230509078; Crampton P, 2000, DEGREES DEPRIVATION; Crengle S., 2005, 6 MIN HLTH; Cunningham J, 2005, POLICY POLIT, V33, P461, DOI 10.1332/0305573054325684; *DEP LAB BUR LAB S, 2005, EMPL SIT SUMM SEPT 2; Division of Statistics Department of Economic Affairs Federated States of Micronesia, 2002, FED STAT MICR 2000 P; Durie M., 1998, WHAIORA MAORI HLTH D; Durie Mason, 1998, TE MANA TE KAWANATAN; Else IRN, 2004, HULILI MULTIDISCIPLI, V1, P241; HEZEL F, 2004, MICRONESIAN COUNSELO, V54, P2; *HI STAT DEP HLTH, 2003, HAW HLTH SURV; *HI STAT DEP HLTH, 2004, BEH RISK FACT SURV S; Ichiho Henry M, 2004, Pac Health Dialog, V11, P44; Johnson David B, 2004, Pac Health Dialog, V11, P120; *KAM SCH, RAC DISTR STAT HAW; Kame'eleihiwa Lilikala, 1992, NATIVE LAND FOREIGN; KANAIAUPUNI S, 2005, FINDINGS 2005 NATIVE; KANAIAUPUNI S, 2005, KA HUAKAI 2005 NAT H; Kelsey J, 1997, NZ EXPT WORLD MODEL; KING HA, 2000, NZ HLTH STRATEGY; King T., 2002, COYOTE COLUMBUS STOR; KOCHANEK K, ANAL RECENT TRENDS S; Kroon Eugene, 2004, Pac Health Dialog, V11, P70; KUYKENDALL R, 1938, HAWAIIAN KINGDOM, V3; Kuykendall Ralph, 1938, HAWAIIAN KINGDOM, V1; MALONE N, 2005, CHARACTERISTICS NATI; McGregor Russell, 1997, IMAGINED DESTINIES A; *MIN HLTH, CHILD YOUTH HLTH; *MIN JUST, 2005, FOR SEAB; Ministry of Health, 2004, PORTR HLTH KEY RES 2; *NCI DIV CANC EP G, 2004, EST BAS NUMB CANC MA; NORDYKE EC, 1989, PEOPLING HAWAII; *NZ HLTH INF SERV, 2005, FET INF DEATHS 2001; *OFF HI AFF, 2002, NAT HAW HLTH DAT BOO; *OFF HLTH STAT MON, HAW HLTH SURV MULT Y; *OFF IND POL COORD, 2005, INDD COORD CTR QUEST; *OFF INS AFF, OIA STAT ONL; Orange C., 1987, TREATY WAITANGI; Palafox Neal A., 1997, Asian Am Pac Isl J Health, V5, P48; Palafox Neal A, 2004, Pac Health Dialog, V11, P78; POMARE E, 1995, HAUORA MAORI STANDAR, V3; Pool I., 1991, TE IWI MAORI NZ POPU; POWELL L, 2004, TE OPE MANA TAI SUMM; Reid P, 2005, HLTH SOC AOTEAROA NZ; *REP MARSH ISL MIN, 2004, MIN HLTH ANN REP FY; Reynolds H., 1996, FRONTIER ABORIGINES; *RMI NUCL CLAIMS T, NUCL CLAIMS TRIB PER; Robson B, 2004, EC DETERMINANTS MAOR; Royal Commission on Social Policy and Ivor Richardson, 1988, APR REP REP ROYAL CO; SALMOND C, 2000, SOCIAL INEQUALITIES; *STAT NZ, CENS; *STAT NZ, AG GROUP SEX MAOR ET; Statistics New Zealand, 2002, 2001 CENS POP DWELL; Stephens C, 2005, LANCET, V366, P10, DOI 10.1016/S0140-6736(05)66801-8; THOMSON N, 2004, OVERVIEW AUSTR INDIG; TSARK JU, 2004, PAC HLTH DIALOG, V11, P5; Tukuitonga CF, 2002, NEW ZEAL MED J, V115, P179; *US NAT CTR ED STA, DIG ED STAT 2004; Walker R., 1990, KA WHAWAHI TONU MATO; *WHO W PAC REG OFF, MICR FED STAT; *WHO W PAC REG OFF, MARSH ISL; Yuen NYC, 2000, J AM ACAD CHILD PSY, V39, P360, DOI 10.1097/00004583-200003000-00019; 1898, LILIUOKALANI HAWAIIS; WORLD FACT BOOK PACI; 2004, HAWAII WOMENS HLTH S; 2005, HONOLULU STAR B 0719	99	217	219	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1775	1785		10.1016/S0140-6736(06)68773-4	http://dx.doi.org/10.1016/S0140-6736(06)68773-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047BE	16731273				2022-12-28	WOS:000237854000033
J	Cuzzi, JN; Alexander, CMO				Cuzzi, JN; Alexander, CMO			Chondrule formation in particle-rich nebular regions at least hundreds of kilometres across	NATURE			English	Article							SOLAR NEBULA; ISOTOPIC FRACTIONATION; PROTOPLANETARY DISK; EVOLUTION; MODEL; CONSTRAINTS; ORIGIN; SHOCKS	Chondrules are millimetre-sized spherules (mostly silicate) that dominate the texture of primitive meteorites(1). Their formation mechanism is debated, but their sheer abundance suggests that the mechanism was both energetic and ubiquitous in the early inner Solar System(2). The processes suggested-such as shock waves, solar flares or nebula lightning(3-7)-operate on different length scales that have been hard to relate directly to chondrule properties. Chondrules are depleted in volatile elements, but surprisingly they show little evidence for the associated loss of lighter isotopes one would expect(8). Here we report a model in which molten chondrules come to equilibrium with the gas that was evaporated from other chondrules, and which explains the observations in a natural way. The regions within which the chondrules formed must have been larger than 150-6,000 km in radius, and must have had a precursor number density of at least 10 m(-3). These constraints probably exclude nebula lightning, and also make formation far from the nebula midplane problematic. The wide range of chondrule compositions may be the result of different combinations of the local concentrations of precursors and the local abundance of water ice or vapour.	NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Carnegie Institution for Science	Cuzzi, JN (corresponding author), NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA.	jcuzzi@mail.arc.nasa.gov	Alexander, Conel M. O'D./N-7533-2013	Alexander, Conel M. O'D./0000-0002-8558-1427				Alexander CMO, 2004, GEOCHIM COSMOCHIM AC, V68, P3943, DOI 10.1016/j.gca.2004.03.030; Alexander CMO, 2000, METEORIT PLANET SCI, V35, P859, DOI 10.1111/j.1945-5100.2000.tb01469.x; Ciesla FJ, 2004, METEORIT PLANET SCI, V39, P1809, DOI 10.1111/j.1945-5100.2004.tb00077.x; Ciesla FJ, 2002, ICARUS, V158, P281, DOI 10.1006/icar.2002.6895; CIESLA FJ, 2005, ASTRONOMICAL SOC PAC, V341, P811; Cuzzi JN, 2004, ASTROPHYS J, V614, P490, DOI 10.1086/423611; Cuzzi JN, 2001, ASTROPHYS J, V546, P496, DOI 10.1086/318233; Davis A. M., 2005, CHONDRITES PROTOPLAN, P432; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; Desch SJ, 2000, ICARUS, V143, P87, DOI 10.1006/icar.1999.6245; Ebel DS, 2000, GEOCHIM COSMOCHIM AC, V64, P339, DOI 10.1016/S0016-7037(99)00284-7; Galy A, 2000, SCIENCE, V290, P1751, DOI 10.1126/science.290.5497.1751; HEWINS RH, 2005, ASP C SERIES, V341, P286; HOOD LL, 2005, ASP C SER, V341, P873; Iida A, 2001, ICARUS, V153, P430, DOI 10.1006/icar.2001.6682; Jones RH., 2005, CHONDRITE PROTOPLANE, V341, P251, DOI DOI 10.1038/NC0MMS6445); JONES RH, 2000, PROTOSTARS PLANETS, V4; Krot AN, 2005, ASTROPHYS J, V622, P1333, DOI 10.1086/428382; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Nagahara H, 2000, CHEM GEOL, V169, P45, DOI 10.1016/S0009-2541(99)00230-2; Nakamoto T., 2005, ASTRON SOC PACIF C S, V341, P883; Rayleigh J.W.S., 1896, PHILOS MAG, V42, P77; Richter FM, 2002, GEOCHIM COSMOCHIM AC, V66, P521, DOI 10.1016/S0016-7037(01)00782-7; Young ED, 2004, REV MINERAL GEOCHEM, V55, P197, DOI 10.2138/gsrmg.55.1.197; YOUNG ED, 2004, LUNAR PLANET SCI C, V35; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	27	105	105	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2006	441	7092					483	485		10.1038/nature04834	http://dx.doi.org/10.1038/nature04834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724060				2022-12-28	WOS:000237778900043
J	Chen, ZZ; Zang, JY; Whetstine, J; Hong, X; Davrazou, F; Kutateladze, TG; Simpson, M; Mao, QL; Pan, CH; Dai, SD; Hagman, J; Hansen, K; Shi, Y; Zhang, GY				Chen, Zhongzhou; Zang, Jianye; Whetstine, Johnathan; Hong, Xia; Davrazou, Foteini; Kutateladze, Tatiana G.; Simpson, Michael; Mao, Qilong; Pan, Cheol-Ho; Dai, Shaodong; Hagman, James; Hansen, Kirk; Shi, Yang; Zhang, Gongyi			Structural insights into histone demethylation by JMJD2 family members	CELL			English	Article							PROTEIN; METHYLATION; JUMONJI; IDENTIFICATION; HYDROXYLASES; CHROMATIN; RECEPTOR; OXIDASE; BINDING; MODELS	Posttranslational modifications of histones regulate chromatin structure and gene expression. Histone demethylases, members of a newly emerging transcription-factor family, remove methyl groups from the lysine residues of the histone tails and thereby regulate the transcriptional activity of target genes. JmjC-domaincontaining proteins have been predicted to be demethylases. For example, the JmjC-containing protein JMJD2A has been characterized as a H3-K9me3- and H3-K36me3-specific demethylase. Here, structures of the catalytic-core domain of JMJD2A with and without alpha-ketoglutarate in the presence of Fe2+ have been determined by X-ray crystallography. The structure of the core domain, consisting of the JmjN domain, the JmjC domain, the C-terminal domain, and a zinc-finger motif, revealed the unique elements that form a potential substrate binding pocket. Sited-directed mutagenesis in conjunction with demethylase activity assays allowed us to propose a molecular model for substrate selection by the JMJD2 histone demethylase family.	Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Program Biomol Struct, Denver, CO 80045 USA; Univ Colorado, Ctr Canc, Aurora, CO 80045 USA	National Jewish Health; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhang, GY (corresponding author), Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA.	zhangg@njc.org	Hagman, James/R-7013-2019; Zang, Jianye/E-5228-2013; chen, zhong/E-3900-2015	Hagman, James/0000-0002-5436-8455; chen, zhong/0000-0003-1319-9664; Kutateladze, Tatiana/0000-0001-7375-6990	NIAID NIH HHS [AI22295] Funding Source: Medline; NIGMS NIH HHS [GM071004, GM058012] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLIS CD, 1980, CELL, V20, P55; ARAVIND L, 2001, GENOME BIOL, V2; Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Gane PJ, 1998, J MOL EVOL, V46, P488, DOI 10.1007/PL00006329; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HUANG Y, 2006, SCIENCE; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Katoh M, 2004, INT J ONCOL, V24, P1623; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lancaster DE, 2004, BIOCHEM SOC T, V32, P943, DOI 10.1042/BST0320943; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tomchick DR, 1998, STRUCTURE, V6, P337, DOI 10.1016/S0969-2126(98)00036-7; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V122, P654, DOI 10.1016/j.cell.2005.08.022; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang ZQ, 2000, CANCER RES, V60, P4735; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	39	292	309	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					691	702		10.1016/j.cell.2006.04.024	http://dx.doi.org/10.1016/j.cell.2006.04.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16677698	Bronze			2022-12-28	WOS:000237886000015
J	Satoh-Nagasawa, N; Nagasawa, N; Malcomber, S; Sakai, H; Jackson, D				Satoh-Nagasawa, N; Nagasawa, N; Malcomber, S; Sakai, H; Jackson, D			A trehalose metabolic enzyme controls inflorescence architecture in maize	NATURE			English	Article							ARABIDOPSIS-THALIANA; TREHALOSE-6-PHOSPHATE; GENES; GROWTH; SHOOT; IDENTIFICATION; BIOSYNTHESIS; ACCUMULATION; PHOSPHATASES; 6-PHOSPHATE	Inflorescence branching is a major yield trait in crop plants controlled by the developmental fate of axillary shoot meristems(1). Variations in branching patterns lead to diversity in flower-bearing architectures ( inflorescences) and affect crop yield by influencing seed number or harvesting ability(2,3). Several growth regulators such as auxins, cytokinins and carotenoid derivatives regulate branching architectures(4). Inflorescence branching in maize is regulated by three RAMOSA genes(5). Here we show that one of these genes, RAMOSA3 (RA3), encodes a trehalose-6-phosphate phosphatase expressed in discrete domains subtending axillary inflorescence meristems. Genetic and molecular data indicate that RA3 functions through the predicted transcriptional regulator RAMOSA1 (RA1)(5). We propose that RA3 regulates inflorescence branching by modification of a sugar signal that moves into axillary meristems. Alternatively, the fact that RA3 acts upstream of RA1 supports a hypothesis that RA3 itself may have a transcriptional regulatory function.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; DuPont Crop Genet Expt Stn E353, Wilmington, DE 19880 USA; Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Cold Spring Harbor Laboratory; DuPont; University of Missouri System; University of Missouri Saint Louis	Jackson, D (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu		Malcomber, Simon/0000-0001-6440-6606				Bommert P, 2005, PLANT CELL PHYSIOL, V46, P69, DOI 10.1093/pcp/pci504; CABIB E, 1958, J BIOL CHEM, V231, P259; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; DOEBLEY J, 1992, TRENDS GENET, V8, P302, DOI 10.1016/0168-9525(92)90261-2; Eastmond PJ, 2003, J EXP BOT, V54, P533, DOI 10.1093/jxb/erg039; Emrich SJ, 2004, BIOINFORMATICS, V20, P140, DOI 10.1093/bioinformatics/bth017; Goddijn OJM, 1999, TRENDS PLANT SCI, V4, P315, DOI 10.1016/S1360-1385(99)01446-6; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; *I GEN RES, TIGR MAIZ DAT ONL; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Klutts S, 2003, J BIOL CHEM, V278, P2093, DOI 10.1074/jbc.M209937200; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Leyman B, 2001, TRENDS PLANT SCI, V6, P510, DOI 10.1016/S1360-1385(01)02125-2; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Pellny TK, 2004, PLANT BIOTECHNOL J, V2, P71, DOI 10.1111/j.1467-7652.2004.00053.x; PERRY HS, MAIZE GENETICS GENOM; Schluepmann H, 2004, PLANT PHYSIOL, V135, P879, DOI 10.1104/pp.104.039503; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Schmitz G, 2005, CURR OPIN PLANT BIOL, V8, P506, DOI 10.1016/j.pbi.2005.07.010; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Vogel G, 1998, PLANT J, V13, P673, DOI 10.1046/j.1365-313X.1998.00064.x; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Ward SP, 2004, CURR OPIN PLANT BIOL, V7, P73, DOI 10.1016/j.pbi.2003.10.002	27	289	316	7	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					227	230		10.1038/nature04725	http://dx.doi.org/10.1038/nature04725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688177				2022-12-28	WOS:000237418800048
J	Shu, DG; Morris, SC; Han, J; Li, Y; Zhang, XL; Hua, H; Zhang, ZF; Liu, JN; Guo, JF; Yao, Y; Yasui, K				Shu, DG; Morris, SC; Han, J; Li, Y; Zhang, XL; Hua, H; Zhang, ZF; Liu, JN; Guo, JF; Yao, Y; Yasui, K			Lower Cambrian vendobionts from China and early diploblast evolution	SCIENCE			English	Article							EDIACARAN; FOSSILS; PHYLOGENY; ORIGIN	Ediacaran assemblages immediately predate the Cambrian explosion of metazoans and should have played a crucial role in this radiation. Their wider relationships, however, have remained refractory and difficult to integrate with early metazoan phylogeny. Here, we describe a frondlike fossil, Stromatoveris ( S. psygmoglena sp. nov.), from the Lower Cambrian Chengjiang Lagerstatte ( Yunnan, China) that is strikingly similar to Ediacaran vendobionts. The exquisite preservation reveals closely spaced branches, probably ciliated, that appear to represent precursors of the diagnostic comb rows of ctenophores. Therefore, this finding has important implications for the early evolution of this phylum and related diploblasts, some of which independently evolved a frondose habit.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Key Lab Continental Dynam, Xian 710069, Peoples R China; China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Changan Univ, Coll Earth Sci & Land Resources, Xian 710054, Peoples R China; Hiroshima Univ, Grad Sch Sci, Marine Biol Lab, Hiroshima 7220073, Japan	Northwest University Xi'an; Northwest University Xi'an; China University of Geosciences; University of Cambridge; Chang'an University; Hiroshima University	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.	elidgshu@nwu.edu.cn; sc113@esc.cam.ac.uk		zhang, zhifei/0000-0003-0325-5116				BUSS LW, 1994, PALEOBIOLOGY, V20, P1, DOI 10.1017/S0094837300011088; Clapham ME, 2003, PALEOBIOLOGY, V29, P527, DOI 10.1666/0094-8373(2003)029<0527:POTOKA>2.0.CO;2; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; CONWAY MS, 1993, PALAEONTOLOGY, V36, P593; Dzik J, 2002, J MORPHOL, V252, P315, DOI 10.1002/jmor.1108; Ender A, 2003, MOL BIOL EVOL, V20, P130, DOI 10.1093/molbev/msg018; Fedonkin M.A., 1990, VENDIAN SYSTEM, P71, DOI DOI 10.1007/978-3-642-73972-9_3; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Ford T. D., 1958, Proceedings of the Yorkshire Geological Society, V31, P211; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; Glaessner M.F., 1984, DAWN ANIMAL LIFE BIO; Grazhdankin D, 2004, PALEOBIOLOGY, V30, P203, DOI 10.1666/0094-8373(2004)030<0203:PODITE>2.0.CO;2; Hadrys T, 2005, MOL BIOL EVOL, V22, P1569, DOI 10.1093/molbev/msi150; Hagadorn JW, 2000, J PALEONTOL, V74, P731, DOI 10.1666/0022-3360(2000)074<0731:ECETFF>2.0.CO;2; Ivantsov AY, 2002, PALAEONTOLOGY, V45, P1219, DOI 10.1111/1475-4983.00283; JENKINS R J F, 1978, Records of the South Australian Museum (Adelaide), V17, P347; Jensen S, 1998, NATURE, V393, P567, DOI 10.1038/31215; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Narbonne GM, 2004, SCIENCE, V305, P1141, DOI 10.1126/science.1099727; Peterson KJ, 2003, INTEGR COMP BIOL, V43, P127, DOI 10.1093/icb/43.1.127; Peterson KJ, 2005, PALEOBIOLOGY, V31, P36, DOI 10.1666/0094-8373(2005)031[0036:TAMOEA]2.0.CO;2; Podar M, 2001, MOL PHYLOGENET EVOL, V21, P218, DOI 10.1006/mpev.2001.1036; RETALLACK GJ, 1994, PALEOBIOLOGY, V20, P523, DOI 10.1017/S0094837300012975; Runnegar Bruce, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V195, P303; SEILACHER A, 1992, J GEOL SOC LONDON, V149, P607, DOI 10.1144/gsjgs.149.4.0607; Seilacher Adolf, 2003, Paleontological Research, V7, P43, DOI 10.2517/prpsj.7.43; WAGGONER BM, 1995, PALEOBIOLOGY, V21, P393, DOI 10.1017/S0094837300013373; Zhang Wen-Tang, 2001, Acta Palaeontologica Sinica, V40, P201; Zhang XL, 2003, PALAEONTOLOGY, V46, P447, DOI 10.1111/1475-4983.00307; ZHURAVLEV AY, 1993, NEUES JB GEOL PAL, V180, P299	31	56	70	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					731	734		10.1126/science.1124565	http://dx.doi.org/10.1126/science.1124565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675697				2022-12-28	WOS:000237312100046
J	Newkome, GR; Wang, PS; Moorefield, CN; Cho, TJ; Mohapatra, PP; Li, SN; Hwang, SH; Lukoyanova, O; Echegoyen, L; Palagallo, JA; Iancu, V; Hla, SW				Newkome, George R.; Wang, Pingshan; Moorefield, Charles N.; Cho, Tae Joon; Mohapatra, Prabhu P.; Li, Sinan; Hwang, Seok-Ho; Lukoyanova, Olena; Echegoyen, Luis; Palagallo, Judith A.; Iancu, Violeta; Hla, Saw-Wai			Nanoassembly of a fractal polymer: A molecular "Sierpinski hexagonal gasket"	SCIENCE			English	Article							ABSORPTION-SPECTRA; COMPLEXES; STEPWISE	Mathematics and art converge in the fractal forms that also abound in nature. We used molecular self-assembly to create a synthetic, nanometer-scale, Sierpinski hexagonal gasket. This non-dendritic, perfectly self-similar fractal macromolecule is composed of bis-terpyridine building blocks that are bound together by coordination to 36 Ru and 6 Fe ions to form a nearly planar array of increasingly larger hexagons around a hollow center.	Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA; Univ Akron, Dept Chem, Akron, OH 44325 USA; Univ Akron, Dept Polymer Engn, Akron, OH 44325 USA; Univ Akron, Dept Theoret & Appl Mech, Akron, OH 44325 USA; Clemson Univ, Dept Chem, Clemson, SC 29634 USA; Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron; University System of Ohio; University of Akron; University System of Ohio; University of Akron; Clemson University; University System of Ohio; Ohio University	Newkome, GR (corresponding author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.	newkome@uakron.edu	Echegoyen, Luis/B-4570-2011; Mohapatra, Prabhu P/O-5415-2014; Newkome, George R./P-3093-2018; Iancu, Violeta/B-7657-2008	Newkome, George R./0000-0001-6019-5071; Iancu, Violeta/0000-0003-1146-2959; Mohapatra, Prabhu/0000-0002-6707-048X; Cho, Tae Joon/0000-0001-9467-0491				Ascher M, 2002, AM SCI, V90, P56; Atwood JL, 2003, CRYST GROWTH DES, V3, P3, DOI 10.1021/cg020063o; BRATERMAN PS, 1992, INORG CHEM, V31, P555, DOI 10.1021/ic00030a006; Braun KF, 2005, NANO LETT, V5, P73, DOI 10.1021/nl048367f; Caulder DL, 2001, J AM CHEM SOC, V123, P8923, DOI 10.1021/ja0104507; CONSTABLE EC, 1992, J CHEM SOC CHEM COMM, P617, DOI 10.1039/c39920000617; Fujita M, 2001, CHEM COMMUN, P509, DOI 10.1039/b008684n; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Mandelbrot B.B., 1982, FRACTAL GEOMETRY NAT, P480; NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052; Newkome GR, 2004, CHEM-EUR J, V10, P1493, DOI 10.1002/chem.200305267; Newkome GR, 2002, CHEM-EUR J, V8, P2946, DOI 10.1002/1521-3765(20020703)8:13<2946::AID-CHEM2946>3.0.CO;2-M; Newkome GR, 1999, ANGEW CHEM INT EDIT, V38, P3717, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3717::AID-ANIE3717>3.0.CO;2-C; Newkome GR, 2001, DENDRIMERS DENDRONS; Nguyen CV, 2004, J PHYS CHEM B, V108, P2816, DOI 10.1021/jp0361529; SAUVAGE JP, 1994, CHEM REV, V94, P993, DOI 10.1021/cr00028a006; Seidel SR, 2002, ACCOUNTS CHEM RES, V35, P972, DOI 10.1021/ar010142d; Sierpinski W, 1915, CR HEBD ACAD SCI, V160, P302; Sugiura K, 1999, CHEM LETT, P1193, DOI 10.1246/cl.1999.1193; TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117; Wang P, 2006, INT J MASS SPECTROM, V255, P86, DOI 10.1016/j.ijms.2006.03.006; Wang PS, 2005, ANGEW CHEM INT EDIT, V44, P1679, DOI 10.1002/anie.200462379; Wang PS, 2004, ORG LETT, V6, P1197, DOI 10.1021/ol0364529	23	246	249	6	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1782	1785		10.1126/science.1125894	http://dx.doi.org/10.1126/science.1125894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16690820				2022-12-28	WOS:000238452800054
J	Young, R; Sweeting, H; West, P				Young, Robert; Sweeting, Helen; West, Patrick			Self harm in Goth youth subculture: authors' reply	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Young, R (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	robert@msoc.mrc.gla.ac.uk						*WIK CONTR, 2006, WIK FREE ENC; 2006, BMJ, V332, P1215	2	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1335	1335		10.1136/bmj.332.7553.1335-a	http://dx.doi.org/10.1136/bmj.332.7553.1335-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16740576	Green Published			2022-12-28	WOS:000238197000039
J	Pickering, TG; Shimbo, D; Haas, D				Pickering, Thomas G.; Shimbo, Daichi; Haas, Donald			Current concepts: Ambulatory blood-pressure monitoring	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGNOSTIC VALUE; WHITE-COAT; HEART-RATE; HYPERTENSIVE PATIENTS; EUROPEAN-SOCIETY; OLDER PATIENTS; RECOMMENDATIONS; HOME; VARIABILITY; POPULATION		Columbia Presbyterian Med Ctr, Dept Med, Behav Cardiovasc Hlth & Hypertens Program, New York, NY 10032 USA; Mt Sinai Sch Med, Zena & Michael S Wiener Cardiovasc Inst, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Icahn School of Medicine at Mount Sinai	Pickering, TG (corresponding author), Columbia Presbyterian Med Ctr, Dept Med, Behav Cardiovasc Hlth & Hypertens Program, New York, NY 10032 USA.							ARMITAGE P, 1966, CLIN SCI, V30, P325; Bjorklund K, 2004, J HYPERTENS, V22, P1691; Bobrie G, 2004, JAMA-J AM MED ASSOC, V291, P1342, DOI 10.1001/jama.291.11.1342; Chalmers J, 1999, J HYPERTENS, V17, P151; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Ernst Michael E, 2003, BMC Fam Pract, V4, P15, DOI 10.1186/1471-2296-4-15; Fagard RH, 2000, CIRCULATION, V102, P1139, DOI 10.1161/01.CIR.102.10.1139; FRATTOLA A, 1993, J HYPERTENS, V11, P1133, DOI 10.1097/00004872-199310000-00019; Imai Y, 2001, BLOOD PRESS MONIT, V6, P273, DOI 10.1097/00126097-200112000-00001; KAIN HK, 1964, CIRCULATION, V30, P882, DOI 10.1161/01.CIR.30.6.882; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kario K, 2001, J AM COLL CARDIOL, V38, P238, DOI 10.1016/S0735-1097(01)01325-0; Khattar RS, 1998, CIRCULATION, V98, P1892, DOI 10.1161/01.CIR.98.18.1892; Krakoff LR, 2006, HYPERTENSION, V47, P29, DOI 10.1161/01.HYP.0000197195.84725.66; Little P, 2002, BMJ-BRIT MED J, V325, P254, DOI 10.1136/bmj.325.7358.254; LITTLER WA, 1974, Q J MED, V43, P441; Liu JE, 1999, ANN INTERN MED, V131, P564, DOI 10.7326/0003-4819-131-8-199910190-00003; Mancia G, 1997, CIRCULATION, V96, P1065; Mancia G, 2004, J HYPERTENS, V22, P435, DOI 10.1097/01.hjh.0000098263.58662.13; MANCIA G, 1995, AM J HYPERTENS, V8, P311, DOI 10.1016/0895-7061(94)00250-F; MANN S, 1983, CIRCULATION, V68, P477, DOI 10.1161/01.CIR.68.3.477; Myers MG, 2005, AM J HYPERTENS, V18, P1369, DOI 10.1016/j.amjhyper.2005.04.024; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; O'Brien E, 2002, BLOOD PRESS MONIT, V7, P3, DOI 10.1097/00126097-200202000-00002; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Parati G, 2006, HYPERTENSION, V47, P137, DOI 10.1161/01.HYP.0000198542.51471.c4; PERLOFF D, 1989, J HYPERTENS       S3, V7, P3; PICKERING TG, 1982, JAMA-J AM MED ASSOC, V247, P992, DOI 10.1001/jama.247.7.992; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Pickering TG, 2002, BLOOD PRESS MONIT, V7, P293, DOI 10.1097/00126097-200212000-00001; PICKERING TG, 1994, AM J HYPERTENS, V7, P848, DOI 10.1093/ajh/7.9.848; Pickering Thomas G, 2003, J Clin Hypertens (Greenwich), V5, P171, DOI 10.1111/j.1524-6175.2003.01927.x; PIEPER C, 1993, J HYPERTENS, V11, P177, DOI 10.1097/00004872-199302000-00010; Pierdomenico SD, 2005, AM J HYPERTENS, V18, P1422, DOI 10.1016/j.amjhyper.2005.05.014; Profant J, 1999, HYPERTENSION, V33, P1099, DOI 10.1161/01.HYP.33.5.1099; Redon J, 1998, HYPERTENSION, V31, P712, DOI 10.1161/01.HYP.31.2.712; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; SHEAR MK, 1992, J ANXIETY DISORD, V6, P213, DOI 10.1016/0887-6185(92)90034-5; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Svensson P, 2001, HYPERTENSION, V38, pE28, DOI 10.1161/hy1101.099502; Verdecchia, 1996, Blood Press Monit, V1, P3; Verdecchia P, 2005, HYPERTENSION, V45, P203, DOI 10.1161/01.HYP.0000151623.49780.89; Verdecchia P, 2000, HYPERTENSION, V35, P844, DOI 10.1161/01.HYP.35.3.844; VERDECCHIA P, 1995, HYPERTENSION, V25, P462; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; Yusuf S, 2000, NEW ENGL J MED, V342, P145	49	634	657	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2368	2374		10.1056/NEJMra060433	http://dx.doi.org/10.1056/NEJMra060433			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738273				2022-12-28	WOS:000237918500009
J	Samson, RA; Nadkarni, VM; Meaney, PA; Carey, SM; Berg, MD; Berg, RA				Samson, Ricardo A.; Nadkarni, Vinay M.; Meaney, Peter A.; Carey, Scott M.; Berg, Marc D.; Berg, Robert A.		Amer Heart Assoc Natl Registry CPR	Outcomes of in-hospital ventricular fibrillation in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEDIATRIC CARDIOPULMONARY-RESUSCITATION; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; CARDIAC-ARREST; INTENSIVE-CARE; UTSTEIN STYLE; RECOMMENDED GUIDELINES; ASSISTED VENTILATION; CHEST COMPRESSIONS; TASK-FORCE	Background: Ventricular fibrillation and ventricular tachycardia are less common causes of cardiac arrest in children than in adults. These tachyarrhythmias can also begin during cardiopulmonary resuscitation (CPR), presumably as reperfusion arrhythmias. We determined whether the outcome is better for initial than for subsequent ventricular fibrillation or tachycardia. Methods: All cardiac arrests in persons under 18 years of age were identified from a large, multicenter, in-hospital cardiac-arrest registry. The results from children with initial ventricular fibrillation or tachycardia, children in whom ventricular fibrillation or tachycardia developed during CPR, and children with no ventricular fibrillation or tachycardia were compared by chi-square and multivariable logistic-regression analysis. Results: Of 1005 index patients with in-hospital cardiac arrest, 272 (27 percent) had documented ventricular fibrillation or tachycardia during the arrest. In 104 patients (10 percent), ventricular fibrillation or tachycardia was the initial pulseless rhythm; in 149 patients (15 percent), it developed during the arrest. The time of initiation of ventricular fibrillation or tachycardia was not documented in 19 patients. Thirty-five percent of patients with initial ventricular fibrillation or tachycardia survived to hospital discharge, as compared with 11 percent of patients with subsequent ventricular fibrillation or tachycardia (odds ratio, 2.6; 95 percent confidence interval, 1.2 to 5.8). Twenty-seven percent of patients with no ventricular fibrillation or tachycardia survived to hospital discharge, as compared with 11 percent of patients with subsequent ventricular fibrillation or tachycardia (odds ratio, 3.8; 95 percent confidence interval, 1.8 to 7.6). Conclusions: In pediatric patients with in-hospital cardiac arrests, survival outcomes were highest among patients in whom ventricular fibrillation or tachycardia was present initially than among those in whom it developed subsequently. The outcomes for patients with subsequent ventricular fibrillation or tachycardia were substantially worse than those for patients with asystole or pulseless electrical activity.	Univ Arizona, Coll Med, Steele Childrens Res Ctr, Tucson, AZ 85724 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA; Digital Innovat, Forest Hill, MD USA	University of Arizona; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Berg, RA (corresponding author), Univ Arizona, Coll Med, Steele Childrens Res Ctr, 1501 N Campbell Ave,POB 245073, Tucson, AZ 85724 USA.	rberg@peds.arizona.edu		Berg, Marc/0000-0001-8842-5369; Meaney, Peter/0000-0001-9898-6928				Berg RA, 1997, CIRCULATION, V95, P1635; Berg RA, 1999, CRIT CARE MED, V27, P1893, DOI 10.1097/00003246-199909000-00030; Berg RA, 2000, CIRCULATION, V101, P1743; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; EISENBERG MS, 1990, ANN EMERG MED, V19, P1249, DOI 10.1016/S0196-0644(05)82283-8; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Garrey WE, 1914, AM J PHYSIOL, V33, P397, DOI 10.1152/ajplegacy.1914.33.3.397; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Leng CT, 2001, CIRCULATION, V104, P723, DOI 10.1161/hc0701.092217; Lopez-Herce J, 2005, RESUSCITATION, V64, P79, DOI 10.1016/j.resuscitation.2004.07.010; MOGAYZEL C, 1995, ANN EMERG MED, V25, P484, DOI 10.1016/S0196-0644(95)70263-6; Nichols D G, 1986, Pediatr Emerg Care, V2, P1, DOI 10.1097/00006565-198603000-00001; PANIDIS IP, 1983, J AM COLL CARDIOL, V2, P798, DOI 10.1016/S0735-1097(83)80225-3; Parra DA, 2000, CRIT CARE MED, V28, P3296, DOI 10.1097/00003246-200009000-00030; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; Suominen P, 2000, RESUSCITATION, V45, P17, DOI 10.1016/S0300-9572(00)00167-2; Torres A, 1997, PEDIATR EMERG CARE, V13, P369, DOI 10.1097/00006565-199712000-00002; WALSH CK, 1983, AM J CARDIOL, V51, P557, DOI 10.1016/S0002-9149(83)80096-4; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X; ZARITSKY A, 1987, ANN EMERG MED, V16, P1107, DOI 10.1016/S0196-0644(87)80465-1; ZARITSKY A, 1995, CIRCULATION, V92, P2006, DOI 10.1161/01.CIR.92.7.2006	23	170	171	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2328	2339		10.1056/NEJMoa052917	http://dx.doi.org/10.1056/NEJMoa052917			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738269				2022-12-28	WOS:000237918500005
J	Sebastian, SE; Harrison, N; Batista, CD; Balicas, L; Jaime, M; Sharma, PA; Kawashima, N; Fisher, IR				Sebastian, S. E.; Harrison, N.; Batista, C. D.; Balicas, L.; Jaime, M.; Sharma, P. A.; Kawashima, N.; Fisher, I. R.			Dimensional reduction at a quantum critical point	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; TRANSITIONS; DISORDER; LADDERS; STATES; FIELD		Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Los Alamos Natl Lab, NHMFL, Los Alamos, NM 87545 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan	Stanford University; Stanford University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; State University System of Florida; Florida State University; University of Tokyo	Sebastian, SE (corresponding author), Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA.	suchitra@stanfordalumni.org	Batista, Cristian D/J-8008-2016; Sharma, Peter A/G-1917-2011; Balicas, Luis/A-3110-2008; Kawashima, Naoki/AAH-6161-2020; Jaime, Marcelo/F-3791-2015	Jaime, Marcelo/0000-0001-5360-5220; Fisher, Ian/0000-0002-1278-7862; Harrison, Neil/0000-0001-5456-7756				Batista CD, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045137; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Giamarchi T, 1999, PHYS REV B, V59, P11398, DOI 10.1103/PhysRevB.59.11398; HARRIS AB, 1974, J PHYS C SOLID STATE, V7, P1671, DOI 10.1088/0022-3719/7/9/009; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Jaime M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.087203; Kawashima N, 2004, J PHYS SOC JPN, V73, P3219, DOI 10.1143/JPSJ.73.3219; Maltseva M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174415; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; Mila F, 1998, EUR PHYS J B, V6, P201, DOI 10.1007/s100510050542; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Nikuni T, 2000, PHYS REV LETT, V84, P5868, DOI 10.1103/PhysRevLett.84.5868; Nohadani O, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.220402; Rice TM, 2002, SCIENCE, V298, P760, DOI 10.1126/science.1078819; Ruegg C, 2003, NATURE, V423, P62, DOI 10.1038/nature01617; Sachdev S, 2000, SCIENCE, V288, P475, DOI 10.1126/science.288.5465.475; Sachdev S., 1999, QUANTUM PHASE TRANSI; Samulon EC, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.100407; Sasago Y, 1997, PHYS REV B, V55, P8357, DOI 10.1103/PhysRevB.55.8357; Sebastian SE, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.100404; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Sparta KM, 2004, ACTA CRYSTALLOGR B, V60, P491, DOI [10.1107/S0108768104011644, 10.1107/SO108768104011644]; Stockert O, 1998, PHYS REV LETT, V80, P5627, DOI 10.1103/PhysRevLett.80.5627; Tewari S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.060505; Vojta T, 2004, PHYS STATUS SOLIDI B, V241, P2118, DOI 10.1002/pssb.200404798; West, 1992, STUD CONSERV, V37, P145, DOI DOI 10.1179/SIC.1992.37.S1.031; Xu CK, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.064455	29	205	206	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					617	620		10.1038/nature04732	http://dx.doi.org/10.1038/nature04732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738655	Green Submitted			2022-12-28	WOS:000237920800043
J	Halkes, PHA; van Gijn, J; Kappelle, LJ; Koudstaal, PJ; Algra, A				Halkes, P. H. A.; van Gijn, J.; Kappelle, L. J.; Koudstaal, P. J.; Algra, A.		ESPRIT Study Grp	Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial	LANCET			English	Article							HIGH-RISK PATIENTS; SECONDARY PREVENTION; INTEROBSERVER AGREEMENT; STROKE PATIENTS; VESSEL DISEASE; CLOPIDOGREL; EVENTS; ATTACK; METAANALYSIS; INFARCTION	Background Results of trials of aspirin and dipyridamole combined versus aspirin alone for the secondary prevention of vascular events after ischaemic stroke of presumed arterial origin are inconsistent. Our aim was to resolve this uncertainty. Methods We did a randomised controlled trial in which we assigned patients to aspirin (30-325 mg daily) with (n=1363) or without (n=1376) dipyridamole (200 mg twice daily) within 6 months of a transient ischaemic attack or minor stroke of presumed arterial origin. Our primary outcome event was the composite of death from all vascular causes, non-fatal stroke, non-fatal myocardial infarction, or major bleeding complication, whichever happened first. Treatment was open, but auditing of outcome events was blinded. Primary analysis was by intention to treat. This study is registered as an International Standard Randomised Controlled Trial (number ISRCTN73824458) and with ClinicalTrials.gov (NCT00161070). Findings Mean follow-up was 3.5 years (SD 2.0). Median aspirin dose was 75 mg in both treatment groups (range 30-325); extended-release dipyridamole was used by 83% (n=1131) of patients on the combination regimen. Primary outcome events arose in 173 (13%) patients on aspirin and dipyridamole and in 216 (16%) on aspirin alone (hazard ratio 0.80, 95% CI 0.66-0.98; absolute risk reduction 1.0% per year, 95% CI 0.1-1.8). Addition of the ESPRIT data to the meta-analysis of previous trials resulted in an overall risk ratio for the composite of vascular death, stroke, or myocardial infarction of 0.82 (95% CI 0.74-0.91). Patients on aspirin and dipyridamole discontinued trial medication more often than those on aspirin alone (470 vs 184), mainly because of headache. Interpretation The ESPRIT results, combined with the results of previous trials, provide sufficient evidence to prefer the combination regimen of aspirin plus dipyridamole over aspirin alone as antithrombotic therapy after cerebral ischaemia of arterial origin.	Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Algra, A (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	A.Algra@umcutrecht.nl	Lindley, Richard/B-8148-2013; Chen, Christopher/E-7023-2013; van Gijn, Jan/A-9444-2008	Lindley, Richard/0000-0002-0104-5679; Chen, Christopher/0000-0002-1047-9225; 				Algra A, 1996, J NEUROL NEUROSUR PS, V60, P197, DOI 10.1136/jnnp.60.2.197; Algra A, 1999, J NEUROL NEUROSUR PS, V66, P557, DOI 10.1136/jnnp.66.5.557; ALGRA A, 1994, LANCET, V343, P1040, DOI 10.1016/S0140-6736(94)90161-9; Algra A, 1999, J NEUROL NEUROSUR PS, V66, P255, DOI 10.1136/jnnp.66.2.255; Ariesen MJ, 2006, STROKE, V37, P134, DOI 10.1161/01.STR.0000195045.40409.85; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; BOUSSER MG, 1983, STROKE, V14, P5, DOI 10.1161/01.STR.14.1.5; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; De Schryver ELLM, 2003, STROKE, V34, P2072, DOI 10.1161/01.STR.0000082381.23938.0E; De Schryver ELLM, 2001, CEREBROVASC DIS, V11, P286, DOI 10.1159/000047654; De Schryver ELLM, 2000, CEREBROVASC DIS, V10, P147, DOI 10.1159/000016044; Derendorf H, 2005, J CLIN PHARMACOL, V45, P845, DOI 10.1177/0091270005276738; DESCHRYVER ELL, 2005, J NEUROL NEUROS 0224; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Diener HC, 1997, J NEUROL SCI, V151, pS1, DOI 10.1016/S0022-510X(97)86566-5; FIELDS WS, 1985, STROKE, V16, P406; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GUIRAUDCHAUMEIL B, 1982, REV NEUROL, V138, P367; HALKES PHA, 2006, STROKE          0504; KAPPELLE LJ, 1995, J NEUROL NEUROSUR PS, V59, P127, DOI 10.1136/jnnp.59.2.127; KAYE J, 1990, TRIAL EVALUATE RELAT; Lindgren A, 2004, J NEUROL SCI, V223, P179, DOI 10.1016/j.jns.2004.05.011; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WARLOW C, 1992, LANCET, V339, P724, DOI 10.1016/0140-6736(92)90608-6	30	694	718	2	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2006	367	9523					1665	1673						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045LH	16714187				2022-12-28	WOS:000237743100030
J	Sholl, DS; Johnson, JK				Sholl, DS; Johnson, JK			Making high-flux membranes with carbon nanotubes	SCIENCE			English	Editorial Material							TRANSPORT; FLOW		Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sholl, DS (corresponding author), Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.	sholl@andrew.cmu.edu; karlj@pitt.edu	Johnson, Karl/E-9733-2013	Johnson, Karl/0000-0002-3608-8003				Chen HB, 2006, J MEMBRANE SCI, V269, P152, DOI 10.1016/j.memsci.2005.06.030; Freeman BD, 1999, MACROMOLECULES, V32, P375, DOI 10.1021/ma9814548; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Kalra A, 2003, P NATL ACAD SCI USA, V100, P10175, DOI 10.1073/pnas.1633354100; Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a; Merkel TC, 2002, SCIENCE, V296, P519, DOI 10.1126/science.1069580; Skoulidas AI, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2151173; Skoulidas AI, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.185901; Sokhan VP, 2002, J CHEM PHYS, V117, P8531, DOI 10.1063/1.1512643	10	181	198	1	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1003	1004		10.1126/science.1127261	http://dx.doi.org/10.1126/science.1127261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709770				2022-12-28	WOS:000237628800027
J	Huybers, P; Curry, W				Huybers, P; Curry, W			Links between annual, Milankovitch and continuum temperature variability	NATURE			English	Article							CLIMATE; SPECTRUM	Climate variability exists at all timescales - and climatic processes are intimately coupled, so that understanding variability at any one timescale requires some understanding of the whole. Records of the Earth's surface temperature illustrate this interdependence, having a continuum of variability following a power-law scaling(1-7). But although specific modes of interannual variability are relatively well understood(8,9), the general controls on continuum variability are uncertain and usually described as purely stochastic processes(10-13). Here we show that power-law relationships of surface temperature variability scale with annual and Milankovitch-period ( 23,000- and 41,000- year) cycles. The annual cycle corresponds to scaling at monthly to decadal periods, while millennial and longer periods are tied to the Milankovitch cycles. Thus the annual, Milankovitch and continuum temperature variability together represent the response to deterministic insolation forcing. The identification of a deterministic control on the continuum provides insight into the mechanisms governing interannual and longer-period climate variability.	Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Huybers, P (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	phuybers@whoi.edu	lionel, Scotto/K-8141-2012	Huybers, Peter/0000-0002-3734-8145				Ashkenazy Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018099; Blender R, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017666; Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Delworth TL, 2002, CLIM DYNAM, V19, P555, DOI 10.1007/s00382-002-0249-5; DeWitt DG, 1999, MON WEATHER REV, V127, P381, DOI 10.1175/1520-0493(1999)127<0381:TPDTAC>2.0.CO;2; Ditlevsen PD, 1996, NATURE, V379, P810, DOI 10.1038/379810a0; ELGAR S, 1989, J GEOPHYS RES-OCEANS, V94, P10993, DOI 10.1029/JC094iC08p10993; Fraedrich K, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.037301; Fraedrich K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108501; GARRETT C, 1979, ANNU REV FLUID MECH, V80, P291; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; Huybers P, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2002PA000857; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KOMINZ MA, 1979, SCIENCE, V204, P171, DOI 10.1126/science.204.4389.171; McCoy EJ, 1998, IEEE T SIGNAL PROCES, V46, P655, DOI 10.1109/78.661333; Pelletier JD, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003120; Pelletier JD, 1998, EARTH PLANET SC LETT, V158, P157, DOI 10.1016/S0012-821X(98)00051-X; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; PHILANDER GS, 1990, EL NINO LA NINA SO O; Raymo M.E., 1992, PALEOCEANOGRAPHY, V6, P205; SCHMITT F, 1995, GEOPHYS RES LETT, V22, P1689, DOI 10.1029/95GL01522; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; SHACKLETON NJ, 1990, CLIMATIC CHANGE, V16, P217, DOI 10.1007/BF00134658; Willson K, 2002, PHYSIOL MEAS, V23, P385, DOI 10.1088/0967-3334/23/2/314; Wunsch C, 2003, CLIM DYNAM, V20, P353, DOI 10.1007/s00382-002-0279-z; WUNSCH C, 1972, DEEP-SEA RES, V19, P577, DOI 10.1016/0011-7471(72)90041-1; WUNSCH C, 2003, GEO-MAR LETT, V23, P64, DOI DOI 10.1007/S00367-003-0125-2	30	210	218	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					329	332		10.1038/nature04745	http://dx.doi.org/10.1038/nature04745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710417	Green Submitted			2022-12-28	WOS:000237593200043
J	Nemazee, D; Gavin, A; Hoebe, K; Beutler, B				Nemazee, D; Gavin, A; Hoebe, K; Beutler, B			Toll-like receptors and antibody responses	NATURE			English	Letter									Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Nemazee, D (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nemazee@scripps.edu		Hoebe, Kasper/0000-0002-3626-8098	NIGMS NIH HHS [R01 GM044809] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044809] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267	3	74	79	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2006	441	7091					E4	E4		10.1038/nature04875	http://dx.doi.org/10.1038/nature04875			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710369	Bronze, Green Accepted			2022-12-28	WOS:000237593200036
J	Nussbaumer, AD; Fisher, CR; Bright, M				Nussbaumer, AD; Fisher, CR; Bright, M			Horizontal endosymbiont transmission in hydrothermal vent tubeworms	NATURE			English	Article							BACTERIAL ENDOSYMBIONTS; APOPTOSIS; POGONOPHORA; ANNELIDA; WORMS; GUT	Transmission of obligate bacterial symbionts between generations is vital for the survival of the host. Although the larvae of certain hydrothermal vent tubeworms (Vestimentifera, Siboglinidae) are symbiont-free and possess a transient digestive system, these structures are lost during development, resulting in adult animals that are nutritionally dependent on their bacterial symbionts. Thus, each generation of tubeworms must be newly colonized with its specific symbiont(1,2). Here we present a model for tubeworm symbiont acquisition and the development of the symbiont-housing organ, the trophosome. Our data indicate that the bacterial symbionts colonize the developing tube of the settled larvae and enter the host through the skin, a process that continues through the early juvenile stages during which the trophosome is established from mesodermal tissue. In later juvenile stages we observed massive apoptosis of host epidermis, muscles and undifferentiated mesodermal tissue, which was coincident with the cessation of the colonization process. Characterizing the symbiont transmission process in this finely tuned mutualistic symbiosis provides another model of symbiont acquisition and additional insights into underlying mechanisms common to both pathogenic infections and beneficial host - symbiont interactions.	Univ Vienna, Dept Marine Biol, A-1090 Vienna, Austria; Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA	University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bright, M (corresponding author), Univ Vienna, Dept Marine Biol, Althanstr 14, A-1090 Vienna, Austria.	monika.bright@univie.ac.at	Fisher, Charles/H-7912-2012; Nussbaumer, Andrea D/C-6080-2013; Bright, Monika/AAA-7015-2021; Bright, Monika/I-5542-2012	Bright, Monika/0000-0001-7066-1363; 				Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Bright M, 2003, INVERTEBR BIOL, V122, P347; CALLSENCENCIC P, 1995, SARSIA, V80, P73, DOI 10.1080/00364827.1995.10413582; Cary S. C., 1993, Molecular Marine Biology and Biotechnology, V2, P51; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Cordes EE, 2005, PLOS BIOL, V3, P497, DOI 10.1371/journal.pbio.0030077; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Di Meo CA, 2000, APPL ENVIRON MICROB, V66, P651, DOI 10.1128/AEM.66.2.651-658.2000; DUBILIER N, 1995, APPL ENVIRON MICROB, V61, P2346, DOI 10.1128/AEM.61.6.2346-2350.1995; Feldman RA, 1997, MOL MAR BIOL BIOTECH, V6, P268; Foster JS, 1998, DEV GENES EVOL, V208, P295, DOI 10.1007/s004270050185; Heimler W., 1988, Microfauna Marina, V4, P353; JONES ML, 1988, P BIOL SOC WASH, V101, P423; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; McFall-Ngai MJ, 2000, CURR OPIN MICROBIOL, V3, P603, DOI 10.1016/S1369-5274(00)00147-8; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Mullineaux LS, 2000, OECOLOGIA, V123, P275, DOI 10.1007/s004420051014; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Southward EC, 2005, HYDROBIOLOGIA, V535, P227, DOI 10.1007/s10750-004-4401-6; SOUTHWARD EC, 1988, J MAR BIOL ASSOC UK, V68, P465, DOI 10.1017/S0025315400043344; TRENCH RK, 1993, ENDOCYTOBIOSIS CELL, V9, P135; Twomey C, 2005, J CELL MOL MED, V9, P345, DOI 10.1111/j.1582-4934.2005.tb00360.x; VANRHIJN P, 1995, MICROBIOL REV, V59, P124, DOI 10.1128/MMBR.59.1.124-142.1995; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; Young CM, 1996, NATURE, V381, P514, DOI 10.1038/381514a0; Zychlinsky A, 1997, J CLIN INVEST, V100, P493, DOI 10.1172/JCI119557	30	176	188	0	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					345	348		10.1038/nature04793	http://dx.doi.org/10.1038/nature04793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710420				2022-12-28	WOS:000237593200047
J	Bouman, HA; Ulloa, O; Scanlan, DJ; Zwirglmaier, K; Li, WKW; Platt, T; Stuart, V; Barlow, R; Leth, O; Clementson, L; Lutz, V; Fukasawa, M; Watanabe, S; Sathyendranath, S				Bouman, HA; Ulloa, O; Scanlan, DJ; Zwirglmaier, K; Li, WKW; Platt, T; Stuart, V; Barlow, R; Leth, O; Clementson, L; Lutz, V; Fukasawa, M; Watanabe, S; Sathyendranath, S			Oceanographic basis of the global surface distribution of Prochlorococcus ecotypes	SCIENCE			English	Article							NORTH-ATLANTIC OCEAN; COMMUNITY STRUCTURE; CYANOBACTERIUM PROCHLOROCOCCUS; PHYTOPLANKTON; POPULATIONS; GENOME; FLUORESCENCE; SEQUENCE; GULF; SEA	By using data collected during a continuous circumnavigation of the Southern Hemisphere, we observed clear patterns in the population-genetic structure of Prochlorococcus, the most abundant photosynthetic organism on Earth, between and within the three Southern Subtropical Gyres. The same mechanisms that were previously invoked to account for the vertical distribution of ecotypes at local scales accounted for the global ( horizontal) patterns we observed. Basin-scale and seasonal variations in the structure and strength of vertical stratification provide a basis for understanding large-scale horizontal distribution in genetic and physiological traits of Prochlorococcus, and perhaps of marine microbial communities in general.	Univ Concepcion, Dept Oceanog, Lab Proc Oceanog & Clima, Concepcion, Chile; Univ Concepcion, Ctr Invest Oceanog Pacifico SurOriental, Dept Geofis, Concepcion, Chile; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; Marine & Coastal Management, ZA-8012 Cape Town, South Africa; CSIRO, Marine Res, Hobart, Tas 7001, Australia; Inst Nacl Invest & Desarrollo Pesquero, RA-7600 Mar Del Plata, Argentina; Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Universidad de Concepcion; Universidad de Concepcion; University of Warwick; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Fisheries Research & Development Institute (INIDEP); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Bouman, HA (corresponding author), Univ Concepcion, Dept Oceanog, Lab Proc Oceanog & Clima, Concepcion, Chile.	heather@profc.udec.cl	Zwirglmaier, Katrin/H-9799-2014; Ulloa, Osvaldo/E-1821-2011; Scanlan, David J/G-4080-2016; Clementson, Lesley A/M-6905-2013	Zwirglmaier, Katrin/0000-0001-8598-9572; Ulloa, Osvaldo/0000-0002-9501-5576; Scanlan, David J/0000-0003-3093-4245; Clementson, Lesley/0000-0003-4415-993X	Natural Environment Research Council [NE/C000536/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Babin M, 1996, DEEP-SEA RES PT I, V43, P1241, DOI 10.1016/0967-0637(96)00058-1; Bailey S, 2005, FEBS LETT, V579, P275, DOI 10.1016/j.febslet.2004.11.091; Bouman HA, 2003, MAR ECOL PROG SER, V258, P19, DOI 10.3354/meps258019; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Dusenberry JA, 1999, LIMNOL OCEANOGR, V44, P431, DOI 10.4319/lo.1999.44.2.0431; Ferris MJ, 1998, NATURE, V396, P226, DOI 10.1038/24297; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Fuller NJ, 2005, LIMNOL OCEANOGR, V50, P363, DOI 10.4319/lo.2005.50.1.0363; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; LI WKW, IN PRESS MARINE MACR; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; PALENIK B, 1994, APPL ENVIRON MICROB, V60, P3212, DOI 10.1128/AEM.60.9.3212-3219.1994; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Pommier T, 2005, AQUAT MICROB ECOL, V41, P79, DOI 10.3354/ame041079; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; UCHIDA H, 2005, WHP P6 13 14 REVISIT; Urbach E, 1998, LIMNOL OCEANOGR, V43, P1615, DOI 10.4319/lo.1998.43.7.1615; Veldhuis MJW, 2004, DEEP-SEA RES PT I, V51, P507, DOI 10.1016/j.dsr.2003.12.002; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Zinser ER, 2006, APPL ENVIRON MICROB, V72, P723, DOI 10.1128/AEM.72.1.723-732.2006	32	161	165	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					918	921		10.1126/science.1122692	http://dx.doi.org/10.1126/science.1122692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690867				2022-12-28	WOS:000237452900049
J	Field, J; Cronin, A; Bridge, C				Field, J; Cronin, A; Bridge, C			Future fitness and helping in social queues	NATURE			English	Article							EUSOCIAL HOVER WASPS; KIN SELECTION; REPRODUCTIVE SKEW; ANIMAL SOCIETIES; GENETIC-MARKERS; GROUP-SIZE; RELATEDNESS; VERTEBRATES; EVOLUTION; HELPERS	Helpers in primitively eusocial and cooperatively breeding animal societies forfeit their own reproduction to rear the offspring of a queen or breeding pair, but may eventually attain breeding status themselves. Kin selection(1) provides a widely accepted theoretical framework for understanding these societies, but differences in genetic relatedness do not explain a universal societal feature: the huge variation between individuals in helping effort(2-10). An alternative explanation for this variation lies in a fundamental trade-off faced by helpers: by working harder, they increase the indirect component of their fitness, but simultaneously decrease their own future survival and fecundity(2,4,8). Here, we show that individuals work less hard when they stand to lose more future fitness through working. We experimentally manipulated two components of future fitness in social queues of hover wasps (Stenogastrinae): a helper's chance of inheriting an egg-laying position, and the workforce available to rear her offspring should she inherit. After each manipulation, helpers increased or decreased their effort as appropriate to the change in expected future fitness that they experienced. Although helping provides significant indirect fitness benefits for hover wasps(11), our study shows that variation in the costs associated with helping is the major determinant of helping effort.	UCL, Dept Biol, London NW1 2HE, England	University of London; University College London	Field, J (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	jeremy.field@ucl.ac.uk						BRIDGE CAL, 2005, THESIS U COL LONDON; Cant MA, 2005, BEHAV ECOL, V16, P708, DOI 10.1093/beheco/ari051; Cant MA, 2001, P ROY SOC B-BIOL SCI, V268, P1959, DOI 10.1098/rspb.2001.1754; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Crawley MJ., 2002, STAT COMPUTING INTRO; Field J, 1999, ANIM BEHAV, V57, P633, DOI 10.1006/anbe.1999.0995; Field J, 1999, BEHAV ECOL SOCIOBIOL, V45, P378, DOI 10.1007/s002650050574; Field J, 2000, NATURE, V404, P869, DOI 10.1038/35009097; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Heinsohn R, 1999, TRENDS ECOL EVOL, V14, P53, DOI 10.1016/S0169-5347(98)01545-6; HEINSOHN R, 1994, P ROY SOC B-BIOL SCI, V256, P293, DOI 10.1098/rspb.1994.0083; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Keller L, 1997, TRENDS ECOL EVOL, V12, P99, DOI 10.1016/S0169-5347(96)10065-3; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, 10.1111/j.1558-5646.1989.tb04226.x]; Queller DC, 2000, NATURE, V405, P784, DOI 10.1038/35015552; Shreeves G, 2003, P ROY SOC B-BIOL SCI, V270, P1617, DOI 10.1098/rspb.2003.2409; Shreeves G, 2002, AM NAT, V159, P81, DOI 10.1086/324125; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; Sumner S, 2002, P ROY SOC B-BIOL SCI, V269, P179, DOI 10.1098/rspb.2001.1884; Sundstrom L, 1996, SCIENCE, V274, P993, DOI 10.1126/science.274.5289.993; *U TECHN, 2005, R PROJ STAT COMP; West-Eberhard M.J., 1981, P3	28	89	94	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2006	441	7090					214	217		10.1038/nature04560	http://dx.doi.org/10.1038/nature04560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688175				2022-12-28	WOS:000237418800045
J	Bethony, J; Brooker, S; Albonico, M; Geiger, SM; Loukas, A; Diemert, D; Hotez, PJ				Bethony, J; Brooker, S; Albonico, M; Geiger, SM; Loukas, A; Diemert, D; Hotez, PJ			Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm	LANCET			English	Review							INTESTINAL NEMATODE INFECTIONS; NECATOR-AMERICANUS; ANTHELMINTIC TREATMENT; SECRETED PROTEIN; GASTROINTESTINAL NEMATODES; ANCYLOSTOMA-DUODENALE; MEBENDAZOLE TREATMENT; PRESCHOOL-CHILDREN; PLATELET INHIBITOR; WORM CONTROL	The three main soil-transmitted helminth infections, ascariasis, trichuriasis, and hookworm, are common clinical disorders in man. The gastrointestinal tract of a child living in poverty in a less developed country is likely to be parasitised with at least one, and in many cases all three soil-transmitted helminths, with resultant impairments in physical, intellectual, and cognitive development. The benzimidazole anthelmintics, mebendazole and albendazole, are commonly used to remove these infections. The use of these drugs is not limited to treatment of symptomatic soil-transmitted helminth infections, but also for large-scale prevention of morbidity in children living in endemic areas. As a result of data showing improvements in child health and education after deworming, and the burden of disease attributed to soil-transmitted helminths, the worldwide community is awakening to the importance of these infections. Concerns about the sustainability of periodic deworming with benzimidazole anthelmintics and the emergence of resistance have prompted efforts to develop and test new control tools.	George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Fdn Ivo de Carnen, Turin, Italy; Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Albert B Sabin Vaccine Inst, Washington, DC USA	George Washington University; University of London; London School of Hygiene & Tropical Medicine; Fundacao Oswaldo Cruz; QIMR Berghofer Medical Research Institute	Hotez, PJ (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.	mtmpjh@gwumc.edu	Loukas, Alex/B-7355-2014; Geiger, Stefan M/E-6748-2016; Diemert, David/AAQ-3353-2020	Loukas, Alex/0000-0002-0896-8441; Diemert, David/0000-0002-2789-0512; ALBONICO, Marco/0000-0002-7805-2391; Geiger, Stefan/0000-0002-9741-2727; Hotez, Peter/0000-0001-8770-1042				Adams VJ, 2004, SAMJ S AFR MED J, V94, P972; Albonico M, 1998, INT J EPIDEMIOL, V27, P530, DOI 10.1093/ije/27.3.530; Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P343; Albonico M, 2002, T ROY SOC TROP MED H, V96, P685, DOI 10.1016/S0035-9203(02)90352-4; Albonico M, 2002, ANN TROP MED PARASIT, V96, P717, DOI 10.1179/000349802125001942; ANDERSON R M, 1991; ANDERSON RM, 1985, ADV PARASIT, V24, P1, DOI 10.1016/S0065-308X(08)60561-8; Asojo OA, 2005, J MOL BIOL, V346, P801, DOI 10.1016/j.jmb.2004.12.023; ATUKORALA TMS, 1994, AM J CLIN NUTR, V60, P286, DOI 10.1093/ajcn/60.2.286; Awasthi S, 2000, Indian Pediatr, V37, P19; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Bethony J, 2005, FASEB J, V19, P1743, DOI 10.1096/fj.05-3936fje; Bethony J, 2002, CLIN INFECT DIS, V35, P1336, DOI 10.1086/344268; Blackwell V, 2001, BRIT J DERMATOL, V145, P434, DOI 10.1046/j.1365-2133.2001.04406.x; Bleakley H, 2003, J EUR ECON ASSOC, V1, P376, DOI 10.1162/154247603322391017; Bradley JE, 2004, PARASITE IMMUNOL, V26, P429, DOI 10.1111/j.0141-9838.2004.00730.x; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Bundy D. A. P., 1989, Advances in Parasitology, V28, P107, DOI 10.1016/S0065-308X(08)60332-2; Bundy D. A. P., 2002, BIOL NEMATODES, P599; BUNDY DA, IN PRESS DIS CONTROL; Bundy DAP, 2004, GLOBAL EPIDEMIOLOGY, P243; CAPPELLO M, 1995, P NATL ACAD SCI USA, V92, P6152, DOI 10.1073/pnas.92.13.6152; Chadderdon RC, 1999, J INFECT DIS, V179, P1235, DOI 10.1086/314724; CHAN L, 1994, T ROY SOC TROP MED H, V88, P46, DOI 10.1016/0035-9203(94)90492-8; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; CHAN MS, 1994, PARASITOLOGY, V109, P373, DOI 10.1017/S0031182000078410; Chan PWK, 2001, PEDIATR INT, V43, P350, DOI 10.1046/j.1442-200X.2001.01421.x; Christian P, 2004, LANCET, V364, P981, DOI 10.1016/S0140-6736(04)17023-2; Crompton DWT, 2001, ADV PARASIT, V48, P285, DOI 10.1016/S0065-308X(01)48008-0; CROMPTON DWT, 1990, HOOKWORM DISEASE : CURRENT STATUS AND NEW DIRECTIONS, P231; Culley FJ, 2000, J IMMUNOL, V165, P6447, DOI 10.4049/jimmunol.165.11.6447; Dayan AD, 2003, ACTA TROP, V86, P141, DOI 10.1016/S0001-706X(03)00031-7; de Silva NR, 1999, LANCET, V353, P1145, DOI 10.1016/S0140-6736(98)06308-9; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Deehan MR, 2002, PARASITE IMMUNOL, V24, P463, DOI 10.1046/j.1365-3024.2002.00489.x; Del Valle A, 2003, MOL BIOCHEM PARASIT, V129, P167, DOI 10.1016/S0166-6851(03)00121-X; Delaney A, 2005, INT J PARASITOL, V35, P303, DOI 10.1016/j.ijpara.2004.11.014; Despommier D.D., 2005, PARASITIC DIS; Don TA, 2004, INT J PARASITOL, V34, P1029, DOI 10.1016/j.ijpara.2004.04.013; DRAKE L, 1994, P ROY SOC B-BIOL SCI, V257, P255, DOI 10.1098/rspb.1994.0123; DUNN A, 1986, J HELMINTHOL, V60, P260, DOI 10.1017/S0022149X00008464; ELKINS DB, 1988, PARASITOLOGY, V96, P171, DOI 10.1017/S0031182000081749; Faust EC, 1964, CRAIG FAUSTS CLIN PA; Fincham JE, 2003, ACTA TROP, V86, P315, DOI 10.1016/S0001-706X(03)00063-9; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; FORRESTER JE, 1988, T ROY SOC TROP MED H, V82, P282, DOI 10.1016/0035-9203(88)90448-8; Fujiwara RT, 2006, VACCINE, V24, P501, DOI 10.1016/j.vaccine.2005.07.091; Galvani AP, 2005, J PARASITOL, V91, P24, DOI 10.1645/GE-191R1; Geerts S, 1997, PARASITOL TODAY, V13, P149, DOI 10.1016/S0169-4758(97)01024-7; Geiger SM, 2002, PARASITE IMMUNOL, V24, P499, DOI 10.1046/j.1365-3024.2002.00600.x; GELPI AP, 1968, AM J MED, V44, P377, DOI 10.1016/0002-9343(68)90109-5; Gilles HM, 2002, TRENDS PARASITOL, V18, P95, DOI 10.1016/S1471-4922(01)02205-X; Goodridge HS, 2005, IMMUNOLOGY, V115, P296, DOI 10.1111/j.1365-2567.2005.02167.x; Goud GN, 2005, VACCINE, V23, P4754, DOI 10.1016/j.vaccine.2005.04.040; Goud GN, 2004, J INFECT DIS, V189, P919, DOI 10.1086/381901; Hawdon JM, 1999, MOL BIOCHEM PARASIT, V99, P149, DOI 10.1016/S0166-6851(99)00011-0; Hawdon JM, 1996, CURR OPIN GENET DEV, V6, P618, DOI 10.1016/S0959-437X(96)80092-X; Horton J, 2003, TRENDS PARASITOL, V19, P405, DOI 10.1016/S1471-4922(03)00171-5; Hotez PJ, 2005, PLOS MED, V2, P187, DOI 10.1371/journal.pmed.0020067; Hotez PJ, 2002, J PARASITOL, V88, P684, DOI 10.1645/0022-3395(2002)088[0684:EOVWRF]2.0.CO;2; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; HOTEZ PJ, 2006, TROPICAL INFECT DIS, P1265; Hsieh GCF, 2004, J IMMUNOL, V173, P2699, DOI 10.4049/jimmunol.173.4.2699; Jackson JA, 2004, INT J PARASITOL, V34, P1237, DOI 10.1016/j.ijpara.2004.07.009; Jackson JA, 2004, J INFECT DIS, V190, P1804, DOI 10.1086/425014; Jiang N, 1998, BRAIN RES, V788, P25, DOI 10.1016/S0006-8993(97)01503-5; Kaplan KJ, 2001, AM J SURG PATHOL, V25, P1316, DOI 10.1097/00000478-200110000-00014; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; KHUROO MS, 1990, LANCET, V335, P1503, DOI 10.1016/0140-6736(90)93037-P; Khuroo MS, 1996, GASTROENTEROL CLIN N, V25, P553, DOI 10.1016/S0889-8553(05)70263-6; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Koumanidou C, 2004, ANN TROP PAEDIATR, V24, P329, DOI 10.1179/027249304225019154; LACEY E, 1990, PARASITOL TODAY, V6, P112, DOI 10.1016/0169-4758(90)90227-U; Le Hesran JY, 2004, T ROY SOC TROP MED H, V98, P397, DOI 10.1016/j.trstmh.2003.10.009; Ledizet Michel, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P1, DOI 10.2174/1568016052773315; Lochnit G, 2000, BIOL CHEM, V381, P839, DOI 10.1515/BC.2000.106; Loukas A, 2005, PLOS MED, V2, P1008, DOI 10.1371/journal.pmed.0020295; Loukas A, 2004, J INFECT DIS, V189, P1952, DOI 10.1086/386346; LWAMBO NJS, 1992, EPIDEMIOL INFECT, V108, P469, DOI 10.1017/S0950268800049980; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2004, J INFECT DIS, V190, P427, DOI 10.1086/422262; Maizels RM, 1999, IMMUNOL REV, V171, P125, DOI 10.1111/j.1600-065X.1999.tb01345.x; MAXWELL C, 1987, AM J TROP MED HYG, V37, P126, DOI 10.4269/ajtmh.1987.37.126; Mendez S, 2005, INFECT IMMUN, V73, P3402, DOI 10.1128/IAI.73.6.3402-3407.2005; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Montresor A, 2003, ACTA TROP, V86, P223, DOI 10.1016/S0001-706X(03)00042-1; Montresor A, 2002, T ROY SOC TROP MED H, V96, P197, DOI 10.1016/S0035-9203(02)90303-2; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MOYLE M, 1994, J BIOL CHEM, V269, P10008; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Navitsky RC, 1998, J PARASITOL, V84, P647, DOI 10.2307/3284746; Ng KKS, 2000, NAT STRUCT BIOL, V7, P653, DOI 10.1038/77950; NUTMAN TB, 1987, J INFECT DIS, V155, P309, DOI 10.1093/infdis/155.2.309; Parthasarathy G, 2005, VET PARASITOL, V131, P317, DOI 10.1016/j.vetpar.2005.03.043; Quinnell RJ, 2004, J INFECT DIS, V190, P430, DOI 10.1086/422256; QUINNELL RJ, 1993, PARASITOLOGY, V106, P379, DOI 10.1017/S0031182000067123; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Santos FLN, 2005, REV SOC BRAS MED TRO, V38, P196, DOI 10.1590/S0037-86822005000200016; Savioli L, 2002, T ROY SOC TROP MED H, V96, P577, DOI 10.1016/S0035-9203(02)90316-0; Savioli L, 2003, AM J OBSTET GYNECOL, V188, P5, DOI 10.1067/mob.2003.78; Savioli L, 1997, PARASITOL TODAY, V13, P156, DOI 10.1016/S0169-4758(97)89813-4; Sharghi N, 2001, CLIN INFECT DIS, V32, pE111, DOI 10.1086/319593; Shin JL, 2004, CAN J GASTROENTEROL, V18, P175, DOI 10.1155/2004/298064; Stanssens P, 1996, P NATL ACAD SCI USA, V93, P2149, DOI 10.1073/pnas.93.5.2149; STEPHENSON LS, 1989, AM J TROP MED HYG, V41, P78, DOI 10.4269/ajtmh.1989.41.78; STEPHENSON LS, 1993, J NUTR, V123, P1036; Stoltzfus RJ, 1997, NUTR REV, V55, P223, DOI 10.1111/j.1753-4887.1997.tb01609.x; Stoltzfus RJ, 2001, BRIT MED J, V323, P1389, DOI 10.1136/bmj.323.7326.1389; Stoltzfus RJ, 2000, J NUTR, V130, P1724, DOI 10.1093/jn/130.7.1724; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Tan THP, 2001, BIOCHEM J, V357, P373, DOI 10.1042/0264-6021:3570373; TAREN DL, 1987, PARASITOLOGY, V95, P603, DOI 10.1017/S0031182000058029; Torlesse H, 2001, T ROY SOC TROP MED H, V95, P195, DOI 10.1016/S0035-9203(01)90164-6; Turner JD, 2003, J INFECT DIS, V188, P1768, DOI 10.1086/379370; van Balkom BWM, 2005, J PROTEOME RES, V4, P958, DOI 10.1021/pr050036w; Viliamizar E, 1996, J PEDIATR SURG, V31, P201, DOI 10.1016/S0022-3468(96)90348-6; *WHO, 2002, WORLD HLTH REP 2002, P186; WHO, 2005, 3 GLOB M PARTN PAR C; WHO, 2002, REP WHO INF CONS US; Williamson AL, 2004, J BIOL CHEM, V279, P35950, DOI 10.1074/jbc.M405842200; WORLD HEALTH ORGANIZATION (WHO), 1996, REP WHO INF CONS HOO; Xiao SH, 2005, ACTA TROP, V94, P1, DOI 10.1016/j.actatropica.2005.01.013; Yatsuda AP, 2003, J BIOL CHEM, V278, P16941, DOI 10.1074/jbc.M212453200; Yazdanbakhsh M, 2001, TRENDS IMMUNOL, V22, P372, DOI 10.1016/S1471-4906(01)01958-5; 2004, MED LETT DRUGS T AUG	130	1407	1479	4	298	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1521	1532		10.1016/S0140-6736(06)68653-4	http://dx.doi.org/10.1016/S0140-6736(06)68653-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679166				2022-12-28	WOS:000237324200033
J	Ho, PM; Rumsfeld, JS				Ho, PM; Rumsfeld, JS			Cardiac risk management in severe mental illness	LANCET			English	Editorial Material							DISEASE; SCHIZOPHRENIA		Univ Colorado, Hlth Sci Ctr, Denver Vet Affairs Med Ctr, Cardiol Sect, Denver, CO 80220 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Ho, PM (corresponding author), Univ Colorado, Hlth Sci Ctr, Denver Vet Affairs Med Ctr, Cardiol Sect, 4200 E 9th Ave, Denver, CO 80220 USA.	Michael.ho@uchsc.edu						Baptista T, 2002, PHARMACOPSYCHIATRY, V35, P205, DOI 10.1055/s-2002-36391; De Luca V, 2004, NEUROPSYCHOPHARMACOL, V29, P1522, DOI 10.1038/sj.npp.1300466; Goff DC, 2005, J CLIN PSYCHIAT, V66, P183, DOI 10.4088/JCP.v66n0205; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Marder SR, 2003, J CLIN PSYCHIAT, V64, P3; Osborn DPJ, 2006, BRIT J PSYCHIAT, V188, P271, DOI 10.1192/bjp.bp.104.008060; Rumsfeld JS, 2004, EUR HEART J, V25, P1565, DOI 10.1016/j.ehj.2004.08.004; Whellan DJ, 2005, AM HEART J, V149, P722, DOI 10.1016/j.ahj.2004.09.023	8	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1469	1471		10.1016/S0140-6736(06)68628-5	http://dx.doi.org/10.1016/S0140-6736(06)68628-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	039RJ	16679146				2022-12-28	WOS:000237324200009
J	Stanton, C; Lawn, JE; Rahman, H; Wilczynska-Ketende, K; Hill, K				Stanton, C; Lawn, JE; Rahman, H; Wilczynska-Ketende, K; Hill, K			Stillbirth rates: delivering estimates in 190 countries	LANCET			English	Article							NEONATAL DEATHS; HEALTH-STATISTICS; MORTALITY RATES; EUROPE; INFORMATION; INDICATORS; ACCURACY; CHILDREN; IMPACT; TIME	Background While information about 4 million neonatal deaths worldwide is limited, even less information is available for stillbirths (babies born dead in the last 12 weeks of pregnancy) and there are no published, systematic global estimates. We sought to identify available data and use these to estimate the rates and numbers of stillbirths for 190 countries for the year 2000, and provide uncertainty estimates. Methods We assessed three sources of stillbirth data according to specified inclusion criteria: vital registration; demographic and health surveys (DHS), based on a new analysis of contraceptive calendar data; and study reports that include published studies identified through systematic literature searches of more than 30000 abstracts and unpublished studies. A random effects regression model was developed to predict national stillbirth rates and associated uncertainty intervals. Findings Data from 44 countries with vital registration (71442 stillbirths), 30 DHS surveys from 16 countries (2989 stillbirths), and 249 study populations from 103 countries (93 023 stillbirths) met the inclusion criteria. Model-based estimates were used for 128 countries. For 62 countries, the observed values were adjusted by a correction factor derived from the model. The resultant stillbirth rates ranged from five per 1000 in rich countries to 32 per 1000 in south Asia and sub-Saharan Africa. The estimated number of global stillbirths is 3.2 million (uncertainty range 2.5-4.1 million). In light of the data limitations and the conservative approach taken, the real number might be higher than this. Interpretation The numbers of stillbirths are high and there is a dearth of usable data in countries and regions in which most stillbirths occur, with under-reporting being a major challenge. Although our estimates are probably underestimates, they represent a rigorous attempt to measure the numbers of babies dying during the last trimester of pregnancy. improving stillbirth data is the first step towards making stillbirths count in public-health action.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Save Children US, Saving Newborn Lives, Cape Town, South Africa; Inst Child Hlth, Int Perinatal Care Unit, London, England; Johns Hopkins Sch Med, Baltimore, MD USA; UNICEF UK, Interagcy Grp Breastfeeding Monitoring, London, England; Harvard Univ, Inst Global Hlth, Cambridge, MA 02138 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Save the Children; University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine; Harvard University	Lawn, JE (corresponding author), 11 South Way, ZA-7405 Cape Town, South Africa.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443				AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; Anthony S, 2001, PAEDIATR PERINAT EP, V15, P306, DOI 10.1046/j.1365-3016.2001.00355.x; BARSON AJ, 1984, ARCH DIS CHILD, V59, P199, DOI 10.1136/adc.59.3.199; Bchir A, 2006, LANCET, V367, P190, DOI 10.1016/S0140-6736(06)68011-2; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; Campbell Oona, 2004, J Perinatol, V24, P284, DOI 10.1038/sj.jp.7211084; CASTERLINE JB, 1989, STUD FAMILY PLANN, V20, P81, DOI 10.2307/1966462; Chen LM, 1998, J EPIDEMIOL COMMUN H, V52, P289, DOI 10.1136/jech.52.5.289; DAVID RJ, 1983, PEDIATRICS, V71, P531; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; GOURBIN C, 1995, B WORLD HEALTH ORGAN, V73, P449; Harper A, 1996, WHO, V12, P1; Horton R, 2005, LANCET, V366, P179, DOI 10.1016/S0140-6736(05)66883-3; Jamison DT, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P427; Kramer MS, 2002, AM J EPIDEMIOL, V156, P493, DOI 10.1093/aje/kwf077; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn J, 2001, HLTH NEWBORN REFER 2; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LAWN JE, 2006, INT J EPIDEMIOL; LEON IG, 1986, PSYCHIATRY, V49, P312, DOI 10.1080/00332747.1986.11024331; LUMBIGANON P, 1990, INT J EPIDEMIOL, V19, P997, DOI 10.1093/ije/19.4.997; Macfarlane A, 2003, EUR J OBSTET GYN R B, V111, pS15, DOI 10.1016/j.ejogrb.2003.09.003; MASUYSTROOBANT G, 1995, EUR J POPUL, V11, P63, DOI 10.1007/BF01264105; *MAT CHILD HLTH RE, 2000, CONF ENQ STILLB DEAT; *MAT CHILD HLTH RE, 1999, CONF ENQ STILLB DEAT; *ORC MACR, 2001, 1 ORC MACR; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Saving Newborn Lives, 2001, SAV NEWB LIV STAT WO, P1; Schaap AHP, 1997, EUR J OBSTET GYN R B, V75, P161, DOI 10.1016/S0301-2115(97)00127-9; Shibuya K, 2005, B WORLD HEALTH ORGAN, V83, P722; *UN POP DIV, 2004, WORLD POP PROSP 2002; *WHO, COV VIT REG DEATHS H; WHO, 2005, MAK EV MOTH CHILD CO; World Health Organization, 1993, ICD 10 CLASS MENT BE, P1, DOI DOI 10.4103/0019; 2005, LANCET, V365, P1983	36	317	322	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1487	1494		10.1016/S0140-6736(06)68586-3	http://dx.doi.org/10.1016/S0140-6736(06)68586-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679161				2022-12-28	WOS:000237324200028
J	Wang, ZL; Song, JH				Wang, ZL; Song, JH			Piezoelectric nanogenerators based on zinc oxide nanowire arrays	SCIENCE			English	Article							SINGLE-CRYSTAL NANORINGS; NANOBELTS; EMISSION; GAN	We have converted nanoscale mechanical energy into electrical energy by means of piezoelectric zinc oxide nanowire ( NW) arrays. The aligned NWs are deflected with a conductive atomic force microscope tip in contact mode. The coupling of piezoelectric and semiconducting properties in zinc oxide creates a strain field and charge separation across the NW as a result of its bending. The rectifying characteristic of the Schottky barrier formed between the metal tip and the NW leads to electrical current generation. The efficiency of the NW-based piezoelectric power generator is estimated to be 17 to 30%. This approach has the potential of converting mechanical, vibrational, and/or hydraulic energy into electricity for powering nanodevices.	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China; Natl Ctr Nanosci & Technol, Beijing 100080, Peoples R China	University System of Georgia; Georgia Institute of Technology; Peking University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	zhong.wang@mse.gatech.edu	Song, Jinhui/C-7524-2013; wang, jie/GRS-0942-2022; Dee, Chang Fu/G-4842-2010; Wang, Zhong Lin/E-2176-2011	Song, Jinhui/0000-0002-0042-2014; Dee, Chang Fu/0000-0003-1015-9181; Wang, Zhong Lin/0000-0002-5530-0380				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Duan XF, 2003, NATURE, V421, P241, DOI 10.1038/nature01353; Gao PX, 2005, SCIENCE, V309, P1700, DOI 10.1126/science.1116495; Hasegawa S, 2005, J CERAM PROCESS RES, V6, P245; He JH, 2005, J AM CHEM SOC, V127, P16376, DOI 10.1021/ja0559193; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Hughes WL, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1853514; Hughes WL, 2004, J AM CHEM SOC, V126, P6703, DOI 10.1021/ja049266m; Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356; Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Park WI, 2003, APPL PHYS LETT, V82, P4358, DOI 10.1063/1.1584089; PIERRET RF, 1996, SEMICONDUCTOR DEVICE, pCH14; Song JH, 2005, NANO LETT, V5, P1954, DOI 10.1021/nl051334v; Wang XD, 2005, J AM CHEM SOC, V127, P7920, DOI 10.1021/ja050807x; Wang XD, 2004, NANO LETT, V4, P423, DOI 10.1021/nl035102c; Wang ZL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.185502; Zhao MH, 2004, NANO LETT, V4, P587, DOI 10.1021/nl035198a; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138; ZHOU J, 2001, ADV MATER, V13, P113	22	5956	6150	284	4029	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					242	246		10.1126/science.1124005	http://dx.doi.org/10.1126/science.1124005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614215				2022-12-28	WOS:000236765300041
